"id","drug_id","traget_id","drug_target_references"
1,"DB01136","BE0000715","# Koshimizu TA, Tsujimoto G, Hirasawa A, Kitagawa Y, Tanoue A: Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res. 2004 Sep 1;63(4):662-72. \"Pubmed\":http://ww"
2,"DB02379","BE0003072",""
3,"DB00453","BE0000127","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4,"DB01864","BE0004242","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5,"DB07332","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6,"DB05066","BE0000704",""
7,"DB00336","BE0000056","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8,"DB08062","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9,"DB00129","BE0002234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
10,"DB01805","BE0001377","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
11,"DB07516","BE0003969","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
12,"DB02663","BE0001881","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
13,"DB00398","BE0000147","# Auclair D, Miller D, Yatsula V, Pickett W, Carter C, Chang Y, Zhang X, Wilkie D, Burd A, Shi H, Rocks S, Gedrich R, Abriola L, Vasavada H, Lynch M, Dumas J, Trail PA, Wilhelm SM: Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia. 2"
14,"DB00609","BE0000466","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
15,"DB00142","BE0000517","# Smirnov SV, Samsonova NN, Novikova AE, Matrosov NG, Rushkevich NY, Kodera T, Ogawa J, Yamanaka H, Shimizu S: A novel strategy for enzymatic synthesis of 4-hydroxyisoleucine: identification of an enzyme possessing HMKP (4-hydroxy-3-methyl-2-keto-pentanoa"
16,"DB00988","BE0000291","# Weber JT, Hayataka K, O'Connor MF, Parker KK: Rabbit cerebral cortex 5HT1a receptors. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1997 May;117(1):19-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9185324# Toll L, Berzetei-Gurske IP, Polgar WE,"
17,"DB05217","BE0002413",""
18,"DB08646","BE0004355","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
19,"DB05458","BE0000850",""
20,"DB00992","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
21,"DB00590","BE0000715","# Lepor H: Alpha blockers for the treatment of benign prostatic hyperplasia. Rev Urol. 2007 Fall;9(4):181-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18231614# Greco KA, McVary KT: The role of combination medical therapy in benign prostatic hyperplasi"
22,"DB08349","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
23,"DB04906","BE0000358",""
24,"DB08139","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
25,"DB00683","BE0003592","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
26,"DB03147","BE0001409","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
27,"DB05481","BE0000952",""
28,"DB06148","BE0000632","# Olianas MC, Dedoni S, Onali P: The atypical antidepressant mianserin exhibits agonist activity at kappa-opioid receptors. Br J Pharmacol. 2012 Nov;167(6):1329-41. doi: 10.1111/j.1476-5381.2012.02078.x. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2270868"
29,"DB03063","BE0001694","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
30,"DB08814","BE0001086","# Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M: Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2005 Jan;25(1):30-40. \"Pubmed\":http://www.ncbi.nlm.nih.go"
31,"DB00436","BE0000535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
32,"DB04523","BE0003417","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
33,"DB05451","BE0001086",""
34,"DB08248","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
35,"DB05266","BE0000436","# Yamazaki T, Anraku T, Matsuzawa S: Ibudilast, a mixed PDE3/4 inhibitor, causes a selective and nitric oxide/cGMP-independent relaxation of the intracranial vertebrobasilar artery. Eur J Pharmacol. 2010 Oct 29. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
36,"DB08144","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
37,"DB00073","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
38,"DB03796","BE0004538","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
39,"DB03147","BE0002881",""
40,"DB02183","BE0001473","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
41,"DB02019","BE0002498","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
42,"DB02854","BE0000886","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
43,"DB03182","BE0004459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
44,"DB01763","BE0000008","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
45,"DB01279","BE0000856","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# White JT, Argento Martell L, Prince WS, Boyer R, Crockett L, "
46,"DB03010","BE0001408","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
47,"DB08178","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
48,"DB01159","BE0000503","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
49,"DB07127","BE0003769","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
50,"DB05147","BE0001408",""
51,"DB00214","BE0000502","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Vormfelde SV, Sehrt D, Toliat MR, Schirmer M, Meineke I, Tzvetkov M, Nurnberg P, Brockmoller J: Ge"
52,"DB02661","BE0003094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
53,"DB00116","BE0000617","# Akar N, Akar E, Ozel D, Deda G, Sipahi T: Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res. 2001 Apr 15;102(2):115-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11323021# Walkup AS, Appling DR: Enzymatic charact"
54,"DB02824","BE0000331","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
55,"DB00747","BE0001176","# Minai-Tehrani D, Fooladi N, Minoui S, Sobhani-Damavandifar Z, Aavani T, Heydarzadeh S, Attar F, Ghaffari M, Nazem H: Structural changes and inhibition of sucrase after binding of scopolamine. Eur J Pharmacol. 2010 Jun 10;635(1-3):23-6. Epub 2010 Mar 15."
56,"DB00142","BE0002277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
57,"DB03203","BE0004247","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
58,"DB02774","BE0001234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
59,"DB00022","BE0000661","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
60,"DB07632","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
61,"DB00074","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
62,"DB00105","BE0000385","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
63,"DB01354","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
64,"DB04953","BE0002400","# Hirano K, Kuratani K, Fujiyoshi M, Tashiro N, Hayashi E, Kinoshita M: Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice. Neurosci Lett. 2007 Feb 14;413(2):159-62. Epub 2006 Dec 20. \"P"
65,"DB02071","BE0000966","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
66,"DB07458","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
67,"DB04315","BE0004618","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
68,"DB04326","BE0003844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
69,"DB02348","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
70,"DB01580","BE0000172","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
71,"DB01595","BE0003619","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
72,"DB01836","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
73,"DB01353","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
74,"DB03115","BE0000870","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
75,"DB03461","BE0000604","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
76,"DB07704","BE0001405","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
77,"DB01549","BE0000756","# Seeman P, Guan HC, Hirbec H: Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse. 2009 Aug;63(8):698-704. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19391150"
78,"DB03190","BE0001868","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
79,"DB01215","BE0003592","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
80,"DB08656","BE0003801","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
81,"DB08342","BE0004276","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
82,"DB07552","BE0003851","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
83,"DB03315","BE0001634","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
84,"DB07223","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
85,"DB01106","BE0000464","# Richard F, Barroso S, Martinez J, Labbe-Jullie C, Kitabgi P: Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol Pharmacol. 2001 Dec;60(6):1392-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11"
86,"DB03948","BE0000761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
87,"DB02950","BE0001082","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
88,"DB08011","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
89,"DB01692","BE0001260","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
90,"DB04147","BE0001863","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
91,"DB04464","BE0003817","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
92,"DB00568","BE0002355","# Singh BN: The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol. 1986;21 Suppl 2:109S-121S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3530295# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca c"
93,"DB08710","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
94,"DB02153","BE0001464","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
95,"DB00814","BE0000262","# Poulsen Nautrup B, Horstermann D: [Pharmacodynamic and pharmacokinetic aspects of the non-inflammatory non-steroidal agent meloxicam in dogs] Dtsch Tierarztl Wochenschr. 1999 Mar;106(3):94-100. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10220944# Teged"
96,"DB04522","BE0003007",""
97,"DB03187","BE0002302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
98,"DB03151","BE0002993",""
99,"DB02930","BE0001580","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
100,"DB01025","BE0000125","# Urisu A, Iimi K, Kondo Y, Horiba F, Masuda S, Tsuruta M, Yazaki T, Torii S: [Inhibitory action amlexanox on interleukin-3-induced enhancement of histamine releasability of human leukocytes] Arerugi. 1990 Oct;39(10):1448-54. \"Pubmed\":http://www.ncbi.nlm."
101,"DB08348","BE0001869","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
102,"DB07930","BE0004135","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
103,"DB03434","BE0001547","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
104,"DB02927","BE0001271","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
105,"DB05245","BE0004796","# McDonnell G, Russell AD: Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999 Jan;12(1):147-79. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9880479"
106,"DB00805","BE0000020","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
107,"DB04190","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
108,"DB00228","BE0000640","# Dildy-Mayfield JE, Eger EI 2nd, Harris RA: Anesthetics produce subunit-selective actions on glutamate receptors. J Pharmacol Exp Ther. 1996 Mar;276(3):1058-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8786535"
109,"DB00674","BE0003584","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
110,"DB00142","BE0000219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
111,"DB00617","BE0000012","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
112,"DB04214","BE0003787","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
113,"DB07276","BE0003790","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
114,"DB00615","BE0001120","# Schnaider T, Somogyi J, Csermely P, Szamel M: The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation. Cell Stress Chaperones. 2000 Jan;5(1):52-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
115,"DB03650","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
116,"DB00642","BE0000882","# Schultz RM, Dempsey JA: Sequence dependence of Alimta (LY231514, MTA) combined with doxorubicin in ZR-75-1 human breast carcinoma cells. Anticancer Res. 2001 Sep-Oct;21(5):3209-14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11848474# Hanauske AR, Chen "
117,"DB02210","BE0001514","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
118,"DB04725","BE0003768","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
119,"DB00543","BE0000291","# Gozlan H, Saddiki-Traki F, Merahi N, Laguzzi R, Hamon M: [Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats]. Encephale. 1991 Dec;17 Spec No 3:415-22. \"Pubmed\":"
120,"DB00127","BE0000566","# Binda C, Angelini R, Federico R, Ascenzi P, Mattevi A: Structural bases for inhibitor binding and catalysis in polyamine oxidase. Biochemistry. 2001 Mar 6;40(9):2766-76. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11258887# Vujcic S, Diegelman P, Bacchi"
121,"DB01032","BE0003719","# Silverman W, Locovei S, Dahl G: Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol. 2008 Sep;295(3):C761-7. Epub 2008 Jul 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18596212# Ransford GA, Fregien N, Qiu F, Dahl G, Con"
122,"DB01963","BE0003531","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
123,"DB03970","BE0004388","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
124,"DB00312","BE0000523","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
125,"DB03449","BE0000067","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
126,"DB00794","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
127,"DB00747","BE0000045","# Reitz AB, Gupta SK, Huang Y, Parker MH, Ryan RR: The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers. Med Chem. 2007 Nov;3(6):543-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18045203"
128,"DB08458","BE0001553","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
129,"DB03097","BE0001344","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
130,"DB05224","BE0002381","# Ochsner UA, Young CL, Stone KC, Dean FB, Janjic N, Critchley IA: Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase. Antimicrob Agents Chemother. 2005 Oct;49(10):4253-62. \"Pubmed\":http://www.ncbi.n"
131,"DB00605","BE0003561","# Hata AN, Lybrand TP, Marnett LJ, Breyer RM: Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. Mol Pharmacol. 2005 Mar;67(3):640-7. Epub 2004 Nov 2"
132,"DB00280","BE0000092","# Yamamoto N, Ozaki T, Keida Y, Ohtsuka M, Goto T: A comparison of the binding characteristics of class I antiarrhythmic agents for human muscarinic m1-m3 receptors. J Cardiovasc Pharmacol. 1999 Jul;34(1):53-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
133,"DB07978","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
134,"DB02379","BE0002830",""
135,"DB08043","BE0000014","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
136,"DB01064","BE0003429","# Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P, Manganiello VC: Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation. Proc Natl Acad Sci U S A. 1990 Jan;87(2):533-7."
137,"DB01718","BE0002512","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
138,"DB00306","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802 (Accessed December 2013)"
139,"DB01942","BE0000689","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
140,"DB04464","BE0003317","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
141,"DB00114","BE0002168","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
142,"DB04039","BE0004169","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
143,"DB04315","BE0001380","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
144,"DB03803","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
145,"DB07537","BE0000369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
146,"DB01223","BE0000436","# Hirota K, Yoshioka H, Kabara S, Koizumi Y, Abe H, Sato T, Matsuki A: Spasmolytic effects of colforsin daropate on serotonin-induced pulmonary hypertension and bronchoconstriction in dogs. Acta Anaesthesiol Scand. 2002 Mar;46(3):297-302. \"Pubmed\":http://"
147,"DB03597","BE0000182","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
148,"DB04653","BE0003346",""
149,"DB04493","BE0001199","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
150,"DB03879","BE0001416","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
151,"DB00586","BE0000248","# Charlier C, Michaux C: Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem. 2003 Jul-Aug;38(7-8):645-59. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
152,"DB00540","BE0000715","# Nojimoto FD, Mueller A, Hebeler-Barbosa F, Akinaga J, Lima V, Kiguti LR, Pupo AS: The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors. Neuropharmacology. 2010 Jul-Aug;59(1"
153,"DB07852","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
154,"DB00002","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
155,"DB03345","BE0000952","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
156,"DB08910","BE0000262","# Ferguson GD, Jensen-Pergakes K, Wilkey C, Jhaveri U, Richard N, Verhelle D, De Parseval LM, Corral LG, Xie W, Morris CL, Brady H, Chan K: Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2. "
157,"DB03147","BE0002974",""
158,"DB03480","BE0000382","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
159,"DB04081","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
160,"DB01330","BE0004643","# Nolan RD, Jude DA: The interactions of [14C]cefotetan with penicillin binding proteins of a wide variety of Gram-positive and gram-negative species. J Antimicrob Chemother. 1983 Jan;11 Suppl:169-77. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6573313"
161,"DB04002","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
162,"DB06335","BE0000854","# Augeri DJ, Robl JA, Betebenner DA, Magnin DR, Khanna A, Robertson JG, Wang A, Simpkins LM, Taunk P, Huang Q, Han SP, Abboa-Offei B, Cap M, Xin L, Tao L, Tozzo E, Welzel GE, Egan DM, Marcinkeviciene J, Chang SY, Biller SA, Kirby MS, Parker RA, Hamann LG:"
163,"DB01277","BE0000033","# Rosenbloom AL: Mecasermin (recombinant human insulin-like growth factor I). Adv Ther. 2009 Jan;26(1):40-54. Epub 2009 Jan 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19198769"
164,"DB01752","BE0001144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
165,"DB05280","BE0000291",""
166,"DB01677","BE0001267","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
167,"DB02379","BE0002739",""
168,"DB03908","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
169,"DB08453","BE0003908","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
170,"DB05262","BE0002204","# Iwanaga T, Kobayashi D, Hirayama M, Maeda T, Tamai I: Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab Dispos. 2005 Dec;33(12):1791-5."
171,"DB02321","BE0001497","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
172,"DB01229","BE0003475","# McGrogan BT, Gilmartin B, Carney DN, McCann A: Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 2008 Apr;1785(2):96-132. Epub 2007 Nov 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18068131"
173,"DB03203","BE0001612","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
174,"DB05505","BE0001893","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
175,"DB01295","BE0000694","# Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Koike K, Miwa S, Muramatsu I: Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life Sci. 2007 Jul 12;81(5)"
176,"DB08519","BE0000369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
177,"DB01422","BE0004812","# Pelletier C, Prognon P, Latrache H, Villart L, Bourlioux P: [Microbiological consequences of chelation of bivalent metal cations by nitroxoline]. Pathol Biol (Paris). 1994 May;42(5):406-11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7824304# Pelletier "
178,"DB00139","BE0000176","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
179,"DB00167","BE0000721","# Berger BJ, English S, Chan G, Knodel MH: Methionine regeneration and aminotransferases in Bacillus subtilis, Bacillus cereus, and Bacillus anthracis. J Bacteriol. 2003 Apr;185(8):2418-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12670965"
180,"DB01942","BE0002654",""
181,"DB05060","BE0002403",""
182,"DB03088","BE0004457","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
183,"DB03607","BE0001397","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
184,"DB05142","BE0003393",""
185,"DB00392","BE0000560","# Burke RE: The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes. Mov Disord. 1986;1(2):135-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2904117# Katayama S, Ishizaki F, Yamamura Y, Khoriyama T, Kito S: Effec"
186,"DB07876","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
187,"DB01135","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
188,"DB04724","BE0000516",""
189,"DB06693","BE0000574","# Kocarek TA, Dahn MS, Cai H, Strom SC, Mercer-Haines NA: Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes. Drug Metab Dispos. 2002 Dec;30(12):1400-5. \"Pubmed\":http://www.ncbi.n"
190,"DB04463","BE0003074","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
191,"DB04233","BE0003978","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
192,"DB07408","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
193,"DB00114","BE0004612","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
194,"DB00171","BE0000264","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
195,"DB05752","BE0000405",""
196,"DB00116","BE0002177","# Li Y, Holmes WB, Appling DR, RajBhandary UL: Initiation of protein synthesis in Saccharomyces cerevisiae mitochondria without formylation of the initiator tRNA. J Bacteriol. 2000 May;182(10):2886-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10781559"
197,"DB07343","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
198,"DB02998","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
199,"DB02656","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
200,"DB01238","BE0000945","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
201,"DB04395","BE0002790",""
202,"DB04649","BE0003364",""
203,"DB04172","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
204,"DB00232","BE0000267","# Puscas I, Coltau M, Baican M, Domuta G, Hecht A: Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action. Drugs Exp Clin Res. 1999;25(6):271-9. \"Pubmed\":http://www.ncbi.nlm"
205,"DB06637","BE0004725","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
206,"DB02394","BE0001243","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
207,"DB01790","BE0003425","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
208,"DB01987","BE0003276",""
209,"DB02991","BE0000067","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
210,"DB01352","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
211,"DB08296","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
212,"DB04272","BE0004566","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
213,"DB06866","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
214,"DB00128","BE0003751","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
215,"DB01156","BE0000486","# Bondarev ML, Bondareva TS, Young R, Glennon RA: Behavioral and biochemical investigations of bupropion metabolites. Eur J Pharmacol. 2003 Aug 1;474(1):85-93. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12909199# Mitchell HA, Ahern TH, Liles LC, Javors M"
216,"DB01961","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
217,"DB00281","BE0000767","# Sakaguchi M, Kuroda Y, Hirose M: The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg. 2006 Apr;102(4):1103-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
218,"DB07918","BE0004127","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
219,"DB00157","BE0000348","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
220,"DB00113","BE0000107","# Fuster D, Maurel J, Muxi A, Setoain X, Ayuso C, Martin F, Ortega ML, Fuertes S, Pons F: Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Q J Nucl Med. 2003 Jun;47(2):109-15. \"Pubmed\":ht"
221,"DB02431","BE0002745",""
222,"DB04137","BE0001453","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
223,"DB04951","BE0002397","# Burghardt I, Tritschler F, Opitz CA, Frank B, Weller M, Wick W: Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Biochem Biophys Res Commun. 2007 Mar 9;354(2):542-7. Epub 2007 Jan 10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/172341"
224,"DB01992","BE0001298","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
225,"DB01589","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472 (Accessed December 2013)"
226,"DB02787","BE0002562",""
227,"DB05521","BE0004701","# Liu-Young G, Kozal MJ: Hepatitis C protease and polymerase inhibitors in development. AIDS Patient Care STDS. 2008 Jun;22(6):449-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18479202"
228,"DB03435","BE0001934","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
229,"DB07652","BE0003870","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
230,"DB03485","BE0001678","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
231,"DB00189","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591 (Accessed December 2013)# Smeyatsky N, Baldwin D, Botros W, Gura R, Kurian T, Lambert MT, Patel AG, Steinert J, Priest RG: The treatment of sleep disorders. S Afr Med "
232,"DB00075","BE0003458","# Todd PA, Brogden RN: Muromonab CD3. A review of its pharmacology and therapeutic potential. Drugs. 1989 Jun;37(6):871-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2503348# Wilde MI, Goa KL: Muromonab CD3: a reappraisal of its pharmacology and use as "
233,"DB04932","BE0000013","# Bianchi G, Barone D, Lanzarotti E, Tettamanti R, Porta R, Moltrasio D, Cedro A, Salvetti L, Mantovani M, Prino G: Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. Eur J Pharmacol. 1993 Jul 20;238(2-3):327-3"
234,"DB00172","BE0000423","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
235,"DB02379","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
236,"DB01099","BE0004796","# Osterman DG, DePillis GD, Wu JC, Matsuda A, Santi DV: 5-Fluorocytosine in DNA is a mechanism-based inhibitor of HhaI methylase. Biochemistry. 1988 Jul 12;27(14):5204-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3167042# Waldorf AR, Polak A: Mechanism"
237,"DB01193","BE0000694","# Fraysse B, Garric J: Prediction and experimental validation of acute toxicity of beta-blockers in Ceriodaphnia dubia. Environ Toxicol Chem. 2005 Oct;24(10):2470-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16268148# Varma DR, Shen H, Deng XF, Peri KG,"
238,"DB04430","BE0001568","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
239,"DB08231","BE0001210","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
240,"DB01267","BE0000342","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243"
241,"DB00686","BE0000689","# Pascu C, Ljungh A, Wadstrom T: Staphylococci bind heparin-binding host growth factors. Curr Microbiol. 1996 Apr;32(4):201-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8867461# Zenjari C, Boilly-Marer Y, Desbiens X, Oudghir M, Hondermarck H, Boilly B: "
242,"DB08070","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
243,"DB05767","BE0001086",""
244,"DB06589","BE0000023","# Sonpavde G, Hutson TE: Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Curr Oncol Rep. 2007 Mar;9(2):115-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17288876"
245,"DB02216","BE0001145","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
246,"DB05219","BE0000487",""
247,"DB01114","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S"
248,"DB02078","BE0004297","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
249,"DB02580","BE0004307","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
250,"DB00999","BE0001653","# Temperini C, Cecchi A, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the diff"
251,"DB03849","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
252,"DB00464","BE0000943","# Parsi K, Exner T, Low J, Ma DD, Joseph JE: In vitro effects of detergent sclerosants on antithrombotic mechanisms. Eur J Vasc Endovasc Surg. 2009 Aug;38(2):220-8. Epub 2009 May 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19442540# Jacobson BF, Franz"
253,"DB02621","BE0004161","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
254,"DB01589","BE0000523","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
255,"DB03253","BE0000854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
256,"DB00155","BE0001092","# Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, Roeder RG, Clarke S, Stallcup MR, Allis CD, Coonrod SA: Human PAD4 regulates histone arginine methylation levels via demethylimination. Science. 2004"
257,"DB03844","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
258,"DB02621","BE0002101","# Coue M, Brenner SL, Spector I, Korn ED: Inhibition of actin polymerization by latrunculin A. FEBS Lett. 1987 Mar 23;213(2):316-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/ 3556584# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shin"
259,"DB07853","BE0004108","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
260,"DB01055","BE0000331","# Oppenheim EW, Nasrallah IM, Mastri MG, Stover PJ: Mimosine is a cell-specific antagonist of folate metabolism. J Biol Chem. 2000 Jun 23;275(25):19268-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10766749# Conti P, Frydas S, Reale M, Barbacane RC, Di "
261,"DB08080","BE0002101","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
262,"DB07181","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
263,"DB00867","BE0000694","# Tanaka N, Tamai T, Mukaiyama H, Hirabayashi A, Muranaka H, Akahane S, Miyata H, Akahane M: Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontine"
264,"DB07997","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
265,"DB01911","BE0001307","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
266,"DB00615","BE0000257","# Maddix DS, Tallian KB, Mead PS: Rifabutin: a review with emphasis on its role in the prevention of disseminated Mycobacterium avium complex infection. Ann Pharmacother. 1994 Nov;28(11):1250-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7849340"
267,"DB06626","BE0000023","# Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB: Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Ph"
268,"DB08109","BE0001430","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
269,"DB00118","BE0000323","# Janosik M, Kery V, Gaustadnes M, Maclean KN, Kraus JP: Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemis"
270,"DB01603","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
271,"DB06207","BE0000575","# Lepor H, Hill LA: Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability. Pharmacotherapy. 2010 Dec;30(12):1303-12. doi: 10.1592/phco.30.12.1303. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21114397"
272,"DB04957","BE0000489","# Schmitt H, Cabo C, Coromilas JC, Wit AL: Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction. J Cardiovasc Electrophysiol. 2001 Sep;"
273,"DB04315","BE0001848","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
274,"DB06262","BE0000572","# Davis MP: Recent advances in the treatment of pain. F1000 Med Rep. 2010 Aug 19;2:63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21173850# Giovannoni MP, Ghelardini C, Vergelli C, Dal Piaz V: Alpha2-agonists as analgesic agents. Med Res Rev. 2009 Mar;29"
275,"DB03247","BE0003028",""
276,"DB01853","BE0001362","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
277,"DB08332","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
278,"DB00157","BE0000299","# Ido Y: Pyridine nucleotide redox abnormalities in diabetes. Antioxid Redox Signal. 2007 Jul;9(7):931-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17508915# Klimacek M, Hellmer H, Nidetzky B: Catalytic mechanism of Zn2+-dependent polyol dehydrogenases"
279,"DB04279","BE0001249","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
280,"DB02282","BE0001456","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
281,"DB01858","BE0003417","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
282,"DB00752","BE0002198","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Volz HP, Gleiter CH: Monoamine oxidase inhibitors. A perspective on their use in the elderly. Drug"
283,"DB03313","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
284,"DB04198","BE0002011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
285,"DB03487","BE0002023","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
286,"DB03301","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
287,"DB02720","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
288,"DB08528","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
289,"DB01948","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
290,"DB00976","BE0004800","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
291,"DB03247","BE0003032",""
292,"DB00668","BE0000172","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Ozakca I, Arioglu E, Guner S, Altan VM, Ozcelikay AT: Role of Beta-3-Adrenoceptor in Catecholamine"
293,"DB00517","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
294,"DB00248","BE0004915","# Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A: Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned "
295,"DB07678","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
296,"DB00128","BE0000187","# Wang J, Matalon R, Bhatia G, Wu G, Li H, Liu T, Lu ZH, Ledeen RW: Bimodal occurrence of aspartoacylase in myelin and cytosol of brain. J Neurochem. 2007 Apr;101(2):448-57. Epub 2007 Jan 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17254025# Bitto E, "
297,"DB01159","BE0000433","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
298,"DB07157","BE0003257","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
299,"DB01752","BE0001211","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
300,"DB04147","BE0004178","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
301,"DB02032","BE0002693","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
302,"DB08152","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
303,"DB08818","BE0004702","# Turley EA: Purification of a hyaluronate-binding protein fraction that modifies cell social behavior. Biochem Biophys Res Commun. 1982 Oct 15;108(3):1016-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6185115"
304,"DB08525","BE0002536","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
305,"DB08125","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
306,"DB08538","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
307,"DB03661","BE0001497","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
308,"DB00594","BE0000678","# Berdiev BK, Xia J, McLean LA, Markert JM, Gillespie GY, Mapstone TB, Naren AP, Jovov B, Bubien JK, Ji HL, Fuller CM, Kirk KL, Benos DJ: Acid-sensing ion channels in malignant gliomas. J Biol Chem. 2003 Apr 25;278(17):15023-34. Epub 2003 Feb 12. \"Pubmed\""
309,"DB04529","BE0003321",""
310,"DB08770","BE0000924","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
311,"DB05327","BE0000747",""
312,"DB04315","BE0004542","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
313,"DB01156","BE0003585","# Fryer JD, Lukas RJ: Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther. 1999 Jan;288(1):88-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9862"
314,"DB03218","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
315,"DB08271","BE0001116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
316,"DB00431","BE0000433","# Vale C, Fonfria E, Bujons J, Messeguer A, Rodriguez-Farre E, Sunol C: The organochlorine pesticides gamma-hexachlorocyclohexane (lindane), alpha-endosulfan and dieldrin differentially interact with GABA(A) and glycine-gated chloride channels in primary "
317,"DB08394","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
318,"DB00347","BE0000483","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
319,"DB08179","BE0000962","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
320,"DB04522","BE0002522",""
321,"DB00071","BE0002126","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
322,"DB00836","BE0000418","# Daly JW, Harper J: Loperamide: novel effects on capacitative calcium influx. Cell Mol Life Sci. 2000 Jan 20;57(1):149-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10949586# Suzuki T, Sakai H, Ikari A, Takeguchi N: Inhibition of thromboxane A(2)-induc"
323,"DB04094","BE0000695","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
324,"DB03880","BE0003730","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
325,"DB00166","BE0000040","# Gunther S, McMillan PJ, Wallace LJ, Muller S: Plasmodium falciparum possesses organelle-specific alpha-keto acid dehydrogenase complexes and lipoylation pathways. Biochem Soc Trans. 2005 Nov;33(Pt 5):977-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1"
326,"DB01174","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
327,"DB00438","BE0003687","# Hayes MV, Orr DC: Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983 Aug;12(2):119-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
328,"DB07018","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
329,"DB03147","BE0002067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
330,"DB07322","BE0001534","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
331,"DB00157","BE0000604","# McKinlay JB, Shachar-Hill Y, Zeikus JG, Vieille C: Determining Actinobacillus succinogenes metabolic pathways and fluxes by NMR and GC-MS analyses of 13C-labeled metabolic product isotopomers. Metab Eng. 2007 Mar;9(2):177-92. Epub 2006 Nov 17. \"Pubmed\":"
332,"DB04947","BE0000647","# Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, Fischman AJ: Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry. 2007 Nov 1;"
333,"DB00157","BE0000287","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
334,"DB08437","BE0003825","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
335,"DB04137","BE0003814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
336,"DB00484","BE0000342","# Trendelenburg AU, Philipp M, Meyer A, Klebroff W, Hein L, Starke K: All three alpha2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):504-12. Epub 2003 Nov 11. \"Pubmed\""
337,"DB02116","BE0001082","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
338,"DB04552","BE0003997","# Jabeen T, Singh N, Singh RK, Sharma S, Somvanshi RK, Dey S, Singh TP: Non-steroidal anti-inflammatory drugs as potent inhibitors of phospholipase A2: structure of the complex of phospholipase A2 with niflumic acid at 2.5 Angstroms resolution. Acta Cryst"
339,"DB04216","BE0003841","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
340,"DB01369","BE0004800","# Barthel D, Schlitzer M, Pradel G: Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum. Antimicrob Agents Chemother. 2008 Feb;52(2):774-7. Epub 2007 Dec 3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18056275# Beyer "
341,"DB00842","BE0003595","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
342,"DB04646","BE0002472","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
343,"DB03761","BE0004794","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
344,"DB03860","BE0000792","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
345,"DB04560","BE0000050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
346,"DB07131","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
347,"DB05213","BE0000147",""
348,"DB01092","BE0000732","# Mentre P, Debey P: An unexpected effect of an ouabain-sensitive ATPase activity on the amount of antigen-antibody complexes formed in situ. Cell Mol Biol (Noisy-le-grand). 1999 Sep;45(6):781-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10541475# Qazz"
349,"DB04946","BE0000291","# Bobo WV: Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Expert Rev Clin Pharmacol. 2013 Jan;6(1):61-91. doi: 10.1586/ecp.12.70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
350,"DB02379","BE0001108","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
351,"DB08658","BE0002180","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
352,"DB03978","BE0004369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
353,"DB01645","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
354,"DB04272","BE0003269",""
355,"DB04104","BE0001657","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
356,"DB00211","BE0000575","# Altenbach RJ, Khilevich A, Kolasa T, Rohde JJ, Bhatia PA, Patel MV, Searle XB, Yang F, Bunnelle WH, Tietje K, Bayburt EK, Carroll WA, Meyer MD, Henry R, Buckner SA, Kuk J, Daza AV, Milicic IV, Cain JC, Kang CH, Ireland LM, Carr TL, Miller TR, Hancock AA"
357,"DB05386","BE0002482",""
358,"DB00157","BE0000676","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
359,"DB00527","BE0000197","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
360,"DB03354","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
361,"DB05463","BE0001171",""
362,"DB02158","BE0001128","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
363,"DB01392","BE0000451","# Baxter GS, Murphy OE, Blackburn TP: Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle. Br J Pharmacol. 1994 May;112(1):323-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8032658# Kauma"
364,"DB01260","BE0000794","# Russell GM, Henley DE, Leendertz J, Douthwaite JA, Wood SA, Stevens A, Woltersdorf WW, Peeters BW, Ruigt GS, White A, Veldhuis JD, Lightman SL: Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in hea"
365,"DB01401","BE0000262","# Simon RA: Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. Curr Allergy Asthma Rep. 2004 Jan;4(1):17-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14680616# Brzozowski T, Konturek PC, Sliwowski Z, Kwiecien S, Drozdowi"
366,"DB08795","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
367,"DB08558","BE0001688","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
368,"DB01329","BE0000488","# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhashi S: Affinity of cefoperazone for penicillin-binding proteins. Antimicrob Agents Chemother. 1980 Jul;18(1):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6448021"
369,"DB07290","BE0001363","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
370,"DB08558","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
371,"DB00687","BE0000132","# Krishnan AV, Zhao XY, Swami S, Brive L, Peehl DM, Ely KR, Feldman D: A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer. Endocrinology. 2002 May;143("
372,"DB01054","BE0002396","# Perez-Reyes E, Van Deusen AL, Vitko I: Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther. 2009 Feb;328(2):621-7. Epub 2008 Oct 30. \"Pubmed\":http://www.ncbi.n"
373,"DB00138","BE0001130","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
374,"DB08846","BE0001209","# Sekiguchi Y, Nakaniwa T, Kinoshita T, Nakanishi I, Kitaura K, Hirasawa A, Tsujimoto G, Tada T: Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid. Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. doi: 10.1016/j.bmcl."
375,"DB00683","BE0000381","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
376,"DB00161","BE0000544","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
377,"DB04279","BE0001699","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
378,"DB01285","BE0001026","# Hellman P, Linder F, Hennings J, Hessman O, Eriksson B, Orlefors H, Akerstrom G: Bilateral adrenalectomy for ectopic Cushing's syndrome-discussions on technique and indication. World J Surg. 2006 May;30(5):909-16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
379,"DB01942","BE0001368","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
380,"DB00233","BE0004655","# Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol. 2000 Dec;95(12):3452-7. \"Pubmed\":http://www.ncb"
381,"DB00018","BE0000385","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
382,"DB00170","BE0000724","# Price PA: Role of vitamin-K-dependent proteins in bone metabolism. Annu Rev Nutr. 1988;8:565-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3060178"
383,"DB08185","BE0004210","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
384,"DB07475","BE0002348","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
385,"DB00824","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
386,"DB07410","BE0003350","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
387,"DB08798","BE0002360","# Prabhu V, Lui H, King J: Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides. Phytochemistry. 1997 May;45(1):23-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9127492"
388,"DB00751","BE0000650","# Dupont LJ, Pype JL, Meade CJ, DeLeyn P, Deneffe G, Demedts MG, Verleden GM: Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro. Eur Respir J. 1999 Nov;14(5):1068-75. "
389,"DB06900","BE0003746","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
390,"DB02681","BE0004552","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
391,"DB04143","BE0004065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
392,"DB01149","BE0000647","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821"
393,"DB06616","BE0001072","# Remsing Rix LL, Rix U, Colinge J, Hantschel O, Bennett KL, Stranzl T, Muller A, Baumgartner C, Valent P, Augustin M, Till JH, Superti-Furga G: Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia. 2"
394,"DB07267","BE0003782","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
395,"DB03444","BE0001065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
396,"DB02857","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
397,"DB05147","BE0001367",""
398,"DB00546","BE0003593","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
399,"DB00157","BE0000128","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
400,"DB08545","BE0004339","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
401,"DB07080","BE0001598","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
402,"DB00201","BE0002406","# Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR: Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem. 2002 Oct "
403,"DB03772","BE0000214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
404,"DB08690","BE0003846","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
405,"DB06589","BE0000205","# Sonpavde G, Hutson TE: Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Curr Oncol Rep. 2007 Mar;9(2):115-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17288876"
406,"DB02482","BE0000923","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
407,"DB03317","BE0002872",""
408,"DB04644","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
409,"DB04253","BE0001616","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
410,"DB03991","BE0001724","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
411,"DB03793","BE0003031",""
412,"DB01296","BE0002387","# Largo R, Alvarez-Soria MA, Diez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, Herrero-Beaumont G: Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage. 2003 Apr;11(4):290-8. \"Pubmed\":"
413,"DB01864","BE0004558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
414,"DB03822","BE0002180",""
415,"DB04039","BE0001470","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
416,"DB03491","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
417,"DB07162","BE0002408","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
418,"DB01180","BE0000221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
419,"DB03203","BE0001854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
420,"DB01150","BE0002392","# Nagai K, Davies TA, Jacobs MR, Appelbaum PC: Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical "
421,"DB01149","BE0000289","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
422,"DB04464","BE0004088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
423,"DB02656","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
424,"DB00880","BE0000322","# Weiner ID, Verlander JW: Renal and hepatic expression of the ammonium transporter proteins, Rh B Glycoprotein and Rh C Glycoprotein. Acta Physiol Scand. 2003 Dec;179(4):331-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14656370# Puscas I, Coltau M, Bai"
425,"DB00036","BE0000403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
426,"DB02098","BE0001306","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
427,"DB03814","BE0004638","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
428,"DB00172","BE0000060","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
429,"DB01105","BE0000749","# Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR: Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroentero"
430,"DB03813","BE0004016","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
431,"DB04371","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
432,"DB02142","BE0001512","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
433,"DB01846","BE0001298","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
434,"DB00253","BE0000794","# Southren AL, Dominguez MO, Gordon GG, Wenk EJ, Hernandez MR, Dunn MW, Weinstein BI: Nuclear translocation of the cytoplasmic glucocorticoid receptor in the iris-ciliary body and adjacent corneoscleral tissue of the rabbit following topical administratio"
435,"DB01309","BE0000033","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Sciacca L, Cassarino MF, Genua M, Pandini G, Le Moli R, Squatrito S, Vigneri R: Insulin analogues "
436,"DB07717","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
437,"DB00145","BE0000745","# Young-Pearse TL, Ivic L, Kriegstein AR, Cepko CL: Characterization of mice with targeted deletion of glycine receptor alpha 2. Mol Cell Biol. 2006 Aug;26(15):5728-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16847326# Qi Z, Stephens NR, Spalding EP: "
438,"DB00580","BE0000262","# Talley JJ, Brown DL, Carter JS, Graneto MJ, Koboldt CM, Masferrer JL, Perkins WE, Rogers RS, Shaffer AF, Zhang YY, Zweifel BS, Seibert K: 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J Me"
439,"DB00370","BE0004863","# Fernandez J, Alonso JM, Andres JI, Cid JM, Diaz A, Iturrino L, Gil P, Megens A, Sipido VK, Trabanco AA: Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents. J Med Chem. 2005 Mar 24;48(6):1709-12. \"Pub"
440,"DB00051","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
441,"DB01224","BE0000389","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
442,"DB03566","BE0001979","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
443,"DB01463","BE0000647","# Seyfried CA: Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study. Biochem Pharmacol. 1983 Aug 1;32(15):2329-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6136281# Li SM, Campbell BL, Katz JL: Interactions"
444,"DB00393","BE0003721","# Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR: Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol. 2007 Jun"
445,"DB08912","BE0004757","# FDA label"
446,"DB08187","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
447,"DB01332","BE0000588","# Shigi Y, Kojo H, Wakasugi M, Nishida M: Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins. Antimicrob Agents Chemother. 1981 Mar;19(3):393-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
448,"DB01496","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
449,"DB00784","BE0000262","# Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K: Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J. 1995 Jan 15;305 ( Pt 2):479-84. \"Pubmed\":http://www.ncbi.nlm"
450,"DB02535","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
451,"DB04869","BE0001103","# Recober A, Russo AF: Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment. IDrugs. 2007 Aug;10(8):566-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17665333"
452,"DB05417","BE0000433",""
453,"DB00133","BE0000441","# Yard BA, Carter LG, Johnson KA, Overton IM, Dorward M, Liu H, McMahon SA, Oke M, Puech D, Barton GJ, Naismith JH, Campopiano DJ: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. J Mol Biol. 2007 Jul 27;370(5):870-86. E"
454,"DB03581","BE0001423","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
455,"DB01277","BE0000970","# Kemp SF: Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options. BioDrugs. 2009;23(3):155-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19627167# Williams RM, McDonald A, O'Savage M,"
456,"DB06800","BE0000770","# Yuan CS: Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Ann Pharmacother. 2007 Jun;41(6):984-93. Epub 2007 May 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17504835"
457,"DB01236","BE0000218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
458,"DB07131","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
459,"DB03333","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
460,"DB00243","BE0001143","# Rajamani S, Shryock JC, Belardinelli L: Block of tetrodotoxin-sensitive, Na(V)1.7 and tetrodotoxin-resistant, Na(V)1.8, Na+ channels by ranolazine. Channels (Austin). 2008 Nov-Dec;2(6):449-60. Epub 2008 Nov 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
461,"DB07392","BE0003850","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
462,"DB06616","BE0004743","# FDA label"
463,"DB01972","BE0001273","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
464,"DB04768","BE0000157","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
465,"DB00626","BE0004829","# Stone KJ, Strominger JL: Mechanism of action of bacitracin: complexation with metal ion and C 55 -isoprenyl pyrophosphate. Proc Natl Acad Sci U S A. 1971 Dec;68(12):3223-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/4332017"
466,"DB02780","BE0002838",""
467,"DB02076","BE0001436","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
468,"DB02930","BE0001592","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
469,"DB00690","BE0003592","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
470,"DB00131","BE0000958","# Ulfhammer E, Larsson P, Karlsson L, Hrafnkelsdottir T, Bokarewa M, Tarkowski A, Jern S: TNF-alpha mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-kappaB- and p38 MAPK-dependent. J Thromb Haemost. "
471,"DB01198","BE0000736","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
472,"DB01942","BE0002664",""
473,"DB02193","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
474,"DB03766","BE0001344","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
475,"DB05149","BE0003382",""
476,"DB00483","BE0000560","# Huang XP, Prilla S, Mohr K, Ellis J: Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-ty"
477,"DB00570","BE0001340","# Jordan MA, Kamath K: How do microtubule-targeted drugs work? An overview. Curr Cancer Drug Targets. 2007 Dec;7(8):730-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18220533# Correia JJ: Effects of antimitotic agents on tubulin-nucleotide interactions."
478,"DB04875","BE0000444","# Ross J, Brough D, Gibson RM, Loddick SA, Rothwell NJ: A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat. Neuropharmacology. 2007 Oct;53(5):638-42. Epub 2007 Aug 10. \"Pubmed\":"
479,"DB00041","BE0002102","# Stauber DJ, Debler EW, Horton PA, Smith KA, Wilson IA: Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2788-93. Epub 2006 Feb 13. \"Pubmed\":http://www.ncbi.nlm"
480,"DB05206","BE0001060",""
481,"DB00933","BE0000451","# Choi S, Haggart D, Toll L, Cuny GD: Synthesis, receptor binding and functional studies of mesoridazine stereoisomers. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4379-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15357957# Rauser L, Savage JE, Meltzer HY,"
482,"DB07565","BE0001544","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
483,"DB00143","BE0002283","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
484,"DB04820","BE0002089","# Parvez S, Parvez SH, Youdim MB: Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancy. Br J Pharmacol. 1975 Feb;53(2):241-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1170911"
485,"DB01050","BE0003591","# Velkov T, Chuang S, Wielens J, Sakellaris H, Charman WN, Porter CJ, Scanlon MJ: The interaction of lipophilic drugs with intestinal fatty acid-binding protein. J Biol Chem. 2005 May 6;280(18):17769-76. Epub 2005 Feb 18. \"Pubmed\":http://www.ncbi.nlm.nih."
486,"DB00157","BE0000648","# Knapp KG, Swartz JR: Evidence for an additional disulfide reduction pathway in Escherichia coli. J Biosci Bioeng. 2007 Apr;103(4):373-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17502280# Aon MA, Cortassa S, Maack C, O'Rourke B: Sequential opening of"
487,"DB08772","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
488,"DB01210","BE0000694","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Quast U, Vollmer KO: Binding of beta-adrenoceptor antagonists to rat and rabbit lung: special refe"
489,"DB08226","BE0003366","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
490,"DB03127","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
491,"DB04751","BE0003958","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
492,"DB00880","BE0000419","# Thakker RV: Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome. Exp Nephrol. 2000 Nov-Dec;8(6):351-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11014932# Schmidt H, Kabesch M, Schwarz HP, Kiess W: Clinical, bioche"
493,"DB03814","BE0004641","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
494,"DB04147","BE0004169","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
495,"DB00200","BE0000777","# Willard HF, Rosenberg LE: Inborn errors of cobalamin metabolism: effect of cobalamin supplementation in culture on methylmalonyl CoA mutase activity in normal and mutant human fibroblasts. Biochem Genet. 1979 Feb;17(1-2):57-75. \"Pubmed\":http://www.ncbi."
496,"DB00706","BE0000501","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Abrams P, Speakman M, Stott M, Arkell D, Pocock R: A dose-ranging study of the efficacy and safety"
497,"DB04299","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
498,"DB00589","BE0000659","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
499,"DB00175","BE0000574","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
500,"DB03801","BE0001258","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
501,"DB00199","BE0004800","# Moazed D, Noller HF: Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie. 1987 Aug;69(8):879-84. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3122849# Sch"
502,"DB01810","BE0001292","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
503,"DB02981","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
504,"DB01115","BE0000430","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Morel N, Buryi V, Feron O, Gomez JP, Christen MO, Godfraind T: The action of calcium channel block"
505,"DB00402","BE0000523","# Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2009 Nov 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19942638# Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: S"
506,"DB03435","BE0004498","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
507,"DB02142","BE0001465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
508,"DB07932","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
509,"DB07023","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
510,"DB00221","BE0000172","# Rodrigues LL, Oliveira MC, Pelegrini-da-Silva A, de Arruda Veiga MC, Parada CA, Tambeli CH: Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J Pain. 2006 Dec;7(12):929-36. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
511,"DB02497","BE0004149","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
512,"DB00111","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
513,"DB02818","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
514,"DB06870","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
515,"DB00310","BE0000502","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
516,"DB00928","BE0004810","# Muller A, Florek M: 5-Azacytidine/Azacitidine. Recent Results Cancer Res. 2010;184:159-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20072837# Kaminskas E, Farrell AT, Wang YC, Sridhara R, Pazdur R: FDA drug approval summary: azacitidine (5-azacytidin"
517,"DB00454","BE0000749","# Lomenzo SA, Rhoden JB, Izenwasser S, Wade D, Kopajtic T, Katz JL, Trudell ML: Synthesis and biological evaluation of meperidine analogues at monoamine transporters. J Med Chem. 2005 Mar 10;48(5):1336-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15743"
518,"DB03088","BE0001671","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
519,"DB08690","BE0003954","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
520,"DB02574","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
521,"DB01444","BE0000770","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
522,"DB01069","BE0000405","# Golembiewski JA, O'Brien D: A systematic approach to the management of postoperative nausea and vomiting. J Perianesth Nurs. 2002 Dec;17(6):364-76. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12476402"
523,"DB03192","BE0000408","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
524,"DB01215","BE0002345","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
525,"DB03648","BE0002810",""
526,"DB00552","BE0002214","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Jackson RC, Leopold WR, Ross DA: The biochemical pharmacology of (2'-R)-chloropentostatin, a novel"
527,"DB00054","BE0001068","# Romagnoli E, Burzotta F, Trani C, Biondi-Zoccai GG, Giannico F, Crea F: Rationale for intracoronary administration of abciximab. J Thromb Thrombolysis. 2007 Feb;23(1):57-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17160551# Ibbotson T, McGavin JK, G"
528,"DB00477","BE0004879","# Herve F, Duche JC, d'Athis P, Marche C, Barre J, Tillement JP: Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding d"
529,"DB08564","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
530,"DB04761","BE0000966","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
531,"DB07994","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
532,"DB03814","BE0003191",""
533,"DB08556","BE0003752","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
534,"DB03787","BE0001506","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
535,"DB04360","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
536,"DB03028","BE0000941","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
537,"DB08185","BE0004220","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
538,"DB04125","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
539,"DB07690","BE0002929","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
540,"DB03147","BE0001969","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
541,"DB07530","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
542,"DB03429","BE0000599","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
543,"DB00285","BE0000749","# Chen F, Larsen MB, Sanchez C, Wiborg O: The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. Eur Neuropsychopharmacol. 2005"
544,"DB01142","BE0000501","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Stahl SM: Selective histam"
545,"DB06663","BE0002147","# Zatelli MC, Piccin D, Vignali C, Tagliati F, Ambrosio MR, Bondanelli M, Cimino V, Bianchi A, Schmid HA, Scanarini M, Pontecorvi A, De Marinis L, Maira G, degli Uberti EC: Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viabil"
546,"DB00393","BE0002355","# Peterson BZ, Catterall WA: Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore. Mol Pharmacol. 2006 Aug;70(2):667-75. Epub 2006 May 4. \"Pubmed\":http://www.nc"
547,"DB01224","BE0000575","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
548,"DB02570","BE0004144","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
549,"DB07671","BE0003846","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
550,"DB08687","BE0002374","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
551,"DB08837","BE0002343","# Akk G, Steinbach JH: Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium. J Physiol. 2003 Aug 15;551(Pt 1):155-68. Epub 2003 Jun 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12824448"
552,"DB04855","BE0000090","# Iwamoto T, Watanabe Y, Kita S, Blaustein MP: Na+/Ca2+ exchange inhibitors: a new class of calcium regulators. Cardiovasc Hematol Disord Drug Targets. 2007 Sep;7(3):188-98. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17896959"
553,"DB00312","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
554,"DB07284","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
555,"DB02426","BE0000599","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
556,"DB01406","BE0000132","# Donaldson VH: Danazol. Am J Med. 1989 Sep;87(3N):49N-55N. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2486535# Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S, Mizuguchi K: Dienogest is a selective progesterone receptor agonist in tra"
557,"DB03216","BE0001684","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
558,"DB02262","BE0001452","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
559,"DB00269","BE0000123","# Kupfer D, Bulger WH: Inactivation of the uterine estrogen receptor binding of estradiol during P-450 catalyzed metabolism of chlorotrianisene (TACE). Speculation that TACE antiestrogenic activity involves covalent binding to the estrogen receptor. FEBS "
560,"DB00804","BE0000560","# Pavia J, Munoz M, Jimenez E, Martos F, Gonzalez-Correa JA, De la Cruz JP, Garcia V, Sanchez de la Cuesta F: Pharmacological characterization and distribution of muscarinic receptors in human placental syncytiotrophoblast brush-border and basal plasma me"
561,"DB00239","BE0004668","# Gebre-Hiwot A, Frommel D: The in-vitro anti-leishmanial activity of inhibitors of ergosterol biosynthesis. J Antimicrob Chemother. 1993 Dec;32(6):837-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8144423"
562,"DB07318","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
563,"DB00820","BE0003558","# Cialis. Product Monograph. _Eli Lilly Canada_. March 2009# Weeks JL 2nd, Corbin JD, Francis SH: Interactions between cyclic nucleotide phosphodiesterase 11 catalytic site and substrates or tadalafil and role of a critical Gln-869 hydrogen bond. J Pharma"
564,"DB00248","BE0000694","# Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A: Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned "
565,"DB05078","BE0002421",""
566,"DB01884","BE0000854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
567,"DB07641","BE0002198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
568,"DB07903","BE0004117","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
569,"DB06204","BE0000311","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
570,"DB04492","BE0001329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
571,"DB08591","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
572,"DB00285","BE0000647","# Dawson LA, Nguyen HQ, Geiger A: Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Neuropharmacology. 1999 Aug;38(8):1153-63. \"Pubmed\":http://www.ncbi."
573,"DB07493","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
574,"DB06875","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
575,"DB03740","BE0001648","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
576,"DB08231","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
577,"DB00668","BE0000289","# Nyronen T, Pihlavisto M, Peltonen JM, Hoffren AM, Varis M, Salminen T, Wurster S, Marjamaki A, Kanerva L, Katainen E, Laaksonen L, Savola JM, Scheinin M, Johnson MS: Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinep"
578,"DB07427","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
579,"DB01595","BE0000141","# McLean MJ, Macdonald RL: Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. J Pharmacol Exp Ther. 1988 Feb;244(2):789-95. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
580,"DB06854","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
581,"DB07057","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
582,"DB08231","BE0004232","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
583,"DB01583","BE0000687","# Jiang W, Miyamoto T, Kakizawa T, Sakuma T, Nishio S, Takeda T, Suzuki S, Hashizume K: Expression of thyroid hormone receptor alpha in 3T3-L1 adipocytes; triiodothyronine increases the expression of lipogenic enzyme and triglyceride accumulation. J Endoc"
584,"DB02763","BE0000981","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
585,"DB01624","BE0000289","# Khalifa AE: Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms. Pharmacol Biochem Behav. 2003 Jul;75(4):755-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12957216"
586,"DB01595","BE0003592","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
587,"DB03564","BE0001225","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
588,"DB00073","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
589,"DB05266","BE0000487","# Huang Z, Liu S, Zhang L, Salem M, Greig GM, Chan CC, Natsumeda Y, Noguchi K: Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life Sci. 2006 May 1;78(23):2663-8. Epub 2005 Nov 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16313925"
590,"DB08848","BE0000249","# Sunol C, Babot Z, Cristofol R, Sonnewald U, Waagepetersen HS, Schousboe A: A possible role of the non-GAT1 GABA transporters in transfer of GABA from GABAergic to glutamatergic neurons in mouse cerebellar neuronal cultures. Neurochem Res. 2010 Sep;35(9)"
591,"DB00314","BE0004846","# Stanley RE, Blaha G, Grodzicki RL, Strickler MD, Steitz TA: The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome. Nat Struct Mol Biol. 2010 Mar;17(3):289-93. Epub 2010 Feb 14. \"Pubmed\":http://www.ncbi.nl"
592,"DB07763","BE0003858","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
593,"DB02059","BE0002544",""
594,"DB03109","BE0001584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
595,"DB00683","BE0003619","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
596,"DB01841","BE0001393","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
597,"DB00707","BE0000710","# Krutmann J, Athar M, Mendel DB, Khan IU, Guyre PM, Mukhtar H, Elmets CA: Inhibition of the high affinity Fc receptor (Fc gamma RI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radical"
598,"DB03564","BE0003131",""
599,"DB05212","BE0001086",""
600,"DB02379","BE0001996","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
601,"DB05014","BE0000205",""
602,"DB08351","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
603,"DB08361","BE0001316","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
604,"DB03144","BE0000005","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
605,"DB06986","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
606,"DB00142","BE0002276","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
607,"DB02007","BE0001108","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
608,"DB04850","BE0002198",""
609,"DB05146","BE0000369",""
610,"DB04077","BE0003206",""
611,"DB03147","BE0000160","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
612,"DB04224","BE0004171","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
613,"DB01224","BE0000342","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
614,"DB04037","BE0001568","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
615,"DB08728","BE0004018","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
616,"DB00654","BE0000610","# Ota T, Aihara M, Narumiya S, Araie M: The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4159-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16249494# Nakajima T, Matsugi T"
617,"DB04393","BE0001774","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
618,"DB03828","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
619,"DB02869","BE0003417","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
620,"DB01147","BE0000142","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
621,"DB00897","BE0003598","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
622,"DB02710","BE0001084","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
623,"DB04646","BE0002473","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
624,"DB03994","BE0002809",""
625,"DB00318","BE0000632","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
626,"DB07306","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
627,"DB07841","BE0000776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
628,"DB01328","BE0000588","# Rake JB, Newman DJ, Actor P: Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12. J Antibiot (Tokyo). 1984 May;37(5):572-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6376452"
629,"DB03382","BE0003066",""
630,"DB00145","BE0000518","# Bashir Q, Rashid N, Akhtar M: Mechanism and substrate stereochemistry of 2-amino-3-oxobutyrate CoA ligase: implications for 5-aminolevulinate synthase and related enzymes. Chem Commun (Camb). 2006 Dec 28;(48):5065-7. Epub 2006 Oct 13. \"Pubmed\":http://ww"
631,"DB07490","BE0003962","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
632,"DB01324","BE0000419","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Monroy A, Plata C, Hebert SC, Gamba G: Characterization of the thiazide-sensitive Na(+)-Cl(-) cotr"
633,"DB03250","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
634,"DB00148","BE0000714","# Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, Zhang J: Bioenergetic and functional consequences of bone marrow-derived multipotent p"
635,"DB01388","BE0000303","# Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms. Pharmacology. 2006;78(1):11-20. Ep"
636,"DB03262","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
637,"DB06847","BE0003735","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
638,"DB04510","BE0001611","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
639,"DB06853","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
640,"DB05630","BE0000971","# Walker J, Saravia NG: Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents. J Parasitol. 2004 Oct;90(5):1155-62. \"Pubmed\":http://www."
641,"DB05651","BE0002365","# Beckers T, Burkhardt C, Wieland H, Gimmnich P, Ciossek T, Maier T, Sanders K: Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer. 2007 Sep 1;121(5):1138-48. \"Pubmed\":http:/"
642,"DB07853","BE0004109","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
643,"DB01622","BE0000451","# Kusumi I, Takahashi Y, Suzuki K, Kameda K, Koyama T: Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain. J Neural Transm. 2000;107(3):295-302. \"Pubmed\":http://ww"
644,"DB08627","BE0000801","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
645,"DB00247","BE0000533","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Johnson MP, Lea RA, Curtain RP, MacMillan JC, Griffiths LR: An investigation of the 5-HT2C recepto"
646,"DB04077","BE0001565","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
647,"DB01073","BE0002804","# Jordheim LP, Galmarini CM, Dumontet C: [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues] Bull Cancer. 2005 Mar;92(3):239-48. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15820918# Yao L, Xu W, Fan L, Miao KR, Wu YJ, Qiao "
648,"DB04464","BE0003816","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
649,"DB01656","BE0001133","# Barone FC, Barton ME, White RF, Legos JJ, Kikkawa H, Shimamura M, Kuratani K, Kinoshita M: Inhibition of Phosphodiesterase Type 4 Decreases Stress-Induced Defecation in Rats and Mice. Pharmacology. 2007 Aug 28;81(1):11-17. \"Pubmed\":http://www.ncbi.nlm.n"
650,"DB00502","BE0000020","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Cai G, Gurdal H, Smith C, Wang HY, Friedman E: Inverse agonist properties of dopaminergic antagoni"
651,"DB00157","BE0000587","# Tanaka M, Ohkubo K, Fukuzumi S: DNA cleavage by UVA irradiation of NADH with dioxygen via radical chain processes. J Phys Chem A. 2006 Sep 28;110(38):11214-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16986858# Goldstone AB, Liochev SI, Fridovich I: I"
652,"DB04272","BE0000845","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
653,"DB00549","BE0000705","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Cazzola M, Boveri B, Carlucci P, Santus P, DiMarco F, Centanni S, Allegra L: Lung function improve"
654,"DB03151","BE0002992",""
655,"DB07587","BE0001646","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
656,"DB05752","BE0000560",""
657,"DB01256","BE0000843","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
658,"DB04799","BE0003858","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
659,"DB00854","BE0000420","# Prommer E: Levorphanol: the forgotten opioid. Support Care Cancer. 2007 Mar;15(3):259-64. Epub 2006 Oct 13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17039381"
660,"DB00674","BE0003585","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
661,"DB00126","BE0000060","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
662,"DB01065","BE0000418","# del Rio B, Garcia Pedrero JM, Martinez-Campa C, Zuazua P, Lazo PS, Ramos S: Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J Biol Chem. 2004 Sep 10;279(37):38294-302. Epub 2004 Jun 30. \"Pubmed\":http://www.ncbi.nlm"
663,"DB08098","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
664,"DB01558","BE0002344","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
665,"DB00267","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
666,"DB00613","BE0002436","# Yokoyama A, Mori S, Takahashi HK, Kanke T, Wake H, Nishibori M: Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice. Eur J Pharmacol. 2007 Mar 8;558(1-3):179-84. "
667,"DB02660","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
668,"DB00246","BE0000560","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
669,"DB03628","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
670,"DB07311","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
671,"DB00543","BE0004797","# Wei HB, Niu XY: [Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration]. Yao Xue Xue Bao. 1990;25(12):881-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19"
672,"DB01069","BE0000560","# Golembiewski JA, O'Brien D: A systematic approach to the management of postoperative nausea and vomiting. J Perianesth Nurs. 2002 Dec;17(6):364-76. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12476402"
673,"DB02379","BE0002060","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
674,"DB07636","BE0003858","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
675,"DB05468","BE0000590",""
676,"DB00281","BE0000197","# Itoh H, Tsuji K, Sakaguchi T, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, Ashihara T, Ito M, Horie M, Imoto K: A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. Int J Cardiol. 2007 Oct 18;121(3):239-48. E"
677,"DB03721","BE0000912","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
678,"DB02632","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
679,"DB05685","BE0003403","# Atar D, Huber K, Rupprecht HJ, Kopecky SL, Schwitter J, Theek C, Brandl K, Henning R, Geudelin B: Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-der"
680,"DB02267","BE0001471","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
681,"DB03939","BE0001862","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
682,"DB03371","BE0002706",""
683,"DB00544","BE0004796","# Wyatt MD, Wilson DM 3rd: Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci. 2009 Mar;66(5):788-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18979208# Ghoshal K, Jacob ST: An alternative molecular mechanism of action of "
684,"DB03814","BE0004634","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
685,"DB01588","BE0000129","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
686,"DB00696","BE0000533","# Bigal ME, Tepper SJ: Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep. 2003 Feb;7(1):55-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12525272"
687,"DB08247","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
688,"DB00458","BE0000247","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
689,"DB07763","BE0003854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
690,"DB01043","BE0000417","# Kashiwagi K, Masuko T, Nguyen CD, Kuno T, Tanaka I, Igarashi K, Williams K: Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. Mol Pharmacol. 2002 Mar;61(3):533-45. \"Pubmed"
691,"DB07353","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
692,"DB03688","BE0001630","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
693,"DB02789","BE0001264","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
694,"DB00491","BE0000837","# Mooradian AD, Thurman JE: Drug therapy of postprandial hyperglycaemia. Drugs. 1999 Jan;57(1):19-29. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9951949# Rossi EJ, Sim L, Kuntz DA, Hahn D, Johnston BD, Ghavami A, Szczepina MG, Kumar NS, Sterchi EE, Nicho"
695,"DB00171","BE0000750","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
696,"DB01049","BE0000756","# Markstein R: Hydergine: interaction with the neurotransmitter systems in the central nervous system. J Pharmacol. 1985;16 Suppl 3:1-17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2869188"
697,"DB07931","BE0000126","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
698,"DB06938","BE0000369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
699,"DB01159","BE0001200","# Ishizawa Y, Sharp R, Liebman PA, Eckenhoff RG: Halothane binding to a G protein coupled receptor in retinal membranes by photoaffinity labeling. Biochemistry. 2000 Jul 25;39(29):8497-502. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10913255# Keller C, G"
700,"DB00126","BE0002213","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
701,"DB04795","BE0000176","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
702,"DB00048","BE0002141","# Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ: Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):646-53. \"Pubmed\":http://www.ncbi.nlm.nih.g"
703,"DB01356","BE0001065","# Borsotto M, Cavarec L, Bouillot M, Romey G, Macciardi F, Delaye A, Nasroune M, Bastucci M, Sambucy JL, Luan JJ, Charpagne A, Jouet V, Leger R, Lazdunski M, Cohen D, Chumakov I: PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder. Pharmacogenom"
704,"DB04889","BE0000486","# Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E: Characterization of the antinociceptive actions of bicifadine in models of acute, persistent"
705,"DB04068","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
706,"DB00248","BE0000650","# Sharif NA, McLaughlin MA, Kelly CR, Katoli P, Drace C, Husain S, Crosson C, Toris C, Zhan GL, Camras C: Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes. Exp Ey"
707,"DB02630","BE0001250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
708,"DB00485","BE0004646","# Gutkind GO, Ogueta SB, de Urtiaga AC, Mollerach ME, de Torres RA: Participation of PBP 3 in the acquisition of dicloxacillin resistance in Listeria monocytogenes. J Antimicrob Chemother. 1990 May;25(5):751-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
709,"DB00667","BE0000146","# Blaya B, Nicolau-Galmes F, Jangi SM, Ortega-Martinez I, Alonso-Tejerina E, Burgos-Bretones J, Perez-Yarza G, Asumendi A, Boyano MD: Histamine and histamine receptor antagonists in cancer biology. Inflamm Allergy Drug Targets. 2010 Jul 1;9(3):146-57. \"Pu"
710,"DB01764","BE0001238","# Manfredi R, Sabbatani S: Novel pharmaceutical molecules against emerging resistant gram-positive cocci. Braz J Infect Dis. 2010 Jan-Feb;14(1):96-108. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20428664"
711,"DB00277","BE0000013","# Nantwi KD, Basura GJ, Goshgarian HG: Adenosine A1 receptor mRNA expression and the effects of systemic theophylline administration on respiratory function 4 months after C2 hemisection. J Spinal Cord Med. 2003 Winter;26(4):364-71. \"Pubmed\":http://www.nc"
712,"DB02508","BE0000776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
713,"DB03147","BE0002975",""
714,"DB00141","BE0000391","# Spiro RG: Role of N-linked polymannose oligosaccharides in targeting glycoproteins for endoplasmic reticulum-associated degradation. Cell Mol Life Sci. 2004 May;61(9):1025-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15112051# Nogawa M, Takahashi H, "
715,"DB00952","BE0000659","# Hargreaves RJ, Shepheard SL: Pathophysiology of migraine--new insights. Can J Neurol Sci. 1999 Nov;26 Suppl 3:S12-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10563228# Donaldson C, Boers PM, Hoskin KL, Zagami AS, Lambert GA: The role of 5-HT1B and 5-"
716,"DB07137","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
717,"DB02726","BE0003844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
718,"DB07838","BE0003780","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
719,"DB00140","BE0000595","# Russell TR, Demeler B, Tu SC: Kinetic mechanism and quaternary structure of Aminobacter aminovorans NADH:flavin oxidoreductase: an unusual flavin reductase with bound flavin. Biochemistry. 2004 Feb 17;43(6):1580-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
720,"DB00761","BE0000047","# Takayama C, Inoue Y: Developmental localization of potassium chloride co-transporter 2 (KCC2) in the Purkinje cells of embryonic mouse cerebellum. Neurosci Res. 2007 Feb;57(2):322-5. Epub 2006 Nov 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17134779"
721,"DB07260","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
722,"DB02845","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
723,"DB04547","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
724,"DB01887","BE0001342","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
725,"DB01805","BE0004529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
726,"DB00706","BE0000575","# Ishiguro M, Futabayashi Y, Ohnuki T, Ahmed M, Muramatsu I, Nagatomo T: Identification of binding sites of prazosin, tamsulosin and KMD-3213 with alpha(1)-adrenergic receptor subtypes by molecular modeling. Life Sci. 2002 Oct 11;71(21):2531-41. \"Pubmed\":"
727,"DB03950","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
728,"DB00142","BE0004640","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
729,"DB01229","BE0003474","# McGrogan BT, Gilmartin B, Carney DN, McCann A: Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 2008 Apr;1785(2):96-132. Epub 2007 Nov 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18068131"
730,"DB06148","BE0004863","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
731,"DB00811","BE0000282","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
732,"DB01588","BE0003598","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
733,"DB00527","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
734,"DB00601","BE0004800","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
735,"DB08811","BE0000436","# Rundfeldt C, Socala K, Wlaz P: The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. J Neural Transm. 2010 Nov;117(11):1319-25. Epub 2010 Oct 22. \"Pub"
736,"DB00198","BE0000914","# Chavas LM, Kato R, Suzuki N, von Itzstein M, Mann MC, Thomson RJ, Dyason JC, McKimm-Breschkin J, Fusi P, Tringali C, Venerando B, Tettamanti G, Monti E, Wakatsuki S: Complexity in influenza virus targeted drug design: interaction with human sialidases. "
737,"DB05171","BE0003410",""
738,"DB00142","BE0000346","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
739,"DB00785","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
740,"DB00122","BE0002179","# Lee JS, Kim JH, Jang IH, Kim HS, Han JM, Kazlauskas A, Yagisawa H, Suh PG, Ryu SH: Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity. J Cell Sci. 2005 Oct 1;11"
741,"DB01325","BE0000419","# Duarte JD, Cooper-DeHoff RM: Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther. 2010 Jun;8(6):793-802. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20528637# Gamba G: The thia"
742,"DB00170","BE0000547","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
743,"DB02355","BE0002733",""
744,"DB08372","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
745,"DB01942","BE0002655",""
746,"DB01812","BE0001306","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
747,"DB00443","BE0000794","# Tanigawa K, Nagase H, Ohmori K, Tanaka K, Miyake H, Kiniwa M, Ikizawa K: Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters. Int Immunopharmacol. 2002 Jun;2(7):941-50. \"Pubmed\":htt"
748,"DB00129","BE0000258","# Camacho JA, Rioseco-Camacho N, Andrade D, Porter J, Kong J: Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinur"
749,"DB00104","BE0000452","# Wang ZZ, Qu W, Wang F, Li Y, Wang SK, Wang JQ: [Expression of somatostatin receptor reporter gene and its correlation with targeted imaging in vivo for detection of pancreas carcinoma] Zhonghua Zhong Liu Za Zhi. 2005 Nov;27(11):663-6. \"Pubmed\":http://ww"
750,"DB00420","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
751,"DB03461","BE0001251","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
752,"DB06809","BE0000919","# Uy GL, Rettig MP, Cashen AF: Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin Biol Ther. 2008 Nov;8(11):1797-804. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18847313# Jujo K, Ii M, Sekiguchi H, Klyachko E, Mi"
753,"DB03317","BE0003053",""
754,"DB00622","BE0002359","# Bell DC, Butcher AJ, Berrow NS, Page KM, Brust PF, Nesterova A, Stauderman KA, Seabrook GR, Nurnberg B, Dolphin AC: Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D), Ca(V)1.3) voltage-dependent calcium currents. "
755,"DB00934","BE0000405","# El-Fakahany E, Richelson E: Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain. Br J Pharmacol. 1983 Jan;78(1):97-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6297650# Golds PR, Przyslo FR, Strange PG: The binding of "
756,"DB05202","BE0001043",""
757,"DB00831","BE0000418","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235# Torres-Piedra M, Figueroa M, Hernandez-Ab"
758,"DB04233","BE0003979","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
759,"DB03735","BE0002011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
760,"DB08373","BE0004289","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
761,"DB00899","BE0000632","# Wong GT, Li R, Jiang LL, Irwin MG: Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand. 2010 Apr;54(4):510-8. Epub 2009 Oct 29. \"Pubmed\":http://www.ncbi.nlm"
762,"DB00116","BE0002176","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
763,"DB08327","BE0003806","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
764,"DB03347","BE0004036","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
765,"DB07040","BE0002622","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
766,"DB02683","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
767,"DB01053","BE0004654","# Beise F, Labischinski H, Bradaczek H: On the relationships between molecular conformation, affinity towards penicillin-binding proteins, and biological activity of penicillin G-sulfoxide. Z Naturforsch C. 1988 Sep-Oct;43(9-10):656-64. \"Pubmed\":http://ww"
768,"DB03397","BE0001521","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
769,"DB00607","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
770,"DB07009","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
771,"DB00523","BE0000144","# Dzhagalov I, Chambon P, He YW: Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J Immunol. 2007 Feb 15;178(4):2113-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17277115"
772,"DB00270","BE0002359","# Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J: alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem. 2001 Jun 22;276(25):22100-6. Epub 2001 Apr 2. \"Pubmed\":http://www.ncbi.nl"
773,"DB04855","BE0000303",""
774,"DB05816","BE0000020",""
775,"DB08706","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
776,"DB08578","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
777,"DB07287","BE0000332","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
778,"DB00200","BE0000320","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
779,"DB05740","BE0000411",""
780,"DB04709","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
781,"DB06216","BE0000581","# Citrome L: Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatr Dis Treat. 2011;7:325-39. Epub 2011 May 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21655346# Tadori Y, Forbes RA, McQuade RD, Kikuchi T: Functional potencies of d"
782,"DB01598","BE0000302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Pichardo C, Rodriguez-Martinez JM, Pachon-Ibanez ME, Conejo C, Ibanez-Martinez J,"
783,"DB02415","BE0004172","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
784,"DB01721","BE0001265","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
785,"DB01412","BE0000487","# Essayan DM: Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol. 2001 Nov;108(5):671-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11692087# Fisone G, Borgkvist A, Usiello A: Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol "
786,"DB08838","BE0004661","# Loring RH: Agmatine acts as an antagonist of neuronal nicotinic receptors. Br J Pharmacol. 1990 Jan;99(1):207-11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2331571"
787,"DB00129","BE0000136","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
788,"DB00716","BE0001120","# Okada M, Itoh H, Hatakeyama T, Tokumitsu H, Kobayashi R: Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox. Biochem J. 2003 Sep 1;374(Pt 2):433-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12803546# Nishikawa M, "
789,"DB01196","BE0001100","# Moraga D, Rivas-Berrios A, Farias G, Wallin M, Maccioni RB: Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and tau. Biochim Biophys Acta. 1992 May 22;1121(1-2):97-103. \"Pubmed\":http://www.ncbi.nlm.nih.g"
790,"DB04058","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
791,"DB01411","BE0001208","# Hojo M, Suzuki M, Maghni K, Hamid Q, Powell WS, Martin JG: Role of cysteinyl leukotrienes in CD4(+) T cell-driven late allergic airway responses. J Pharmacol Exp Ther. 2000 May;293(2):410-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10773010# Nabe T, "
792,"DB00670","BE0000092","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Pedretti RF, Prete G, Foreman RD, Adamson PB, Vanoli E: Autonomic modulation during acute myocardi"
793,"DB00780","BE0002196","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Chiche F, Le Guillou M, Chetrite G, Lasnier F, Dugail I, Carpene C, Moldes M, Feve B: Antidepressa"
794,"DB03566","BE0002032","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
795,"DB07990","BE0003764","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
796,"DB00675","BE0004877","# Paul R, Silve S, De Nys N, Dupuy PH, Bouteiller CL, Rosenfeld J, Ferrara P, Le Fur G, Casellas P, Loison G: Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Delta8-Delta7 sterol isomeras"
797,"DB01857","BE0001282","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
798,"DB05790","BE0000384",""
799,"DB00917","BE0000064","# Baryawno N, Sveinbjornsson B, Eksborg S, Orrego A, Segerstrom L, Oqvist CO, Holm S, Gustavsson B, Kagedal B, Kogner P, Johnsen JI: Tumor-growthpromoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets. Neuro Oncol."
800,"DB07049","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
801,"DB04074","BE0001742","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
802,"DB03405","BE0003417","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
803,"DB08076","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
804,"DB05162","BE0000857",""
805,"DB00945","BE0000017","# Stevenson DD, Szczeklik A: Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006 Oct;118(4):773-86; quiz 787-8. Epub 2006 Sep 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17030227# Flipo RM: [Are the NSAI"
806,"DB05472","BE0000385",""
807,"DB04425","BE0001289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
808,"DB00126","BE0002205","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
809,"DB00157","BE0000297","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
810,"DB00112","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
811,"DB02659","BE0003990","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
812,"DB02078","BE0004296","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
813,"DB02580","BE0004306","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
814,"DB03532","BE0001813","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
815,"DB02754","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
816,"DB01708","BE0004956","# Compagnone NA, Mellon SH: Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4678-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9539798"
817,"DB01598","BE0000790","# Nicolau DP: Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother. 2008 Jan;9(1):23-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18076336# Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA: Compa"
818,"DB02264","BE0001541","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
819,"DB05488","BE0002425","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
820,"DB03061","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
821,"DB05184","BE0000838",""
822,"DB05080","BE0000442",""
823,"DB00144","BE0000189","# Yan X, Poelstra K, Scherphof GL, Kamps JA: A role for scavenger receptor B-I in selective transfer of rhodamine-PE from liposomes to cells. Biochem Biophys Res Commun. 2004 Dec 17;325(3):908-14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15541376# Yanc"
824,"DB02621","BE0002604","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
825,"DB00070","BE0004821","# Nelson, D.L., & Cox, M.M. (2005). _Lehninger principles of biochemistry_ (4 ^th^ ed). New York, NY: W.H. Freeman and Company. \"doi:10.1002/bmb.2005.494033010419\":http://dx.doi.org/10.1002/bmb.2005.494033010419"
826,"DB07159","BE0001316","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
827,"DB01338","BE0000045","# Karpati E, Biro K, Kukorelli T: [Investigation of neuromuscular blocking agents at Richter Ltd.] Acta Pharm Hung. 2002;72(1):37-48. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12426786"
828,"DB01614","BE0000451","# Kusumi I, Takahashi Y, Suzuki K, Kameda K, Koyama T: Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain. J Neural Transm. 2000;107(3):295-302. \"Pubmed\":http://ww"
829,"DB06953","BE0002372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
830,"DB00589","BE0000389","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
831,"DB04740","BE0003355",""
832,"DB07711","BE0002214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
833,"DB03317","BE0003056",""
834,"DB07475","BE0003917","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
835,"DB00813","BE0000632","# Pascoe JE, Williams KL, Mukhopadhyay P, Rice KC, Woods JH, Ko MC: Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys. Psychoneuroendocrinology. 2008 May;33(4):478-86. Epub 2008 Mar "
836,"DB01415","BE0003579","# Wise R, Andrews JM, Ashby JP, Thornber D: Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action. J Antimicrob Chemother. 1990 Aug;26(2):209-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2120175"
837,"DB07756","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
838,"DB01110","BE0000462","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Kikuchi K, Nagatomo T, Abe H, Kawakam"
839,"DB03247","BE0003029",""
840,"DB00142","BE0000755","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
841,"DB08185","BE0004209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
842,"DB08696","BE0000779","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
843,"DB03127","BE0001586","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
844,"DB00811","BE0003540","# Wu JZ, Larson G, Walker H, Shim JH, Hong Z: Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes. Antimicrob Agents Chemother. 2005 Jun;49(6):2164-71. \"Pu"
845,"DB00925","BE0000572","# Frang H, Cockcroft V, Karskela T, Scheinin M, Marjamaki A: Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors. J Biol Chem. 2001 Aug 17;276(33):31279-84. Epub 2001 Jun 6. \"Pubmed\":http://ww"
846,"DB05239","BE0000870",""
847,"DB00543","BE0000797","# Gozlan H, Saddiki-Traki F, Merahi N, Laguzzi R, Hamon M: [Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats]. Encephale. 1991 Dec;17 Spec No 3:415-22. \"Pubmed\":"
848,"DB07640","BE0004026","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
849,"DB02659","BE0000335","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
850,"DB04925","BE0000211","# Dafer RM, Biller J: Desmoteplase in the treatment of acute ischemic stroke. Expert Rev Neurother. 2007 Apr;7(4):333-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17425487"
851,"DB01719","BE0001243","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
852,"DB01646","BE0001200","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
853,"DB04447","BE0003271",""
854,"DB07097","BE0003757","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
855,"DB01239","BE0000405","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
856,"DB03798","BE0001501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
857,"DB08690","BE0003858","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
858,"DB08468","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
859,"DB00098","BE0001155","# Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003 Feb;3(2):189-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12586600"
860,"DB00069","BE0000385","# Blatt LM, Davis JM, Klein SB, Taylor MW: The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. J Interferon Cytokine Res. 1996 Jul;16(7):489-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
861,"DB00334","BE0004916","# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. doi: 10.1177/0269881107082944. Epub 2008 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
862,"DB00852","BE0000486","# Wee S, Ordway GA, Woolverton WL: Reinforcing effect of pseudoephedrine isomers and the mechanism of action. Eur J Pharmacol. 2004 Jun 16;493(1-3):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15189772# Foley KF, Van Dort ME, Sievert MK, Ruoho AE, "
863,"DB08178","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
864,"DB04170","BE0001417","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
865,"DB03586","BE0001920","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
866,"DB00352","BE0004796","# Schwartz EL, Ishiguro K, Sartorelli AC: Induction of leukemia cell differentiation by chemotherapeutic agents. Adv Enzyme Regul. 1983;21:3-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6400065# Riscoe MK, Brouns MC, Fitchen JH: Purine metabolism as a "
867,"DB07856","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
868,"DB02301","BE0001501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
869,"DB00284","BE0001176","# Juretic D, Bernik S, Cop L, Hadzija M, Petlevski R, Lukac-Bajalo J: Short-term effect of acarbose on specific intestinal disaccharidase activities and hyperglycaemia in CBA diabetic mice. J Anim Physiol Anim Nutr (Berl). 2003 Aug;87(7-8):263-8. \"Pubmed\""
870,"DB00131","BE0000639","# Ingram-Smith C, Woods BI, Smith KS: Characterization of the acyl substrate binding pocket of acetyl-CoA synthetase. Biochemistry. 2006 Sep 26;45(38):11482-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16981708# Ingram-Smith C, Smith KS: AMP-forming ac"
871,"DB00457","BE0000462","# Thomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Sc"
872,"DB01117","BE0000382","# Knecht W, Henseling J, Loffler M: Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid. Chem Biol Interact. 2000 Jan 3;124(1):61-76. \"Pubmed\":http://www.ncbi.nlm.nih"
873,"DB01123","BE0000048","# Sie P, Bezeaud A, Dupouy D, Archipoff G, Freyssinet JM, Dugoujon JM, Serre G, Guillin MC, Boneu B: An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme. J Clin Invest. 1991 Jul;88(1):290-6. \"Pubmed\":http://www.ncbi.nl"
874,"DB03088","BE0002802",""
875,"DB08815","BE0000650","# George M, Amrutheshwar R, Rajkumar RP, Kattimani S, Dkhar SA: Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol. 2013 Apr 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23545936"
876,"DB03531","BE0004141","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
877,"DB06218","BE0000177","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
878,"DB08005","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
879,"DB02175","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
880,"DB08353","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
881,"DB03783","BE0000017","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
882,"DB00536","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
883,"DB04513","BE0001024","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
884,"DB06151","BE0001154","# Oka S, Kamata H, Kamata K, Yagisawa H, Hirata H: N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases. FEBS Lett. 2000 Apr 28;472(2-3):196-202. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10788610"
885,"DB07664","BE0000435","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
886,"DB03751","BE0001740","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
887,"DB02408","BE0004187","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
888,"DB07716","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
889,"DB00851","BE0000716","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
890,"DB08891","BE0002340","Belley M, Sullivan R, Reeves A, Evans J, O?Neill G, Ng GY: Synthesis of the nanomolar photoaffinity GABA receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA receptor forms. Bioorg Med Chem. 1999 Dec;7(12):2697-704. Pubmed    Bra"
891,"DB01918","BE0001301","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
892,"DB01220","BE0000257","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
893,"DB07728","BE0004064","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
894,"DB01017","BE0001051","# Sadowski T, Steinmeyer J: Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. J Rheumatol. 2001 Feb;28(2):336-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11246672# Oringer RJ, Al-Shammari KF, Aldredge WA"
895,"DB04551","BE0000046","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
896,"DB00071","BE0002127","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
897,"DB07843","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
898,"DB01796","BE0001347","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
899,"DB00191","BE0000486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
900,"DB08193","BE0003806","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
901,"DB04395","BE0001209","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
902,"DB03147","BE0002064","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
903,"DB00616","BE0000266","# O'Connell JE, Jardine AG, Davidson G, Connell JM: Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension. J Hypertens. 1992 Mar;10(3):271-7. \"Pubmed\":http://www"
904,"DB03260","BE0003044",""
905,"DB04314","BE0001402","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
906,"DB08398","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
907,"DB03801","BE0001733","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
908,"DB01483","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
909,"DB02305","BE0001416","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
910,"DB00157","BE0000284","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
911,"DB00308","BE0000680","# Doggrell SA, Hancox JC: Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opin Investig Drugs. 2005 May;14(5):655-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15926871# Foster RH, Wilde "
912,"DB00767","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
913,"DB08760","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
914,"DB03814","BE0003188",""
915,"DB01288","BE0000694","# de Vries B, Roffel AF, Zaagsma J, Meurs H: Effect of fenoterol-induced constitutive beta(2)-adrenoceptor activity on contractile receptor function in airway smooth muscle. Eur J Pharmacol. 2001 Nov 23;431(3):353-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
916,"DB00455","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Cieslewicz G, Gondorowicz K, Grzelewska-Rzymowska I, Rozniecki J, Wojciechowska B: [Effect of lora"
917,"DB00536","BE0002994",""
918,"DB07863","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
919,"DB01346","BE0000197","# Stokoe KS, Thomas G, Goddard CA, Colledge WH, Grace AA, Huang CL: Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Delta murine hearts modelling long QT syndrome 3. J Physiol. 2007 Jan 1;578(Pt 1):69-84. Epub 2006 Oct 5. \"Pubme"
920,"DB05418","BE0000384",""
921,"DB02189","BE0004486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
922,"DB02812","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
923,"DB08892","BE0002340","1. Belley M, Sullivan R, Reeves A, Evans J, O?Neill G, Ng GY: Synthesis of the nanomolar photoaffinity GABA receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA receptor forms. Bioorg Med Chem. 1999 Dec;7(12):2697-704. Pubmed2. B"
924,"DB00408","BE0000291","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
925,"DB00934","BE0000560","# El-Fakahany E, Richelson E: Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain. Br J Pharmacol. 1983 Jan;78(1):97-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6297650# Golds PR, Przyslo FR, Strange PG: The binding of "
926,"DB03120","BE0003751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
927,"DB04444","BE0003945","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
928,"DB04160","BE0001828","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
929,"DB03745","BE0001557","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
930,"DB00114","BE0000388","# Hashimoto A, Yoshikawa M: Effect of aminooxyacetic acid on extracellular level of D-serine in rat striatum: an in vivo microdialysis study. Eur J Pharmacol. 2005 Nov 21;525(1-3):91-3. Epub 2005 Nov 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1628945"
931,"DB06877","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
932,"DB02109","BE0002700","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
933,"DB00568","BE0000483","# Singh BN: The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol. 1986;21 Suppl 2:109S-121S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3530295# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca c"
934,"DB00242","BE0000325","# Sampat K, Kantarjian H, Borthakur G: Clofarabine: emerging role in leukemias. Expert Opin Investig Drugs. 2009 Oct;18(10):1559-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19715446# Kantarjian HM, Jeha S, Gandhi V, Wess M, Faderl S: Clofarabine: past"
935,"DB00139","BE0000060","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
936,"DB04821","BE0002196","# Egashira T, Takayama F, Yamanaka Y: The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species. Jpn J Pharmacol. 1999 Sep;81(1):115-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10580379"
937,"DB07338","BE0003808","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
938,"DB08929","BE0000988","\"Ligand Presentation (accessed October 2013):http://investor.ligand.com/files/doc_presentations/MK-8931%20Summary.pdf"
939,"DB08379","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
940,"DB02608","BE0001493","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
941,"DB02899","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
942,"DB04465","BE0002766",""
943,"DB01133","BE0000623","# Murakami H, Takahashi N, Tanaka S, Nakamura I, Udagawa N, Nakajo S, Nakaya K, Abe M, Yuda Y, Konno F, Barbier A, Suda T: Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts. Bone. 1997 May;20(5):399-404. \"Pubmed\":http://www.ncbi.nl"
944,"DB03645","BE0004460","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
945,"DB04122","BE0001439","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
946,"DB04799","BE0003860","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
947,"DB01110","BE0000005","# Wolff DJ, Datto GA, Samatovicz RA: The dual mode of inhibition of calmodulin-dependent nitric-oxide synthase by antifungal imidazole agents. J Biol Chem. 1993 May 5;268(13):9430-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7683652# Bogle RG, Whitley G"
948,"DB01110","BE0003196","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
949,"DB01221","BE0000384","# Okamoto T, Minami K, Uezono Y, Ogata J, Shiraishi M, Shigematsu A, Ueta Y: The inhibitory effects of ketamine and pentobarbital on substance p receptors expressed in Xenopus oocytes. Anesth Analg. 2003 Jul;97(1):104-10, table of contents. \"Pubmed\":http:"
950,"DB08618","BE0003805","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
951,"DB04450","BE0004134","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
952,"DB01065","BE0003553","# Minneman KP, Wurtman RJ: The pharmacology of the pineal gland. Annu Rev Pharmacol Toxicol. 1976;16:33-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/180879"
953,"DB00687","BE0000668","# Otte C, Jahn H, Yassouridis A, Arlt J, Stober N, Maass P, Wiedemann K, Kellner M: The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sci. 2003 Aug 22;73(14):18"
954,"DB03345","BE0000962","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
955,"DB00095","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
956,"DB02022","BE0001455","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
957,"DB01179","BE0000742","# Iida A, Kano M, Kubota Y, Koga K, Tomioka K: Podophyllotoxin aza-analogue, a novel DNA topoisomerase II inhibitor. Chem Pharm Bull (Tokyo). 2000 Apr;48(4):486-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10783066# Zhang YL, Shen YC, Wang ZQ, Chen HX, "
958,"DB00408","BE0000092","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
959,"DB01812","BE0000927","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
960,"DB01252","BE0000207","# Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S: The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Eur J Pharmaco"
961,"DB07428","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
962,"DB07319","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
963,"DB07347","BE0003813","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
964,"DB00546","BE0003592","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
965,"DB00408","BE0000405","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
966,"DB03490","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
967,"DB00025","BE0002118","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
968,"DB00201","BE0002407","# Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR: Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem. 2002 Oct "
969,"DB01752","BE0002514",""
970,"DB00459","BE0000206","# Berggren Soderlund M, Johannesson G, Fex G: Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in Escherichia coli. Biochem J. 1995 May 15;308 ( Pt 1):353-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7755585# Zoubo"
971,"DB01394","BE0000026","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
972,"DB08185","BE0004215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
973,"DB08765","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
974,"DB04760","BE0000966","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
975,"DB00956","BE0000770","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kotzer CJ, Hay DW, Dondio G, Giardina G, Petrillo P, Underwood DC: The antitussive activity of del"
976,"DB00334","BE0000289","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
977,"DB01221","BE0000770","# Smith DJ, Pekoe GM, Martin LL, Coalgate B: The interaction of ketamine with the opiate receptor. Life Sci. 1980 Mar 10;26(10):789-95. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6246318# Hustveit O, Maurset A, Oye I: Interaction of the chiral forms of k"
978,"DB02379","BE0002017","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
979,"DB01008","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
980,"DB00354","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
981,"DB00458","BE0000092","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
982,"DB03158","BE0004437","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
983,"DB02007","BE0001334","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
984,"DB01047","BE0004659","# Wang J, Lu J, Bond MC, Chen M, Ren XR, Lyerly HK, Barak LS, Chen W: Identification of select glucocorticoids as Smoothened agonists: potential utility for regenerative medicine. Proc Natl Acad Sci U S A. 2010 May 18;107(20):9323-8. Epub 2010 May 3. \"Pub"
985,"DB00408","BE0000311","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
986,"DB00188","BE0002347","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
987,"DB00025","BE0001011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
988,"DB03496","BE0001913","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
989,"DB01355","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
990,"DB01395","BE0000668","# Krattenmacher R: Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000 Jul;62(1):29-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11024226# Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH: The novel proges"
991,"DB00926","BE0000707","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
992,"DB03124","BE0001162","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
993,"DB05157","BE0003390",""
994,"DB00459","BE0000707","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
995,"DB03183","BE0001287","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
996,"DB00605","BE0001062","# Rice PL, Goldberg RJ, Ray EC, Driggers LJ, Ahnen DJ: Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res. 2001 Feb 15;61(4):1541-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
997,"DB03541","BE0003128",""
998,"DB02052","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic "
999,"DB00157","BE0000741","# Franklin E, Browne S, Hayes J, Boland C, Dunne A, Elliot G, Mantle TJ: Activation of biliverdin-IXalpha reductase by inorganic phosphate and related anions. Biochem J. 2007 Jul 1;405(1):61-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17402939"
1000,"DB01812","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1001,"DB00492","BE0000221","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Ondetti MA: Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic "
1002,"DB08050","BE0004152","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1003,"DB08396","BE0004312","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1004,"DB00505","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1005,"DB01089","BE0000118","# Sievert MK, Hajipour AR, Ruoho AE: Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels. Anal Biochem. 2007 Aug 1;367(1):68-78. Epub 2007 May 3. \"Pubmed\":htt"
1006,"DB04884","BE0000533","# Wang WF, Chang L, Minhas S, Ralph DJ: Selective serotonin reuptake inhibitors in the treatment of premature ejaculation. Chin Med J (Engl). 2007 Jun 5;120(11):1000-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17624269"
1007,"DB01159","BE0001030","# Milovic S, Steinecker-Frohnwieser B, Schreibmayer W, Weigl LG: The sensitivity of G protein-activated K+ channels toward halothane is essentially determined by the C terminus. J Biol Chem. 2004 Aug 13;279(33):34240-9. Epub 2004 Jun 2. \"Pubmed\":http://ww"
1008,"DB01234","BE0000005","# Soderberg M, Raffalli-Mathieu F, Lang MA: Regulation of the murine inducible nitric oxide synthase gene by dexamethasone involves a heterogeneous nuclear ribonucleoprotein I (hnRNPI) dependent pathway. Mol Immunol. 2007 May;44(12):3204-10. Epub 2007 Mar"
1009,"DB05895","BE0003433",""
1010,"DB07888","BE0001855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1011,"DB07797","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1012,"DB08289","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1013,"DB04092","BE0001642","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1014,"DB00934","BE0000650","# Lucchelli A, Santagostino-Barbone MG, D'Agostino G, Masoero E, Tonini M: The interaction of antidepressant drugs with enteric 5-HT7 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):284-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/109977"
1015,"DB03033","BE0000966","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1016,"DB02494","BE0004112","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1017,"DB08357","BE0004285","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1018,"DB00056","BE0000710","# Ericson SG, Benoit NE, Mills LE, Fanger MW: The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoieti"
1019,"DB00248","BE0000581","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
1020,"DB00304","BE0000123","# Fuhrmann U, Slater EP, Fritzemeier KH: Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays. Contraception. 1995 Jan;51(1):45-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7750284# Rabe T, Bohlmann M"
1021,"DB05492","BE0000572",""
1022,"DB01248","BE0000956","# Ikezoe T, Hisatake Y, Takeuchi T, Ohtsuki Y, Yang Y, Said JW, Taguchi H, Koeffler HP: HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro "
1023,"DB06701","BE0000486","# Markowitz JS, Patrick KS: Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S54-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18480678# Ding YS, Fow"
1024,"DB03147","BE0000220","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1025,"DB05058","BE0002395",""
1026,"DB03149","BE0001732","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1027,"DB00114","BE0000002","# Skoldberg F, Portela-Gomes GM, Grimelius L, Nilsson G, Perheentupa J, Betterle C, Husebye ES, Gustafsson J, Ronnblom A, Rorsman F, Kampe O: Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-li"
1028,"DB03904","BE0000286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1029,"DB05265","BE0000334","# Koizumi W, Tanabe S, Imaizumi H, Kida M, Ohida M, Koshida Y, Mitomi H, Hosaka Y, Nagaba S, Sasaki T, Higuchi K, Saigenji K: Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, c"
1030,"DB02278","BE0001488","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1031,"DB07780","BE0003570","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1032,"DB02548","BE0001199","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1033,"DB05475","BE0002442",""
1034,"DB00420","BE0000451","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1035,"DB01142","BE0000405","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Ehlert FJ, Delen FM, Yun S"
1036,"DB05317","BE0000574",""
1037,"DB07401","BE0003860","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1038,"DB01862","BE0001404","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1039,"DB07046","BE0000870","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1040,"DB08808","BE0000694","# Lenard NR, Gettys TW, Dunn AJ: Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther. 2003 May;305(2):653-9. Epub 2003 Jan 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12606631"
1041,"DB03147","BE0002966",""
1042,"DB06070","BE0001120",""
1043,"DB00143","BE0002282","# Siritantikorn A, Johansson K, Ahlen K, Rinaldi R, Suthiphongchai T, Wilairat P, Morgenstern R: Protection of cells from oxidative stress by microsomal glutathione transferase 1. Biochem Biophys Res Commun. 2007 Apr 6;355(2):592-6. Epub 2007 Feb 12. \"Pub"
1044,"DB01409","BE0000092","# Hansel TT, Barnes PJ: Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Drugs Today (Barc). 2002 Sep;38(9):585-600. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12582447# Barnes PJ: Tiotropium bromide. Exper"
1045,"DB00321","BE0000659","# Werling LL, Keller A, Frank JG, Nuwayhid SJ: A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder. Exp Neurol. 2007 Oct;207(2):248-57. Epub 2007 Jun 30."
1046,"DB04820","BE0002198","# Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS: Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma. Neuropharmacology. 1989 Aug;28(8):791-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2506486"
1047,"DB04530","BE0003323",""
1048,"DB00805","BE0000092","# Duarte CD, Barreiro EJ, Fraga CA: Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem. 2007 Nov;7(11):1108-19. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18045214# Worms P, Kan JP, Steinberg R,"
1049,"DB04185","BE0000306","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1050,"DB05047","BE0000830",""
1051,"DB02624","BE0000752","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1052,"DB04147","BE0004166","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1053,"DB00172","BE0002330","# Huang TC, Huang YW, Hung HJ, Ho CT, Wu ML: Delta1-pyrroline-5-carboxylic acid formed by proline dehydrogenase from the Bacillus subtilis ssp. natto expressed in Escherichia coli as a precursor for 2-acetyl-1-pyrroline. J Agric Food Chem. 2007 Jun 27;55("
1054,"DB00308","BE0000679","# Doggrell SA, Hancox JC: Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opin Investig Drugs. 2005 May;14(5):655-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15926871# Foster RH, Wilde "
1055,"DB00321","BE0000112","# Angus JA, Black JW: Pharmacological assay of cardiac H2-receptor blockade by amitriptyline and lysergic acid diethylamide. Circ Res. 1980 Jun;46(6 Pt 2):I64-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6103762"
1056,"DB00242","BE0000546","# Zhenchuk A, Lotfi K, Juliusson G, Albertioni F: Mechanisms of anti-cancer action and pharmacology of clofarabine. Biochem Pharmacol. 2009 Dec 1;78(11):1351-9. Epub 2009 Jul 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19576186# Kline JP, Larson RA: Cl"
1057,"DB03961","BE0001303","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1058,"DB01992","BE0002682",""
1059,"DB01003","BE0000553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1060,"DB01136","BE0000979","# Ohta Y, Watanabe K, Nakazawa M, Yamamoto T, Ma M, Fuse K, Ito M, Hirono S, Tanabe T, Hanawa H, Kato K, Kodama M, Aizawa Y: Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart. J Cardiovasc Pharmacol. 2000;36"
1061,"DB00697","BE0000289","# Piletz JE, Zhu H, Chikkala DN: Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther. 1996 Nov;279(2):694-702. \"Pubmed\":http://www.ncbi.nlm.nih.go"
1062,"DB00149","BE0000721","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1063,"DB01218","BE0004805","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1064,"DB06718","BE0004843","# Betancor-Hernandez E, Perez-Machin R, Henriquez-Hernandez L, Mateos-Diaz C, Novoa-Mogollon J, Fernandez-Perez L: Photoaffinity labeling identification of thyroid hormone-regulated glucocorticoid-binding peptides in rat liver endoplasmic reticulum: an ol"
1065,"DB00133","BE0000164","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1066,"DB04147","BE0003883","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1067,"DB00696","BE0000756","# Verhoeff NP, Visser WH, Ferrari MD, Saxena PR, van Royen EA: Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier? Cephalalgia. 1993 Oct;13(5):325-9. \"Pubmed\":h"
1068,"DB00173","BE0000115","# Barrett C, Alley J, Pulido JC, Spurling H, Li P, Parsons T, Mallender WD, Bembenek ME: Configuration of a scintillation proximity assay for the activity assessment of recombinant human adenine phosphoribosyltransferase. Assay Drug Dev Technol. 2006 Dec;"
1069,"DB00111","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1070,"DB00157","BE0000735","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1071,"DB00224","BE0004854","# Wittayanarakul K, Hannongbua S, Feig M: Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors. J Comput Chem. 2007 Sep 11;. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
1072,"DB04446","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1073,"DB03101","BE0001224","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1074,"DB00157","BE0000377","# Norman JP, Perry SW, Kasischke KA, Volsky DJ, Gelbard HA: HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis "
1075,"DB03542","BE0001152","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1076,"DB00145","BE0000760","# Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT: NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007 Mar 14;27(11):2846-57. "
1077,"DB04753","BE0000250","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1078,"DB02083","BE0001301","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1079,"DB01215","BE0002344","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
1080,"DB01200","BE0000659","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
1081,"DB02816","BE0001430","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1082,"DB00030","BE0002125","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1083,"DB00048","BE0002130","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1084,"DB01567","BE0003592","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
1085,"DB03175","BE0003751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1086,"DB03323","BE0001847","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1087,"DB02467","BE0004533","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1088,"DB00313","BE0002366","# Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Gottlicher M: The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 2003 Jul 1;22(13):"
1089,"DB05777","BE0000041",""
1090,"DB01021","BE0000535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1091,"DB07780","BE0000776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1092,"DB01267","BE0000659","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243"
1093,"DB03040","BE0000994","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1094,"DB05003","BE0002450",""
1095,"DB00171","BE0000435","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1096,"DB05139","BE0003411",""
1097,"DB00157","BE0000073","# Xu H, West AH, Cook PF: Determinants of substrate specificity for saccharopine dehydrogenase from Saccharomyces cerevisiae. Biochemistry. 2007 Jun 26;46(25):7625-36. Epub 2007 Jun 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17542618# Xu H, West AH, C"
1098,"DB00129","BE0000212","# Rotmann A, Strand D, Martine U, Closs EI: Protein kinase C activation promotes the internalization of the human cationic amino acid transporter hCAT-1. A new regulatory mechanism for hCAT-1 activity. J Biol Chem. 2004 Dec 24;279(52):54185-92. Epub 2004 "
1099,"DB02726","BE0001877","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1100,"DB00094","BE0000387","# Layman LC: Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. Semin Reprod Med. 2000;18(1):5-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11299519# Leng N, Dattatreyamurty B, Reichert LE Jr: Ident"
1101,"DB07374","BE0003825","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1102,"DB02016","BE0001466","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1103,"DB08692","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1104,"DB07262","BE0002010","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1105,"DB00393","BE0002356","# Weant KA, Ramsey CN 3rd, Cook AM: Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage. Pharmacotherapy. 2010 Apr;30(4):405-17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20334460# Dong CJ, Guo Y, Agey P,"
1106,"DB07927","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1107,"DB02580","BE0004302","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1108,"DB07671","BE0003845","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1109,"DB04349","BE0001917","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1110,"DB01497","BE0001063","# Maneckjee R, Archer S, Zukin RS: Characterization of a polyclonal antibody to the mu opioid receptor. J Neuroimmunol. 1988 Feb;17(3):199-208. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2828423# Stojilkovic SS, Dufau ML, Catt KJ: Opiate receptor subtype"
1111,"DB04369","BE0001583","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1112,"DB00798","BE0000942","# Watanabe A, Nagai J, Adachi Y, Katsube T, Kitahara Y, Murakami T, Takano M: Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists. J Control Release. 2004 Mar 24;95(3):423-33. \"Pubmed\":http:/"
1113,"DB00734","BE0000533","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Canton H, Verriele L, Millan MJ: Competitive ant"
1114,"DB03461","BE0002651",""
1115,"DB03750","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1116,"DB05147","BE0001275",""
1117,"DB04272","BE0004443","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1118,"DB04395","BE0001195","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1119,"DB03758","BE0004330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1120,"DB01189","BE0000218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1121,"DB03316","BE0001397","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1122,"DB03147","BE0002984",""
1123,"DB08154","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1124,"DB02583","BE0000330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1125,"DB00553","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1126,"DB00935","BE0000501","# Yang HT, Endoh M: (+/-)-tamsulosin, an alpha 1A-adrenoceptor antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart. Eur J Pharmacol. 1996 Oct 3;312(3):281-91. \"Pubmed\":http://www.ncbi.nlm.nih."
1127,"DB05078","BE0002420",""
1128,"DB00246","BE0000945","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
1129,"DB02733","BE0001062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
1130,"DB01903","BE0001409","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1131,"DB02486","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1132,"DB08492","BE0000309","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1133,"DB02706","BE0001559","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1134,"DB00805","BE0000451","# Kodama K, Shibata S, Ueki S: Protective effect of minaprine against the abnormal changes of 2-deoxyglucose uptake by rat hippocampal slices induced by hypoxia/hypoglycemia. Jpn J Pharmacol. 1992 Sep;60(1):33-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
1135,"DB06992","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1136,"DB06148","BE0000451","# Grinshpoon A, Valevski A, Moskowitz M, Weizman A: Beneficial effect of the addition of the 5-HT 2A/2C and alpha2 antagonist mianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients. Eur Psychiatry. 200"
1137,"DB04855","BE0002356",""
1138,"DB05920","BE0000742",""
1139,"DB01064","BE0000694","# Abraham G, Kottke C, Dhein S, Ungemach FR: Pharmacological and biochemical characterization of the beta-adrenergic signal transduction pathway in different segments of the respiratory tract. Biochem Pharmacol. 2003 Sep 15;66(6):1067-81. \"Pubmed\":http://"
1140,"DB02597","BE0000266","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1141,"DB00029","BE0000538","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1142,"DB00078","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1143,"DB01115","BE0000781","# Bett GC, Rasmusson RL: Modification of K+ channel-drug interactions by ancillary subunits. J Physiol. 2008 Feb 15;586(4):929-50. Epub 2007 Dec 20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18096604"
1144,"DB03709","BE0002976",""
1145,"DB04520","BE0001584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1146,"DB01242","BE0000814","# Baranczyk-Kuzma A, Sawicki J, Kuzma M, Jagiello J: [Tricyclic antidepressants as inhibitors of brain glutathione-S-transferase] Pol Merkur Lekarski. 2001 Dec;11(66):472-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11899840# Baranczyk-Kuzma A, Kuzma M,"
1147,"DB04538","BE0003325",""
1148,"DB01595","BE0003593","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
1149,"DB01997","BE0000005","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1150,"DB04368","BE0002201","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
1151,"DB00726","BE0000451","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
1152,"DB01632","BE0000115","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1153,"DB00875","BE0000092","# Golds PR, Przyslo FR, Strange PG: The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors. Br J Pharmacol. 1980 Mar;68(3):541-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7052344"
1154,"DB00073","BE0002097","# Niwa R, Hatanaka S, Shoji-Hosaka E, Sakurada M, Kobayashi Y, Uehara A, Yokoi H, Nakamura K, Shitara K: Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism. Clin Cancer Res"
1155,"DB00132","BE0002247","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1156,"DB04106","BE0001979","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1157,"DB04453","BE0002639",""
1158,"DB05101","BE0000767",""
1159,"DB01989","BE0004479","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1160,"DB01229","BE0001100","# McGrogan BT, Gilmartin B, Carney DN, McCann A: Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 2008 Apr;1785(2):96-132. Epub 2007 Nov 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18068131"
1161,"DB07920","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1162,"DB03268","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1163,"DB07231","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1164,"DB06802","BE0000262","# Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM: Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation. 2000 Aug;24(4):357-7"
1165,"DB00321","BE0003603","# Casis O, Sanchez-Chapula JA: Disopyramide, imipramine, and amitriptyline bind to a common site on the transient outward K+ channel. J Cardiovasc Pharmacol. 1998 Oct;32(4):521-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9781919"
1166,"DB08437","BE0003831","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1167,"DB02168","BE0002706",""
1168,"DB01081","BE0000770","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Baker DE: Loperamide: a pharmacological review. Rev Gastroenterol Disord. 2007;7 Suppl 3:S11-8. \"P"
1169,"DB06692","BE0001739","# Mahdy AM, Webster NR: Perioperative systemic haemostatic agents. Br J Anaesth. 2004 Dec;93(6):842-58. Epub 2004 Jul 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15277296"
1170,"DB04395","BE0001565","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1171,"DB00142","BE0002275","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1172,"DB00907","BE0000092","# Carrera MR, Meijler MM, Janda KD: Cocaine pharmacology and current pharmacotherapies for its abuse. Bioorg Med Chem. 2004 Oct 1;12(19):5019-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15351386"
1173,"DB02269","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1174,"DB03271","BE0001708","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1175,"DB08086","BE0001563","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1176,"DB00477","BE0000575","# Cahir M, King DJ: Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat. Eur Neuropsychopharmacol. 2005 Mar;15(2):231-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15695070"
1177,"DB00853","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1178,"DB04646","BE0002474","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1179,"DB08231","BE0002442","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1180,"DB07543","BE0001248","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1181,"DB04109","BE0001583","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1182,"DB08299","BE0001133","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1183,"DB00303","BE0000588","# Kohler J, Dorso KL, Young K, Hammond GG, Rosen H, Kropp H, Silver LL: In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumo"
1184,"DB08603","BE0004345","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1185,"DB00679","BE0000451","# Andree TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY: Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. J Neurochem. 1986 Jan;46(1):191-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
1186,"DB03130","BE0000962","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1187,"DB04326","BE0004565","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1188,"DB00733","BE0000426","# Jokanovic M, Prostran M: Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem. 2009;16(17):2177-88. \"Pubmed\":http://www.ncbi.nlm.nih.g"
1189,"DB01215","BE0003594","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
1190,"DB02524","BE0001431","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1191,"DB04476","BE0001084","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1192,"DB02606","BE0001892","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1193,"DB00644","BE0000203","# Lu ZL, Gallagher R, Sellar R, Coetsee M, Millar RP: Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-a"
1194,"DB07816","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1195,"DB03800","BE0001400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1196,"DB07441","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1197,"DB01392","BE0000289","# Laurila JM, Xhaard H, Ruuskanen JO, Rantanen MJ, Karlsson HK, Johnson MS, Scheinin M: The second extracellular loop of alpha2A-adrenoceptors contributes to the binding of yohimbine analogues. Br J Pharmacol. 2007 Aug;151(8):1293-304. Epub 2007 Jun 11. \""
1198,"DB05319","BE0002446",""
1199,"DB02309","BE0001240","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1200,"DB04464","BE0003815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1201,"DB00568","BE0002357","# Singh BN: The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol. 1986;21 Suppl 2:109S-121S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3530295# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca c"
1202,"DB01004","BE0004796","# Martin M, Azzi A, Lin SX, Boivin G: Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity. Antivir Ther. 2010;15(4):579-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20587851# Boivin G, Goyette"
1203,"DB02153","BE0001462","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1204,"DB01752","BE0001456","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1205,"DB01009","BE0000262","# Kay-Mugford P, Benn SJ, LaMarre J, Conlon P: In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res. 2000 Jul;61(7):802-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10895904# Sommerauer M, Ates M, Gu"
1206,"DB00273","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1207,"DB02010","BE0001341","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1208,"DB01955","BE0001276","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1209,"DB00143","BE0001117","# Martinez Molina D, Wetterholm A, Kohl A, McCarthy AA, Niegowski D, Ohlson E, Hammarberg T, Eshaghi S, Haeggstrom JZ, Nordlund P: Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature. 2007 Aug 2;448(7153):613-"
1210,"DB03942","BE0002042","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1211,"DB07528","BE0000369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1212,"DB01812","BE0001541","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1213,"DB07557","BE0000412","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1214,"DB01598","BE0000588","# Nicolau DP: Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother. 2008 Jan;9(1):23-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18076336# Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA: Compa"
1215,"DB00199","BE0002464","# Halling SM, Jensen AE: Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications. BMC Microbiol. 2006 Oct 2;6:84. \"Pubmed\":http://www.ncbi.nlm.nih.g"
1216,"DB01190","BE0000743","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1217,"DB01769","BE0002148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1218,"DB08391","BE0000631","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1219,"DB04799","BE0003859","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1220,"DB02145","BE0001234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1221,"DB08689","BE0004378","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1222,"DB02153","BE0002704",""
1223,"DB02109","BE0002231","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1224,"DB06987","BE0000994","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1225,"DB08901","BE0002133","# Gozgit JM, Squillace RM, Wongchenko MJ, Miller D, Wardwell S, Mohemmad Q, Narasimhan NI, Wang F, Clackson T, Rivera VM: Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endomet"
1226,"DB01073","BE0000325","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1227,"DB03215","BE0002807",""
1228,"DB00126","BE0000168","# Kang JS, Kim HN, Jung da J, Kim JE, Mun GH, Kim YS, Cho D, Shin DH, Hwang YI, Lee WJ: Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membr"
1229,"DB01239","BE0000247","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
1230,"DB08620","BE0003963","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1231,"DB02494","BE0003827","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1232,"DB03101","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1233,"DB00087","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1234,"DB05147","BE0003401",""
1235,"DB03600","BE0000801","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1236,"DB06061","BE0003430",""
1237,"DB04272","BE0002690",""
1238,"DB02181","BE0001442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1239,"DB04310","BE0002201","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1240,"DB07038","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1241,"DB05004","BE0002419",""
1242,"DB05743","BE0000659",""
1243,"DB01363","BE0000694","# Vansal SS, Feller DR: Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol. 1999 Sep 1;58(5):807-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10449190"
1244,"DB04112","BE0001640","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1245,"DB08234","BE0004138","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1246,"DB01975","BE0001348","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1247,"DB00805","BE0000393","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1248,"DB08022","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1249,"DB03814","BE0002180",""
1250,"DB05511","BE0000354",""
1251,"DB03247","BE0001807","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1252,"DB07763","BE0003855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1253,"DB03459","BE0001928","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1254,"DB02039","BE0002695",""
1255,"DB07557","BE0003848","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1256,"DB06832","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1257,"DB04558","BE0000041","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1258,"DB04842","BE0000756","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1259,"DB03818","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1260,"DB08231","BE0000014","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1261,"DB06920","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1262,"DB00668","BE0000753","# Erlandsen H, Flatmark T, Stevens RC, Hough E: Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution. Biochemistry. 1998 Nov 10;37(45):15638-46. \"Pubmed\":http://www.ncbi.nlm.n"
1263,"DB04811","BE0003363",""
1264,"DB05888","BE0003429",""
1265,"DB07551","BE0003849","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1266,"DB00619","BE0000453","# Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK: Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Dig Dis Sci. 2006 Jun;51(6):1043-6. \"Pubmed\""
1267,"DB00714","BE0000797","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
1268,"DB08903","BE0004748","# FDA label # Koul A, Dendouga N, Vergauwen K, Molenberghs B, Vranckx L, Willebrords R, Ristic Z, Lill H, Dorange I, Guillemont J, Bald D, Andries K: Diarylquinolines target subunit c of mycobacterial ATP synthase. Nat Chem Biol. 2007 Jun;3(6):323-4. Epub"
1269,"DB07529","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1270,"DB06734","BE0003569","# Schuhmann T, Grond S: Biosynthetic investigations of the V-type ATPase inhibitors bafilomycin A1, B1 and concanamycin A. J Antibiot (Tokyo). 2004 Oct;57(10):655-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15638326"
1271,"DB01115","BE0000418","# Lamers JM, Cysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. Biochem Pharmacol. 1985 Nov 1;34(21):3837-43. \"Pubmed\":http://www.n"
1272,"DB02637","BE0001641","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1273,"DB01026","BE0002090","# Weber MM, Will A, Adelmann B, Engelhardt D: Effect of ketoconazole on human ovarian C17,20-desmolase and aromatase. J Steroid Biochem Mol Biol. 1991 Feb;38(2):213-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2004042"
1274,"DB08233","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1275,"DB03147","BE0002976",""
1276,"DB02190","BE0001249","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1277,"DB01267","BE0000572","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243"
1278,"DB02359","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1279,"DB08815","BE0000756","# George M, Amrutheshwar R, Rajkumar RP, Kattimani S, Dkhar SA: Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol. 2013 Apr 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23545936"
1280,"DB01407","BE0000704","# Izeboud CA, Mocking JA, Monshouwer M, van Miert AS, Witkamp RF: Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):191-202. \"Pubmed\":http://www.ncb"
1281,"DB00157","BE0000360","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1282,"DB04373","BE0001694","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1283,"DB03274","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1284,"DB01642","BE0001219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1285,"DB02674","BE0001668","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1286,"DB07469","BE0003893","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1287,"DB00142","BE0000835","# Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor "
1288,"DB07374","BE0003827","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1289,"DB03286","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1290,"DB04843","BE0000092","# Tsai CS, Guede-Guina F, Smith MO, Vangah-Manda M, Ochillo RF: Isolation of cholinergic active ingredients in aqueous extracts of Mareya micrantha using the longitudinal muscle of isolated guinea-pig ileum as a pharmacological activity marker. J Ethnopha"
1291,"DB03884","BE0004112","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1292,"DB00359","BE0002360","# de Araujo MV, Vieira EK, Silva Lazaro G, Conegero LS, Almeida LE, Barreto LS, da Costa NB Jr, Gimenez IF: Sulfadiazine/hydroxypropyl-beta-cyclodextrin host-guest system: Characterization, phase-solubility and molecular modeling. Bioorg Med Chem. 2008 Ma"
1293,"DB01095","BE0000574","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Podar K, Tai YT, Hideshima T, Vallet S, Richardson PG, Anderson KC: Emerging therapies for multipl"
1294,"DB07506","BE0003968","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1295,"DB03801","BE0001801","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1296,"DB01588","BE0003599","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
1297,"DB00128","BE0002225","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1298,"DB00701","BE0004854","# Wittayanarakul K, Hannongbua S, Feig M: Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors. J Comput Chem. 2007 Sep 11;. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
1299,"DB03771","BE0001553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1300,"DB02875","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1301,"DB01028","BE0000503","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1302,"DB03320","BE0002838",""
1303,"DB03348","BE0000426","# He XC, Feng S, Wang ZF, Shi Y, Zheng S, Xia Y, Jiang H, Tang XC, Bai D: Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B. Bioorg Med Chem. 2007 Feb 1;15(3):1394-408. Epub 2006 Nov 9. \""
1304,"DB08874","BE0004732","# Venugopal AA, Johnson S: Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection. Clin Infect Dis. 2012 Feb 15;54(4):568-74. doi: 10.1093/cid/cir830. Epub 2011 Dec 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
1305,"DB04032","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1306,"DB02615","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1307,"DB01942","BE0002656",""
1308,"DB00015","BE0000211","# Hilleman DE, Tsikouris JP, Seals AA, Marmur JD: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Pharmacotherapy. 2007 Nov;27(11):1558-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17963464# Longstaff C, Williams S"
1309,"DB03228","BE0001616","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1310,"DB00466","BE0000745","# Yang Z, Cromer BA, Harvey RJ, Parker MW, Lynch JW: A proposed structural basis for picrotoxinin and picrotin binding in the glycine receptor pore. J Neurochem. 2007 Oct;103(2):580-9. Epub 2007 Aug 20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17714449"
1311,"DB04162","BE0001767","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1312,"DB03674","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1313,"DB03413","BE0001364","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1314,"DB03317","BE0003052",""
1315,"DB01363","BE0000118","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Henry JP, Sagne C, Bedet C, Gasnier B: The vesicula"
1316,"DB03937","BE0001721","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1317,"DB01364","BE0000118","# Ellis JD, German CL, Birdsall E, Hanson JE, Crosby MA, Rowley SD, Sawada NA, West JN, Hanson GR, Fleckenstein AE: Ephedrine decreases vesicular monoamine transporter-2 function. Synapse. 2010 Dec 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21162110#"
1318,"DB00277","BE0000436","# Rickards KJ, Andrews MJ, Waterworth TH, Alexander GB, Cunningham FM: Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation. J Vet Pharmacol Ther. 200"
1319,"DB04132","BE0002659",""
1320,"DB00543","BE0004864","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881"
1321,"DB00409","BE0000156","# Lang A, Soosaar A, Koks S, Volke V, Bourin M, Bradwejn J, Vasar E: Pharmacological comparison of antipsychotic drugs and sigma-antagonists in rodents. Pharmacol Toxicol. 1994 Sep-Oct;75(3-4):222-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7800667# Ok"
1322,"DB03801","BE0001725","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1323,"DB08023","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1324,"DB02379","BE0002006","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1325,"DB01700","BE0001240","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1326,"DB04578","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1327,"DB02731","BE0002256","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1328,"DB00248","BE0000289","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
1329,"DB04432","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1330,"DB01392","BE0000581","# Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, Coge F, Galizzi JP, Boutin JA, Rivet JM, Dekeyne A, Gobert A: Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, seroton"
1331,"DB05758","BE0000704",""
1332,"DB00157","BE0000446","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1333,"DB04315","BE0003277",""
1334,"DB00114","BE0000409","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1335,"DB03814","BE0001920","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1336,"DB00373","BE0000172","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Nieminen T, Uusitalo H, Maenpaa J, Turjanmaa V, Rane A, Lundgren S, Ropo A, Rontu R, Lehtimaki T, "
1337,"DB06213","BE0000924","# Zoghbi GJ, Iskandrian AE: Selective adenosine agonists and myocardial perfusion imaging. J Nucl Cardiol. 2012 Feb;19(1):126-41. doi: 10.1007/s12350-011-9474-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/22130964"
1338,"DB07309","BE0001534","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1339,"DB04031","BE0001896","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1340,"DB04160","BE0001218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1341,"DB02329","BE0000329","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
1342,"DB02458","BE0001189","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1343,"DB03397","BE0001901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1344,"DB03796","BE0004171","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1345,"DB01254","BE0000841","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1346,"DB01987","BE0003274",""
1347,"DB02031","BE0001433","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1348,"DB05216","BE0000915",""
1349,"DB05024","BE0000779",""
1350,"DB00212","BE0000270","# van Paassen P, Navis GJ, De Jong PE, De Zeeuw D: Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension. Eur J Clin Invest. 1999 Dec;29(12):1019-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
1351,"DB04223","BE0000067","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1352,"DB00171","BE0001069","# Materna V, Stege A, Surowiak P, Priebsch A, Lage H: RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Biochem Biophys Res Commun. 2006 Sep 15;348(1):153-7. Epub 2006 Jul 14. \"Pubmed\":http://www.ncbi.nlm.n"
1353,"DB02324","BE0001403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1354,"DB02994","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1355,"DB01137","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1356,"DB01225","BE0000216","# Graff J, Picard-Willems B, Harder S: Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a. Int J Clin Ph"
1357,"DB08036","BE0003800","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1358,"DB00546","BE0000129","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
1359,"DB00586","BE0000897","# Peretz A, Degani N, Nachman R, Uziyel Y, Gibor G, Shabat D, Attali B: Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol. 2005 Ap"
1360,"DB03910","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1361,"DB07454","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1362,"DB05147","BE0001391",""
1363,"DB08675","BE0000117","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1364,"DB00912","BE0000215","# Scarsi M, Podvinec M, Roth A, Hug H, Kersten S, Albrecht H, Schwede T, Meyer UA, Rucker C: Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol Phar"
1365,"DB02314","BE0001538","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1366,"DB03742","BE0000123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1367,"DB06216","BE0000291","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235# Shahid M, Walker GB, Zorn SH, Wong EH: As"
1368,"DB02333","BE0001400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1369,"DB04754","BE0000250","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1370,"DB01785","BE0000776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1371,"DB05036","BE0002480",""
1372,"DB01548","BE0001063","# Law PY, Hom DS, Loh HH: Multiple affinity states of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Opiate agonist association rate is a function of receptor occupancy. J Biol Chem. 1985 Mar 25;260(6):3561-9. \"Pubmed\":http://www.ncbi.nl"
1373,"DB03317","BE0001749","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1374,"DB07911","BE0003969","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1375,"DB00184","BE0000850","# Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley T, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, Rhee SH, Schlaepfer I, Smolen A, Stallings MC, Young SE, Zeiger JS: Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subje"
1376,"DB04465","BE0001947","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1377,"DB00920","BE0000627","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1378,"DB06948","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1379,"DB00126","BE0002206","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1380,"DB00726","BE0000442","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
1381,"DB02078","BE0004295","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1382,"DB00477","BE0000756","# Oades RD, Rao ML, Bender S, Sartory G, Muller BW: Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy. Behav Pharmaco"
1383,"DB08059","BE0003745","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1384,"DB02098","BE0000908","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1385,"DB04173","BE0001687","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1386,"DB00321","BE0000715","# Nojimoto FD, Mueller A, Hebeler-Barbosa F, Akinaga J, Lima V, Kiguti LR, Pupo AS: The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors. Neuropharmacology. 2010 Jul-Aug;59(1"
1387,"DB01626","BE0002198","# Patkar AA, Pae CU, Masand PS: Transdermal selegiline: the new generation of monoamine oxidase inhibitors. CNS Spectr. 2006 May;11(5):363-75. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16641841# Azzaro AJ, Ziemniak J, Kemper E, Campbell BJ, VanDenBerg C"
1388,"DB07144","BE0000330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1389,"DB02240","BE0001551","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1390,"DB01576","BE0001044","# Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DK: Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. J Pharmacol Exp Ther. 2007 Apr;321(1):17"
1391,"DB00704","BE0000770","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kato H: [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependen"
1392,"DB00887","BE0001195","# Reddy MM, Quinton PM: Bumetanide blocks CFTR GCl in the native sweat duct. Am J Physiol. 1999 Jan;276(1 Pt 1):C231-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9886939"
1393,"DB00463","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
1394,"DB01100","BE0000090","# Kang J, Wang L, Cai F, Rampe D: High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide. Eur J Pharmacol. 2000 Mar 31;392(3):137-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10762666# Osypenko VM, Degtiar VIe, Naid'onov VG"
1395,"DB02581","BE0001029","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1396,"DB03076","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1397,"DB00386","BE0000118","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1398,"DB01254","BE0000891","# Fiskus W, Pranpat M, Balasis M, Bali P, Estrella V, Kumaraswamy S, Rao R, Rocha K, Herger B, Lee F, Richon V, Bhalla K: Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-s"
1399,"DB07780","BE0004072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1400,"DB06168","BE0001051","# Church LD, McDermott MF: Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther. 2009 Feb;11(1):81-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19169963"
1401,"DB02264","BE0001457","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1402,"DB02474","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1403,"DB08357","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1404,"DB00321","BE0002398","# Punke MA, Friederich P: Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels. Anesth Analg. 2007 May;104(5):1256-64, tables of contents. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17456683"
1405,"DB02258","BE0000144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1406,"DB05039","BE0000694","# Cazzola M, Matera MG, Lotvall J: Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2005 Jul;14(7):775-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16022567"
1407,"DB03663","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1408,"DB03705","BE0003133",""
1409,"DB04035","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1410,"DB00986","BE0000560","# Haddad EB, Patel H, Keeling JE, Yacoub MH, Barnes PJ, Belvisi MG: Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways. Br J Pharmacol. 1999 May;127(2):413-20. \"Pubmed\":http://www.ncbi.n"
1411,"DB07118","BE0003785","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1412,"DB01819","BE0001394","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1413,"DB00220","BE0000664","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1414,"DB00306","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
1415,"DB03937","BE0001199","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1416,"DB01147","BE0002475","# Nicola G, Tomberg J, Pratt RF, Nicholas RA, Davies C: Crystal structures of covalent complexes of beta-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity. Biochemistry. 2010 Sep 21;49"
1417,"DB01023","BE0000430","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T: Selectivities of dihydropyridine der"
1418,"DB02103","BE0001165","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1419,"DB03181","BE0000315","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1420,"DB08014","BE0001612","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1421,"DB01415","BE0000588","# Wise R, Andrews JM, Ashby JP, Thornber D: Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action. J Antimicrob Chemother. 1990 Aug;26(2):209-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2120175"
1422,"DB04137","BE0002231","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1423,"DB00439","BE0000574","# Shiomi M, Ito T: Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits. Br J Pharmacol. 1999 Feb;126(4):961-8. \"Pubmed\":ht"
1424,"DB00441","BE0000637","# Vernejoul F, Ghenassia L, Souque A, Lulka H, Drocourt D, Cordelier P, Pradayrol L, Pyronnet S, Buscail L, Tiraby G: Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth. Mol Ther. 2006 Dec;14(6):758-67. Epub 2006 Sep 2"
1425,"DB08261","BE0004080","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1426,"DB00241","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
1427,"DB03247","BE0001525","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1428,"DB04645","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1429,"DB00334","BE0004915","# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. doi: 10.1177/0269881107082944. Epub 2008 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
1430,"DB01202","BE0000993","# Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B: The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9861-6. Epub 2004 Jun 21. \"Pubm"
1431,"DB04133","BE0000576","# Powell JK, Young KD: Lysis of Escherichia coli by beta-lactams which bind penicillin-binding proteins 1a and 1b: inhibition by heat shock proteins. J Bacteriol. 1991 Jul;173(13):4021-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2061284"
1432,"DB06589","BE0004714","# Deeks ED: Pazopanib: in advanced soft tissue sarcoma. Drugs. 2012 Nov 12;72(16):2129-40. doi: 10.2165/11209950-000000000-00000. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23072642"
1433,"DB00767","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1434,"DB00125","BE0000052","# Rotmann A, Simon A, Martine U, Habermeier A, Closs EI: Activation of classical protein kinase C decreases transport via systems y+ and y+L. Am J Physiol Cell Physiol. 2007 Jun;292(6):C2259-68. Epub 2007 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
1435,"DB00603","BE0000557","# Risch HA, Bale AE, Beck PA, Zheng W: PGR +331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1738-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16985038# Madauss KP, Stewart EL, Williams SP: The e"
1436,"DB06968","BE0001337","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1437,"DB01153","BE0000233","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1438,"DB00908","BE0000090","# Po SS, Wang DW, Yang IC, Johnson JP Jr, Nie L, Bennett PB: Modulation of HERG potassium channels by extracellular magnesium and quinidine. J Cardiovasc Pharmacol. 1999 Feb;33(2):181-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10028924# Dong DL, Li Z,"
1439,"DB03147","BE0001979","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1440,"DB00284","BE0000837","# Okumiya T, Keulemans JL, Kroos MA, Van der Beek NM, Boer MA, Takeuchi H, Van Diggelen OP, Reuser AJ: A new diagnostic assay for glycogen storage disease type II in mixed leukocytes. Mol Genet Metab. 2006 May;88(1):22-8. Epub 2005 Dec 15. \"Pubmed\":http:/"
1441,"DB00546","BE0000471","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
1442,"DB00200","BE0000936","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1443,"DB04338","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1444,"DB02257","BE0001469","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1445,"DB07452","BE0001405","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1446,"DB01030","BE0004796","# Staker BL, Hjerrild K, Feese MD, Behnke CA, Burgin AB Jr, Stewart L: The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15387-92. Epub 2002 Nov 8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
1447,"DB07767","BE0003007","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1448,"DB08457","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1449,"DB05007","BE0000511",""
1450,"DB00485","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
1451,"DB03857","BE0001335","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1452,"DB05657","BE0003383","# Venkova K, Fraser G, Hoveyda HR, Greenwood-Van Meerveld B: Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus. Dig Dis Sci. 2007 Sep;52(9):2241-8. Epub 2007 Apr 10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
1453,"DB00683","BE0000523","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
1454,"DB02191","BE0001412","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1455,"DB04156","BE0004551","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1456,"DB00050","BE0000203","# Volker P, Grundker C, Schmidt O, Schulz KD, Emons G: Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteini"
1457,"DB02703","BE0001800","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1458,"DB00276","BE0000742","# Finlay GJ, Atwell GJ, Baguley BC: Inhibition of the action of the topoisomerase II poison amsacrine by simple aniline derivatives: evidence for drug-protein interactions. Oncol Res. 1999;11(6):249-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10691026"
1459,"DB03612","BE0000377","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1460,"DB05110","BE0000944",""
1461,"DB00408","BE0000650","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
1462,"DB00496","BE0000560","# Jha S, Parsons M: Treatment of overactive bladder in the aging population: focus on darifenacin. Clin Interv Aging. 2006;1(4):309-16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18046909# Moriya H, Takagi Y, Nakanishi T, Hayashi M, Tani T, Hirotsu I: Af"
1463,"DB00071","BE0002124","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1464,"DB08570","BE0001930","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1465,"DB00584","BE0000221","# Andujar-Sanchez M, Jara-Perez V, Camara-Artigas A: Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method. FEBS Lett. 2007 Jul 24;581(18):3449-54. Epub 2007 Jun 27. \"Pubmed\":http://www.n"
1466,"DB06216","BE0000451","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235# Citrome L: Role of sublingual asenapine i"
1467,"DB05387","BE0000642",""
1468,"DB07669","BE0004047","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1469,"DB00512","BE0002817","# Mulichak AM, Lu W, Losey HC, Walsh CT, Garavito RM: Crystal structure of vancosaminyltransferase GtfD from the vancomycin biosynthetic pathway: interactions with acceptor and nucleotide ligands. Biochemistry. 2004 May 11;43(18):5170-80. \"Pubmed\":http://"
1470,"DB00162","BE0000726","# Maeda A, Maeda T, Imanishi Y, Sun W, Jastrzebska B, Hatala DA, Winkens HJ, Hofmann KP, Janssen JJ, Baehr W, Driessen CA, Palczewski K: Retinol dehydrogenase (RDH12) protects photoreceptors from light-induced degeneration in mice. J Biol Chem. 2006 Dec 8"
1471,"DB04747","BE0003358",""
1472,"DB00134","BE0000734","# Taurog RE, Matthews RG: Activation of methyltetrahydrofolate by cobalamin-independent methionine synthase. Biochemistry. 2006 Apr 25;45(16):5092-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16618098# Hughes JA: In vivo hydrolysis of S-adenosyl-L-met"
1473,"DB00545","BE0000426","# Drake-Baumann R, Seil FJ: Effects of exposure to low-dose pyridostigmine on neuromuscular junctions in vitro. Muscle Nerve. 1999 Jun;22(6):696-703. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10366222# Ricordel I, Meunier J: [Chemical weapons: antidotes"
1474,"DB04464","BE0001738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1475,"DB00071","BE0000858","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1476,"DB01163","BE0003579","# Neu HC: Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death. Am J Med. 1983 Aug 29;75(2A):9-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6311012# Licht J, Gally D, Henderson T, Young K, Cooper S: Effect of mecillinam "
1477,"DB01992","BE0002677",""
1478,"DB08437","BE0003823","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1479,"DB08080","BE0004156","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1480,"DB00679","BE0000020","# Hammock RG, Schroeder SR, Levine WR: The effect of clozapine on self-injurious behavior. J Autism Dev Disord. 1995 Dec;25(6):611-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8720030"
1481,"DB02027","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1482,"DB01069","BE0000756","# Golembiewski JA, O'Brien D: A systematic approach to the management of postoperative nausea and vomiting. J Perianesth Nurs. 2002 Dec;17(6):364-76. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12476402"
1483,"DB00106","BE0000203","# Debruyne FM: Gonadotropin-releasing hormone antagonist in the management of prostate cancer. Rev Urol. 2004;6 Suppl 7:S25-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16985933"
1484,"DB00758","BE0000110","# Dorsam RT, Murugappan S, Ding Z, Kunapuli SP: Clopidogrel: Interactions with the P2Y12 Receptor and Clinical Relevance. Hematology. 2003 Dec;8(6):359-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14668029# Herbert JM, Savi P: P2Y12, a new platelet ADP"
1485,"DB03685","BE0001956","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1486,"DB02537","BE0001831","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1487,"DB04101","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1488,"DB00457","BE0000289","# Uhlen S, Wikberg JE: Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound. Eur J Pharmacol. 1991 Sep 17;202(2):235-43. \"Pubmed\""
1489,"DB00114","BE0002159","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1490,"DB08475","BE0004332","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1491,"DB08848","BE0004777","# Ruiz-Tachiquin ME, Sanchez-Lemus E, Soria-Jasso LE, Arias-Montano JA, Ortega A: Gamma-aminobutyric acid transporter (BGT-1) expressed in human astrocytoma U373 MG cells: pharmacological and molecular characterization and phorbol ester-induced inhibition"
1492,"DB00721","BE0004796","# Villar-Garea A, Fraga MF, Espada J, Esteller M: Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res. 2003 Aug 15;63(16):4984-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12941824"
1493,"DB08236","BE0004252","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1494,"DB01043","BE0000311","# Rammes G, Rupprecht R, Ferrari U, Zieglgansberger W, Parsons CG: The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems"
1495,"DB07244","BE0000270","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1496,"DB01586","BE0000622","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1497,"DB01118","BE0002396","# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol. 1992 Oct;100(4):703-28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1281221# Lewalter T, Pittrow"
1498,"DB00246","BE0000247","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
1499,"DB00966","BE0000215","# Tagami T, Yamamoto H, Moriyama K, Sawai K, Usui T, Shimatsu A, Naruse M: A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones. Endocrinology. 2009 Feb;1"
1500,"DB07451","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1501,"DB00768","BE0001090","# Okada M, Tokumitsu H, Kubota Y, Kobayashi R: Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein. Biochem Biophys Res Commun. 2002 Apr 12;292(4):"
1502,"DB02633","BE0001184","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1503,"DB01215","BE0000523","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
1504,"DB02436","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1505,"DB08422","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1506,"DB04302","BE0004351","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1507,"DB02658","BE0001804","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1508,"DB00477","BE0004881","# Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. \"Pu"
1509,"DB00216","BE0000797","# Napier C, Stewart M, Melrose H, Hopkins B, McHarg A, Wallis R: Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Eur J Pharmacol. 1999 Mar 5;368(2-3):259-68. "
1510,"DB00902","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1511,"DB01239","BE0000045","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
1512,"DB07476","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1513,"DB00426","BE0000308","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Schmid-Wendtner MH, Korting HC: Penciclovir cream--improved t"
1514,"DB03940","BE0001741","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1515,"DB00715","BE0000451","# Bixo M, Allard P, Backstrom T, Mjorndal T, Nyberg S, Spigset O, Sundstrom-Poromaa I: Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disord"
1516,"DB00595","BE0004799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1517,"DB04149","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1518,"DB01877","BE0001116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1519,"DB08714","BE0004017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1520,"DB03865","BE0002128","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1521,"DB05489","BE0001902",""
1522,"DB00579","BE0000486","# Raffel DM, Chen W: Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies. Naunyn Schmiedebergs Arch Pharmacol. 2004 Jul;370(1):9-16. Epub 2004 Jul 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15300361# Raffel"
1523,"DB08911","BE0000870","# FDA label # Salama AK, Kim KB: Trametinib (GSK1120212) in the treatment of melanoma. Expert Opin Pharmacother. 2013 Apr;14(5):619-27. doi: 10.1517/14656566.2013.770475. Epub 2013 Feb 23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23432625"
1524,"DB07395","BE0000007","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1525,"DB07690","BE0004056","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1526,"DB01329","BE0003685","# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhashi S: Affinity of cefoperazone for penicillin-binding proteins. Antimicrob Agents Chemother. 1980 Jul;18(1):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6448021"
1527,"DB05838","BE0000293",""
1528,"DB01197","BE0001680","# Thunnissen MM, Andersson B, Samuelsson B, Wong CH, Haeggstrom J: Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors. FASEB J. 2002 Oct;16(12):1648-50. Epub 2002 Aug 7. \"Pubmed\":http://ww"
1529,"DB04084","BE0001911","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1530,"DB00025","BE0002119","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1531,"DB08256","BE0000950","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1532,"DB00186","BE0000736","# Venneti S, Lopresti BJ, Wiley CA: The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol. 2006 Dec;80(6):308-22. Epub 2006 Dec 6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17156911# "
1533,"DB00319","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
1534,"DB08185","BE0004212","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1535,"DB00409","BE0000389","# Seeman P, Corbett R, Van Tol HH: Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology. 1997 Feb;16(2):93-110; discussion 111-35. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9015795"
1536,"DB04075","BE0001589","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1537,"DB01942","BE0000735","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1538,"DB08889","BE0002349","# Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ: Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models"
1539,"DB00340","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1540,"DB00841","BE0000694","# Tibayan FA, Chesnutt AN, Folkesson HG, Eandi J, Matthay MA: Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):438-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
1541,"DB07113","BE0000270","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1542,"DB01388","BE0000864","# Brueggemann LI, Martin BL, Barakat J, Byron KL, Cribbs LL: Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking. Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H923-35. Epub 2004 Oct 21. "
1543,"DB04460","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1544,"DB02772","BE0002788",""
1545,"DB05157","BE0003391",""
1546,"DB01403","BE0000342","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205# Dahl SG, Hough E, Hals PA: Phenothiazine drugs and metabolites: molecular conformation and "
1547,"DB07910","BE0004120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1548,"DB01236","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694 (Accessed December 2013)"
1549,"DB07168","BE0003792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1550,"DB01752","BE0004441","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1551,"DB06979","BE0003766","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1552,"DB04957","BE0000672","# Schmitt H, Cabo C, Coromilas JC, Wit AL: Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction. J Cardiovasc Electrophysiol. 2001 Sep;"
1553,"DB01571","BE0000770","# Subramanian G, Paterlini MG, Portoghese PS, Ferguson DM: Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J Med Chem. 2000 Feb 10;43(3):381-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10669565# Jin WQ, Xu "
1554,"DB00142","BE0000378","# Akama K, Takaiwa F: C-terminal extension of rice glutamate decarboxylase (OsGAD2) functions as an autoinhibitory domain and overexpression of a truncated mutant results in the accumulation of extremely high levels of GABA in plant cells. J Exp Bot. 2007"
1555,"DB08155","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1556,"DB03410","BE0001226","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1557,"DB00647","BE0000420","# Neil A: Affinities of some common opioid analgesics towards four binding sites in mouse brain. Naunyn Schmiedebergs Arch Pharmacol. 1984 Nov;328(1):24-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6151117"
1558,"DB02379","BE0004501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1559,"DB01236","BE0000781","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1560,"DB08168","BE0001399","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1561,"DB04209","BE0001268","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1562,"DB02479","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1563,"DB08330","BE0003857","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1564,"DB00260","BE0000733","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1565,"DB01273","BE0003587","# Mihalak KB, Carroll FI, Luetje CW: Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006 Sep;70(3):801-5. Epub 2006 Jun 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16766716"
1566,"DB01328","BE0002393","# Rake JB, Newman DJ, Actor P: Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12. J Antibiot (Tokyo). 1984 May;37(5):572-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6376452"
1567,"DB00675","BE0000792","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC: Potential of endogenous e"
1568,"DB02611","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1569,"DB00246","BE0000756","# Seeman P: Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11873706# Kopecek M, Bares M, Mohr P: Ziprasidone-induced galactorrhea: a case report. Neuro Endocrinol Lett. 200"
1570,"DB04489","BE0004568","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1571,"DB02898","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1572,"DB08560","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1573,"DB00622","BE0002354","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Striessnig, J. (2004). Ca ^2+^ channel blockers. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclo"
1574,"DB08249","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1575,"DB00456","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
1576,"DB03312","BE0001403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1577,"DB04835","BE0000911","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1578,"DB07502","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1579,"DB07585","BE0000428","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1580,"DB04404","BE0001649","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1581,"DB01765","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1582,"DB00114","BE0000181","# Gospe SM Jr: Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol. 2006 Apr;19(2):148-53. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16538088# Hwang IK, Kim DW, Jung JY, Yoo KY, Cho JH,"
1583,"DB04045","BE0001780","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1584,"DB04585","BE0000286","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1585,"DB01242","BE0000451","# Hentall ID, Kurle PJ, White TR: Correlations between serotonin level and single-cell firing in the rat's nucleus raphe magnus. Neuroscience. 2000;95(4):1081-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10682715# Contreras CM, Marvan ML, Munoz-Mendez A"
1586,"DB06103","BE0000761",""
1587,"DB01944","BE0003893","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1588,"DB02666","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1589,"DB00540","BE0004882","# Jenck F, Moreau JL, Mutel V, Martin JR, Haefely WE: Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol. 1993 Feb 9;231(2):223-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8453978"
1590,"DB07361","BE0000991","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1591,"DB03469","BE0001802","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1592,"DB00143","BE0000889","# Ohkama-Ohtsu N, Zhao P, Xiang C, Oliver DJ: Glutathione conjugates in the vacuole are degraded by gamma-glutamyl transpeptidase GGT3 in Arabidopsis. Plant J. 2007 Mar;49(5):878-88. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17316176# Martin MN, Salador"
1593,"DB00909","BE0000012","# Schulze-Bonhage A: Zonisamide in the treatment of epilepsy. Expert Opin Pharmacother. 2010 Jan;11(1):115-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20001433# Kothare SV, Kaleyias J: Zonisamide: review of pharmacology, clinical efficacy, tolerabilit"
1594,"DB04786","BE0000739","# Wolner I, Kassack MU, Ullmann H, Karel A, Hohenegger M: Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676. Br J Pharmacol. 2005 Oct;146(4):525-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16056233"
1595,"DB02659","BE0003992","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1596,"DB00145","BE0002310","# Eulenburg V, Becker K, Gomeza J, Schmitt B, Becker CM, Betz H: Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys Res Commun. 2006 Sep 22;348(2):400-5. Epub 2006 Jul 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
1597,"DB01975","BE0002669",""
1598,"DB04561","BE0001621","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1599,"DB00143","BE0002285","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1600,"DB03487","BE0003751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1601,"DB04530","BE0003322",""
1602,"DB00418","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
1603,"DB05294","BE0003379","# http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515"
1604,"DB07750","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1605,"DB00157","BE0000180","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1606,"DB05047","BE0000831",""
1607,"DB00606","BE0000267","# Rammes G, Zeilhofer HU, Collingridge GL, Parsons CG, Swandulla D: Expression of early hippocampal CA1 LTP does not lead to changes in AMPA-EPSC kinetics or sensitivity to cyclothiazide. Pflugers Arch. 1999 Jan;437(2):191-6. \"Pubmed\":http://www.ncbi.nlm."
1608,"DB04147","BE0004167","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1609,"DB00172","BE0002333","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1610,"DB04315","BE0001710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1611,"DB04639","BE0003344","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1612,"DB01200","BE0000501","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
1613,"DB01328","BE0000488","# Rake JB, Newman DJ, Actor P: Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12. J Antibiot (Tokyo). 1984 May;37(5):572-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6376452"
1614,"DB01233","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# See RE, Lynch AM, Sorg BA: Subchronic administration of clozapine, but not haloperidol or metoclop"
1615,"DB08657","BE0004368","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1616,"DB01992","BE0002683",""
1617,"DB03570","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1618,"DB00540","BE0004864","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Oct 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from: http://pdsp.med.unc.edu/pdsp.php# Brunton L, Chabner B, Knollman B. Goodman and Gilman?s The "
1619,"DB08132","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1620,"DB06148","BE0000533","# Grinshpoon A, Valevski A, Moskowitz M, Weizman A: Beneficial effect of the addition of the 5-HT 2A/2C and alpha2 antagonist mianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients. Eur Psychiatry. 200"
1621,"DB03793","BE0004141","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1622,"DB04682","BE0003566","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1623,"DB06862","BE0001162","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1624,"DB04674","BE0000126","# Dhagat U, Carbone V, Chung RP, Matsunaga T, Endo S, Hara A, El-Kabbani O: A salicylic acid-based analogue discovered from virtual screening as a potent inhibitor of human 20alpha-hydroxysteroid dehydrogenase. Med Chem. 2007 Nov;3(6):546-50. \"Pubmed\":htt"
1625,"DB00157","BE0000044","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1626,"DB03464","BE0002027","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1627,"DB01224","BE0000442","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
1628,"DB02333","BE0001527","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1629,"DB07497","BE0003966","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1630,"DB04641","BE0001448",""
1631,"DB04340","BE0001349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1632,"DB05271","BE0000581","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
1633,"DB05091","BE0000293",""
1634,"DB02726","BE0001596","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1635,"DB03867","BE0000648","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1636,"DB07403","BE0003862","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1637,"DB07726","BE0002868","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1638,"DB02265","BE0001411","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1639,"DB00653","BE0000679","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1640,"DB03147","BE0000114","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1641,"DB03877","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1642,"DB02061","BE0001451","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1643,"DB00054","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1644,"DB00773","BE0000742","# de Lucio B, Manuel V, Barrera-Rodriguez R: Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha. Cancer Sci. 2005 Nov;96(11):774-83. \"Pubmed\":http://www.ncbi.nlm.nih.go"
1645,"DB07773","BE0004066","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1646,"DB00075","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1647,"DB00242","BE0000250","# Bzowska A, Kazimierczuk Z: 2-Chloro-2'-deoxyadenosine (cladribine) and its analogues are good substrates and potent selective inhibitors of Escherichia coli purine-nucleoside phosphorylase. Eur J Biochem. 1995 Nov 1;233(3):886-90. \"Pubmed\":http://www.nc"
1648,"DB07379","BE0002212","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1649,"DB00171","BE0000434","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1650,"DB07401","BE0003856","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1651,"DB01909","BE0001243","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1652,"DB00631","BE0000546","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1653,"DB02379","BE0001567","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1654,"DB08910","BE0004755","# McCurdy AR, Lacy MQ: Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologist. Ther Adv Hematol. 2013 Jun;4(3):211-6. doi: 10.1177/2040620713480155. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2"
1655,"DB01702","BE0004034","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1656,"DB02552","BE0004107","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1657,"DB07374","BE0003824","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1658,"DB02312","BE0001435","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1659,"DB01442","BE0000647","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanso"
1660,"DB08701","BE0004385","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1661,"DB00393","BE0002357","# Weant KA, Ramsey CN 3rd, Cook AM: Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage. Pharmacotherapy. 2010 Apr;30(4):405-17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20334460# Dong CJ, Guo Y, Agey P,"
1662,"DB08818","BE0004943","# Huang L, Grammatikakis N, Yoneda M, Banerjee SD, Toole BP: Molecular characterization of a novel intracellular hyaluronan-binding protein. J Biol Chem. 2000 Sep 22;275(38):29829-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10887182"
1663,"DB01595","BE0000381","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
1664,"DB01183","BE0000770","# Narita M, Suzuki M, Mizoguchi H, Narita M, Yajima Y, Sakurada S, Tseng LF, Suzuki T: Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment. Neurosci Lett. 2003 Feb "
1665,"DB00467","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1666,"DB04272","BE0001907","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1667,"DB00293","BE0000700","# Innocenti F, Ratain MJ: Update on pharmacogenetics in cancer chemotherapy. Eur J Cancer. 2002 Mar;38(5):639-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11916544"
1668,"DB02742","BE0003505","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1669,"DB03461","BE0001927","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1670,"DB03201","BE0003753","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1671,"DB03147","BE0002987",""
1672,"DB01710","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1673,"DB00144","BE0002297","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1674,"DB01520","BE0000534","# Stirling JM, Cross AJ, Green AR: The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex. Neuropharmacology. 1989 Jan;28(1):1-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2538766# Geldenhuys WJ, Malan SF, B"
1675,"DB00995","BE0000907","# Rigobello MP, Scutari G, Boscolo R, Bindoli A: Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative. Br J Pharmacol. 2002 Aug;136(8):1162-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12163349# Venardos K, Har"
1676,"DB08231","BE0004017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1677,"DB08348","BE0004282","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1678,"DB00174","BE0002230","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1679,"DB00996","BE0002226","# Cheng JK, Chen CC, Yang JR, Chiou LC: The antiallodynic action target of intrathecal gabapentin: Ca2+ channels, KATP channels or N-methyl-d-aspartic acid receptors? Anesth Analg. 2006 Jan;102(1):182-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1636882"
1680,"DB03814","BE0001865","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1681,"DB07278","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1682,"DB03814","BE0001799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1683,"DB04651","BE0003345",""
1684,"DB08217","BE0004225","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1685,"DB01303","BE0000013","# Nantwi KD, Basura GJ, Goshgarian HG: Adenosine A1 receptor mRNA expression and the effects of systemic theophylline administration on respiratory function 4 months after C2 hemisection. J Spinal Cord Med. 2003 Winter;26(4):364-71. \"Pubmed\":http://www.nc"
1686,"DB07011","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1687,"DB07557","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1688,"DB00683","BE0003597","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
1689,"DB06262","BE0000172","# Mersmann HJ: Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action. J Anim Sci. 1998 Jan;76(1):160-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9464897# El-Armouche A, Eschenhagen T: Beta-adrener"
1690,"DB01242","BE0000393","# Sargent PA, Quested DJ, Cowen PJ: Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptors. Psychopharmacology (Berl). 1998 Nov;140(1):120-2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9862411# Sugi"
1691,"DB01752","BE0002518",""
1692,"DB07230","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1693,"DB08453","BE0002472","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1694,"DB08330","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1695,"DB00143","BE0000815","# Tulayakul P, Dong KS, Li JY, Manabe N, Kumagai S: The effect of feeding piglets with the diet containing green tea extracts or coumarin on in vitro metabolism of aflatoxin B1 by their tissues. Toxicon. 2007 Sep 1;50(3):339-48. Epub 2007 Apr 22. \"Pubmed\""
1696,"DB01595","BE0003594","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
1697,"DB08450","BE0003782","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1698,"DB04564","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1699,"DB02379","BE0001330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1700,"DB00157","BE0000330","# Argyrou A, Jin L, Siconilfi-Baez L, Angeletti RH, Blanchard JS: Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis. Biochemistry. 2006 Nov 28;45(47):13947-53. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17115689# Vickers TJ, Orso"
1701,"DB00543","BE0000389","# Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR: Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylcloz"
1702,"DB07077","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1703,"DB00132","BE0002246","# Portolesi R, Powell BC, Gibson RA: Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J Lipid Res. 2007 Jul;48(7):1592-8. Epub 2007 Apr 4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/174"
1704,"DB07688","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1705,"DB00231","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL967 (Accessed December 2013)"
1706,"DB00351","BE0000794","# Wermers RA, Hurley DL, Kearns AE: Osteoporosis associated with megestrol acetate. Mayo Clin Proc. 2004 Dec;79(12):1557-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15595341# Gonzalez Villarroel P, Fernandez Perez I, Paramo C, Gentil Gonzalez M, Carne"
1707,"DB00157","BE0000485","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1708,"DB05367","BE0000521",""
1709,"DB00590","BE0000462","# Thomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Sc"
1710,"DB08409","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1711,"DB06707","BE0000486","# Habecker BA, Willison BD, Shi X, Woodward WR: Chronic depolarization stimulates norepinephrine transporter expression via catecholamines. J Neurochem. 2006 May;97(4):1044-51. Epub 2006 Mar 29. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16573647# Bonisc"
1712,"DB00321","BE0003604","# Casis O, Sanchez-Chapula JA: Disopyramide, imipramine, and amitriptyline bind to a common site on the transient outward K+ channel. J Cardiovasc Pharmacol. 1998 Oct;32(4):521-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9781919"
1713,"DB01223","BE0002366","# Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ: A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8921-6. "
1714,"DB06098","BE0002470",""
1715,"DB03535","BE0002148","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1716,"DB05659","BE0000142","# Dalhoff A, Nasu T, Okamoto K: Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria. Chemotherapy. 2003 Jul;49(4):172-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12886052"
1717,"DB01919","BE0003761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1718,"DB00142","BE0002274","# Xu Y, Labedan B, Glansdorff N: Surprising arginine biosynthesis: a reappraisal of the enzymology and evolution of the pathway in microorganisms. Microbiol Mol Biol Rev. 2007 Mar;71(1):36-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17347518"
1719,"DB01173","BE0000177","# Pubill D, Canudas AM, Pallas M, Sureda FX, Escubedo E, Camins A, Camarasa J: Assessment of the adrenergic effects of orphenadrine in rat vas deferens. J Pharm Pharmacol. 1999 Mar;51(3):307-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10344632"
1720,"DB01365","BE0004872","# Mohta M, Janani SS, Sethi AK, Agarwal D, Tyagi A: Comparison of phenylephrine hydrochloride and mephentermine sulphate for prevention of post spinal hypotension. Anaesthesia. 2010 Dec;65(12):1200-5. doi: 10.1111/j.1365-2044.2010.06559.x. \"Pubmed\":http:/"
1721,"DB00236","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1722,"DB00780","BE0002173","# McKenna KF, McManus DJ, Baker GB, Coutts RT: Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function. J Neural Transm Suppl. 1994;41:115-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7931216"
1723,"DB08864","BE0000956","# Sharma D, Lau AJ, Sherman MA, Chang TK: Agonism of human pregnane X receptor by rilpivirine and etravirine: Comparison with first generation non-nucleoside reverse transcriptase inhibitors. Biochem Pharmacol. 2013 Apr 9. pii: S0006-2952(13)00224-4. doi:"
1724,"DB07971","BE0004059","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1725,"DB08039","BE0000418","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1726,"DB03461","BE0004353","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1727,"DB07071","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1728,"DB01520","BE0000396","# Stirling JM, Cross AJ, Green AR: The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex. Neuropharmacology. 1989 Jan;28(1):1-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2538766"
1729,"DB03413","BE0003078",""
1730,"DB00252","BE0000141","# Tate SK, Depondt C, Sisodiya SM, Cavalleri GL, Schorge S, Soranzo N, Thom M, Sen A, Shorvon SD, Sander JW, Wood NW, Goldstein DB: Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and "
1731,"DB07922","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1732,"DB07668","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1733,"DB03389","BE0001339","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1734,"DB04395","BE0003294",""
1735,"DB04465","BE0001411","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1736,"DB01472","BE0000118","# Biezonski DK, Meyer JS: Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem. 2010 Feb;112(4):951-62. Epu"
1737,"DB01226","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1738,"DB00458","BE0000647","# Melikian HE, Buckley KM: Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci. 1999 Sep 15;19(18):7699-710. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10479674"
1739,"DB00074","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1740,"DB01373","BE0000899","# Chen FH, Herndon ME, Patel N, Hecht JT, Tuan RS, Lawler J: Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem. 2007 Aug 24;282(34):24591-8. Epub 2007 Jun 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1758894"
1741,"DB03904","BE0000985","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1742,"DB03092","BE0002639",""
1743,"DB00661","BE0000090","# Duan JJ, Ma JH, Zhang PH, Wang XP, Zou AR, Tu DN: Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain. Acta Pharmacol Sin. 2007 Jul;28(7):959-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17588331# Cheng HC,"
1744,"DB00210","BE0000707","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1745,"DB00648","BE0000731","# Lindhe O, Skogseid B, Brandt I: Cytochrome P450-catalyzed binding of 3-methylsulfonyl-DDE and o,p'-DDD in human adrenal zona fasciculata/reticularis. J Clin Endocrinol Metab. 2002 Mar;87(3):1319-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11889204"
1746,"DB01660","BE0001257","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1747,"DB05301","BE0000444",""
1748,"DB02141","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1749,"DB01195","BE0002083","# Desaphy JF, De Luca A, Didonna MP, George AL Jr, Camerino Conte D: Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block. J Physiol. 2004 Jan 15;554(Pt 2):321-34. Epub 2003 Nov 7. \"Pubmed\":http://ww"
1750,"DB00162","BE0000513","# Isken A, Holzschuh J, Lampert JM, Fischer L, Oberhauser V, Palczewski K, von Lintig J: Sequestration of retinyl esters is essential for retinoid signaling in the zebrafish embryo. J Biol Chem. 2007 Jan 12;282(2):1144-51. Epub 2006 Nov 10. \"Pubmed\":http:"
1751,"DB01216","BE0003610","# Drury JE, Di Costanzo L, Penning TM, Christianson DW: Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complex. J Biol Chem. 2009 Jul 24;284(30):19786-90. Epub 2009 Jun 10. \"Pubmed\":http://www.ncb"
1752,"DB01727","BE0001249","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1753,"DB00537","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1754,"DB04294","BE0001336","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1755,"DB01558","BE0003592","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
1756,"DB00575","BE0000572","# Hein, L. (2004). &alpha;-Adrenergic system. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclopedic reference of molecular pharmacology_ (pp. 27-30). Berlin, Germany: Springer."
1757,"DB02512","BE0001683","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1758,"DB00157","BE0000589","# Drew DP, Lunde C, Lahnstein J, Fincher GB: Heterologous expression of cDNAs encoding monodehydroascorbate reductases from the moss, Physcomitrella patens and characterization of the expressed enzymes. Planta. 2007 Mar;225(4):945-54. \"Pubmed\":http://www."
1759,"DB01014","BE0000215","# Tursi A: Balsalazide in treating colonic diseases. Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1555-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19708827# Iacucci M, de Silva S, Ghosh S: Mesalazine in inflammatory bowel disease: a trendy topic onc"
1760,"DB01594","BE0000129","# Walash MI, Belal F, Metwally ME, Hefnawy MM: A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
1761,"DB02482","BE0001913","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1762,"DB08168","BE0004194","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1763,"DB03136","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1764,"DB06204","BE0000420","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1765,"DB04272","BE0000115","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1766,"DB00199","BE0002465","# Halling SM, Jensen AE: Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications. BMC Microbiol. 2006 Oct 2;6:84. \"Pubmed\":http://www.ncbi.nlm.nih.g"
1767,"DB02844","BE0001674","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1768,"DB04799","BE0003856","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1769,"DB00195","BE0000694","# Rait JL: Systemic effects of topical ophthalmic beta-adrenoceptor antagonists. Aust N Z J Ophthalmol. 1999 Feb;27(1):57-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10080340"
1770,"DB05715","BE0000477","# McEachern KA, Fung J, Komarnitsky S, Siegel CS, Chuang WL, Hutto E, Shayman JA, Grabowski GA, Aerts JM, Cheng SH, Copeland DP, Marshall J: A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. "
1771,"DB08689","BE0004379","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1772,"DB08414","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1773,"DB00957","BE0000123","# Pasqualini JR: Differential effects of progestins on breast tissue enzymes. Maturitas. 2003 Dec 10;46 Suppl 1:S45-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14670645# Juchem M, Pollow K: Binding of oral contraceptive progestogens to serum proteins "
1774,"DB01558","BE0002346","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
1775,"DB01238","BE0000560","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
1776,"DB03231","BE0001289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1777,"DB07981","BE0000017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1778,"DB07752","BE0004072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1779,"DB01567","BE0003599","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
1780,"DB00157","BE0000771","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1781,"DB08231","BE0001326","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1782,"DB04522","BE0001369","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1783,"DB01185","BE0000794","# Mayer M, Rosen F: Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol. Am J Physiol. 1975 Nov;229(5):1381-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/173192"
1784,"DB05147","BE0003400",""
1785,"DB00599","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
1786,"DB00159","BE0000996","# Heimli H, Hollung K, Drevon CA: Eicosapentaenoic acid-induced apoptosis depends on acyl CoA-synthetase. Lipids. 2003 Mar;38(3):263-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12784866# Covault J, Pettinati H, Moak D, Mueller T, Kranzler HR: Associati"
1787,"DB00949","BE0000417","# Kleckner NW, Glazewski JC, Chen CC, Moscrip TD: Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action. J Pharmacol Exp Ther. 1999 May;289(2):886-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
1788,"DB01577","BE0004674","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Henry JP, Sagne C, Bedet C, Gasnier B: The vesicula"
1789,"DB02861","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1790,"DB05004","BE0002418",""
1791,"DB00074","BE0000651","# Onrust SV, Wiseman LR: Basiliximab. Drugs. 1999 Feb;57(2):207-13; discussion 214. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10188761# Hausen B, Gummert J, Berry GJ, Christians U, Serkova N, Ikonen T, Hook L, Legay F, Schuler W, Schreier MH, Morris RE:"
1792,"DB00002","BE0000767","# Hosokawa N, Yamamoto S, Uehara Y, Hori M, Tsuchiya KS: Effect of thiazinotrienomycin B, an ansamycin antibiotic, on the function of epidermal growth factor receptor in human stomach tumor cells. J Antibiot (Tokyo). 1999 May;52(5):485-90. \"Pubmed\":http:/"
1793,"DB00231","BE0003619","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
1794,"DB02175","BE0002702",""
1795,"DB05271","BE0000020","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
1796,"DB04103","BE0001402","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1797,"DB01238","BE0000291","# Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA: The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol. 2002 Apr 26;441(3):137-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12063084# Ma"
1798,"DB00122","BE0000426","# Amenta F, Tayebati SK, Vitali D, Di Tullio MA: Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission. Mech Ageing Dev. 2006 Feb;127(2):173-9"
1799,"DB02402","BE0001302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1800,"DB07763","BE0003856","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1801,"DB07429","BE0003868","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1802,"DB02593","BE0001212","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1803,"DB00173","BE0001128","# Chow WA, Bedell V, Gaytan P, Borden E, Goldblum J, Hicks D, Slovak ML: Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas. Cancer Genet Cytogenet. 2006 Apr 15;16"
1804,"DB03723","BE0001971","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1805,"DB04194","BE0003751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1806,"DB02375","BE0001315","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1807,"DB00009","BE0000211","# Longstaff C, Williams S, Thelwell C: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy. Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18673235# Melandri G, Vag"
1808,"DB07702","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1809,"DB07771","BE0004071","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1810,"DB07475","BE0003914","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1811,"DB06738","BE0000770","# Kristensen K, Christensen CB, Christrup LL, Nielsen LC: The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene. Pharmacol Toxicol. 1996 Aug;79(2):103-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
1812,"DB00126","BE0002211","# Nytko KJ, Spielmann P, Camenisch G, Wenger RH, Stiehl DP: Regulated function of the prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins. Antioxid Redox Signal. 2007 Sep;9(9):1329-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17627474# Bruegge K, "
1813,"DB04158","BE0001450","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1814,"DB00123","BE0000562","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1815,"DB02300","BE0000779","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1816,"DB00909","BE0000267","# De Simone G, Di Fiore A, Menchise V, Pedone C, Antel J, Casini A, Scozzafava A, Wurl M, Supuran CT: Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallo"
1817,"DB04284","BE0002045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1818,"DB07763","BE0003861","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1819,"DB07789","BE0003745","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1820,"DB00115","BE0002175","# Chandler RJ, Aswani V, Tsai MS, Falk M, Wehrli N, Stabler S, Allen R, Sedensky M, Kazazian HH, Venditti CP: Propionyl-CoA and adenosylcobalamin metabolism in Caenorhabditis elegans: evidence for a role of methylmalonyl-CoA epimerase in intermediary meta"
1821,"DB00002","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1822,"DB08896","BE0001039","# FDA label"
1823,"DB00181","BE0000217","# Bowery NG: GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol. 1993;33:109-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8388192# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http:/"
1824,"DB03147","BE0002977",""
1825,"DB07004","BE0001177","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1826,"DB01151","BE0000486","# Zavosh A, Schaefer J, Ferrel A, Figlewicz DP: Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells. Brain Res Bull. 1999 Jul 1;49(4):291-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10424850# W"
1827,"DB04267","BE0001986","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1828,"DB02692","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1829,"DB07634","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1830,"DB01732","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1831,"DB00795","BE0004655","# Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000 Nov;119(5):1209-18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
1832,"DB07601","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1833,"DB01842","BE0002566",""
1834,"DB08667","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1835,"DB00248","BE0000393","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
1836,"DB00142","BE0000834","# Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor "
1837,"DB04841","BE0000483","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1838,"DB02165","BE0000807","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1839,"DB05303","BE0000704",""
1840,"DB00159","BE0000888","# Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH: Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000 Aug;130(8):1925-31. \"Pubmed\":http://www.n"
1841,"DB00428","BE0001045","# Wang Z, Gleichmann H: GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes. 1998 Jan;47(1):50-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9421374# Schnedl WJ, Ferber S, Jo"
1842,"DB08073","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1843,"DB05864","BE0001534",""
1844,"DB01159","BE0000641","# Perouansky M, Kirson ED, Yaari Y: Halothane blocks synaptic excitation of inhibitory interneurons. Anesthesiology. 1996 Dec;85(6):1431-8; discussion 29A. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8968191"
1845,"DB05127","BE0000155",""
1846,"DB00409","BE0000451","# Seeman P, Corbett R, Van Tol HH: Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology. 1997 Feb;16(2):93-110; discussion 111-35. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9015795"
1847,"DB00396","BE0000123","# Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES: Type and duration of exogenous hormone use affects breast cancer histology. Ann Surg Oncol. 2007 Feb;14(2):695-703. Epub 2006 Nov 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
1848,"DB01588","BE0003596","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
1849,"DB03203","BE0003372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1850,"DB01373","BE0000904","# Hanna RA, Garcia-Diaz BE, Davies PL: Calpastatin simultaneously binds four calpains with different kinetic constants. FEBS Lett. 2007 Jun 26;581(16):2894-8. Epub 2007 May 25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17543955# De Tullio R, Averna M, S"
1851,"DB00081","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1852,"DB01239","BE0000581","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1853,"DB00555","BE0002081","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1854,"DB00278","BE0000048","# Kawada T, Okada Y, Hoson M, Endo S, Yokoyama M, Kitanaka Y, Kimura K, Abe H, Yamate N: Argatroban, an attractive anticoagulant, for left heart bypass with centrifugal pump for repair of traumatic aortic rupture. Jpn J Thorac Cardiovasc Surg. 1999 Mar;47"
1855,"DB08822","BE0000062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Miura SI, Matsuo Y, Nakayama A, Tomita S, Suematsu Y, Saku K: Ability of the new AT1 receptor bloc"
1856,"DB00668","BE0000342","# Bylund DB: Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J. 1992 Feb 1;6(3):832-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1346768/# Shen, Howard (2008).Illustrated Pharmacology Memory Cards: PharMnemonics. Minireview. p.4.ISBN1-5"
1857,"DB00668","BE0001012","# Shen, Howard (2008).Illustrated Pharmacology Memory Cards: PharMnemonics. Minireview. p.4.ISBN1-59541-101-1"
1858,"DB00589","BE0000393","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
1859,"DB00159","BE0001093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1860,"DB00691","BE0000221","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Chrysant SG, Chrysant GS: Pharmacological and clinical profile of moexipril: a concise review. J C"
1861,"DB01942","BE0002657",""
1862,"DB02452","BE0001912","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1863,"DB08324","BE0004269","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1864,"DB03389","BE0002828",""
1865,"DB01100","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Seeman P: Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. \"P"
1866,"DB03317","BE0003051",""
1867,"DB03554","BE0000960","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1868,"DB00749","BE0000412","# Kolluri SK, Corr M, James SY, Bernasconi M, Lu D, Liu W, Cottam HB, Leoni LM, Carson DA, Zhang XK: The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Proc Natl Acad Sci U "
1869,"DB01972","BE0002668",""
1870,"DB00691","BE0000982","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Chrysant SG, Chrysant GS: Pharmacological and clinical profile of moexipril: a concise review. J C"
1871,"DB04530","BE0001524","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1872,"DB00543","BE0004863","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881/# Brunton L, Chabner B, Knollman B. Good"
1873,"DB03533","BE0001668","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1874,"DB00247","BE0000291","# Scrogin KE, Johnson AK, Brooks VL: Methysergide delays the decompensatory responses to severe hemorrhage by activating 5-HT(1A) receptors. Am J Physiol Regul Integr Comp Physiol. 2000 Nov;279(5):R1776-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1104"
1875,"DB03543","BE0001549","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1876,"DB03344","BE0004433","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1877,"DB05361","BE0000280",""
1878,"DB04048","BE0001972","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1879,"DB07212","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1880,"DB05152","BE0000092",""
1881,"DB05047","BE0003394",""
1882,"DB04447","BE0001751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1883,"DB04065","BE0000227","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1884,"DB00358","BE0000924","# Gillespie RJ, Adams DR, Bebbington D, Benwell K, Cliffe IA, Dawson CE, Dourish CT, Fletcher A, Gaur S, Giles PR, Jordan AM, Knight AR, Knutsen LJ, Lawrence A, Lerpiniere J, Misra A, Porter RH, Pratt RM, Shepherd R, Upton R, Ward SE, Weiss SM, Williamson"
1885,"DB00479","BE0000279","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1886,"DB05867","BE0004604","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1887,"DB03661","BE0001970","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1888,"DB01254","BE0000840","# Trevino JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, Lee FY, Donato NJ, Abbruzzese JL, Baker CH, Gallick GE: Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic n"
1889,"DB04216","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1890,"DB00842","BE0000523","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
1891,"DB04435","BE0001210","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1892,"DB01987","BE0003275",""
1893,"DB07520","BE0001646","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1894,"DB01992","BE0002566",""
1895,"DB08235","BE0004249","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1896,"DB04395","BE0001885","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1897,"DB03944","BE0001024","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1898,"DB08896","BE0000634","# FDA label"
1899,"DB07374","BE0003832","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1900,"DB08676","BE0002372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1901,"DB03316","BE0000999","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1902,"DB07416","BE0001355","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1903,"DB03019","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1904,"DB00766","BE0000302","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Hugonnet JE, Blanchard JS: Irreversible Inhibition of the Myc"
1905,"DB01163","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
1906,"DB07161","BE0002408","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1907,"DB04288","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1908,"DB00237","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
1909,"DB01169","BE0000923","# Dong Z: The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ Health Perspect. 2002 Oct;110 Suppl 5:757-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12426127# He Z, Ma WY, Liu G, Zhang Y, Bode AM, Dong Z: Arsenite-indu"
1910,"DB08421","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1911,"DB00875","BE0000451","# Reimold M, Solbach C, Noda S, Schaefer JE, Bartels M, Beneke M, Machulla HJ, Bares R, Glaser T, Wormstall H: Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone"
1912,"DB00559","BE0000521","# Albertini M, Lafortuna CL, Ciminaghi B, Mazzola S, Clement MG: Endothelin involvement in respiratory centre activity. Prostaglandins Leukot Essent Fatty Acids. 2001 Sep;65(3):157-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11728166# Chen X, Ji ZL, C"
1913,"DB08110","BE0001430","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1914,"DB02142","BE0001509","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1915,"DB00315","BE0000659","# Whale R, Bhagwagar Z, Cowen PJ: Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors? Psychopharmacology (Berl). 1999 Jul;145(2):223-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10463324# Hargreaves RJ, Shepheard SL: Pa"
1916,"DB07015","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1917,"DB00396","BE0000668","# Rupprecht R, Reul JM, van Steensel B, Spengler D, Soder M, Berning B, Holsboer F, Damm K: Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol. 1993 Oct 15;247(2):145-54. \"Pubmed"
1918,"DB04751","BE0004274","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1919,"DB00633","BE0000289","# Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL: alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther. 2002 Jan;300(1):282-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/117521"
1920,"DB00703","BE0003629","# Mincione F, Scozzafava A, Supuran CT: The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18336310"
1921,"DB06714","BE0000118","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Docherty JR: Pharmacology of stimulants prohibited "
1922,"DB04659","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1923,"DB05386","BE0000628",""
1924,"DB00157","BE0000011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1925,"DB02363","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1926,"DB05470","BE0001051",""
1927,"DB01954","BE0001287","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1928,"DB07776","BE0004080","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1929,"DB07914","BE0004124","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1930,"DB02712","BE0000747","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Pro"
1931,"DB00936","BE0000017","# Moon C, Ahn M, Jee Y, Heo S, Kim S, Kim H, Sim KB, Koh CS, Shin YG, Shin T: Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclo"
1932,"DB04555","BE0001622","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1933,"DB01856","BE0001297","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1934,"DB08182","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1935,"DB08582","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1936,"DB07463","BE0003891","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1937,"DB04097","BE0001901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1938,"DB04062","BE0002039","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1939,"DB03010","BE0001275","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1940,"DB00373","BE0000694","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Fuchsjager-Mayrl G, Markovic O, Losert D, Lucas T, Wachek V, Muller M, Schmetterer L: Polymorphism"
1941,"DB01183","BE0000420","# Moncada A, Cendan CM, Baeyens JM, Del Pozo E: Effects of serine/threonine protein phosphatase inhibitors on morphine-induced antinociception in the tail flick test in mice. Eur J Pharmacol. 2003 Mar 28;465(1-2):53-60. \"Pubmed\":http://www.ncbi.nlm.nih.go"
1942,"DB01174","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
1943,"DB04400","BE0000753","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1944,"DB03814","BE0000814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1945,"DB03492","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1946,"DB03374","BE0004373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1947,"DB03721","BE0002857",""
1948,"DB03112","BE0001668","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1949,"DB00543","BE0000092","# Richelson E: Antimuscarinic and other receptor-blocking properties of antidepressants. Mayo Clin Proc. 1983 Jan;58(1):40-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6130192# Buckley NA, McManus PR: Can the fatal toxicity of antidepressant drugs be pr"
1950,"DB01355","BE0000523","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
1951,"DB04237","BE0001976","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1952,"DB04650","BE0001668","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1953,"DB00571","BE0000291","# Smejkal-Jagar L, Boranic M: Serotonin and serotoninergic agents affect proliferation of normal and transformed lymphoid cells. Immunopharmacol Immunotoxicol. 1995 Feb;17(1):151-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7759768"
1954,"DB00637","BE0000442","# Salata JJ, Jurkiewicz NK, Wallace AA, Stupienski RF 3rd, Guinosso PJ Jr, Lynch JJ Jr: Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res. 1995 "
1955,"DB03030","BE0002006","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1956,"DB07068","BE0003769","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1957,"DB00198","BE0000584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1958,"DB07406","BE0001373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1959,"DB00153","BE0000779","# Carvallo L, Henriquez B, Olate J, van Wijnen AJ, Lian JB, Stein GS, Onate S, Stein JL, Montecino M: The 1alpha,25-dihydroxy Vitamin D3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene. J Steroid Biochem"
1960,"DB00029","BE0000240","# Hilleman DE, Tsikouris JP, Seals AA, Marmur JD: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Pharmacotherapy. 2007 Nov;27(11):1558-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17963464"
1961,"DB00572","BE0000092","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Overington JP, Al-Lazikani"
1962,"DB00231","BE0003598","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
1963,"DB06919","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1964,"DB00400","BE0004660","# Nakamichi I, Hatakeyama S, Nakayama KI: Formation of Mallory body-like inclusions and cell death induced by deregulated expression of keratin 18. Mol Biol Cell. 2002 Oct;13(10):3441-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12388748# Sobue S, Seki"
1965,"DB01161","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1966,"DB07394","BE0003842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1967,"DB02638","BE0000293","# Boson WL, Della Manna T, Damiani D, Miranda DM, Gadelha MR, Liberman B, Correa H, Romano-Silva MA, Friedman E, Silva FF, Ribeiro PA, De Marco L: Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients. Genet "
1968,"DB01579","BE0000575","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1969,"DB01159","BE0000415","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1970,"DB08690","BE0003856","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1971,"DB04873","BE0000084","# Darblade B, Behr-Roussel D, Gorny D, Lebret T, Benoit G, Hieble JP, Brooks D, Alexandre L, Giuliano F: Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detru"
1972,"DB08186","BE0002683","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1973,"DB01454","BE0000647","# Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE: Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity. J Pharmacol Exp Ther. 2002 Mar;300(3):"
1974,"DB03472","BE0002029","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1975,"DB01403","BE0000715","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205# Dahl SG, Hough E, Hals PA: Phenothiazine drugs and metabolites: molecular conformation and "
1976,"DB00726","BE0004882","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
1977,"DB01163","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
1978,"DB02091","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1979,"DB03403","BE0001600","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1980,"DB07677","BE0004049","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1981,"DB00543","BE0004890","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881/# National Institute of Mental Health. P"
1982,"DB01023","BE0000864","# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol. 1992 Oct;100(4):703-28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1281221# Perez-Reyes E, Van "
1983,"DB00978","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1984,"DB07171","BE0003793","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1985,"DB02929","BE0004149","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1986,"DB00652","BE0000156","# Chien CC, Pasternak GW: (-)-Pentazocine analgesia in mice: interactions with a sigma receptor system. Eur J Pharmacol. 1995 Dec 27;294(1):303-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8788445# Colabufo NA, Contino M, Inglese C, Niso M, Perrone R, R"
1987,"DB06089","BE0000672",""
1988,"DB03147","BE0002196",""
1989,"DB00246","BE0000650","# Stark AD, Jordan S, Allers KA, Bertekap RL, Chen R, Mistry Kannan T, Molski TF, Yocca FD, Sharp T, Kikuchi T, Burris KD: Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo elect"
1990,"DB02689","BE0000286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1991,"DB01264","BE0004854","# Dierynck I, De Wit M, Gustin E, Keuleers I, Vandersmissen J, Hallenberger S, Hertogs K: Binding kinetics of darunavir to HIV-1 protease explain the potent antiviral activity and high genetic barrier. J Virol. 2007 Oct 10;. \"Pubmed\":http://www.ncbi.nlm.n"
1992,"DB00358","BE0000130","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1993,"DB06843","BE0003732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1994,"DB00642","BE0000330","# Hanauske AR, Chen V, Paoletti P, Niyikiza C: Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors. Oncologist. 2001;6(4):363-73. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11524555# Norman P: Pemetrexed disodium (Eli "
1995,"DB07746","BE0001534","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1996,"DB00342","BE0000092","# Yasuda SU, Yasuda RP: Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes. Pharmacotherapy. 1999 Apr;19(4):447-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10212017"
1997,"DB07151","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
1998,"DB02281","BE0002007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
1999,"DB00558","BE0000057","# Macdonald SJ, Cameron R, Demaine DA, Fenton RJ, Foster G, Gower D, Hamblin JN, Hamilton S, Hart GJ, Hill AP, Inglis GG, Jin B, Jones HT, McConnell DB, McKimm-Breschkin J, Mills G, Nguyen V, Owens IJ, Parry N, Shanahan SE, Smith D, Watson KG, Wu WY, Tuck"
2000,"DB00453","BE0004799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2001,"DB00119","BE0000669","# Duerr JM, Tucker K: Pyruvate transport in isolated cardiac mitochondria from two species of amphibian exhibiting dissimilar aerobic scope: Bufo marinus and Rana catesbeiana. J Exp Zool Part A Ecol Genet Physiol. 2007 Aug 1;307(8):425-38. \"Pubmed\":http:/"
2002,"DB04469","BE0001287","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2003,"DB03740","BE0000978","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2004,"DB01589","BE0003619","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
2005,"DB00071","BE0002125","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2006,"DB00935","BE0000575","# Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bonisch H: Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010 Dec;24(6):729-39. doi: 10.1111/j.1472-8206.2009.00805.x. \"Pubmed\":ht"
2007,"DB00622","BE0000418","# Thayer SA, Fairhurst AS: The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors. Mol Pharmacol. 1983 Jul;24(1):6-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6865927"
2008,"DB03470","BE0001551","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2009,"DB01149","BE0000749","# Owens MJ, Ieni JR, Knight DL, Winders K, Nemeroff CB: The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies. Life Sci. 1995;57(24):PL373-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7475971# Naraya"
2010,"DB07344","BE0003812","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2011,"DB03389","BE0003069",""
2012,"DB07669","BE0004046","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2013,"DB01137","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
2014,"DB08779","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2015,"DB03522","BE0001613","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2016,"DB05260","BE0002450","# Chitambar CR: Apoptotic mechanisms of gallium nitrate: basic and clinical investigations. Oncology (Williston Park). 2004 Nov;18(13 Suppl 10):39-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15651176# Narasimhan J, Antholine WE, Chitambar CR: Effect o"
2017,"DB00398","BE0000634","# Flaherty KT: Chemotherapy and targeted therapy combinations in advanced melanoma. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2366s-2370s. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16609060# Haluska FG, Ibrahim N: Therapeutic targets in melanoma: map kinas"
2018,"DB05087","BE0000795",""
2019,"DB03296","BE0002533",""
2020,"DB00131","BE0000746","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2021,"DB00575","BE0000289","# Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL: alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther. 2002 Jan;300(1):282-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/117521"
2022,"DB08209","BE0004222","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2023,"DB01992","BE0002676",""
2024,"DB04491","BE0003305",""
2025,"DB00704","BE0000632","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Helm S, Trescot AM, Colson J, Sehgal N, Silverman S: Opioid antagonists, partial agonists, and ago"
2026,"DB00786","BE0001182","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
2027,"DB00481","BE0000792","# Bryant HU, Glasebrook AL, Yang NN, Sato M: An estrogen receptor basis for raloxifene action in bone. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):37-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10418979# Iannone MA, Consler TG, Pearce KH, Stimmel"
2028,"DB04407","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2029,"DB02285","BE0000085","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2030,"DB02259","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2031,"DB07780","BE0004092","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2032,"DB01028","BE0000781","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2033,"DB03814","BE0002075","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2034,"DB00110","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2035,"DB00015","BE0000717","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2036,"DB02907","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2037,"DB00062","BE0001119","# Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K: Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther. 2006 Jun;317(3):1246-53. E"
2038,"DB04003","BE0000842","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2039,"DB03685","BE0001501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2040,"DB00829","BE0003619","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2041,"DB00458","BE0000442","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
2042,"DB05232","BE0002082","# Sage D, Salin P, Alcaraz G, Castets F, Giraud P, Crest M, Mazet B, Clerc N: Na(v)1.7 and Na(v)1.3 are the only tetrodotoxin-sensitive sodium channels expressed by the adult guinea pig enteric nervous system. J Comp Neurol. 2007 Oct 1;504(4):363-78. \"Pub"
2043,"DB04498","BE0001681","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2044,"DB04315","BE0004242","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2045,"DB04530","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2046,"DB07204","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2047,"DB00128","BE0000383","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2048,"DB02460","BE0001816","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2049,"DB01186","BE0000501","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
2050,"DB07489","BE0003958","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2051,"DB00869","BE0000322","# Lachmann C, Jorg KM, Trinkmann R: [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)] Kl"
2052,"DB02988","BE0004141","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2053,"DB00312","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
2054,"DB05339","BE0000291",""
2055,"DB06854","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2056,"DB03357","BE0001498","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2057,"DB02871","BE0000465","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2058,"DB05447","BE0004019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2059,"DB01496","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
2060,"DB04541","BE0001584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2061,"DB02379","BE0001427","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2062,"DB00720","BE0000599","# Lehenkari PP, Kellinsalmi M, Napankangas JP, Ylitalo KV, Monkkonen J, Rogers MJ, Azhayev A, Vaananen HK, Hassinen IE: Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-c"
2063,"DB04685","BE0001205","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2064,"DB00567","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
2065,"DB00088","BE0004806","# Pastores GM, Hughes DA: Gaucher Disease  \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20301446"
2066,"DB08895","BE0004145","From FDA label."
2067,"DB00514","BE0000770","# Codd EE, Shank RP, Schupsky JJ, Raffa RB: Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995 Sep;274(3):1263-70. \"Pubmed\":http://www.ncb"
2068,"DB02332","BE0001550","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2069,"DB04868","BE0000453","# Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR: Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clin Cancer"
2070,"DB04888","BE0000291","# Bardin L, Kleven MS, Barret-Grevoz C, Depoortere R, Newman-Tancredi A: Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties. Neuropsychopharmacology. 2006 Sep;31(9):1869-79. Epub"
2071,"DB01295","BE0000501","# Shiraishi K, Moriya M, Miyake N, Takayanagi I: Alpha 1-adrenoceptor blocking activities of bevantolol hydrochloride(NC-1400) and labetalol in rat isolated thoracic aorta--do they distinguish between subtypes? Gen Pharmacol. 1992 Sep;23(5):843-5. \"Pubmed"
2072,"DB06933","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2073,"DB07918","BE0004129","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2074,"DB07347","BE0000542","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2075,"DB00459","BE0000078","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2076,"DB03323","BE0002951",""
2077,"DB04450","BE0004132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2078,"DB07960","BE0003200","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2079,"DB03419","BE0001925","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2080,"DB08875","BE0000369","# Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EE, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Muller T, Ratain MJ, Salgia R: Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in"
2081,"DB03345","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2082,"DB00990","BE0002090","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Koutras A, Giannopoulou E, Kritikou I, Antonacopoulou A, Evans TR, Papavassiliou AG, Kalofonos H: "
2083,"DB02532","BE0001467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2084,"DB01110","BE0004422","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
2085,"DB03147","BE0002001","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2086,"DB07842","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2087,"DB07659","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2088,"DB01978","BE0001402","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2089,"DB02367","BE0001116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2090,"DB07702","BE0004057","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2091,"DB07280","BE0003540","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2092,"DB08232","BE0000333","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2093,"DB03297","BE0002128","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2094,"DB01841","BE0001386","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2095,"DB02114","BE0003758","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2096,"DB07401","BE0003858","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2097,"DB03159","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2098,"DB02809","BE0001614","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2099,"DB00709","BE0004853","# van Leeuwen R, Lange JM, Hussey EK, Donn KH, Hall ST, Harker AJ, Jonker P, Danner SA: The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: a phase I study. AIDS. 1992 Dec;6(12):1471-5. \"Pubmed\":http:"
2100,"DB08060","BE0000316","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2101,"DB02632","BE0001404","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2102,"DB01915","BE0001317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2103,"DB00421","BE0000132","# Ye P, Yamashita T, Pollock DM, Sasano H, Rainey WE: Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis. Horm Metab Res. 2009 Jan;41(1):35-9. Epub 2008 Sep 25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18819053"
2104,"DB08185","BE0004213","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2105,"DB03171","BE0004065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2106,"DB00011","BE0000385","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2107,"DB07583","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2108,"DB00151","BE0000529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2109,"DB08231","BE0004246","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2110,"DB00397","BE0000501","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Wellman PJ, McMahon LR, Green T, Tole A: Effects of the alpha"
2111,"DB08889","BE0002348","# Kortuem KM, Stewart AK: Carfilzomib. Blood. 2013 Feb 7;121(6):893-7. doi: 10.1182/blood-2012-10-459883. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23393020"
2112,"DB00716","BE0000995","# Peroni DG, Melotti P, Piacentini GL, Bonizzato C, Boner AL: Effects of nedocromil sodium on the binding of N-formyl-methionyl-leucyl-phenylalanine in human neutrophils. Agents Actions. 1992 Jul;36(3-4):212-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
2113,"DB06694","BE0000572","# Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bonisch H: Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010 Dec;24(6):729-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/200307"
2114,"DB07925","BE0004065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2115,"DB02896","BE0002011","# Bennett EM, Li C, Allan PW, Parker WB, Ealick SE: Structural basis for substrate specificity of Escherichia coli purine nucleoside phosphorylase. J Biol Chem. 2003 Nov 21;278(47):47110-8. Epub 2003 Aug 21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/129"
2116,"DB08358","BE0004064","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2117,"DB00188","BE0002349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2118,"DB03152","BE0003818","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2119,"DB01200","BE0000451","# Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I: Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO c"
2120,"DB03672","BE0002180","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2121,"DB07036","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2122,"DB04985","BE0002402","# Annabi B, Currie JC, Bouzeghrane M, Dulude H, Daigneault L, Garde S, Rabbani SA, Panchal C, Wu JJ, Beliveau R: Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding. Biochem Bioph"
2123,"DB01054","BE0002359","# Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J: Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol. 2009 Feb;75(2):407-14. Epub 200"
2124,"DB07864","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2125,"DB03435","BE0001400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2126,"DB07780","BE0003350","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2127,"DB08480","BE0002196","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2128,"DB02077","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2129,"DB04799","BE0001005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2130,"DB04077","BE0001779","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2131,"DB01819","BE0004460","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2132,"DB05461","BE0000393",""
2133,"DB02740","BE0003779","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2134,"DB00746","BE0004818","# Kontoghiorghes GJ: Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs. Toxicol Lett. 1995 Oct;80(1-3):1-18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7482575# Yokel RA: Aluminum chelation: ch"
2135,"DB06926","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2136,"DB00599","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
2137,"DB00783","BE0000792","# Vijayanathan V, Greenfield NJ, Thomas TJ, Ivanova MM, Tyulmenkov VV, Klinge CM, Gallo MA, Thomas T: Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta. Biochem Cell Biol. 200"
2138,"DB02800","BE0000331","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2139,"DB07635","BE0001730","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2140,"DB01987","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2141,"DB05475","BE0001171",""
2142,"DB03382","BE0003065",""
2143,"DB02107","BE0004563","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2144,"DB04769","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2145,"DB06978","BE0003757","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2146,"DB00772","BE0002180","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2147,"DB01622","BE0000020","# Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7918347"
2148,"DB00542","BE0000221","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Song JC, White CM: Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin con"
2149,"DB01198","BE0000523","# Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2009 Nov 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19942638# Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: S"
2150,"DB05361","BE0000928",""
2151,"DB00619","BE0000852","# Yi ES, Strong CR, Piao Z, Perucho M, Weidner N: Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity. Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):157-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1589492"
2152,"DB08440","BE0001998","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2153,"DB01452","BE0000770","# Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK: Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. "
2154,"DB00025","BE0000216","# BLATRIX C, SOULIER JP: [Preparation of a fraction rich in prothrombin, proconvertin, Stuart factor and antihemophilic factor B (P.P.B. fraction)] Pathol Biol (Paris). 1959 Dec;7:2477-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/13801371# LUNDBLAD RL,"
2155,"DB00048","BE0002140","# Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ: Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and lo"
2156,"DB01265","BE0004796","# Nash K: Telbivudine in the treatment of chronic hepatitis B. Adv Ther. 2009 Feb;26(2):155-69. Epub 2009 Feb 18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19225726# Gaeta GB, Stornaiuolo G: Therapy of chronic hepatitis B: focus on telbivudine. Dig Live"
2157,"DB03801","BE0001492","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2158,"DB01873","BE0001275","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2159,"DB07155","BE0000332","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2160,"DB00063","BE0001155","# Amoroso G, van Boven AJ, van Veldhuisen DJ, Tio RA, Balje-Volkers CP, Petronio AS, van Oeveren W: Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients with coron"
2161,"DB00690","BE0003597","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2162,"DB01694","BE0002506",""
2163,"DB07666","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2164,"DB02339","BE0001553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2165,"DB00163","BE0000872","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2166,"DB00834","BE0000557","# Greb RR, Kiesel L, Selbmann AK, Wehrmann M, Hodgen GD, Goodman AL, Wallwiener D: Disparate actions of mifepristone (RU 486) on glands and stroma in the primate endometrium. Hum Reprod. 1999 Jan;14(1):198-206. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
2167,"DB01847","BE0001323","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2168,"DB02391","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2169,"DB00119","BE0000253","# Andersen G, Andersen B, Dobritzsch D, Schnackerz KD, Piskur J: A gene duplication led to specialized gamma-aminobutyrate and beta-alanine aminotransferase in yeast. FEBS J. 2007 Apr;274(7):1804-17. Epub 2007 Mar 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
2170,"DB04786","BE0000048","# Monteiro RQ, Campana PT, Melo PA, Bianconi ML: Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies. Int J Biochem Cell Biol. 2004 Oct;36(10):2077-85. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15203120"
2171,"DB02659","BE0003993","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2172,"DB00415","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
2173,"DB00432","BE0004796","# Bijnsdorp IV, Kruyt FA, Fukushima M, Smid K, Gokoel S, Peters GJ: Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines. C"
2174,"DB00143","BE0002284","# Diwakar L, Kenchappa RS, Annepu J, Ravindranath V: Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity. Neurochem Int. 2007 Jul;51(1):37-46. Epub 2007 Apr 5. \"Pubm"
2175,"DB00431","BE0000745","# Vale C, Fonfria E, Bujons J, Messeguer A, Rodriguez-Farre E, Sunol C: The organochlorine pesticides gamma-hexachlorocyclohexane (lindane), alpha-endosulfan and dieldrin differentially interact with GABA(A) and glycine-gated chloride channels in primary "
2176,"DB03546","BE0000882","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2177,"DB03723","BE0002493",""
2178,"DB02421","BE0001901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2179,"DB02647","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2180,"DB00125","BE0000448","# Kotil K, Kuscuoglu U, Kirali M, Uzun H, Akcetin M, Bilge T: Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial. J Neurosurg Spine. 2006 May;4(5):"
2181,"DB00590","BE0000090","# Thomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Sc"
2182,"DB03559","BE0000360","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2183,"DB03435","BE0001933","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2184,"DB04147","BE0004164","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2185,"DB00172","BE0002332","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2186,"DB03755","BE0001492","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2187,"DB05882","BE0000792",""
2188,"DB04156","BE0002023","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2189,"DB00714","BE0000581","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
2190,"DB00200","BE0000456","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2191,"DB01124","BE0000207","# Mizuno CS, Chittiboyina AG, Kurtz TW, Pershadsingh HA, Avery MA: Type 2 diabetes and oral antihyperglycemic drugs. Curr Med Chem. 2008;15(1):61-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18220763"
2192,"DB01992","BE0002680",""
2193,"DB00245","BE0000647","# Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, Newman AH: Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in r"
2194,"DB00002","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2195,"DB01267","BE0000020","# Leysen JE, Janssen PM, Megens AA, Schotte A: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry. 1994 May;55 Suppl:5-12. \"Pubmed\":http://www.ncbi.nlm."
2196,"DB01915","BE0002281","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2197,"DB04570","BE0000588","# Labia R, Baron P, Masson JM: Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins. J Antimicrob Chemother. 1985 Jan;15(1):9-15. \"Pubmed\":http://www.ncbi.nlm.nih.go"
2198,"DB03604","BE0000315","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2199,"DB02075","BE0001516","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2200,"DB05025","BE0002390",""
2201,"DB06094","BE0003432",""
2202,"DB08162","BE0001016","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2203,"DB05492","BE0000442",""
2204,"DB02079","BE0000316","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2205,"DB05255","BE0000509",""
2206,"DB07019","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2207,"DB03613","BE0002496",""
2208,"DB04395","BE0000858","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2209,"DB02799","BE0002022","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2210,"DB04272","BE0001693","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2211,"DB08795","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
2212,"DB01193","BE0000172","# van den Meiracker AH, Man in 't Veld AJ, Fischberg DJ, Molinoff PB, van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA: Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldostero"
2213,"DB08265","BE0002006","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2214,"DB03568","BE0002180",""
2215,"DB07096","BE0001717","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2216,"DB05258","BE0000661",""
2217,"DB03741","BE0002742",""
2218,"DB07752","BE0004074","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2219,"DB01934","BE0001322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2220,"DB03751","BE0002493",""
2221,"DB03600","BE0004039","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2222,"DB02041","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2223,"DB00370","BE0000632","# Schreiber S, Rigai T, Katz Y, Pick CG: The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull. 2002 Sep 30;58(6):601-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12372565"
2224,"DB03814","BE0000540","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2225,"DB03349","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2226,"DB07859","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2227,"DB07186","BE0003745","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2228,"DB00171","BE0000437","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2229,"DB00170","BE0000380","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2230,"DB03051","BE0001787","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2231,"DB02481","BE0000400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2232,"DB06155","BE0000061","# Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P: Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem. 1996 Mar 22;271(12):6941-6. \"Pu"
2233,"DB03510","BE0002231","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2234,"DB01929","BE0004001","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2235,"DB04315","BE0001792","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2236,"DB01155","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2237,"DB08818","BE0004942","# Acharya S, Foletta VC, Lee JW, Rayborn ME, Rodriguez IR, Young WS 3rd, Hollyfield JG: SPACRCAN, a novel human interphotoreceptor matrix hyaluronan-binding proteoglycan synthesized by photoreceptors and pinealocytes. J Biol Chem. 2000 Mar 10;275(10):6945"
2238,"DB08025","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2239,"DB00129","BE0000306","# Barcelona-Andres B, Marina A, Rubio V: Gene structure, organization, expression, and potential regulatory mechanisms of arginine catabolism in Enterococcus faecalis. J Bacteriol. 2002 Nov;184(22):6289-300. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/123"
2240,"DB00108","BE0000590","# Sheremata WA, Minagar A, Alexander JS, Vollmer T: The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications. CNS Drugs. 2005;19(11):909-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16268663# N"
2241,"DB00440","BE0000324","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2242,"DB07841","BE0001142","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2243,"DB01769","BE0000992","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2244,"DB03147","BE0002986",""
2245,"DB00312","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
2246,"DB00144","BE0002296","# Yamaguchi Y, Shirai Y, Matsubara T, Sanse K, Kuriyama M, Oshiro N, Yoshino K, Yonezawa K, Ono Y, Saito N: Phosphorylation and up-regulation of diacylglycerol kinase gamma via its interaction with protein kinase C gamma. J Biol Chem. 2006 Oct 20;281(42):"
2247,"DB00801","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970 (Accessed December 2013)"
2248,"DB00686","BE0000326","# Zugmaier G, Lippman ME, Wellstein A: Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J Natl Cancer Inst. 1992 Nov 18;84(22):1716-24. \"Pubmed\":http://www"
2249,"DB08078","BE0001007","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2250,"DB00012","BE0000654","# LaMontagne KR, Butler J, Marshall DJ, Tullai J, Gechtman Z, Hall C, Meshaw A, Farrell FX: Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models. Mol Cancer Ther. 2006 Feb;5(2):347-55. \"Pubmed\":htt"
2251,"DB01996","BE0000966","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2252,"DB00659","BE0004852","# Mann K, Kiefer F, Spanagel R, Littleton J: Acamprosate: recent findings and future research directions. Alcohol Clin Exp Res. 2008 Jul;32(7):1105-10. doi: 10.1111/j.1530-0277.2008.00690.x. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18540918# Witkiewitz"
2253,"DB05137","BE0000411",""
2254,"DB00157","BE0000149","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2255,"DB01106","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Sugimoto Y, Iba Y, Ishizawa K, Suzuki G, Kamei C: Effects of levocabastine on lipid mediator relea"
2256,"DB03401","BE0001627","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2257,"DB00121","BE0000702","# Liu Y, Zalameda L, Kim KW, Wang M, McCarter JD: Discovery of acetyl-coenzyme A carboxylase 2 inhibitors: comparison of a fluorescence intensity-based phosphate assay and a fluorescence polarization-based ADP Assay for high-throughput screening. Assay Dr"
2258,"DB04793","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2259,"DB02546","BE0002796",""
2260,"DB08217","BE0004224","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2261,"DB00605","BE0000017","# Giuliano F, Warner TD: Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br J Pharmacol. 1999 Apr;126(8):1824-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10372826# Lim JT, Piazza GA, Han EK, Delohery"
2262,"DB01833","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2263,"DB00173","BE0004323","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2264,"DB00683","BE0003596","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2265,"DB03796","BE0003179",""
2266,"DB08074","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2267,"DB01028","BE0000484","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2268,"DB00295","BE0000420","# Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M: Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Brain Res. 2006 Apr 14;1083(1):61-9. Epub 2006 Mar 10. \"Pubmed\":http://www.nc"
2269,"DB08453","BE0002473","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2270,"DB08482","BE0000920","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2271,"DB01761","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2272,"DB01904","BE0001330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2273,"DB01595","BE0003595","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2274,"DB02755","BE0004494","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2275,"DB00363","BE0000581","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
2276,"DB02751","BE0000567","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2277,"DB02883","BE0001600","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2278,"DB02331","BE0001478","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2279,"DB00458","BE0000451","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Zanoveli JM, Nogueira RL, "
2280,"DB02023","BE0001520","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2281,"DB00925","BE0000715","# Minneman KP, Theroux TL, Hollinger S, Han C, Esbenshade TA: Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol. 1994 Nov;46(5):929-36. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7969082"
2282,"DB01126","BE0000585","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Rathnayake D, Sinclair R: Male androgenetic alopecia. Expert Opin Pharmacother. 2010 Jun;11(8):129"
2283,"DB04765","BE0001217",""
2284,"DB00068","BE0000385","# Russell-Harde D, Wagner TC, Perez HD, Croze E: Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphoryl"
2285,"DB08902","BE0004747","# FDA label"
2286,"DB01288","BE0000172","# Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN: Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):151-9. E"
2287,"DB04179","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2288,"DB04137","BE0004582","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2289,"DB07132","BE0001193","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2290,"DB00321","BE0003605","# Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K: Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol. 2009 Jun 26;16(6):644-56. \"Pubmed\":http://www.nc"
2291,"DB05022","BE0002425",""
2292,"DB07425","BE0000315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2293,"DB02379","BE0001295","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2294,"DB02528","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2295,"DB08388","BE0000966","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2296,"DB02059","BE0001523","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2297,"DB06910","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2298,"DB00311","BE0000267","# Kohling R, Vreugdenhil M, Bracci E, Jefferys JG: Ictal epileptiform activity is facilitated by hippocampal GABAA receptor-mediated oscillations. J Neurosci. 2000 Sep 15;20(18):6820-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10995826# Perez Velazquez"
2299,"DB05035","BE0000315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2300,"DB02887","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2301,"DB00934","BE0000045","# El-Fakahany E, Richelson E: Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain. Br J Pharmacol. 1983 Jan;78(1):97-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6297650# Golds PR, Przyslo FR, Strange PG: The binding of "
2302,"DB06216","BE0000393","# Citrome L: Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatr Dis Treat. 2011;7:325-39. Epub 2011 May 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21655346# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharm"
2303,"DB02196","BE0001521","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2304,"DB00002","BE0000901","# Snyder LC, Astsaturov I, Weiner LM: Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer. Clin Colorectal Cancer. 2005 Nov;5 Suppl 2:S71-80. \"Pubmed\":http://www.ncbi.nlm.nih.go"
2305,"DB03461","BE0004352","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2306,"DB08469","BE0002743","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2307,"DB07242","BE0003788","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2308,"DB00142","BE0000667","# Ohgami N, Upadhyay S, Kabata A, Morimoto K, Kusakabe H, Suzuki H: Determination of the activities of glutamic oxaloacetic transaminase and glutamic pyruvic transaminase in a microfluidic system. Biosens Bioelectron. 2007 Feb 15;22(7):1330-6. Epub 2006 J"
2309,"DB07873","BE0003570","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2310,"DB07793","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2311,"DB08653","BE0004362","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2312,"DB00117","BE0000740","# Nagatoyo Y, Iwaki J, Suzuki S, Kuno A, Hasegawa T: Molecular recognition of histidine tRNA by histidyl-tRNA synthetase from hyperthermophilic archaeon, Aeropyrum pernix K1. Nucleic Acids Symp Ser (Oxf). 2005;(49):307-8. \"Pubmed\":http://www.ncbi.nlm.nih."
2313,"DB07562","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2314,"DB02379","BE0004111","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2315,"DB02615","BE0000123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2316,"DB00941","BE0002180","# Schuh FR: Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium. Naunyn Schmiedebergs Arch Pharmacol. 1976;293(1):11-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/948350# Chen X, Ji ZL, Chen YZ: TTD: Therapeuti"
2317,"DB01215","BE0003596","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
2318,"DB00074","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2319,"DB07512","BE0002196","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2320,"DB01307","BE0000033","# Hennige AM, Sartorius T, Tschritter O, Preissl H, Fritsche A, Ruth P, Haring HU: Tissue selectivity of insulin detemir action in vivo. Diabetologia. 2006 Jun;49(6):1274-82. Epub 2006 Mar 29. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16570163# Kurtzhal"
2321,"DB01660","BE0001241","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2322,"DB00151","BE0000323","# Zhang H, Zhi L, Moore PK, Bhatia M: Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1193-201. Epub 2006 Jan 20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1642826"
2323,"DB05651","BE0002366","# Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested M: Determination of the class and isoform selectivity of small-molecule his"
2324,"DB04395","BE0001471","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2325,"DB00692","BE0000501","# Giussani DA, Moore PJ, Bennet L, Spencer JA, Hanson MA: Alpha 1- and alpha 2-adrenoreceptor actions of phentolamine and prazosin on breathing movements in fetal sheep in utero. J Physiol. 1995 Jul 1;486 ( Pt 1):249-55. \"Pubmed\":http://www.ncbi.nlm.nih.g"
2326,"DB04933","BE0002442","# Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee JO: Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007 Sep 7;130(5):906-17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
2327,"DB00420","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2328,"DB01238","BE0000442","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
2329,"DB03237","BE0002036","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2330,"DB03117","BE0001595","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2331,"DB01356","BE0000983","# Cryns K, Shamir A, Shapiro J, Daneels G, Goris I, Van Craenendonck H, Straetemans R, Belmaker RH, Agam G, Moechars D, Steckler T: Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology. 2007 Apr;32(4):881-9"
2332,"DB01403","BE0000501","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205# Dahl SG, Hough E, Hals PA: Phenothiazine drugs and metabolites: molecular conformation and "
2333,"DB08006","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2334,"DB08515","BE0003918","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2335,"DB07183","BE0000369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2336,"DB00872","BE0000165","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Ali F, Raufi MA, Washington B, Ghali JK: Conivaptan: a dual vasopressin receptor v1a/v2 antagonist"
2337,"DB07696","BE0001162","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2338,"DB00086","BE0000928","# McRedmond JP, Harriott P, Walker B, Fitzgerald DJ: Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1. Blood. 2000 Feb 15;95(4):1301-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
2339,"DB08768","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2340,"DB06268","BE0000521","# Girgis RE, Frost AE, Hill NS, Horn EM, Langleben D, McLaughlin VV, Oudiz RJ, Robbins IM, Seibold JR, Shapiro S, Tapson VF, Barst RJ: Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connecti"
2341,"DB04799","BE0003861","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2342,"DB04799","BE0003857","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2343,"DB07749","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2344,"DB01066","BE0003624","# Yamada M, Watanabe T, Miyara T, Baba N, Saito J, Takeuchi Y, Ohsawa F: Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity. Antimicrob Agents Chemoth"
2345,"DB07296","BE0002971","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2346,"DB04616","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2347,"DB04836","BE0000749","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2348,"DB07437","BE0002456","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2349,"DB05023","BE0000858",""
2350,"DB03812","BE0001270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2351,"DB08629","BE0003841","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2352,"DB00067","BE0000293","# Boson WL, Della Manna T, Damiani D, Miranda DM, Gadelha MR, Liberman B, Correa H, Romano-Silva MA, Friedman E, Silva FF, Ribeiro PA, De Marco L: Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients. Genet "
2353,"DB04050","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2354,"DB05161","BE0000394",""
2355,"DB04287","BE0001640","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2356,"DB06911","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2357,"DB01567","BE0003598","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
2358,"DB02450","BE0001559","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2359,"DB01169","BE0000428","# Fauconneau B, Petegnief V, Sanfeliu C, Piriou A, Planas AM: Induction of heat shock proteins (HSPs) by sodium arsenite in cultured astrocytes and reduction of hydrogen peroxide-induced cell death. J Neurochem. 2002 Dec;83(6):1338-48. \"Pubmed\":http://www"
2360,"DB00228","BE0004857","# Grasshoff C, Antkowiak B: Effects of isoflurane and enflurane on GABAA and glycine receptors contribute equally to depressant actions on spinal ventral horn neurones in rats. Br J Anaesth. 2006 Nov;97(5):687-94. Epub 2006 Sep 13. \"Pubmed\":http://www.ncb"
2361,"DB03721","BE0004592","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2362,"DB00241","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
2363,"DB02628","BE0001156","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2364,"DB08712","BE0001723","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2365,"DB08897","BE0000092","# FDA label"
2366,"DB03059","BE0002938",""
2367,"DB00868","BE0000197","# Thimann DA, Huang CJ, Goto CS, Feng SY: Benzonatate toxicity in a teenager resulting in coma, seizures, and severe metabolic acidosis. J Pediatr Pharmacol Ther. 2012 Jul;17(3):270-3. doi: 10.5863/1551-6776-17.3.270. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
2368,"DB07817","BE0004100","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2369,"DB03143","BE0001846","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2370,"DB07674","BE0003349","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2371,"DB00157","BE0000135","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2372,"DB01782","BE0003790","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2373,"DB04315","BE0004533","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2374,"DB03748","BE0001553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2375,"DB01356","BE0000831","# Karkanias NB, Papke RL: Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus oocytes. Neurosci Lett. 1999 Dec 31;277(3):153-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10626836"
2376,"DB01011","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2377,"DB06980","BE0003767","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2378,"DB07763","BE0003857","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2379,"DB01843","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2380,"DB03421","BE0001477","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2381,"DB08073","BE0001172","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2382,"DB00270","BE0000430","# Berjukow S, Marksteiner R, Gapp F, Sinnegger MJ, Hering S: Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation. J Biol Chem. 2000 Jul 21;275(29):22114-20. \"Pubmed\":http://www.ncbi.nlm.nih.g"
2383,"DB01238","BE0000311","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
2384,"DB00231","BE0002344","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
2385,"DB07607","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2386,"DB04238","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2387,"DB01826","BE0002564",""
2388,"DB02059","BE0001707","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2389,"DB07766","BE0004076","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2390,"DB00187","BE0000172","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Jahn P, Eckrich B, Schneidrowski B, Volz-Zang C, Schulte B, Mutschler E, Palm D: Beta 1-adrenocept"
2391,"DB00095","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2392,"DB01992","BE0001383","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2393,"DB05087","BE0000523",""
2394,"DB00150","BE0002311","# Paley EL, Denisova G, Sokolova O, Posternak N, Wang X, Brownell AL: Tryptamine Induces Tryptophanyl-tRNA Synthetase-Mediated Neurodegeneration With Neurofibrillary Tangles in Human Cell and Mouse Models. Neuromolecular Med. 2007;9(1):55-82. \"Pubmed\":htt"
2395,"DB00320","BE0000289","# Villalon CM, Centurion D, Willems EW, Arulmani U, Saxena PR, Valdivia LF: 5-HT1B receptors and alpha 2A/2C-adrenoceptors mediate external carotid vasoconstriction to dihydroergotamine. Eur J Pharmacol. 2004 Jan 26;484(2-3):287-90. \"Pubmed\":http://www.nc"
2396,"DB00477","BE0000418","# Marshak DR, Lukas TJ, Watterson DM: Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins. Biochemistry. 1985 Jan 1;24(1):144-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/298667"
2397,"DB00408","BE0004889","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
2398,"DB00485","BE0004645","# Gutkind GO, Ogueta SB, de Urtiaga AC, Mollerach ME, de Torres RA: Participation of PBP 3 in the acquisition of dicloxacillin resistance in Listeria monocytogenes. J Antimicrob Chemother. 1990 May;25(5):751-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
2399,"DB08551","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2400,"DB00002","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2401,"DB00367","BE0000539","# Hammond GL, Rabe T, Wagner JD: Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy. Am J Obstet Gynecol. 2001 Aug;185(2 Suppl):S24-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11521119# Rabe "
2402,"DB01200","BE0000342","# de Leeuw van Weenen JE, Parlevliet ET, Maechler P, Havekes LM, Romijn JA, Ouwens DM, Pijl H, Guigas B: The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors i"
2403,"DB02088","BE0002012","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2404,"DB03147","BE0002970",""
2405,"DB00741","BE0000422","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2406,"DB00379","BE0003721","# Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR: Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol. 2007 Jun"
2407,"DB05079","BE0000451",""
2408,"DB04246","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2409,"DB00112","BE0000901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2410,"DB04074","BE0000721","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2411,"DB07783","BE0002214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2412,"DB04884","BE0000797",""
2413,"DB00801","BE0003619","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
2414,"DB00513","BE0001088","# Husain SS, Hasan AA, Budzynski AZ: Differences between binding of one-chain and two-chain tissue plasminogen activators to non-cross-linked and cross-linked fibrin clots. Blood. 1989 Aug 15;74(3):999-1006. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/250"
2415,"DB00142","BE0000833","# Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor "
2416,"DB07591","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2417,"DB07384","BE0003840","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2418,"DB00023","BE0004798","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2419,"DB00381","BE0002226","# Furukawa T, Nukada T, Suzuki K, Fujita Y, Mori Y, Nishimura M, Yamanaka M: Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine. Br J Pharmacol. 1997 Jul;121(6):1136-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9249249# Furukaw"
2420,"DB04272","BE0002653",""
2421,"DB02995","BE0001291","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2422,"DB00594","BE0000497","# Viemann M, Peter M, Lopez-Siguero JP, Simic-Schleicher G, Sippell WG: Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations "
2423,"DB00171","BE0000359","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2424,"DB07912","BE0004122","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2425,"DB01633","BE0001219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2426,"DB08047","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2427,"DB00914","BE0002441","# Aziz Q, Thomas A, Khambra T, Tinker A: Phenformin has a direct inhibitory effect on the ATP-sensitive potassium channel. Eur J Pharmacol. 2010 May 25;634(1-3):26-32. Epub 2010 Feb 25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20188727"
2428,"DB02906","BE0002845","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2429,"DB08778","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2430,"DB01840","BE0004496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2431,"DB05014","BE0002131",""
2432,"DB01959","BE0001287","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2433,"DB07232","BE0003798","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2434,"DB04695","BE0004094","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2435,"DB03086","BE0001534","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2436,"DB03608","BE0000351","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2437,"DB03358","BE0001402","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2438,"DB00051","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2439,"DB07851","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2440,"DB01103","BE0001081","# Biondi C, Pavan B, Ferretti ME, Corradini FG,  Neri LM, Vesce F: Formyl-methionyl-leucyl-phenylalanine induces prostaglandin E2 release from human amnion-derived WISH cells by phospholipase C-mediated [Ca+]i rise. Biol Reprod. 2001 Mar;64(3):865-70. \"Pu"
2441,"DB08217","BE0000957","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2442,"DB02290","BE0001270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2443,"DB04465","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2444,"DB04894","BE0003528","# Fortune BE, Jackson J, Leonard J, Trotter JF: Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding. Expert Opin Pharmacother. 2009 Oct;10(14):2337-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19708854"
2445,"DB00116","BE0000734","# Hall DA, Jordan-Starck TC, Loo RO, Ludwig ML, Matthews RG: Interaction of flavodoxin with cobalamin-dependent methionine synthase. Biochemistry. 2000 Sep 5;39(35):10711-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10978155# Fowler B: The folate cycle "
2446,"DB04967","BE0000742","# Bases RE, Mendez F: Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1133-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9169823# Dassonneville L, Bailly C: Stimulation of topoisom"
2447,"DB02989","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2448,"DB01359","BE0000694","# Kulkarni RD, DaSilva LM, Chabria NL, Chadha DR: Beta-2 adrenoceptor blocking activity of penbutolol and propranolol at very low doses. Clin Pharmacol Ther. 1977 Jun;21(6):685-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16716# Hjorth S, Sharp T: In v"
2449,"DB02346","BE0001508","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2450,"DB03134","BE0001297","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2451,"DB02831","BE0000869","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2452,"DB00477","BE0000533","# Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. \"Pu"
2453,"DB00537","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Robinson MJ, Martin BA, Gootz TD, McGuirk PR, Osheroff N: Effects of novel fluoroquinolones on the"
2454,"DB06886","BE0003743","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2455,"DB04395","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2456,"DB06947","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2457,"DB00383","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2458,"DB00897","BE0003593","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2459,"DB05897","BE0000858",""
2460,"DB02670","BE0001243","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2461,"DB07107","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2462,"DB00446","BE0004650","# Murray IA, Cann PA, Day PJ, Derrick JP, Sutcliffe MJ, Shaw WV, Leslie AG: Steroid recognition by chloramphenicol acetyltransferase: engineering and structural analysis of a high affinity fusidic acid binding site. J Mol Biol. 1995 Dec 15;254(5):993-1005"
2463,"DB00072","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2464,"DB06637","BE0004721","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
2465,"DB03048","BE0000960","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2466,"DB05501","BE0000919",""
2467,"DB04328","BE0001759","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2468,"DB02287","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2469,"DB05075","BE0000023",""
2470,"DB07546","BE0003984","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2471,"DB00223","BE0000794","# Pearce DJ, Spencer L, Hu J, Balkrishnan R, Fleischer AB Jr, Feldman SR: Class I topical corticosteroid use by psoriasis patients in an academic practice. J Dermatolog Treat. 2004 Jul;15(4):235-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15764038"
2472,"DB08935","BE0000066","# Robak T: GA-101, a third-generation, humanized and glyco-engineered anti-CD20 mAb for the treatment of B-cell lymphoid malignancies. Curr Opin Investig Drugs. 2009 Jun;10(6):588-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19513948"
2473,"DB07821","BE0002705","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2474,"DB08099","BE0000270","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2475,"DB00480","BE0003517","# Akobeng AK, Stokkers PC: Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007351. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19370685# Melchert M, List A: The thalidomi"
2476,"DB00306","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
2477,"DB00562","BE0000535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2478,"DB01369","BE0002464","# Barthel D, Schlitzer M, Pradel G: Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum. Antimicrob Agents Chemother. 2008 Feb;52(2):774-7. Epub 2007 Dec 3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18056275# Harms "
2479,"DB07184","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2480,"DB04315","BE0004558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2481,"DB01134","BE0000668","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2482,"DB08375","BE0004290","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2483,"DB02448","BE0001640","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2484,"DB02473","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2485,"DB00696","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2486,"DB07614","BE0001167","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2487,"DB00454","BE0000396","# Yamakura T, Sakimura K, Shimoji K: N-methyl-D-aspartate receptor channel block by meperidine is dependent on extracellular pH. Anesth Analg. 2000 Apr;90(4):928-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10735801"
2488,"DB08366","BE0000800","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2489,"DB00671","BE0000103","# Takahata S, Senju N, Osaki Y, Yoshida T, Ida T: Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2006 Nov;50(11"
2490,"DB08649","BE0004363","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2491,"DB00090","BE0004822","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2492,"DB03892","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2493,"DB02835","BE0004461","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2494,"DB00896","BE0000794","# Hochhaus G, Moellmann HW: Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissue. Agents Actions. 1990 Jun;30(3-4):377-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
2495,"DB08604","BE0000332","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2496,"DB00767","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2497,"DB00794","BE0000523","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
2498,"DB01873","BE0001415","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2499,"DB07557","BE0003610","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2500,"DB01229","BE0000956","# Harmsen S, Meijerman I, Beijnen JH, Schellens JH: Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor. Cancer Chemother Pharmacol. 2009 Jun;64(1):35-43. doi: 10.1007/s00280-008-0842-3. E"
2501,"DB01136","BE0000694","# Irodova NL, Krasnikova TL, Masenko VP, Kochetov AG, Chazova IE: [Carvedilol in treating primary pulmonary hypertension patients: effect on severity of cardiac failure, degree of pulmonary hypertension, concentration of catecholamines in blood plasma and"
2502,"DB00157","BE0000010","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2503,"DB00159","BE0000262","# Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH: Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2003 Mar;44(3):479-86. Epub 2002 Dec 1. \"Pubm"
2504,"DB08185","BE0004214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2505,"DB00126","BE0002208","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2506,"DB00371","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979 (Accessed December 2013)"
2507,"DB03729","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2508,"DB02580","BE0004303","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2509,"DB01972","BE0001290","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2510,"DB04272","BE0002757",""
2511,"DB08567","BE0003930","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2512,"DB00829","BE0003599","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2513,"DB02404","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2514,"DB00709","BE0000555","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2515,"DB00145","BE0000536","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2516,"DB04272","BE0003258",""
2517,"DB01912","BE0001790","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2518,"DB08216","BE0001668","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2519,"DB00445","BE0004796","# Ganzina F: 4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. Cancer Treat Rev. 1983 Mar;10(1):1-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6342772# Williams LD, Frederick CA, Ughetto G, Rich"
2520,"DB01234","BE0000794","# Warne JP, John CD, Christian HC, Morris JF, Flower RJ, Sugden D, Solito E, Gillies GE, Buckingham JC: Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue. Am J Physiol Endocrinol Metab."
2521,"DB01587","BE0003595","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2522,"DB01198","BE0000795","# Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2009 Nov 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19942638# Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: S"
2523,"DB04461","BE0001629","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2524,"DB01109","BE0001159","# Simonis D, Fritzsche J, Alban S, Bendas G: Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition. Biochemistry. 2007 May 22;46(20):6156-64. Epub 2007 Apr 26. \"Pubmed\":htt"
2525,"DB02555","BE0001029","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2526,"DB04141","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2527,"DB00316","BE0000262","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Lee YS, Kim H, Brahim JS, Rowan J, Lee G, Dionne RA: Acetaminophen selectively suppresses peripher"
2528,"DB05806","BE0000971",""
2529,"DB01064","BE0001012","# Ahlquist RP: Present state of alpha- and beta-adrenergic drugs I. The adrenergic receptor. Am Heart J. 1976 Nov;92(5):661-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10722# Schiffelers SL, Blaak EE, Saris WH, van Baak MA: In vivo beta3-adrenergic sti"
2530,"DB01960","BE0001402","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2531,"DB08141","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2532,"DB06203","BE0000854","# FDA label"
2533,"DB00850","BE0000756","# Seeman P: Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11873706# Hoyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielsen M, Salvesen I: Risperidone versus perphenaz"
2534,"DB00078","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2535,"DB00231","BE0003599","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
2536,"DB05389","BE0003375",""
2537,"DB03966","BE0000799","# Tsai FT, Singh OM, Skarzynski T, Wonacott AJ, Weston S, Tucker A, Pauptit RA, Breeze AL, Poyser JP, O'Brien R, Ladbury JE, Wigley DB: The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent "
2538,"DB07464","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2539,"DB03083","BE0003334","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2540,"DB08453","BE0003857","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2541,"DB05507","BE0000444",""
2542,"DB05766","BE0000581",""
2543,"DB01327","BE0003723","# Truesdell SE, Zurenko GE, Laborde AL: Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1989 Apr;23 Suppl D:13-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2722720# Y"
2544,"DB08690","BE0003857","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2545,"DB08575","BE0000266","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2546,"DB07549","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2547,"DB02010","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2548,"DB02519","BE0001827","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2549,"DB02044","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2550,"DB01660","BE0001269","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2551,"DB01163","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
2552,"DB03264","BE0001723","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2553,"DB03465","BE0004460","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2554,"DB03703","BE0000400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2555,"DB03425","BE0000826","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2556,"DB05299","BE0001029",""
2557,"DB00194","BE0004499","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2558,"DB01752","BE0002523",""
2559,"DB03541","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2560,"DB01175","BE0000442","# Bareggi SR, Mundo E, Dell'Osso B, Altamura AC: The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):741-53. \"Pubmed\":http://www.ncbi.nlm.n"
2561,"DB07866","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2562,"DB04950","BE0004796","# Ranpirnase: amphibian ribonuclease A, P-30 protein-alfacell. Drugs R D. 2007;8(2):120-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17324010"
2563,"DB03298","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2564,"DB05822","BE0000017",""
2565,"DB03814","BE0002707",""
2566,"DB00458","BE0000560","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
2567,"DB00114","BE0000692","# Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C: Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol. 2006 Mar 14;12(10):1607-12. \"Pubme"
2568,"DB00753","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2569,"DB06843","BE0003731","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2570,"DB00477","BE0000451","# Kusumi I, Takahashi Y, Suzuki K, Kameda K, Koyama T: Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain. J Neural Transm. 2000;107(3):295-302. \"Pubmed\":http://ww"
2571,"DB01962","BE0001424","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2572,"DB00139","BE0002202","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2573,"DB03563","BE0001466","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2574,"DB08498","BE0001162","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2575,"DB01677","BE0001487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2576,"DB00142","BE0000180","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2577,"DB07345","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2578,"DB03461","BE0002072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2579,"DB00716","BE0000099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2580,"DB01419","BE0000262","# Albertini R, Aimbire F, Villaverde AB, Silva JA Jr, Costa MS: COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm Res. 2007 Jun;56(6):228-9. \"Pubmed\":ht"
2581,"DB01992","BE0004459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2582,"DB00100","BE0000016","# Neels JG, Bovenschen N, van Zonneveld AJ, Lenting PJ: Interaction between factor VIII and LDL receptor-related protein. Modulation of coagulation? Trends Cardiovasc Med. 2000 Jan;10(1):8-14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11150722# Carr ME "
2583,"DB01406","BE0001047","# Boucher A, Lemay A, Akoum A: Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis. Fertil Steril. 2000 Nov;74(5):969-75. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11056242# "
2584,"DB05115","BE0000033",""
2585,"DB01000","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
2586,"DB03389","BE0003068",""
2587,"DB08280","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2588,"DB01868","BE0001349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2589,"DB06884","BE0003742","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2590,"DB00907","BE0000749","# Patkar AA, Berrettini WH, Hoehe M, Thornton CC, Gottheil E, Hill K, Weinstein SP: Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals. Psychiatry Res. 20"
2591,"DB01992","BE0002675",""
2592,"DB02175","BE0001917","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2593,"DB03361","BE0001531","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2594,"DB02894","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2595,"DB01520","BE0000641","# Stirling JM, Cross AJ, Green AR: The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex. Neuropharmacology. 1989 Jan;28(1):1-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2538766# Geldenhuys WJ, Malan SF, B"
2596,"DB01097","BE0000382","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Goldenberg MM: Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthrit"
2597,"DB01752","BE0002529",""
2598,"DB07780","BE0004093","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2599,"DB04233","BE0003941","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2600,"DB00355","BE0000790","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2601,"DB00829","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12 (Accessed December 2013)"
2602,"DB00708","BE0000632","# Zhu J, Xue JC, Law PY, Claude PA, Luo LY, Yin J, Chen C, Liu-Chen LY: The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor. FEBS Lett. 1996 Apr 15;384(2):198-20"
2603,"DB01173","BE0000534","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2604,"DB09014","BE0000533","# Ring RM, Regan CM: Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonism. J Psychopharmacol. 2013 Oct;27(10):930-9. doi: 10.1177/0269881113497614. Ep"
2605,"DB00110","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2606,"DB01175","BE0000486","# Bareggi SR, Mundo E, Dell'Osso B, Altamura AC: The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):741-53. \"Pubmed\":http://www.ncbi.nlm.n"
2607,"DB08262","BE0000629","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2608,"DB00729","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2609,"DB00514","BE0003585","# Damaj MI, Flood P, Ho KK, May EL, Martin BR: Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J Pharmacol Exp Ther. 2005 Feb;312(2):780-5. Epub 2004 Sep 8. \"Pubmed\":http://www.ncbi"
2610,"DB07892","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2611,"DB05232","BE0002081","# Sage D, Salin P, Alcaraz G, Castets F, Giraud P, Crest M, Mazet B, Clerc N: Na(v)1.7 and Na(v)1.3 are the only tetrodotoxin-sensitive sodium channels expressed by the adult guinea pig enteric nervous system. J Comp Neurol. 2007 Oct 1;504(4):363-78. \"Pub"
2612,"DB02343","BE0003797","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2613,"DB01043","BE0000641","# Smothers CT, Woodward JJ: Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther. 2007 Aug;322(2):739-48. Epub 2007 May 14. \"Pubmed\":http://www.ncbi.nlm."
2614,"DB01220","BE0000956","# Cheng J, Shah YM, Ma X, Pang X, Tanaka T, Kodama T, Kristopher KW, Gonzalez FJ: Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther. 2010 Jul 13. \"Pubmed\":http:/"
2615,"DB08901","BE0000453","# FDA label # Gleixner KV, Peter B, Blatt K, Suppan V, Reiter A, Radia D, Hadzijusufovic E, Valent P: Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V. Haematologica. 2013 Mar 28. \"Pub"
2616,"DB00114","BE0000618","# Nakai T, Nakagawa N, Maoka N, Masui R, Kuramitsu S, Kamiya N: Structure of P-protein of the glycine cleavage system: implications for nonketotic hyperglycinemia. EMBO J. 2005 Apr 20;24(8):1523-36. Epub 2005 Mar 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
2617,"DB04787","BE0000557","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2618,"DB07363","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2619,"DB00374","BE0000110","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2620,"DB08688","BE0004376","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2621,"DB07898","BE0004116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2622,"DB00025","BE0001043","# Shord SS, Lindley CM: Coagulation products and their uses. Am J Health Syst Pharm. 2000 Aug 1;57(15):1403-17; quiz 1418-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10938981# Lillicrap D, Poon MC, Walker I, Xie F, Schwartz BA: Efficacy and safety of "
2623,"DB00335","BE0000694","# Nuttall SL, Routledge HC, Kendall MJ: A comparison of the beta1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther. 2003 Jun;28(3):179-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12795776"
2624,"DB00143","BE0002292","# Hashemy SI, Johansson C, Berndt C, Lillig CH, Holmgren A: Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity. J Biol Chem. 2007 May 11;282(19):14428-36. Epub 2007 Mar 13. \"Pub"
2625,"DB01088","BE0002353","# Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW: Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation. 2001 Sep 11;104(11):1218-22. \"Pubmed\":http://www.ncbi.nlm.ni"
2626,"DB03350","BE0001922","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2627,"DB01221","BE0000420","# Smith DJ, Pekoe GM, Martin LL, Coalgate B: The interaction of ketamine with the opiate receptor. Life Sci. 1980 Mar 10;26(10):789-95. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6246318# Hustveit O, Maurset A, Oye I: Interaction of the chiral forms of k"
2628,"DB05147","BE0001340",""
2629,"DB07890","BE0004066","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2630,"DB02556","BE0001026","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2631,"DB02578","BE0001349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2632,"DB01054","BE0002354","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Striessnig, J. (2004). Ca ^2+^ channel blockers. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclo"
2633,"DB03222","BE0001269","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2634,"DB01363","BE0001012","# Vansal SS, Feller DR: Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol. 1999 Sep 1;58(5):807-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10449190"
2635,"DB00710","BE0000776","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Chapurlat RD, Delmas PD: Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin P"
2636,"DB08810","BE0000451","# Alarcon-de-la-Lastra Romero C, Lopez A, Martin MJ, la Casa C, Motilva V: Cinitapride protects against ethanol-induced gastric mucosal injury in rats: role of 5-hydroxytryptamine, prostaglandins and sulfhydryl compounds. Pharmacology. 1997 Apr;54(4):193-"
2637,"DB04450","BE0004133","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2638,"DB03976","BE0003531","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2639,"DB04282","BE0002060","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2640,"DB01244","BE0002396","# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol. 1992 Oct;100(4):703-28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1281221# Bezprozvanny I, Tsi"
2641,"DB01110","BE0004423","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
2642,"DB07074","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2643,"DB00413","BE0000533","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
2644,"DB00397","BE0000172","# Thomas SH, Clark KL, Allen R, Smith SE: A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies. Br J Clin Pharmacol. 1991 Dec;32(6):705-11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/172"
2645,"DB01863","BE0001300","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2646,"DB08906","BE0000794","# FDA label"
2647,"DB01910","BE0001456","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2648,"DB00822","BE0000133","# Mackenzie IS, Maki-Petaja KM, McEniery CM, Bao YP, Wallace SM, Cheriyan J, Monteith S, Brown MJ, Wilkinson IB: Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1891-5. E"
2649,"DB06943","BE0003754","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2650,"DB02377","BE0001556","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2651,"DB00666","BE0000472","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2652,"DB01558","BE0002345","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
2653,"DB00674","BE0004662","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
2654,"DB00095","BE0000901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2655,"DB08653","BE0004363","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2656,"DB01184","BE0000756","# Cavallotti C, Nuti F, Bruzzone P, Mancone M: Age-related changes in dopamine D2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):412-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12010185# Osinski MA, Uchic "
2657,"DB06216","BE0000572","# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. Epub 2008 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18308814"
2658,"DB07085","BE0003752","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2659,"DB06845","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2660,"DB05290","BE0000521",""
2661,"DB04301","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2662,"DB03461","BE0002364","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2663,"DB00157","BE0000313","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2664,"DB00560","BE0000127","# Olson MW, Ruzin A, Feyfant E, Rush TS 3rd, O'Connell J, Bradford PA: Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother. 2006 Jun;50(6):2156-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
2665,"DB00543","BE0000581","# Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR: Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylcloz"
2666,"DB08231","BE0004227","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2667,"DB07925","BE0004066","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2668,"DB04879","BE0000029","# Yamamoto A, Watanabe H, Sueki H, Nakanishi T, Yasuhara H, Iijima M: Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity. J Dermatol. 2007 J"
2669,"DB03793","BE0001413","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2670,"DB01119","BE0000708","# D'hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A, Vivaudou M: Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12162-7. \"Pubmed\":http://w"
2671,"DB00188","BE0002348","# Politou M, Karadimitris A, Terpos E, Kotsianidis I, Apperley JF, Rahemtulla A: No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib. Leuk Res. 2006 Feb;30(2):240-1. Epub 2005 Au"
2672,"DB04395","BE0001547","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2673,"DB00160","BE0002166","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2674,"DB07317","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2675,"DB00109","BE0000398","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2676,"DB02225","BE0001560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2677,"DB08231","BE0004236","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2678,"DB01442","BE0000486","# Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR: New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681-98. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17209801"
2679,"DB07430","BE0001373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2680,"DB00110","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2681,"DB04451","BE0004793","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2682,"DB02740","BE0003778","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2683,"DB01436","BE0000779","# Reinhart GA: Vitamin D analogs: novel therapeutic agents for cardiovascular disease? Curr Opin Investig Drugs. 2004 Sep;5(9):947-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15503649# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic "
2684,"DB02620","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2685,"DB07152","BE0003782","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2686,"DB00400","BE0000283","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2687,"DB08802","BE0000442","# Moreau A, Dompmartin A, Dubreuil A, Leroy D: Phototoxic and photoprotective effects of topical isothipendyl. Photodermatol Photoimmunol Photomed. 1995 Apr;11(2):50-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8546983"
2688,"DB01024","BE0000761","# Dzidic A, Prgomet C, Mohr A, Meyer K, Bauer J, Meyer HH, Pfaffl MW: Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep. J Vet Med A Physiol Pathol Clin Med. 2006"
2689,"DB02772","BE0001483","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2690,"DB02694","BE0001387","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2691,"DB03247","BE0004614","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2692,"DB08202","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2693,"DB03880","BE0001637","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2694,"DB01016","BE0000207","# Dabrowski M, Ashcroft FM, Ashfield R, Lebrun P, Pirotte B, Egebjerg J, Bondo Hansen J, Wahl P: The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. Diabetes. 2002 Jun;51(6"
2695,"DB00127","BE0004796","# Trubetskoy VS, Wolff JA, Budker VG: The role of a microscopic colloidally stabilized phase in solubilizing oligoamine-condensed DNA complexes. Biophys J. 2003 Feb;84(2 Pt 1):1124-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12547793# Cho SK, Kwon YJ:"
2696,"DB08330","BE0003855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2697,"DB03222","BE0001811","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2698,"DB03896","BE0004515","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2699,"DB01273","BE0003585","# Mihalak KB, Carroll FI, Luetje CW: Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006 Sep;70(3):801-5. Epub 2006 Jun 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16766716"
2700,"DB02222","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2701,"DB00480","BE0004755","# Zhu YX, Kortuem KM, Stewart AK: Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma. Leuk Lymphoma. 2013 Apr;54(4):683-7. doi: 10.3109/10428194.2012.728597. Epub 2012 Sep 28. \"Pubmed\":h"
2702,"DB00619","BE0000853","# Dewar AL, Zannettino AC, Hughes TP, Lyons AB: Inhibition of c-fms by imatinib: expanding the spectrum of treatment. Cell Cycle. 2005 Jul;4(7):851-3. Epub 2005 Jul 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15917650# Taylor JR, Brownlow N, Domin J, "
2703,"DB00118","BE0000304","# Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti G, Caruso U, Lorini R, Watkins D, Matiaszuk N, Rosenblatt DS, Schwahn B, Rozen R, LeGros L, Kotb M, Capdevila A, Luka Z, Finkelstein JD, Tangerman A, Stabler SP, Allen RH, Wagner C: Glycine N-methyl"
2704,"DB01603","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
2705,"DB01247","BE0002198","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Thase ME, Trivedi MH, Rush AJ: MAOIs in the contemporary treatment of depression. Neuropsychopharm"
2706,"DB08764","BE0002411","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2707,"DB01236","BE0000484","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2708,"DB00114","BE0000007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2709,"DB01354","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
2710,"DB01001","BE0000172","# Baker JG: The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol. 2005 Feb;144(3):317-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15655528"
2711,"DB03206","BE0001371","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2712,"DB07450","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2713,"DB02035","BE0004538","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2714,"DB00690","BE0003596","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2715,"DB00418","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
2716,"DB04530","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2717,"DB00246","BE0000451","# Mansbach RS, Carver J, Zorn SH: Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone. Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):535-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11509214# Ichikawa J, Li Z, Da"
2718,"DB00114","BE0000667","# Cheung PY, Fong CC, Ng KT, Lam WC, Leung YC, Tsang CW, Yang M, Wong MS: Interaction between pyridoxal kinase and pyridoxal-5-phosphate-dependent enzymes. J Biochem (Tokyo). 2003 Nov;134(5):731-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14688239# Hal"
2719,"DB07063","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2720,"DB01942","BE0002660",""
2721,"DB07145","BE0003754","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2722,"DB04272","BE0001380","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2723,"DB02415","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2724,"DB03138","BE0001876","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2725,"DB04805","BE0003832","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2726,"DB04908","BE0000291","# Invernizzi RW, Sacchetti G, Parini S, Acconcia S, Samanin R: Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors. Br J Pharmacol. 2003 Aug;139"
2727,"DB03925","BE0000394","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Yoshimura Y, Hiramatsu Y, Sato Y, Homma S, Enomoto Y, Jikuya T, Sakakibara Y: ONO-6818, a novel, p"
2728,"DB00114","BE0000292","# Bhavani S, Trivedi V, Jala VR, Subramanya HS, Kaul P, Prakash V, Appaji Rao N, Savithri HS: Role of Lys-226 in the catalytic mechanism of Bacillus stearothermophilus serine hydroxymethyltransferase--crystal structure and kinetic studies. Biochemistry. 2"
2729,"DB00340","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2730,"DB00415","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
2731,"DB00741","BE0000794","# Grossman R, Yehuda R, Golier J, McEwen B, Harvey P, Maria NS: Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects. Ann N Y Acad Sci. 2006 Jul;1071:410-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1689158"
2732,"DB00143","BE0002287","# Chattopadhyay S, Sahoo DK, Subudhi U, Chainy GB: Differential expression profiles of antioxidant enzymes and glutathione redox status in hyperthyroid rats: a temporal analysis. Comp Biochem Physiol C Toxicol Pharmacol. 2007 Sep;146(3):383-91. Epub 2007 "
2733,"DB00120","BE0000614","# Fukami MH, Haavik J, Flatmark T: Phenylalanine as substrate for tyrosine hydroxylase in bovine adrenal chromaffin cells. Biochem J. 1990 Jun 1;268(2):525-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1973034# Ogawa S, Ichinose H: Effect of metals and p"
2734,"DB03766","BE0002652","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2735,"DB02801","BE0001857","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2736,"DB00408","BE0000045","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
2737,"DB08133","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2738,"DB05265","BE0002423","# Kusumoto K, Kawahara T, Kuwano Y, Teshima-Kondo S, Morita K, Kishi K, Rokutan K: Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells. Am J Physiol Gastroint"
2739,"DB00777","BE0000533","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2740,"DB01602","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2741,"DB03814","BE0000520","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2742,"DB04147","BE0004165","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2743,"DB00413","BE0000659","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
2744,"DB00448","BE0000349","# Matheson AJ, Jarvis B: Lansoprazole: an update of its place in the management of acid-related disorders. Drugs. 2001;61(12):1801-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11693467# Langtry HD, Wilde MI: Lansoprazole. An update of its pharmacologic"
2745,"DB03247","BE0000621","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2746,"DB01148","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2747,"DB07427","BE0000629","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2748,"DB01942","BE0002661",""
2749,"DB02849","BE0001506","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2750,"DB01992","BE0002681",""
2751,"DB07826","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2752,"DB01936","BE0001997","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2753,"DB06718","BE0004844","# Luzardo OP, Machin RP, Diaz-Chico BN, Fernandez L: Photoaffinity labeling identification of a specific binding protein for the anabolic steroids stanozolol and danazol: an oligomeric protein regulated by age, pituitary hormones, and ethinyl estradiol. E"
2754,"DB04239","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2755,"DB02930","BE0002850",""
2756,"DB00142","BE0000568","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2757,"DB00111","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2758,"DB00408","BE0000647","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
2759,"DB04253","BE0000220","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2760,"DB02560","BE0001397","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2761,"DB01359","BE0000797","# Hjorth S, Sharp T: In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J Pharmacol Exp Ther. 1993 May;265(2):707-12. \"Pubmed\":http://www.ncbi.nlm.nih."
2762,"DB03573","BE0001504","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2763,"DB05458","BE0000849",""
2764,"DB08584","BE0000915","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2765,"DB08814","BE0000005","# Anninos H, Andrikopoulos G, Pastromas S, Sakellariou D, Theodorakis G, Vardas P: Triflusal: an old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness. Hellenic J Cardiol. 2009 May-Jun;50(3):199-207. \"Pubmed\":http://"
2766,"DB00151","BE0002312","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2767,"DB07503","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2768,"DB07245","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2769,"DB00907","BE0000192","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2770,"DB08115","BE0004120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2771,"DB03863","BE0001329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2772,"DB00458","BE0000749","# Leboyer M, Quintin P, Manivet P, Varoquaux O, Allilaire JF, Launay JM: Decreased serotonin transporter binding in unaffected relatives of manic depressive patients. Biol Psychiatry. 1999 Dec 15;46(12):1703-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
2773,"DB00842","BE0000471","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2774,"DB08732","BE0004014","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2775,"DB04233","BE0001610","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2776,"DB08610","BE0004348","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2777,"DB03442","BE0001240","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2778,"DB04530","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2779,"DB01827","BE0001353","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2780,"DB01403","BE0000405","# Dahl SG, Hough E, Hals PA: Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding. Biochem Pharmacol. 1986 Apr 15;35(8):1263-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
2781,"DB01694","BE0004525","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2782,"DB04447","BE0003311",""
2783,"DB02596","BE0002733",""
2784,"DB04905","BE0001032","# Vincent M: Tesmilifene may enhance breast cancer chemotherapy by killing a clone of aggressive, multi-drug resistant cells through its action on the p-glycoprotein pump. Med Hypotheses. 2006;66(4):715-31. Epub 2006 Jan 18. \"Pubmed\":http://www.ncbi.nlm.n"
2785,"DB01766","BE0000230","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2786,"DB00421","BE0000685","# Braunstein GD: Clinical practice. Gynecomastia. N Engl J Med. 2007 Sep 20;357(12):1229-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17881754"
2787,"DB07243","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2788,"DB00767","BE0000247","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2789,"DB03461","BE0002962",""
2790,"DB02052","BE0003819","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2791,"DB00363","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Roegge CS, Perraut C, Hao X, Levin ED: Histamine H1 receptor involvement in prepulse inhibition an"
2792,"DB05362","BE0000216",""
2793,"DB05767","BE0001051",""
2794,"DB08130","BE0000870","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2795,"DB05483","BE0002842",""
2796,"DB00321","BE0000749","# Gould GG, Altamirano AV, Javors MA, Frazer A: A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry. 2006 Mar 1;59(5):408-14. Epub 2005 Sep 2. \"Pubmed\":http:/"
2797,"DB01992","BE0001757","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2798,"DB00622","BE0000575","# Thayer SA, Welcome M, Chhabra A, Fairhurst AS: Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Biochem Pharmacol. 1985 Jan 15;34(2):175-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/298"
2799,"DB02432","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2800,"DB01205","BE0000795","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Wingrove PB, Safo P, Wheat L, Thompson SA, Wafford KA, Whitin"
2801,"DB08873","BE0004701","# Ali A, Aydin C, Gildemeister R, Romano KP, Cao H, Ozen A, Soumana D, Newton A, Petropoulos CJ, Huang W, Schiffer CA: Evaluating the Role of Macrocycles in the Susceptibility of Hepatitis C Virus NS3/4A Protease Inhibitors to Drug Resistance. ACS Chem Bi"
2802,"DB00487","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
2803,"DB03147","BE0004580","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2804,"DB03147","BE0002981",""
2805,"DB00248","BE0000342","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
2806,"DB00801","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2807,"DB07676","BE0001065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2808,"DB01224","BE0000756","# Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P: A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psy"
2809,"DB00611","BE0000420","# Fan LW, Tanaka S, Tien LT, Ma T, Rockhold RW, Ho IK: Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain. Brain Res Bull. 2002 Jun;58(2):149-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/121"
2810,"DB00904","BE0000084","# van Wijngaarden I, Tulp MT, Soudijn W: The concept of selectivity in 5-HT receptor research. Eur J Pharmacol. 1990 Jun 12;188(6):301-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2164935"
2811,"DB00157","BE0000148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2812,"DB00600","BE0000252","# Chen YR, Y-Y R, Lin TY, Huang CP, Tang WC, Chen ST, Lin SB: Identification of an Alkylhydroquinone from Rhus succedanea as an Inhibitor of Tyrosinase and Melanogenesis. J Agric Food Chem. 2009 Mar 25;57(6):2200-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
2813,"DB01038","BE0000756","# Vinar O, Formankova M, Taussigova D, Ruzicka S: Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial. Act Nerv Super (Praha). 1967 Nov;9(4):353-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/4889058# Bora G: Comparison of "
2814,"DB04447","BE0003313",""
2815,"DB01684","BE0002148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2816,"DB03026","BE0002021","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2817,"DB03161","BE0002995",""
2818,"DB03399","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2819,"DB03666","BE0001218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2820,"DB03127","BE0004529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2821,"DB04467","BE0002823",""
2822,"DB01559","BE0000129","# Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 2008 Oct;9(8):827-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18855614"
2823,"DB01771","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2824,"DB07191","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2825,"DB04894","BE0000384","# Betoin F, Advenier C, Fardin V, Wilcox G, Lavarenne J, Eschalier A: In vitro and in vivo evidence for a tachykinin NK1 receptor antagonist effect of vapreotide, an analgesic cyclic analog of somatostatin. Eur J Pharmacol. 1995 Jun 12;279(2-3):241-9. \"Pu"
2826,"DB00683","BE0003595","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2827,"DB02679","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2828,"DB07242","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2829,"DB01151","BE0000973","# Testai FD, Landek MA, Dawson G: Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. J Neurosci Res. 2004 Jan 1;75(1):66-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14689449# Kolzer M, Werth N, Sandhoff K: Interactions of acid sp"
2830,"DB00114","BE0000916","# Livanova NB, Chebotareva NA, Eronina TB, Kurganov BI: Pyridoxal 5'-phosphate as a catalytic and conformational cofactor of muscle glycogen phosphorylase B. Biochemistry (Mosc). 2002 Oct;67(10):1089-98. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1246010"
2831,"DB01238","BE0000342","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
2832,"DB01595","BE0003596","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2833,"DB04272","BE0000372","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2834,"DB01972","BE0000182","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2835,"DB00157","BE0000336","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2836,"DB00372","BE0000020","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2837,"DB02726","BE0001818","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2838,"DB00420","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2839,"DB07539","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2840,"DB00829","BE0000795","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2841,"DB03661","BE0003144",""
2842,"DB02723","BE0000048","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2843,"DB08344","BE0004280","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2844,"DB03692","BE0002041","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2845,"DB03801","BE0001535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2846,"DB04539","BE0001759","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2847,"DB07731","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2848,"DB08891","BE0000217","References:    Bowery NG: GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol. 1993;33:109-47. Pubmed    Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. Pubmed    Garcia-Gil L, de Miguel R, Romero J"
2849,"DB02964","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2850,"DB05745","BE0001680",""
2851,"DB04375","BE0001620","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2852,"DB00142","BE0000824","# Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor "
2853,"DB00073","BE0000901","# Treon SP, Hansen M, Branagan AR, Verselis S, Emmanouilides C, Kimby E, Frankel SR, Touroutoglou N, Turnbull B, Anderson KC, Maloney DG, Fox EA: Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab i"
2854,"DB08411","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2855,"DB00078","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2856,"DB03801","BE0001538","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2857,"DB04464","BE0003987","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2858,"DB01412","BE0000013","# Chou CC, Vickroy TW: Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues. Am J Vet Res. 2003 Feb;64(2):216-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12602592# Gaytan SP, Saadani-Makki F, Bodineau L, F"
2859,"DB01263","BE0000233","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2860,"DB06719","BE0000134","# Kirby RS, Fitzpatrick JM, Clarke N: Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer. BJU Int. 2009 Dec;104(11):1580-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20053189"
2861,"DB04343","BE0001750","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2862,"DB02465","BE0002194","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2863,"DB04021","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2864,"DB01099","BE0000892","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2865,"DB02164","BE0003766","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2866,"DB08360","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2867,"DB05278","BE0000877",""
2868,"DB00878","BE0004833","# Zorko M, Jerala R: Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. J Antimicrob Chemother. 2008 Oct;62(4):730-7. Epub 2008 Jul 16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18635"
2869,"DB07022","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2870,"DB08497","BE0001162","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2871,"DB01215","BE0003599","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
2872,"DB02155","BE0003761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2873,"DB01488","BE0000156","# Su TP, Hayashi T, Vaupel DB: When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor. Sci Signal. 2009 Mar 10;2(61):pe12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19278957"
2874,"DB03754","BE0002580",""
2875,"DB04447","BE0000554","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2876,"DB04840","BE0000486","# Joyce PI, Rizzi D, Calo G, Rowbotham DJ, Lambert DG: The effect of guanethidine and local anesthetics on the electrically stimulated mouse vas deferens. Anesth Analg. 2002 Nov;95(5):1339-43, table of contents. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
2877,"DB00333","BE0000420","# Gross ER, Hsu AK, Gross GJ: Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion. Anesth Analg. 2009 Nov;109(5):1395-402. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19843777"
2878,"DB08185","BE0004201","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2879,"DB08107","BE0001258","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2880,"DB03127","BE0001656","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2881,"DB05905","BE0000084",""
2882,"DB06908","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2883,"DB06822","BE0000280","# Bisio A, Vecchietti D, Citterio L, Guerrini M, Raman R, Bertini S, Eisele G, Naggi A, Sasisekharan R, Torri G: Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. Thromb Haemost. 2009 Nov;102(5):865-73. \"Pubmed"
2884,"DB08301","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2885,"DB01643","BE0001218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2886,"DB07407","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2887,"DB01942","BE0001397","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2888,"DB00819","BE0000535","# Avvaru BS, Wagner JM, Maresca A, Scozzafava A, Robbins AH, Supuran CT, McKenna R: Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding poc"
2889,"DB01238","BE0000575","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
2890,"DB00277","BE0001133","# Wang K, Chen JQ, Chen Z, Chen JC: Inhibition of human phosphodiesterase 4A expressed in yeast cell GL62 by theophylline, rolipram, and acetamide-45. Acta Pharmacol Sin. 2002 Nov;23(11):1013-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12421478# Haider"
2891,"DB03478","BE0003362","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2892,"DB02724","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2893,"DB01942","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2894,"DB03412","BE0001532","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2895,"DB07432","BE0003869","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2896,"DB07995","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2897,"DB01110","BE0000553","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
2898,"DB00142","BE0002237","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2899,"DB03971","BE0001639","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2900,"DB00351","BE0000557","# Vadivelu S, Sharer L, Schulder M: Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg. 2010 May;112(5):920-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19731987# Mokbel K: Focus on ana"
2901,"DB00829","BE0000523","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
2902,"DB00246","BE0000797","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
2903,"DB04799","BE0003854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2904,"DB01115","BE0000864","# Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms. Pharmacology. 2006;78(1):11-20. Ep"
2905,"DB08846","BE0000577","# Abe I, Kashiwagi Y, Noguchi H, Tanaka T, Ikeshiro Y, Kashiwada Y: Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase. J Nat Prod. 2001 Aug;64(8):1010-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11520216"
2906,"DB00157","BE0000479","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2907,"DB06288","BE0000650","# Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL: Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl). 2009 Jul;205(1):119-28. Epub 2009 Apr 1. \"Pubmed\":http://www.ncbi.nlm.nih.go"
2908,"DB08629","BE0003840","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2909,"DB06923","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2910,"DB02184","BE0001270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2911,"DB01224","BE0000311","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
2912,"DB00713","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2913,"DB00173","BE0002706",""
2914,"DB05241","BE0001315",""
2915,"DB01194","BE0003626","# Vullo D, Franchi M, Gallori E, Antel J, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J Med Chem. 2004 Feb 26;47(5):1272-9. \"Pubmed\":http://www.ncbi.nlm.nih.go"
2916,"DB00162","BE0000593","# Keller B, Adamski J: RDH12, a retinol dehydrogenase causing Leber's congenital amaurosis, is also involved in steroid metabolism. J Steroid Biochem Mol Biol. 2007 May;104(3-5):190-4. Epub 2007 Mar 23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17512723"
2917,"DB05147","BE0003402",""
2918,"DB00848","BE0004925","# Culetto E, Baylis HA, Richmond JE, Jones AK, Fleming JT, Squire MD, Lewis JA, Sattelle DB: The Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive nicotinic acetylcholine receptor alpha subunit. J Biol Chem. 2004 Oct 8;279(41):42476-83. Ep"
2919,"DB02009","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2920,"DB06711","BE0000501","# Bogacka E: [Decongestants in treatment of nasal obstruction]. Otolaryngol Pol. 1999;53(3):347-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10481510# Leonardi A: Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. \"Pubme"
2921,"DB03147","BE0002967",""
2922,"DB04444","BE0001997","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2923,"DB08838","BE0000365","# Yang XC, Reis DJ: Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther. 1999 Feb;288(2):544-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9918557"
2924,"DB08651","BE0004366","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2925,"DB00546","BE0000381","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
2926,"DB01782","BE0003791","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2927,"DB04447","BE0000574","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2928,"DB04077","BE0003814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2929,"DB01351","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
2930,"DB01890","BE0003418","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2931,"DB01273","BE0000849","# Nakamura M, Oshima A, Fujimoto Y, Maruyama N, Ishibashi T, Reeves KR: Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-we"
2932,"DB02252","BE0001335","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2933,"DB03401","BE0004522","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2934,"DB02908","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2935,"DB00768","BE0000885","# Okada M, Tokumitsu H, Kubota Y, Kobayashi R: Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein. Biochem Biophys Res Commun. 2002 Apr 12;292(4):"
2936,"DB02596","BE0001450","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2937,"DB00887","BE0000281","# Panet R, Marcus M, Atlan H: Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts. J Cell Physiol. 2000 Jan;182(1):109-18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1056"
2938,"DB03836","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2939,"DB00583","BE0000406","# Xu ZR, Wang MQ, Mao HX, Zhan XA, Hu CH: Effects of L-carnitine on growth performance, carcass composition, and metabolism of lipids in male broilers. Poult Sci. 2003 Mar;82(3):408-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12705401# Morillas M, Lop"
2940,"DB00231","BE0002345","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
2941,"DB01826","BE0002563",""
2942,"DB00430","BE0003686","# Pfaller MA, Niles AC, Murray PR: In vitro antibacterial activity of cefpiramide. Antimicrob Agents Chemother. 1984 Mar;25(3):368-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6426381# Fass RJ, Helsel VL: In vitro activity of cefpiramide (SM-1652) agai"
2943,"DB07766","BE0004077","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2944,"DB04607","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2945,"DB00348","BE0000455","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Fisher AA, Davis MW: Alkaptonuric ochronosis with aortic valve and joint replacements and femoral "
2946,"DB07573","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2947,"DB00121","BE0000698","# Liu L, Li Y, Zhu Y, Du G, Chen J: Redistribution of carbon flux in Torulopsis glabrata by altering vitamin and calcium level. Metab Eng. 2007 Jan;9(1):21-9. Epub 2006 Aug 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17008113# Ferreira G, Weiss WP: Ef"
2948,"DB01946","BE0001193","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2949,"DB07129","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2950,"DB01015","BE0000124","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2951,"DB00477","BE0000650","# Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. \"Pu"
2952,"DB02752","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2953,"DB00002","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2954,"DB00408","BE0000389","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
2955,"DB01762","BE0004531","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2956,"DB01242","BE0000749","# Alvarez JC, Gluck N, Arnulf I, Quintin P, Leboyer M, Pecquery R, Launay JM, Perez-Diaz F, Spreux-Varoquaux O: Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effect"
2957,"DB03147","BE0002971",""
2958,"DB06800","BE0000632","# Yuan CS: Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Ann Pharmacother. 2007 Jun;41(6):984-93. Epub 2007 May 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17504835"
2959,"DB00487","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2960,"DB00398","BE0000369","# Schoffski P, Dumez H, Clement P, Hoeben A, Prenen H, Wolter P, Joniau S, Roskams T, Van Poppel H: Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review. Ann Oncol. 2006 Aug;17(8):1185-96. Epub 2006 Jan 17. "
2961,"DB04447","BE0003844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2962,"DB01813","BE0001396","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2963,"DB06216","BE0000389","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235# Citrome L: Role of sublingual asenapine i"
2964,"DB03668","BE0001677","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2965,"DB00142","BE0000832","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2966,"DB03309","BE0003050",""
2967,"DB02761","BE0002823",""
2968,"DB06835","BE0003257","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2969,"DB03445","BE0002015","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2970,"DB01224","BE0000560","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
2971,"DB00784","BE0000017","# Sinniah R, Lye WC: Acute renal failure from hemoglobinuric and interstitial nephritis secondary to iodine and mefenamic acid. Clin Nephrol. 2001 Mar;55(3):254-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11316248# Joo Y, Kim HS, Woo RS, Park CH, Shin "
2972,"DB01588","BE0003594","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
2973,"DB01021","BE0000502","# Li J, Wang DH: Function and regulation of epithelial sodium transporters in the kidney of a salt-sensitive hypertensive rat model. J Hypertens. 2007 May;25(5):1065-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17414671# Hasannejad H, Takeda M, Taki K,"
2974,"DB06944","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2975,"DB03258","BE0001489","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2976,"DB08425","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2977,"DB00172","BE0002331","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2978,"DB00413","BE0000145","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
2979,"DB05317","BE0002444",""
2980,"DB00879","BE0004853","# Modrzejewski KA, Herman RA: Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor. Ann Pharmacother. 2004 Jun;38(6):1006-14. Epub 2004 Apr 30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15121999# Bang LM, Scott LJ: Emtricitabine: an an"
2981,"DB03902","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2982,"DB04447","BE0004493","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2983,"DB00548","BE0003610","# Stamatiadis D, Bulteau-Portois MC, Mowszowicz I: Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol. 1988 Nov;119(5):627-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3207614"
2984,"DB02435","BE0001291","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2985,"DB08690","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2986,"DB07626","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2987,"DB07906","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2988,"DB06936","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2989,"DB03317","BE0003057",""
2990,"DB04235","BE0000253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2991,"DB06779","BE0000280","# Frydman A: Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Haemostasis. 1996;26 Suppl 2:24-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8707165# Rey E, Rivard GE: Prophylaxis and treatm"
2992,"DB00875","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2993,"DB01036","BE0000045","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Schneider T, Fetscher C, Krege S, Michel MC: Signal transduction underlying carbachol-induced cont"
2994,"DB01082","BE0004799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2995,"DB06948","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
2996,"DB00341","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Christophe B, Carlier B, Gillard M, Chatelain P, Peck M, Massingham R: Histamine H1 receptor antag"
2997,"DB04838","BE0002705","# Heffron F, Middleton B, White DA: Inhibition of acyl coenzyme A: cholesterol acyl transferase by trimethylcyclohexanylmandelate (cyclandelate). Biochem Pharmacol. 1990 Feb 1;39(3):575-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2306268"
2998,"DB02363","BE0002010","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
2999,"DB01149","BE0000533","# Millan MJ: Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie. 2005 Sep-Oct;60(5):441-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16433010# Chen X, Ji ZL, Chen Y"
3000,"DB00898","BE0000400","# Hernandez-Tobias A, Julian-Sanchez A, Pina E, Riveros-Rosas H: Natural alcohol exposure: Is ethanol the main substrate for alcohol dehydrogenases in animals? Chem Biol Interact. 2011 Feb 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21329681# Matsumot"
3001,"DB07801","BE0000991","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3002,"DB01452","BE0000420","# Klein G, Juni A, Arout CA, Waxman AR, Inturrisi CE, Kest B: Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors. Eur J Pharmacol. 2008 May 31;586(1-3):179-88. Epub 2008 Feb 19. \"Pubmed\":http://www.ncbi"
3003,"DB01238","BE0000145","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
3004,"DB02187","BE0000194","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3005,"DB06637","BE0004722","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
3006,"DB00133","BE0000388","# Fujitani Y, Horiuchi T, Ito K, Sugimoto M: Serine racemases from barley, Hordeum vulgare L., and other plant species represent a distinct eukaryotic group: gene cloning and recombinant protein characterization. Phytochemistry. 2007 Jun;68(11):1530-6. Ep"
3007,"DB01254","BE0000842","# Das J, Chen P, Norris D, Padmanabha R, Lin J, Moquin RV, Shen Z, Cook LS, Doweyko AM, Pitt S, Pang S, Shen DR, Fang Q, de Fex HF, McIntyre KW, Shuster DJ, Gillooly KM, Behnia K, Schieven GL, Wityak J, Barrish JC: 2-aminothiazole as a novel kinase inhibi"
3008,"DB04349","BE0001524","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3009,"DB03691","BE0001504","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3010,"DB07249","BE0002453","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3011,"DB08465","BE0001898","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3012,"DB04964","BE0002439","# Berek JS: Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab. Expert Opin Biol Ther. 2004 Jul;4(7):1159-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15268682# Oregovomab: anti-CA-125 monoclonal antibody B43.13--AltaRex, B43.13, MA"
3013,"DB00548","BE0000474","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3014,"DB00376","BE0000405","# Bognar IT, Altes U, Beinhauer C, Kessler I, Fuder H: A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jun;345(6):611-8. \"Pubmed\":http://w"
3015,"DB08572","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3016,"DB03597","BE0000812","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3017,"DB00734","BE0000572","# Fenton C, Scott LJ: Risperidone: a review of its use in the treatment of bipolar mania. CNS Drugs. 2005;19(5):429-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15907153# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors fo"
3018,"DB08322","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3019,"DB00674","BE0002343","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
3020,"DB07374","BE0003830","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3021,"DB01223","BE0000354","# Stella L, de Novellis V, Marabese I, Berrino L, Maione S, Filippelli A, Rossi F: The role of A3 adenosine receptors in central regulation of arterial blood pressure. Br J Pharmacol. 1998 Oct;125(3):437-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/980"
3022,"DB01564","BE0000132","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Brodkin RA, Cooper MR: Calusterone. Ann Intern Med. 1978 Dec;"
3023,"DB00887","BE0000502","# Thakker RV: Chloride channels in renal disease. Adv Nephrol Necker Hosp. 1999;29:289-98. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10561751# Karolyi L, Koch MC, Grzeschik KH, Seyberth HW: The molecular genetic approach to \"Bartter's syndrome\". J Mol M"
3024,"DB00802","BE0000770","# Garrido M, Gubbens-Stibbe J, Tukker E, Cox E, von Frijtag J, Kunzel D, IJzerman A, Danhof M, van der Graaf PH: Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor \"kno"
3025,"DB00130","BE0000874","# MacLeod TJ, Lunn FA, Bearne SL: The role of lysine residues 297 and 306 in nucleoside triphosphate regulation of E. coli CTP synthase: inactivation by 2',3'-dialdehyde ATP and mutational analyses. Biochim Biophys Acta. 2006 Feb;1764(2):199-210. Epub 200"
3026,"DB08175","BE0003781","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3027,"DB04315","BE0004559","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3028,"DB00163","BE0000339","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3029,"DB02829","BE0001468","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3030,"DB05294","BE0000767","# http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515"
3031,"DB00849","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
3032,"DB00811","BE0000457","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3033,"DB01271","BE0000856","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3034,"DB06637","BE0004717","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
3035,"DB05708","BE0002341","# Kim SW, Ding YS, Alexoff D, Patel V, Logan J, Lin KS, Shea C, Muench L, Xu Y, Carter P, King P, Constanzo JR, Ciaccio JA, Fowler JS: Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alph"
3036,"DB00040","BE0002134","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3037,"DB04454","BE0000787","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3038,"DB00315","BE0000797","# Le Grand B, Panissie A, Perez M, Pauwels PJ, John GW: Zolmitriptan stimulates a Ca(2+)-dependent K(+) current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors. Eur J Pharmacol. 2000 Jun 2;397(2-3):297-302. \"Pubmed\":http://www.nc"
3039,"DB01966","BE0001175","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3040,"DB00434","BE0000451","# Rashid M, Nakazawa M, Nagatomo T: Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery. Jpn J Pharmacol. 2002 Aug;89(4):405-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/122338"
3041,"DB01595","BE0000523","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3042,"DB06262","BE0000694","# Mersmann HJ: Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action. J Anim Sci. 1998 Jan;76(1):160-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9464897# Sanders VM: The role of norepinephrine and"
3043,"DB00308","BE0000303","# Doggrell SA, Hancox JC: Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opin Investig Drugs. 2005 May;14(5):655-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15926871# Foster RH, Wilde "
3044,"DB05900","BE0000858",""
3045,"DB07374","BE0003826","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3046,"DB03397","BE0001252","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3047,"DB05316","BE0000451",""
3048,"DB01085","BE0000045","# Sykes DA, Dowling MR, Charlton SJ: Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor. Mol Pharmacol. 2009 Sep;76(3):543-51. Epub 2009 Jun 4. \"Pubmed\":http://www.ncbi."
3049,"DB07722","BE0004062","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3050,"DB04982","BE0000830","# Langan YM, Lucas R, Jewell H, Toublanc N, Schaefer H, Sander JW, Patsalos PN: Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia. 2003 J"
3051,"DB05359","BE0000327",""
3052,"DB03461","BE0001961","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3053,"DB04857","BE0000756","# Zhu M, Whigan DB, Chang SY, Dockens RC: Disposition and Metabolism of [14C]Brasofensine in Rats, Monkeys and Humans. Drug Metab Dispos. 2007 Oct 1;. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17908924"
3054,"DB00168","BE0000395","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3055,"DB09028","BE0002341","# Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C: Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/25"
3056,"DB07377","BE0001534","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3057,"DB00442","BE0004796","# Sims KA, Woodland AM: Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection. Pharmacotherapy. 2006 Dec;26(12):1745-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17125436# Walsh AW, Langley DR, Colonno RJ, Tenney DJ: Mec"
3058,"DB02655","BE0001532","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3059,"DB03824","BE0000865","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3060,"DB06922","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3061,"DB02223","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3062,"DB04066","BE0003795","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3063,"DB00446","BE0001544","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3064,"DB00872","BE0000293","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Wada K, Fujimori A, Matsukawa U, Arai Y, Sudoh K, Yatsu T, Sasamata M, Miyata K: Intravenous admin"
3065,"DB00829","BE0003598","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3066,"DB00951","BE0000332","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3067,"DB04139","BE0001403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3068,"DB02338","BE0001467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3069,"DB04083","BE0001519","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3070,"DB08231","BE0001333","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3071,"DB01155","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3072,"DB04150","BE0002200","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3073,"DB06702","BE0000045","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Nilvebrant L: Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor anta"
3074,"DB07918","BE0004126","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3075,"DB01131","BE0000563","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3076,"DB08896","BE0000369","# FDA label"
3077,"DB02181","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3078,"DB00413","BE0000389","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agon"
3079,"DB01200","BE0000572","# de Leeuw van Weenen JE, Parlevliet ET, Maechler P, Havekes LM, Romijn JA, Ouwens DM, Pijl H, Guigas B: The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors i"
3080,"DB00316","BE0004892","# Botting R, Ayoub SS: COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins Leukot Essent Fatty Acids. 2005 Feb;72(2):85-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15626590"
3081,"DB03909","BE0002643",""
3082,"DB04315","BE0001843","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3083,"DB01101","BE0004810","# Walko CM, Lindley C: Capecitabine: a review. Clin Ther. 2005 Jan;27(1):23-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15763604# Thomas DM, Zalcberg JR: 5-fluorouracil: a pharmacological paradigm in the use of cytotoxics. Clin Exp Pharmacol Physiol. "
3084,"DB04609","BE0001594",""
3085,"DB08364","BE0004287","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3086,"DB00441","BE0000325","# Kwon WS, Rha SY, Choi YH, Lee JO, Park KH, Jung JJ, Kim TS, Jeung HC, Chung HC: Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines. Pharmacogenet Genomics. 2006 Jun;16(6):4"
3087,"DB01437","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1102 (Accessed December 2013)"
3088,"DB08530","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3089,"DB00573","BE0000017","# Poggi JC, Barissa GR, Donadi EA, Foss MC, Cunha FQ, Lanchote VL, dos Reis ML: Pharmacodynamics, chiral pharmacokinetics, and pharmacokinetic-pharmacodynamic modeling of fenoprofen in patients with diabetes mellitus. J Clin Pharmacol. 2006 Nov;46(11):132"
3090,"DB04013","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3091,"DB05047","BE0000640",""
3092,"DB02702","BE0001594","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3093,"DB07768","BE0000126","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3094,"DB03909","BE0003888","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3095,"DB00592","BE0002345","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3096,"DB04825","BE0004946","# Lamers JM, Cysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. Biochem Pharmacol. 1985 Nov 1;34(21):3837-43. \"Pubmed\":http://www.n"
3097,"DB04297","BE0003525","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3098,"DB06831","BE0002406","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3099,"DB08690","BE0003854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3100,"DB01190","BE0004800","# Schlunzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F: Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 2001 Oct 25;413(6858):814-21. \"Pubmed\":http://www.n"
3101,"DB08374","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3102,"DB07871","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3103,"DB00408","BE0000172","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
3104,"DB05374","BE0000767",""
3105,"DB02008","BE0000906","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3106,"DB00457","BE0000090","# Thomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Sc"
3107,"DB08509","BE0003372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3108,"DB00806","BE0001096","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Ustunsoy H, Sivrikoz MC, Tarakcioglu M, Bakir K, Guldur E, Celkan MA: The effects of pentoxifyllin"
3109,"DB02801","BE0001769","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3110,"DB02062","BE0000266","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3111,"DB06706","BE0000118","# Valdivia LF, Centurion D, Perusquia M, Arulmani U, Saxena PR, Villalon CM: Pharmacological analysis of the mechanisms involved in the tachycardic and vasopressor responses to the antimigraine agent, isometheptene, in pithed rats. Life Sci. 2004 May 14;7"
3112,"DB07772","BE0001182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3113,"DB00983","BE0000694","# Handley DA, Senanayake CH, Dutczak W, Benovic JL, Walle T, Penn RB, Wilkinson HS, Tanoury GJ, Andersson RG, Johansson F, Morley J: Biological actions of formoterol isomers. Pulm Pharmacol Ther. 2002;15(2):135-45. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
3114,"DB04485","BE0002493",""
3115,"DB01159","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3116,"DB02368","BE0001526","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3117,"DB03566","BE0001953","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3118,"DB01904","BE0001361","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3119,"DB03103","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3120,"DB00661","BE0000749","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821# Brown NL,"
3121,"DB01035","BE0000892","# Oelke K, Lu Q, Richardson D, Wu A, Deng C, Hanash S, Richardson B: Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 2004 Jun;50(6):1850-60. \"Pubmed\":http:/"
3122,"DB07443","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3123,"DB02819","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3124,"DB00397","BE0000694","# Moya-Huff FA, Maher TJ: Adrenergic receptor subtype activation by (+)-, (-)- and (+/-)-norephedrine in the pithed rat. J Pharm Pharmacol. 1987 Feb;39(2):108-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2881994"
3125,"DB06594","BE0000515","# Millan MJ, Brocco M, Gobert A, Dekeyne A: Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl). 2005 Feb;177(4):448-58. Epub 2004 Jul 31. \"Pu"
3126,"DB03761","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3127,"DB00172","BE0000723","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3128,"DB04867","BE0000402","# Kreiss C, Schwizer W, Borovicka J, Jansen JB, Bouloux C, Pignol R, Bischof Delaloye A, Fried M: Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans. Regul Pept. 1998 Jun 30;74(2-3):143-9. \"Pubmed\":"
3129,"DB00497","BE0004899","# Smith MT: Differences between and combinations of opioids re-visited. Curr Opin Anaesthesiol. 2008 Oct;21(5):596-601. doi: 10.1097/ACO.0b013e32830a4c4a. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18784485"
3130,"DB04427","BE0001292","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3131,"DB02315","BE0002085","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3132,"DB01422","BE0001534","# Shim JS, Matsui Y, Bhat S, Nacev BA, Xu J, Bhang HE, Dhara S, Han KC, Chong CR, Pomper MG, So A, Liu JO: Effect of nitroxoline on angiogenesis and growth of human bladder cancer. J Natl Cancer Inst. 2010 Dec 15;102(24):1855-73. Epub 2010 Nov 18. \"Pubmed"
3133,"DB07180","BE0003796","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3134,"DB01040","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3135,"DB04285","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3136,"DB05165","BE0000957",""
3137,"DB00999","BE0002437","# Temperini C, Cecchi A, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the diff"
3138,"DB06702","BE0000092","# Nilvebrant L: Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor antagonists. Pharmacol Toxicol. 2002 May;90(5):260-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12076307"
3139,"DB04555","BE0001522","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3140,"DB08524","BE0002536","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3141,"DB04204","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3142,"DB00544","BE0004810","# Wyatt MD, Wilson DM 3rd: Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci. 2009 Mar;66(5):788-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18979208# Ghoshal K, Jacob ST: An alternative molecular mechanism of action of "
3143,"DB04669","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3144,"DB00698","BE0000621","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3145,"DB01018","BE0000289","# Avery RA, Franowicz JS, Studholme C, van Dyck CH, Arnsten AF: The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmac"
3146,"DB01992","BE0000496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3147,"DB03685","BE0000259","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3148,"DB03768","BE0000787","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3149,"DB01713","BE0002000","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3150,"DB00157","BE0000609","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3151,"DB02662","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3152,"DB08142","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3153,"DB08848","BE0004733","# Sunol C, Babot Z, Cristofol R, Sonnewald U, Waagepetersen HS, Schousboe A: A possible role of the non-GAT1 GABA transporters in transfer of GABA from GABAergic to glutamatergic neurons in mouse cerebellar neuronal cultures. Neurochem Res. 2010 Sep;35(9)"
3154,"DB02094","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3155,"DB00248","BE0000501","# Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A: Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned "
3156,"DB00139","BE0002259","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3157,"DB00713","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
3158,"DB06288","BE0000451","# Tyson PJ, Roberts KH, Mortimer AM: Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors? Int J Neurosci. 2004 Jun;114(6):593-611. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15204055"
3159,"DB00334","BE0000560","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919# Bymaster FP, Nelson DL, DeLapp NW"
3160,"DB00051","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3161,"DB01752","BE0002528",""
3162,"DB08285","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3163,"DB00319","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
3164,"DB07701","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3165,"DB00514","BE0003584","# Damaj MI, Flood P, Ho KK, May EL, Martin BR: Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J Pharmacol Exp Ther. 2005 Feb;312(2):780-5. Epub 2004 Sep 8. \"Pubmed\":http://www.ncbi"
3166,"DB01054","BE0000691","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Striessnig, J. (2004). Ca ^2+^ channel blockers. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclo"
3167,"DB01496","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
3168,"DB00182","BE0000749","# Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR: New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681-98. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17209801"
3169,"DB04714","BE0003350","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3170,"DB02843","BE0001703","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3171,"DB00364","BE0000953","# Tarnawski A, Tanoue K, Santos AM, Sarfeh IJ: Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment? Scand J Gastroenterol Suppl. 1995;210:9-14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/857821"
3172,"DB00139","BE0002260","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3173,"DB04485","BE0001224","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3174,"DB01049","BE0001042","# Lu WJ, Huang JD, Lai ML: The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine. J Clin Pharmacol. 2006 Jun;46(6):628-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16707409"
3175,"DB06829","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3176,"DB03283","BE0002483",""
3177,"DB01139","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3178,"DB03740","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3179,"DB06719","BE0000203","# Kirby RS, Fitzpatrick JM, Clarke N: Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer. BJU Int. 2009 Dec;104(11):1580-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20053189"
3180,"DB01418","BE0000713","# Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. \"Pubmed\":http://www.ncbi.nl"
3181,"DB00661","BE0000197","# Milberg P, Reinsch N, Osada N, Wasmer K, Monnig G, Stypmann J, Breithardt G, Haverkamp W, Eckardt L: Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact"
3182,"DB03290","BE0001397","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3183,"DB07480","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3184,"DB07700","BE0000592","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3185,"DB08348","BE0004283","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3186,"DB00909","BE0002196","# Sonsalla PK, Wong LY, Winnik B, Buckley B: The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance. Exp Neurol. 2010 Feb;221(2):329-34. Epub 2009 Dec 4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/199481"
3187,"DB04734","BE0002001",""
3188,"DB07905","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3189,"DB01224","BE0000247","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
3190,"DB00095","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3191,"DB08916","BE0000767","# FDA label"
3192,"DB00465","BE0000262","# Hocherl K, Kammerl MC, Schumacher K, Endemann D, Grobecker HF, Kurtz A: Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake. Am J Physiol Renal Physiol. 2002 Aug;283(2):F294-301. \"Pubmed\":http://www.ncbi.nlm.nih."
3193,"DB04464","BE0003852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3194,"DB03247","BE0003031",""
3195,"DB03380","BE0004370","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3196,"DB02180","BE0003780","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3197,"DB08774","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3198,"DB08881","BE0000634","# Jordan EJ, Kelly CM: Vemurafenib for the treatment of melanoma. Expert Opin Pharmacother. 2012 Dec;13(17):2533-43. doi: 10.1517/14656566.2012.737780. Epub 2012 Oct 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23094782"
3199,"DB00159","BE0000986","# Xiao YF, Ke Q, Chen Y, Morgan JP, Leaf A: Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells. Biochem Biophys Res Commun. 2004 Aug 13;321(1):116-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15358223"
3200,"DB02180","BE0001502","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3201,"DB03309","BE0001802","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3202,"DB01930","BE0001387","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3203,"DB00342","BE0000090","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Gessner G, Zacharias M, Bechstedt S, Schonherr R, Heinemann SH: Molecular determinants for high-af"
3204,"DB03600","BE0004038","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3205,"DB00458","BE0000756","# Peddi S, Roth BL, Glennon RA, Westkaemper RB: Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorg Med Chem Lett. 2004 May 3;14(9):2279-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
3206,"DB00674","BE0004663","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
3207,"DB04640","BE0001448",""
3208,"DB08191","BE0004105","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3209,"DB08185","BE0004211","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3210,"DB01373","BE0000430","# Boda D, Giri J, Henderson D, Eisenberg B, Gillespie D: Analyzing the components of the free-energy landscape in a calcium selective ion channel by Widom's particle insertion method. J Chem Phys. 2011 Feb 7;134(5):055102. \"Pubmed\":http://www.ncbi.nlm.nih"
3211,"DB02001","BE0001302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3212,"DB02142","BE0001561","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3213,"DB02270","BE0004051","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3214,"DB08231","BE0004244","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3215,"DB00284","BE0002639","# Jonas L, Mikkat U, Lehmann R, Schareck W, Walzel H, Schroder W, Lopp H, Pussa T, Toomik P: Inhibitory effects of human and porcine alpha-amylase on CCK-8-stimulated lipase secretion of isolated rat pancreatic acini. Pancreatology. 2003;3(4):342-8. \"Pubm"
3216,"DB03530","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3217,"DB02772","BE0001849","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3218,"DB02060","BE0002499",""
3219,"DB02783","BE0001510","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3220,"DB06772","BE0000026","# DailyMed: \"JEVTANA\":http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ndc=0024-5824-11&start=1"
3221,"DB01812","BE0002559",""
3222,"DB08003","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3223,"DB00100","BE0000216","# Worfolk LA, Robinson RA, Tracy PB: Factor Xa interacts with two sites on monocytes with different functional activities. Blood. 1992 Oct 15;80(8):1989-97. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1391956# Jones KC, Mann KG: A model for the tissue fac"
3224,"DB00098","BE0000598","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3225,"DB03798","BE0003183",""
3226,"DB02379","BE0001762","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3227,"DB02709","BE0000262","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
3228,"DB00288","BE0000794","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3229,"DB00459","BE0000301","# Berni R, Clerici M, Malpeli G, Cleris L, Formelli F: Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol. FASEB J. 1993 Sep;7(12):1179-84. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8375617"
3230,"DB04590","BE0000333",""
3231,"DB01767","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3232,"DB03232","BE0001599","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3233,"DB07779","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3234,"DB01444","BE0000420","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3235,"DB01825","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3236,"DB00005","BE0000901","# Hart SP, Ross JA, Ross K, Haslett C, Dransfield I: Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 2000 May;7(5):493-503. \"Pubmed\":http://ww"
3237,"DB01023","BE0000691","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T: Selectivities of dihydropyridine der"
3238,"DB01267","BE0002362","# Yasui-Furukori N, Hidestrand M, Spina E, Facciola G, Scordo MG, Tybring G: Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. Drug Metab Dispos. 2001 Oct;29(10):1263-8. \"Pubmed\":http://www.ncbi.nlm.nih."
3239,"DB00801","BE0000523","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
3240,"DB03800","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3241,"DB05467","BE0000144","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3242,"DB02198","BE0000017","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3243,"DB02144","BE0001505","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3244,"DB06216","BE0000650","# Citrome L: Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatr Dis Treat. 2011;7:325-39. Epub 2011 May 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21655346# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharm"
3245,"DB08330","BE0003854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3246,"DB02039","BE0001422","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3247,"DB05335","BE0000262",""
3248,"DB00408","BE0000451","# Li Z, Ichikawa J, Meltzer HY: A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens. Psychopharmacology (Berl). 2003 May;167(3):315-23. Epub "
3249,"DB06707","BE0000501","# Jastak JT, Yagiela JA: Vasoconstrictors and local anesthesia: a review and rationale for use. J Am Dent Assoc. 1983 Oct;107(4):623-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6355236# Hersh EV, Giannakopoulos H: Beta-adrenergic blocking agents and d"
3250,"DB00131","BE0000254","# Richter EA, Kiens B, Wojtaszewski JF: [5'-adenosine monophosphate-activated protein kinase and lifestyle-mediated diseases] Ugeskr Laeger. 2006 Feb 27;168(9):896-900. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16513051# Neurath KM, Keough MP, Mikkelsen"
3251,"DB00257","BE0000415","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, Alper SL, Platt OS: Therapy with oral "
3252,"DB08183","BE0003493","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3253,"DB01942","BE0001381","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3254,"DB00321","BE0000451","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
3255,"DB01992","BE0002025","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3256,"DB04540","BE0004545","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3257,"DB03317","BE0001009","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3258,"DB00926","BE0000412","# Zitnik RJ, Kotloff RM, Latifpour J, Zheng T, Whiting NL, Schwalb J, Elias JA: Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. J Immunol. 1994 Feb 1;152(3):1419-27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8301142# "
3259,"DB07687","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3260,"DB01048","BE0004853","# De Clercq E: New anti-HIV agents and targets. Med Res Rev. 2002 Nov;22(6):531-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12369088# Faletto MB, Miller WH, Garvey EP, St Clair MH, Daluge SM, Good SS: Unique intracellular activation of the potent anti"
3261,"DB00690","BE0003595","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3262,"DB07924","BE0003818","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3263,"DB03389","BE0001416","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3264,"DB00410","BE0000804","# Hurdle JG, O'Neill AJ, Chopra I: The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden. J Antimicrob Chemother. 2004 Jan;53(1):"
3265,"DB00939","BE0000897","# Peretz A, Degani N, Nachman R, Uziyel Y, Gibor G, Shabat D, Attali B: Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol. 2005 Ap"
3266,"DB01972","BE0001473","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3267,"DB01186","BE0000575","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
3268,"DB04942","BE0000663","# Miwako I, Kagechika H: Tamibarotene. Drugs Today (Barc). 2007 Aug;43(8):563-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17925887# Sanda T, Kuwano T, Nakao S, Iida S, Ishida T, Komatsu H, Shudo K, Kuwano M, Ono M, Ueda R: Antimyeloma effects of a nove"
3269,"DB03541","BE0001501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3270,"DB03683","BE0000058","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3271,"DB01669","BE0001238","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3272,"DB02784","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3273,"DB01282","BE0000844","# Engstrom T, Barth T, Melin P, Vilhardt H: Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol. 1998 Aug 21;355(2-3):203-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9760"
3274,"DB02659","BE0003991","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3275,"DB03147","BE0002962",""
3276,"DB00030","BE0001123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3277,"DB01591","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3278,"DB00157","BE0000645","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3279,"DB01625","BE0000405","# Lane MA: Muscarinic cholinergic activation of mouse spleen cells cytotoxic to tumor cells in vitro. J Natl Cancer Inst. 1978 Sep;61(3):923-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/29133# Eglen RM, Whiting RL: Competitive and non-competitive antago"
3280,"DB02841","BE0001568","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3281,"DB01142","BE0000342","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
3282,"DB04147","BE0004162","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3283,"DB00651","BE0000706","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3284,"DB05164","BE0003406",""
3285,"DB07128","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3286,"DB01717","BE0001262","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3287,"DB03680","BE0000148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3288,"DB01030","BE0000971","# Schmidt F, Rieger J, Wischhusen J, Naumann U, Weller M: Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage. Eur J Pharmacol. 2001 Jan 19;412(1):21-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11166732# strel'tsov SA"
3289,"DB00909","BE0002083","# Janszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases] Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20025128# Kothare SV, Kaleyias J: Zonisamide: review of pharm"
3290,"DB08632","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3291,"DB01992","BE0002686",""
3292,"DB08471","BE0002743","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3293,"DB01174","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
3294,"DB03984","BE0001646","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3295,"DB04315","BE0003282",""
3296,"DB04545","BE0001219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3297,"DB02930","BE0002851",""
3298,"DB04315","BE0004281","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3299,"DB00111","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3300,"DB00102","BE0000910","# Lizonova A, Bizik J, Grofova M, Vaheri A: Coexpression of tumor-associated alpha 2-macroglobulin and growth factors in human melanoma cell lines. J Cell Biochem. 1990 Aug;43(4):315-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1697862# Bonner JC, Osor"
3301,"DB01010","BE0002180","# Harel M, Sussman JL, Krejci E, Bon S, Chanal P, Massoulie J, Silman I: Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10827-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
3302,"DB00201","BE0000739","# Daly JW: Caffeine analogs: biomedical impact. Cell Mol Life Sci. 2007 Aug;64(16):2153-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17514358"
3303,"DB07082","BE0001598","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3304,"DB00157","BE0000720","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3305,"DB07497","BE0003965","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3306,"DB06988","BE0001831","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3307,"DB08420","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3308,"DB04220","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3309,"DB01666","BE0002497",""
3310,"DB01731","BE0002513","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3311,"DB00583","BE0002204","# Di Giacomo C, Latteri F, Fichera C, Sorrenti V, Campisi A, Castorina C, Russo A, Pinturo R, Vanella A: Effect of acetyl-L-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neurochem Res. 1993 Nov;18(11):1157-62. \"Pubm"
3312,"DB06080","BE0000147",""
3313,"DB00231","BE0000381","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
3314,"DB07932","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3315,"DB00485","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
3316,"DB00246","BE0000289","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
3317,"DB06581","BE0001594","# Stoddart CA, Joshi P, Sloan B, Bare JC, Smith PC, Allaway GP, Wild CT, Martin DE: Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice. PLoS ONE. 2007 Nov 28;2(11):e1251. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1804375"
3318,"DB03967","BE0001965","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3319,"DB02116","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3320,"DB02420","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3321,"DB06228","BE0000216","# Melillo SN, Scanlon JV, Exter BP, Steinberg M, Jarvis CI: Rivaroxaban for Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery (June) (CE). Ann Pharmacother. 2010 Apr 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20424181# Ufer M: Compar"
3322,"DB04703","BE0003404","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3323,"DB03319","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3324,"DB01339","BE0000738","# Jonsson Fagerlund M, Dabrowski M, Eriksson LI: Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor. Anesthesiology. 2009 Jun;110(6):1244-52. \"Pubmed\":h"
3325,"DB02121","BE0001443","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3326,"DB05412","BE0001019",""
3327,"DB01227","BE0003585","# Xiao Y, Smith RD, Caruso FS, Kellar KJ: Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs. J Pharmacol Exp Ther. 2001 Oct;299(1):366-71. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11561100"
3328,"DB00379","BE0000197","# Valdivia CR, Ackerman MJ, Tester DJ, Wada T, McCormack J, Ye B, Makielski JC: A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine. Cardiovasc Res. 2002 Aug 1;55(2):279-89. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1"
3329,"DB06148","BE0000486","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821"
3330,"DB01413","BE0003579","# Grassi GG, Grassi C: Cefepime: overview of activity in vitro and in vivo. J Antimicrob Chemother. 1993 Nov;32 Suppl B:87-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8150771"
3331,"DB01769","BE0002538",""
3332,"DB02335","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3333,"DB03082","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3334,"DB01642","BE0002490",""
3335,"DB01056","BE0000197","# Georgijevic Milic L: [Molecular genetics in the hereditary form of long QT syndrome] Med Pregl. 2000 Jan-Feb;53(1-2):51-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10953551# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res."
3336,"DB01864","BE0001273","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3337,"DB00508","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3338,"DB07784","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3339,"DB03147","BE0002985",""
3340,"DB04447","BE0001927","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3341,"DB01955","BE0001640","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3342,"DB07234","BE0001373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3343,"DB03147","BE0002980",""
3344,"DB04627","BE0002997",""
3345,"DB07185","BE0003752","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3346,"DB02468","BE0000735","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3347,"DB00988","BE0000650","# Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW, et al.: A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron. 1993 Se"
3348,"DB06144","BE0000945","# Pouzet B, Didriksen M, Arnt J: Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol Biochem Behav. 2002 Apr;71(4):635-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11888555# Mork A, Witten LM, Arnt J: Ef"
3349,"DB06038","BE0003427",""
3350,"DB01737","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3351,"DB07475","BE0003918","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3352,"DB03331","BE0000720","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3353,"DB02341","BE0003758","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3354,"DB07901","BE0004117","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3355,"DB00171","BE0000310","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3356,"DB01198","BE0000381","# Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2009 Nov 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19942638# Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: S"
3357,"DB00926","BE0000206","# Zitnik RJ, Kotloff RM, Latifpour J, Zheng T, Whiting NL, Schwalb J, Elias JA: Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. J Immunol. 1994 Feb 1;152(3):1419-27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8301142# "
3358,"DB00719","BE0000442","# Singh N, Puri SK: Causal prophylactic activity of antihistaminic agents against Plasmodium yoelii nigeriensis infection in Swiss mice. Acta Trop. 1998 Jun;69(3):255-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9638277# Mann KV, Crowe JP, Tietze KJ: N"
3359,"DB03796","BE0003601","# Barbana C, Perez MD, Pocovi C, Sanchez L, Wehbi Z: Interaction of human alpha-lactalbumin with fatty acids: determination of binding parameters. Biochemistry (Mosc). 2008 Jun;73(6):711-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18620538"
3360,"DB00683","BE0003594","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3361,"DB05343","BE0001177",""
3362,"DB03814","BE0004481","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3363,"DB01859","BE0001303","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3364,"DB07045","BE0003774","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3365,"DB00069","BE0000661","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3366,"DB00157","BE0000093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3367,"DB03685","BE0004582","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3368,"DB01595","BE0003597","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3369,"DB05142","BE0002085",""
3370,"DB00204","BE0000090","# Lees-Miller JP, Duan Y, Teng GQ, Duff HJ: Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. Mol Pharmacol. 2000 Feb;57(2):367-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1064864"
3371,"DB00114","BE0000378","# Hwang IK, Yoo KY, Kim DS, Eum WS, Park JK, Park J, Kwon OS, Kang TC, Choi SY, Won MH: Changes of pyridoxal kinase expression and activity in the gerbil hippocampus following transient forebrain ischemia. Neuroscience. 2004;128(3):511-8. \"Pubmed\":http://"
3372,"DB00073","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3373,"DB05398","BE0002050",""
3374,"DB03661","BE0003143",""
3375,"DB07374","BE0003829","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3376,"DB00494","BE0002089","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Najib J: Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Park"
3377,"DB01132","BE0000215","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Sugii S, Olson P, Sears DD, Saberi M, Atkins AR, Barish GD, Hong SH, Castro GL, Yin YQ, Nelson MC,"
3378,"DB04821","BE0001075","# Obach RS, Dalvie DK: Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes. Drug Metab Dispos. 2006 Aug;34(8):1310-6. Epub 2006 May 5. \"Pubmed\":http://w"
3379,"DB00114","BE0000424","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3380,"DB07889","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3381,"DB04137","BE0001791","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3382,"DB02494","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3383,"DB03792","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3384,"DB02452","BE0001910","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3385,"DB04265","BE0001992","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3386,"DB00834","BE0000794","# LeVan TD, Babin EA, Yamamura HI, Bloom JW: Pharmacological characterization of glucocorticoid receptors in primary human bronchial epithelial cells. Biochem Pharmacol. 1999 May 1;57(9):1003-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10796070# Attard"
3387,"DB02229","BE0001537","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3388,"DB01183","BE0000123","# Farooqui M, Geng ZH, Stephenson EJ, Zaveri N, Yee D, Gupta K: Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells. Mol Cancer Ther. 2006 Mar;5(3):611-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16546975"
3389,"DB07763","BE0001005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3390,"DB00121","BE0000445","# Friebel D, von der Hagen M, Baumgartner ER, Fowler B, Hahn G, Feyh P, Heubner G, Baumgartner MR, Hoffmann GF: The first case of 3-methylcrotonyl-CoA carboxylase (MCC) deficiency responsive to biotin. Neuropediatrics. 2006 Apr;37(2):72-8. \"Pubmed\":http:/"
3391,"DB00480","BE0000262","# Payvandi F, Wu L, Haley M, Schafer PH, Zhang LH, Chen RS, Muller GW, Stirling DI: Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner. Cell Immunol. "
3392,"DB08453","BE0003905","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3393,"DB04464","BE0003986","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3394,"DB00110","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3395,"DB03205","BE0003017",""
3396,"DB02527","BE0002795",""
3397,"DB00972","BE0000442","# Casale TB: The interaction of azelastine with human lung histamine H1, beta, and muscarinic receptor-binding sites. J Allergy Clin Immunol. 1989 Apr;83(4):771-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2540229# Conde Hernandez DJ, Palma Aqilar JL, D"
3398,"DB06706","BE0000501","# Valdivia LF, Centurion D, Perusquia M, Arulmani U, Saxena PR, Villalon CM: Pharmacological analysis of the mechanisms involved in the tachycardic and vasopressor responses to the antimigraine agent, isometheptene, in pithed rats. Life Sci. 2004 May 14;7"
3399,"DB00705","BE0004853","# Geitmann M, Unge T, Danielson UH: Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors. J Med Chem. 2006 Apr 20;49(8):2367-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16610780#"
3400,"DB06976","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3401,"DB08901","BE0002131","# Ren M, Hong M, Liu G, Wang H, Patel V, Biddinger P, Silva J, Cowell J, Hao Z: Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1. Oncol Rep. 2013 Jun;29(6):2181-90. doi: 10.3892/or.2013.2386. Ep"
3402,"DB00794","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
3403,"DB00980","BE0000327","# Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M: Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. 2005 Feb;48(2):301-10. \"Pubmed\":http://www.ncbi.nl"
3404,"DB02233","BE0001532","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3405,"DB00488","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3406,"DB02795","BE0003768","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3407,"DB05457","BE0000324",""
3408,"DB08453","BE0003855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3409,"DB04975","BE0000742","# Atkinson SJ, Loadman PM, Sutton C, Patterson LH, Clench MR: Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Comm"
3410,"DB00589","BE0000533","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler "
3411,"DB01215","BE0003598","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
3412,"DB05153","BE0003379",""
3413,"DB00140","BE0000370","# Werner R, Manthey KC, Griffin JB, Zempleni J: HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium. J Nutr Biochem. 2005 Oct;16(10):617-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16081269# Solov"
3414,"DB07488","BE0003958","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3415,"DB04352","BE0001942","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3416,"DB01857","BE0001357","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3417,"DB00120","BE0000789","# Shennan DB, Calvert DT, Travers MT, Kudo Y, Boyd CA: A study of L-leucine, L-phenylalanine and L-alanine transport in the perfused rat mammary gland: possible involvement of LAT1 and LAT2. Biochim Biophys Acta. 2002 Aug 19;1564(1):133-9. \"Pubmed\":http:/"
3418,"DB03240","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3419,"DB01144","BE0000322","# Mincione F, Scozzafava A, Supuran CT: The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18336310"
3420,"DB04832","BE0002198","# Egashira T, Takayama F, Yamanaka Y: Effects of long-term treatment with dicyclic, tricyclic, tetracyclic, and noncyclic antidepressant drugs on monoamine oxidase activity in mouse brain. Gen Pharmacol. 1996 Jul;27(5):773-8. \"Pubmed\":http://www.ncbi.nlm."
3421,"DB02210","BE0000794","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3422,"DB00909","BE0000483","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3423,"DB05234","BE0000132",""
3424,"DB04147","BE0001965","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3425,"DB04639","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3426,"DB02220","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3427,"DB01558","BE0003597","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
3428,"DB02032","BE0000221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3429,"DB00115","BE0002176","# Nakamura T, Saionji K, Hiejima Y, Hirayama H, Tago K, Takano H, Tajiri M, Hayashi K, Kawabata M, Funamizu M, Makita Y, Hata A: Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients. "
3430,"DB03637","BE0001583","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3431,"DB04799","BE0003855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3432,"DB08756","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3433,"DB01142","BE0000572","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
3434,"DB02411","BE0000787","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3435,"DB00184","BE0003588","# Mansvelder HD, Mertz M, Role LW: Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol. 2009 Jun;20(4):432-40. Epub 2009 Jan 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19560048# Narahashi T, Fe"
3436,"DB04695","BE0003866","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3437,"DB08026","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3438,"DB00108","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3439,"DB08838","BE0002226","# Weng XC, Gai XD, Zheng JQ, Li J: Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons. Acta Pharmacol Sin. 2003 Aug;24(8):746-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12904272"
3440,"DB08731","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3441,"DB08896","BE0000023","# FDA label"
3442,"DB02440","BE0001854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3443,"DB00237","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
3444,"DB01119","BE0000553","# Klockner U, Trieschmann U, Isenberg G: Pharmacological modulation of calcium and potassium channels in isolated vascular smooth muscle cells. Arzneimittelforschung. 1989 Jan;39(1A):120-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2541731# O'Malley D, "
3445,"DB01272","BE0004494","# Chavez CA, Bohnsack RN, Kudo M, Gotschall RR, Canfield WM, Dahms NM: Domain 5 of the cation-independent mannose 6-phosphate receptor preferentially binds phosphodiesters (mannose 6-phosphate N-acetylglucosamine ester). Biochemistry. 2007 Nov 6;46(44):12"
3446,"DB03142","BE0002844",""
3447,"DB00848","BE0004926","# Culetto E, Baylis HA, Richmond JE, Jones AK, Fleming JT, Squire MD, Lewis JA, Sattelle DB: The Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive nicotinic acetylcholine receptor alpha subunit. J Biol Chem. 2004 Oct 8;279(41):42476-83. Ep"
3448,"DB03385","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3449,"DB04077","BE0001754","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3450,"DB04053","BE0001937","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3451,"DB01672","BE0001084","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3452,"DB00316","BE0000017","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
3453,"DB04917","BE0000311","# Tack J, Middleton SJ, Horne MC, Piessevaux H, Bloor JS, Meyers NL, Palmer RM: Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther."
3454,"DB00157","BE0000137","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3455,"DB01363","BE0000342","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Kobayashi S, Endou M, Sakuraya F, Matsuda N, Zhang "
3456,"DB05469","BE0000575",""
3457,"DB03217","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3458,"DB02175","BE0002707",""
3459,"DB00681","BE0004803","# Laniado-Laborin R, Cabrales-Vargas MN: Amphotericin B: side effects and toxicity. Rev Iberoam Micol. 2009 Dec 31;26(4):223-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19836985# Baginski M, Czub J: Amphotericin B and its new derivatives - mode of acti"
3460,"DB05415","BE0000182",""
3461,"DB08235","BE0004250","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3462,"DB03814","BE0003194",""
3463,"DB04555","BE0001617","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3464,"DB04302","BE0000801","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3465,"DB03234","BE0001553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3466,"DB08017","BE0004018","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3467,"DB02576","BE0001771","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3468,"DB03032","BE0000812","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3469,"DB00231","BE0002346","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
3470,"DB01454","BE0000393","# Lyon RA, Glennon RA, Titeler M: 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Psychopharmacology (Berl). 1986;88(4):525-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2871581"
3471,"DB04781","BE0000050","# Erskine PT, Coates L, Newbold R, Brindley AA, Stauffer F, Beaven GD, Gill R, Coker A, Wood SP, Warren MJ, Shoolingin-Jordan PM, Neier R, Cooper JB: Structure of yeast 5-aminolaevulinic acid dehydratase complexed with the inhibitor 5-hydroxylaevulinic ac"
3472,"DB07486","BE0000516","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3473,"DB08996","BE0000426","# Ishitani R, Sato T, Suga T, Kitagawa H: Studies on the ultrastructural distribution of H 3 -dimetacrine in rat cerebral cortex. Jpn J Pharmacol. 1972 Jun;22(3):313-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/4539395"
3474,"DB00821","BE0000262","# Kay-Mugford P, Benn SJ, LaMarre J, Conlon P: In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res. 2000 Jul;61(7):802-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10895904# Brideau C, Van Staden C,"
3475,"DB00075","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3476,"DB00173","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3477,"DB00002","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3478,"DB06927","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3479,"DB01045","BE0000956","# Chen J, Raymond K: Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Ann Clin Microbiol Antimicrob. 2006 Feb 15;5:3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16480505# Cheng J, M"
3480,"DB03147","BE0002972",""
3481,"DB07446","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3482,"DB00162","BE0000570","# Zhang M, Hu P, Krois CR, Kane MA, Napoli JL: Altered vitamin A homeostasis and increased size and adiposity in the rdh1-null mouse. FASEB J. 2007 Sep;21(11):2886-96. Epub 2007 Apr 13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17435174# Maeda A, Maeda "
3483,"DB00797","BE0000289","# Song W, Zhang Y, Xia L, Liu G: [Effects of some mexiletine derivatives on alpha 1-adrenoceptors] Yao Xue Xue Bao. 1998;33(2):102-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11938943"
3484,"DB00054","BE0001155","# Amoroso G, van Boven AJ, van Veldhuisen DJ, Tio RA, Balje-Volkers CP, Petronio AS, van Oeveren W: Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients with coron"
3485,"DB00231","BE0000478","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
3486,"DB03256","BE0001753","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3487,"DB02552","BE0003570","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3488,"DB00450","BE0000756","# Grip G, Svensson BA, Gordh T Jr, Post C, Hartvig P: Histopathology and evaluation of potentiation of morphine-induced antinociception by intrathecal droperidol in the rat. Acta Anaesthesiol Scand. 1992 Feb;36(2):145-52. \"Pubmed\":http://www.ncbi.nlm.nih."
3489,"DB00142","BE0000831","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3490,"DB00551","BE0000334","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3491,"DB01183","BE0000958","# Li J, Li YH, Yuan XR: Changes of phosphorylation of cAMP response element binding protein in rat nucleus accumbens after chronic ethanol intake: naloxone reversal. Acta Pharmacol Sin. 2003 Sep;24(9):930-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/129"
3492,"DB02058","BE0000748","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
3493,"DB01544","BE0000736","# Katz Y, Weizman R, Weizman A, Gavish M: Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor. J Pharmacol Exp Ther. 1992 Jul;262(1):394-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1320691# Papadop"
3494,"DB08090","BE0001810","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3495,"DB00594","BE0000495","# Yamamura H, Ugawa S, Ueda T, Nagao M, Shimada S: Protons activate the delta-subunit of the epithelial Na+ channel in humans. J Biol Chem. 2004 Mar 26;279(13):12529-34. Epub 2004 Jan 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14726523# Ji HL, Bishop"
3496,"DB00328","BE0000962","# Sato S, Kwon Y, Kamisuki S, Srivastava N, Mao Q, Kawazoe Y, Uesugi M: Polyproline-rod approach to isolating protein targets of bioactive small molecules: isolation of a new target of indomethacin. J Am Chem Soc. 2007 Jan 31;129(4):873-80. \"Pubmed\":http:"
3497,"DB04855","BE0002359",""
3498,"DB00098","BE0002099","# Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003 Feb;3(2):189-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12586600"
3499,"DB00562","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3500,"DB06148","BE0000289","# Dekeyne A, Millan MJ: Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin. Neuropha"
3501,"DB04304","BE0001804","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3502,"DB04494","BE0001941","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3503,"DB00328","BE0000071","# Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA: Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1997 Feb 7;272(6):3406-10. \"Pubmed\":http:/"
3504,"DB00193","BE0000045","# Shiraishi M, Minami K, Uezono Y, Yanagihara N, Shigematsu A: Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M1 receptors. J Pharmacol Exp Ther. 2001 Oct"
3505,"DB01851","BE0001355","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3506,"DB06827","BE0004846","# Stanley RE, Blaha G, Grodzicki RL, Strickler MD, Steitz TA: The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome. Nat Struct Mol Biol. 2010 Mar;17(3):289-93. doi: 10.1038/nsmb.1755. Epub 2010 Feb 14. \"Pu"
3507,"DB05687","BE0000451",""
3508,"DB04707","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3509,"DB01565","BE0000770","# Crooks PA, Kottayil SG, Al-Ghananeem AM, Byrn SR, Butterfield DA: Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4291-5. Epub 2006 Jun 13. \"Pubmed\":htt"
3510,"DB00960","BE0000291","# Smeraldi E, Benedetti F, Barbini B, Campori E, Colombo C: Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology. 1999 Apr;20(4):380-5. \"Pubmed\":http://www.n"
3511,"DB00374","BE0000475","# Falcetti E, Hall SM, Phillips PG, Patel J, Morrell NW, Haworth SG, Clapp LH: Smooth Muscle Proliferation and Role of the Prostacyclin (IP) Receptor in Idiopathic Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2010 Jul 9. \"Pubmed\":http://www"
3512,"DB02120","BE0001407","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3513,"DB03128","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3514,"DB00795","BE0000248","# Nielsen OH, Bukhave K, Elmgreen J, Ahnfelt-Ronne I: Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci. 1987 Jun;32(6):577-82. \"Pubmed\":http://www.ncbi.nlm.nih"
3515,"DB07778","BE0001005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3516,"DB00809","BE0000045","# Betz AJ, McLaughlin PJ, Burgos M, Weber SM, Salamone JD: The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors. Psychopharmacology (Berl). 2007 Oct;194(3"
3517,"DB00032","BE0000387","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3518,"DB08126","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3519,"DB00157","BE0000243","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3520,"DB01108","BE0000051","# Naville D, Keeney DS, Jenkin G, Murry BA, Head JR, Mason JI: Regulation of expression of male-specific rat liver microsomal 3 beta-hydroxysteroid dehydrogenase. Mol Endocrinol. 1991 Aug;5(8):1090-100. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1944305#"
3521,"DB04082","BE0001726","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3522,"DB00363","BE0000451","# Goldstein JM: Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today (Barc). 1999 Mar;35(3):193-210. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12973385# McDonald LM, Moran PM, Vythelingum GN, Joseph MH, Stephenson JD, Gray JA: Enhan"
3523,"DB00160","BE0000294","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3524,"DB08597","BE0000695","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3525,"DB00019","BE0000394","# Carter CR, Whitmore KM, Thorpe R: The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation. J Leukoc Biol. 2004 Mar;75(3):515-22. Epub 2003 Dec 4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
3526,"DB00157","BE0000513","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3527,"DB03777","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3528,"DB01685","BE0002204","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3529,"DB00540","BE0000092","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
3530,"DB08713","BE0004017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3531,"DB08231","BE0004148","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3532,"DB01196","BE0001169","# Stearns ME, Wang M, Sousa O: Evidence that estramustine binds MAP-1A to inhibit type IV collagenase secretion. J Cell Sci. 1991 Jan;98 ( Pt 1):55-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1647395"
3533,"DB00489","BE0000090","# Shimizu W, Antzelevitch C: Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation. 2000 Aug 8;102(6):706-12. \"Pubmed\":http://w"
3534,"DB04265","BE0001724","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3535,"DB08220","BE0001777","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3536,"DB00143","BE0002286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3537,"DB01752","BE0001398","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3538,"DB02701","BE0001869","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3539,"DB03251","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3540,"DB07471","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3541,"DB04275","BE0000909","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3542,"DB08820","BE0001195","# Yu H, Burton B, Huang CJ, Worley J, Cao D, Johnson JP Jr, Urrutia A, Joubran J, Seepersaud S, Sussky K, Hoffman BJ, Van Goor F: Ivacaftor potentiation of multiple CFTR channels with gating mutations. J Cyst Fibros. 2012 Jan 30. \"Pubmed\":http://www.ncbi."
3543,"DB06958","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3544,"DB00111","BE0000710","# Simms HH, Gaither TA, Fries LF, Frank MM: Monokines released during short-term Fc gamma receptor phagocytosis up-regulate polymorphonuclear leukocytes and monocyte-phagocytic function. J Immunol. 1991 Jul 1;147(1):265-72. \"Pubmed\":http://www.ncbi.nlm.ni"
3545,"DB02609","BE0001581","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3546,"DB07374","BE0003831","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3547,"DB06905","BE0003750","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3548,"DB08551","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3549,"DB04919","BE0000538","# Ahmed NK, Tennant KD, Markland FS, Lacz JP: Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom. Haemostasis. 1990;20(3):147-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1696922"
3550,"DB02218","BE0002639",""
3551,"DB00679","BE0000090","# Milnes JT, Witchel HJ, Leaney JL, Leishman DJ, Hancox JC: hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656. Biochem Biophys Res Commun. 2006 Dec 8;351(1):273-80. Epub 2006 Oct 23. \"Pubmed\""
3552,"DB07785","BE0002214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3553,"DB00336","BE0000805","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3554,"DB06994","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3555,"DB00529","BE0000343","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3556,"DB04217","BE0000791","# Yu S, Sugahara K, Nakayama K, Awata S, Kodama H: Accumulation of cystathionine, cystathionine ketimine, and perhydro-1,4-thiazepine-3,5-dicarboxylic acid in whole brain and various regions of the brain of D, L-propargylglycine-treated rats. Metabolism. "
3557,"DB06637","BE0004716","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
3558,"DB02659","BE0001967","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3559,"DB04841","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3560,"DB00116","BE0002154","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3561,"DB03709","BE0000211","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3562,"DB02726","BE0001889","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3563,"DB03345","BE0004637","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3564,"DB00496","BE0000045","# Bharucha AE, Ravi K, Zinsmeister AR: Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans. Am J Physiol Gastrointest Liver Physiol. 2010 Jul;299(1):G215-9. Epub 2010 Apr 15. \""
3565,"DB00215","BE0000092","# Bareggi SR, Mundo E, Dell'Osso B, Altamura AC: The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):741-53. \"Pubmed\":http://www.ncbi.nlm.n"
3566,"DB07729","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3567,"DB07244","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3568,"DB00728","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3569,"DB01881","BE0001225","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3570,"DB01439","BE0000420","# Rodrigues AR, Castro MS, Francischi JN, Perez AC, Duarte ID: Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats. Braz J Med Biol Res. 2005 Jan;38(1):91-7. Epub 2005 Jan 18. \"Pubmed\":http://www.ncbi.nl"
3571,"DB04464","BE0001177","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3572,"DB04516","BE0004496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3573,"DB02127","BE0001535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3574,"DB00073","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3575,"DB01186","BE0000451","# Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I: Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO c"
3576,"DB02796","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3577,"DB08485","BE0001769","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3578,"DB06594","BE0000533","# Millan MJ, Brocco M, Gobert A, Dekeyne A: Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl). 2005 Feb;177(4):448-58. Epub 2004 Jul 31. \"Pu"
3579,"DB00755","BE0000078","# Stafslien DK, Vedvik KL, De Rosier T, Ozers MS: Analysis of ligand-dependent recruitment of coactivator peptides to RXRbeta in a time-resolved fluorescence resonance energy transfer assay. Mol Cell Endocrinol. 2007 Jan 29;264(1-2):82-9. Epub 2006 Dec 20"
3580,"DB08555","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3581,"DB01603","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
3582,"DB03814","BE0002802",""
3583,"DB04257","BE0001960","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3584,"DB00897","BE0000478","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3585,"DB02014","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3586,"DB02379","BE0001243","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3587,"DB00145","BE0000534","# Smothers CT, Woodward JJ: Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther. 2007 Aug;322(2):739-48. Epub 2007 May 14. \"Pubmed\":http://www.ncbi.nlm."
3588,"DB00363","BE0000291","# Hagino Y, Watanabe M: Effects of clozapine on the efflux of serotonin and dopamine in the rat brain: the role of 5-HT1A receptors. Can J Physiol Pharmacol. 2002 Dec;80(12):1158-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12564641# Chou YH, Halldin C"
3589,"DB01242","BE0000486","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821# Jungkun G"
3590,"DB02579","BE0002015","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3591,"DB08092","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3592,"DB06626","BE0000029","# Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB: Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Ph"
3593,"DB01231","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3594,"DB04447","BE0004624","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3595,"DB06148","BE0000647","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821/# Roth, BL"
3596,"DB01151","BE0000442","# Sawynok J, Esser MJ, Reid AR: Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain. 1999 Aug;82(2):149-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10467920# Cusack B, Nelson A"
3597,"DB00055","BE0000041","# Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344(10"
3598,"DB01872","BE0001329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3599,"DB04395","BE0004554","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3600,"DB05072","BE0000384",""
3601,"DB07374","BE0003833","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3602,"DB06738","BE0004956","# Ebert B, Andersen S, Krogsgaard-Larsen P: Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995 Mar 10;187(3):165-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
3603,"DB00441","BE0000324","# Rosell R, Taron M, Sanchez JM, Moran T, Reguart N, Besse B, Isla D, Massuti B, Alberola V, Sanchez JJ: The promise of pharmacogenomics: gemcitabine and pemetrexed. Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):70-6. \"Pubmed\":http://www.ncbi.nlm.nih"
3604,"DB02169","BE0001447","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3605,"DB06148","BE0000945","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
3606,"DB08283","BE0000978","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3607,"DB04079","BE0001863","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3608,"DB00543","BE0000020","# Nasu R, Matsuo H, Takanaga H, Ohtani H, Sawada Y: Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice. Biopharm Drug Dispos. 2000 May;21(4):129-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11180191"
3609,"DB06148","BE0000342","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
3610,"DB06042","BE0000143",""
3611,"DB04395","BE0004323","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3612,"DB04058","BE0001323","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3613,"DB00168","BE0001023","# Riera CE, Vogel H, Simon SA, le Coutre J: Artificial sweeteners and salts producing a metallic taste sensation activate TRPV1 receptors. Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R626-34. Epub 2007 Jun 13. \"Pubmed\":http://www.ncbi.nlm.nih."
3614,"DB08811","BE0001133","# Rundfeldt C, Socala K, Wlaz P: The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. J Neural Transm. 2010 Nov;117(11):1319-25. Epub 2010 Oct 22. \"Pub"
3615,"DB01819","BE0001721","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3616,"DB08690","BE0003855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3617,"DB01167","BE0000875","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Cotrim PC, Garrity LK, Beverley SM: Isolation of genes mediating resistance to inhibitors of nucle"
3618,"DB02996","BE0003872","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3619,"DB00368","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3620,"DB08039","BE0004108","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3621,"DB08515","BE0002349","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3622,"DB03147","BE0002938",""
3623,"DB02207","BE0000005","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3624,"DB07829","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3625,"DB07010","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3626,"DB04599","BE0000756","# Nakamura K, Kurasawa M: Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. Eur J Pharmacol. 2001 May 18;420(1):33-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11412837"
3627,"DB07332","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3628,"DB00967","BE0000442","# Wu RL, Anthes JC, Kreutner W, Harris AG, West RE Jr: Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor. Int Arch Allergy Immunol. 2004 Dec;135(4):313-"
3629,"DB01866","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3630,"DB00562","BE0001653","# Temperini C, Cecchi A, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the diff"
3631,"DB03631","BE0001222","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3632,"DB00160","BE0000480","# Zhang Z, Papageorgiou G, Corrie JE, Grewer C: Pre-steady-state currents in neutral amino acid transporters induced by photolysis of a new caged alanine derivative. Biochemistry. 2007 Mar 27;46(12):3872-80. Epub 2007 Feb 21. \"Pubmed\":http://www.ncbi.nlm."
3633,"DB00711","BE0000017","# McGarry HF, Plant LD, Taylor MJ: Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J. 2005 Jun 2;4:4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15932"
3634,"DB03814","BE0002709",""
3635,"DB00586","BE0002398","# Xiong Q, Gao Z, Wang W, Li M: Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds. Trends Pharmacol Sci. 2008 Feb;29(2):99-107. Epub 2008 Jan 18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18206251# Peretz A, Degani N, Nach"
3636,"DB04083","BE0003210",""
3637,"DB03624","BE0001271","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3638,"DB02832","BE0001900","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3639,"DB07742","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3640,"DB04444","BE0004491","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3641,"DB00734","BE0000289","# Fenton C, Scott LJ: Risperidone: a review of its use in the treatment of bipolar mania. CNS Drugs. 2005;19(5):429-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15907153# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors fo"
3642,"DB03606","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3643,"DB07918","BE0003960","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3644,"DB03309","BE0001919","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3645,"DB01119","BE0000732","# Lawrence CL, Rainbow RD, Davies NW, Standen NB: Effect of metabolic inhibition on glimepiride block of native and cloned cardiac sarcolemmal K(ATP) channels. Br J Pharmacol. 2002 Jul;136(5):746-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12086984# G"
3646,"DB03840","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3647,"DB03540","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3648,"DB06905","BE0003749","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3649,"DB02338","BE0000960","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3650,"DB00321","BE0000045","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
3651,"DB04147","BE0003977","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3652,"DB02262","BE0001525","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3653,"DB00934","BE0000451","# Peroutka SJ, Lebovitz RM, Snyder SH: Two distinct central serotonin receptors with different physiological functions. Science. 1981 May 15;212(4496):827-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7221567"
3654,"DB04272","BE0003265",""
3655,"DB08319","BE0003956","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3656,"DB00568","BE0004889","# Nasu R, Matsuo H, Takanaga H, Ohtani H, Sawada Y: Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice. Biopharm Drug Dispos. 2000 May;21(4):129-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11180191"
3657,"DB00142","BE0000073","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3658,"DB02521","BE0002707","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3659,"DB02741","BE0000144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3660,"DB02637","BE0004459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3661,"DB01169","BE0001040","# Muscarella DE, Bloom SE: Differential activation of the c-Jun N-terminal kinase pathway in arsenite-induced apoptosis and sensitization of chemically resistant compared to susceptible B-lymphoma cell lines. Toxicol Sci. 2002 Jul;68(1):82-92. \"Pubmed\":ht"
3662,"DB03389","BE0003072",""
3663,"DB00546","BE0000795","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
3664,"DB00459","BE0000144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3665,"DB00661","BE0000430","# Dilmac N, Hilliard N, Hockerman GH: Molecular determinants of frequency dependence and Ca2+ potentiation of verapamil block in the pore region of Cav1.2. Mol Pharmacol. 2004 Nov;66(5):1236-47. Epub 2004 Jul 30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
3666,"DB01839","BE0001234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3667,"DB02267","BE0000520","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3668,"DB02142","BE0000273","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3669,"DB00051","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3670,"DB07780","BE0004091","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3671,"DB03674","BE0001705","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3672,"DB00458","BE0000045","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
3673,"DB01614","BE0000575","# Cahir M, King DJ: Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat. Eur Neuropsychopharmacol. 2005 Mar;15(2):231-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15695070"
3674,"DB00110","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3675,"DB01144","BE0000535","# Mincione F, Scozzafava A, Supuran CT: The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18336310"
3676,"DB00413","BE0000291","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
3677,"DB00309","BE0000026","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3678,"DB04480","BE0003782","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3679,"DB08631","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3680,"DB04552","BE0002376","# Picollo A, Liantonio A, Babini E, Camerino DC, Pusch M: Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels. J Membr Biol. 2007 Apr;216(2-3):73-82. Epub 2007 Jul 21. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
3681,"DB01483","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
3682,"DB01022","BE0000724","# Sato Y, Tsuru T, Oizumi K, Kaji M: Vitamin K deficiency and osteopenia in disuse-affected limbs of vitamin D-deficient elderly stroke patients. Am J Phys Med Rehabil. 1999 Jul-Aug;78(4):317-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10418836# Schur"
3683,"DB02776","BE0001696","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3684,"DB00139","BE0002261","# Ventura FV, Ruiter J, Ijlst L, de Almeida IT, Wanders RJ: Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation def"
3685,"DB03687","BE0001574","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3686,"DB08347","BE0000172","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3687,"DB04346","BE0003287",""
3688,"DB01162","BE0000501","# Chapple CR: Medical therapy and quality of life. Eur Urol. 1998;34 Suppl 2:10-7; discussion 46. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9732824# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pu"
3689,"DB02078","BE0000839","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3690,"DB07821","BE0004103","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3691,"DB00673","BE0000384","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Brands KM, Payack JF, Rosen JD, Nelson TD, Candelario A, Huffman MA, Zhao MM, Li J, Craig B, Song "
3692,"DB03544","BE0002076","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3693,"DB02010","BE0001385","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3694,"DB08165","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3695,"DB07986","BE0001116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3696,"DB05465","BE0000147",""
3697,"DB00143","BE0002290","# Ago H, Kanaoka Y, Irikura D, Lam BK, Shimamura T, Austen KF, Miyano M: Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis. Nature. 2007 Aug 2;448(7153):609-12. Epub 2007 Jul 15. \"Pubmed\":http://www.ncbi.nlm.nih."
3698,"DB00191","BE0000749","# John CE, Jones SR: Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology. 2007 Jun;52(8):1596-605. Epub 2007 Mar "
3699,"DB02773","BE0000017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3700,"DB07949","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3701,"DB00721","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3702,"DB04604","BE0003334","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3703,"DB03909","BE0001431","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3704,"DB01454","BE0000749","# Shankaran M, Yamamoto BK, Gudelsky GA: Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur J Pharmacol. 1999 Dec 3;385(2-3):103-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
3705,"DB03214","BE0004566","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3706,"DB07895","BE0002372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3707,"DB07996","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3708,"DB02526","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3709,"DB03152","BE0003884","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3710,"DB02763","BE0001876","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3711,"DB04162","BE0001793","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3712,"DB00246","BE0000389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3713,"DB06710","BE0000132","# Small EJ, Ryan CJ: The case for secondary hormonal therapies in the chemotherapy age. J Urol. 2006 Dec;176(6 Pt 2):S66-71. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17084172# Omwancha J, Brown TR: Selective androgen receptor modulators: in pursuit of "
3714,"DB00055","BE0001151","# Gresele P, Agnelli G: Novel approaches to the treatment of thrombosis. Trends Pharmacol Sci. 2002 Jan;23(1):25-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11804648# Pineda AO, Chen ZW, Caccia S, Cantwell AM, Savvides SN, Waksman G, Mathews FS, Di Ce"
3715,"DB00114","BE0002160","# Tan EK, Cheah SY, Fook-Chong S, Yew K, Chandran VR, Lum SY, Yi Z: Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 5;137(1):1-4. \"Pubmed\":http://www.ncbi.nlm.nih.go"
3716,"DB04198","BE0002488",""
3717,"DB04447","BE0000170","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3718,"DB01496","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
3719,"DB00674","BE0000426","# Tonkopii VD, Prozorovskii VB, Suslova IM: [Interaction of reversible inhibitors with the catalytic centers and allosteric sites of cholinesterases] Biull Eksp Biol Med. 1976 Aug;82(8):947-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1026294# Greenbla"
3720,"DB00520","BE0004669","# Sucher AJ, Chahine EB, Balcer HE: Echinocandins: the newest class of antifungals. Ann Pharmacother. 2009 Oct;43(10):1647-57. Epub 2009 Sep 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19724014# Morrison VA: Caspofungin: an overview. Expert Rev Anti In"
3721,"DB00708","BE0000420","# Freye E, Latasch L, Portoghese PS: The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects. Eur J Anaesthesiol. 1992 Nov;9(6):457-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1330549#"
3722,"DB07884","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3723,"DB04419","BE0003309",""
3724,"DB04270","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3725,"DB01241","BE0000071","# Clavey V, Copin C, Mariotte MC, Bauge E, Chinetti G, Fruchart J, Fruchart JC, Dallongeville J, Staels B: Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells. Cell Physiol Biochem. 1999"
3726,"DB04265","BE0001946","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3727,"DB07684","BE0001088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3728,"DB00157","BE0000421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3729,"DB06062","BE0001051",""
3730,"DB02263","BE0002606",""
3731,"DB03600","BE0002397","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3732,"DB02691","BE0001967","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3733,"DB04688","BE0003805","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3734,"DB01215","BE0003595","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
3735,"DB02175","BE0001513","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3736,"DB00152","BE0003530","# Liberman MC, Tartaglini E, Fleming JC, Neufeld EJ: Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype. J Assoc Res Otolaryngol. 2006 Sep;7(3):211-7. Epub 2006 Apr 27. \""
3737,"DB06151","BE0004839","# Jones AL: Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol. 1998;36(4):277-85. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9711192# Prescott LF, Critc"
3738,"DB08889","BE0004738","# FDA label # Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ: Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against precli"
3739,"DB00028","BE0002097","# Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110"
3740,"DB02104","BE0000330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3741,"DB01207","BE0000759","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Heinisch G, Holzer W, Kunz F, Langer T, Lukavsky P, Pechlaner C, Weissenberger H: On the bioisoste"
3742,"DB04182","BE0001497","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3743,"DB07076","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3744,"DB04557","BE0001566","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3745,"DB08286","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3746,"DB01921","BE0001339","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3747,"DB04636","BE0003330",""
3748,"DB00463","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
3749,"DB01177","BE0004796","# Zahraei Z, Rabbani-Chadegani A: A comparison of the effect of anticancer drugs, idarubicin and adriamycin, on soluble chromatin. Eur J Pharmacol. 2007 Dec 1;575(1-3):28-33. Epub 2007 Jul 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17716648# Hollings"
3750,"DB01993","BE0001344","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3751,"DB08342","BE0004275","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3752,"DB00540","BE0000575","# Nojimoto FD, Mueller A, Hebeler-Barbosa F, Akinaga J, Lima V, Kiguti LR, Pupo AS: The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors. Neuropharmacology. 2010 Jul-Aug;59(1"
3753,"DB08689","BE0004380","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3754,"DB00160","BE0002164","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3755,"DB00157","BE0000408","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3756,"DB00696","BE0000715","# Gornemann T, Jahnichen S, Schurad B, Latte KP, Horowski R, Tack J, Flieger M, Pertz HH: Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jan;376(5):321-30. Ep"
3757,"DB08355","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3758,"DB01267","BE0000451","# Cohen LJ: Risperidone. Pharmacotherapy. 1994 May-Jun;14(3):253-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7524043# He H, Richardson JS: A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks seroton"
3759,"DB02700","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3760,"DB00237","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
3761,"DB04090","BE0001184","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3762,"DB04777","BE0003318",""
3763,"DB08231","BE0004226","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3764,"DB00036","BE0000333","# Perera L, Darden TA, Pedersen LG: Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association. Biophys J. 1999 Jul;77(1):99-113. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10388743# Shapiro A: Inh"
3765,"DB03761","BE0001409","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3766,"DB00354","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3767,"DB07935","BE0004136","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3768,"DB03516","BE0002204","# Porter DJ: Reaction of 5-ethynyluracil with rat liver xanthine oxidase. J Biol Chem. 1994 Nov 11;269(45):27932-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7961725"
3769,"DB01786","BE0001346","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3770,"DB05271","BE0000572","# Scheller D, Ullmer C, Berkels R, Gwarek M, Lubbert H: The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):73-86. doi: 10.1007/s00210-008-0341-4. Epub 200"
3771,"DB01267","BE0002363","# Boerth JM, Caley CF, Goethe JW: Interpreting serum risperidone concentrations. Pharmacotherapy. 2005 Feb;25(2):299-302. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15767244"
3772,"DB08893","BE0001012","# Kashyap M, Tyagi P: The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option. Expert Opin Drug Metab Toxicol. 2013 May;9(5):617-27. doi: 10.1517/17425255.2013.786700. Epub 2013 Apr 4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
3773,"DB00852","BE0004898","# Fiebich BL, Collado JA, Stratz C, Valina C, Hochholzer W, Munoz E, Bellido LM: Pseudoephedrine inhibits T-cell activation by targeting NF-kappaB, NFAT and AP-1 signaling pathways. Immunopharmacol Immunotoxicol. 2012 Feb;34(1):98-106. doi: 10.3109/089239"
3774,"DB07064","BE0001852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3775,"DB00709","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3776,"DB04982","BE0000640","# Langan YM, Lucas R, Jewell H, Toublanc N, Schaefer H, Sander JW, Patsalos PN: Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia. 2003 J"
3777,"DB00589","BE0000451","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler "
3778,"DB08691","BE0004043","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3779,"DB05655","BE0000084",""
3780,"DB00334","BE0000945","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
3781,"DB00216","BE0000659","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Napier C, Stewart M, Melrose H, Hopkins B, McHarg A, Wallis R: Characterisation of the 5-HT recept"
3782,"DB04099","BE0001768","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3783,"DB02431","BE0002020","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3784,"DB03801","BE0002666",""
3785,"DB00018","BE0000661","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3786,"DB04419","BE0000753","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3787,"DB07298","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3788,"DB05492","BE0000451",""
3789,"DB00121","BE0000094","# Luo S, Kansara VS, Zhu X, Mandava NK, Pal D, Mitra AK: Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery. Mol Pharm. 2006 May-Jun;3(3):329-39. \"Pubmed\":http://ww"
3790,"DB08882","BE0000854","# Forst T, Pfutzner A: Linagliptin, a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy in a broad range of patients with type 2 diabetes. Expert Opin Pharmacother. 2012 Jan;13(1):101-10. doi: 10.1517/14656566.2012.64286"
3791,"DB08048","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3792,"DB07218","BE0003789","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3793,"DB00721","BE0004909","# MacFarlane MD: Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase. Fed Proc. 1975 Jan;34(1):108-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1109354"
3794,"DB00625","BE0004853","# Gazzard BG: Efavirenz in the management of HIV infection. Int J Clin Pract. 1999 Jan-Feb;53(1):60-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10344069# Adkins JC, Noble S: Efavirenz. Drugs. 1998 Dec;56(6):1055-64; discussion 1065-6. \"Pubmed\":http://w"
3795,"DB00114","BE0000822","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3796,"DB05203","BE0000270",""
3797,"DB02032","BE0004195","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3798,"DB00748","BE0000442","# Oishi R, Shishido S, Yamori M, Saeki K: Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):140-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
3799,"DB00434","BE0000560","# Eltze M, Lambrecht G, Mutschler E: Cyproheptadine displays high affinity for muscarinic receptors but does not discriminate between receptor subtypes. Eur J Pharmacol. 1989 Dec 7;173(2-3):219-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2625138"
3800,"DB00690","BE0003594","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3801,"DB04485","BE0004639","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3802,"DB02803","BE0000270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3803,"DB03463","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3804,"DB01942","BE0002662",""
3805,"DB06712","BE0000430","# Rosenthal J: Nilvadipine: profile of a new calcium antagonist. An overview. J Cardiovasc Pharmacol. 1994;24 Suppl 2:S92-107. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7898101# Morel N, Buryi V, Feron O, Gomez JP, Christen MO, Godfraind T: The action o"
3806,"DB01660","BE0004571","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3807,"DB06905","BE0002326","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3808,"DB08697","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3809,"DB05470","BE0000704",""
3810,"DB00163","BE0000956","# Rabovsky A, Cuomo J, Eich N: Measurement of plasma antioxidant reserve after supplementation with various antioxidants in healthy subjects. Clin Chim Acta. 2006 Sep;371(1-2):55-60. Epub 2006 Mar 6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16603143# M"
3811,"DB01004","BE0000308","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3812,"DB01926","BE0001084","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3813,"DB02659","BE0003996","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3814,"DB03147","BE0002961",""
3815,"DB03549","BE0001668","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3816,"DB00143","BE0002289","# Giovannini C, Scazzocchio B, Matarrese P, Vari R, D'Archivio M, Di Benedetto R, Casciani S, Dessi MR, Straface E, Malorni W, Masella R: Apoptosis induced by oxidized lipids is associated with up-regulation of p66Shc in intestinal Caco-2 cells: protectiv"
3817,"DB08001","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3818,"DB08181","BE0001668","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3819,"DB07321","BE0002431","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3820,"DB02878","BE0000050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3821,"DB07743","BE0004014","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3822,"DB00182","BE0001044","# Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DK: Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. J Pharmacol Exp Ther. 2007 Apr;321(1):17"
3823,"DB01331","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
3824,"DB06637","BE0004724","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
3825,"DB00909","BE0002082","# Janszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases] Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20025128# Kothare SV, Kaleyias J: Zonisamide: review of pharm"
3826,"DB02445","BE0001423","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3827,"DB00753","BE0000484","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3828,"DB01992","BE0002687",""
3829,"DB06689","BE0004817","# Kang JH, Kambayashi J, Sakon M, Shiozaki H, Ogawa Y, Ohshiro T, Mori T: Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices. Br J Surg. 1987 Jan;74(1):50-3. \"Pubmed\":http://www.ncbi.nlm.nih.g"
3830,"DB07821","BE0002409","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3831,"DB02686","BE0001440","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3832,"DB01002","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3833,"DB01016","BE0000703","# Byrne JA, Strautnieks SS, Mieli-Vergani G, Higgins CF, Linton KJ, Thompson RJ: The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology. 2002 Nov;123(5):1649-58. \"Pubmed\":http://www.nc"
3834,"DB08456","BE0001248","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3835,"DB02930","BE0002852",""
3836,"DB07164","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3837,"DB00566","BE0004814","# Ozuah PO: Mercury poisoning. Curr Probl Pediatr. 2000 Mar;30(3):91-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10742922# Miller AL: Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998 Ju"
3838,"DB04043","BE0001084","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3839,"DB03956","BE0004490","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3840,"DB05253","BE0000557",""
3841,"DB08690","BE0001005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3842,"DB00388","BE0000575","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Hein, L. (2004). &alpha;-Adrenergic system. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclopedic"
3843,"DB08453","BE0003907","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3844,"DB00016","BE0000654","# LaMontagne KR, Butler J, Marshall DJ, Tullai J, Gechtman Z, Hall C, Meshaw A, Farrell FX: Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models. Mol Cancer Ther. 2006 Feb;5(2):347-55. \"Pubmed\":htt"
3845,"DB00157","BE0000051","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3846,"DB06689","BE0004672","# Takada K, Matsumoto A, Miyoshi H, Oshiba S: Changes in thrombin-antithrombin III complex after endoscopic injection sclerotherapy. Am J Gastroenterol. 1991 Jan;86(1):123-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1986546# Kang JH, Kambayashi J, Sako"
3847,"DB01041","BE0000704","# Richardson P, Hideshima T, Anderson K: Thalidomide in multiple myeloma. Biomed Pharmacother. 2002 May;56(3):115-28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12046682# Fu LM, Fu-Liu CS: Thalidomide and tuberculosis. Int J Tuberc Lung Dis. 2002 Jul;6(7"
3848,"DB08795","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
3849,"DB04915","BE0002434","# Morre DJ, Chueh PJ, Yagiz K, Balicki A, Kim C, Morre DM: ECTO-NOX target for the anticancer isoflavene phenoxodiol. Oncol Res. 2007;16(7):299-312. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17518268"
3850,"DB00438","BE0004290","# Hayes MV, Orr DC: Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983 Aug;12(2):119-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
3851,"DB06888","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3852,"DB06932","BE0001193","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3853,"DB00690","BE0002345","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3854,"DB00444","BE0000742","# de Lucio B, Manuel V, Barrera-Rodriguez R: Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha. Cancer Sci. 2005 Nov;96(11):774-83. \"Pubmed\":http://www.ncbi.nlm.nih.go"
3855,"DB00418","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
3856,"DB08655","BE0004367","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3857,"DB07043","BE0002622","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3858,"DB00634","BE0004657","# Patel OG, Mberu EK, Nzila AM, Macreadie IG: Sulfa drugs strike more than once. Trends Parasitol. 2004 Jan;20(1):1-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14700578"
3859,"DB07800","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3860,"DB01419","BE0000017","# Hassan SM, Olivesi A, Fish A, Turner P: A comparison of antrafenine and aspirin on platelet aggregation and frusemide-induced diuresis. Postgrad Med J. 1982 Jan;58(675):17-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7088753# Berry H, Coquelin JP, Gor"
3861,"DB00170","BE0000364","# Berkessel A, Guixa M, Schmidt F, Neudorfl JM, Lex J: Highly enantioselective epoxidation of 2-methylnaphthoquinone (vitamin K3) mediated by new cinchona alkaloid phase-transfer catalysts. Chemistry. 2007;13(16):4483-98. \"Pubmed\":http://www.ncbi.nlm.nih."
3862,"DB00726","BE0000647","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821"
3863,"DB02230","BE0000250","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Pro"
3864,"DB08897","BE0000045","# FDA label"
3865,"DB03144","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3866,"DB03441","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3867,"DB00180","BE0000794","# Hochhaus G, Moellmann HW: Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissue. Agents Actions. 1990 Jun;30(3-4):377-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
3868,"DB02327","BE0002731",""
3869,"DB01227","BE0003584","# Xiao Y, Smith RD, Caruso FS, Kellar KJ: Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs. J Pharmacol Exp Ther. 2001 Oct;299(1):366-71. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11561100"
3870,"DB04272","BE0004459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3871,"DB00274","BE0002063","# de la Rosa EJ, de Pedro MA, Vazquez D: Penicillin binding proteins: role in initiation of murein synthesis in Escherichia coli. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5632-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3898066"
3872,"DB00524","BE0000419","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
3873,"DB08231","BE0000358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3874,"DB00139","BE0000528","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3875,"DB02635","BE0000721","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3876,"DB00292","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681 (Accessed December 2013)"
3877,"DB02762","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3878,"DB08362","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3879,"DB08081","BE0004158","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3880,"DB00228","BE0000484","# Kosk-Kosicka D, Roszczynska G: Inhibition of plasma membrane Ca(2+)-ATPase activity by volatile anesthetics. Anesthesiology. 1993 Oct;79(4):774-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8214757"
3881,"DB00622","BE0000715","# Thayer SA, Welcome M, Chhabra A, Fairhurst AS: Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Biochem Pharmacol. 1985 Jan 15;34(2):175-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/298"
3882,"DB04570","BE0000488","# Labia R, Baron P, Masson JM: Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins. J Antimicrob Chemother. 1985 Jan;15(1):9-15. \"Pubmed\":http://www.ncbi.nlm.nih.go"
3883,"DB00634","BE0000803","# Hevener KE, Zhao W, Ball DM, Babaoglu K, Qi J, White SW, Lee RE: Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase. J Chem Inf Model. 2009 Jan 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19170653# BROWN "
3884,"DB05235","BE0000104",""
3885,"DB03316","BE0004452","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3886,"DB04689","BE0000215",""
3887,"DB01181","BE0004796","# Furlanut M, Franceschi L: Pharmacology of ifosfamide. Oncology. 2003;65 Suppl 2:2-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14586139# Hartley JM, Spanswick VJ, Gander M, Giacomini G, Whelan J, Souhami RL, Hartley JA: Measurement of DNA cross-linkin"
3888,"DB00381","BE0000691","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Striessnig, J. (2004). Ca ^2+^ channel blockers. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclo"
3889,"DB03147","BE0002983",""
3890,"DB00346","BE0000090","# The hERG Cardiac Potassium Channel: Structure, Function and Long QT Syndrome ? (By Novartis Foundation)  books.google.ca/books?isbn=0470021411"
3891,"DB04844","BE0000756","# FDA label"
3892,"DB05740","BE0000849",""
3893,"DB02062","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3894,"DB08052","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3895,"DB01842","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3896,"DB00128","BE0002227","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3897,"DB03428","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3898,"DB00328","BE0000262","# Armstrong PJ, Franklin DP, Carey DJ, Elmore JR: Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors. Ann Vasc Surg. 2005 Mar;19(2):248-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
3899,"DB03978","BE0000230","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3900,"DB02854","BE0001679","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3901,"DB00059","BE0004798","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3902,"DB05033","BE0003412",""
3903,"DB06995","BE0000915","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3904,"DB03403","BE0001303","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3905,"DB01406","BE0000123","# Fujimoto J, Hori M, Itoh T, Ichigo S, Nishigaki M, Tamaya T: Danazol decreases transcription of estrogen receptor gene in human monocytes. Gen Pharmacol. 1995 May;26(3):507-16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7540578# Snyder BW, Beecham GD, "
3906,"DB08253","BE0001400","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3907,"DB02111","BE0001448","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3908,"DB02519","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3909,"DB01962","BE0000453","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3910,"DB00363","BE0000476","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
3911,"DB03947","BE0001225","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3912,"DB00280","BE0000560","# Yamamoto N, Ozaki T, Keida Y, Ohtsuka M, Goto T: A comparison of the binding characteristics of class I antiarrhythmic agents for human muscarinic m1-m3 receptors. J Cardiovasc Pharmacol. 1999 Jul;34(1):53-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
3913,"DB06842","BE0001287","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3914,"DB08408","BE0001422","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3915,"DB04115","BE0001268","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3916,"DB02200","BE0001292","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3917,"DB07841","BE0004072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3918,"DB07060","BE0003028","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3919,"DB01595","BE0003598","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
3920,"DB01298","BE0000803","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3921,"DB03170","BE0001757","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3922,"DB05398","BE0003377",""
3923,"DB00583","BE0000579","# Sekoguchi E, Sato N, Yasui A, Fukada S, Nimura Y, Aburatani H, Ikeda K, Matsuura A: A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting. J Biol Chem. 2003 Oct 3;278(40):38796-802. Epub 2003 Jul 25. \"Pubme"
3924,"DB00030","BE0001147","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3925,"DB00462","BE0000045","# Sykes DA, Dowling MR, Charlton SJ: Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor. Mol Pharmacol. 2009 Sep;76(3):543-51. Epub 2009 Jun 4. \"Pubmed\":http://www.ncbi."
3926,"DB03524","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3927,"DB06101","BE0000029",""
3928,"DB01829","BE0001320","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3929,"DB00384","BE0000024","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3930,"DB04315","BE0004633","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3931,"DB00944","BE0000426","# Ward DA, Abney K, Oliver JW: The effects of topical ocular application of 0.25% demecarium bromide on serum acetylcholinesterase levels in normal dogs. Vet Ophthalmol. 2003 Mar;6(1):23-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12641839# Chen X, Ji "
3932,"DB02930","BE0001493","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3933,"DB04983","BE0002401","# Maminishkis A, Jalickee S, Blaug SA, Rymer J, Yerxa BR, Peterson WM, Miller SS: The P2Y(2) receptor agonist INS37217 stimulates RPE fluid transport in vitro and retinal reattachment in rat. Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3555-66. \"Pubmed\":ht"
3934,"DB03257","BE0001667","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3935,"DB01065","BE0000327","# Radogna F, Paternoster L, De Nicola M, Cerella C, Ammendola S, Bedini A, Tarzia G, Aquilano K, Ciriolo M, Ghibelli L: Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicol Appl Phar"
3936,"DB04628","BE0001584","# Cederkvist FH, Saua SF, Karlsen V, Sakuda S, Eijsink VG, Sorlie M: Thermodynamic analysis of allosamidin binding to a family 18 chitinase. Biochemistry. 2007 Oct 30;46(43):12347-54. Epub 2007 Oct 4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17915946# "
3937,"DB00142","BE0002278","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3938,"DB03147","BE0000965","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3939,"DB00661","BE0002226","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880"
3940,"DB04782","BE0003361",""
3941,"DB02764","BE0001854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3942,"DB08245","BE0001360","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3943,"DB00898","BE0000465","# Hernandez-Tobias A, Julian-Sanchez A, Pina E, Riveros-Rosas H: Natural alcohol exposure: Is ethanol the main substrate for alcohol dehydrogenases in animals? Chem Biol Interact. 2011 Feb 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21329681# Matsumot"
3944,"DB00142","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3945,"DB00152","BE0000157","# Pylypchuk SIu, Parkhomenko IuM, Protasova ZS, Vovk AI, Donchenko HV: [Interaction of rat brain thiamine kinase with thiamine and its derivatives] Ukr Biokhim Zh. 2001 Mar-Apr;73(2):51-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11642045# Melnick J, L"
3946,"DB03205","BE0003016",""
3947,"DB03461","BE0003118",""
3948,"DB02527","BE0002794",""
3949,"DB07215","BE0000071","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3950,"DB01769","BE0001879","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3951,"DB00571","BE0000797","# Bailey SR, Elliott J: Evidence for different 5-HT1B/1D receptors mediating vasoconstriction of equine digital arteries and veins. Eur J Pharmacol. 1998 Aug 21;355(2-3):175-87. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9760032# Choppin A, O'Connor SE: "
3952,"DB02386","BE0003882","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3953,"DB00622","BE0003323","# Sharma RK, Wang JH, Wu Z: Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists. J Neurochem. 1997 Aug;69(2):845-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9231746"
3954,"DB07416","BE0003864","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3955,"DB03089","BE0001291","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3956,"DB07359","BE0001056","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3957,"DB02266","BE0000592","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Lovering AL, Ride JP, Bunce CM, Desmond JC, Cummings SM, Whit"
3958,"DB02534","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3959,"DB03382","BE0003067",""
3960,"DB06637","BE0000781","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
3961,"DB00170","BE0000713","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3962,"DB08453","BE0003854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3963,"DB01497","BE0000632","# Niwa M, al-Essa LY, Ohta S, Kohno K, Nozaki M, Tsurumi K, Iwamura T, Kataoka T: Opioid receptor interaction and adenylyl cyclase inhibition of dihydroetorphine: direct comparison with etorphine. Life Sci. 1995;56(21):PL395-400. \"Pubmed\":http://www.ncbi."
3964,"DB00259","BE0000803","# Djapa LY, Zelikson R, Delahodde A, Bolotin-Fukuhara M, Mazabraud A: Plasmodium vivax dihydrofolate reductase as a target of sulpha drugs. FEMS Microbiol Lett. 2006 Mar;256(1):105-11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16487326# Nzila A: Inhibit"
3965,"DB02595","BE0002019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3966,"DB02845","BE0001897","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3967,"DB04020","BE0000792","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3968,"DB01621","BE0000020","# Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7918347"
3969,"DB01599","BE0002705","# Jeon SM, Park YB, Kwon OS, Huh TL, Lee WH, Do KM, Park T, Choi MS: Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol. J Biochem Mol Toxicol. 2005;19(5):"
3970,"DB00331","BE0000254","# Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR: Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem. 2003 Oct 10;278(41):39422-7. Epub 2003 Jul 29. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
3971,"DB00819","BE0003634","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3972,"DB01392","BE0004905","# Plant TD, Henquin JC: Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br J Pharmacol. 1990 Sep;101(1):115-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2282453"
3973,"DB00126","BE0001225","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3974,"DB05303","BE0000565",""
3975,"DB04255","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3976,"DB00916","BE0000564","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3977,"DB01558","BE0003596","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
3978,"DB05421","BE0000384",""
3979,"DB08780","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3980,"DB00142","BE0002235","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3981,"DB03005","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3982,"DB03352","BE0001876","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3983,"DB08385","BE0002194","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3984,"DB01031","BE0000267","# Parr JS, Khalifah RG: Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. J Biol Chem. 1992 Dec 15;267(35):25044-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1460006"
3985,"DB00420","BE0000020","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3986,"DB05194","BE0000628",""
3987,"DB03996","BE0001852","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3988,"DB02153","BE0001485","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3989,"DB08260","BE0001810","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3990,"DB03814","BE0000329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
3991,"DB08605","BE0002006","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3992,"DB01791","BE0001287","# Beeh KM, Beier J, Lerch C, Schulz AK, Buhl R: Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Lung. 2004;182(6):369-77. \"Pubmed\":http://www.ncbi.nlm.nih"
3993,"DB01043","BE0000760","# Chen HS, Lipton SA: Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. J Pharmacol Exp Ther. 2005 Sep;314(3):961-71. Epub 2005 May 18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
3994,"DB00182","BE0000647","# Lott DC, Kim SJ, Cook EH Jr, de Wit H: Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology. 2005 Mar;30(3):602-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15602501# Fone KC, Nutt DJ: Stimul"
3995,"DB07372","BE0003822","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3996,"DB08629","BE0003842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3997,"DB07248","BE0003090","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3998,"DB07788","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
3999,"DB03156","BE0001416","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4000,"DB01567","BE0003595","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
4001,"DB00622","BE0000247","# Thayer SA, Welcome M, Chhabra A, Fairhurst AS: Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Biochem Pharmacol. 1985 Jan 15;34(2):175-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/298"
4002,"DB03726","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4003,"DB00396","BE0000557","# Madauss KP, Stewart EL, Williams SP: The evolution of progesterone receptor ligands. Med Res Rev. 2007 May;27(3):374-400. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17013809# Gizard F, Robillard R, Gross B, Barbier O, Revillion F, Peyrat JP, Torpier G,"
4004,"DB00484","BE0000572","# Trendelenburg AU, Philipp M, Meyer A, Klebroff W, Hein L, Starke K: All three alpha2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):504-12. Epub 2003 Nov 11. \"Pubmed\""
4005,"DB08013","BE0001612","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4006,"DB00530","BE0000956","# Harmsen S, Meijerman I, Beijnen JH, Schellens JH: Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor. Cancer Chemother Pharmacol. 2009 Jun;64(1):35-43. Epub 2008 Oct 7. \"Pubmed\":http://"
4007,"DB05744","BE0000877",""
4008,"DB05191","BE0000924",""
4009,"DB07648","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4010,"DB06716","BE0002345","# Franks NP: Molecular targets underlying general anaesthesia. Br J Pharmacol. 2006 Jan;147 Suppl 1:S72-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16402123"
4011,"DB00643","BE0001340","# Lubega GW, Geary TG, Klein RD, Prichard RK: Expression of cloned beta-tubulin genes of Haemonchus contortus in Escherichia coli: interaction of recombinant beta-tubulin with native tubulin and mebendazole. Mol Biochem Parasitol. 1993 Dec;62(2):281-92. \""
4012,"DB00518","BE0001340","# Ramirez T, Benitez-Bribiesca L, Ostrosky-Wegman P, Herrera LA: In vitro effects of albendazole and its metabolites on the cell proliferation kinetics and micronuclei frequency of stimulated human lymphocytes. Arch Med Res. 2001 Mar-Apr;32(2):119-22. \"Pu"
4013,"DB00071","BE0001123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4014,"DB04079","BE0001713","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4015,"DB00962","BE0000736","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4016,"DB00028","BE0000901","# Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110"
4017,"DB00126","BE0000138","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4018,"DB08235","BE0004251","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4019,"DB01812","BE0000886","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4020,"DB00714","BE0000289","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
4021,"DB01992","BE0001317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4022,"DB07541","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4023,"DB00762","BE0000971","# Yoshikawa M, Ikegami Y, Hayasaka S, Ishii K, Ito A, Sano K, Suzuki T, Togawa T, Yoshida H, Soda H, Oka M, Kohno S, Sawada S, Ishikawa T, Tanabe S: Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells. Int J "
4024,"DB03945","BE0001964","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4025,"DB02379","BE0001935","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4026,"DB01559","BE0000523","# Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 2008 Oct;9(8):827-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18855614"
4027,"DB00461","BE0000262","# Fackovcova D, Kristova V, Kriska M: Renal damage induced by the treatment with non-opioid analgesics--theoretical assumption or clinical significance. Bratisl Lek Listy. 2000;101(8):417-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11153163# Roy HK, K"
4028,"DB02552","BE0000776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4029,"DB08199","BE0003355","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4030,"DB07340","BE0003809","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4031,"DB04315","BE0004491","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4032,"DB07955","BE0003758","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4033,"DB02893","BE0001534","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4034,"DB07210","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4035,"DB00241","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
4036,"DB02382","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4037,"DB02644","BE0000005","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4038,"DB04208","BE0001389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4039,"DB03345","BE0000181","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4040,"DB00075","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4041,"DB00694","BE0002425","# Aubel-Sadron G, Londos-Gagliardi D: Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 1984 May;66(5):333-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6380596# Zunino F, Capranico G: DNA topoi"
4042,"DB01694","BE0002504",""
4043,"DB04447","BE0003316",""
4044,"DB05785","BE0000206",""
4045,"DB00401","BE0002359","# Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J: Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol. 2009 Feb;75(2):407-14. Epub 200"
4046,"DB01267","BE0000575","# Cohen LJ: Risperidone. Pharmacotherapy. 1994 May-Jun;14(3):253-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7524043# Eltze M: In functional experiments, risperidone is selective, not for the B, but for the A subtype of alpha 1-adrenoceptors. Eur J Ph"
4047,"DB00425","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4048,"DB02998","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4049,"DB03785","BE0001856","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4050,"DB01014","BE0000248","# Wiggins JB, Rajapakse R: Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis. Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1279-84. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19743890# Rask-Madsen J, Bukhave "
4051,"DB00142","BE0000830","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4052,"DB07863","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4053,"DB07690","BE0001817","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4054,"DB04216","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4055,"DB00115","BE0000777","# Worgan LC, Niles K, Tirone JC, Hofmann A, Verner A, Sammak A, Kucic T, Lepage P, Rosenblatt DS: Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype. Hum Mutat. 2006 Jan;27(1):31-43. \"Pubmed\""
4056,"DB02761","BE0002825",""
4057,"DB02580","BE0004309","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4058,"DB00493","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
4059,"DB07592","BE0003417","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4060,"DB07148","BE0002148","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4061,"DB05004","BE0002451",""
4062,"DB01395","BE0000132","# Krattenmacher R: Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000 Jul;62(1):29-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11024226"
4063,"DB01588","BE0003592","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
4064,"DB01973","BE0004529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4065,"DB00726","BE0000756","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
4066,"DB00940","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4067,"DB00870","BE0000262","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4068,"DB06957","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4069,"DB05506","BE0000623",""
4070,"DB02363","BE0001445","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4071,"DB01590","BE0002386","# Ettenger R, Hoyer PF, Grimm P, Webb N, Loirat C, Mahan JD, Mentser M, Niaudet P, Offner G, Vandamme-Lombaerts R, Hexham JM: Multicenter trial of everolimus in pediatric renal transplant recipients: results at three year. Pediatr Transplant. 2008 Jun;12("
4072,"DB05271","BE0000145","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
4073,"DB00008","BE0000661","# Dhalluin C, Ross A, Huber W, Gerber P, Brugger D, Gsell B, Senn H: Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNA"
4074,"DB04272","BE0002545",""
4075,"DB00981","BE0000426","# Nguyen PV, Aniksztejn L, Catarsi S, Drapeau P: Maturation of neuromuscular transmission during early development in zebrafish. J Neurophysiol. 1999 Jun;81(6):2852-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10368402# Tuovinen K, Kaliste-Korhonen E, "
4076,"DB01373","BE0001024","# Dweck D, Reynaldo DP, Pinto JR, Potter JD: A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin-actin binding. J Biol Chem. 2010 Jun 4;285(23):17371-9. Epub 2010 Apr 6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
4077,"DB03461","BE0001439","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4078,"DB01173","BE0000396","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4079,"DB03415","BE0001745","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4080,"DB03317","BE0003055",""
4081,"DB08156","BE0000267","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4082,"DB04137","BE0004594","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4083,"DB00456","BE0001349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4084,"DB01882","BE0001319","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4085,"DB04451","BE0001909","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4086,"DB00363","BE0000666","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
4087,"DB02772","BE0002718",""
4088,"DB01057","BE0002180","# Henderson EG, Post-Munson DJ, Reynolds LS, Epstein PM: Echothiophate and cogeners decrease the voltage dependence of end-plate current decay in frog skeletal muscle. J Pharmacol Exp Ther. 1989 Dec;251(3):810-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
4089,"DB00690","BE0000764","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
4090,"DB04612","BE0001156",""
4091,"DB07678","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4092,"DB00848","BE0003585","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4093,"DB01708","BE0000156","# Waterhouse RN, Chang RC, Atuehene N, Collier TL: In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPS. Synapse. 2007 Jul;61(7):540-6. \"Pubmed\":http://www.ncbi"
4094,"DB03345","BE0004493","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4095,"DB00114","BE0000404","# Jackson LK, Goldsmith EJ, Phillips MA: X-ray structure determination of Trypanosoma brucei ornithine decarboxylase bound to D-ornithine and to G418: insights into substrate binding and ODC conformational flexibility. J Biol Chem. 2003 Jun 13;278(24):220"
4096,"DB08558","BE0000172","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4097,"DB04555","BE0001635","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4098,"DB01942","BE0002663",""
4099,"DB01861","BE0001521","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4100,"DB02059","BE0002697",""
4101,"DB02235","BE0003392","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4102,"DB02036","BE0001486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4103,"DB07740","BE0004067","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4104,"DB04252","BE0001452","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4105,"DB00134","BE0002249","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4106,"DB02518","BE0000747","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4107,"DB00977","BE0000956","# Xue Y, Moore LB, Orans J, Peng L, Bencharit S, Kliewer SA, Redinbo MR: Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. Mol Endocrinol. 2007 May;21(5):1028-38. Epub 2007 Feb 27. \"Pubmed\":http:"
4108,"DB02445","BE0001626","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4109,"DB04786","BE0001640","# Murakami MT, Arruda EZ, Melo PA, Martinez AB, Calil-Elias S, Tomaz MA, Lomonte B, Gutierrez JM, Arni RK: Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin. J Mol Biol. 2005 Jul 15;350(3):416-26. \"Pubmed\""
4110,"DB04137","BE0001073","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4111,"DB02973","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4112,"DB00674","BE0002341","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
4113,"DB01165","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4114,"DB00157","BE0000761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4115,"DB01130","BE0000794","# Boudinot FD, D'Ambrosio R, Jusko WJ: Receptor-mediated pharmacodynamics of prednisolone in the rat. J Pharmacokinet Biopharm. 1986 Oct;14(5):469-93. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2879901# Ikonomidis I, Tzortzis S, Lekakis J, Paraskevaidis "
4116,"DB04930","BE0000141","# Cao Z, Shafer TJ, Murray TF: Mechanisms of pyrethroid insecticide-induced stimulation of calcium influx in neocortical neurons. J Pharmacol Exp Ther. 2011 Jan;336(1):197-205. Epub 2010 Sep 29. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20881019# Liu N,"
4117,"DB02379","BE0004457","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4118,"DB01182","BE0000197","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4119,"DB06869","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4120,"DB00918","BE0000659","# Napier C, Stewart M, Melrose H, Hopkins B, McHarg A, Wallis R: Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Eur J Pharmacol. 1999 Mar 5;368(2-3):259-68. "
4121,"DB03147","BE0002963",""
4122,"DB00842","BE0000795","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
4123,"DB02482","BE0003761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4124,"DB01905","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4125,"DB02673","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4126,"DB00139","BE0000611","# Oshiro N, Pajor AM: Functional characterization of high-affinity Na(+)/dicarboxylate cotransporter found in Xenopus laevis kidney and heart. Am J Physiol Cell Physiol. 2005 Nov;289(5):C1159-68. Epub 2005 Jun 8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
4127,"DB03505","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4128,"DB00402","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522 (Accessed December 2013)"
4129,"DB07703","BE0004058","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4130,"DB08647","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4131,"DB05064","BE0000329",""
4132,"DB08521","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4133,"DB03473","BE0002514",""
4134,"DB00615","BE0001165","# Barzilay E, Ben-Califa N, Supino-Rosin L, Kashman Y, Hirschberg K, Elazar Z, Neumann D: Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity. J Biol Chem. 2004 Feb 20;279(8):6847-52. Epub 2003 Dec 1. \"P"
4135,"DB07444","BE0001776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4136,"DB04591","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4137,"DB04861","BE0000172","# Gielen W, Cleophas TJ, Agrawal R: Nebivolol: a review of its clinical and pharmacological characteristics. Int J Clin Pharmacol Ther. 2006 Aug;44(8):344-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16961165# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic T"
4138,"DB04395","BE0004572","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4139,"DB01361","BE0003674","# Scharre KA, Eckels DD, Gershwin ME: Depression of colony formation by human thymus-derived lymphocytes with rifampin and other antimicrobial agents. J Infect Dis. 1981 Jun;143(6):832-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6972981"
4140,"DB04630","BE0000668","# Bruner KL, Derfoul A, Robertson NM, Guerriero G, Fernandes-Alnemri T, Alnemri ES, Litwack G: The unliganded mineralocorticoid receptor is associated with heat shock proteins 70 and 90 and the immunophilin FKBP-52. Recept Signal Transduct. 1997;7(2):85-9"
4141,"DB02899","BE0004008","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4142,"DB00062","BE0004795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4143,"DB00091","BE0001399","# Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW: Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984 Nov 2;226(4674):544-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6238408"
4144,"DB03252","BE0001806","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4145,"DB08901","BE0003379","# FDA label"
4146,"DB02852","BE0000826","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4147,"DB08020","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4148,"DB00777","BE0000389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4149,"DB07707","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4150,"DB01069","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Suzuki A, Yasui-Furukori N, Mihara K, Kondo T, Furukori H, Inoue Y, Kaneko S, Otani K: Histamine H"
4151,"DB01244","BE0003565","# Lamers JM, Cysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. Biochem Pharmacol. 1985 Nov 1;34(21):3837-43. \"Pubmed\":http://www.n"
4152,"DB03951","BE0001626","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4153,"DB07519","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4154,"DB00777","BE0000715","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4155,"DB02804","BE0001342","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4156,"DB06274","BE0000632","# Beattie DT, Cheruvu M, Mai N, O'Keefe M, Johnson-Rabidoux S, Peterson C, Kaufman E, Vickery R: The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone. Naunyn Schmiedebergs Arch P"
4157,"DB04736","BE0003077","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4158,"DB00083","BE0000390","# Zhou JY, Wang ZF, Ren XM, Tang MZ, Shi YL: Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin. FEBS Lett. 2003 Dec 4;555(2):375-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14644446# Flynn TC: M"
4159,"DB00157","BE0000173","# Gyan S, Shiohira Y, Sato I, Takeuchi M, Sato T: Regulatory loop between redox sensing of the NADH/NAD(+) ratio by Rex (YdiH) and oxidation of NADH by NADH dehydrogenase Ndh in Bacillus subtilis. J Bacteriol. 2006 Oct;188(20):7062-71. \"Pubmed\":http://www"
4160,"DB01442","BE0000118","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Henry JP, Sagne C, Bedet C, Gasnier B: The vesicula"
4161,"DB04850","BE0004800",""
4162,"DB00649","BE0004853","# Lea AP, Faulds D: Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection. Drugs. 1996 May;51(5):846-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8861550"
4163,"DB00133","BE0000063","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4164,"DB01192","BE0000420","# Chamberlin KW, Cottle M, Neville R, Tan J: Oral oxymorphone for pain management. Ann Pharmacother. 2007 Jul;41(7):1144-52. Epub 2007 Jun 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17595308# Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Dav"
4165,"DB01197","BE0000221","# Andujar-Sanchez M, Jara-Perez V, Camara-Artigas A: Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method. FEBS Lett. 2007 Jul 24;581(18):3449-54. Epub 2007 Jun 27. \"Pubmed\":http://www.n"
4166,"DB08185","BE0004208","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4167,"DB01104","BE0000749","# Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A: Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci. 1999 Dec 1;19(23):10494-501. \"Pubmed\":http://www.ncbi.nl"
4168,"DB03940","BE0001448","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4169,"DB05868","BE0003427",""
4170,"DB00078","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4171,"DB07002","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4172,"DB02153","BE0002702",""
4173,"DB04315","BE0002231","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4174,"DB07415","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4175,"DB02452","BE0001442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4176,"DB03146","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4177,"DB03884","BE0004318","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4178,"DB08690","BE0003852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4179,"DB03472","BE0002015","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4180,"DB00387","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4181,"DB01942","BE0004470","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4182,"DB08515","BE0002348","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4183,"DB03160","BE0001794","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4184,"DB00623","BE0000418","# Mongin AA, Cai Z, Kimelberg HK: Volume-dependent taurine release from cultured astrocytes requires permissive [Ca(2+)](i) and calmodulin. Am J Physiol. 1999 Oct;277(4 Pt 1):C823-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10516112# Kawai M, Nakashim"
4185,"DB03800","BE0001318","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4186,"DB08424","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4187,"DB07633","BE0000214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4188,"DB04946","BE0000581","# George M, Amrutheshwar R, Rajkumar RP, Kattimani S, Dkhar SA: Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol. 2013 Apr 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23545936"
4189,"DB01029","BE0000062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Voigt JP, Bramlage P, Fink H: Hypophagic effect of the angiotensin AT1 receptor antagonist irbesar"
4190,"DB02445","BE0001567","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4191,"DB08771","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4192,"DB02475","BE0001314","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4193,"DB06956","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4194,"DB04005","BE0001245","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4195,"DB06974","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4196,"DB04216","BE0003842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4197,"DB02032","BE0002694","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4198,"DB03162","BE0001448","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4199,"DB03400","BE0001389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4200,"DB00134","BE0000845","# Slow S, Garrow TA: Liver choline dehydrogenase and kidney betaine-homocysteine methyltransferase expression are not affected by methionine or choline intake in growing rats. J Nutr. 2006 Sep;136(9):2279-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16"
4201,"DB04503","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4202,"DB07602","BE0000767","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4203,"DB03078","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4204,"DB04216","BE0003757","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4205,"DB01191","BE0000749","# Eddahibi S, Adnot S, Frisdal E, Levame M, Hamon M, Raffestin B: Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J Pharmacol Exp Ther. 2001 Apr;297(1):148-54. \"Pu"
4206,"DB00819","BE0000322","# Avvaru BS, Wagner JM, Maresca A, Scozzafava A, Robbins AH, Supuran CT, McKenna R: Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding poc"
4207,"DB00157","BE0000578","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4208,"DB07918","BE0003961","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4209,"DB06148","BE0004889","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
4210,"DB08918","BE0000486","# FDA label"
4211,"DB00734","BE0000756","# Catafau AM, Corripio I, Perez V, Martin JC, Schotte A, Carrio I, Alvarez E: Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response. Psychiatry Res. 2006 Dec 1;148(2-3):175-83. Epub 2006 Oct 23. \"Pub"
4212,"DB04719","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4213,"DB00607","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
4214,"DB00132","BE0000986","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4215,"DB00318","BE0000770","# Grond S, Sablotzki A: Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879-923. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15509185# Takahama K, Shirasaki T: Central and peripheral mechanisms of narcotic antitussives: codeine-sensitiv"
4216,"DB01352","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
4217,"DB00801","BE0000381","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
4218,"DB07664","BE0003958","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4219,"DB00157","BE0000307","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4220,"DB04786","BE0001457","# Ganesh VK, Muthuvel SK, Smith SA, Kotwal GJ, Murthy KH: Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein. Biochemistry. 2005 Aug 16;44(32):10757-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16086578"
4221,"DB04272","BE0003264",""
4222,"DB00110","BE0000901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4223,"DB00688","BE0000722","# Vannozzi F, Filipponi F, Di Paolo A, Danesi R, Urbani L, Bocci G, Catalano G, De Simone P, Mosca F, Del Tacca M: An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant rec"
4224,"DB00340","BE0000405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4225,"DB04272","BE0003270",""
4226,"DB03088","BE0004465","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4227,"DB01275","BE0000060","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Knowles HJ, Tian YM, Mole DR, Harris AL: Novel mechanism of action for hydralazine: induction of h"
4228,"DB03156","BE0001361","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4229,"DB01769","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4230,"DB00474","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4231,"DB01828","BE0001338","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4232,"DB00512","BE0004826","# Reynolds PE: Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis. 1989 Nov;8(11):943-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2532132# Reynolds PE, Somner EA: Comparison of the target sites"
4233,"DB05146","BE0000205",""
4234,"DB04272","BE0002555",""
4235,"DB07355","BE0001333","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4236,"DB00051","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4237,"DB01615","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4238,"DB03773","BE0001734","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4239,"DB01638","BE0001216","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4240,"DB01403","BE0000145","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205"
4241,"DB07138","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4242,"DB08897","BE0000405","# FDA label"
4243,"DB00004","BE0000651","# Foss F, Demierre MF, DiVenuti G: A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood. 2005 Jul 15;106(2):454-7. Epub 2005 Apr 5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15811"
4244,"DB03053","BE0001378","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4245,"DB07817","BE0004099","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4246,"DB04770","BE0000042","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4247,"DB01872","BE0002584",""
4248,"DB05509","BE0000291",""
4249,"DB01112","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4250,"DB00401","BE0000430","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Hu H, Marban E: Isoform-specific inhibition of L-type calcium channels by dihydropyridines is inde"
4251,"DB02379","BE0002059","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4252,"DB01558","BE0003619","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
4253,"DB02142","BE0001344","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4254,"DB07644","BE0001215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4255,"DB06144","BE0000501","# Lindstrom E, Levander S: Sertindole: efficacy and safety in schizophrenia. Expert Opin Pharmacother. 2006 Sep;7(13):1825-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16925508# Hietala J, Kuonnamaki M, Palvimaki EP, Laakso A, Majasuo H, Syvalahti E: S"
4256,"DB00721","BE0000641","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4257,"DB00237","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
4258,"DB00029","BE0000717","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4259,"DB00988","BE0000486","# Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS: Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001 Jan;39(1):32-41. \"Pubmed\":htt"
4260,"DB08087","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4261,"DB02319","BE0001545","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4262,"DB01289","BE0002441","# Szewczyk A, Wojcik G, Lobanov NA, Nalecz MJ: The mitochondrial sulfonylurea receptor: identification and characterization. Biochem Biophys Res Commun. 1997 Jan 23;230(3):611-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9015372# Sato T, Costa AD, Saito"
4263,"DB00143","BE0002291","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4264,"DB07192","BE0000332","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4265,"DB00536","BE0000133","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4266,"DB01140","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
4267,"DB07996","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4268,"DB02467","BE0002747",""
4269,"DB01351","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
4270,"DB04576","BE0000429","# Drlica K, Zhao X: DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9293187# Chaudhry U, Ray K, Bala M, Saluja D: Mutation patterns in gyrA and parC genes of ci"
4271,"DB00248","BE0000145","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Kvernmo T, Hartter S, Burger E: A review of the receptor"
4272,"DB00751","BE0000451","# Dupont LJ, Pype JL, Meade CJ, DeLeyn P, Deneffe G, Demedts MG, Verleden GM: Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro. Eur Respir J. 1999 Nov;14(5):1068-75. "
4273,"DB00170","BE0000048","# Lee SK, Lee JY, Lee MY, Chung SM, Chung JH: Advantages of calcium green-1 over other fluorescent dyes in measuring cytosolic calcium in platelets. Anal Biochem. 1999 Sep 10;273(2):186-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10469489# Casper HH, "
4274,"DB07289","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4275,"DB07453","BE0002433","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4276,"DB00114","BE0002161","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4277,"DB00696","BE0000486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4278,"DB01548","BE0000420","# Willoch F, Tolle TR, Wester HJ, Munz F, Petzold A, Schwaiger M, Conrad B, Bartenstein P: Central pain after pontine infarction is associated with changes in opioid receptor binding: a PET study with 11C-diprenorphine. AJNR Am J Neuroradiol. 1999 Apr;20("
4279,"DB03373","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4280,"DB01110","BE0004426","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
4281,"DB00213","BE0000349","# Moreira Dias L: Pantoprazole: a proton pump inhibitor. Clin Drug Investig. 2009;29 Suppl 2:3-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19938880# Cheer SM, Prakash A, Faulds D, Lamb HM: Pantoprazole: an update of its pharmacological properties and "
4282,"DB06875","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4283,"DB03041","BE0001872","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4284,"DB07365","BE0003820","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4285,"DB04147","BE0003936","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4286,"DB05134","BE0001898",""
4287,"DB04855","BE0000715","# Dale KM, White CM: Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother. 2007 Apr;41(4):599-605. Epub 2007 Mar 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17389667"
4288,"DB08403","BE0001182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4289,"DB08725","BE0003372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4290,"DB00622","BE0000092","# Thayer SA, Welcome M, Chhabra A, Fairhurst AS: Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Biochem Pharmacol. 1985 Jan 15;34(2):175-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/298"
4291,"DB01708","BE0000194","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4292,"DB08682","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4293,"DB00674","BE0004661","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
4294,"DB03247","BE0001922","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4295,"DB08690","BE0003851","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4296,"DB00884","BE0004801","# Jahnke W, Henry C: An in vitro assay to measure targeted drug delivery to bone mineral. ChemMedChem. 2010 May 3;5(5):770-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20209564# Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russ"
4297,"DB08889","BE0004739","# Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ: Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models"
4298,"DB00028","BE0002098","# Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110"
4299,"DB00675","BE0000123","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Sasson S: Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activ"
4300,"DB00836","BE0000356","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4301,"DB00143","BE0000817","# Walshe J, Serewko-Auret MM, Teakle N, Cameron S, Minto K, Smith L, Burcham PC, Russell T, Strutton G, Griffin A, Chu FF, Esworthy S, Reeve V, Saunders NA: Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma "
4302,"DB00468","BE0004805","# Alumasa JN, Gorka AP, Casabianca LB, Comstock E, de Dios AC, Roepe PD: The hydroxyl functionality and a rigid proximal N are required for forming a novel non-covalent quinine-heme complex. J Inorg Biochem. 2010 Sep 21. \"Pubmed\":http://www.ncbi.nlm.nih.g"
4303,"DB08788","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4304,"DB07200","BE0002403","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4305,"DB00055","BE0001129","# Carr ME: Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001 Jan-Feb;15(1):44-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11259926"
4306,"DB00370","BE0000486","# Fernandez J, Alonso JM, Andres JI, Cid JM, Diaz A, Iturrino L, Gil P, Megens A, Sipido VK, Trabanco AA: Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents. J Med Chem. 2005 Mar 24;48(6):1709-12. \"Pub"
4307,"DB07094","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4308,"DB08807","BE0000694","# Rubenstein LA, Zauhar RJ, Lanzara RG: Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation. J Mol Graph Model. 2006 Dec;25(4):396-409. Epub 2006 Mar 30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1657"
4309,"DB02659","BE0002705","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4310,"DB01844","BE0003758","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4311,"DB01146","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4312,"DB04946","BE0000451","# Kongsamut S, Roehr JE, Cai J, Hartman HB, Weissensee P, Kerman LL, Tang L, Sandrasagra A: Iloperidone binding to human and rat dopamine and 5-HT receptors. Eur J Pharmacol. 1996 Dec 19;317(2-3):417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8997630"
4313,"DB01588","BE0000471","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
4314,"DB00360","BE0000263","# Heller R, Munscher-Paulig F, Grabner R, Till U: L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem. 1999 Mar 19;274(12):8254-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10075731# Huang A, Vita JA, Venema RC, Keaney "
4315,"DB04014","BE0001065","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4316,"DB01591","BE0000247","# Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E: Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. J Pharmacol Exp Ther. 2009 Mar;328(3)"
4317,"DB01820","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4318,"DB01175","BE0000092","# Bareggi SR, Mundo E, Dell'Osso B, Altamura AC: The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):741-53. \"Pubmed\":http://www.ncbi.nlm.n"
4319,"DB06616","BE0001424","# FDA label"
4320,"DB01752","BE0004446","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4321,"DB04315","BE0001273","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4322,"DB03569","BE0001416","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4323,"DB07277","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4324,"DB01426","BE0000197","# Barajas-Martinez HM, Hu D, Cordeiro JM, Wu Y, Kovacs RJ, Meltser H, Kui H, Elena B, Brugada R, Antzelevitch C, Dumaine R: Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. Circ Res. 2008 Aug 15"
4325,"DB01108","BE0000123","# Puddefoot JR, Barker S, Vinson GP: Trilostane in advanced breast cancer. Expert Opin Pharmacother. 2006 Dec;7(17):2413-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17109615# Puddefoot JR, Barker S, Glover HR, Malouitre SD, Vinson GP: Non-competitive s"
4326,"DB04958","BE0000183","# Steinfeld SD, Youinou P: Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases. Expert Opin Biol Ther. 2006 Sep;6(9):943-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16918261# Leonard JP, Goldenberg DM: Preclinical and clinical evaluation "
4327,"DB00739","BE0004644","# Neu HC: Aminopenicillins - clinical pharmacology and use in disease states. Int J Clin Pharmacol Biopharm. 1975 Mar;11(2):132-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1095502# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lacta"
4328,"DB08472","BE0003930","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4329,"DB07705","BE0000875","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4330,"DB04478","BE0000299","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4331,"DB08607","BE0002887","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4332,"DB01812","BE0002560",""
4333,"DB01183","BE0002442","# Lewis SS, Loram LC, Hutchinson MR, Li CM, Zhang Y, Maier SF, Huang Y, Rice KC, Watkins LR: (+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats. J Pain. 2012 May;13(5):49"
4334,"DB08359","BE0000801","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4335,"DB00382","BE0002180","# Wang H, Tang XC: Anticholinesterase effects of huperzine A, E2020, and tacrine in rats. Zhongguo Yao Li Xue Bao. 1998 Jan;19(1):27-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10375753# Krustev AD, Argirova MD, Getova DP, Turiiski VI, Prissadova NA: "
4336,"DB07954","BE0001287","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4337,"DB08885","BE0004736","# Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW: Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol. 2012 Aug;154(2):222-6. doi: 10.1016/j.ajo.2012.04.020. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/228"
4338,"DB01122","BE0000426","# Lockhart B, Closier M, Howard K, Steward C, Lestage P: Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors. Naunyn Schmiedebergs Arch"
4339,"DB00595","BE0000127","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4340,"DB01142","BE0000146","# Roth, BL; Driscol, J (12 January 2011). PDSP Ki Database. Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 20 October 2013."
4341,"DB04559","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4342,"DB00201","BE0002385","# Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR: Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem. 2002 Oct "
4343,"DB00307","BE0000707","# Lowe MN, Plosker GL: Bexarotene. Am J Clin Dermatol. 2000 Jul-Aug;1(4):245-50; discussion 251-2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11702369# Tsai DE, Luger SM, Andreadis C, Vogl DT, Kemner A, Potuzak M, Goradia A, Loren AW, Perl AE, Schuster S"
4344,"DB01023","BE0001024","# Bostrom SL, Westerlund C, Rochester S, Vogel HJ: Binding of a dihydropyridine felodipine-analogue to calmodulin and related calcium-binding proteins. Biochem Pharmacol. 1988 Oct 1;37(19):3723-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3178884"
4345,"DB07846","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4346,"DB02659","BE0002088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4347,"DB00935","BE0000342","# Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bonisch H: Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010 Dec;24(6):729-39. doi: 10.1111/j.1472-8206.2009.00805.x. \"Pubmed\":ht"
4348,"DB06712","BE0002354","# Rosenthal J: Nilvadipine: profile of a new calcium antagonist. An overview. J Cardiovasc Pharmacol. 1994;24 Suppl 2:S92-107. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7898101# Honerjager P, Seibel K: Pharmacodynamics of nilvadipine, a new dihydropyrid"
4349,"DB00458","BE0000945","# Grimaldi B, Bonnin A, Fillion MP, Ruat M, Traiffort E, Fillion G: Characterization of 5-ht6 receptor and expression of 5-ht6 mRNA in the rat brain during ontogenetic development. Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):393-400. \"Pubmed\":htt"
4350,"DB00456","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
4351,"DB07419","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4352,"DB04133","BE0000302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4353,"DB08493","BE0003690","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4354,"DB06069","BE0000971",""
4355,"DB04164","BE0001625","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4356,"DB01942","BE0001778","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4357,"DB03793","BE0002742",""
4358,"DB08737","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4359,"DB02109","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4360,"DB06058","BE0003427",""
4361,"DB07401","BE0003861","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4362,"DB00926","BE0000078","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4363,"DB03766","BE0002742",""
4364,"DB03801","BE0001344","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4365,"DB04464","BE0003777","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4366,"DB00193","BE0000749","# Barann M, Urban B, Stamer U, Dorner Z, Bonisch H, Bruss M: Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis. Eur J Pharmacol. 2006 Feb 15;531(1"
4367,"DB00005","BE0002100","# Hart SP, Ross JA, Ross K, Haslett C, Dransfield I: Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 2000 May;7(5):493-503. \"Pubmed\":http://ww"
4368,"DB02243","BE0001504","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4369,"DB02659","BE0003997","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4370,"DB07041","BE0002622","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4371,"DB00777","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4372,"DB01892","BE0000248","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
4373,"DB02010","BE0001065","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4374,"DB07875","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4375,"DB04569","BE0001346","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4376,"DB00373","BE0001248","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4377,"DB05284","BE0000143",""
4378,"DB00568","BE0000756","# Hirose G: Drug induced parkinsonism: A review. J Neurol. 2006 Aug;253 Suppl 3:iii22-iii24. \"doi:10.1007/s00415-006-3004-8\":http://dx.doi.org/10.1007/s00415-006-3004-8# Brucke T, Wober C, Podreka I, Wober-Bingol C, Asenbaum S, Aull S, Wenger S, Ilieva D,"
4379,"DB03023","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4380,"DB03033","BE0001116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4381,"DB02033","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4382,"DB07092","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4383,"DB01026","BE0004884","# Trachtenberg J, Zadra J: Steroid synthesis inhibition by ketoconazole: sites of action. Clin Invest Med. 1988 Feb;11(1):1-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2966691"
4384,"DB03884","BE0004152","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4385,"DB07806","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4386,"DB00228","BE0000781","# Matchett GA, Allard MW, Martin RD, Zhang JH: Neuroprotective effect of volatile anesthetic agents: molecular mechanisms. Neurol Res. 2009 Mar;31(2):128-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19298752"
4387,"DB03747","BE0003173",""
4388,"DB08063","BE0003781","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4389,"DB01992","BE0002684",""
4390,"DB00809","BE0000560","# Betz AJ, McLaughlin PJ, Burgos M, Weber SM, Salamone JD: The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors. Psychopharmacology (Berl). 2007 Oct;194(3"
4391,"DB02684","BE0000188","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4392,"DB00481","BE0000123","# Khovidhunkit W, Shoback DM: Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 1999 Mar 2;130(5):431-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10068418# Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L,"
4393,"DB08896","BE0002411","# FDA label"
4394,"DB05280","BE0000389",""
4395,"DB04295","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4396,"DB01614","BE0000020","# Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7918347"
4397,"DB00056","BE0000901","# Caron PC, Lai LT, Scheinberg DA: Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia. Clin Cancer Res. 1995 Jan;1(1):63-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9815888# Rogler G, Ha"
4398,"DB01306","BE0000033","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Zib I, Raskin P: Novel insulin analogues and its mitogenic potential. Diabetes Obes Metab. 2006 No"
4399,"DB07007","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4400,"DB03687","BE0001661","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4401,"DB00888","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4402,"DB00157","BE0000722","# Wang J, Zeevi A, Webber S, Girnita DM, Addonizio L, Selby R, Hutchinson IV, Burckart GJ: A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity. Pharmacogenet Genomics. 2007 Apr;17(4):283-90"
4403,"DB02446","BE0001423","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4404,"DB02667","BE0002812",""
4405,"DB00328","BE0000215","# Cho MC, Lee HS, Kim JH, Choe YK, Hong JT, Paik SG, Yoon DY: A simple ELISA for screening ligands of peroxisome proliferator-activated receptor-gamma. J Biochem Mol Biol. 2003 Mar 31;36(2):207-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12689521# Leh"
4406,"DB07991","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4407,"DB07683","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4408,"DB02059","BE0003362","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4409,"DB02470","BE0001887","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4410,"DB04721","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4411,"DB03717","BE0001339","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4412,"DB00907","BE0000197","# Antzelevitch C: Brugada syndrome. Pacing Clin Electrophysiol. 2006 Oct;29(10):1130-59. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17038146# Satish OS, Yeh KH, Wen MS: Brugada syndrome--an update. Chang Gung Med J. 2005 Feb;28(2):69-76. \"Pubmed\":http://"
4413,"DB00690","BE0002344","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
4414,"DB01064","BE0000172","# Sato M, Gong H, Terracciano CM, Ranu H, Harding SE: Loss of beta-adrenoceptor response in myocytes overexpressing the Na+/Ca(2+)-exchanger. J Mol Cell Cardiol. 2004 Jan;36(1):43-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14734046# Jurgens CW, Rau KE"
4415,"DB05492","BE0000342",""
4416,"DB08195","BE0001646","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4417,"DB00551","BE0001198","# Mannino C, Nievo M, Machetti F, Papakyriakou A, Calderone V, Fragai M, Guarna A: Synthesis of bicyclic molecular scaffolds (BTAa): an investigation towards new selective MMP-12 inhibitors. Bioorg Med Chem. 2006 Nov 15;14(22):7392-403. Epub 2006 Aug 8. \""
4418,"DB01741","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4419,"DB06844","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4420,"DB07791","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4421,"DB00155","BE0000608","# Tran CT, Fox MF, Vallance P, Leiper JM: Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics. 2000 Aug 15;68(1):101-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
4422,"DB03994","BE0003201",""
4423,"DB03886","BE0000909","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4424,"DB08029","BE0001116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4425,"DB00092","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4426,"DB03875","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4427,"DB06782","BE0004814","# Flora SJ, Pachauri V: Chelation in metal intoxication. Int J Environ Res Public Health. 2010 Jul;7(7):2745-88. Epub 2010 Jun 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20717537"
4428,"DB03579","BE0003132",""
4429,"DB02485","BE0004564","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4430,"DB02327","BE0002730",""
4431,"DB08635","BE0004312","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4432,"DB02227","BE0002584",""
4433,"DB07782","BE0001327","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4434,"DB02218","BE0002713",""
4435,"DB04716","BE0004145","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4436,"DB07374","BE0003823","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4437,"DB00769","BE0000794","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4438,"DB05001","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4439,"DB01248","BE0000246","# Gligorov J, Lotz JP: Preclinical pharmacology of the taxanes: implications of the differences. Oncologist. 2004;9 Suppl 2:3-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15161985# Marshall J, Chen H, Yang D, Figueira M, Bouker KB, Ling Y, Lippman M, Fr"
4440,"DB06972","BE0000516","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4441,"DB01992","BE0001750","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4442,"DB03243","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4443,"DB01138","BE0000785","# Evers R, de Haas M, Sparidans R, Beijnen J, Wielinga PR, Lankelma J, Borst P: Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer. 2000 Aug;83(3):375-83. \"Pubmed\":http://www.n"
4444,"DB00098","BE0003576","# Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003 Feb;3(2):189-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12586600"
4445,"DB04472","BE0003318","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4446,"DB00076","BE0004837","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4447,"DB02379","BE0001947","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4448,"DB03147","BE0002204","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4449,"DB00737","BE0000442","# Oishi R, Shishido S, Yamori M, Saeki K: Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):140-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
4450,"DB08749","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4451,"DB02122","BE0001274","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4452,"DB07187","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4453,"DB03147","BE0002982",""
4454,"DB01327","BE0002393","# Truesdell SE, Zurenko GE, Laborde AL: Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1989 Apr;23 Suppl D:13-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2722720# Y"
4455,"DB07270","BE0002431","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4456,"DB07813","BE0004097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4457,"DB01992","BE0002575",""
4458,"DB00128","BE0002228","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4459,"DB02785","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4460,"DB03565","BE0003997","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4461,"DB06101","BE0000369",""
4462,"DB07216","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4463,"DB04335","BE0002011",""
4464,"DB01622","BE0000756","# Oades RD, Rao ML, Bender S, Sartory G, Muller BW: Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy. Behav Pharmaco"
4465,"DB00135","BE0000692","# Dong S, Kang S, Gu TL, Kardar S, Fu H, Lonial S, Khoury HJ, Khuri F, Chen J: 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood. 2007 Jul 1;110(1):360-9. Epub 2007 Mar 27. \""
4466,"DB07650","BE0001723","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4467,"DB07411","BE0001968","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4468,"DB01831","BE0001343","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4469,"DB04853","BE0000924","# Hodgson JM, Dib N, Kern MJ, Bach RG, Barrett RJ: Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist. Am J Cardiol. 2007 Jun 1;99(11):1507-12. Epub 2007 Apr 16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17531571# "
4470,"DB01970","BE0001223","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4471,"DB08709","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4472,"DB08113","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4473,"DB04141","BE0003887","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4474,"DB04462","BE0001209","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4475,"DB01997","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4476,"DB03660","BE0002747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4477,"DB03127","BE0002833","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4478,"DB01595","BE0003599","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
4479,"DB07160","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4480,"DB07380","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4481,"DB01632","BE0002489",""
4482,"DB02010","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4483,"DB03661","BE0003141",""
4484,"DB02506","BE0003749","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4485,"DB04961","BE0004796","# Boivin AJ, Gourdeau H, Momparler RL: Action of troxacitabine on cells transduced with human cytidine deaminase cDNA. Cancer Invest. 2004;22(1):25-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15069761"
4486,"DB01901","BE0000689","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4487,"DB04828","BE0003561","# Hata AN, Lybrand TP, Marnett LJ, Breyer RM: Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. Mol Pharmacol. 2005 Mar;67(3):640-7. Epub 2004 Nov 2"
4488,"DB00411","BE0000092","# Weiner DM, Goodman MW, Colpitts TM, Feddock MA, Duggento KL, Nash NR, Levey AI, Brann MR: Functional screening of drug target genes: m1 muscarinic acetylcholine receptor phenotypes in degenerative dementias. Am J Pharmacogenomics. 2004;4(2):119-28. \"Pub"
4489,"DB03461","BE0002963",""
4490,"DB02448","BE0003768","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4491,"DB08437","BE0003830","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4492,"DB04903","BE0000381","# Atack JR, Pike A, Marshall G, Stanley J, Lincoln R, Cook SM, Lewis RT, Blackaby WP, Goodacre SC, McKernan RM, Dawson GR, Wafford KA, Reynolds DS: The in vivo properties of pagoclone in rat are most likely mediated by 5'-hydroxy pagoclone. Neuropharmacol"
4493,"DB08621","BE0001544","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4494,"DB00953","BE0000659","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Longmore J, Hargreaves RJ, Boulanger CM, Brown MJ, Desta B, Ferro A, Schofield WN, Taylor AA, Hill"
4495,"DB04327","BE0001161","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4496,"DB06944","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4497,"DB00142","BE0000003","# Dossena L, Curti B, Vanoni MA: Activation and coupling of the glutaminase and synthase reaction of glutamate synthase is mediated by E1013 of the ferredoxin-dependent enzyme, belonging to loop 4 of the synthase domain. Biochemistry. 2007 Apr 17;46(15):4"
4498,"DB03307","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4499,"DB03461","BE0003119",""
4500,"DB08756","BE0001016","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4501,"DB00726","BE0000749","# Diamond M, Kelly JP, Connor TJ: Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur Neuropsychopharmacol. 2006 Oct;16(7):481-90. Epub 2006 Jan 4. \"Pubmed\":http://www.ncbi.nlm.nih.g"
4502,"DB00984","BE0000132","# Cen Y, Li K, Liu XX: [Effect of nandrolone phenylpropionate on expression of hepatic albumin-mRNA and androgen receptor in burned rats] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2003 Nov;17(6):439-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14663936"
4503,"DB00312","BE0000795","# Steinbach JH, Akk G: Modulation of GABA(A) receptor channel gating by pentobarbital. J Physiol. 2001 Dec 15;537(Pt 3):715-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11744750# Whiting PJ: The GABAA receptor gene family: new opportunities for drug de"
4504,"DB02657","BE0001423","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4505,"DB06700","BE0000486","# Deecher DC, Beyer CE, Johnston G, Bray J, Shah S, Abou-Gharbia M, Andree TH: Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther. 2006 Aug;318(2):657-65. Epub 2006 May 4. \"Pubmed\":http://www.ncbi.nlm.nih"
4506,"DB00058","BE0000394","# Topic A, Ljujic M, Nikolic A, Petrovic-Stanojevic N, Dopudja-Pantic V, Mitic-Milikic M, Radojkovic D: Alpha-1-antitrypsin Phenotypes and Neutrophil Elastase Gene Promoter Polymorphisms in Lung Cancer. Pathol Oncol Res. 2010 Jun 3. \"Pubmed\":http://www.nc"
4507,"DB02585","BE0001583","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4508,"DB04345","BE0000595","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4509,"DB08401","BE0004313","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4510,"DB03127","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4511,"DB00325","BE0000556","# Fortin Y, De Lean A: Role of cyclic GMP and calcineurin in homologous and heterologous desensitization of natriuretic peptide receptor-A. Can J Physiol Pharmacol. 2006 May;84(5):539-46. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16902599# Madhani M, Ok"
4512,"DB02833","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4513,"DB02680","BE0001911","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4514,"DB05434","BE0001121",""
4515,"DB04681","BE0000214",""
4516,"DB00055","BE0000943","# Cvirn G, Gallistl S, Koestenberger M, Kutschera J, Leschnik B, Muntean W: Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma. Thromb Res. 2002 "
4517,"DB00514","BE0000632","# Codd EE, Shank RP, Schupsky JJ, Raffa RB: Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995 Sep;274(3):1263-70. \"Pubmed\":http://www.ncb"
4518,"DB08416","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4519,"DB08846","BE0001653","# Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j"
4520,"DB00778","BE0000743","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4521,"DB01186","BE0000145","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
4522,"DB03995","BE0001996","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4523,"DB04066","BE0004033","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4524,"DB02467","BE0002490",""
4525,"DB07619","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4526,"DB03147","BE0001551","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4527,"DB03060","BE0000330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4528,"DB05764","BE0003420",""
4529,"DB04447","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4530,"DB01238","BE0000572","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
4531,"DB07535","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4532,"DB00129","BE0000424","# Levillain O, Balvay S, Peyrol S: Localization and differential expression of arginase II in the kidney of male and female mice. Pflugers Arch. 2005 Feb;449(5):491-503. Epub 2004 Dec 23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15616821# Inubushi T, T"
4533,"DB03156","BE0002819",""
4534,"DB01558","BE0003595","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
4535,"DB00783","BE0000956","# Xue Y, Moore LB, Orans J, Peng L, Bencharit S, Kliewer SA, Redinbo MR: Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. Mol Endocrinol. 2007 May;21(5):1028-38. Epub 2007 Feb 27. \"Pubmed\":http:"
4536,"DB07487","BE0003783","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4537,"DB07995","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4538,"DB00142","BE0001115","# Glowatzki E, Cheng N, Hiel H, Yi E, Tanaka K, Ellis-Davies GC, Rothstein JD, Bergles DE: The glutamate-aspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea. J Neurosci. 2006 Jul 19;26(29):76"
4539,"DB00869","BE0000535","# Sugrue MF: The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocul Pharmacol Ther. 1996 Fall;12(3):363-76. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8875343"
4540,"DB00155","BE0000788","# Husson A, Brasse-Lagnel C, Fairand A, Renouf S, Lavoinne A: Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem. 2003 May;270(9):1887-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12709047# Hammermann R, Bliesene"
4541,"DB07375","BE0003837","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4542,"DB05452","BE0000773",""
4543,"DB08226","BE0003370","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4544,"DB02607","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4545,"DB08486","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4546,"DB03662","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4547,"DB08681","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4548,"DB03163","BE0001784","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4549,"DB03916","BE0001412","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4550,"DB05890","BE0000163",""
4551,"DB03144","BE0001433","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4552,"DB05097","BE0002477",""
4553,"DB00371","BE0000478","# Rho JM, Donevan SD, Rogawski MA: Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther. 1997 Mar;280(3):1383-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9067327# Gonzalez LA, Gatch MB, Taylor CM, Be"
4554,"DB05169","BE0003404",""
4555,"DB03931","BE0001820","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4556,"DB01209","BE0000770","# Picker MJ: Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists. J Pharmacol Exp Ther. 1997 Dec;283(3):1009-17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9399970# Barrett A"
4557,"DB03876","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4558,"DB03142","BE0002039","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4559,"DB07950","BE0003767","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4560,"DB00937","BE0000486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4561,"DB00816","BE0000694","# Kimura M, Ogihara M: Stimulation by transforming growth factor-alpha of DNA synthesis and proliferation of adult rat hepatocytes in primary cultures: modulation by alpha- and beta-adrenoceptor agonists. J Pharmacol Exp Ther. 1999 Oct;291(1):171-80. \"Pub"
4562,"DB01520","BE0000417","# Stirling JM, Cross AJ, Green AR: The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex. Neuropharmacology. 1989 Jan;28(1):1-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2538766"
4563,"DB00635","BE0000329","# Raza K, Hardy R, Cooper MS: The 11beta-hydroxysteroid dehydrogenase enzymes--arbiters of the effects of glucocorticoids in synovium and bone. Rheumatology (Oxford). 2010 Nov;49(11):2016-23. doi: 10.1093/rheumatology/keq212. Epub 2010 Jul 15. \"Pubmed\":ht"
4564,"DB02494","BE0003826","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4565,"DB05461","BE0000572",""
4566,"DB08837","BE0001355","# Ahern CA, Eastwood AL, Lester HA, Dougherty DA, Horn R: A cation-pi interaction between extracellular TEA and an aromatic residue in potassium channels. J Gen Physiol. 2006 Dec;128(6):649-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17130518# Bisset "
4567,"DB00166","BE0002327","# Morikawa T, Yasuno R, Wada H: Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 2001 Jun 1;498(1):16-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11389890# Ya"
4568,"DB04410","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4569,"DB00734","BE0000451","# Fenton C, Scott LJ: Risperidone: a review of its use in the treatment of bipolar mania. CNS Drugs. 2005;19(5):429-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15907153# Keks NA, Culhane C: Risperidone (Risperdal): clinical experience with a new antip"
4570,"DB03935","BE0004149","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4571,"DB04224","BE0001566","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4572,"DB01196","BE0000123","# Ferno M, Borg A, Ingvar C, Jonsson PE: Estrogen receptor and binding site for estramustine in metastatic malignant melanoma. Anticancer Res. 1987 Jul-Aug;7(4B):741-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3314674# Yoshizumi N: [The effects of site"
4573,"DB08259","BE0000950","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4574,"DB00157","BE0000131","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4575,"DB01942","BE0001905","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4576,"DB01822","BE0001304","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4577,"DB01000","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
4578,"DB00696","BE0000572","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4579,"DB00683","BE0000795","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
4580,"DB08235","BE0004252","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4581,"DB08604","BE0001774","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4582,"DB03010","BE0000026","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4583,"DB03666","BE0001221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4584,"DB05752","BE0000092",""
4585,"DB04865","BE0004749","# Gurel G, Blaha G, Moore PB, Steitz TA: U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome. J Mol Biol. 2009 May 29;389(1):146-56. doi: 10.1016/j.j"
4586,"DB08167","BE0004193","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4587,"DB08542","BE0004337","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4588,"DB03466","BE0000144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4589,"DB07583","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4590,"DB06616","BE0004744","# Remsing Rix LL, Rix U, Colinge J, Hantschel O, Bennett KL, Stranzl T, Muller A, Baumgartner C, Valent P, Augustin M, Till JH, Superti-Furga G: Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia. 2"
4591,"DB00820","BE0000182","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Curran M, Keating G: Tadalafil. Drugs. 2003;63(20):2203-12; discussion 2213-4. \"Pubmed\":http://www"
4592,"DB07861","BE0004110","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4593,"DB00098","BE0000846","# Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003 Feb;3(2):189-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12586600"
4594,"DB02774","BE0003814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4595,"DB04387","BE0000270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4596,"DB01694","BE0002505",""
4597,"DB06946","BE0003755","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4598,"DB03597","BE0003134",""
4599,"DB07393","BE0000648","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4600,"DB01044","BE0003726","# Harding I, Simpson I: Fluoroquinolones: is there a different mechanism of action and resistance against Streptococcus pneumoniae? J Chemother. 2000 Oct;12 Suppl 4:7-15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11131958# Rafii F, Park M, Novak JS: Alt"
4601,"DB00420","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4602,"DB01115","BE0002359","# Bell DC, Butcher AJ, Berrow NS, Page KM, Brust PF, Nesterova A, Stauderman KA, Seabrook GR, Nurnberg B, Dolphin AC: Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D), Ca(V)1.3) voltage-dependent calcium currents. "
4603,"DB01200","BE0000715","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
4604,"DB03793","BE0001710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4605,"DB04267","BE0001983","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4606,"DB00523","BE0000412","# Bartholin L, Powers SE, Melhuish TA, Lasse S, Weinstein M, Wotton D: TGIF inhibits retinoid signaling. Mol Cell Biol. 2006 Feb;26(3):990-1001. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16428452# Calleja C, Messaddeq N, Chapellier B, Yang H, Krezel W, "
4607,"DB02854","BE0002840","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4608,"DB06927","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4609,"DB01565","BE0000632","# Crooks PA, Kottayil SG, Al-Ghananeem AM, Byrn SR, Butterfield DA: Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4291-5. Epub 2006 Jun 13. \"Pubmed\":htt"
4610,"DB03988","BE0003199",""
4611,"DB00145","BE0000898","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4612,"DB00865","BE0000289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4613,"DB01136","BE0000289","# Koshimizu TA, Tsujimoto G, Hirasawa A, Kitagawa Y, Tanoue A: Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res. 2004 Sep 1;63(4):662-72. \"Pubmed\":http://ww"
4614,"DB00157","BE0000545","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4615,"DB02761","BE0002824",""
4616,"DB00054","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4617,"DB00233","BE0000054","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4618,"DB06637","BE0003603","# Goodman AD, Stone RT: Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy). Neurotherapeutics. 2013 Jan;10(1):106-10. doi: 10.1007/s13311-012-0156-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23184313"
4619,"DB05184","BE0000858",""
4620,"DB04077","BE0002517",""
4621,"DB01588","BE0003593","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
4622,"DB04023","BE0001849","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4623,"DB01186","BE0000389","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
4624,"DB08597","BE0000264","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4625,"DB07134","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4626,"DB00453","BE0000019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4627,"DB04732","BE0004188","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4628,"DB03909","BE0001547","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4629,"DB07689","BE0003983","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4630,"DB03120","BE0003970","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4631,"DB04392","BE0001616","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4632,"DB01026","BE0000233","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4633,"DB03235","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4634,"DB06589","BE0001341","# Deeks ED: Pazopanib: in advanced soft tissue sarcoma. Drugs. 2012 Nov 12;72(16):2129-40. doi: 10.2165/11209950-000000000-00000. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23072642"
4635,"DB07190","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4636,"DB07335","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4637,"DB03500","BE0001503","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4638,"DB08901","BE0004315","# O'Hare T, Shakespeare WC, Zhu X, Eide CA, Rivera VM, Wang F, Adrian LT, Zhou T, Huang WS, Xu Q, Metcalf CA 3rd, Tyner JW, Loriaux MM, Corbin AS, Wardwell S, Ning Y, Keats JA, Wang Y, Sundaramoorthi R, Thomas M, Zhou D, Snodgrass J, Commodore L, Sawyer T"
4639,"DB08158","BE0004189","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4640,"DB00201","BE0004874","# Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT: Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 1999 Sep 1;59(17):4375-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10485486#"
4641,"DB00177","BE0000062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Azizi M, Menard J, Bissery A, Guyenne TT, Bura-Riviere A, Vaidyanathan S, Camisasca RP: Pharmacolo"
4642,"DB01735","BE0001378","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4643,"DB01151","BE0000749","# Holmes A, Yang RJ, Murphy DL, Crawley JN: Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology. 2002 Dec;27(6):914-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12464448# Gould GG"
4644,"DB06940","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4645,"DB02516","BE0001666","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4646,"DB07724","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4647,"DB00370","BE0000342","# Fernandez J, Alonso JM, Andres JI, Cid JM, Diaz A, Iturrino L, Gil P, Megens A, Sipido VK, Trabanco AA: Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents. J Med Chem. 2005 Mar 24;48(6):1709-12. \"Pub"
4648,"DB03556","BE0003130",""
4649,"DB07598","BE0000829","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4650,"DB08381","BE0003821","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4651,"DB00759","BE0004799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4652,"DB07973","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4653,"DB04178","BE0000599","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4654,"DB00368","BE0000694","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4655,"DB06663","BE0000452","# Zatelli MC, Piccin D, Vignali C, Tagliati F, Ambrosio MR, Bondanelli M, Cimino V, Bianchi A, Schmid HA, Scanarini M, Pontecorvi A, De Marinis L, Maira G, degli Uberti EC: Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viabil"
4656,"DB00918","BE0000797","# Napier C, Stewart M, Melrose H, Hopkins B, McHarg A, Wallis R: Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Eur J Pharmacol. 1999 Mar 5;368(2-3):259-68. "
4657,"DB00777","BE0000247","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4658,"DB08066","BE0000991","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4659,"DB01043","BE0000756","# Seeman P, Caruso C, Lasaga M: Memantine agonist action at dopamine D2High receptors. Synapse. 2008 Feb;62(2):149-53. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18000814"
4660,"DB02185","BE0004111","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4661,"DB00605","BE0000262","# Giuliano F, Warner TD: Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br J Pharmacol. 1999 Apr;126(8):1824-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10372826# Molina MA, Sitja-Arnau M, Lemoine M"
4662,"DB00755","BE0000653","# Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R, Issa JP: Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Cancer Res. 2004 Apr 1;64(7):2411-7. \"Pubmed\":http://www.ncbi.nlm.nih"
4663,"DB02052","BE0000890","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Pro"
4664,"DB00755","BE0000707","# Koda T, Imai H, Morita M: Antiestrogenic activity of vitamin A in in vivo uterotrophic assay. Life Sci. 2007 Feb 13;80(10):945-9. Epub 2006 Nov 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17161848# He JC, Lu TC, Fleet M, Sunamoto M, Husain M, Fang W"
4665,"DB03408","BE0000185","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4666,"DB00458","BE0000650","# Lucchelli A, Santagostino-Barbone MG, D'Agostino G, Masoero E, Tonini M: The interaction of antidepressant drugs with enteric 5-HT7 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):284-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/109977"
4667,"DB00412","BE0000996","# Askari B, Kanter JE, Sherrid AM, Golej DL, Bender AT, Liu J, Hsueh WA, Beavo JA, Coleman RA, Bornfeldt KE: Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferato"
4668,"DB04522","BE0001385","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4669,"DB02859","BE0000702","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4670,"DB07104","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4671,"DB00940","BE0000112","# Hough LB, Barker LA: Histamine H2-receptor antagonism by propantheline and derivatives. J Pharmacol Exp Ther. 1981 Nov;219(2):453-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6116801"
4672,"DB01097","BE0000871","# Pytel D, Sliwinski T, Poplawski T, Ferriola D, Majsterek I: Tyrosine kinase blockers: new hope for successful cancer therapy. Anticancer Agents Med Chem. 2009 Jan;9(1):66-76. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19149483# Fukushima R, Kanamori S,"
4673,"DB03801","BE0003184",""
4674,"DB01646","BE0002494","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4675,"DB02848","BE0002431","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4676,"DB03793","BE0001631","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4677,"DB00637","BE0000090","# Zhou Z, Vorperian VR, Gong Q, Zhang S, January CT: Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole. J Cardiovasc Electrophysiol. 1999 Jun;10(6):836-43. \"Pubmed\":http://www.ncbi.n"
4678,"DB03685","BE0002034","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4679,"DB06833","BE0003722","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4680,"DB01990","BE0004545","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4681,"DB08340","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4682,"DB01167","BE0000690","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4683,"DB01992","BE0000558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4684,"DB03385","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4685,"DB01174","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
4686,"DB05036","BE0002478",""
4687,"DB06917","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4688,"DB01200","BE0000145","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
4689,"DB02379","BE0004492","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4690,"DB07876","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4691,"DB01421","BE0003676","# Dlugosz M, Trylska J: Aminoglycoside association pathways with the 30S ribosomal subunit. J Phys Chem B. 2009 May 21;113(20):7322-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19438282"
4692,"DB00334","BE0000092","# Uchida S, Kato Y, Hirano K, Kagawa Y, Yamada S: Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine. Life Sci. 2007 Apr 3;80(17):1635-40. Epub 2007 Jan 27. \"Pubmed\":http://"
4693,"DB04522","BE0004463","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4694,"DB04029","BE0004262","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4695,"DB01023","BE0002396","# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol. 1992 Oct;100(4):703-28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1281221# Perez-Reyes E, Van "
4696,"DB03452","BE0001914","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4697,"DB00454","BE0000770","# Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier MC, Deprez B: From hit to lead. Combining two complementary methods for focused library design. Application to mu opiate ligands. J Med Chem. 2001 Oct 11;44(21):3378-90. \"Pubmed\":http://ww"
4698,"DB02786","BE0001769","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4699,"DB05490","BE0000215",""
4700,"DB00973","BE0000802","# Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP: Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004 Feb 20;303(5661):1201-4. "
4701,"DB05814","BE0000695",""
4702,"DB01094","BE0000232","# Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW: Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res. 2001 May;42(5):725-34. \"Pubmed\":http://www.ncbi.nlm"
4703,"DB00155","BE0000067","# Kominami S, Yamazaki T, Koga T, Hori H: EPR studies on the photo-induced intermediates of ferric NO complexes of rat neuronal nitric oxide synthase trapped at low temperature. J Biochem (Tokyo). 1999 Oct;126(4):756-61. \"Pubmed\":http://www.ncbi.nlm.nih.g"
4704,"DB05010","BE0000217",""
4705,"DB00715","BE0000486","# Rubin RT: Paroxetine binding to the rat norepinephrine transporter in vivo. Biol Psychiatry. 2000 Nov 1;48(9):954-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11203183# Gilmor ML, Owens MJ, Nemeroff CB: Inhibition of norepinephrine uptake in patients "
4706,"DB02007","BE0001390","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4707,"DB00780","BE0000667","# Todd KG, Baker GB: Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. J Pharm Pharm Sci. 2008 May 16;11(2):14s-21s. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19203467# Tanay VA,"
4708,"DB02860","BE0001447","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4709,"DB01071","BE0000442","# Nakamura K, Yokoi T, Kodama T, Inoue K, Nagashima K, Shimada N, Shimizu T, Kamataki T: Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. J Pharmacol Exp Ther. 1998 Feb;284(2):437-42. \"Pubmed\""
4710,"DB01154","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4711,"DB02642","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4712,"DB02527","BE0004631","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4713,"DB01910","BE0002526",""
4714,"DB00674","BE0000738","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
4715,"DB02272","BE0000050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4716,"DB02263","BE0002717",""
4717,"DB05041","BE0002456",""
4718,"DB04272","BE0003254",""
4719,"DB04509","BE0002705",""
4720,"DB08019","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4721,"DB02191","BE0004000","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4722,"DB00387","BE0000405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4723,"DB01610","BE0004796","# Martin M, Azzi A, Lin SX, Boivin G: Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity. Antivir Ther. 2010;15(4):579-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20587851# Boivin G, Goyette"
4724,"DB04967","BE0000971","# Bases RE, Mendez F: Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1133-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9169823# Dassonneville L, Bailly C: Stimulation of topoisom"
4725,"DB00540","BE0004897","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Oct 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from: http://pdsp.med.unc.edu/pdsp.php# Brunton L, Chabner B, Knollman B. Goodman and Gilman?s The "
4726,"DB01200","BE0000575","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
4727,"DB00594","BE0000895","# Vakili J, Standker L, Detheux M, Vassart G, Forssmann WG, Parmentier M: Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active. J Immunol. 2001 Sep 15;167(6):3406-13. \"Pubmed\":http://www.ncbi.nlm.nih."
4728,"DB04365","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4729,"DB08314","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4730,"DB01222","BE0000794","# Zhang X, Moilanen E, Kankaanranta H: Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone. Eur J Pharmacol. 2000 Oct 20;406(3):325-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11040338# Henriksson G, Nor"
4731,"DB00282","BE0004801","# Jahnke W, Henry C: An in vitro assay to measure targeted drug delivery to bone mineral. ChemMedChem. 2010 May 3;5(5):770-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20209564"
4732,"DB07348","BE0003814","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4733,"DB02108","BE0000939","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4734,"DB01727","BE0004527","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4735,"DB03104","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4736,"DB02617","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4737,"DB07086","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4738,"DB00078","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4739,"DB04079","BE0001200","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4740,"DB04697","BE0000048",""
4741,"DB02379","BE0002844",""
4742,"DB04233","BE0001470","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4743,"DB02419","BE0001014","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4744,"DB00313","BE0000573","# Ito M, Ikeda Y, Arnez JG, Finocchiaro G, Tanaka K: The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase. Biochim Biophys Acta. 1990 May 16;1034("
4745,"DB00368","BE0000118","# Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E: Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci U S A. 1996 May 14;93(10):5166-71"
4746,"DB04416","BE0001116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4747,"DB01277","BE0003623","# Rosenbloom AL: Mecasermin (recombinant human insulin-like growth factor I). Adv Ther. 2009 Jan;26(1):40-54. Epub 2009 Jan 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19198769"
4748,"DB06802","BE0000017","# Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM: Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation. 2000 Aug;24(4):357-7"
4749,"DB02501","BE0001871","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4750,"DB01169","BE0001979","# Lu J, Chew EH, Holmgren A: Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12288-93. Epub 2007 Jul 18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17640917"
4751,"DB03304","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4752,"DB03058","BE0001840","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4753,"DB00543","BE0000533","# Glusa E, Pertz HH: Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors. Br J Pharmacol. 2000 Jun;130(3):692-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10821800/# National Institute of M"
4754,"DB01009","BE0000017","# Parsadaniantz SM, Lebeau A, Duval P, Grimaldi B, Terlain B, Kerdelhue B: Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat. J N"
4755,"DB07434","BE0003783","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4756,"DB01200","BE0000289","# de Leeuw van Weenen JE, Parlevliet ET, Maechler P, Havekes LM, Romijn JA, Ouwens DM, Pijl H, Guigas B: The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors i"
4757,"DB04272","BE0002077","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4758,"DB01186","BE0000342","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
4759,"DB00202","BE0000560","# Hou VY, Hirshman CA, Emala CW: Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. Anesthesiology. 1998 Mar;88(3):744-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9523819"
4760,"DB02453","BE0001885","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4761,"DB04566","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4762,"DB08387","BE0000631","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4763,"DB08231","BE0004243","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4764,"DB08218","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4765,"DB08604","BE0004347","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4766,"DB07328","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4767,"DB00139","BE0002206","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4768,"DB07918","BE0003962","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4769,"DB07712","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4770,"DB04147","BE0003971","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4771,"DB03271","BE0000005","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4772,"DB00935","BE0000572","# Uhlen S, Wikberg JE: Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound. Eur J Pharmacol. 1991 Sep 17;202(2):235-43. \"Pubmed\""
4773,"DB08552","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4774,"DB01221","BE0000632","# Smith DJ, Pekoe GM, Martin LL, Coalgate B: The interaction of ketamine with the opiate receptor. Life Sci. 1980 Mar 10;26(10):789-95. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6246318# Hustveit O, Maurset A, Oye I: Interaction of the chiral forms of k"
4775,"DB04272","BE0003267",""
4776,"DB04216","BE0004096","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4777,"DB03574","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4778,"DB07841","BE0003570","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4779,"DB04510","BE0001227","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4780,"DB02471","BE0004111","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4781,"DB00535","BE0003621","# Ochiai S, Sekiguchi S, Hayashi A, Shimadzu M, Ishiko H, Matsushima-Nishiwaki R, Kozawa O, Yasuda M, Deguchi T: Decreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae. J Antimicrob"
4782,"DB04036","BE0000397","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4783,"DB03389","BE0003070",""
4784,"DB01352","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
4785,"DB08809","BE0003862","# Stacpoole PW: The pharmacology of dichloroacetate. Metabolism. 1989 Nov;38(11):1124-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2554095"
4786,"DB07228","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4787,"DB04272","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4788,"DB07020","BE0003772","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4789,"DB08120","BE0001298","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4790,"DB00051","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4791,"DB01752","BE0002525",""
4792,"DB01303","BE0000924","# Pechlivanova DM, Georgiev VP: Effects of single and long-term theophylline treatment on the threshold of mechanical nociception: contribution of adenosine A1 and alpha2-adrenoceptors. Methods Find Exp Clin Pharmacol. 2005 Nov;27(9):659-64. \"Pubmed\":http"
4793,"DB04044","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4794,"DB03974","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4795,"DB00536","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4796,"DB00231","BE0000523","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
4797,"DB02140","BE0003970","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4798,"DB08286","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4799,"DB06144","BE0000090","# Rampe D, Murawsky MK, Grau J, Lewis EW: The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. J Pharmacol Exp Ther. 1998 Aug;286(2):788-93. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9694935# Kang"
4800,"DB08848","BE0004776","# Schousboe A, Thorbek P, Hertz L, Krogsgaard-Larsen P: Effects of GABA analogues of restricted conformation on GABA transport in astrocytes and brain cortex slices and on GABA receptor binding. J Neurochem. 1979 Jul;33(1):181-9. \"Pubmed\":http://www.ncbi."
4801,"DB05403","BE0002790",""
4802,"DB00097","BE0000387","# Jameson JL: Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol. 1996 Dec 20;125(1-2):143-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9027352# Lin W, Bernard MP, Cao D, Myers RV, Kerrigan JE, Moyle WR: Follitropin receptors contain "
4803,"DB02379","BE0002058","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4804,"DB04087","BE0004607","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4805,"DB00114","BE0000383","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4806,"DB06852","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4807,"DB00160","BE0000253","# Amadasi A, Bertoldi M, Contestabile R, Bettati S, Cellini B, di Salvo ML, Borri-Voltattorni C, Bossa F, Mozzarelli A: Pyridoxal 5'-phosphate enzymes as targets for therapeutic agents. Curr Med Chem. 2007;14(12):1291-324. \"Pubmed\":http://www.ncbi.nlm.nih"
4808,"DB00179","BE0000248","# Audouin C, Mestdagh N, Lassoie MA, Houssin R, Henichart JP: N-Aminoindoline derivatives as inhibitors of 5-lipoxygenase. Bioorg Med Chem Lett. 2001 Mar 26;11(6):845-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11277534# Lambert JD, Meyers RO, Timmerma"
4809,"DB08400","BE0002194","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4810,"DB01812","BE0001950","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4811,"DB01100","BE0000418","# Papadopoulos V, Brown AS, Hall PF: Calcium-calmodulin-dependent phosphorylation of cytoskeletal proteins from adrenal cells. Mol Cell Endocrinol. 1990 Dec 3;74(2):109-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1965307# Wang XB, Sato N, Greer MA, Gr"
4812,"DB00473","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4813,"DB01278","BE0000859","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4814,"DB00298","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4815,"DB01791","BE0000487","# Beeh KM, Beier J, Lerch C, Schulz AK, Buhl R: Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Lung. 2004;182(6):369-77. \"Pubmed\":http://www.ncbi.nlm.nih"
4816,"DB03401","BE0004452","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4817,"DB04842","BE0000679","# Kenny BA, Fraser S, Kilpatrick AT, Spedding M: Selective antagonism of calcium channel activators by fluspirilene. Br J Pharmacol. 1990 Jun;100(2):211-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1696149# Wang SJ: Inhibition of glutamate release by fl"
4818,"DB00320","BE0000659","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Lesage AS, Wouters R, Van Gompel P, Heylen L, Vanhoenacker P, Haegeman G, Luyten WH, Leysen JE: Ag"
4819,"DB03909","BE0001247","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4820,"DB01812","BE0001264","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4821,"DB00114","BE0000721","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4822,"DB07440","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4823,"DB01238","BE0000389","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
4824,"DB00814","BE0000017","# Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F: Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol. 1999 Jun;26(6):1366-73. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10381057# Panara MR, Rend"
4825,"DB02467","BE0002746",""
4826,"DB01611","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4827,"DB00408","BE0000572","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
4828,"DB04325","BE0001222","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4829,"DB08397","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4830,"DB00114","BE0002162","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4831,"DB00548","BE0000498","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4832,"DB04325","BE0004529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4833,"DB00104","BE0003528","# Yim CB, Boerman OC, de Visser M, de Jong M, Dechesne AC, Rijkers DT, Liskamp RM: Versatile conjugation of octreotide to dendrimers by cycloaddition (\"click\") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers. Bioconjug Chem. 2009 Ju"
4834,"DB00636","BE0000071","# Barclay TB, Peters JM, Sewer MB, Ferrari L, Gonzalez FJ, Morgan ET: Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent. J Pharmacol Exp Ther. 1999 Sep;290("
4835,"DB00690","BE0000795","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
4836,"DB00509","BE0000315","# Bernal J: Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):249-59. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17315033# Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A: Thyroid hormone recepto"
4837,"DB01094","BE0000105","# Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW: Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res. 2001 May;42(5):725-34. \"Pubmed\":http://www.ncbi.nlm"
4838,"DB04410","BE0004529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4839,"DB00313","BE0000152","# Johannessen CU, Johannessen SI: Valproate: past, present, and future. CNS Drug Rev. 2003 Summer;9(2):199-216. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12847559"
4840,"DB00647","BE0000632","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Neil A: Affinities of some common opioid analgesics towards four binding sites in mouse brain. Nau"
4841,"DB02065","BE0002699",""
4842,"DB05510","BE0000426",""
4843,"DB00157","BE0000427","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4844,"DB00568","BE0000430","# Singh BN: The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol. 1986;21 Suppl 2:109S-121S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3530295# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca c"
4845,"DB04241","BE0001506","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4846,"DB00604","BE0000084","# Crema F, Modini C, Croci T, Langlois M, de Ponti F: Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo. J Pharmacol Exp Ther. 1999 "
4847,"DB00334","BE0000020","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-bindin"
4848,"DB02930","BE0001547","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4849,"DB00143","BE0000185","# Herrera K, Cahoon RE, Kumaran S, Jez J: Reaction mechanism of glutathione synthetase from Arabidopsis thaliana: site-directed mutagenesis of active site residues. J Biol Chem. 2007 Jun 8;282(23):17157-65. Epub 2007 Apr 22. \"Pubmed\":http://www.ncbi.nlm.n"
4850,"DB00111","BE0000658","# Shamsi TS, Irfan M, Farzana T, Ansari SH, Ahmad G, Shakoor N, Baig MI: Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamo"
4851,"DB00627","BE0000635","# Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, Ignar DM, Murdock PR, Steplewski K, Green A, Brown AJ, Dowell SJ, Szekeres PG, Hassall DG, Marshall FH, Wilson S, Pike NB: Molecular identification of high and low affinity receptors for n"
4852,"DB04946","BE0000020","# Bobo WV: Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Expert Rev Clin Pharmacol. 2013 Jan;6(1):61-91. doi: 10.1586/ecp.12.70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
4853,"DB00365","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4854,"DB00915","BE0000641","# Blanpied TA, Clarke RJ, Johnson JW: Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci. 2005 Mar 30;25(13):3312-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15800186# Hesselink MB, De Boer AG, Breimer "
4855,"DB00028","BE0002099","# Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110"
4856,"DB00891","BE0000120","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4857,"DB00458","BE0004889","# Toll L, Berzetei-Gurske IP, Polgar WE, Brandt SR, Adapa ID, Rodriguez L, Schwartz RW, Haggart D, O'Brien A, White A, Kennedy JM, Craymer K, Farrington L, Auh JS: Standard binding and functional assays related to medications development division testing "
4858,"DB00849","BE0000523","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
4859,"DB00778","BE0001032","# Beltinger J, Haschke M, Kaufmann P, Michot M, Terracciano L, Krahenbuhl S: Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin. Ann Pharmacother. 2006 Apr;40(4):767-70. Epub 2006 Mar 7. \"Pubmed\":htt"
4860,"DB00143","BE0000814","# Ramachandran K, Navarro L, Gordian E, Das PM, Singal R: Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells. Anticancer Res. 2007 Mar-Apr;27(2):921-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17465221"
4861,"DB07142","BE0003735","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4862,"DB00408","BE0000945","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
4863,"DB00095","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4864,"DB00202","BE0000411","# Jonsson M, Dabrowski M, Gurley DA, Larsson O, Johnson EC, Fredholm BB, Eriksson LI: Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. 2006 Apr;104(4):724-33. \"Pubmed\":http://ww"
4865,"DB03963","BE0001618","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4866,"DB00454","BE0000632","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4867,"DB00975","BE0001133","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
4868,"DB00650","BE0000324","# Aschele C, Debernardis D, Bandelloni R, Cascinu S, Catalano V, Giordani P, Barni S, Turci D, Drudi G, Lonardi S, Gallo L, Maley F, Monfardini S: Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leu"
4869,"DB00144","BE0001001","# Bettache N, Baisamy L, Baghdiguian S, Payrastre B, Mangeat P, Bienvenue A: Mechanical constraint imposed on plasma membrane through transverse phospholipid imbalance induces reversible actin polymerization via phosphoinositide 3-kinase activation. J Cel"
4870,"DB02614","BE0001568","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4871,"DB00837","BE0000217","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Agmo A, Belzung C: Interactions between dopamine and GABA in the control of ambulatory activity an"
4872,"DB01100","BE0000581","# Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G: Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther. 1994 Jan;268(1):417-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
4873,"DB00408","BE0000560","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
4874,"DB03317","BE0002886",""
4875,"DB08329","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4876,"DB01039","BE0000071","# Clavey V, Copin C, Mariotte MC, Bauge E, Chinetti G, Fruchart J, Fruchart JC, Dallongeville J, Staels B: Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells. Cell Physiol Biochem. 1999"
4877,"DB05802","BE0000590",""
4878,"DB00321","BE0000560","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
4879,"DB01268","BE0000023","# Roskoski R Jr: Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun. 2007 May 4;356(2):323-8. Epub 2007 Mar 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17367763# Deprimo SE, Bello CL, Smeraglia J, "
4880,"DB04174","BE0001291","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4881,"DB00934","BE0000442","# Noguchi S, Inukai T, Kuno T, Tanaka C: The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking. Physiol Behav. 1992 Jun;51(6):1123-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1"
4882,"DB03247","BE0003034",""
4883,"DB02477","BE0001502","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4884,"DB07741","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4885,"DB08477","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4886,"DB03733","BE0001234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4887,"DB02303","BE0000960","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4888,"DB01607","BE0003577","# Chambers HF, Sachdeva M, Kennedy S: Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus. J Infect Dis. 1990 Sep;162(3):705-10. \"Pubmed\":http:/"
4889,"DB01016","BE0002218","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
4890,"DB08330","BE0003859","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4891,"DB03651","BE0002499",""
4892,"DB00560","BE0003708","# Olson MW, Ruzin A, Feyfant E, Rush TS 3rd, O'Connell J, Bradford PA: Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother. 2006 Jun;50(6):2156-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
4893,"DB05212","BE0002387",""
4894,"DB00598","BE0004863","# Bernstein JS, Ebert TJ, Stowe DF, Schmeling WT, Nelson MA, Woods MP: Partial attenuation of hemodynamic responses to rapid sequence induction and intubation with labetalol. J Clin Anesth. 1989;1(6):444-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/269"
4895,"DB07914","BE0004125","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4896,"DB00142","BE0000828","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4897,"DB01589","BE0003593","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
4898,"DB05266","BE0001287","# Huang Z, Liu S, Zhang L, Salem M, Greig GM, Chan CC, Natsumeda Y, Noguchi K: Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life Sci. 2006 May 1;78(23):2663-8. Epub 2005 Nov 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16313925"
4899,"DB01414","BE0000488","# Truesdell SE, Zurenko GE, Laborde AL: Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1989 Apr;23 Suppl D:13-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2722720# Y"
4900,"DB04447","BE0003164",""
4901,"DB04676","BE0004610","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4902,"DB01351","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
4903,"DB04124","BE0001735","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4904,"DB01398","BE0000017","# Moon C, Ahn M, Jee Y, Heo S, Kim S, Kim H, Sim KB, Koh CS, Shin YG, Shin T: Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclo"
4905,"DB00909","BE0000322","# De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19703035# Supuran CT, Di Fiore A, De S"
4906,"DB00909","BE0001653","# De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19703035# Supuran CT, Di Fiore A, De S"
4907,"DB04315","BE0004448","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4908,"DB01594","BE0003593","# Walash MI, Belal F, Metwally ME, Hefnawy MM: A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
4909,"DB01186","BE0000572","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
4910,"DB03403","BE0001522","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4911,"DB00491","BE0004698","# Fukaya N, Mochizuki K, Tanaka Y, Kumazawa T, Jiuxin Z, Fuchigami M, Goda T: The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. Eur J Pharmacol. 2009 Dec"
4912,"DB05797","BE0000015",""
4913,"DB04626","BE0004799","# Woodcock J, Moazed D, Cannon M, Davies J, Noller HF: Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J. 1991 Oct;10(10):3099-103. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1915283# Kondo J, Francois B, Urzhumtse"
4914,"DB01054","BE0000430","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Striessnig, J. (2004). Ca ^2+^ channel blockers. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclo"
4915,"DB00930","BE0004809","# Levy P, Jellinger PS: The potential role of colesevelam in the management of prediabetes and type 2 diabetes mellitus. Postgrad Med. 2010 May;122(3Suppl):1-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20581432# Staels B: A review of bile acid sequestr"
4916,"DB03189","BE0003751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4917,"DB01138","BE0001069","# Bakos E, Evers R, Sinko E, Varadi A, Borst P, Sarkadi B: Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol. 2000 Apr;57(4):760-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10727523# Evers R, de Ha"
4918,"DB01202","BE0002226","# De Smedt T, Raedt R, Vonck K, Boon P: Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data. CNS Drug Rev. 2007 Spring;13(1):43-56. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17461889# Lukyanetz EA, Shkryl VM, Kostyuk PG: S"
4919,"DB03148","BE0002669",""
4920,"DB00321","BE0000650","# Lucchelli A, Santagostino-Barbone MG, D'Agostino G, Masoero E, Tonini M: The interaction of antidepressant drugs with enteric 5-HT7 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):284-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/109977"
4921,"DB07341","BE0000214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4922,"DB08185","BE0004205","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4923,"DB00157","BE0000425","# Semenza GL: Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J. 2007 Jul 1;405(1):1-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17555402# Draghia AC: Histochemical and histopathological study of the gast"
4924,"DB04530","BE0003324",""
4925,"DB07910","BE0000787","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4926,"DB00988","BE0000749","# Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS: Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001 Jan;39(1):32-41. \"Pubmed\":htt"
4927,"DB06928","BE0000568","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4928,"DB08147","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4929,"DB08910","BE0000704","# Gertz MA: Pomalidomide and myeloma meningitis. Leuk Lymphoma. 2013 Apr;54(4):681-2. doi: 10.3109/10428194.2012.723708. Epub 2013 Jan 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/22917017"
4930,"DB01244","BE0000418","# Lamers JM, Cysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. Biochem Pharmacol. 1985 Nov 1;34(21):3837-43. \"Pubmed\":http://www.n"
4931,"DB07934","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4932,"DB07499","BE0003967","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4933,"DB01656","BE0000487","# Barone FC, Barton ME, White RF, Legos JJ, Kikkawa H, Shimamura M, Kuratani K, Kinoshita M: Inhibition of Phosphodiesterase Type 4 Decreases Stress-Induced Defecation in Rats and Mice. Pharmacology. 2007 Aug 28;81(1):11-17. \"Pubmed\":http://www.ncbi.nlm.n"
4934,"DB01942","BE0002651",""
4935,"DB00456","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4936,"DB01992","BE0002685",""
4937,"DB02653","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4938,"DB02822","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4939,"DB01410","BE0000794","# Barnes NC: The properties of inhaled corticosteroids: similarities and differences. Prim Care Respir J. 2007 Jun;16(3):149-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17530144"
4940,"DB06890","BE0001730","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4941,"DB00368","BE0000172","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Mersmann HJ: Overview of the effects of beta-adrenergic receptor agonists on animal growth includi"
4942,"DB00734","BE0000342","# Fenton C, Scott LJ: Risperidone: a review of its use in the treatment of bipolar mania. CNS Drugs. 2005;19(5):429-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15907153# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors fo"
4943,"DB05188","BE0001007",""
4944,"DB07795","BE0002212","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4945,"DB05289","BE0002394",""
4946,"DB01972","BE0002351","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4947,"DB03070","BE0000722","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4948,"DB02457","BE0003620","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4949,"DB00543","BE0000501","# Wei HB, Niu XY: [Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration] Yao Xue Xue Bao. 1990;25(12):881-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/196"
4950,"DB04315","BE0001190","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4951,"DB07778","BE0003854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4952,"DB00588","BE0000557","# Issar M, Sahasranaman S, Buchwald P, Hochhaus G: Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. Eur Respir J. 2006 Mar;27(3):511-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16507850# Austin RJ, Masc"
4953,"DB00933","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weine"
4954,"DB03008","BE0003505","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4955,"DB07748","BE0004066","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4956,"DB00892","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4957,"DB03461","BE0000126","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4958,"DB00916","BE0004435","# Sisson G, Jeong JY, Goodwin A, Bryden L, Rossler N, Lim-Morrison S, Raudonikiene A, Berg DE, Hoffman PS: Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA"
4959,"DB00458","BE0000486","# Mitchell HA, Ahern TH, Liles LC, Javors MA, Weinshenker D: The effects of norepinephrine transporter inactivation on locomotor activity in mice. Biol Psychiatry. 2006 Nov 15;60(10):1046-52. Epub 2006 Aug 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16"
4960,"DB01388","BE0000012","# Massie BM: Mibefradil: a selective T-type calcium antagonist. Am J Cardiol. 1997 Nov 6;80(9A):23I-32I. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9375939# Clozel JP, Ertel EA, Ertel SI: Discovery and main pharmacological properties of mibefradil (Ro 40"
4961,"DB00219","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4962,"DB03855","BE0001250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4963,"DB03374","BE0004371","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4964,"DB00669","BE0000659","# Koran LM, Pallanti S, Quercioli L: Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder. Eur Neuropsychopharmacol. 2001 Apr;11(2):169-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11313163# Baxter LR Jr: Brain mediation of Anolis social d"
4965,"DB05171","BE0003409",""
4966,"DB04147","BE0004184","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4967,"DB04216","BE0004327","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4968,"DB00334","BE0000533","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Zhang JY, Kowal DM, Nawoschik SP, Lou Z, Dunlop J: Distinct functional profiles of aripiprazole an"
4969,"DB00174","BE0000219","# Tesson AR, Soper TS, Ciustea M, Richards NG: Revisiting the steady state kinetic mechanism of glutamine-dependent asparagine synthetase from Escherichia coli. Arch Biochem Biophys. 2003 May 1;413(1):23-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/127"
4970,"DB01355","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
4971,"DB05219","BE0002353",""
4972,"DB02945","BE0001416","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4973,"DB01618","BE0000092","# Neeper R, Richelson E, Nelson A: Neuroleptic binding to muscarinic M2 receptors of normal human heart in vitro and comparison with binding to M1 and dopamine D2 receptors of brain. Neuropharmacology. 1991 May;30(5):527-9. \"Pubmed\":http://www.ncbi.nlm.ni"
4974,"DB06064","BE0003431",""
4975,"DB04395","BE0001065","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4976,"DB08689","BE0003850","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4977,"DB00413","BE0000020","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
4978,"DB00142","BE0002240","# Re DB, Nafia I, Melon C, Shimamoto K, Kerkerian-Le Goff L, Had-Aissouni L: Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transpo"
4979,"DB06993","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4980,"DB04716","BE0004146","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4981,"DB07608","BE0004012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4982,"DB08633","BE0001534","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
4983,"DB00675","BE0004895","# O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res. 1985 Jun;45(6):2462-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3157445"
4984,"DB04562","BE0004504","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4985,"DB00408","BE0000486","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
4986,"DB00202","BE0000045","# Hou VY, Hirshman CA, Emala CW: Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. Anesthesiology. 1998 Mar;88(3):744-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9523819# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Databas"
4987,"DB01708","BE0000123","# Chen F, Knecht K, Birzin E, Fisher J, Wilkinson H, Mojena M, Moreno CT, Schmidt A, Harada S, Freedman LP, Reszka AA: Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology. 2005 Nov;146(11):4568-76. Epub 2005 Jun 30. \"Pubmed\":http:"
4988,"DB00098","BE0003575","# Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003 Feb;3(2):189-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12586600"
4989,"DB00629","BE0000289","# Piletz JE, Sletten K: Nonadrenergic imidazoline binding sites on human platelets. J Pharmacol Exp Ther. 1993 Dec;267(3):1493-502. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8263811# Bockman CS, Jeffries WB, Abel PW: Binding and functional characterizat"
4990,"DB03696","BE0001466","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4991,"DB00714","BE0000393","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
4992,"DB03942","BE0001659","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4993,"DB00585","BE0000112","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Enriz RD, Jauregui EA: [Theoretical conformation study of tiotidine and nizatidine, two strong his"
4994,"DB00668","BE0000715","# Cotecchia S: The alpha1-adrenergic receptors: diversity of signaling networks and regulation. J Recept Signal Transduct Res. 2010 Dec;30(6):410-9. Epub 2010 Oct 18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20954794# Shieh JP, Chu CC, Wang JJ, Lin MT:"
4995,"DB00457","BE0000699","# Thomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Sc"
4996,"DB00294","BE0000123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
4997,"DB00738","BE0002517","# Sun T, Zhang Y: Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation. Nucleic Acids Res. 2008 Mar;36(5):1654-64. Epub 2008 Feb 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18263620"
4998,"DB00268","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# de Mey C, Enterling D, Meineke I, Yeulet S: Interactions between domperidone and ropinirole, a nov"
4999,"DB07428","BE0000629","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5000,"DB04135","BE0001862","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5001,"DB00128","BE0002229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5002,"DB04725","BE0000248","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Vidal C, Gomez-Hernandez A, Sanchez-Galan E, Gonzalez A, Ortega L, Gomez-Gerique JA, Tunon J, Egid"
5003,"DB02884","BE0002842",""
5004,"DB06741","BE0004852","# Warach S, Kaufman D, Chiu D, Devlin T, Luby M, Rashid A, Clayton L, Kaste M, Lees KR, Sacco R, Fisher M: Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Subst"
5005,"DB03447","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5006,"DB02342","BE0002374","# Zhou D, Matchett GA, Jadhav V, Dach N, Zhang JH: The effect of 2-methoxyestradiol, a HIF-1alpha inhibitor, in global cerebral ischemia in rats. Neurol Res. 2007 Aug 22;. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17716391# Dai Y, Xu M, Wang Y, Pasha Z,"
5007,"DB08217","BE0004223","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5008,"DB00497","BE0000770","# Ordonez Gallego A, Gonzalez Baron M, Espinosa Arranz E: Oxycodone: a pharmacological and clinical review. Clin Transl Oncol. 2007 May;9(5):298-307. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17525040# Riley J, Eisenberg E, Muller-Schwefe G, Drewes AM, "
5009,"DB00777","BE0000405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5010,"DB08562","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5011,"DB00683","BE0003599","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5012,"DB08113","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5013,"DB04477","BE0000720","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5014,"DB05528","BE0004845","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# FDA label."
5015,"DB04315","BE0001864","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5016,"DB00715","BE0000405","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
5017,"DB02507","BE0002793","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5018,"DB02197","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5019,"DB01159","BE0003583","# Lazarenko RM, Willcox SC, Shu S, Berg AP, Jevtovic-Todorovic V, Talley EM, Chen X, Bayliss DA: Motoneuronal TASK channels contribute to immobilizing effects of inhalational general anesthetics. J Neurosci. 2010 Jun 2;30(22):7691-704. \"Pubmed\":http://www"
5020,"DB00172","BE0002253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5021,"DB07877","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5022,"DB00842","BE0003598","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5023,"DB04887","BE0004854","# Hazen R, Harvey R, Ferris R, Craig C, Yates P, Griffin P, Miller J, Kaldor I, Ray J, Samano V, Furfine E, Spaltenstein A, Hale M, Tung R, St Clair M, Hanlon M, Boone L: In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus"
5024,"DB04573","BE0000123","# Sasson S: Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor. Pathol Biol (Paris). 1991 Jan;39(1):59-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2011412# Chen X, Ji ZL, Chen YZ: TTD"
5025,"DB01632","BE0002488",""
5026,"DB01454","BE0000533","# Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA: Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neurosci Lett. 1994 Aug 15;177(1-2):111-5. \"Pubmed\":htt"
5027,"DB01819","BE0000906","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5028,"DB07543","BE0000694","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5029,"DB03661","BE0003140",""
5030,"DB00321","BE0004872","# Werling LL, Keller A, Frank JG, Nuwayhid SJ: A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder. Exp Neurol. 2007 Oct;207(2):248-57. Epub 2007 Jun 30."
5031,"DB08371","BE0000230","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5032,"DB00333","BE0000641","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5033,"DB05079","BE0000442",""
5034,"DB00975","BE0000182","# Kulkarni SK, Patil CS: Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol. 2004 Dec;26(10):789-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15672122# Santini F, Casali G"
5035,"DB06865","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5036,"DB02963","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5037,"DB02671","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5038,"DB04522","BE0003761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5039,"DB00216","BE0000460","# Napier C, Stewart M, Melrose H, Hopkins B, McHarg A, Wallis R: Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Eur J Pharmacol. 1999 Mar 5;368(2-3):259-68. "
5040,"DB08273","BE0004265","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5041,"DB07854","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5042,"DB02998","BE0000557","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5043,"DB08398","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5044,"DB04315","BE0001735","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5045,"DB03141","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5046,"DB00014","BE0000134","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5047,"DB04698","BE0001743","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5048,"DB08218","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5049,"DB02498","BE0001717","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5050,"DB01871","BE0001292","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5051,"DB07844","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5052,"DB02590","BE0001295","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5053,"DB00142","BE0000417","# Verkhratsky A, Kirchhoff F: NMDA Receptors in glia. Neuroscientist. 2007 Feb;13(1):28-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17229973# Miglio G, Dianzani C, Fallarini S, Fantozzi R, Lombardi G: Stimulation of N-methyl-D-aspartate receptors modu"
5054,"DB00173","BE0000702","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5055,"DB01038","BE0000145","# Vinar O, Formankova M, Taussigova D, Ruzicka S: Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial. Act Nerv Super (Praha). 1967 Nov;9(4):353-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/4889058# Bora G: Comparison of "
5056,"DB05764","BE0003421",""
5057,"DB07207","BE0001178","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5058,"DB03335","BE0001234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5059,"DB00589","BE0000291","# Kimura K, Akai T, Nakamura K, Yamaguchi M, Nakagawa H, Oshino N: Dual activation by lisuride of central serotonin 5-HT(1A) and dopamine D(2) receptor sites: drug discrimination and receptor binding studies. Behav Pharmacol. 1991 Apr;2(2):105-112. \"Pubme"
5060,"DB03951","BE0001567","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5061,"DB08900","BE0002134","# Burness CB, McCormack PL: Teduglutide: A Review of its Use in the Treatment of Patients with Short Bowel Syndrome. Drugs. 2013 Jun 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23729002"
5062,"DB08453","BE0003856","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5063,"DB00327","BE0000632","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5064,"DB07256","BE0002453","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5065,"DB04272","BE0001524","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5066,"DB03299","BE0002494","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5067,"DB00193","BE0000641","# Hara K, Minami K, Sata T: The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth Analg. 2005 May;100(5):1400-5, table of contents. \"Pubmed\":http://www.ncbi"
5068,"DB04898","BE0000048","# Testa L, Bhindi R, Agostoni P, Abbate A, Zoccai GG, van Gaal WJ: The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile. Expert Opin Drug Saf. 2007 Jul"
5069,"DB08654","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5070,"DB02433","BE0001394","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5071,"DB00211","BE0000715","# Altenbach RJ, Khilevich A, Meyer MD, Buckner SA, Milicic I, Daza AV, Brune ME, O'Neill AB, Gauvin DM, Cain JC, Nakane M, Holladay MW, Williams M, Brioni JD, Sullivan JP: N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alph"
5072,"DB08212","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5073,"DB05020","BE0002424",""
5074,"DB00934","BE0004864","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881"
5075,"DB03800","BE0001409","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5076,"DB06148","BE0000749","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821"
5077,"DB07671","BE0003342","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5078,"DB03147","BE0001550","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5079,"DB00039","BE0001031","# Berman B, Ostrovsky O, Shlissel M, Lang T, Regan D, Vlodavsky I, Ishai-Michaeli R, Ron D: Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor"
5080,"DB03461","BE0001467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5081,"DB00174","BE0000285","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5082,"DB01186","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Fuller RW, Hemrick-Luecke SK, Perry KW, Toomey RE: Pergolide elevation of MHPG sulphate concentrat"
5083,"DB01558","BE0003594","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
5084,"DB02638","BE0000165","# Hiroyama M, Wang S, Aoyagi T, Oikawa R, Sanbe A, Takeo S, Tanoue A: Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Eur J Pharmacol. 2007 Mar 22;559(2-3):89-97. Epub 2006 Dec 29. \"Pubmed\":http://www.ncbi"
5085,"DB01625","BE0000045","# Eglen RM, Whiting RL: Competitive and non-competitive antagonism exhibited by 'selective' antagonists at atrial and ileal muscarinic receptor subtypes. Br J Pharmacol. 1987 Apr;90(4):701-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3580704# Lane MA: M"
5086,"DB02077","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5087,"DB07390","BE0001116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5088,"DB01355","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
5089,"DB07375","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5090,"DB00715","BE0000092","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
5091,"DB08271","BE0003696","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5092,"DB00835","BE0000045","# Yasuda SU, Yasuda RP: Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes. Pharmacotherapy. 1999 Apr;19(4):447-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10212017"
5093,"DB06589","BE0000852","# Sonpavde G, Hutson TE: Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Curr Oncol Rep. 2007 Mar;9(2):115-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17288876"
5094,"DB00157","BE0000006","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5095,"DB04355","BE0001901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5096,"DB03952","BE0002011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5097,"DB06148","BE0000146","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
5098,"DB04367","BE0001824","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5099,"DB07612","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5100,"DB08056","BE0000842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5101,"DB02123","BE0001999","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5102,"DB01062","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5103,"DB05238","BE0000634",""
5104,"DB03639","BE0001149","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5105,"DB02379","BE0003249",""
5106,"DB00145","BE0002306","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5107,"DB03900","BE0001308","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5108,"DB00231","BE0000764","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
5109,"DB02791","BE0001884","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5110,"DB04405","BE0001198","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5111,"DB00048","BE0000025","# Egeblad M, Shen HC, Behonick DJ, Wilmes L, Eichten A, Korets LV, Kheradmand F, Werb Z, Coussens LM: Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development. Dev Dyn. 2007 Jun;236(6):1683-93. \"Pubmed\":http://www"
5112,"DB03382","BE0001513","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5113,"DB03397","BE0004519","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5114,"DB06842","BE0001133","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5115,"DB01133","BE0003569","# David P, Nguyen H, Barbier A, Baron R: The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Miner Res. 1996 Oct;11(10):1498-507. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8889850"
5116,"DB08215","BE0003952","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5117,"DB02893","BE0002843",""
5118,"DB08520","BE0000695","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5119,"DB00696","BE0000797","# Villalon CM, De Vries P, Rabelo G, Centurion D, Sanchez-Lopez A, Saxena P: Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors. Br J Pharmacol. 1999 Feb;126(3):"
5120,"DB03799","BE0001537","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5121,"DB03010","BE0001367","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5122,"DB04794","BE0000233","# Carrillo-Munoz AJ, Giusiano G, Ezkurra PA, Quindos G: Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter. 2006 Jun;19(2):130-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16964330# Rossello A, Bertini S, Lapucci A, Macchia M, Martinell"
5123,"DB02395","BE0001184","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5124,"DB01279","BE0004819","# Tifft C, Proud V, Levy P, DeMarco K, Nicely H, Turbeville S: Enzyme replacement therapy in the home setting for mucopolysaccharidosis VI: a survey of patient characteristics and physicians' early findings in the United States. J Infus Nurs. 2009 Jan-Feb"
5125,"DB04249","BE0001009","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5126,"DB08235","BE0004253","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5127,"DB03000","BE0001403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5128,"DB04298","BE0001478","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5129,"DB05470","BE0000918",""
5130,"DB04946","BE0000442","# Bobo WV: Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Expert Rev Clin Pharmacol. 2013 Jan;6(1):61-91. doi: 10.1586/ecp.12.70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
5131,"DB02876","BE0001430","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5132,"DB05829","BE0004703","# Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F: Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution. J Biol Chem. 2000 Sep 1;275(35):27238-44. \"Pubmed\":http://www.ncbi.nlm.ni"
5133,"DB00108","BE0001085","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5134,"DB00514","BE0004896","# Chou YC, Liao JF, Chang WY, Lin MF, Chen CF: Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res. 1999 Mar 13;821(2):516-9. \"Pubmed\":http://www.ncbi.nl"
5135,"DB08907","BE0004754","# Lamos EM, Younk LM, Davis SN: Canagliflozin , an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus. Expert Opin Drug Metab Toxicol. 2013 Jun;9(6):763-75. doi: 10.1517/17425255.2013.791282. Epub 2013 Apr 17. \"Pubm"
5136,"DB08157","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5137,"DB01717","BE0001244","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5138,"DB02544","BE0001553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5139,"DB04272","BE0002611",""
5140,"DB08742","BE0000779","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5141,"DB08561","BE0000966","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5142,"DB07217","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5143,"DB02154","BE0003881","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5144,"DB01355","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
5145,"DB00871","BE0000694","# Schafers RF, Piest U, von Birgelen C, Jakubetz J, Daul AE, Philipp T, Brodde OE: Disodium cromoglycate does not prevent terbutaline-induced desensitization of beta 2-adrenoceptor-mediated cardiovascular in vivo functions in human volunteers. J Cardiovas"
5146,"DB04892","BE0000426","# Greig NH, Ruckle J, Comer P, Brownell L, Holloway HW, Flanagan DR Jr, Canfield CJ, Burford RG: Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects. Curr Alzheimer Res. 2005 Oct;2(4):483-92. \"Pubmed\":http://www."
5147,"DB01694","BE0002502",""
5148,"DB00945","BE0000262","# Brzozowski T, Konturek PC, Sliwowski Z, Kwiecien S, Drozdowicz D, Pawlik M, Mach K, Konturek SJ, Pawlik WW: Interaction of nonsteroidal anti - inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. J Physi"
5149,"DB07907","BE0003028","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5150,"DB00144","BE0000673","# Wu WI, Voelker DR: Reconstitution of phosphatidylserine transport from chemically defined donor membranes to phosphatidylserine decarboxylase 2 implicates specific lipid domains in the process. J Biol Chem. 2004 Feb 20;279(8):6635-42. Epub 2003 Dec 4. \""
5151,"DB01044","BE0003727","# Harding I, Simpson I: Fluoroquinolones: is there a different mechanism of action and resistance against Streptococcus pneumoniae? J Chemother. 2000 Oct;12 Suppl 4:7-15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11131958# Rafii F, Park M, Novak JS: Alt"
5152,"DB04178","BE0001112","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5153,"DB08915","BE0000071","# Cavender MA, Lincoff AM: Therapeutic potential of aleglitazar, a new dual PPAR-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. Am J Cardiovasc Drugs. 2010;10(4):209-16. doi: 10.2165/11539500-000000000-000"
5154,"DB00120","BE0000753","# Thorolfsson M, Ibarra-Molero B, Fojan P, Petersen SB, Sanchez-Ruiz JM, Martinez A: L-phenylalanine binding and domain organization in human phenylalanine hydroxylase: a differential scanning calorimetry study. Biochemistry. 2002 Jun 18;41(24):7573-85. \""
5155,"DB04992","BE0004796",""
5156,"DB00572","BE0000045","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Overington JP, Al-Lazikani"
5157,"DB03745","BE0001253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5158,"DB01873","BE0001340","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5159,"DB08231","BE0000695","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5160,"DB00072","BE0000901","# Bowles JA, Weiner GJ: CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells. J Immunol Methods. 2005 Sep;304(1-2):88-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16109421# Shahied LS, Tang Y, Alpaugh RK, Somer R, Gre"
5161,"DB05492","BE0002378",""
5162,"DB01388","BE0002357","# Mocanu MM, Gadgil S, Yellon DM, Baxter GF: Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism. Cardiovasc Drugs Ther. 1999 Apr;13(2):115-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
5163,"DB07581","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5164,"DB00450","BE0000501","# Zupko I, Janossy K, Maul K, Marki A, Falkay G: Alpha-adrenergic blockade: a possible mechanism of tocolytic action of certain benzodiazepines in a postpartum rat model in vivo. Life Sci. 2003 Jan 24;72(10):1093-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
5165,"DB08513","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5166,"DB08263","BE0002503","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5167,"DB06637","BE0004719","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
5168,"DB07946","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5169,"DB04572","BE0004796","# Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, Aplenc R, Vaughan WP, Tallman MS, Rebbeck TR, DeMichele A: Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective "
5170,"DB05688","BE0000749",""
5171,"DB00157","BE0000512","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5172,"DB01018","BE0000572","# Uhlen S, Wikberg JE: Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound. Eur J Pharmacol. 1991 Sep 17;202(2):235-43. \"Pubmed\""
5173,"DB08558","BE0002505","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5174,"DB02626","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5175,"DB02733","BE0004323","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5176,"DB03435","BE0000214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5177,"DB08194","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5178,"DB01956","BE0001384","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5179,"DB01103","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5180,"DB01576","BE0000575","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5181,"DB01166","BE0000436","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Hong KW, Lee JH, Kima KY, Park SY, Lee WS: Cilostazol: therapeutic potential against focal cerebra"
5182,"DB05260","BE0003813","# Bockman R: The effects of gallium nitrate on bone resorption. Semin Oncol. 2003 Apr;30(2 Suppl 5):5-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12776254# Mattsson JP, Skyman C, Palokangas H, Vaananen KH, Keeling DJ: Characterization and cellular dis"
5183,"DB01752","BE0000865","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5184,"DB02171","BE0001626","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5185,"DB07426","BE0003350","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5186,"DB02959","BE0001830","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5187,"DB03866","BE0000262","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5188,"DB06096","BE0000659",""
5189,"DB01942","BE0002647",""
5190,"DB00035","BE0000293","# Del Tredici AL, Vanover KE, Knapp AE, Bertozzi SM, Nash NR, Burstein ES, Lameh J, Currier EA, Davis RE, Brann MR, Mohell N, Olsson R, Piu F: Identification of novel selective V2 receptor non-peptide agonists. Biochem Pharmacol. 2008 Oct 30;76(9):1134-41"
5191,"DB08081","BE0004160","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5192,"DB02315","BE0003425","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5193,"DB08183","BE0004145","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5194,"DB00119","BE0000178","# Bonen A, Heynen M, Hatta H: Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle. Appl Physiol Nutr Metab. 2006 Feb;31(1):31-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16604139"
5195,"DB01050","BE0001195","# Devor DC, Schultz BD: Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion. J Clin Invest. 1998 Aug 15;102(4):679-87. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9710435"
5196,"DB00812","BE0000117","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5197,"DB04908","BE0000451","# Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S: Pharmacology of flibanserin. CNS Drug Rev. 2002 Summer;8(2):117-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12177684# Invernizzi RW, Sacchetti G, Parini S, Acconcia S, Samanin R: Fliba"
5198,"DB01973","BE0001331","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5199,"DB00295","BE0000632","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5200,"DB02195","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5201,"DB00334","BE0000581","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-bindin"
5202,"DB07279","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5203,"DB04315","BE0001076","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5204,"DB02726","BE0002004","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5205,"DB02542","BE0004560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5206,"DB08689","BE0004381","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5207,"DB00959","BE0000794","# Owen HC, Miner JN, Ahmed SF, Farquharson C: The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438. Mol Cell Endocrinol. 2007 Jan 29;264(1-2):164-70. Epub 2006 Dec 19. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1718"
5208,"DB00755","BE0000513","# Mic FA, Sirbu IO, Duester G: Retinoic acid synthesis controlled by Raldh2 is required early for limb bud initiation and then later as a proximodistal signal during apical ectodermal ridge formation. J Biol Chem. 2004 Jun 18;279(25):26698-706. Epub 2004 "
5209,"DB08317","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5210,"DB01656","BE0002353","# Barone FC, Barton ME, White RF, Legos JJ, Kikkawa H, Shimamura M, Kuratani K, Kinoshita M: Inhibition of Phosphodiesterase Type 4 Decreases Stress-Induced Defecation in Rats and Mice. Pharmacology. 2007 Aug 28;81(1):11-17. \"Pubmed\":http://www.ncbi.nlm.n"
5211,"DB01194","BE0000267","# Winum JY, Casini A, Mincione F, Starnotti M, Montero JL, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits. Bioorg Med Chem Lett. 2"
5212,"DB04522","BE0003320",""
5213,"DB04888","BE0000756","# Auclair AL, Galinier A, Besnard J, Newman-Tancredi A, Depoortere R: Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats. Psychopharmaco"
5214,"DB07752","BE0004073","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5215,"DB08129","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5216,"DB00945","BE0004903","# Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994 Aug 12;265(5174):956-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8052854"
5217,"DB04851","BE0000785","# Minderman H, O'Loughlin KL, Pendyala L, Baer MR: VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Clin Cancer "
5218,"DB00438","BE0000488","# Hayes MV, Orr DC: Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983 Aug;12(2):119-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
5219,"DB00945","BE0003469","# Stevenson MA, Zhao MJ, Asea A, Coleman CN, Calderwood SK: Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes. J Immunol."
5220,"DB00142","BE0000383","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5221,"DB01224","BE0000533","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
5222,"DB08676","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5223,"DB00920","BE0003718","# Castillo JG, Gamboa PM, Garcia BE, Oehling A: Effect of ketotifen on phosphodiesterase activity from asthmatic individuals. Allergol Immunopathol (Madr). 1990 Jul-Aug;18(4):197-201. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1702263"
5224,"DB00141","BE0002265","# Weihofen WA, Berger M, Chen H, Saenger W, Hinderlich S: Structures of human N-Acetylglucosamine kinase in two complexes with N-Acetylglucosamine and with ADP/glucose: insights into substrate specificity and regulation. J Mol Biol. 2006 Dec 1;364(3):388-"
5225,"DB06273","BE0002859","# Smolen JS, Maini RN: Interleukin-6: a new therapeutic target. Arthritis Res Ther. 2006;8 Suppl 2:S5. Epub 2006 Jul 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16899109"
5226,"DB07457","BE0001193","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5227,"DB03496","BE0001082","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5228,"DB06822","BE0001150","# Koo CY, Sen YP, Bay BH, Yip GW: Targeting heparan sulfate proteoglycans in breast cancer treatment. Recent Pat Anticancer Drug Discov. 2008 Nov;3(3):151-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18991783"
5229,"DB06934","BE0001248","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5230,"DB06148","BE0000442","# Csaba G, Kovacs P, Pallinger E: Prolonged effect of the tricyclic antidepressant, mianserin on the serotonin and histamine content of young rats' white blood cells and mast cells. A case of late-imprinting. Pharmacol Res. 2003 Nov;48(5):457-60. \"Pubmed\""
5231,"DB00268","BE0000342","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
5232,"DB06733","BE0003569","# Takami M, Suda K, Sahara T, Itoh K, Nagai K, Sasaki T, Udagawa N, Takahashi N: Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts. Bone. 2003 Apr;32(4):341-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12689676"
5233,"DB05036","BE0002479",""
5234,"DB03188","BE0001539","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5235,"DB03461","BE0003122",""
5236,"DB03912","BE0001943","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5237,"DB08782","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5238,"DB00368","BE0000289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5239,"DB04797","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5240,"DB07995","BE0003794","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5241,"DB06209","BE0000110","# Dovlatova NL, Jakubowski JA, Sugidachi A, Heptinstall S: The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. J Thromb Haemost. 200"
5242,"DB00041","BE0000651","# Stauber DJ, Debler EW, Horton PA, Smith KA, Wilson IA: Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2788-93. Epub 2006 Feb 13. \"Pubmed\":http://www.ncbi.nlm"
5243,"DB08540","BE0003372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5244,"DB00825","BE0003416","# Macpherson LJ, Hwang SW, Miyamoto T, Dubin AE, Patapoutian A, Story GM: More than cool: promiscuous relationships of menthol and other sensory compounds. Mol Cell Neurosci. 2006 Aug;32(4):335-43. Epub 2006 Jul 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
5245,"DB05913","BE0000453",""
5246,"DB00631","BE0004796","# Pession A, Masetti R, Kleinschmidt K, Martoni A: Use of clofarabine for acute childhood leukemia. Biologics. 2010 Jun 24;4:111-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20631817# Harned TM, Gaynon PS: Treating refractory leukemias in childhood, rol"
5247,"DB00852","BE0000694","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5248,"DB08448","BE0000330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5249,"DB00939","BE0000262","# Kalgutkar AS, Crews BC, Rowlinson SW, Marnett AB, Kozak KR, Remmel RP, Marnett LJ: Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitor"
5250,"DB03327","BE0001344","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5251,"DB02597","BE0003783","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5252,"DB04086","BE0001219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5253,"DB00126","BE0002223","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5254,"DB00242","BE0002450","# Sampat K, Kantarjian H, Borthakur G: Clofarabine: emerging role in leukemias. Expert Opin Investig Drugs. 2009 Oct;18(10):1559-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19715446# Kantarjian HM, Jeha S, Gandhi V, Wess M, Faderl S: Clofarabine: past"
5255,"DB08177","BE0001363","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5256,"DB00116","BE0000010","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5257,"DB01915","BE0001377","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5258,"DB00690","BE0000471","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5259,"DB05041","BE0002457",""
5260,"DB04272","BE0003255",""
5261,"DB01173","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5262,"DB02953","BE0001182","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5263,"DB00909","BE0003633","# De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19703035# Supuran CT, Di Fiore A, De S"
5264,"DB00321","BE0000501","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Nojimoto FD, Mueller A, He"
5265,"DB00759","BE0004651","# Buck MA, Cooperman BS: Single protein omission reconstitution studies of tetracycline binding to the 30S subunit of Escherichia coli ribosomes. Biochemistry. 1990 Jun 5;29(22):5374-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2200507"
5266,"DB03483","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5267,"DB08763","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5268,"DB00157","BE0000175","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5269,"DB04185","BE0000347","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5270,"DB00724","BE0003518","# Dummer R, Urosevic M, Kempf W, Hoek K, Hafner J, Burg G: Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol. 2003 Nov;149 Suppl 66:57-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14616353# Zhu J, Lai K, Brownile R, Babiuk LA, Mutwiri G"
5271,"DB02610","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5272,"DB03821","BE0003195",""
5273,"DB04326","BE0001683","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5274,"DB04490","BE0001732","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5275,"DB02550","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5276,"DB02902","BE0000951","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5277,"DB06287","BE0002386","# Patard JJ, Pouessel D, Bensalah K, Culine S: Targeted therapy in renal cell carcinoma. World J Urol. 2008 Apr;26(2):135-40. Epub 2008 Feb 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18265991# Radulovic S, Bjelogrlic SK: Sunitinib, sorafenib and mTOR"
5278,"DB00312","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
5279,"DB05449","BE0001032",""
5280,"DB00502","BE0000417","# Hattori K, Uchino S, Isosaka T, Maekawa M, Iyo M, Sato T, Kohsaka S, Yagi T, Yuasa S: Fyn is required for haloperidol-induced catalepsy in mice. J Biol Chem. 2006 Mar 17;281(11):7129-35. Epub 2006 Jan 10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1640"
5281,"DB00306","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
5282,"DB07342","BE0000735","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5283,"DB00078","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5284,"DB03395","BE0000270","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5285,"DB00246","BE0000501","# Andersohn F, Schmedt N, Weinmann S, Willich SN, Garbe E: Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol. 2010 Feb;30(1):68-71. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20075651# Nasrallah HA: Aty"
5286,"DB03317","BE0002793",""
5287,"DB01219","BE0000739","# Britt BA, Scott E, Frodis W, Clements MJ, Endrenyi L: Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle. Can Anaesth Soc J. 1984 Mar;31(2):130-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6704779# Har"
5288,"DB04433","BE0001584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5289,"DB02613","BE0001790","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5290,"DB03461","BE0003795","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5291,"DB03935","BE0001015","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5292,"DB01074","BE0000406","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5293,"DB01598","BE0000488","# Nicolau DP: Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother. 2008 Jan;9(1):23-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18076336# Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA: Compa"
5294,"DB02745","BE0004434","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5295,"DB00774","BE0001653","# Temperini C, Cecchi A, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the diff"
5296,"DB03940","BE0000068","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5297,"DB08690","BE0003850","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5298,"DB00172","BE0000225","# Huang TC, Huang YW, Hung HJ, Ho CT, Wu ML: Delta1-pyrroline-5-carboxylic acid formed by proline dehydrogenase from the Bacillus subtilis ssp. natto expressed in Escherichia coli as a precursor for 2-acetyl-1-pyrroline. J Agric Food Chem. 2007 Jun 27;55("
5299,"DB04868","BE0000014","# Maekawa T, Ashihara E, Kimura S: The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias. Int J Clin Oncol. 2007 Oct;12(5):327-40. Epub 2007 Oct 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
5300,"DB02937","BE0001609","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5301,"DB01776","BE0003491","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5302,"DB01942","BE0002624","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5303,"DB00280","BE0000197","# Sugao M, Fujiki A, Nishida K, Sakabe M, Tsuneda T, Iwamoto J, Mizumaki K, Inoue H: Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide. J Cardiovasc Pharmacol. 2005 Jun;45("
5304,"DB02616","BE0002214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5305,"DB06148","BE0000460","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
5306,"DB01250","BE0000987","# Lewis LD, Benin A, Szumlanski CL, Otterness DM, Lennard L, Weinshilboum RM, Nierenberg DW: Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction. Clin Pharmacol Ther. 1997 Oct;62(4):464-75. \"Pubmed\":http://www"
5307,"DB04528","BE0002499",""
5308,"DB07979","BE0004141","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5309,"DB00578","BE0004840","# Sainsbury S, Bird L, Rao V, Shepherd SM, Stuart DI, Hunter WN, Owens RJ, Ren J: Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa: Comparison of native and antibiotic-bound forms. J Mol Biol. 2010 Oct 22. \"Pubmed\":http://www"
5310,"DB00161","BE0000517","# Chen CD, Huang TF, Lin CH, Guan HH, Hsieh YC, Lin YH, Huang YC, Liu MY, Chang WC, Chen CJ: Purification, crystallization and preliminary X-ray crystallographic analysis of branched-chain aminotransferase from Deinococcus radiodurans. Acta Crystallogr Se"
5311,"DB07137","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5312,"DB01965","BE0001318","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5313,"DB08543","BE0003372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5314,"DB01691","BE0002006","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5315,"DB08932","BE0000521","# Bolli MH, Boss C, Binkert C, Buchmann S, Bur D, Hess P, Iglarz M, Meyer S, Rein J, Rey M, Treiber A, Clozel M, Fischli W, Weller T: The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-p ropylsulfamide (Macite"
5316,"DB03450","BE0001349","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5317,"DB02636","BE0003768","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5318,"DB01702","BE0002511","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5319,"DB08708","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5320,"DB07728","BE0001373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5321,"DB03433","BE0001652","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5322,"DB05785","BE0000663",""
5323,"DB01818","BE0004482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5324,"DB04138","BE0001616","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5325,"DB00545","BE0002180","# Somani SM, Husain K, Asha T, Helfert R: Interactive and delayed effects of pyridostigmine and physical stress on biochemical and histological changes in peripheral tissues of mice. J Appl Toxicol. 2000 Jul-Aug;20(4):327-34. \"Pubmed\":http://www.ncbi.nlm."
5326,"DB01200","BE0000756","# Cavallotti C, Nuti F, Bruzzone P, Mancone M: Age-related changes in dopamine D2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):412-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12010185# Chen X, Ji ZL, Che"
5327,"DB05492","BE0000393",""
5328,"DB03871","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5329,"DB02151","BE0002012","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5330,"DB00683","BE0002345","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5331,"DB04447","BE0001716","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5332,"DB08531","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5333,"DB00051","BE0000901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5334,"DB04796","BE0000779","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5335,"DB01752","BE0000372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5336,"DB04272","BE0003266",""
5337,"DB02379","BE0001393","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5338,"DB00268","BE0000797","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
5339,"DB01028","BE0000218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5340,"DB03389","BE0003071",""
5341,"DB08173","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5342,"DB02026","BE0001555","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5343,"DB04231","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5344,"DB08494","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5345,"DB01752","BE0002524",""
5346,"DB04315","BE0001035","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5347,"DB01079","BE0000451","# Beattie DT, Smith JA, Marquess D, Vickery RG, Armstrong SR, Pulido-Rios T, McCullough JL, Sandlund C, Richardson C, Mai N, Humphrey PP: The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol. 2"
5348,"DB05210","BE0002385",""
5349,"DB02196","BE0001429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5350,"DB07292","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5351,"DB01955","BE0003768","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5352,"DB04629","BE0002101","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5353,"DB07763","BE0003859","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5354,"DB02242","BE0001389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5355,"DB00468","BE0000415","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5356,"DB02044","BE0000067","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5357,"DB00321","BE0000291","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
5358,"DB00160","BE0000536","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5359,"DB03157","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5360,"DB00822","BE0000138","# Gaval-Cruz M, Weinshenker D: mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv. 2009 Aug;9(4):175-87. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19720750 *"
5361,"DB01407","BE0000172","# Baker JG: The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. Br J Pharmacol. 2010 Jul;160(5):1048-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20590599"
5362,"DB04272","BE0003253",""
5363,"DB07976","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5364,"DB07360","BE0000991","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5365,"DB07872","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5366,"DB01007","BE0000233","# Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res."
5367,"DB04320","BE0001234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5368,"DB06878","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5369,"DB04324","BE0001534","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5370,"DB04599","BE0000451","# Nakamura K, Kurasawa M: Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. Eur J Pharmacol. 2001 May 18;420(1):33-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11412837"
5371,"DB00334","BE0000291","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
5372,"DB01404","BE0003721","# Wang Y, Ye X, Ma Z, Liang Q, Lu B, Tan H, Xiao C, Zhang B, Gao Y: Induction of cytochrome P450 1A1 expression by ginsenoside Rg1 and Rb1 in HepG2 cells. Eur J Pharmacol. 2008 Dec 28;601(1-3):73-8. Epub 2008 Nov 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
5373,"DB01281","BE0000847","# Kremer JM: Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis. J Clin Rheumatol. 2005 Jun;11(3 Suppl):S55-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16357751# Weyand CM, Goronzy JJ: T-cell-targeted therap"
5374,"DB00114","BE0000102","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5375,"DB02382","BE0001336","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5376,"DB06937","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5377,"DB06961","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5378,"DB08185","BE0004199","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5379,"DB03023","BE0004315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5380,"DB02232","BE0001459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5381,"DB08711","BE0003007","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5382,"DB06726","BE0004872","# Zimmerman TJ, Boger WP 3rd: The beta-adrenergic blocking agents and the treatment of glaucoma. Surv Ophthalmol. 1979 May-Jun;23(6):347-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/37605"
5383,"DB00398","BE0000205","# Gollob JA: Sorafenib: scientific rationales for single-agent and combination therapy in clear-cell renal cell carcinoma. Clin Genitourin Cancer. 2005 Dec;4(3):167-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16425993# Guida T, Anaganti S, Provitera L"
5384,"DB00418","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
5385,"DB07918","BE0004128","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5386,"DB00294","BE0000557","# Macpherson AM, Archer DF, Leslie S, Charnock-Jones DS, Makkink WK, Smith SK: The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium. Hum Reprod. 1999 Dec;14(12):3080-7. \""
5387,"DB03889","BE0001825","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5388,"DB00753","BE0000433","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5389,"DB04634","BE0003878","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5390,"DB07005","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5391,"DB05692","BE0000928",""
5392,"DB03814","BE0001911","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5393,"DB00157","BE0000169","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5394,"DB00114","BE0002163","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5395,"DB03687","BE0001303","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5396,"DB02053","BE0002544",""
5397,"DB00504","BE0000770","# Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA: Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists. J Pharmacol Exp Ther. 1996 Dec;2"
5398,"DB01110","BE0004424","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
5399,"DB04716","BE0003788","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5400,"DB02021","BE0000747","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5401,"DB04147","BE0004180","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5402,"DB07809","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5403,"DB01769","BE0002534",""
5404,"DB01618","BE0000291","# Nguyen TV, Juorio AV: Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):366-71. \"Pubmed"
5405,"DB03461","BE0003983","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5406,"DB04350","BE0001058","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5407,"DB03345","BE0001552","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5408,"DB04537","BE0000228","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5409,"DB07599","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5410,"DB04751","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5411,"DB01917","BE0001328","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5412,"DB03721","BE0001263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5413,"DB01577","BE0000749","# Numachi Y, Ohara A, Yamashita M, Fukushima S, Kobayashi H, Hata H, Watanabe H, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora I: Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol. 2007"
5414,"DB04278","BE0001029","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5415,"DB00342","BE0000405","# Yasuda SU, Yasuda RP: Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes. Pharmacotherapy. 1999 Apr;19(4):447-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10212017"
5416,"DB05798","BE0003424",""
5417,"DB07655","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5418,"DB07533","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5419,"DB08231","BE0004240","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5420,"DB07035","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5421,"DB00193","BE0000533","# Ogata J, Minami K, Uezono Y, Okamoto T, Shiraishi M, Shigematsu A, Ueta Y: The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes. Anesth Analg. 2004 May;98(5):1401-6, table of contents. \"Pubmed\":http://"
5422,"DB07067","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5423,"DB00931","BE0004799","# Nawaz M, Sung K, Khan SA, Khan AA, Steele R: Biochemical and molecular characterization of tetracycline-resistant Aeromonas veronii isolates from catfish. Appl Environ Microbiol. 2006 Oct;72(10):6461-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/170211"
5424,"DB01143","BE0000457","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5425,"DB08901","BE0000838","# O'Hare T, Shakespeare WC, Zhu X, Eide CA, Rivera VM, Wang F, Adrian LT, Zhou T, Huang WS, Xu Q, Metcalf CA 3rd, Tyner JW, Loriaux MM, Corbin AS, Wardwell S, Ning Y, Keats JA, Wang Y, Sundaramoorthi R, Thomas M, Zhou D, Snodgrass J, Commodore L, Sawyer T"
5426,"DB01496","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
5427,"DB00756","BE0000180","# Li M, Smith CJ, Walker MT, Smith TJ: Novel inhibitors complexed with glutamate dehydrogenase: allosteric regulation by control of protein dynamics. J Biol Chem. 2009 Aug 21;284(34):22988-3000. Epub 2009 Jun 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
5428,"DB07685","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5429,"DB01589","BE0000381","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
5430,"DB05688","BE0000486",""
5431,"DB00734","BE0000659","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243"
5432,"DB07197","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5433,"DB05087","BE0000764",""
5434,"DB01267","BE0000533","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243"
5435,"DB00260","BE0000806","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5436,"DB01159","BE0000218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5437,"DB02937","BE0001332","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5438,"DB00277","BE0000241","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV: Postconditioning protects rabbit hearts "
5439,"DB00518","BE0001487","# Barrowman MM, Marriner SE, Bogan JA: The fumarate reductase system as a site of anthelmintic attack in Ascaris suum. Biosci Rep. 1984 Oct;4(10):879-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6518278"
5440,"DB07642","BE0001215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5441,"DB00081","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5442,"DB08807","BE0000797","# Dawson LA, Nguyen HQ: The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol. Neuropharmacology. 2000 Apr 3;39(6):1044-52. \"Pubmed\":http://www."
5443,"DB05774","BE0000767",""
5444,"DB07475","BE0003916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5445,"DB00025","BE0001098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5446,"DB02857","BE0002841",""
5447,"DB04865","BE0003833","# Tujebajeva RM, Graifer DM, Matasova NB, Fedorova OS, Odintsov VB, Ajtkhozhina NA, Karpova GG: Selective inhibition of the polypeptide chain elongation in eukaryotic cells. Biochim Biophys Acta. 1992 Jan 6;1129(2):177-82. \"Pubmed\":http://www.ncbi.nlm.nih"
5448,"DB01211","BE0000743","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5449,"DB00334","BE0000311","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
5450,"DB07524","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5451,"DB00013","BE0000211","# Zhang X, Zhou H, Shen G, Liu Z, Hu Y, Wei W, Song S: Study on the mechanism of the annexin II-mediated co-assembly of t-PA and plasminogen. J Huazhong Univ Sci Technolog Med Sci. 2002;22(1):21-3, 76. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12658774#"
5452,"DB03940","BE0001324","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5453,"DB04859","BE0000426","# Hatip-Al-Khatib I, Iwasaki K, Yoshimitsu Y, Arai T, Egashira N, Mishima K, Ikeda T, Fujiwara M: Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats. Br "
5454,"DB06684","BE0000291","# Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I: Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carb oxamide (EMD 68843): a combined selective inhibitor of serotonin reu"
5455,"DB06850","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5456,"DB03880","BE0003872","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5457,"DB08330","BE0003858","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5458,"DB00560","BE0003709","# Olson MW, Ruzin A, Feyfant E, Rush TS 3rd, O'Connell J, Bradford PA: Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother. 2006 Jun;50(6):2156-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
5459,"DB07331","BE0003806","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5460,"DB03252","BE0001844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5461,"DB00573","BE0000262","# Poggi JC, Barissa GR, Donadi EA, Foss MC, Cunha FQ, Lanchote VL, dos Reis ML: Pharmacodynamics, chiral pharmacokinetics, and pharmacokinetic-pharmacodynamic modeling of fenoprofen in patients with diabetes mellitus. J Clin Pharmacol. 2006 Nov;46(11):132"
5462,"DB00193","BE0000632","# Sun HL, Zheng JW, Wang K, Liu RK, Liang JH: Tramadol reduces the 5-HTP-induced head-twitch response in mice via the activation of mu and kappa opioid receptors. Life Sci. 2003 Jan 31;72(11):1221-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12570923"
5463,"DB01224","BE0000945","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
5464,"DB01353","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
5465,"DB00540","BE0000045","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
5466,"DB01589","BE0003592","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
5467,"DB03022","BE0001270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5468,"DB07987","BE0001116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5469,"DB03026","BE0002054","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5470,"DB00724","BE0000155","# Gibson SJ, Lindh JM, Riter TR, Gleason RM, Rogers LM, Fuller AE, Oesterich JL, Gorden KB, Qiu X, McKane SW, Noelle RJ, Miller RL, Kedl RM, Fitzgerald-Bocarsly P, Tomai MA, Vasilakos JP: Plasmacytoid dendritic cells produce cytokines and mature in respon"
5471,"DB00723","BE0000575","# Tsujimoto G, Tsujimoto A, Suzuki E, Hashimoto K: Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+"
5472,"DB03995","BE0001427","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5473,"DB00690","BE0003599","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5474,"DB01800","BE0003195","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5475,"DB02976","BE0002699",""
5476,"DB01694","BE0002507",""
5477,"DB00255","BE0000123","# Munoz G, Ovilo C, Estelle J, Silio L, Fernandez A, Rodriguez C: Association with litter size of new polymorphisms on ESR1 and ESR2 genes in a Chinese-European pig line. Genet Sel Evol. 2007 Mar-Apr;39(2):195-206. Epub 2007 Feb 17. \"Pubmed\":http://www.nc"
5478,"DB07264","BE0000923","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5479,"DB00686","BE0001015","# Zugmaier G, Favoni R, Jaeger R, Rosen N, Knabbe C: Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors. Ann N Y Acad Sci. 1999;886:243-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10667230# Mucha S, Melen-Mucha G, Step"
5480,"DB07974","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5481,"DB02196","BE0001428","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5482,"DB01594","BE0003592","# Walash MI, Belal F, Metwally ME, Hefnawy MM: A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
5483,"DB00786","BE0003694","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
5484,"DB00491","BE0004699","# Fukaya N, Mochizuki K, Tanaka Y, Kumazawa T, Jiuxin Z, Fuchigami M, Goda T: The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. Eur J Pharmacol. 2009 Dec"
5485,"DB01442","BE0000749","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5486,"DB01054","BE0000679","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targe"
5487,"DB04293","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5488,"DB08057","BE0000842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5489,"DB01149","BE0000291","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
5490,"DB02659","BE0003995","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5491,"DB05250","BE0001051",""
5492,"DB03667","BE0000017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5493,"DB07966","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5494,"DB00157","BE0000317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5495,"DB08185","BE0004204","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5496,"DB07109","BE0003784","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5497,"DB01055","BE0001047","# Conti P, Frydas S, Reale M, Barbacane RC, Di Gioacchino M, Felaco M, Trakatellis A: Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis. Mol Cell Biochem. 2002 Jan;229("
5498,"DB00775","BE0000439","# Theroux P, Alexander J Jr, Pharand C, Barr E, Snapinn S, Ghannam AF, Sax FL: Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet"
5499,"DB01558","BE0000478","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
5500,"DB04920","BE0002355","# Nordlander M, Sjoquist PO, Ericsson H, Ryden L: Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev. 2004 Fall;22(3):227-50. \"Pubmed\":http://"
5501,"DB07839","BE0001646","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5502,"DB07412","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5503,"DB04303","BE0002819",""
5504,"DB01821","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5505,"DB01885","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5506,"DB00156","BE0000482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5507,"DB04464","BE0004085","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5508,"DB03987","BE0001555","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5509,"DB00831","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Seeman P: Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. \"P"
5510,"DB00283","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Taniguchi K, Urakami M, Takanaka K: [Effects of antiallergic agents on polymorphonuclear leukocyte"
5511,"DB02066","BE0002011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5512,"DB02297","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5513,"DB03584","BE0002490",""
5514,"DB03970","BE0004185","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5515,"DB02067","BE0000331","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5516,"DB08013","BE0004148","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5517,"DB01147","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5518,"DB00745","BE0000647","# Zhou J, He R, Johnson KM, Ye Y, Kozikowski AP: Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization. J Med Chem. 2004 Nov 18;47(24):5821-4. \"Pubmed\":"
5519,"DB01677","BE0002001","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5520,"DB01033","BE0000077","# Dubinsky MC: Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15354273"
5521,"DB02118","BE0001198","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5522,"DB03502","BE0001681","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5523,"DB00890","BE0000123","# Juriansz RL, Huseby RA, Wilcox RB: Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia. Cancer Res. 1988 Jan 1;48(1):14-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
5524,"DB07778","BE0003855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5525,"DB01972","BE0001360","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5526,"DB00722","BE0000982","# Parish RC, Miller LJ: Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update. Drug Saf. 1992 Jan-Feb;7(1):14-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1536695# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic"
5527,"DB01186","BE0000715","# Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10641988"
5528,"DB09016","BE0000749","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881# Wander TJ, Nelson A, Okazaki H, Richels"
5529,"DB08234","BE0003735","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5530,"DB02704","BE0002050","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5531,"DB00200","BE0000340","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5532,"DB00690","BE0002346","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5533,"DB07261","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5534,"DB00028","BE0004686","# Baerenwaldt A, Biburger M, Nimmerjahn F: Mechanisms of action of intravenous immunoglobulins. Expert Rev Clin Immunol. 2010 May;6(3):425-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20441428# Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, K"
5535,"DB00173","BE0002007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5536,"DB07472","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5537,"DB00028","BE0003455","# Baerenwaldt A, Biburger M, Nimmerjahn F: Mechanisms of action of intravenous immunoglobulins. Expert Rev Clin Immunol. 2010 May;6(3):425-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20441428# Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, K"
5538,"DB00849","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
5539,"DB00072","BE0000767","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5540,"DB08215","BE0003852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5541,"DB01544","BE0000381","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5542,"DB08733","BE0003872","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5543,"DB00133","BE0000660","# Yard BA, Carter LG, Johnson KA, Overton IM, Dorward M, Liu H, McMahon SA, Oke M, Puech D, Barton GJ, Naismith JH, Campopiano DJ: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. J Mol Biol. 2007 Jul 27;370(5):870-86. E"
5544,"DB03254","BE0002707",""
5545,"DB00897","BE0000795","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5546,"DB06860","BE0001501","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5547,"DB07482","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5548,"DB01013","BE0000794","# Fitzgerald P, O'Brien SM, Scully P, Rijkers K, Scott LV, Dinan TG: Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med. 2006 Jan;36(1):37-43. Epub 2005 Oct 28. \"Pubmed\":h"
5549,"DB01046","BE0000765","# Lubiprostone: RU 0211, SPI 0211. Drugs R D. 2005;6(4):245-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15991886# Moeser AJ, Nighot PK, Engelke KJ, Ueno R, Blikslager AT: Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimu"
5550,"DB04858","BE0004796",""
5551,"DB02941","BE0001271","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5552,"DB08689","BE0003851","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5553,"DB01259","BE0000511","# Xia W, Liu LH, Ho P, Spector NL: Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016. Oncogene. 2004 Jan 22;23(3):646-53. \"Pubmed\":"
5554,"DB01378","BE0000732","# Buchachenko AL, Kuznetsov DA, Berdinskii VL: [New mechanisms of biological effects of electromagnetic fields] Biofizika. 2006 May-Jun;51(3):545-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16808357# Sirijovski N, Olsson U, Lundqvist J, Al-Karadaghi S"
5555,"DB00145","BE0000409","# Turbeville TD, Zhang J, Hunter GA, Ferreira GC: Histidine 282 in 5-aminolevulinate synthase affects substrate binding and catalysis. Biochemistry. 2007 May 22;46(20):5972-81. Epub 2007 May 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17469798# He XM, "
5556,"DB00384","BE0000190","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5557,"DB07351","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5558,"DB00125","BE0000263","# Akamine EH, Kawamoto EM, Scavone C, Nigro D, Carvalho MH, de Cassia A Tostes R, Britto LR, Fortes ZB: Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. J Vasc Res. 2006;43(4):309-20. Epub 2006 May "
5559,"DB01045","BE0000257","# Villain-Guillot P, Bastide L, Gualtieri M, Leonetti JP: Progress in targeting bacterial transcription. Drug Discov Today. 2007 Mar;12(5-6):200-8. Epub 2007 Feb 5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17331884# White RJ, Lancini GC, Silvestri LG: "
5560,"DB04233","BE0003973","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5561,"DB04997","BE0000590",""
5562,"DB07213","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5563,"DB08028","BE0001182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5564,"DB07555","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5565,"DB01238","BE0000092","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
5566,"DB04574","BE0000792","# Vijayanathan V, Greenfield NJ, Thomas TJ, Ivanova MM, Tyulmenkov VV, Klinge CM, Gallo MA, Thomas T: Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta. Biochem Cell Biol. 200"
5567,"DB08453","BE0002474","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5568,"DB00774","BE0002437","# Temperini C, Cecchi A, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the diff"
5569,"DB01433","BE0000770","# Mancino MJ, McGaugh J, Feldman Z, Poling J, Oliveto A: Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis. Am J Addict. 2010 Mar;"
5570,"DB04786","BE0002401","# Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR: PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br J Pharmacol. 1996 Jun;118(3):704-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8762097# Bogdanov YD, Wildman SS,"
5571,"DB03338","BE0000695","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5572,"DB08390","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5573,"DB02232","BE0001308","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5574,"DB05022","BE0000742",""
5575,"DB00431","BE0002344","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5576,"DB02566","BE0004326","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5577,"DB07732","BE0004066","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5578,"DB05177","BE0001680",""
5579,"DB01297","BE0000172","# Abrahamsson T: The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat. Br J Pharmacol. 1986 Apr;87(4):657-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
5580,"DB04784","BE0003337","# Schlieben NH, Niefind K, Muller J, Riebel B, Hummel W, Schomburg D: Atomic resolution structures of R-specific alcohol dehydrogenase from Lactobacillus brevis provide the structural bases of its substrate and cosubstrate specificity. J Mol Biol. 2005 Ju"
5581,"DB03368","BE0001116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5582,"DB00157","BE0000554","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5583,"DB06210","BE0003440","# Kuter DJ: Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med. 2009;60:193-206. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19642221"
5584,"DB03280","BE0001221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5585,"DB00845","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5586,"DB00683","BE0003598","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5587,"DB00151","BE0000569","# Roopnarinesingh ES, Steventon GB, Harris RM, Waring RH, Mitchell SC: Induction of cysteine dioxygenase activity by oral administration of cysteine analogues to the rat: implications for drug efficacy and safety. Drug Metabol Drug Interact. 2005;21(2):75"
5588,"DB01483","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
5589,"DB01159","BE0003582","# Lazarenko RM, Willcox SC, Shu S, Berg AP, Jevtovic-Todorovic V, Talley EM, Chen X, Bayliss DA: Motoneuronal TASK channels contribute to immobilizing effects of inhalational general anesthetics. J Neurosci. 2010 Jun 2;30(22):7691-704. \"Pubmed\":http://www"
5590,"DB07808","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5591,"DB08264","BE0004260","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5592,"DB07582","BE0004004","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5593,"DB06779","BE0000967","# Mousa SA: Low-molecular-weight heparins in thrombosis and cancer: emerging links. Cardiovasc Drug Rev. 2004 Summer;22(2):121-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15179449# Naumnik B, Rydzewska-Rosolowska A, Mysliwiec M: Different Effects of E"
5594,"DB00173","BE0002755",""
5595,"DB08004","BE0003794","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5596,"DB05740","BE0002343",""
5597,"DB01709","BE0001256","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5598,"DB00495","BE0004853","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Barry M, Gibbons S, Back D, Mulcahy F: Protease inhibitors in"
5599,"DB02726","BE0001905","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5600,"DB04213","BE0000950","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5601,"DB07291","BE0003737","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5602,"DB08674","BE0002372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5603,"DB08007","BE0003758","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5604,"DB04773","BE0003360",""
5605,"DB07778","BE0003856","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5606,"DB00157","BE0000009","# Schirwitz K, Schmidt A, Lamzin VS: High-resolution structures of formate dehydrogenase from Candida boidinii. Protein Sci. 2007 Jun;16(6):1146-56. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17525463# Baumchen C, Roth AH, Biedendieck R, Malten M, Follma"
5607,"DB03313","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
5608,"DB01367","BE0000246","# Youdim MB, Weinstock M: Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. Cell Mol Neurobiol. 2001 Dec;21(6):555-73. \"Pubmed\":http://www.ncbi.nlm.ni"
5609,"DB01997","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5610,"DB04186","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5611,"DB02458","BE0000807","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5612,"DB00004","BE0002102","# Foss F, Demierre MF, DiVenuti G: A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood. 2005 Jul 15;106(2):454-7. Epub 2005 Apr 5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15811"
5613,"DB00216","BE0000393","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5614,"DB00020","BE0002115","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5615,"DB02643","BE0002196","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5616,"DB00583","BE0000097","# Sekoguchi E, Sato N, Yasui A, Fukada S, Nimura Y, Aburatani H, Ikeda K, Matsuura A: A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting. J Biol Chem. 2003 Oct 3;278(40):38796-802. Epub 2003 Jul 25. \"Pubme"
5617,"DB00247","BE0000393","# Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H: Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci. 1996 May;8(5):959-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8743744"
5618,"DB01588","BE0003595","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
5619,"DB07506","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5620,"DB00083","BE0003572","# Ishida H, Zhang X, Erickson K, Ray P: Botulinum toxin type A targets RhoB to inhibit lysophosphatidic acid-stimulated actin reorganization and acetylcholine release in nerve growth factor-treated PC12 cells. J Pharmacol Exp Ther. 2004 Sep;310(3):881-9. "
5621,"DB05651","BE0002367","# Beckers T, Burkhardt C, Wieland H, Gimmnich P, Ciossek T, Maier T, Sanders K: Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer. 2007 Sep 1;121(5):1138-48. \"Pubmed\":http:/"
5622,"DB01349","BE0003426","# Unger T: Pharmacology of AT1-receptor blockers. Blood Press Suppl. 2001;(3):5-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11683476"
5623,"DB00678","BE0000062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Sardo MA, Castaldo M, Cinquegrani M, Bonaiuto M, Fontana L, Campo S, Campo GM, Altavilla D, Saitta"
5624,"DB00142","BE0000760","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5625,"DB08262","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5626,"DB04251","BE0002180",""
5627,"DB03921","BE0003782","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5628,"DB01226","BE0000045","# Habre W, Adamicza A, Lele E, Novak T, Sly PD, Petak F: The involvement of histaminic and muscarinic receptors in the bronchoconstriction induced by myorelaxant administration in sensitized rabbits. Anesth Analg. 2008 Dec;107(6):1899-906. \"Pubmed\":http:/"
5629,"DB02126","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5630,"DB00428","BE0004258","# He Y, Martinez-Fleites C, Bubb A, Gloster TM, Davies GJ: Structural insight into the mechanism of streptozotocin inhibition of O-GlcNAcase. Carbohydr Res. 2009 Mar 31;344(5):627-31. doi: 10.1016/j.carres.2008.12.007. Epub 2008 Dec 13. \"Pubmed\":http://ww"
5631,"DB00801","BE0003599","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
5632,"DB01814","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5633,"DB00603","BE0000123","# Jain JK, Li A, Yang W, Minoo P, Felix JC: Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate. Fertil Steril. 2007 Jan;87(1):8-23. Epub 2006 Nov 7. \"Pubmed\":http://www.ncbi.nlm."
5634,"DB01077","BE0003569","# David P, Nguyen H, Barbier A, Baron R: The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Miner Res. 1996 Oct;11(10):1498-507. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8889850"
5635,"DB00376","BE0000560","# Bognar IT, Altes U, Beinhauer C, Kessler I, Fuder H: A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jun;345(6):611-8. \"Pubmed\":http://w"
5636,"DB07705","BE0004059","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5637,"DB01204","BE0004796","# Mazerski J, Martelli S, Borowski E: The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: molecular dynamics simulations. Acta Biochim Pol. 1998;45(1):1-11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9701490# Hajihas"
5638,"DB00687","BE0000794","# Trune DR, Kempton JB: Low dose combination steroids control autoimmune mouse hearing loss. J Neuroimmunol. 2010 Aug 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20800906"
5639,"DB07211","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5640,"DB07938","BE0004138","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5641,"DB00171","BE0000639","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5642,"DB00235","BE0000436","# Cone J, Wang S, Tandon N, Fong M, Sun B, Sakurai K, Yoshitake M, Kambayashi J, Liu Y: Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol. 1999 O"
5643,"DB01212","BE0003624","# Tomberg J, Unemo M, Davies C, Nicholas RA: Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins in Neisseria gonorrhoeae: Role of Epistatic Mutations"
5644,"DB00303","BE0002393","# Kohler J, Dorso KL, Young K, Hammond GG, Rosen H, Kropp H, Silver LL: In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumo"
5645,"DB00590","BE0000699","# Thomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Sc"
5646,"DB05014","BE0002133",""
5647,"DB00157","BE0000225","# Wang ZQ, Yuan YZ, Ou JQ, Lin QH, Zhang CF: Glutamine synthetase and glutamate dehydrogenase contribute differentially to proline accumulation in leaves of wheat (Triticum aestivum) seedlings exposed to different salinity. J Plant Physiol. 2007 Jun;164(6"
5648,"DB08119","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5649,"DB01140","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
5650,"DB01227","BE0000770","# Yu Y, Zhang L, Yin X, Sun H, Uhl GR, Wang JB: Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem. 1997 Nov 14;272(46):28869-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9360954# Skoulis NP, James RC, Harbison RD, Ro"
5651,"DB00424","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5652,"DB05829","BE0003508","# Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F: Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution. J Biol Chem. 2000 Sep 1;275(35):27238-44. \"Pubmed\":http://www.ncbi.nlm.ni"
5653,"DB00246","BE0000020","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
5654,"DB03721","BE0001074","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5655,"DB08936","BE0000442","# Enright BP, Gu YZ, Snyder RD, Dugyala RR, Obert LA, Treinen KA, McIntyre BS, Veneziale RW: Effects of the histamine H1 antagonist chlorcyclizine on rat fetal palate development. Birth Defects Res B Dev Reprod Toxicol. 2010 Dec;89(6):474-84. doi: 10.1002"
5656,"DB00999","BE0000267","# Puscas I, Coltau M, Baican M, Domuta G, Hecht A: Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action. Drugs Exp Clin Res. 1999;25(6):271-9. \"Pubmed\":http://www.ncbi.nlm"
5657,"DB07798","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5658,"DB00184","BE0003584","# Mansvelder HD, Mertz M, Role LW: Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol. 2009 Jun;20(4):432-40. Epub 2009 Jan 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19560048# Narahashi T, Fe"
5659,"DB02320","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5660,"DB01194","BE0000535","# Vullo D, Franchi M, Gallori E, Antel J, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J Med Chem. 2004 Feb 26;47(5):1272-9. \"Pubmed\":http://www.ncbi.nlm.nih.go"
5661,"DB00291","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5662,"DB07511","BE0001501","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5663,"DB00338","BE0000349","# Tajima A, Koizumi K, Suzuki K, Higashi N, Takahashi M, Shimada T, Terano A, Hiraishi H, Kuwayama H: Proton pump inhibitors and recurrent bleeding in peptic ulcer disease. J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S237-41. \"Pubmed\":http://www.ncbi.nlm"
5664,"DB02379","BE0003248",""
5665,"DB00145","BE0002307","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5666,"DB01567","BE0003596","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
5667,"DB02592","BE0001691","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5668,"DB00125","BE0000005","# Cui YY, Tang CS, Geng B: [Restraint stress down-regulates L-Arg/NOS/NO pathway of platelet and aortic intima in rats] Beijing Da Xue Xue Bao. 2006 Jun 18;38(3):231-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16778961# Devan BD, Pistell PJ, Daffin LW "
5669,"DB00122","BE0002186","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5670,"DB07437","BE0001224","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5671,"DB01023","BE0002359","# Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J: Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol. 2009 Feb;75(2):407-14. Epub 200"
5672,"DB08215","BE0003953","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5673,"DB07896","BE0004115","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5674,"DB01403","BE0000451","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205"
5675,"DB05075","BE0001356",""
5676,"DB00477","BE0000945","# Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. \"Pu"
5677,"DB00157","BE0000133","# Quintanilla ME, Tampier L, Sapag A, Gerdtzen Z, Israel Y: Sex differences, alcohol dehydrogenase, acetaldehyde burst, and aversion to ethanol in the rat: a systems perspective. Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E531-7. Epub 2007 May 8. \"Pub"
5678,"DB00312","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
5679,"DB01351","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
5680,"DB06699","BE0000203","# Steinberg M: Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer. Clin Ther. 2009;31 Pt 2:2312-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20110043# Kirby RS, Fitzpatrick JM, Clarke N: Abarelix and other gona"
5681,"DB08162","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5682,"DB08405","BE0004133","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5683,"DB00114","BE0002173","# Tong JC, Myers MA, Mackay IR, Zimmet PZ, Rowley MJ: The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera. Ann N Y Acad Sci. 2002 Apr;958:182-9. \"Pubmed\":http://www.ncbi.nlm.nih"
5684,"DB00042","BE0002138","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5685,"DB04852","BE0000232","# Ueshima K, Akihisa-Umeno H, Nagayoshi A, Takakura S, Matsuo M, Mutoh S: Implitapide, a microsomal triglyceride transfer protein inhibitor, reduces progression of atherosclerosis in apolipoprotein E knockout mice fed a Western-type diet: involvement of t"
5686,"DB07771","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5687,"DB01351","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
5688,"DB00430","BE0002393","# Fass RJ, Helsel VL: In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli. Diagn Microbiol Infect Dis. 1986 Jan;4(1):77-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3943292# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhash"
5689,"DB02726","BE0001752","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5690,"DB03800","BE0001501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5691,"DB01747","BE0001379","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5692,"DB04464","BE0000503","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5693,"DB04434","BE0003782","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5694,"DB06616","BE0000870","# Remsing Rix LL, Rix U, Colinge J, Hantschel O, Bennett KL, Stranzl T, Muller A, Baumgartner C, Valent P, Augustin M, Till JH, Superti-Furga G: Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia. 2"
5695,"DB08595","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5696,"DB01694","BE0002503",""
5697,"DB07073","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5698,"DB00002","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5699,"DB00797","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5700,"DB01044","BE0003724","# Harding I, Simpson I: Fluoroquinolones: is there a different mechanism of action and resistance against Streptococcus pneumoniae? J Chemother. 2000 Oct;12 Suppl 4:7-15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11131958# Rafii F, Park M, Novak JS: Alt"
5701,"DB00139","BE0002197","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5702,"DB01929","BE0001302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5703,"DB04051","BE0001389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5704,"DB00145","BE0000102","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5705,"DB00131","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5706,"DB02596","BE0001387","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5707,"DB02379","BE0004472","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5708,"DB06643","BE0003517","# Lipton A, Jun S: RANKL inhibition in the treatment of bone metastases. Curr Opin Support Palliat Care. 2008 Sep;2(3):197-203. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18685421# Westenfeld R, Ketteler M, Brandenburg VM: Anti-RANKL therapy--implication"
5709,"DB00683","BE0000471","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5710,"DB02761","BE0002826",""
5711,"DB08689","BE0003852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5712,"DB00910","BE0000779","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5713,"DB03801","BE0001778","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5714,"DB02379","BE0002948",""
5715,"DB01768","BE0002533",""
5716,"DB01107","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5717,"DB05192","BE0000315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5718,"DB08539","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5719,"DB04632","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5720,"DB00308","BE0000430","# Doggrell SA, Hancox JC: Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opin Investig Drugs. 2005 May;14(5):655-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15926871# Foster RH, Wilde "
5721,"DB01623","BE0000020","# Shultz PJ, Sedor JR, Abboud HE: Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells. Am J Physiol. 1987 Aug;253(2 Pt 2):H358-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3039860# Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G"
5722,"DB07662","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5723,"DB00011","BE0000661","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5724,"DB01430","BE0000732","# Rigoulet M: Control processes in oxidative phosphorylation: kinetic constraints and stoichiometry. Biochim Biophys Acta. 1990 Jul 25;1018(2-3):185-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2144185# Rigoulet M, Fraisse L, Ouhabi R, Guerin B, Fontain"
5725,"DB00505","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5726,"DB06930","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5727,"DB02342","BE0002089","# Parvez S, Parvez SH, Youdim MB: Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancy. Br J Pharmacol. 1975 Feb;53(2):241-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1170911"
5728,"DB00514","BE0000849","# Damaj MI, Flood P, Ho KK, May EL, Martin BR: Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J Pharmacol Exp Ther. 2005 Feb;312(2):780-5. Epub 2004 Sep 8. \"Pubmed\":http://www.ncbi"
5729,"DB02778","BE0002431","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5730,"DB01548","BE0000770","# Leung K: [6-O-methyl-11C]Diprenorphine  \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20641600"
5731,"DB08210","BE0001056","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5732,"DB00572","BE0000560","# Roman S, Badia A, Camps P, Munoz-Torrero D, Clos MV: Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors. Brain Res. 2005 Nov 9;1061(2):73-9. Epub 2005 Oct"
5733,"DB04832","BE0000749","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5734,"DB04395","BE0002101","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5735,"DB00920","BE0001287","# Castillo JG, Gamboa PM, Garcia BE, Oehling A: Effect of ketotifen on phosphodiesterase activity from asthmatic individuals. Allergol Immunopathol (Madr). 1990 Jul-Aug;18(4):197-201. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1702263# Huang Z, Liu S, Zh"
5736,"DB01942","BE0002646",""
5737,"DB07690","BE0004055","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5738,"DB00303","BE0000744","# Kohler J, Dorso KL, Young K, Hammond GG, Rosen H, Kropp H, Silver LL: In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumo"
5739,"DB08183","BE0004146","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5740,"DB00321","BE0000092","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
5741,"DB08476","BE0001182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5742,"DB03475","BE0001930","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5743,"DB01066","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5744,"DB08010","BE0001097","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5745,"DB03496","BE0002212","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5746,"DB00119","BE0000046","# Percy MJ, van Wijk R, Haggan S, Savage GA, Boyd K, Dempsey S, Hamilton J, Kettle P, Kyle A, Shepherd CW, van Solinge WW, Lappin TR, McMullin MF: Pyruvate kinase deficient hemolytic anemia in the Northern Irish population. Blood Cells Mol Dis. 2007 Sep-O"
5747,"DB02749","BE0001914","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5748,"DB03077","BE0004186","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5749,"DB03865","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5750,"DB02968","BE0001904","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5751,"DB00330","BE0000122","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5752,"DB07371","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5753,"DB08201","BE0002180","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5754,"DB03959","BE0004149","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5755,"DB00607","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
5756,"DB01284","BE0000848","# Schwerin M, Kanitz E, Tuchscherer M, Brussow KP, Nurnberg G, Otten W: Stress-related gene expression in brain and adrenal gland of porcine fetuses and neonates. Theriogenology. 2005 Mar 1;63(4):1220-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/157102"
5757,"DB01217","BE0002090","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Mauras N, Bishop K, Merinbaum D, Emeribe U, Agbo F, Lowe E: Pharmacokinetics and pharmacodynamics "
5758,"DB00388","BE0000715","# Hein, L. (2004). &alpha;-Adrenergic system. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclopedic reference of molecular pharmacology_ (pp. 27-30). Berlin, Germany: Springer."
5759,"DB02320","BE0000007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5760,"DB00108","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5761,"DB07392","BE0003851","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5762,"DB03685","BE0001938","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5763,"DB00342","BE0000560","# Yasuda SU, Yasuda RP: Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes. Pharmacotherapy. 1999 Apr;19(4):447-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10212017"
5764,"DB00462","BE0000560","# Soukup O, Proska J, Binder J, Karasova JZ, Tobin G, Jun D, Marek J, Musilek K, Fusek J, Kuca K: Methylacridinium and its cholinergic properties. Neurotox Res. 2009 Nov;16(4):372-7. Epub 2009 Jun 30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19565307# "
5765,"DB05219","BE0001287",""
5766,"DB03247","BE0002499",""
5767,"DB08698","BE0004383","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5768,"DB04137","BE0001076","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5769,"DB03476","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5770,"DB07374","BE0003835","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5771,"DB03496","BE0002216","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
5772,"DB02761","BE0001511","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5773,"DB00157","BE0000762","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5774,"DB00920","BE0003717","# Castillo JG, Gamboa PM, Garcia BE, Oehling A: Effect of ketotifen on phosphodiesterase activity from asthmatic individuals. Allergol Immunopathol (Madr). 1990 Jul-Aug;18(4):197-201. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1702263"
5775,"DB03206","BE0001789",""
5776,"DB00387","BE0000045","# Myhrer T: Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment. Neurotoxicology. 2010 Jul 17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20624420# Waelbroeck M, Camus J, Tastenoy M, Mutsc"
5777,"DB01007","BE0000875","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5778,"DB03313","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
5779,"DB00141","BE0002264","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5780,"DB07593","BE0003417","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5781,"DB00928","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5782,"DB00172","BE0002208","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5783,"DB00651","BE0000013","# Schwabe U, Ukena D, Lohse MJ: Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):212-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2997628"
5784,"DB05745","BE0003419",""
5785,"DB01370","BE0000732","# Menz RI, Walker JE, Leslie AG: Structure of bovine mitochondrial F(1)-ATPase with nucleotide bound to all three catalytic sites: implications for the mechanism of rotary catalysis. Cell. 2001 Aug 10;106(3):331-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
5786,"DB03979","BE0001704","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5787,"DB05390","BE0002401",""
5788,"DB01079","BE0000084","# Camilleri M: Review article: tegaserod. Aliment Pharmacol Ther. 2001 Mar;15(3):277-89. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11207504# Kamm MA: Review article: the complexity of drug development for irritable bowel syndrome. Aliment Pharmacol Ther"
5789,"DB00497","BE0000420","# Ordonez Gallego A, Gonzalez Baron M, Espinosa Arranz E: Oxycodone: a pharmacological and clinical review. Clin Transl Oncol. 2007 May;9(5):298-307. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17525040# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Dat"
5790,"DB00780","BE0001002","# Tipnis UR, Tao M, Boor PJ: Purification and characterization of semicarbazide-sensitive amine oxidase from porcine aorta. Cell Mol Biol (Noisy-le-grand). 1992 Aug-Sep;38(5-6):575-84. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1483111# Kumar D, Trent MB"
5791,"DB07336","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5792,"DB07969","BE0000915","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5793,"DB03461","BE0003121",""
5794,"DB01981","BE0002670",""
5795,"DB01972","BE0001376","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5796,"DB00831","BE0004350","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235# Malashkevich VN, Dulyaninova NG, Ramagopa"
5797,"DB00988","BE0000145","# Ostadali MR, Ahangari G, Eslami MB, Razavi A, Zarrindast MR, Ahmadkhaniha HR, Boulhari J: The Detection of Dopamine Gene Receptors (DRD1-DRD5) Expression on Human Peripheral Blood Lymphocytes by Real Time PCR. Iran J Allergy Asthma Immunol. 2004 Dec;3(4"
5798,"DB04566","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5799,"DB00699","BE0000501","# Alvarez-Guerra M, Bertholom N, Garay RP: Selective blockade by nicergoline of vascular responses elicited by stimulation of alpha 1A-adrenoceptor subtype in the rat. Fundam Clin Pharmacol. 1999;13(1):50-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/100"
5800,"DB03046","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5801,"DB06952","BE0003759","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5802,"DB05494","BE0002804",""
5803,"DB06589","BE0000029","# Sonpavde G, Hutson TE: Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Curr Oncol Rep. 2007 Mar;9(2):115-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17288876"
5804,"DB00072","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5805,"DB02000","BE0003783","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5806,"DB03401","BE0004490","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5807,"DB01331","BE0002393","# Matsuhashi M, Tamaki S: Enzymatic studies on the mechanism of action of cefoxitin. Correlation between the affinities of cefoxitin to penicillin-binding proteins and its rates of inhibition of the respective penicillin-sensitive reactions in E. coli. J "
5808,"DB02170","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5809,"DB04141","BE0003860","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5810,"DB03222","BE0000113","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5811,"DB01224","BE0000145","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
5812,"DB04085","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5813,"DB01065","BE0001075","# Galijasevic S, Abdulhamid I, Abu-Soud HM: Melatonin is a potent inhibitor for myeloperoxidase. Biochemistry. 2008 Feb 26;47(8):2668-77. Epub 2008 Feb 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18237195"
5814,"DB03706","BE0000812","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5815,"DB01421","BE0004799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5816,"DB04286","BE0001942","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5817,"DB01142","BE0000289","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
5818,"DB00755","BE0000697","# Xu J, Tian J, Shapiro SD: Normal lung development in RAIG1-deficient mice despite unique lung epithelium-specific expression. Am J Respir Cell Mol Biol. 2005 May;32(5):381-7. Epub 2005 Jan 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15677768# Inoue "
5819,"DB08765","BE0001855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5820,"DB00131","BE0003540","# Park J, Gupta RS: Adenosine kinase and ribokinase--the RK family of proteins. Cell Mol Life Sci. 2008 Sep;65(18):2875-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18560757# Leoncini R, Vannoni D, Santoro A, Giglioni S, Carli R, Marinello E: Adenosine"
5821,"DB03280","BE0001218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5822,"DB04272","BE0003256",""
5823,"DB03177","BE0001229","# Cheong CG, Escalante-Semerena JC, Rayment I: Structural investigation of the biosynthesis of alternative lower ligands for cobamides by nicotinate mononucleotide: 5,6-dimethylbenzimidazole phosphoribosyltransferase from Salmonella enterica. J Biol Chem."
5824,"DB07394","BE0003841","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5825,"DB01338","BE0000738","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Karpati E, Biro K, Kukorelli T: [Investigation of neuromuscul"
5826,"DB07751","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5827,"DB01003","BE0001191","# Arumugam T, Ramachandran V, Logsdon CD: Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst. 2006 Dec 20;98(24):1806-18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17179482"
5828,"DB02080","BE0001640","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5829,"DB00157","BE0000592","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5830,"DB01034","BE0000801","# Kauppinen S, Siggaard-Andersen M, von Wettstein-Knowles P: beta-Ketoacyl-ACP synthase I of Escherichia coli: nucleotide sequence of the fabB gene and identification of the cerulenin binding residue. Carlsberg Res Commun. 1988;53(6):357-70. \"Pubmed\":http"
5831,"DB05280","BE0000581",""
5832,"DB01352","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
5833,"DB00327","BE0000770","# Quigley C: Hydromorphone for acute and chronic pain. Cochrane Database Syst Rev. 2002;(1):CD003447. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11869661# Inturrisi CE: Clinical pharmacology of opioids for pain. Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-1"
5834,"DB00751","BE0000501","# Dupont LJ, Meade CJ, Demedts MG, Verleden GM: Epinastine (WAL 801CL) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptor. Eur Respir J. 1996 Jul;9(7):1433-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
5835,"DB01136","BE0000575","# Koshimizu TA, Tsujimoto G, Hirasawa A, Kitagawa Y, Tanoue A: Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res. 2004 Sep 1;63(4):662-72. \"Pubmed\":http://ww"
5836,"DB04311","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5837,"DB00754","BE0000197","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5838,"DB00268","BE0000145","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
5839,"DB00324","BE0000794","# Samudre SS, Lattanzio FA Jr, Williams PB, Sheppard JD Jr: Comparison of topical steroids for acute anterior uveitis. J Ocul Pharmacol Ther. 2004 Dec;20(6):533-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15684812# Grossman R, Yehuda R, Golier J, McEw"
5840,"DB00346","BE0000575","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM: Evaluation of the pharmac"
5841,"DB03807","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5842,"DB01497","BE0000947","# Sanchez-Blazquez P, Garzon J: Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice. Life Sci. 1992;50(26):2083-97. \"Pubmed\":http://www.ncbi.nl"
5843,"DB04464","BE0003849","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5844,"DB02007","BE0001423","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5845,"DB00078","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5846,"DB04395","BE0004622","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5847,"DB01024","BE0000722","# Vannozzi F, Filipponi F, Di Paolo A, Danesi R, Urbani L, Bocci G, Catalano G, De Simone P, Mosca F, Del Tacca M: An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant rec"
5848,"DB04849","BE0000369","# Wedge SR, Kendrew J, Hennequin LF, Valentine PJ, Barry ST, Brave SR, Smith NR, James NH, Dukes M, Curwen JO, Chester R, Jackson JA, Boffey SJ, Kilburn LL, Barnett S, Richmond GH, Wadsworth PF, Walker M, Bigley AL, Taylor ST, Cooper L, Beck S, Jurgensmei"
5849,"DB05424","BE0000767",""
5850,"DB04893","BE0002373","# Wakeling AE: Inhibitors of growth factor signalling. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S183-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16113095"
5851,"DB07571","BE0004002","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5852,"DB00246","BE0000575","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
5853,"DB08238","BE0000689","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5854,"DB02115","BE0000133","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5855,"DB03247","BE0003020",""
5856,"DB01363","BE0004674","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Henry JP, Sagne C, Bedet C, Gasnier B: The vesicula"
5857,"DB04075","BE0001949","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5858,"DB04493","BE0003931","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5859,"DB03147","BE0001543","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5860,"DB00159","BE0000017","# Malkowski MG, Thuresson ED, Lakkides KM, Rieke CJ, Micielli R, Smith WL, Garavito RM: Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J Biol Chem. 2001 Oct 5;276(40):37547-55. Epub "
5861,"DB08599","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5862,"DB08562","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5863,"DB08674","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5864,"DB04447","BE0001823","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5865,"DB07558","BE0003916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5866,"DB00155","BE0000766","# Mishima T, Hamada T, Ui-Tei K, Takahashi F, Miyata Y, Imaki J, Suzuki H, Yamashita K: Expression of DDAH1 in chick and rat embryos. Brain Res Dev Brain Res. 2004 Feb 20;148(2):223-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14766200# Tran CT, Fox MF"
5867,"DB05271","BE0000756","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
5868,"DB02039","BE0000558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5869,"DB01702","BE0002510","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5870,"DB02266","BE0000017","# Ouellet M, Percival MD: Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem J. 1995 Feb 15;306 ( Pt 1):247-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7864817"
5871,"DB00463","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
5872,"DB00396","BE0000344","# Haidar S, Hartmann RW: C16 and C17 substituted derivatives of pregnenolone and progesterone as inhibitors of 17alpha-hydroxylase-C17, 20-lyase: synthesis and biological evaluation. Arch Pharm (Weinheim). 2002;335(11-12):526-34. \"Pubmed\":http://www.ncbi."
5873,"DB00139","BE0002208","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5874,"DB02482","BE0001200","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5875,"DB04988","BE0000511","# Farhan H, Schuster C, Klinger M, Weisz E, Waxenecker G, Schuster M, Sexl V, Mudde GC, Freissmuth M, Kircheis R: Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen. J Pharmacol Exp T"
5876,"DB07362","BE0000991","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5877,"DB01826","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5878,"DB03814","BE0002626",""
5879,"DB00823","BE0000123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5880,"DB00683","BE0002344","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
5881,"DB07953","BE0004065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5882,"DB04232","BE0001116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5883,"DB03010","BE0001415","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5884,"DB08112","BE0001258","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5885,"DB04272","BE0003261",""
5886,"DB01150","BE0003395","# Nagai K, Davies TA, Jacobs MR, Appelbaum PC: Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical "
5887,"DB01329","BE0000744","# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhashi S: Affinity of cefoperazone for penicillin-binding proteins. Antimicrob Agents Chemother. 1980 Jul;18(1):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6448021"
5888,"DB02994","BE0003945","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5889,"DB00602","BE0000414","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Yates DM, Wolstenholme AJ: An ivermectin-sensitive glutamate-"
5890,"DB01136","BE0000342","# Koshimizu TA, Tsujimoto G, Hirasawa A, Kitagawa Y, Tanoue A: Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res. 2004 Sep 1;63(4):662-72. \"Pubmed\":http://ww"
5891,"DB03730","BE0002666",""
5892,"DB00894","BE0002090","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Raman JD, Schlegel PN: Aromatase inhibitors for male infertility. J Urol. 2002 Feb;167(2 Pt 1):624"
5893,"DB04395","BE0003931","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5894,"DB01023","BE0000418","# Bostrom SL, Westerlund C, Rochester S, Vogel HJ: Binding of a dihydropyridine felodipine-analogue to calmodulin and related calcium-binding proteins. Biochem Pharmacol. 1988 Oct 1;37(19):3723-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3178884# Johns"
5895,"DB03147","BE0002774",""
5896,"DB04395","BE0000799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5897,"DB08896","BE0004742","# FDA label"
5898,"DB02407","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5899,"DB05466","BE0000384",""
5900,"DB00306","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
5901,"DB03102","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5902,"DB00157","BE0000096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5903,"DB01752","BE0002527",""
5904,"DB08896","BE0004741","# FDA label"
5905,"DB00206","BE0000118","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5906,"DB02440","BE0003761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5907,"DB05210","BE0002386",""
5908,"DB00110","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5909,"DB05216","BE0000453","# Mahadevan D, Cooke L, Riley C, Swart R, Simons B, Della Croce K, Wisner L, Iorio M, Shakalya K, Garewal H, Nagle R, Bearss D: A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene. 2007 Jun 7;2"
5910,"DB00530","BE0000767","# Kim TE, Murren JR: Erlotinib OSI/Roche/Genentech. Curr Opin Investig Drugs. 2002 Sep;3(9):1385-95. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12498017# Laird AD, Cherrington JM: Small molecule tyrosine kinase inhibitors: clinical development of antican"
5911,"DB01081","BE0000420","# Coupar IM: The peristaltic reflex in the rat ileum: evidence for functional mu- and delta-opiate receptors. J Pharm Pharmacol. 1995 Aug;47(8):643-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8583364"
5912,"DB01608","BE0000020","# Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7918347"
5913,"DB06782","BE0004802","# Flora SJ, Pachauri V: Chelation in metal intoxication. Int J Environ Res Public Health. 2010 Jul;7(7):2745-88. Epub 2010 Jun 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20717537"
5914,"DB00975","BE0000631","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5915,"DB07645","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5916,"DB00321","BE0000897","# Punke MA, Friederich P: Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels. Anesth Analg. 2007 May;104(5):1256-64, tables of contents. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17456683"
5917,"DB00656","BE0000749","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821"
5918,"DB00886","BE0000221","# Azizi M, Massien C, Michaud A, Corvol P: In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor. Hypertension. 2000 Jun;35(6):1226-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10856268# Ferdinand KC: Ad"
5919,"DB03968","BE0000270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5920,"DB08446","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5921,"DB03382","BE0002390","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5922,"DB00487","BE0004950","# Tabary X, Moreau N, Dureuil C, Le Goffic F: Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I. Antimicrob Agents Chemother. 1987 Dec;31(12):1925-8. \"Pubmed\":http://www.ncbi"
5923,"DB01204","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Takeda K, Shinohara K, Kameda N, Ariyoshi K: A case of therapy-related acute myeloblastic leukemia"
5924,"DB00334","BE0004797","# Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT: Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 1996 Feb;14(2):87-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8822"
5925,"DB01281","BE0000846","# Scheinfeld N: Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists. J Dermatolog Treat. 2006;17(4):229-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16971318# Vincenti F, Luggen M: T cell costimulation: a "
5926,"DB08726","BE0004228","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5927,"DB00205","BE0000330","# Rastelli G, Pacchioni S, Parenti MD: Structure of Plasmodium vivax dihydrofolate reductase determined by homology modeling and molecular dynamics refinement. Bioorg Med Chem Lett. 2003 Oct 6;13(19):3257-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12"
5928,"DB00977","BE0000123","# Micevych PE, Chaban V, Ogi J, Dewing P, Lu JK, Sinchak K: Estradiol stimulates progesterone synthesis in hypothalamic astrocyte cultures. Endocrinology. 2007 Feb;148(2):782-9. Epub 2006 Nov 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17095591# Garcia"
5929,"DB01809","BE0001424","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5930,"DB08185","BE0004198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5931,"DB07391","BE0001982","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5932,"DB04556","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5933,"DB03074","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5934,"DB03629","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5935,"DB00612","BE0000172","# Breed JG, Ciampricotti R, Tromp GP, Valster FA, Lageweg E, Van Bortel LM: Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril. J Cardiovasc Pharmacol. 1992;20(5):750-5. \"Pubmed\":http://www.ncbi.n"
5936,"DB06713","BE0000557","# Pasqualini JR: Breast cancer and steroid metabolizing enzymes: the role of progestogens. Maturitas. 2009 Dec;65 Suppl 1:S17-21. Epub 2009 Dec 3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19962254# London RS, Chapdelaine A, Upmalis D, Olson W, Smith J:"
5937,"DB08222","BE0003898","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5938,"DB02613","BE0000382","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5939,"DB00653","BE0002355","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5940,"DB04634","BE0003879","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5941,"DB02506","BE0003750","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5942,"DB00321","BE0000486","# Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ: Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry. 2004 Feb 1;55(3):320-2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14744"
5943,"DB00114","BE0002164","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5944,"DB00862","BE0003556","# Zhang XJ, Cahill KB, Elfenbein A, Arshavsky VY, Cote RH: Direct allosteric regulation between the GAF domain and catalytic domain of photoreceptor phosphodiesterase PDE6. J Biol Chem. 2008 Oct 31;283(44):29699-705. Epub 2008 Sep 8. \"Pubmed\":http://www.n"
5945,"DB00118","BE0000372","# Rowling MJ, Schalinske KL: Retinoid compounds activate and induce hepatic glycine N-methyltransferase in rats. J Nutr. 2001 Jul;131(7):1914-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11435507# Luka Z, Cerone R, Phillips JA 3rd, Mudd HS, Wagner C: Mu"
5946,"DB01110","BE0004425","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
5947,"DB05046","BE0000770",""
5948,"DB02703","BE0001542","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5949,"DB04147","BE0004181","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5950,"DB05452","BE0000165",""
5951,"DB00245","BE0000092","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targe"
5952,"DB08515","BE0003913","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5953,"DB02338","BE0001979","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5954,"DB04224","BE0001854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5955,"DB00794","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
5956,"DB00477","BE0000020","# Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7918347"
5957,"DB04147","BE0001200","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5958,"DB00157","BE0000126","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5959,"DB00142","BE0000365","# Miglio G, Dianzani C, Fallarini S, Fantozzi R, Lombardi G: Stimulation of N-methyl-D-aspartate receptors modulates Jurkat T cell growth and adhesion to fibronectin. Biochem Biophys Res Commun. 2007 Sep 21;361(2):404-9. Epub 2007 Jul 20. \"Pubmed\":http://"
5960,"DB07237","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5961,"DB00674","BE0004664","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
5962,"DB05341","BE0002458",""
5963,"DB08378","BE0004292","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5964,"DB00795","BE0001154","# Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000 Nov;119(5):1209-18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
5965,"DB02210","BE0001076","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5966,"DB03909","BE0004454","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5967,"DB04430","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5968,"DB03461","BE0000574","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5969,"DB00847","BE0004827","# Omran Z, Kay G, Di Salvo A, Knott RM, Cairns D: PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis. Bioorg Med Chem Lett. 2011 Jan 1;21(1):45-7. Epub 2010 Nov 21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21147534"
5970,"DB07257","BE0003335","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5971,"DB09016","BE0000442","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881# Wander TJ, Nelson A, Okazaki H, Richels"
5972,"DB00143","BE0000812","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5973,"DB04757","BE0000250","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5974,"DB03970","BE0002015","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5975,"DB04149","BE0001287",""
5976,"DB07029","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5977,"DB00546","BE0002346","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
5978,"DB00215","BE0000749","# Eriksson E, Engberg G, Bing O, Nissbrandt H: Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain. Neuropsychopharmacology. 1999 Mar;20(3):287-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10063489# Maines LW, Kec"
5979,"DB07525","BE0002131","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5980,"DB01355","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
5981,"DB08273","BE0004264","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5982,"DB03035","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5983,"DB01922","BE0002639",""
5984,"DB01837","BE0000017","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5985,"DB01880","BE0001293","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5986,"DB04205","BE0001977","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5987,"DB04892","BE0002180","# Janas AM, Cunningham SC, Duffy KB, Devan BD, Greig NH, Holloway HW, Yu QS, Markowska AL, Ingram DK, Spangler EL: The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats. Life Sci. 2005 Jan 21;76(10):1"
5988,"DB04391","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5989,"DB01037","BE0002198","# Patkar AA, Pae CU, Masand PS: Transdermal selegiline: the new generation of monoamine oxidase inhibitors. CNS Spectr. 2006 May;11(5):363-75. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16641841# Azzaro AJ, Ziemniak J, Kemper E, Campbell BJ, VanDenBerg C"
5990,"DB00149","BE0000450","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5991,"DB08576","BE0001982","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5992,"DB04113","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5993,"DB00127","BE0000964","# Lopatin AN, Shantz LM, Mackintosh CA, Nichols CG, Pegg AE: Modulation of potassium channels in the hearts of transgenic and mutant mice with altered polyamine biosynthesis. J Mol Cell Cardiol. 2000 Nov;32(11):2007-24. \"Pubmed\":http://www.ncbi.nlm.nih.go"
5994,"DB00162","BE0000583","# Nakazawa N, Montedonico S, Takayasu H, Paradisi F, Puri P: Disturbance of retinol transportation causes nitrofen-induced hypoplastic lung. J Pediatr Surg. 2007 Feb;42(2):345-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17270546# Everts HB, Sundberg JP"
5995,"DB04872","BE0002371","# Tian G, Wilkins D, Scott CW: Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competitio"
5996,"DB04272","BE0001719","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5997,"DB07226","BE0003335","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
5998,"DB02954","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
5999,"DB04244","BE0003417","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6000,"DB01915","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6001,"DB08346","BE0001898","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6002,"DB01403","BE0000442","# Hals PA, Hall H, Dahl SG: Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites. Life Sci. 1988;43(5):405-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2899826"
6003,"DB00157","BE0000569","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6004,"DB02216","BE0000941","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6005,"DB04788","BE0003367","# Vassylyev DG, Svetlov V, Vassylyeva MN, Perederina A, Igarashi N, Matsugaki N, Wakatsuki S, Artsimovitch I: Structural basis for transcription inhibition by tagetitoxin. Nat Struct Mol Biol. 2005 Dec;12(12):1086-93. Epub 2005 Nov 6. \"Pubmed\":http://www."
6006,"DB01589","BE0003595","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
6007,"DB00155","BE0000671","# Braissant O, Honegger P, Loup M, Iwase K, Takiguchi M, Bachmann C: Hyperammonemia: regulation of argininosuccinate synthetase and argininosuccinate lyase genes in aggregating cell cultures of fetal rat brain. Neurosci Lett. 1999 May 7;266(2):89-92. \"Pub"
6008,"DB01247","BE0002196","# Mason ST: Chronic administration of type A monoamine oxidase inhibitors increases duration of thiopentone anaesthesia in the rat. Physiol Behav. 1985 Aug;35(2):201-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/4070383# Kettler R, Da Prada M, Burkard WP"
6009,"DB04940","BE0000246","# Kuznetsov G, Towle MJ, Cheng H, Kawamura T, TenDyke K, Liu D, Kishi Y, Yu MJ, Littlefield BA: Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389. Cancer Res. 2004 A"
6010,"DB00151","BE0001145","# Niture SK, Velu CS, Smith QR, Bhat GJ, Srivenugopal KS: Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines. Carcinogenesis. 2007 Feb;28(2):378-89"
6011,"DB07125","BE0003788","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6012,"DB01142","BE0000291","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Maj J, Gancarczyk L, Gorsz"
6013,"DB00690","BE0003598","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
6014,"DB07827","BE0000966","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6015,"DB05184","BE0000014",""
6016,"DB01726","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6017,"DB04210","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6018,"DB00786","BE0003695","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
6019,"DB03553","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6020,"DB00685","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6021,"DB00917","BE0000368","# Baryawno N, Sveinbjornsson B, Eksborg S, Orrego A, Segerstrom L, Oqvist CO, Holm S, Gustavsson B, Kagedal B, Kogner P, Johnsen JI: Tumor-growthpromoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets. Neuro Oncol."
6022,"DB08453","BE0003906","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6023,"DB01000","BE0003577","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6024,"DB03140","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6025,"DB01968","BE0002667",""
6026,"DB05070","BE0001192",""
6027,"DB00054","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6028,"DB04217","BE0001511","# Mihara H, Fujii T, Kato S, Kurihara T, Hata Y, Esaki N: Structure of external aldimine of Escherichia coli CsdB, an IscS/NifS homolog: implications for its specificity toward selenocysteine. J Biochem. 2002 May;131(5):679-85. \"Pubmed\":http://www.ncbi.nl"
6029,"DB02779","BE0001071","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6030,"DB06147","BE0002360","# Nichols BP, Guay GG: Gene amplification contributes to sulfonamide resistance in Escherichia coli. Antimicrob Agents Chemother. 1989 Dec;33(12):2042-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2694948"
6031,"DB05442","BE0001051",""
6032,"DB02508","BE0004143","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6033,"DB02966","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6034,"DB01727","BE0001251","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6035,"DB00514","BE0000290","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6036,"DB03018","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6037,"DB01026","BE0004883","# Trachtenberg J, Zadra J: Steroid synthesis inhibition by ketoconazole: sites of action. Clin Invest Med. 1988 Feb;11(1):1-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2966691# Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D: Ketoconazole blocks adren"
6038,"DB03673","BE0000753","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6039,"DB00091","BE0002143","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6040,"DB03698","BE0001961","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6041,"DB01393","BE0001007","# Tenenbaum A, Motro M, Fisman EZ: Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol. 2005 Sep 16;4:14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16168052"
6042,"DB06216","BE0000020","# Citrome L: Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatr Dis Treat. 2011;7:325-39. Epub 2011 May 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21655346# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharm"
6043,"DB03247","BE0003030",""
6044,"DB00141","BE0000109","# Lee YC, Wu HM, Chang YN, Wang WC, Hsu WH: The central cavity from the (alpha/alpha)6 barrel structure of Anabaena sp. CH1 N-acetyl-D-glucosamine 2-epimerase contains two key histidine residues for reversible conversion. J Mol Biol. 2007 Mar 30;367(3):89"
6045,"DB01174","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
6046,"DB03600","BE0004040","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6047,"DB04752","BE0003359",""
6048,"DB02728","BE0001855","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6049,"DB01329","BE0002063","# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhashi S: Affinity of cefoperazone for penicillin-binding proteins. Antimicrob Agents Chemother. 1980 Jul;18(1):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6448021"
6050,"DB02688","BE0002667",""
6051,"DB00801","BE0000471","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
6052,"DB02831","BE0002022","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6053,"DB08680","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6054,"DB00852","BE0000172","# Vansal SS, Feller DR: Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol. 1999 Sep 1;58(5):807-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10449190"
6055,"DB07521","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6056,"DB04015","BE0002012","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6057,"DB04456","BE0001321","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6058,"DB00690","BE0000129","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
6059,"DB01238","BE0000581","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6060,"DB00567","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6061,"DB01200","BE0000650","# Knight JA, Smith C, Toohey N, Klein MT, Teitler M: Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists. Mol Pharmacol. 2009"
6062,"DB01121","BE0000141","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6063,"DB08423","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6064,"DB04727","BE0000369",""
6065,"DB00028","BE0004685","# Baerenwaldt A, Biburger M, Nimmerjahn F: Mechanisms of action of intravenous immunoglobulins. Expert Rev Clin Immunol. 2010 May;6(3):425-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20441428# Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, K"
6066,"DB06921","BE0003257","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6067,"DB00268","BE0000659","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
6068,"DB05777","BE0000048",""
6069,"DB00143","BE0000807","# Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, Garcia-Closas R, Silverman D, Chanock S, Welch R, Tardon A, Serra C, Carrato A, Dosemeci M, Garcia-Closas M: Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and su"
6070,"DB01675","BE0000605","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6071,"DB01244","BE0001024","# Abusamhadneh E, Abbott MB, Dvoretsky A, Finley N, Sasi S, Rosevear PR: Interaction of bepridil with the cardiac troponin C/troponin I complex. FEBS Lett. 2001 Sep 28;506(1):51-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11591369# Wang X, Li MX, Sykes"
6072,"DB08231","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6073,"DB01346","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
6074,"DB01690","BE0001231","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6075,"DB05391","BE0001025",""
6076,"DB04699","BE0003351",""
6077,"DB08221","BE0003379","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6078,"DB01812","BE0002561",""
6079,"DB00157","BE0000525","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6080,"DB05321","BE0001313",""
6081,"DB05034","BE0000556",""
6082,"DB01065","BE0000220","# Radogna F, Paternoster L, De Nicola M, Cerella C, Ammendola S, Bedini A, Tarzia G, Aquilano K, Ciriolo M, Ghibelli L: Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicol Appl Phar"
6083,"DB07027","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6084,"DB02249","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6085,"DB03721","BE0004482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6086,"DB04991","BE0002404",""
6087,"DB03435","BE0001334","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6088,"DB05387","BE0001198",""
6089,"DB05035","BE0000687",""
6090,"DB00098","BE0003573","# Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003 Feb;3(2):189-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12586600"
6091,"DB03793","BE0001660","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6092,"DB04615","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6093,"DB07080","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6094,"DB00945","BE0000521","# Talbodec A, Berkane N, Blandin V, Breittmayer JP, Ferrari E, Frelin C, Vigne P: Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism. Mol Pharmacol. 2000 Apr;57(4):797-804. \"Pubmed\":http://www.ncbi.nlm.nih.go"
6095,"DB00477","BE0000973","# Yoshida Y, Arimoto K, Sato M, Sakuragawa N, Arima M, Satoyoshi E: Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs. J Biochem. 1985 Dec;98(6):1669-79. \"Pubmed\":http://www.ncbi.nlm.n"
6096,"DB01173","BE0000641","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6097,"DB04272","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6098,"DB04201","BE0001860","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6099,"DB04693","BE0001607",""
6100,"DB00254","BE0000019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6101,"DB02358","BE0000617","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6102,"DB03486","BE0001746","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6103,"DB04099","BE0001832","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6104,"DB02865","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6105,"DB04014","BE0001082","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
6106,"DB04570","BE0000744","# Labia R, Baron P, Masson JM: Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins. J Antimicrob Chemother. 1985 Jan;15(1):9-15. \"Pubmed\":http://www.ncbi.nlm.nih.go"
6107,"DB01107","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790 (Accessed December 2013)"
6108,"DB07193","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6109,"DB02566","BE0004325","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6110,"DB04821","BE0000486","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821"
6111,"DB01331","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6112,"DB04132","BE0000962","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6113,"DB07204","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6114,"DB02056","BE0000592","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6115,"DB02919","BE0000330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6116,"DB00015","BE0000240","# Hilleman DE, Tsikouris JP, Seals AA, Marmur JD: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Pharmacotherapy. 2007 Nov;27(11):1558-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17963464"
6117,"DB01151","BE0000533","# Palvimaki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J: Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berl). 1996 Aug;126(3):234-40. \"Pubmed\":http://www.ncbi.nlm"
6118,"DB00119","BE0000195","# Kay HH, Zhu S, Tsoi S: Hypoxia and lactate production in trophoblast cells. Placenta. 2007 Aug-Sep;28(8-9):854-60. Epub 2007 Feb 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17275903# Han M, Trotta P, Coleman C, Linask KK: MCT-4, A511/Basigin and EF5 "
6119,"DB01149","BE0000575","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 20"
6120,"DB02899","BE0004009","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6121,"DB05383","BE0000747",""
6122,"DB04132","BE0002281",""
6123,"DB00798","BE0000279","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6124,"DB03793","BE0001976","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6125,"DB04066","BE0003205","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6126,"DB05202","BE0001025",""
6127,"DB08527","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6128,"DB04180","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6129,"DB02869","BE0001909","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6130,"DB00978","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
6131,"DB00458","BE0000575","# Nojimoto FD, Mueller A, Hebeler-Barbosa F, Akinaga J, Lima V, Kiguti LR, Pupo AS: The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors. Neuropharmacology. 2010 Jul-Aug;59(1"
6132,"DB00157","BE0000338","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6133,"DB00449","BE0000426","# Nakamura M, Shirasawa E, Hikida M: Characterization of esterases involved in the hydrolysis of dipivefrin hydrochloride. Ophthalmic Res. 1993;25(1):46-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8446367"
6134,"DB08183","BE0002408","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6135,"DB02772","BE0002832",""
6136,"DB00207","BE0004800","# Ng LK, Martin I, Liu G, Bryden L: Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2002 Sep;46(9):3020-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12183262# Jalava J, Vaara M, Huovinen P"
6137,"DB08901","BE0000842","# Gushwa NN, Kang S, Chen J, Taunton J: Selective targeting of distinct active site nucleophiles by irreversible SRC-family kinase inhibitors. J Am Chem Soc. 2012 Dec 19;134(50):20214-7. doi: 10.1021/ja310659j. Epub 2012 Dec 4. \"Pubmed\":http://www.ncbi.nl"
6138,"DB00131","BE0000350","# Ingram-Smith C, Smith KS: AMP-forming acetyl-CoA synthetases in Archaea show unexpected diversity in substrate utilization. Archaea. 2007 May;2(2):95-107. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17350930# Linne U, Schafer A, Stubbs MT, Marahiel MA: "
6139,"DB01254","BE0000453","# Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY, Bokemeyer C, Deininger MW, Druker BJ, Heinrich MC: Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation "
6140,"DB00116","BE0001240","# Wolan DW, Greasley SE, Wall MJ, Benkovic SJ, Wilson IA: Structure of avian AICAR transformylase with a multisubstrate adduct inhibitor beta-DADF identifies the folate binding site. Biochemistry. 2003 Sep 23;42(37):10904-14. \"Pubmed\":http://www.ncbi.nlm."
6141,"DB02892","BE0001593","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6142,"DB03106","BE0000978","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6143,"DB03313","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6144,"DB01133","BE0004801","# Jahnke W, Henry C: An in vitro assay to measure targeted drug delivery to bone mineral. ChemMedChem. 2010 May 3;5(5):770-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20209564# Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russ"
6145,"DB04707","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6146,"DB00909","BE0003638","# Janszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases] Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20025128# Kothare SV, Kaleyias J: Zonisamide: review of pharm"
6147,"DB04100","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6148,"DB00020","BE0002114","# Menon K, Wu Y, Haas J, Sahu SK, Yang B, Zaheer A: Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice. Neurosci Res. 2007 Jun;58(2):156-63. Epub 2007 Feb 22."
6149,"DB02472","BE0002214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6150,"DB03721","BE0001947","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6151,"DB01772","BE0001065","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6152,"DB03568","BE0001647","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6153,"DB07483","BE0003956","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6154,"DB00661","BE0002358","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880"
6155,"DB00075","BE0000901","# Pellegrini P, Berghella AM, Del Beato T, Adorno D, Casciani CU: Immunological directives for biotherapy improvement in the treatment of colorectal cancer. Cancer Biother Radiopharm. 1996 Apr;11(2):113-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10851"
6156,"DB00422","BE0000749","# Dresel SH, Kung MP, Huang X, Plossl K, Hou C, Shiue CY, Karp J, Kung HF: In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates. Eur J Nucl Med. 1999 Apr;26(4):342-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10199939# Ize"
6157,"DB02175","BE0002708",""
6158,"DB03721","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6159,"DB00142","BE0000825","# Karmaker S, Saha TK, Yoshikawa Y, Yasui H, Sakurai H: A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex. J Inorg Biochem. 2006 Sep;100(9):1535-46. Epub 2006 May 24. \"Pubmed\":http://www.ncbi.nlm.n"
6160,"DB07686","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6161,"DB02007","BE0001199","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6162,"DB01681","BE0004462","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6163,"DB00546","BE0003619","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
6164,"DB04168","BE0001289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6165,"DB01224","BE0000045","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
6166,"DB04310","BE0001651","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6167,"DB03758","BE0001165","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6168,"DB00126","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6169,"DB04482","BE0001522","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6170,"DB07154","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6171,"DB00030","BE0000941","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6172,"DB01049","BE0004797","# Tvrdeic A, Pericic D: Effect of ergot alkaloids on 3H-flunitrazepam binding to mouse brain GABAA receptors. Coll Antropol. 2003;27 Suppl 1:175-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12955907# Tvrdeic A, Pericic D: Dihydrogenated ergot compounds"
6173,"DB00307","BE0000412","# Lowe MN, Plosker GL: Bexarotene. Am J Clin Dermatol. 2000 Jul-Aug;1(4):245-50; discussion 251-2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11702369# Tsai DE, Luger SM, Andreadis C, Vogl DT, Kemner A, Potuzak M, Goradia A, Loren AW, Perl AE, Schuster S"
6174,"DB00801","BE0003598","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
6175,"DB07553","BE0003985","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6176,"DB01262","BE0000892","# Ando T, Nishimura M, Oka Y: Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells. Leukemia. 2000 Nov;14(11):1915-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11069027# Karpf AR, Moore BC, Ririe "
6177,"DB06858","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6178,"DB07496","BE0003964","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6179,"DB04606","BE0000333",""
6180,"DB04417","BE0004457","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6181,"DB02214","BE0001449","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6182,"DB02407","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6183,"DB02743","BE0002730",""
6184,"DB03081","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6185,"DB03904","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6186,"DB03869","BE0001579","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6187,"DB00274","BE0003577","# Yokota T, Yoshida R, Utsui Y, Tajima M: Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus. Drugs Exp Clin Res. 1985;11(1):29-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3915273"
6188,"DB03517","BE0001301","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6189,"DB04845","BE0001415","# Vahdat L: Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms. Oncologist. 2008 Mar;13(3):214-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18378531# Denduluri N, Swain SM: Ixabepilone for the trea"
6190,"DB03360","BE0002848",""
6191,"DB07033","BE0001193","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6192,"DB00483","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6193,"DB03461","BE0001681","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6194,"DB00454","BE0000417","# Yamakura T, Sakimura K, Shimoji K: N-methyl-D-aspartate receptor channel block by meperidine is dependent on extracellular pH. Anesth Analg. 2000 Apr;90(4):928-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10735801"
6195,"DB08266","BE0003367","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6196,"DB04154","BE0001412","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6197,"DB03659","BE0004793","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6198,"DB00184","BE0003585","# Mansvelder HD, Mertz M, Role LW: Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol. 2009 Jun;20(4):432-40. Epub 2009 Jan 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19560048# Narahashi T, Fe"
6199,"DB04573","BE0000792","# Mishra RG, Stanczyk FZ, Burry KA, Oparil S, Katzenellenbogen BS, Nealen ML, Katzenellenbogen JA, Hermsmeyer RK: Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H295-3"
6200,"DB00143","BE0001825","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6201,"DB08315","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6202,"DB03461","BE0001249","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6203,"DB00306","BE0000523","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
6204,"DB04039","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6205,"DB00760","BE0000744","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6206,"DB02379","BE0003247","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6207,"DB00145","BE0002304","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6208,"DB03814","BE0001495","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6209,"DB02228","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6210,"DB00413","BE0000581","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agon"
6211,"DB08795","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6212,"DB03203","BE0004148","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6213,"DB03067","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6214,"DB00777","BE0000756","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6215,"DB07887","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6216,"DB00836","BE0000632","# DeHaven-Hudkins DL, Burgos LC, Cassel JA, Daubert JD, DeHaven RN, Mansson E, Nagasaka H, Yu G, Yaksh T: Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J Pharmacol Exp Ther. 1999 Apr;289(1):494-502. \"Pubmed\":http:/"
6217,"DB04077","BE0001751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6218,"DB08215","BE0003954","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6219,"DB03191","BE0000407","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6220,"DB01224","BE0000020","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6221,"DB01299","BE0002360","# Raman J, Little F, Roper C, Kleinschmidt I, Cassam Y, Maharaj R, Barnes KI: Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozam"
6222,"DB00312","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448 (Accessed December 2013)"
6223,"DB04395","BE0001858","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6224,"DB07230","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6225,"DB02709","BE0000017","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
6226,"DB00320","BE0000797","# Willems EW, Trion M, De Vries P, Heiligers JP, Villalon CM, Saxena PR: Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs. Br J Pharmacol. 1999 Jul;127(5):126"
6227,"DB01189","BE0004797","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
6228,"DB00114","BE0002172","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6229,"DB07376","BE0000333","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6230,"DB00042","BE0002137","# Liu W, Montana V, Chapman ER, Mohideen U, Parpura V: Botulinum toxin type B micromechanosensor. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13621-5. Epub 2003 Oct 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14573702# Chen X, Ji ZL, Chen YZ: TTD: T"
6231,"DB00988","BE0000138","# Goldman JM, Cooper RL, Murr AS: Reproductive functions and hypothalamic catecholamines in response to the soil fumigant metam sodium: adaptations to extended exposures. Neurotoxicol Teratol. 2007 May-Jun;29(3):368-76. Epub 2006 Dec 6. \"Pubmed\":http://ww"
6232,"DB07771","BE0002372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6233,"DB04946","BE0000501","# George M, Amrutheshwar R, Rajkumar RP, Kattimani S, Dkhar SA: Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol. 2013 Apr 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23545936"
6234,"DB01695","BE0003844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6235,"DB08548","BE0004332","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6236,"DB07475","BE0003912","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6237,"DB07314","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6238,"DB01406","BE0000203","# Tian ZZ, Zhao H, Chen BY: [Effect of Chinese herbal medicine for nourishing yin and purging fire on mRNA expressions of gonadotropin-releasing hormone and its receptor in precocious puberty model rats] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Sep;23(9):"
6239,"DB05675","BE0000538","# Spuentrup E, Katoh M, Buecker A, Fausten B, Wiethoff AJ, Wildberger JE, Haage P, Parsons EC Jr, Botnar RM, Graham PB, Vettelschoss M, Gunther RW: Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contra"
6240,"DB03825","BE0001268","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6241,"DB03317","BE0002913",""
6242,"DB05223","BE0002366",""
6243,"DB00540","BE0000486","# Roubert C, Cox PJ, Bruss M, Hamon M, Bonisch H, Giros B: Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity. J Biol Chem. 2001 Mar 16;276(11):8254-60. Epub 2000 Nov 22. \"Pubmed\":http://www"
6244,"DB02753","BE0002706",""
6245,"DB00126","BE0002217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6246,"DB01088","BE0000475","# Takamatsu H, Tsukada H, Watanabe Y, Cui Y, Kataoka Y, Hosoya T, Suzuki M, Watanabe Y: Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia. Brain Res. 2002 Jan 25;925(2):176-82. \"P"
6247,"DB01928","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6248,"DB07810","BE0004096","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6249,"DB02182","BE0001998","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6250,"DB02379","BE0001056","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6251,"DB01044","BE0003725","# Harding I, Simpson I: Fluoroquinolones: is there a different mechanism of action and resistance against Streptococcus pneumoniae? J Chemother. 2000 Oct;12 Suppl 4:7-15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11131958# Rafii F, Park M, Novak JS: Alt"
6252,"DB03799","BE0002012","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6253,"DB01454","BE0000118","# Biezonski DK, Meyer JS: Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem. 2010 Feb;112(4):951-62. Epu"
6254,"DB08683","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6255,"DB03139","BE0001668","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6256,"DB03775","BE0001731","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6257,"DB01616","BE0000291","# Coelho AM, Jacob L, Fioramonti J, Bueno L: Rectal antinociceptive properties of alverine citrate are linked to antagonism at the 5-HT1A receptor subtype. J Pharm Pharmacol. 2001 Oct;53(10):1419-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11697552"
6258,"DB07304","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6259,"DB00759","BE0003708","# Buck MA, Cooperman BS: Single protein omission reconstitution studies of tetracycline binding to the 30S subunit of Escherichia coli ribosomes. Biochemistry. 1990 Jun 5;29(22):5374-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2200507"
6260,"DB07433","BE0003758","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6261,"DB02450","BE0003881","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6262,"DB07095","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6263,"DB04091","BE0004482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6264,"DB06850","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6265,"DB04233","BE0003982","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6266,"DB00281","BE0001143","# Sheets PL, Jackson JO 2nd, Waxman SG, Dib-Hajj SD, Cummins TR: A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol. 2007 Jun 15;581(Pt 3):10"
6267,"DB02124","BE0001548","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6268,"DB00171","BE0000350","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6269,"DB04548","BE0001329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6270,"DB08175","BE0000078","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6271,"DB06267","BE0000182","# Gur S, Sikka SC, Hellstrom WJ: Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stress. Expert Opin Investig Drugs. 2008 Jun;17(6):855-64. \"Pubmed\":http://www.ncbi.nlm.ni"
6272,"DB07039","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6273,"DB08426","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6274,"DB00679","BE0000501","# Sleight AJ, Koek W, Bigg DC: Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors. Eur J Pharmacol. 1993 Jul 20;238(2-3):407-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/76916"
6275,"DB00399","BE0004801","# Jahnke W, Henry C: An in vitro assay to measure targeted drug delivery to bone mineral. ChemMedChem. 2010 May 3;5(5):770-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20209564# Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russ"
6276,"DB07466","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6277,"DB00244","BE0001075","# Nandi J, Saud B, Zinkievich JM, Palma DT, Levine RA: 5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats. Dig Dis Sci. 2008 Jan;53(1):123-32. Epub 2007 May 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
6278,"DB08451","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6279,"DB08095","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6280,"DB08231","BE0003491","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6281,"DB02933","BE0002007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6282,"DB01173","BE0000365","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6283,"DB07053","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6284,"DB00997","BE0004796","# Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Gewirtz DA: Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol. 1994 Apr;45(4):649-56. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8183243# Momparler RL, Karon M, Sie"
6285,"DB07733","BE0000444","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6286,"DB00846","BE0000794","# Baschant U, Tuckermann J: The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol. 2010 May 31;120(2-3):69-75. Epub 2010 Mar 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20346397# Fitzgerald P, O'Brien SM, Scu"
6287,"DB02729","BE0001594","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6288,"DB00313","BE0004901","# Farber NB, Jiang XP, Heinkel C, Nemmers B: Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity. Mol Psychiatry. 2002;7(7):726-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12192617"
6289,"DB04610","BE0001450","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6290,"DB03021","BE0002101","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6291,"DB00668","BE0000704","# van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF: Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest. 1996 Feb 1;97(3):713-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
6292,"DB05168","BE0000271",""
6293,"DB08433","BE0001352","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6294,"DB00157","BE0000244","# Inagaki E, Ohshima N, Takahashi H, Kuroishi C, Yokoyama S, Tahirov TH: Crystal structure of Thermus thermophilus Delta1-pyrroline-5-carboxylate dehydrogenase. J Mol Biol. 2006 Sep 22;362(3):490-501. Epub 2006 Jul 29. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
6295,"DB00202","BE0003438","# Rogers KR, Fernando JC, Thompson RG, Valdes JJ, Eldefrawi ME: Detection of nicotinic receptor ligands with a light addressable potentiometric sensor. Anal Biochem. 1992 Apr;202(1):111-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1621972# Fiacchino F, "
6296,"DB02431","BE0001661","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6297,"DB05155","BE0000632",""
6298,"DB00456","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6299,"DB08646","BE0004359","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6300,"DB04062","BE0001678","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6301,"DB07910","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6302,"DB04586","BE0001438",""
6303,"DB08083","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6304,"DB04894","BE0002147","# Fortune BE, Jackson J, Leonard J, Trotter JF: Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding. Expert Opin Pharmacother. 2009 Oct;10(14):2337-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19708854"
6305,"DB04518","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6306,"DB03814","BE0001423","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6307,"DB01251","BE0000207","# Gribble FM, Ashcroft FM: Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism. 2000 Oct;49(10 Suppl 2):3-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11078468# Harrower"
6308,"DB04400","BE0000005","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6309,"DB00988","BE0000389","# Ostadali MR, Ahangari G, Eslami MB, Razavi A, Zarrindast MR, Ahmadkhaniha HR, Boulhari J: The Detection of Dopamine Gene Receptors (DRD1-DRD5) Expression on Human Peripheral Blood Lymphocytes by Real Time PCR. Iran J Allergy Asthma Immunol. 2004 Dec;3(4"
6310,"DB01337","BE0000738","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Dilger JP, Vidal AM, Liu M, Mettewie C, Suzuki T, Pham A, Dem"
6311,"DB07510","BE0003969","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6312,"DB00413","BE0000342","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
6313,"DB00108","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6314,"DB07392","BE0003852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6315,"DB03084","BE0001097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6316,"DB03608","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6317,"DB01016","BE0001195","# Reddy MM, Quinton PM: Effect of anion transport blockers on CFTR in the human sweat duct. J Membr Biol. 2002 Sep 1;189(1):15-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12202948# Jiang J, Song Y, Bai C, Koller BH, Matthay MA, Verkman AS: Pleural sur"
6318,"DB04941","BE0004746","# Tradtrantip L, Namkung W, Verkman AS: Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels. Mol Pharmacol. 2010 Jan;77(1):69-78. doi: 10.1124/mol.109.06105"
6319,"DB01987","BE0002003","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6320,"DB00005","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6321,"DB00571","BE0000172","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Lewis CJ, Gong H, Brown MJ, Harding SE: Overexpression of beta 1-adrenoceptors in adult rat ventri"
6322,"DB04395","BE0003289",""
6323,"DB02163","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6324,"DB03932","BE0000516","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6325,"DB00380","BE0000742","# Hasinoff BB, Chee GL, Thampatty P, Allan WP, Yalowich JC: The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synth"
6326,"DB05849","BE0000694",""
6327,"DB03010","BE0001388","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6328,"DB02105","BE0002089","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6329,"DB03507","BE0001139","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6330,"DB03355","BE0001923","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6331,"DB05266","BE0002353","# Huang Z, Liu S, Zhang L, Salem M, Greig GM, Chan CC, Natsumeda Y, Noguchi K: Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life Sci. 2006 May 1;78(23):2663-8. Epub 2005 Nov 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16313925"
6332,"DB03147","BE0002364","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6333,"DB08818","BE0004948","# Politz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S, Svineng G, Franke P, Kannicht C, Kzhyshkowska J, Longati P, Velten FW, Johansson S, Goerdt S: Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor hom"
6334,"DB00034","BE0000661","# Dhalluin C, Ross A, Huber W, Gerber P, Brugger D, Gsell B, Senn H: Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNA"
6335,"DB02655","BE0001346","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6336,"DB08595","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6337,"DB04163","BE0001302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6338,"DB07050","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6339,"DB01483","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
6340,"DB03106","BE0002943",""
6341,"DB03461","BE0003120",""
6342,"DB05256","BE0002409",""
6343,"DB08896","BE0000852","# FDA label"
6344,"DB00246","BE0000311","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6345,"DB08827","BE0000232","Stated on FDA label."
6346,"DB07507","BE0001501","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6347,"DB03037","BE0002498","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6348,"DB00142","BE0000253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6349,"DB00915","BE0000630","# Wang C, Takeuchi K, Pinto LH, Lamb RA: Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol. 1993 Sep;67(9):5585-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7688826# Jing X, Ma C, Ohigashi Y, Olivei"
6350,"DB00013","BE0000942","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6351,"DB08890","BE0003502","# Busby RW, Kessler MM, Bartolini WP, Bryant AP, Hannig G, Higgins CS, Solinga RM, Tobin JV, Wakefield JD, Kurtz CB, Currie MG: Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of"
6352,"DB07645","BE0000629","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6353,"DB00849","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
6354,"DB01438","BE0000141","# Ragsdale DS, McPhee JC, Scheuer T, Catterall WA: Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9270-5. \"Pubmed\":http://www.ncbi.nlm"
6355,"DB08316","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6356,"DB00813","BE0000770","# You HJ, Colpaert FC, Arendt-Nielsen L: The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes. Exp Neurol. 2005 Jan;191(1):174-83. \"Pu"
6357,"DB03731","BE0000758","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6358,"DB00334","BE0000112","# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. doi: 10.1177/0269881107082944. Epub 2008 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
6359,"DB02580","BE0004308","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6360,"DB07246","BE0000058","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6361,"DB01235","BE0000581","# Onofrj M, Bonanni L, Thomas A: An expert opinion on safinamide in Parkinson's disease. Expert Opin Investig Drugs. 2008 Jul;17(7):1115-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18549347# Deleu D, Northway MG, Hanssens Y: Clinical pharmacokinetic a"
6362,"DB00126","BE0002221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6363,"DB04842","BE0000451","# Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE: Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73. \"Pu"
6364,"DB03206","BE0001414","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6365,"DB01341","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6366,"DB07000","BE0000634","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6367,"DB08758","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6368,"DB00420","BE0000756","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6369,"DB00456","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6370,"DB08766","BE0003882","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6371,"DB04272","BE0003257",""
6372,"DB03221","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6373,"DB07394","BE0003840","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6374,"DB03226","BE0001076","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6375,"DB01280","BE0000546","# Ono K, Ohashi A, Yamamoto A, Matsukage A, Takahasi T, Saneyoshi M, Ueda T: Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus."
6376,"DB08810","BE0000291","# Alarcon-de-la-Lastra Romero C, Lopez A, Martin MJ, la Casa C, Motilva V: Cinitapride protects against ethanol-induced gastric mucosal injury in rats: role of 5-hydroxytryptamine, prostaglandins and sulfhydryl compounds. Pharmacology. 1997 Apr;54(4):193-"
6377,"DB02448","BE0003997","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6378,"DB01643","BE0001950","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6379,"DB02900","BE0004494","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6380,"DB00349","BE0004797","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
6381,"DB08846","BE0001132","# Wang BH, Lu ZX, Polya GM: Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol. Planta Med. 1998 Apr;64(3):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9581512"
6382,"DB03963","BE0001210","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6383,"DB01034","BE0000800","# Heath RJ, White SW, Rock CO: Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics. Appl Microbiol Biotechnol. 2002 May;58(6):695-703. Epub 2002 Mar 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12021787# Schujman GE, Choi KH, Altabe S,"
6384,"DB04654","BE0001474",""
6385,"DB07638","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6386,"DB04160","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6387,"DB01941","BE0000078","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6388,"DB04665","BE0003336",""
6389,"DB03796","BE0001200","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6390,"DB00714","BE0000451","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
6391,"DB06042","BE0000742",""
6392,"DB01250","BE0000944","# Egan LJ, Sandborn WJ: Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy? Gastroenterology. 1998 Nov;115(5):1295-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9797390# Ito R, Shin-Ya M, Kishida T, "
6393,"DB03904","BE0002010","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6394,"DB07859","BE0001065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6395,"DB03283","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6396,"DB06216","BE0000533","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235# Citrome L: Role of sublingual asenapine i"
6397,"DB06822","BE0000590","# Schlesinger M, Simonis D, Schmitz P, Fritzsche J, Bendas G: Binding between heparin and the integrin VLA-4. Thromb Haemost. 2009 Nov;102(5):816-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19888514"
6398,"DB02342","BE0002090","# Purohit A, Singh A, Ghilchik MW, Reed MJ: Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol. Biochem Biophys Res Commun. 1999 Jul 22;261(1):214-7. \"Pubmed\":http:/"
6399,"DB02379","BE0001728","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6400,"DB07327","BE0003804","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6401,"DB07133","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6402,"DB02515","BE0001256","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6403,"DB05209","BE0002389",""
6404,"DB00157","BE0000194","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6405,"DB00151","BE0000606","# Ashida H, Sawa Y, Shibata H: Cloning, biochemical and phylogenetic characterizations of gamma-glutamylcysteine synthetase from Anabaena sp. PCC 7120. Plant Cell Physiol. 2005 Apr;46(4):557-62. Epub 2005 Feb 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
6406,"DB08257","BE0000950","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6407,"DB04256","BE0000824","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6408,"DB05096","BE0002342",""
6409,"DB05793","BE0003399",""
6410,"DB08566","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6411,"DB00047","BE0000858","# Smith TJ: Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev. 2010 Jun;62(2):199-236. Epub 2010 Apr 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20392809"
6412,"DB00489","BE0000172","# Lowe MD, Lynham JA, Grace AA, Kaumann AJ: Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium. Br J Pharmacol. 2002 Jan;135(2):451-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1181538"
6413,"DB00243","BE0000197","# Hale SL, Kloner RA: Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. J Cardiovasc Pharmacol Ther. 2006 Dec;11(4):249-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17220471# Rajaman"
6414,"DB02545","BE0001777","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6415,"DB04315","BE0004562","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6416,"DB00071","BE0000942","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6417,"DB06855","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6418,"DB00951","BE0000466","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6419,"DB00623","BE0000756","# Seeman P: Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11873706# Hoyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielsen M, Salvesen I: Risperidone versus perphenaz"
6420,"DB01890","BE0000071","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6421,"DB02452","BE0001218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6422,"DB00210","BE0000412","# Bernard BA: Adapalene, a new chemical entity with retinoid activity. Skin Pharmacol. 1993;6 Suppl 1:61-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8142113# Kim MJ, Ciletti N, Michel S, Reichert U, Rosenfield RL: The role of specific retinoid receptor"
6423,"DB07405","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6424,"DB04553","BE0001641","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6425,"DB04550","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6426,"DB00157","BE0000574","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6427,"DB04861","BE0000694","# Nuttall SL, Routledge HC, Kendall MJ: A comparison of the beta1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther. 2003 Jun;28(3):179-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12795776"
6428,"DB04695","BE0003350","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6429,"DB04924","BE0000756","# Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR: A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neuroga"
6430,"DB04395","BE0001247","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6431,"DB03751","BE0002627",""
6432,"DB08437","BE0003833","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6433,"DB02614","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6434,"DB06959","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6435,"DB03289","BE0001321","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6436,"DB00449","BE0000501","# Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G, Tanoue A: alpha(1)-Adrenoceptors are required for normal male sexual function. Br J Pharmacol. 2007 Oct;152(3):332-40. Epub 2007 Jul 2. \"Pubmed\":http://www.ncbi.nlm"
6437,"DB04272","BE0003260",""
6438,"DB02482","BE0002789",""
6439,"DB04398","BE0001787","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6440,"DB03912","BE0001958","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6441,"DB02494","BE0003825","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6442,"DB01483","BE0000523","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
6443,"DB00129","BE0000201","# Korman SH, Kanazawa N, Abu-Libdeh B, Gutman A, Tsujino S: Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family. J Neurol Sci. 2"
6444,"DB00535","BE0003622","# Sanbongi Y, Suzuki T, Osaki Y, Senju N, Ida T, Ubukata K: Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob Agents Chemother. 2006 Jul;50"
6445,"DB00483","BE0000426","# Radic Z, Taylor P: The influence of peripheral site ligands on the reaction of symmetric and chiral organophosphates with wildtype and mutant acetylcholinesterases. Chem Biol Interact. 1999 May 14;119-120:111-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
6446,"DB00210","BE0000078","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6447,"DB00621","BE0000132","# Juul A: The effects of oestrogens on linear bone growth. Hum Reprod Update. 2001 May-Jun;7(3):303-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11392377# Zhao J, Bauman WA, Huang R, Caplan AJ, Cardozo C: Oxandrolone blocks glucocorticoid signaling in "
6448,"DB00139","BE0002253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6449,"DB04566","BE0002047","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6450,"DB07106","BE0002436","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6451,"DB02161","BE0002705","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6452,"DB06692","BE0001091","# Mahdy AM, Webster NR: Perioperative systemic haemostatic agents. Br J Anaesth. 2004 Dec;93(6):842-58. Epub 2004 Jul 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15277296"
6453,"DB01752","BE0002526",""
6454,"DB00163","BE0002324","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6455,"DB07984","BE0000017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6456,"DB06701","BE0000647","# Markowitz JS, Patrick KS: Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S54-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18480678# Ding YS, Fow"
6457,"DB00619","BE0001124","# Gotlib J, Berube C, Growney JD, Chen CC, George TI, Williams C, Kajiguchi T, Ruan J, Lilleberg SL, Durocher JA, Lichy JH, Wang Y, Cohen PS, Arber DA, Heinrich MC, Neckers L, Galli SJ, Gilliland DG, Coutre SE: Activity of the tyrosine kinase inhibitor PK"
6458,"DB02078","BE0004301","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6459,"DB00824","BE0001133","# Featherstone RL, Chambers DJ: Long-term hypothermic lung preservation: does adenosine A1 receptor antagonism have a role in ischemic preconditioning protection? Interact Cardiovasc Thorac Surg. 2004 Mar;3(1):182-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
6460,"DB05369","BE0000112",""
6461,"DB08553","BE0000634","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6462,"DB08661","BE0003317","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6463,"DB04083","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6464,"DB07636","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6465,"DB02890","BE0004473","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6466,"DB00795","BE0000030","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Gout PW, Buckley AR, Simms CR, Bruchovsky N: Sulfasalazine, a potent suppressor of lymphoma growth"
6467,"DB00095","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6468,"DB07708","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6469,"DB00337","BE0000695","# Reitamo S, Remitz A, Kyllonen H, Saarikko J: Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. Am J Clin Dermatol. 2002;3(6):381-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12113647"
6470,"DB02383","BE0000747","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Pro"
6471,"DB07874","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6472,"DB00638","BE0002352","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6473,"DB00114","BE0000778","# Ikeda M, Kihara A, Igarashi Y: Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun. 2004 Dec 3;325(1):338-43."
6474,"DB01142","BE0000247","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Ehlert FJ, Delen FM, Yun S"
6475,"DB04656","BE0001769","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6476,"DB01559","BE0000471","# Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 2008 Oct;9(8):827-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18855614"
6477,"DB08463","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6478,"DB07575","BE0001210","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6479,"DB03588","BE0000939","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6480,"DB03585","BE0003768","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6481,"DB04272","BE0000999","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6482,"DB04742","BE0003356","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6483,"DB08016","BE0001270","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6484,"DB08757","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6485,"DB02429","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6486,"DB02379","BE0001847","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6487,"DB05487","BE0002387",""
6488,"DB00173","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6489,"DB04137","BE0000180","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6490,"DB03963","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6491,"DB01622","BE0000291","# Cosi C, Koek W: Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells. Eur J Pharmacol. 2001 Dec 14;433(1):55-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11755134# Newma"
6492,"DB08846","BE0003634","# Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j"
6493,"DB06945","BE0003730","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6494,"DB00909","BE0002198","# Okada M, Kaneko S, Hirano T, Mizuno K, Kondo T, Otani K, Fukushima Y: Effects of zonisamide on dopaminergic system. Epilepsy Res. 1995 Nov;22(3):193-205. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8991786# Murata M: Zonisamide: a new drug for Parkinson"
6495,"DB01148","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6496,"DB00653","BE0002354","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6497,"DB00230","BE0000356","# Gazulla J, Tintore M: The P/Q-type voltage-dependent calcium channel: a therapeutic target in spinocerebellar ataxia type 6. Acta Neurol Scand. 2007 May;115(5):356-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17489948# Gazulla J, Tintore MA: The P/Q-"
6498,"DB02856","BE0001772","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6499,"DB01068","BE0000736","# Carmel I, Fares FA, Leschiner S, Scherubl H, Weisinger G, Gavish M: Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem Pharmacol. 1999 Jul 15;58(2):273-8. \"Pubmed\":http://www.nc"
6500,"DB00095","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6501,"DB00862","BE0003557","# Zhang XJ, Cahill KB, Elfenbein A, Arshavsky VY, Cote RH: Direct allosteric regulation between the GAF domain and catalytic domain of photoreceptor phosphodiesterase PDE6. J Biol Chem. 2008 Oct 31;283(44):29699-705. Epub 2008 Sep 8. \"Pubmed\":http://www.n"
6502,"DB02196","BE0000214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6503,"DB01942","BE0001792","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6504,"DB06841","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6505,"DB02116","BE0000890","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
6506,"DB04741","BE0001005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6507,"DB00476","BE0000486","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Gould GG, Javors MA, Frazer A: Effect of chronic administration of duloxetine on serotonin and nor"
6508,"DB04648","BE0000286","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6509,"DB08162","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6510,"DB05479","BE0002447",""
6511,"DB02193","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6512,"DB03247","BE0004577","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6513,"DB08231","BE0004242","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6514,"DB08161","BE0004190","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6515,"DB00334","BE0000797","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6516,"DB04677","BE0002196","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6517,"DB07748","BE0004065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6518,"DB00674","BE0004665","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
6519,"DB04342","BE0001274","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6520,"DB06738","BE0000632","# Christensen CB: The opioid receptor binding profiles of ketobemidone and morphine. Pharmacol Toxicol. 1993 Dec;73(6):344-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8153059"
6521,"DB02897","BE0001903","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6522,"DB03147","BE0001523","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6523,"DB04147","BE0003902","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6524,"DB08378","BE0004293","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6525,"DB03518","BE0001856","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6526,"DB00321","BE0000797","# Werling LL, Keller A, Frank JG, Nuwayhid SJ: A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder. Exp Neurol. 2007 Oct;207(2):248-57. Epub 2007 Jun 30."
6527,"DB06148","BE0000572","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
6528,"DB00739","BE0004335","# Neu HC: Aminopenicillins - clinical pharmacology and use in disease states. Int J Clin Pharmacol Biopharm. 1975 Mar;11(2):132-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1095502# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lacta"
6529,"DB01381","BE0002346","# Hanrahan JR, Chebib M, Davucheron NL, Hall BJ, Johnston GA: Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2281-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12824018"
6530,"DB01355","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
6531,"DB00143","BE0000813","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6532,"DB01536","BE0000051","# Ishii-Ohba H, Inano H, Tamaoki B: Purification and properties of testicular 3 beta-hydroxy-5-ene-steroid dehydrogenase and 5-ene-4-ene isomerase. J Steroid Biochem. 1986 Oct;25(4):555-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2945972"
6533,"DB03661","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6534,"DB08645","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6535,"DB08901","BE0000748","# Gozgit JM, Squillace RM, Wongchenko MJ, Miller D, Wardwell S, Mohemmad Q, Narasimhan NI, Wang F, Clackson T, Rivera VM: Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endomet"
6536,"DB04315","BE0001109",""
6537,"DB02333","BE0001318","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6538,"DB00546","BE0002345","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
6539,"DB02900","BE0001369","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6540,"DB06831","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6541,"DB04229","BE0001952","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6542,"DB00721","BE0004917","# Kawashima Y, Nakagawa M, Suzuki Y, Uchiyama M: The relationship between chain elongation of palmitoyl-CoA and phospholipid content in rat liver microsomes. Biochim Biophys Acta. 1976 Aug 23;441(2):173-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9529"
6543,"DB00587","BE0000705","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Adelroth E, Inman MD, Summers E, Pace D, Modi M, O'Byrne PM: Prolonged protection against exercise"
6544,"DB06725","BE0000262","# Renner RM, Jensen JT, Nichols MD, Edelman AB: Pain control in first-trimester surgical abortion: a systematic review of randomized controlled trials. Contraception. 2010 May;81(5):372-88. Epub 2010 Jan 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/203"
6545,"DB05471","BE0002387",""
6546,"DB01254","BE0000014","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Piccaluga PP, Paolini S, Martinelli G: Tyrosine kinase inhibi"
6547,"DB01035","BE0000197","# Weiss R, Barmada MM, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, Angelilli A, Villanueva F, McNamara DM, London B: Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation. 2002 Feb 12;105(6):707-1"
6548,"DB03461","BE0003011",""
6549,"DB08305","BE0000829","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6550,"DB00716","BE0000705","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6551,"DB00116","BE0000933","# Fu TF, Maras B, Barra D, Schirch V: A noncatalytic tetrahydrofolate tight binding site is on the small domain of 10-formyltetrahydrofolate dehydrogenase. Arch Biochem Biophys. 1999 Jul 15;367(2):161-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1039573"
6552,"DB02095","BE0002196",""
6553,"DB01603","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
6554,"DB00013","BE0000895","# Bell WR: Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics. Rev Cardiovasc Med. 2002;3 Suppl 2:S34-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12556741# Gamberi G, Serra M, Ragazzini P, Magagnoli G, Pazzagli"
6555,"DB04520","BE0004374","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6556,"DB01805","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6557,"DB00693","BE0003837","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6558,"DB06955","BE0003760","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6559,"DB07120","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6560,"DB07561","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6561,"DB03970","BE0001430","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6562,"DB04593","BE0000333",""
6563,"DB00640","BE0000924","# Trincavelli ML, Daniele S, Martini C: Adenosine receptors: what we know and what we are learning. Curr Top Med Chem. 2010;10(9):860-77. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20370662# Schenone S, Brullo C, Musumeci F, Bruno O, Botta M: A1 receptor"
6564,"DB02005","BE0001410","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6565,"DB07017","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6566,"DB04395","BE0001294","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6567,"DB01571","BE0000632","# Jin WQ, Xu H, Zhu YC, Fang SN, Xia XL, Huang ZM, Ge BL, Chi ZQ: Studies on synthesis and relationship between analgesic activity and receptor affinity for 3-methyl fentanyl derivatives. Sci Sin. 1981 May;24(5):710-20. \"Pubmed\":http://www.ncbi.nlm.nih.go"
6568,"DB00028","BE0002100","# Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110"
6569,"DB01815","BE0001350","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6570,"DB00234","BE0000486","# Rauhut AS, Mullins SN, Dwoskin LP, Bardo MT: Reboxetine: attenuation of intravenous nicotine self-administration in rats. J Pharmacol Exp Ther. 2002 Nov;303(2):664-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12388649# Wilson AA, Johnson DP, Mozley D"
6571,"DB00599","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
6572,"DB02398","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6573,"DB04801","BE0001007",""
6574,"DB00849","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
6575,"DB00171","BE0000219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6576,"DB00843","BE0000426","# Davis KL: Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington. Geriatrics. 1999 Feb;54(2):42-7; quiz 48. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10024872# Kryger G, Silman I, Sussman JL: Structure of ac"
6577,"DB02054","BE0001561","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6578,"DB01589","BE0003594","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
6579,"DB03879","BE0004482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6580,"DB02552","BE0004106","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6581,"DB04960","BE0002372","# Venkatasubbarao K, Choudary A, Freeman JW: Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases. Cancer Res. 2005 Apr 1;65(7):28"
6582,"DB05383","BE0003371",""
6583,"DB07172","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6584,"DB01354","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
6585,"DB02379","BE0001263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6586,"DB06912","BE0003751","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6587,"DB03205","BE0001728","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6588,"DB04147","BE0001338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6589,"DB08484","BE0002431","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6590,"DB05087","BE0000471",""
6591,"DB07225","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6592,"DB02442","BE0001377","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6593,"DB00786","BE0003696","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
6594,"DB04356","BE0000077","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6595,"DB02301","BE0001438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6596,"DB00017","BE0000431","# Bouizar Z, Fouchereau-Peron M, Taboulet J, Moukhtar MS, Milhaud G: Purification and characterization of calcitonin receptors in rat kidney membranes by covalent cross-linking techniques. Eur J Biochem. 1986 Feb 17;155(1):141-7. \"Pubmed\":http://www.ncbi."
6597,"DB04542","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6598,"DB00656","BE0000501","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
6599,"DB01852","BE0004151","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6600,"DB00054","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6601,"DB08235","BE0004255","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6602,"DB08185","BE0004206","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6603,"DB00289","BE0000486","# Biederman J, Heiligenstein JH, Faries DE, Galil N, Dittmann R, Emslie GJ, Kratochvil CJ, Laws HF, Schuh KJ: Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder. Pediatrics. 2002 Dec;110(6):e75. \"Pubme"
6604,"DB08818","BE0004944","# Bono P, Rubin K, Higgins JM, Hynes RO: Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol Biol Cell. 2001 Apr;12(4):891-900. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11294894"
6605,"DB07448","BE0003882","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6606,"DB01541","BE0000132","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6607,"DB00631","BE0000325","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6608,"DB08896","BE0003390","# FDA label"
6609,"DB02379","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6610,"DB06127","BE0000854",""
6611,"DB00056","BE0000674","# Naito K, Takeshita A, Shigeno K, Nakamura S, Fujisawa S, Shinjo K, Yoshida H, Ohnishi K, Mori M, Terakawa S, Ohno R: Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive"
6612,"DB00577","BE0000458","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6613,"DB00035","BE0000773","# Pequeux C, Keegan BP, Hagelstein MT, Geenen V, Legros JJ, North WG: Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway. Endocr Relat Cancer. 2004 Dec;11(4):871-85. \"Pubmed"
6614,"DB04522","BE0003319",""
6615,"DB00589","BE0000020","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6616,"DB00134","BE0000763","# Kim DJ, Park BL, Koh JM, Kim GS, Kim LH, Cheong HS, Shin HD, Hong JM, Kim TH, Shin HI, Park EK, Kim SY: Methionine synthase reductase polymorphisms are associated with serum osteocalcin levels in postmenopausal women. Exp Mol Med. 2006 Oct 31;38(5):519-"
6617,"DB06810","BE0004796","# Fox KR, Howarth NR: Investigations into the sequence-selective binding of mithramycin and related ligands to DNA. Nucleic Acids Res. 1985 Dec 20;13(24):8695-714. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2934687# Lombo F, Menendez N, Salas JA, Mendez "
6618,"DB06698","BE0000442","# Serc monograph. (2010). [Electronic version]. e-CPS. Retrieved November 28, 2010.# Barak N: Betahistine: what's new on the agenda? Expert Opin Investig Drugs. 2008 May;17(5):795-804. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18447604# Lacour M, Sterke"
6619,"DB00129","BE0000758","# Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, Ochoa JB, Ochoa AC: L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol. 2003 Aug 1;171(3):1232-9. \"Pubmed\":http://www.ncbi.nlm"
6620,"DB04263","BE0000404","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6621,"DB00162","BE0002319","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6622,"DB01957","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6623,"DB00861","BE0000017","# Cappon GD, Cook JC, Hurtt ME: Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Birth Defects Res B Dev Re"
6624,"DB03777","BE0001193","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6625,"DB07907","BE0003766","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6626,"DB08701","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6627,"DB00454","BE0000647","# Lomenzo SA, Izenwasser S, Gerdes RM, Katz JL, Kopajtic T, Trudell ML: Synthesis, dopamine and serotonin transporter binding affinities of novel analogues of meperidine. Bioorg Med Chem Lett. 1999 Dec 6;9(23):3273-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
6628,"DB04646","BE0003909","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6629,"DB03403","BE0001748","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6630,"DB00925","BE0000501","# Stam WB, Van der Graaf PH, Saxena PR: Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol. 1999 Jun;127(3):661-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10401556# Michel MC, Hanft G, Gross G: Functional st"
6631,"DB01016","BE0000119","# Reddy ST, Hama S, Ng C, Grijalva V, Navab M, Fogelman AM: ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1877-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/124262"
6632,"DB03584","BE0001219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6633,"DB07778","BE0003857","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6634,"DB04147","BE0003952","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6635,"DB01873","BE0000143","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6636,"DB04948","BE0000289","# Jin Y, Verstappen A, Elko E, Cammarata P, Yorio T: Effects of lofexidine, an alpha 2-adrenoreceptor agonist, on ocular blood flow and ion transport of rabbit iris-ciliary body. J Ocul Pharmacol. 1992 Spring;8(1):23-33. \"Pubmed\":http://www.ncbi.nlm.nih.g"
6637,"DB08321","BE0003505","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6638,"DB00082","BE0000075","# Moller L, Norrelund H, Jessen N, Flyvbjerg A, Pedersen SB, Gaylinn BD, Liu J, Thorner MO, Moller N, Lunde Jorgensen JO: Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects. J Clin Endocrinol Metab. 2009 "
6639,"DB00145","BE0000618","# Mukherjee M, Brown MT, McArthur AG, Johnson PJ: Proteins of the glycine decarboxylase complex in the hydrogenosome of Trichomonas vaginalis. Eukaryot Cell. 2006 Dec;5(12):2062-71. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17158739# Kanno J, Hutchin T,"
6640,"DB00747","BE0000092","# Murasaki O, Kaibara M, Nagase Y, Mitarai S, Doi Y, Sumikawa K, Taniyama K: Site of action of the general anesthetic propofol in muscarinic M1 receptor-mediated signal transduction. J Pharmacol Exp Ther. 2003 Dec;307(3):995-1000. Epub 2003 Oct 8. \"Pubmed"
6641,"DB01255","BE0000575","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nuc"
6642,"DB05200","BE0000876",""
6643,"DB00028","BE0004684","# Siberil S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV: Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective. Ann N Y Acad Sci. 2007 Sep;1110"
6644,"DB08068","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6645,"DB00142","BE0000727","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6646,"DB03088","BE0004464","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6647,"DB01238","BE0000501","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6648,"DB00368","BE0000753","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6649,"DB01942","BE0001613","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6650,"DB00810","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6651,"DB00142","BE0002166","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6652,"DB07384","BE0003842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6653,"DB01026","BE0004873","# Trachtenberg J, Zadra J: Steroid synthesis inhibition by ketoconazole: sites of action. Clin Invest Med. 1988 Feb;11(1):1-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2966691"
6654,"DB04566","BE0001828","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6655,"DB04749","BE0001559",""
6656,"DB08350","BE0000014","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6657,"DB02059","BE0004281","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6658,"DB04394","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6659,"DB01405","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6660,"DB03297","BE0001038","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6661,"DB00279","BE0000315","# Bernal J: Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):249-59. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17315033# Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A: Thyroid hormone recepto"
6662,"DB08750","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6663,"DB00072","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6664,"DB03721","BE0003170",""
6665,"DB01103","BE0001077","# Nuttle LC, Ligon AL, Farrell KR, Hester RL: Inhibition of phospholipase A2 attenuates functional hyperemia in the hamster cremaster muscle. Am J Physiol. 1999 Apr;276(4 Pt 2):H1289-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10199854# Sastry BV, Hem"
6666,"DB00893","BE0000130","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6667,"DB07239","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6668,"DB08864","BE0004853","# Garvey L, Winston A: Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor. Expert Opin Investig Drugs. 2009 Jul;18(7):1035-41. doi: 10.1517/13543780903055056. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19548857"
6669,"DB02413","BE0001907","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6670,"DB00008","BE0000385","# Dhalluin C, Ross A, Huber W, Gerber P, Brugger D, Gsell B, Senn H: Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNA"
6671,"DB00632","BE0000712","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6672,"DB04855","BE0000172","# Dale KM, White CM: Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother. 2007 Apr;41(4):599-605. Epub 2007 Mar 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17389667"
6673,"DB00139","BE0002258","# Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, Watkins NA, van der Schoot CE, Ouwehand WH: Comparative gene expression profiling of in vitro differentiated megakaryocytes and"
6674,"DB03317","BE0002916",""
6675,"DB08885","BE0000163","# Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW: Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol. 2012 Aug;154(2):222-6. doi: 10.1016/j.ajo.2012.04.020. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/228"
6676,"DB07014","BE0001065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6677,"DB01812","BE0000951","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6678,"DB08162","BE0004191","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6679,"DB01937","BE0001366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6680,"DB08644","BE0003935","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6681,"DB00157","BE0000552","# Gao L, He P, Sha J, Liu C, Dai L, Hui N, Ni X: Corticotropin-releasing hormone receptor type 1 and type 2 mediate differential effects on 15-hydroxy prostaglandin dehydrogenase expression in cultured human chorion trophoblasts. Endocrinology. 2007 Aug;1"
6682,"DB01756","BE0004438","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6683,"DB00139","BE0000022","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6684,"DB08171","BE0001723","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6685,"DB08338","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6686,"DB00782","BE0000092","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Lukacs VA, Korting HC: [Antiperspirants and deodorants--ingre"
6687,"DB05900","BE0000767",""
6688,"DB08930","BE0004855","# Hare S, Smith SJ, Metifiot M, Jaxa-Chamiec A, Pommier Y, Hughes SH, Cherepanov P: Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572). Mol Pharmacol. 2011 Oct;80(4):565-72. doi: 10."
6689,"DB01353","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
6690,"DB00924","BE0000451","# Honda M, Nishida T, Ono H: Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors. Eur J Pharmacol. 2003 Jan 1;458(1-2):91-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12498"
6691,"DB00190","BE0002151","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR: Variable absorption of ca"
6692,"DB02772","BE0002833",""
6693,"DB05740","BE0002341",""
6694,"DB01752","BE0001261","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6695,"DB08690","BE0003885","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6696,"DB08231","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6697,"DB06838","BE0001713","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6698,"DB08356","BE0004284","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6699,"DB01403","BE0000389","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205"
6700,"DB00996","BE0000013","# De Vry J, Kuhl E, Franken-Kunkel P, Eckel G: Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol. 2004 May 3;491(2-3):137-48. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15140630# Zuchora B, Wie"
6701,"DB08459","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6702,"DB00131","BE0000677","# Mayes MA, Laforest MF, Guillemette C, Gilchrist RB, Richard FJ: Adenosine 5'-monophosphate kinase-activated protein kinase (PRKA) activators delay meiotic resumption in porcine oocytes. Biol Reprod. 2007 Apr;76(4):589-97. Epub 2006 Dec 13. \"Pubmed\":http"
6703,"DB05712","BE0003407",""
6704,"DB00852","BE0000749","# Wee S, Ordway GA, Woolverton WL: Reinforcing effect of pseudoephedrine isomers and the mechanism of action. Eur J Pharmacol. 2004 Jun 16;493(1-3):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15189772"
6705,"DB02805","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6706,"DB03147","BE0000960","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6707,"DB02192","BE0001535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6708,"DB07088","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6709,"DB08640","BE0003758","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6710,"DB01823","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6711,"DB04141","BE0000214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6712,"DB00661","BE0002359","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880"
6713,"DB00541","BE0000143","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6714,"DB01559","BE0003598","# Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 2008 Oct;9(8):827-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18855614"
6715,"DB00759","BE0003710","# Buck MA, Cooperman BS: Single protein omission reconstitution studies of tetracycline binding to the 30S subunit of Escherichia coli ribosomes. Biochemistry. 1990 Jun 5;29(22):5374-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2200507"
6716,"DB00142","BE0000826","# Wong AY, MacLean DM, Bowie D: Na+/Cl- dipole couples agonist binding to kainate receptor activation. J Neurosci. 2007 Jun 20;27(25):6800-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17581967"
6717,"DB01136","BE0001095","# Yeh HI, Lee PY, Su CH, Tian TY, Ko YS, Tsai CH: Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment. Am J Hypertens. 2006 Feb;19(2):129-35. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
6718,"DB00197","BE0003722","# Wang Y, Fang F, Wong CW: Troglitazone is an estrogen-related receptor alpha and gamma inverse agonist. Biochem Pharmacol. 2010 Jul 1;80(1):80-5. Epub 2010 Mar 16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20298676"
6719,"DB02986","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6720,"DB04937","BE0002449","# Kokhaei P, Palma M, Hansson L, Osterborg A, Mellstedt H, Choudhury A: Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells. Exp Hematol. 2007 Feb;35(2):29"
6721,"DB05198","BE0000369",""
6722,"DB08249","BE0001305","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6723,"DB00321","BE0000533","# Di Matteo V, De Blasi A, Di Giulio C, Esposito E: Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci. 2001 May;22(5):229-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11339973"
6724,"DB01229","BE0000026","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6725,"DB01032","BE0000879","# Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Kobayashi Y, Yamamoto T, Sekine T, Cha SH, Niwa T, Endou H: Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther. 2002 Jun;301(3):7"
6726,"DB08598","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6727,"DB02142","BE0001396","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6728,"DB00828","BE0000468","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6729,"DB00570","BE0000143","# Jordan MA, Kamath K: How do microtubule-targeted drugs work? An overview. Curr Cancer Drug Targets. 2007 Dec;7(8):730-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18220533# Correia JJ: Effects of antimitotic agents on tubulin-nucleotide interactions."
6730,"DB00903","BE0000502","# Bowes TJ, Gupta RS: Induction of mitochondrial fusion by cysteine-alkylators ethacrynic acid and N-ethylmaleimide. J Cell Physiol. 2005 Mar;202(3):796-804. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15389563# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Ta"
6731,"DB00583","BE0002705","# Bell FP: Carnitine ester hydrolysis in arteries from normal and cholesterol-fed rabbits and the effects of carnitine esters on arterial microsomal ACAT. Comp Biochem Physiol B. 1984;79(2):125-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6509906"
6732,"DB09028","BE0003587","# Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C: Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/25"
6733,"DB02341","BE0000394","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6734,"DB07095","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6735,"DB00086","BE0000211","# Caballero AR, Lottenberg R, Johnston KH: Cloning, expression, sequence analysis, and characterization of streptokinases secreted by porcine and equine isolates of Streptococcus equisimilis. Infect Immun. 1999 Dec;67(12):6478-86. \"Pubmed\":http://www.ncbi"
6736,"DB07485","BE0002088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6737,"DB00543","BE0000756","# Wei HB, Niu XY: [Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration] Yao Xue Xue Bao. 1990;25(12):881-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/196"
6738,"DB08443","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6739,"DB00346","BE0000715","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM: Evaluation of the pharmac"
6740,"DB08300","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6741,"DB08744","BE0000220","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6742,"DB00368","BE0001012","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6743,"DB03147","BE0001590","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6744,"DB02726","BE0004550","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6745,"DB00364","BE0001015","# Szabo S: The mode of action of sucralfate: the 1 x 1 x 1 mechanism of action. Scand J Gastroenterol Suppl. 1991;185:7-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1957124# Tarnawski A, Tanoue K, Santos AM, Sarfeh IJ: Cellular and molecular mechanisms"
6746,"DB00328","BE0003560","# Wu YH, Ko TP, Guo RT, Hu SM, Chuang LM, Wang AH: Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2. Structure. 2008 Nov 12;16(11):1714-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19000823"
6747,"DB01041","BE0000262","# Horrobin DF: A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels. Med Hypotheses. 2003 May;60(5):615-23. \"Pubmed\":http://www.ncbi.nlm.ni"
6748,"DB00905","BE0002375","# Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX: Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther. "
6749,"DB00568","BE0002359","# Singh BN: The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol. 1986;21 Suppl 2:109S-121S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3530295# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca c"
6750,"DB04215","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6751,"DB03925","BE0003758","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6752,"DB08600","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6753,"DB01102","BE0001012","# Abou-Mohamed G, Nagarajan R, Ibrahim TM, Caldwell RW: Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing. Cardiovasc Drugs Ther. 1996 Mar;10(1):39-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8"
6754,"DB01652","BE0002495",""
6755,"DB00363","BE0000247","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6756,"DB07286","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6757,"DB07754","BE0000568","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6758,"DB01355","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
6759,"DB07697","BE0000088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6760,"DB06605","BE0000216","# Spyropoulos AC: Investigational treatments of venous thromboembolism. Expert Opin Investig Drugs. 2007 Apr;16(4):431-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17371192# Harenberg J, Wehling M: Current and future prospects for anticoagulant therapy"
6761,"DB05342","BE0002050",""
6762,"DB08819","BE0000610","# Pantcheva MB, Seibold LK, Awadallah NS, Kahook MY: Tafluprost: a novel prostaglandin analog for treatment of glaucoma. Adv Ther. 2011 Sep;28(9):707-15. Epub 2011 Aug 18. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21858491"
6763,"DB01483","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
6764,"DB07410","BE0003570","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6765,"DB00184","BE0003586","# Mansvelder HD, Mertz M, Role LW: Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol. 2009 Jun;20(4):432-40. Epub 2009 Jan 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19560048# Narahashi T, Fe"
6766,"DB00040","BE0000857","# Korner M, Stockli M, Waser B, Reubi JC: GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007 May;48(5):736-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17475961# Baggio LL, Drucker DJ: "
6767,"DB03346","BE0000951","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6768,"DB02827","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6769,"DB00934","BE0000247","# El-Fakahany E, Richelson E: Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain. Br J Pharmacol. 1983 Jan;78(1):97-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6297650# Golds PR, Przyslo FR, Strange PG: The binding of "
6770,"DB01000","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6771,"DB01331","BE0003685","# Matsuhashi M, Tamaki S: Enzymatic studies on the mechanism of action of cefoxitin. Correlation between the affinities of cefoxitin to penicillin-binding proteins and its rates of inhibition of the respective penicillin-sensitive reactions in E. coli. J "
6772,"DB04296","BE0002042","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6773,"DB00300","BE0004853","# Fung HB, Stone EA, Piacenti FJ: Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection. Clin Ther. 2002 Oct;24(10):1515-48. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12462284# DeChristoforo R, Pe"
6774,"DB04493","BE0001818","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6775,"DB01748","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6776,"DB02379","BE0003246",""
6777,"DB00145","BE0002305","# Narasipura SD, Ren P, Dyavaiah M, Auger I, Chaturvedi V, Chaturvedi S: An efficient method for homologous gene reconstitution in Cryptococcus gattii using URA5 auxotrophic marker. Mycopathologia. 2006 Dec;162(6):401-9. \"Pubmed\":http://www.ncbi.nlm.nih.g"
6778,"DB00434","BE0000045","# Eltze M, Lambrecht G, Mutschler E: Cyproheptadine displays high affinity for muscarinic receptors but does not discriminate between receptor subtypes. Eur J Pharmacol. 1989 Dec 7;173(2-3):219-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2625138"
6779,"DB03721","BE0003168",""
6780,"DB03541","BE0003983","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6781,"DB01110","BE0000263","# Wolff DJ, Datto GA, Samatovicz RA: The dual mode of inhibition of calmodulin-dependent nitric-oxide synthase by antifungal imidazole agents. J Biol Chem. 1993 May 5;268(13):9430-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7683652# Bogle RG, Whitley G"
6782,"DB07550","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6783,"DB04343","BE0001761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6784,"DB00970","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6785,"DB00119","BE0000440","# Bonen A, Heynen M, Hatta H: Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle. Appl Physiol Nutr Metab. 2006 Feb;31(1):31-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16604139# Hinoi E, Takarada T, Tsuchih"
6786,"DB00558","BE0003200","# Chavas LM, Kato R, Suzuki N, von Itzstein M, Mann MC, Thomson RJ, Dyason JC, McKimm-Breschkin J, Fusi P, Tringali C, Venerando B, Tettamanti G, Monti E, Wakatsuki S: Complexity in influenza virus targeted drug design: interaction with human sialidases. "
6787,"DB03147","BE0001301","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6788,"DB03859","BE0001539","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6789,"DB00074","BE0000658","# Choy BY, Chan TM, Li FK, Lui SL, Lo WK, Yip T, Tse KC, Lai KN: IL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipients. Transplant Proc. 2003 Feb;35(1):195. \"Pubmed\":http://"
6790,"DB03127","BE0001624","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6791,"DB01060","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6792,"DB00734","BE0000389","# Leysen JE, Janssen PM, Megens AA, Schotte A: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry. 1994 May;55 Suppl:5-12. \"Pubmed\":http://www.ncbi.nlm."
6793,"DB00303","BE0000103","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6794,"DB00114","BE0002171","# Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, Berry MJ, Gladyshev VN, Hatfield DL: Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2007 Jan;5(1):e4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17194211# Kernebeck T, Lohse AW"
6795,"DB00042","BE0002136","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6796,"DB03039","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6797,"DB05281","BE0001391",""
6798,"DB01589","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6799,"DB04315","BE0001756","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6800,"DB06439","BE0000239","# Levine S, Saltzman A: A procedure for inducing sustained hyperlipemia in rats by administration of a surfactant. J Pharmacol Toxicol Methods. 2007 Mar-Apr;55(2):224-6. Epub 2006 Jun 3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16839786# Rodrigues B, B"
6801,"DB02388","BE0001097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6802,"DB04338","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6803,"DB04099","BE0001695","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6804,"DB02772","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6805,"DB04132","BE0000814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6806,"DB04126","BE0003970","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6807,"DB01894","BE0001411","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6808,"DB07868","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6809,"DB00157","BE0000268","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6810,"DB07712","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6811,"DB01694","BE0002501",""
6812,"DB00548","BE0000585","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6813,"DB02843","BE0002493",""
6814,"DB00114","BE0000518","# Schmidt A, Sivaraman J, Li Y, Larocque R, Barbosa JA, Smith C, Matte A, Schrag JD, Cygler M: Three-dimensional structure of 2-amino-3-ketobutyrate CoA ligase from Escherichia coli complexed with a PLP-substrate intermediate: inferred reaction mechanism."
6815,"DB04242","BE0001507","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6816,"DB01614","BE0000756","# Oades RD, Rao ML, Bender S, Sartory G, Muller BW: Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy. Behav Pharmaco"
6817,"DB01567","BE0000129","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
6818,"DB01113","BE0000631","# Weber M, Breier M, Ko D, Thangaraj N, Marzan DE, Swerdlow NR: Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine. Psychopharmacology (Berl). 2009 May;203(4):723-35. Epub 2008 Dec 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
6819,"DB05282","BE0000965",""
6820,"DB06775","BE0004671","# Carglumic acid: a second look. Confirmed progress in a rare urea cycle disorder. Prescrire Int. 2008 Apr;17(94):50-1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18516804# Hart EJ, Powers-Lee SG: Role of Cys-1327 and Cys-1337 in redox sensitivity and al"
6821,"DB02825","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6822,"DB02403","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6823,"DB03721","BE0001978","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6824,"DB05443","BE0000632",""
6825,"DB01353","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
6826,"DB00557","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM: Histamine H1 blocker hydroxyzine improves s"
6827,"DB01627","BE0000743","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Odom OW, Hardesty B: Use of 50 S-binding antibiotics to chara"
6828,"DB00560","BE0000279","# Olson MW, Ruzin A, Feyfant E, Rush TS 3rd, O'Connell J, Bradford PA: Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother. 2006 Jun;50(6):2156-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
6829,"DB02587","BE0003733","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6830,"DB00540","BE0000291","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
6831,"DB07649","BE0004031","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6832,"DB08838","BE0000644","# Shepherd RM, Hashmi MN, Kane C, Squires PE, Dunne MJ: Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release. Br J Pharmacol. 1996 Nov;119(5):911-6. \"Pubmed\":http://ww"
6833,"DB00334","BE0000572","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6834,"DB02854","BE0003805","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6835,"DB01228","BE0000197","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Starmer CF, Lastra AA, Nesterenko VV, Grant AO: Proarrhythmic"
6836,"DB02828","BE0001285","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6837,"DB01427","BE0004908","# Weishaar RE, Kobylarz-Singer DC, Steffen RP, Kaplan HR: Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Circ Res. 1987 Oct;61(4):539-47. \"Pubmed\":http://www.ncb"
6838,"DB07425","BE0003867","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6839,"DB02377","BE0001055","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
6840,"DB01826","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6841,"DB08017","BE0003372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6842,"DB02309","BE0000077","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6843,"DB00248","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Lombardi G, Varsaldi F, Miglio G, Papini MG, Battaglia A, Canonico PL: Cabergoline prevents necrot"
6844,"DB07841","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6845,"DB00144","BE0001132","# Yu D, Kazanietz MG, Harvey RG, Penning TM: Polycyclic aromatic hydrocarbon o-quinones inhibit the activity of the catalytic fragment of protein kinase C. Biochemistry. 2002 Oct 1;41(39):11888-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12269833# Rod"
6846,"DB04258","BE0000779","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6847,"DB04472","BE0004333","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6848,"DB07435","BE0003870","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6849,"DB08437","BE0003832","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6850,"DB00297","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6851,"DB01535","BE0000420","# Mayberg HS, Sadzot B, Meltzer CC, Fisher RS, Lesser RP, Dannals RF, Lever JR, Wilson AA, Ravert HT, Wagner HN Jr, et al.: Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol. 1991 Jul"
6852,"DB02462","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6853,"DB00030","BE0001183","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6854,"DB02042","BE0002498",""
6855,"DB07130","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6856,"DB01429","BE0000418","# Levine SN, Hollier B: Aprindine inhibits calmodulin-stimulated phosphodiesterase and Ca-ATPase activities. J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):151-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6186851"
6857,"DB01238","BE0000405","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
6858,"DB01942","BE0002644",""
6859,"DB00852","BE0004878","# Fiebich BL, Collado JA, Stratz C, Valina C, Hochholzer W, Munoz E, Bellido LM: Pseudoephedrine inhibits T-cell activation by targeting NF-kappaB, NFAT and AP-1 signaling pathways. Immunopharmacol Immunotoxicol. 2012 Feb;34(1):98-106. doi: 10.3109/089239"
6860,"DB03238","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6861,"DB00575","BE0000715","# Roth, BL; Driscol, J (12 January 2011).PDSP KiDatabase.Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 25 November 2013."
6862,"DB00606","BE0000229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6863,"DB00157","BE0000245","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6864,"DB07940","BE0002180","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6865,"DB04522","BE0002660",""
6866,"DB08646","BE0004358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6867,"DB00368","BE0000342","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6868,"DB02405","BE0003957","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6869,"DB02657","BE0001686","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6870,"DB01221","BE0000486","# Salt PJ, Barnes PK, Beswick FJ: Inhibition of neuronal and extraneuronal uptake of noradrenaline by ketamine in the isolated perfused rat heart. Br J Anaesth. 1979 Sep;51(9):835-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/508488"
6871,"DB00114","BE0000151","# Ollagnier-De-Choudens S, Mulliez E, Hewitson KS, Fontecave M: Biotin synthase is a pyridoxal phosphate-dependent cysteine desulfurase. Biochemistry. 2002 Jul 23;41(29):9145-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12119030# You D, Wang L, Yao F, "
6872,"DB08184","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6873,"DB04018","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6874,"DB01973","BE0001279","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6875,"DB00247","BE0000650","# Sugimoto Y, Inoue K, Yamada J: The tricyclic antidepressant clomipramine increases plasma glucose levels of mice. J Pharmacol Sci. 2003 Sep;93(1):74-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14501155"
6876,"DB08846","BE0000322","# Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j"
6877,"DB06851","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6878,"DB02701","BE0003362","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6879,"DB02326","BE0001182","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6880,"DB01623","BE0000756","# Shultz PJ, Sedor JR, Abboud HE: Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells. Am J Physiol. 1987 Aug;253(2 Pt 2):H358-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3039860# Oades RD, Rao ML, Bender S, Sartory G, Muller"
6881,"DB00108","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6882,"DB01407","BE0001094","# Culmsee C, Semkova I, Krieglstein J: NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int. 1999 Jul;35(1):47-57. \"Pubmed\":http://www.ncbi.nlm.nih."
6883,"DB04493","BE0001073","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6884,"DB00102","BE0000852","# Abdiu A, Walz TM, Nishikawa BK, Wingren S, Larsson SE, Wasteson A: Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha "
6885,"DB02659","BE0001392","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6886,"DB00517","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6887,"DB00465","BE0000017","# Bosch-Marce M, Claria J, Titos E, Masferrer JL, Altuna R, Poo JL, Jimenez W, Arroyo V, Rivera F, Rodes J: Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Gastroenterology. 1999 M"
6888,"DB02376","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6889,"DB00761","BE0000281","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6890,"DB05802","BE0003414",""
6891,"DB04272","BE0000182","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6892,"DB06834","BE0001316","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6893,"DB00162","BE0000554","# Asson-Batres MA, Smith WB: Localization of retinaldehyde dehydrogenases and retinoid binding proteins to sustentacular cells, glia, Bowman's gland cells, and stroma: potential sites of retinoic acid synthesis in the postnatal rat olfactory organ. J Comp"
6894,"DB00172","BE0002149","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6895,"DB00157","BE0000344","# Pandey AV, Kempna P, Hofer G, Mullis PE, Fluck CE: Modulation of Human CYP19A1 Activity by Mutant NADPH P450 Oxidoreductase. Mol Endocrinol. 2007 Oct;21(10):2579-95. Epub 2007 Jun 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17595315"
6896,"DB03428","BE0000890","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
6897,"DB00141","BE0002266","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6898,"DB00898","BE0000433","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6899,"DB01176","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Leza JC, Lizasoain I, Lorenzo P: H1- and H2-histamine receptor blockers and opiate analgesia in mi"
6900,"DB03420","BE0001667","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6901,"DB04464","BE0000280","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6902,"DB00191","BE0002196","# Rothman RB: Does phentermine inhibit monoamine oxidase? Lancet. 1999 Apr 17;353(9161):1362-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10218558# Rothman RB: Is phentermine an inhibitor of monoamine oxidase? A critical appraisal. Synapse. 1999 May;32("
6903,"DB05259","BE0002416","# Arnon R, Aharoni R: Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14593-8. Epub 2004 Sep 15. \"Pubmed\":http://www.ncbi.nlm.nih.g"
6904,"DB07164","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6905,"DB00558","BE0003527","# Eiland LS, Eiland EH: Zanamivir for the prevention of influenza in adults and children age 5 years and older. Ther Clin Risk Manag. 2007 Jun;3(3):461-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18488077# Oakley AJ, Barrett S, Peat TS, Newman J, Strel"
6906,"DB00827","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6907,"DB01913","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6908,"DB07623","BE0003336","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6909,"DB05785","BE0001040",""
6910,"DB05190","BE0000036",""
6911,"DB01054","BE0000864","# Perez-Reyes E, Van Deusen AL, Vitko I: Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther. 2009 Feb;328(2):621-7. Epub 2008 Oct 30. \"Pubmed\":http://www.ncbi.n"
6912,"DB01624","BE0000756","# Gareri P, De Fazio P, Stilo M, Ferreri G, De Sarro G: Conventional and Atypical Antipsychotics in the Elderly : A Review. Clin Drug Investig. 2003;23(5):287-322. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17535043# Lublin H, Gerlach J, Hagert U, Meidah"
6913,"DB08439","BE0000994","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6914,"DB08912","BE0000036","# FDA label"
6915,"DB04637","BE0003331",""
6916,"DB01440","BE0002344","# Maitre M, Humbert JP, Kemmel V, Aunis D, Andriamampandry C: [A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse]. Med Sci (Paris). 2005 Mar;21(3):284-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15745703"
6917,"DB00099","BE0000394","# Carter CR, Whitmore KM, Thorpe R: The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation. J Leukoc Biol. 2004 Mar;75(3):515-22. Epub 2003 Dec 4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
6918,"DB03147","BE0001382","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6919,"DB00205","BE0000563","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6920,"DB08914","BE0000033","# Desbuquois B, Chauvet G, Kouach M, Authier F: Cell itinerary and metabolic fate of proinsulin in rat liver: in vivo and in vitro studies. Endocrinology. 2003 Dec;144(12):5308-21. Epub 2003 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12970169# Ch"
6921,"DB06103","BE0000722",""
6922,"DB01118","BE0000090","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Wang SP, Wang JA, Luo RH, Cui WY, Wang H: Potassium channel currents in rat mesenchymal stem cells"
6923,"DB00128","BE0000277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6924,"DB03044","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6925,"DB03712","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6926,"DB00203","BE0000182","# Carson CC: Long-term use of sildenafil. Expert Opin Pharmacother. 2003 Mar;4(3):397-405. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12614192# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":"
6927,"DB00210","BE0000206","# Shroot B, Michel S: Pharmacology and chemistry of adapalene. J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S96-103. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9204085# Shroot B, Michel S, Allec J, Chatelus A, Wagner N: A new concept of drug delivery for acne"
6928,"DB02381","BE0000286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6929,"DB06766","BE0000442","# DailyMed: \"LASTACAFT\":http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?ndc=68669-412-03&start=1# Simons FE, Simons KJ: Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011 Dec;128(6):1139-1150.e4. doi: 10.1016/"
6930,"DB00795","BE0000262","# Mifflin RC, Saada JI, Di Mari JF, Valentich JD, Adegboyega PA, Powell DW: Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts. Mol Pharmacol. 2004 Feb;65(2):470-8. \"Pubmed\":http://www.ncbi.nlm."
6931,"DB06614","BE0003527","# Bantia S, Arnold CS, Parker CD, Upshaw R, Chand P: Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antiviral Res. 2006 Jan;69(1):39-45. Epub 2005 Nov 21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16325932"
6932,"DB07376","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6933,"DB01364","BE0000486","# Kobayashi S, Endou M, Sakuraya F, Matsuda N, Zhang XH, Azuma M, Echigo N, Kemmotsu O, Hattori Y, Gando S: The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release? Anesth Analg. 2003 Nov;97(5"
6934,"DB06845","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6935,"DB05018","BE0002422",""
6936,"DB00877","BE0002386","# Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N: Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta. 2010 Mar;1804(3):433-9. Epub 2009 Dec 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20005306# Shuuin T, Karashima H: ["
6937,"DB07680","BE0001038","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6938,"DB01950","BE0001065","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6939,"DB02843","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6940,"DB02692","BE0000753","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6941,"DB07574","BE0001340","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6942,"DB03461","BE0004480","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6943,"DB07919","BE0002198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6944,"DB00340","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6945,"DB03814","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6946,"DB00171","BE0001032","# Lage H: MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Curr Drug Targets. 2006 Jul;7(7):813-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16842213# Gardner ER, Burger H, van Schaik RH, van Oostero"
6947,"DB00794","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
6948,"DB07207","BE0000333","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6949,"DB00013","BE0000240","# Gamberi G, Serra M, Ragazzini P, Magagnoli G, Pazzaglia L, Ponticelli F, Ferrari C, Zanasi M, Bertoni F, Picci P, Benassi MS: Identification of markers of possible prognostic value in 57 giant cell tumors of bone. Oncol Rep. 2003 Mar-Apr;10(2):351-6. \"P"
6950,"DB01812","BE0004436","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6951,"DB07848","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6952,"DB08215","BE0003851","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6953,"DB02552","BE0001748","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6954,"DB02594","BE0004639","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6955,"DB00612","BE0000694","# Brouri F, Hanoun N, Mediani O, Saurini F, Hamon M, Vanhoutte PM, Lechat P: Blockade of beta 1- and desensitization of beta 2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. Eur J Pharmacol. 2004 Feb 6;485(1-3):227-34. \"Pubmed\":http://www.ncb"
6956,"DB04175","BE0002431","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6957,"DB03024","BE0000270","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6958,"DB00945","BE0000126","# Dhagat U, Carbone V, Chung RP, Matsunaga T, Endo S, Hara A, El-Kabbani O: A salicylic acid-based analogue discovered from virtual screening as a potent inhibitor of human 20alpha-hydroxysteroid dehydrogenase. Med Chem. 2007 Nov;3(6):546-50. \"Pubmed\":htt"
6959,"DB02024","BE0002692",""
6960,"DB04212","BE0001378","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6961,"DB02274","BE0001519","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6962,"DB03551","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6963,"DB03886","BE0004520","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6964,"DB00185","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6965,"DB03496","BE0002224","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
6966,"DB04789","BE0000010",""
6967,"DB07042","BE0002622","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6968,"DB01110","BE0000415","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Alvarez J, Montero M, Garcia-Sancho J"
6969,"DB04066","BE0001293","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6970,"DB00181","BE0002340","# Belley M, Sullivan R, Reeves A, Evans J, O'Neill G, Ng GY: Synthesis of the nanomolar photoaffinity GABA(B) receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA(B) receptor forms. Bioorg Med Chem. 1999 Dec;7(12):2697-704. \"Pubm"
6971,"DB00246","BE0000659","# Stahl SM, Shayegan DK: The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. J Clin Psychiatry. 2003;64 Suppl 19:6-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14728084# Wilner KD, Anziano RJ, Johnson"
6972,"DB00696","BE0000659","# Silberstein SD, McCrory DC: Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache. 2003 Feb;43(2):144-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12558771# Lovenberg TW, Erlander MG, Baron BM, Racke M, Slone AL, Siegel BW, "
6973,"DB03132","BE0003844","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6974,"DB02734","BE0002672",""
6975,"DB07609","BE0003336","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6976,"DB08069","BE0003355","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6977,"DB01912","BE0002637",""
6978,"DB04855","BE0000342","# Dale KM, White CM: Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother. 2007 Apr;41(4):599-605. Epub 2007 Mar 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17389667"
6979,"DB00418","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
6980,"DB04444","BE0001589","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6981,"DB04576","BE0000366","# Naber KG: Fleroxacin overview. Chemotherapy. 1996 Mar;42 Suppl 1:1-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8861529# Asahina Y, Iwase K, Iinuma F, Hosaka M, Ishizaki T: Synthesis and antibacterial activity of 1-(2-fluorovinyl)-7-substituted-4-quin"
6982,"DB00683","BE0002346","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
6983,"DB01938","BE0001281","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6984,"DB01536","BE0000592","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6985,"DB00147","BE0000042","# Tang L, Li MH, Cao P, Wang F, Chang WR, Bach S, Reinhardt J, Ferandin Y, Galons H, Wan Y, Gray N, Meijer L, Jiang T, Liang DC: Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives. J Biol Chem. 2005 Sep 2;280(35):31220-9. Ep"
6986,"DB00148","BE0000567","# Almeida LS, Vilarinho L, Darmin PS, Rosenberg EH, Martinez-Munoz C, Jakobs C, Salomons GS: A prevalent pathogenic GAMT mutation (c.59G>C) in Portugal. Mol Genet Metab. 2007 May;91(1):1-6. Epub 2007 Mar 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1733"
6987,"DB07024","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6988,"DB04077","BE0000400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6989,"DB00698","BE0000158","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6990,"DB01352","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
6991,"DB00013","BE0001656","# Suzuki M, Kobayashi H, Kanayama N, Saga Y, Suzuki M, Lin CY, Dickson RB, Terao T: Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J Biol Chem. 2004 Apr 9;279(15):14"
6992,"DB02718","BE0001838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6993,"DB04495","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6994,"DB00897","BE0003599","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
6995,"DB04008","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6996,"DB07985","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
6997,"DB02901","BE0000132","# Askew EB, Gampe RT Jr, Stanley TB, Faggart JL, Wilson EM: Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone. J Biol Chem. 2007 Aug 31;282(35):25801-16. Epub 2007 Jun 25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
6998,"DB00787","BE0000633","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
6999,"DB08345","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7000,"DB00139","BE0002252","# Brink I, Schaefer O, Walz M, Neumann HP: Fluorine-18 DOPA PET imaging of paraganglioma syndrome. Clin Nucl Med. 2006 Jan;31(1):39-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16374125# Sun F, Huo X, Zhai Y, Wang A, Xu J, Su D, Bartlam M, Rao Z: Cryst"
7001,"DB00546","BE0000523","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
7002,"DB00051","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7003,"DB01752","BE0002521",""
7004,"DB00163","BE0002325","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7005,"DB03280","BE0001403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7006,"DB03814","BE0003028",""
7007,"DB08529","BE0003570","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7008,"DB00398","BE0000036","# Adnane L, Trail PA, Taylor I, Wilhelm SM: Sorafenib (BAY 43-9006, Nexavar((R))), a Dual-Action Inhibitor That Targets RAF/MEK/ERK Pathway in Tumor Cells and Tyrosine Kinases VEGFR/PDGFR in Tumor Vasculature. Methods Enzymol. 2005;407:597-612. \"Pubmed\":h"
7009,"DB07818","BE0004101","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7010,"DB02764","BE0001603","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7011,"DB02078","BE0004300","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7012,"DB00566","BE0004813","# Miller AL: Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998 Jun;3(3):199-207. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9630737# Blanusa M, Varnai VM, Piasek M, Kostial K: Chelators as"
7013,"DB07909","BE0004119","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7014,"DB04533","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7015,"DB03746","BE0001819","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7016,"DB03796","BE0002887","# Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD, Johnson EF: Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J Biol Chem. 2004 Mar 5;279(10):9497-503. Epub 2003 Dec 15. \"Pubmed\":http://www.ncbi.n"
7017,"DB00489","BE0000694","# Lowe MD, Lynham JA, Grace AA, Kaumann AJ: Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium. Br J Pharmacol. 2002 Jan;135(2):451-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1181538"
7018,"DB01168","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7019,"DB00128","BE0000235","# Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, Ataide A, Almeida J, Borges L, Oliveira C, Oliveira G, Vicente AM: Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mito"
7020,"DB01758","BE0002031","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7021,"DB02153","BE0004515","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7022,"DB05750","BE0000061",""
7023,"DB02761","BE0002377",""
7024,"DB02795","BE0003997","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7025,"DB03923","BE0004586","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7026,"DB04522","BE0001195","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7027,"DB02221","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7028,"DB06148","BE0000650","# Lucchelli A, Santagostino-Barbone MG, D'Agostino G, Masoero E, Tonini M: The interaction of antidepressant drugs with enteric 5-HT7 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):284-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/109977"
7029,"DB00420","BE0000247","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7030,"DB07865","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7031,"DB04272","BE0002493",""
7032,"DB01411","BE0000908","# Horiguchi T, Tachikawa S, Kasahara J, Doi M, Shiga M: Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma. Arzneimittelforschung. 1999 Jan;49(1):35-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
7033,"DB01390","BE0004849","# Nudel DB, Peterson BJ, Buckley BJ, Kaplan NA, Weinhaouse E, Gootman N: Comparative effects of bicarbonate and dichloroacetate in newborn swine with hypoxic lactic acidosis. Dev Pharmacol Ther. 1990;15(2):86-93. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
7034,"DB02329","BE0001554","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7035,"DB04899","BE0002426",""
7036,"DB00817","BE0000799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7037,"DB00518","BE0004789","# Solana HD, Sallovitz JM, Lanusse CE, Rodriguez JA: Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites. Methods Find Exp Clin Pharmacol. 2002 Jan-Feb;24(1):7-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11"
7038,"DB00811","BE0000761","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Gish RG: Treating HCV with ribavirin analogues and ribavirin-like molecules. J Antimicrob Chemothe"
7039,"DB01329","BE0003686","# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhashi S: Affinity of cefoperazone for penicillin-binding proteins. Antimicrob Agents Chemother. 1980 Jul;18(1):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6448021"
7040,"DB00005","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7041,"DB00114","BE0002166","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7042,"DB02268","BE0001468","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7043,"DB00934","BE0000092","# El-Fakahany E, Richelson E: Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain. Br J Pharmacol. 1983 Jan;78(1):97-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6297650# Golds PR, Przyslo FR, Strange PG: The binding of "
7044,"DB01839","BE0001314","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7045,"DB00295","BE0000770","# Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M: Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Brain Res. 2006 Apr 14;1083(1):61-9. Epub 2006 Mar 10. \"Pubmed\":http://www.nc"
7046,"DB07329","BE0003805","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7047,"DB00780","BE0002166","# Todd KG, Baker GB: Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. J Pharm Pharm Sci. 2008 May 16;11(2):14s-21s. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19203467# Tanay VA,"
7048,"DB08163","BE0000101","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7049,"DB04147","BE0004183","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7050,"DB01246","BE0000442","# Santos DE, Liu GJ, Takeuchi H: Blockers for excitatory effects of achatin-I, a tetrapeptide having a D-phenylalanine residue, on a snail neurone. Eur J Pharmacol. 1995 Jan 16;272(2-3):231-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7713167# Chen X, J"
7051,"DB03773","BE0002844",""
7052,"DB08632","BE0000629","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7053,"DB00087","BE0002097","# Lin TS, Flinn IW, Modali R, Lehman TA, Webb J, Waymer S, Moran ME, Lucas MS, Farag SS, Byrd JC: FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia. Blood. 2005 Jan 1;105(1):289-91. Epub 2004 Ju"
7054,"DB01352","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
7055,"DB01154","BE0002441","# Eguchi S, Kawano T, Oshita S, Nakajo N: [Effects of propofol and thiamylal on nicorandil induced ATP-sensitive potassium channel activities in cultured rat aortic smooth muscle cells] Masui. 2005 Apr;54(4):364-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
7056,"DB00126","BE0000087","# Salavoura K, Valari M, Kolialexi A, Mavrou A, Kitsiou S: A case of Ehlers Danlos syndrome type VI. Genet Couns. 2006;17(3):291-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17100196# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Aci"
7057,"DB07825","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7058,"DB08071","BE0004153","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7059,"DB08875","BE0002411","# Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EE, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Muller T, Ratain MJ, Salgia R: Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in"
7060,"DB00157","BE0000622","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7061,"DB00914","BE0000677","# Woollhead AM, Sivagnanasundaram J, Kalsi KK, Pucovsky V, Pellatt LJ, Scott JW, Mustard KJ, Hardie DG, Baines DL: Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial ce"
7062,"DB00289","BE0004956","# Ludolph AG, Udvardi PT, Schaz U, Henes C, Adolph O, Weigt HU, Fegert JM, Boeckers TM, Fohr KJ: Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. Br J Pharmacol. 2010 May;160(2):283-91. doi: 10.1111/j.1476-5381.2010.0070"
7063,"DB00759","BE0001105","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# De Luigi A, Colombo L, Diomede L, Capobianco R, Mangieri M, Miccolo C, Limido L, Forloni G, Taglia"
7064,"DB03121","BE0001640","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7065,"DB00143","BE0000810","# Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, Rannug A, Auvinen A, Christensen HC, Henriksson R, Johansen C, Lindholm C, Malmer B, Salminen T, Schoemaker MJ, Swerdlow AJ, Feychting M: An international case-control study of glutathione transferase and fu"
7066,"DB02379","BE0004592","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7067,"DB07752","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7068,"DB04242","BE0001543","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7069,"DB00434","BE0000533","# Honda M, Nishida T, Ono H: Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors. Eur J Pharmacol. 2003 Jan 1;458(1-2):91-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12498"
7070,"DB00268","BE0000451","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
7071,"DB02270","BE0004050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7072,"DB00546","BE0002344","# Lahti RA, Sethy VH, Barsuhn C, Hester JB: Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology. 1983 Nov;22(11):1277-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6320036# Sethy VH, Collins RJ, Daniels "
7073,"DB02030","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7074,"DB00195","BE0000172","# McLean AJ, Zeng FY, Behan D, Chalmers D, Milligan G: Generation and analysis of constitutively active and physically destabilized mutants of the human beta(1)-adrenoceptor. Mol Pharmacol. 2002 Sep;62(3):747-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
7075,"DB00007","BE0000203","# Castellon E, Clementi M, Hitschfeld C, Sanchez C, Benitez D, Saenz L, Contreras H, Huidobro C: Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma. Cancer Inv"
7076,"DB05461","BE0000342",""
7077,"DB04658","BE0001810",""
7078,"DB00943","BE0004853","# Devineni D, Gallo JM: Zalcitabine. Clinical pharmacokinetics and efficacy. Clin Pharmacokinet. 1995 May;28(5):351-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7614775# Adkins JC, Peters DH, Faulds D: Zalcitabine. An update of its pharmacodynamic and "
7079,"DB02676","BE0001287","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7080,"DB02327","BE0001531","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7081,"DB00246","BE0000045","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7082,"DB03754","BE0001731","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7083,"DB01238","BE0000533","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7084,"DB05291","BE0002433",""
7085,"DB02379","BE0003212",""
7086,"DB07233","BE0003754","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7087,"DB00149","BE0000204","# Ma JJ, Zhao MW, Wang ED: Split leucine-specific domain of leucyl-tRNA synthetase from the hyperthermophilic bacterium Aquifex aeolicus. Biochemistry. 2006 Dec 12;45(49):14809-16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17144674# Zhu B, Zhao MW, Eria"
7088,"DB01016","BE0000406","# Patel TB: Effect of sulfonylureas on hepatic fatty acid oxidation. Am J Physiol. 1986 Aug;251(2 Pt 1):E241-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3090894# Cook GA: The hypoglycemic sulfonylureas glyburide and tolbutamide inhibit fatty acid oxida"
7089,"DB02336","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7090,"DB01064","BE0002383","# Slomiany BL, Slomiany A: Salivary phospholipid secretion in response to beta-adrenergic stimulation is mediated by Src kinase-dependent epidermal growth factor receptor transactivation. Biochem Biophys Res Commun. 2004 May 21;318(1):247-52. \"Pubmed\":htt"
7091,"DB01218","BE0001694","# Friedman R, Caflisch A: Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring. ChemMedChem. 2009 Aug;4(8):1317-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19472268"
7092,"DB00756","BE0002252","# Lokanatha V, Sailaja P, Rajendra W: In vitro kinetics of the rat brain succinate dehydrogenase inhibition by hexachlorophene. J Biochem Mol Toxicol. 1999;13(6):303-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10487417"
7093,"DB08308","BE0001607","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7094,"DB01169","BE0001027","# Hyun Park W, Hee Cho Y, Won Jung C, Oh Park J, Kim K, Hyuck Im Y, Lee MH, Ki Kang W, Park K: Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem Biophys Res Commun. 2003 Jan 3;300(1):230-5."
7095,"DB07312","BE0002431","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7096,"DB03147","BE0002990",""
7097,"DB01059","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7098,"DB01074","BE0000179","# Kennedy JA, Kiosoglous AJ, Murphy GA, Pelle MA, Horowitz JD: Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. J Cardiovasc Pharmacol. 2000 Dec;36(6):794-801. \"Pubm"
7099,"DB00622","BE0000691","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Striessnig, J. (2004). Ca ^2+^ channel blockers. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclo"
7100,"DB04409","BE0000689","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7101,"DB07346","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7102,"DB06984","BE0003505","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7103,"DB08901","BE0004743","# FDA label # Iqbal Z, Aleem A, Iqbal M, Naqvi MI, Gill A, Taj AS, Qayyum A, ur-Rehman N, Khalid AM, Shah IH, Khalid M, Haq R, Khan M, Baig SM, Jamil A, Abbas MN, Absar M, Mahmood A, Rasool M, Akhtar T: Sensitive detection of pre-existing BCR-ABL kinase d"
7104,"DB08138","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7105,"DB08368","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7106,"DB00182","BE0002196","# Clarke DE, Lyles GA, Callingham BA: A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs. Biochem Pharmacol. 1982 Jan 1;31(1):27-35. \"Pubmed\":http://www.ncbi"
7107,"DB08266","BE0003370","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7108,"DB02950","BE0000890","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
7109,"DB03888","BE0001553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7110,"DB00194","BE0000458","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7111,"DB00786","BE0003697","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
7112,"DB04530","BE0001996","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7113,"DB04281","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7114,"DB00407","BE0000280","# Mousa SA: The low molecular weight heparin, tinzaparin, in thrombosis and beyond. Cardiovasc Drug Rev. 2002 Fall;20(3):199-216. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12397367# Lin P, Sinha U, Betz A: Antithrombin binding of low molecular weight he"
7115,"DB08609","BE0004348","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7116,"DB08295","BE0004264","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7117,"DB08801","BE0000442","# Moree WJ, Li BF, Zamani-Kord S, Yu J, Coon T, Huang C, Marinkovic D, Tucci FC, Malany S, Bradbury MJ, Hernandez LM, Wen J, Wang H, Hoare SR, Petroski RE, Jalali K, Yang C, Sacaan A, Madan A, Crowe PD, Beaton G: Identification of a novel selective H1-ant"
7118,"DB08533","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7119,"DB00302","BE0000211","# Dunn CJ, Goa KL: Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999 Jun;57(6):1005-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10400410# Marti DN, Schaller J, Llinas M: Solution structure and dynamics of the plasminog"
7120,"DB04404","BE0001584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7121,"DB00054","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7122,"DB04565","BE0001468","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7123,"DB04464","BE0003993","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7124,"DB06880","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7125,"DB07461","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7126,"DB07302","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7127,"DB01023","BE0003566","# Bostrom SL, Westerlund C, Rochester S, Vogel HJ: Binding of a dihydropyridine felodipine-analogue to calmodulin and related calcium-binding proteins. Biochem Pharmacol. 1988 Oct 1;37(19):3723-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3178884# Berma"
7128,"DB00142","BE0002267","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7129,"DB02024","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7130,"DB00248","BE0000389","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Newman-Tancredi A, Cussac D, Audinot V, Nicolas JP, De C"
7131,"DB04920","BE0002357","# Nordlander M, Sjoquist PO, Ericsson H, Ryden L: Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev. 2004 Fall;22(3):227-50. \"Pubmed\":http://"
7132,"DB05428","BE0002450",""
7133,"DB04059","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7134,"DB01351","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
7135,"DB02669","BE0001346","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7136,"DB04628","BE0001649",""
7137,"DB03186","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7138,"DB00217","BE0000644","# Bkaily G, Caille JP, Payet MD, Peyrow M, Sauve R, Renaud JF, Sperelakis N: Bethanidine increases one type of potassium current and relaxes aortic muscle. Can J Physiol Pharmacol. 1988 Jun;66(6):731-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3167688#"
7139,"DB01595","BE0002344","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
7140,"DB04367","BE0000772","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7141,"DB07538","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7142,"DB07146","BE0000842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7143,"DB08453","BE0003909","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7144,"DB00543","BE0000749","# Spurlock G, Buckland P, O'Donovan M, McGuffin P: Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology. 1994 Mar-Apr;33(3-4):433-40. \"Pubmed\":http://www.nc"
7145,"DB04147","BE0003953","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7146,"DB07091","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7147,"DB04851","BE0001067","# Minderman H, O'Loughlin KL, Pendyala L, Baer MR: VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Clin Cancer "
7148,"DB08515","BE0003915","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7149,"DB01409","BE0000560","# Hansel TT, Barnes PJ: Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Drugs Today (Barc). 2002 Sep;38(9):585-600. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12582447# Barnes PJ, Belvisi MG, Mak JC, Hadda"
7150,"DB02057","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7151,"DB00193","BE0000486","# Sagata K, Minami K, Yanagihara N, Shiraishi M, Toyohira Y, Ueno S, Shigematsu A: Tramadol inhibits norepinephrine transporter function at desipramine-binding sites in cultured bovine adrenal medullary cells. Anesth Analg. 2002 Apr;94(4):901-6, table of "
7152,"DB01558","BE0003593","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
7153,"DB06144","BE0000451","# Lindstrom E, Levander S: Sertindole: efficacy and safety in schizophrenia. Expert Opin Pharmacother. 2006 Sep;7(13):1825-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16925508# Schreiber R, Brocco M, Millan MJ: Blockade of the discriminative stimulus "
7154,"DB00988","BE0004889","# Hubner H, Haubmann C, Utz W, Gmeiner P: Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype. J Med Chem. 2000 F"
7155,"DB03469","BE0001718","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7156,"DB05190","BE0000634",""
7157,"DB02073","BE0000735","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7158,"DB08432","BE0000498","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7159,"DB01624","BE0000442","http://www.lundbeck.com/upload/ca/en/files/pdf/product_monograph/Clopixol_PM_MKT_ctrl_148975_13SEPT2011_CLN_eng.pdf"
7160,"DB00602","BE0002345","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Feng XP, Hayashi J, Beech RN, Prichard RK: Study of the nemat"
7161,"DB07706","BE0002733","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7162,"DB00157","BE0000586","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7163,"DB01151","BE0000291","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
7164,"DB04929","BE0002382",""
7165,"DB00794","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
7166,"DB00142","BE0002244","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7167,"DB00126","BE0001361","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7168,"DB04272","BE0001480","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7169,"DB00402","BE0000795","# Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2009 Nov 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19942638# Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: S"
7170,"DB03247","BE0003766","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7171,"DB01096","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7172,"DB00254","BE0004799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7173,"DB02835","BE0001357","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7174,"DB01992","BE0001422","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7175,"DB04328","BE0001381","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7176,"DB08404","BE0004133","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7177,"DB00244","BE0000248","# Nielsen OH, Bukhave K, Elmgreen J, Ahnfelt-Ronne I: Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci. 1987 Jun;32(6):577-82. \"Pubmed\":http://www.ncbi.nlm.nih"
7178,"DB01803","BE0002557",""
7179,"DB08481","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7180,"DB02052","BE0001082","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
7181,"DB00674","BE0000411","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
7182,"DB04272","BE0001575","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7183,"DB00246","BE0000145","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7184,"DB03461","BE0002069","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7185,"DB00192","BE0000197","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7186,"DB00143","BE0000816","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7187,"DB05216","BE0000852",""
7188,"DB04392","BE0001184","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7189,"DB07379","BE0003838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7190,"DB05495","BE0000058",""
7191,"DB02120","BE0001371","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7192,"DB02912","BE0002846",""
7193,"DB00126","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7194,"DB02811","BE0001688","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7195,"DB08888","BE0001180","# Tsui I, Pan CK, Rahimy E, Schwartz SD: Ocriplasmin for vitreoretinal diseases. J Biomed Biotechnol. 2012;2012:354979. doi: 10.1155/2012/354979. Epub 2012 Oct 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23193358"
7196,"DB07141","BE0000330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7197,"DB02506","BE0003810","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7198,"DB04620","BE0000365","# Herberg LJ, Rose IC: Effects of D-cycloserine and cycloleucine, ligands for the NMDA-associated strychnine-insensitive glycine site, on brain-stimulation reward and spontaneous locomotion. Pharmacol Biochem Behav. 1990 Aug;36(4):735-8. \"Pubmed\":http://w"
7199,"DB03045","BE0001422","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7200,"DB04843","BE0000045","# Tsai CS, Guede-Guina F, Smith MO, Vangah-Manda M, Ochillo RF: Isolation of cholinergic active ingredients in aqueous extracts of Mareya micrantha using the longitudinal muscle of isolated guinea-pig ileum as a pharmacological activity marker. J Ethnopha"
7201,"DB00072","BE0000511","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Leveque D, Gigou L, Bergerat JP: Clinical pharmacology of trastuzumab. Curr Clin Pharmacol. 2008 J"
7202,"DB02132","BE0000747","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7203,"DB00869","BE0000267","# Hasegawa T, Hara K, Hata S: Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro. Drug Metab Dispos. 1994 May-Jun;22(3):377-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8070313# Maren TH, Conroy CW, Wyn"
7204,"DB07294","BE0000144","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7205,"DB01021","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7206,"DB02772","BE0002830",""
7207,"DB01059","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7208,"DB01785","BE0004044","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7209,"DB01041","BE0004898","# Kim JH, Scialli AR: Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol Sci. 2011 Jul;122(1):1-6. doi: 10.1093/toxsci/kfr088. Epub 2011 Apr 19. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21507989"
7210,"DB00618","BE0000127","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7211,"DB04242","BE0002575",""
7212,"DB03669","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7213,"DB03916","BE0004000","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7214,"DB03247","BE0002008","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7215,"DB04932","BE0000924","# Bianchi G, Barone D, Lanzarotti E, Tettamanti R, Porta R, Moltrasio D, Cedro A, Salvetti L, Mantovani M, Prino G: Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. Eur J Pharmacol. 1993 Jul 20;238(2-3):327-3"
7216,"DB03849","BE0001287","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7217,"DB00739","BE0004643","# Neu HC: Aminopenicillins - clinical pharmacology and use in disease states. Int J Clin Pharmacol Biopharm. 1975 Mar;11(2):132-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1095502# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lacta"
7218,"DB00091","BE0000379","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7219,"DB05752","BE0000045",""
7220,"DB08236","BE0004251","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7221,"DB05129","BE0000971",""
7222,"DB00334","BE0004872","# Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT: Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 1996 Feb;14(2):87-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8822"
7223,"DB08846","BE0000535","# Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j"
7224,"DB00171","BE0000139","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7225,"DB01393","BE0000215","# Tenenbaum A, Motro M, Fisman EZ: Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol. 2005 Sep 16;4:14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16168052"
7226,"DB01235","BE0000145","# Onofrj M, Bonanni L, Thomas A: An expert opinion on safinamide in Parkinson's disease. Expert Opin Investig Drugs. 2008 Jul;17(7):1115-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18549347# Deleu D, Northway MG, Hanssens Y: Clinical pharmacokinetic a"
7227,"DB01991","BE0001333","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7228,"DB00876","BE0000062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Heusser K, Vitkovsky J, Schmieder RE, Schobel HP: AT1 antagonism by eprosartan lowers heart rate v"
7229,"DB06971","BE0001182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7230,"DB00162","BE0000786","# Muniz A, Villazana-Espinoza ET, Thackeray B, Tsin AT: 11-cis-Acyl-CoA:retinol O-acyltransferase activity in the primary culture of chicken Muller cells. Biochemistry. 2006 Oct 10;45(40):12265-73. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17014079# Wen"
7231,"DB06966","BE0003764","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7232,"DB00020","BE0002116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7233,"DB00582","BE0000233","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7234,"DB00630","BE0000980","# Opas EE, Rutledge SJ, Golub E, Stern A, Zimolo Z, Rodan GA, Schmidt A: Alendronate inhibition of protein-tyrosine-phosphatase-meg1. Biochem Pharmacol. 1997 Sep 15;54(6):721-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9310349"
7235,"DB07673","BE0003783","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7236,"DB08896","BE0002131","# FDA label"
7237,"DB00413","BE0000393","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
7238,"DB02379","BE0001734","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7239,"DB04282","BE0001339","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7240,"DB00075","BE0000274","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7241,"DB01301","BE0000127","# Carrasco-Pancorbo A, Casado-Terrones S, Segura-Carretero A, Fernandez-Gutierrez A: Reversed-phase high-performance liquid chromatography coupled to ultraviolet and electrospray time-of-flight mass spectrometry on-line detection for the separation of eig"
7242,"DB01395","BE0000557","# Krattenmacher R: Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000 Jul;62(1):29-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11024226# Bray JD, Jelinsky S, Ghatge R, Bray JA, Tunkey C, Saraf K, Jacobsen BM, "
7243,"DB02633","BE0000814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7244,"DB00792","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Shimizu K, Nakajyo S, Urakawa N: [Drug sensitivity of the isolated stomach and ileal preparation f"
7245,"DB04027","BE0000714","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7246,"DB02086","BE0001210","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7247,"DB00726","BE0000501","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
7248,"DB04105","BE0000400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7249,"DB04680","BE0000214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7250,"DB00064","BE0001119","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7251,"DB00074","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7252,"DB00801","BE0003596","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
7253,"DB08342","BE0004279","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7254,"DB00667","BE0000442","# Miyoshi K, Das AK, Fujimoto K, Horio S, Fukui H: Recent advances in molecular pharmacology of the histamine systems: regulation of histamine H1 receptor signaling by changing its expression level. J Pharmacol Sci. 2006 May;101(1):3-6. Epub 2006 Apr 28. "
7255,"DB03364","BE0001323","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7256,"DB07957","BE0003758","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7257,"DB00898","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7258,"DB00430","BE0000488","# Fass RJ, Helsel VL: In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli. Diagn Microbiol Infect Dis. 1986 Jan;4(1):77-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3943292# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhash"
7259,"DB00055","BE0002112","# Shen L, Villoutreix BO, Dahlback B: Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor. Thromb Haemost. 1999 Jul;82(1):72-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
7260,"DB04825","BE0000418","# Lamers JM, Cysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. Biochem Pharmacol. 1985 Nov 1;34(21):3837-43. \"Pubmed\":http://www.n"
7261,"DB00328","BE0003561","# Hata AN, Lybrand TP, Breyer RM: Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2. J Biol Chem. 2005 Sep 16;280(37):32442-51. Epub 2005 Jul 19. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16"
7262,"DB01110","BE0000699","# Hatton CJ, Peers C: Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C85-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8760033# Kikuchi K, Nagatomo T, Abe H, Kawakam"
7263,"DB00568","BE0004890","# Nasu R, Matsuo H, Takanaga H, Ohtani H, Sawada Y: Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice. Biopharm Drug Dispos. 2000 May;21(4):129-38. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11180191"
7264,"DB01621","BE0000291","# Cosi C, Koek W: Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells. Eur J Pharmacol. 2001 Dec 14;433(1):55-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11755134# Newma"
7265,"DB00921","BE0000420","# Induru RR, Davis MP: Buprenorphine for neuropathic pain--targeting hyperalgesia. Am J Hosp Palliat Care. 2009 Dec-2010 Jan;26(6):470-3. Epub 2009 Aug 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19666890# Lester PA, Traynor JR: Comparison of the in vi"
7266,"DB03596","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7267,"DB01159","BE0001080","# Ishizawa Y, Sharp R, Liebman PA, Eckenhoff RG: Halothane binding to a G protein coupled receptor in retinal membranes by photoaffinity labeling. Biochemistry. 2000 Jul 25;39(29):8497-502. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10913255# Zang WJ, Yu"
7268,"DB01129","BE0000349","# Langtry HD, Markham A: Rabeprazole: a review of its use in acid-related gastrointestinal disorders. Drugs. 1999 Oct;58(4):725-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10551440# Carswell CI, Goa KL: Rabeprazole: an update of its use in acid-relate"
7269,"DB01200","BE0000533","# Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I: Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO c"
7270,"DB04147","BE0004177","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7271,"DB00819","BE0000880","# Xiang Y, Ma B, Li T, Yu HM, Li XJ: Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma. Acta Pharmacol Sin. 2002 Aug;23(8):745-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12147198# Mu SM, Ji "
7272,"DB00920","BE0000706","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7273,"DB01791","BE0002353","# Beeh KM, Beier J, Lerch C, Schulz AK, Buhl R: Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Lung. 2004;182(6):369-77. \"Pubmed\":http://www.ncbi.nlm.nih"
7274,"DB00979","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7275,"DB08805","BE0000112","# Black JW, Duncan WA, Emmett JC, Ganellin CR, Hesselbo T, Parsons ME, Wyllie JH: Metiamide--an orally active histamine H2-receptor antagonist. 1973. Agents Actions. 1994 Dec;43(3-4):91-5; discussion 96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7725982"
7276,"DB07436","BE0001331","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7277,"DB00184","BE0003587","# Mansvelder HD, Mertz M, Role LW: Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol. 2009 Jun;20(4):432-40. Epub 2009 Jan 22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19560048# Narahashi T, Fe"
7278,"DB08694","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7279,"DB02427","BE0000330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7280,"DB00586","BE0000353","# Voilley N, de Weille J, Mamet J, Lazdunski M: Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci. 2001 Oct 15;21(20):8026-33. \"Pubmed\":http://www.n"
7281,"DB00540","BE0000560","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
7282,"DB04447","BE0001233","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7283,"DB07372","BE0003821","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7284,"DB00134","BE0001534","# Upadhya R, Zhang HS, Weiss LM: System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2006 Oct;50(10):3389-95. Epub 2006 Aug 17. \"Pubmed\":http://www.ncbi.nlm"
7285,"DB00095","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7286,"DB02379","BE0003245",""
7287,"DB00145","BE0002302","# Kanno J, Hutchin T, Kamada F, Narisawa A, Aoki Y, Matsubara Y, Kure S: Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia. J Med Genet. 2007 Mar;44(3):e69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17361008"
7288,"DB00732","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7289,"DB01567","BE0003593","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
7290,"DB01043","BE0003438","# Aracava Y, Pereira EF, Maelicke A, Albuquerque EX: Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. J Pharmacol Exp Ther. 2005 Mar;312(3):1195-205. Epub 2004 Nov 2. "
7291,"DB03721","BE0003169",""
7292,"DB01208","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
7293,"DB04315","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7294,"DB03827","BE0001560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7295,"DB04137","BE0001834","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7296,"DB00370","BE0000289","# Garcia-Sevilla JA, Ventayol P, Perez V, Rubovszky G, Puigdemont D, Ferrer-Alcon M, Andreoli A, Guimon J, Alvarez E: Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Ne"
7297,"DB07604","BE0003888","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7298,"DB02952","BE0001026","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7299,"DB00895","BE0000049","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7300,"DB06803","BE0004796","# Abreu FC, Goulart MO, Brett AM: Detection of the damage caused to DNA by niclosamide using an electrochemical DNA-biosensor. Biosens Bioelectron. 2002 Dec;17(11-12):913-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12392939"
7301,"DB04809","BE0003363",""
7302,"DB03147","BE0001921","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7303,"DB01062","BE0000560","# Dmochowski R: Improving the tolerability of anticholinergic agents in the treatment of overactive bladder. Drug Saf. 2005;28(7):583-600. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15963006# Nelson CP, Nahorski SR, Challiss RA: Constitutive activity and"
7304,"DB01520","BE0003438","# Pagan OR, Eterovic VA, Garcia M, Vergne D, Basilio CM, Rodriguez AD, Hann RM: Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction. Biochemistry. 2001 Sep 18;40(37):11121-30. \"Pubmed\":http://ww"
7305,"DB03173","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7306,"DB01065","BE0000515","# Radogna F, Paternoster L, De Nicola M, Cerella C, Ammendola S, Bedini A, Tarzia G, Aquilano K, Ciriolo M, Ghibelli L: Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicol Appl Phar"
7307,"DB04723","BE0003257","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7308,"DB00973","BE0001078","# Kramer W, Girbig F, Corsiero D, Pfenninger A, Frick W, Jahne G, Rhein M, Wendler W, Lottspeich F, Hochleitner EO, Orso E, Schmitz G: Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush "
7309,"DB00114","BE0002170","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7310,"DB00358","BE0004805","# Fitch CD: Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci. 2004 Mar 5;74(16):1957-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14967191"
7311,"DB00049","BE0004823","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7312,"DB01587","BE0003593","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
7313,"DB00143","BE0002189","# Sharma P, Ahmad Shah Z, Kumar A, Islam F, Mishra KP: Role of combined administration of Tiron and glutathione against aluminum-induced oxidative stress in rat brain. J Trace Elem Med Biol. 2007;21(1):63-70. Epub 2007 Feb 6. \"Pubmed\":http://www.ncbi.nlm."
7314,"DB04485","BE0002061","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7315,"DB00416","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7316,"DB05168","BE0000652",""
7317,"DB01775","BE0001311","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7318,"DB03197","BE0001450","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7319,"DB00381","BE0000430","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Striessnig, J. (2004). Ca ^2+^ channel blockers. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclo"
7320,"DB00514","BE0000156","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7321,"DB00806","BE0000182","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
7322,"DB01983","BE0000286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7323,"DB00075","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7324,"DB00157","BE0000357","# Siu E, Won K, Park CB: Electrochemical Regeneration of NADH Using Conductive Vanadia-Silica Xerogels. Biotechnol Prog. 2007 Feb 2;23(1):293-296. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17269701# Lu Y, Mei L: Co-expression of P450 BM3 and glucose deh"
7325,"DB00128","BE0002152","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7326,"DB04395","BE0001499","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7327,"DB04510","BE0004454","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7328,"DB01176","BE0000951","# Bamforth KJ, Dalgliesh K, Coughtrie MW: Inhibition of human liver steroid sulfotransferase activities by drugs: a novel mechanism of drug toxicity? Eur J Pharmacol. 1992 May 1;228(1):15-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1397064"
7329,"DB04315","BE0004053","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7330,"DB08326","BE0004272","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7331,"DB04169","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7332,"DB04315","BE0004478","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7333,"DB03147","BE0001487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7334,"DB03516","BE0000960","# Czito BG, Hong TJ, Cohen DP, Petros WP, Tyler DS, Pappas TN, Yu D, Lee CG, Lockhart AC, Morse MA, Fernando N, Hurwitz HI: A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of t"
7335,"DB08689","BE0002257","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7336,"DB05075","BE0000029",""
7337,"DB01435","BE0000262","# Brune K, Neubert A: Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective. Clin Exp Rheumatol. 2001 Nov-Dec;19(6 Suppl 25):S51-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11695253"
7338,"DB05328","BE0001594",""
7339,"DB06953","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7340,"DB02378","BE0000988","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7341,"DB08896","BE0000748","# FDA label"
7342,"DB08513","BE0000033","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7343,"DB08358","BE0001373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7344,"DB03003","BE0002062","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7345,"DB05412","BE0000704",""
7346,"DB00824","BE0000013","# Linden J, Thai T, Figler H, Jin X, Robeva AS: Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol. 1999 Oct;56(4):705-13"
7347,"DB05492","BE0000289",""
7348,"DB04714","BE0004107","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7349,"DB01221","BE0000641","# Smothers CT, Woodward JJ: Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther. 2007 Aug;322(2):739-48. Epub 2007 May 14. \"Pubmed\":http://www.ncbi.nlm."
7350,"DB00075","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7351,"DB01067","BE0000215","# Scarsi M, Podvinec M, Roth A, Hug H, Kersten S, Albrecht H, Schwede T, Meyer UA, Rucker C: Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol Phar"
7352,"DB01083","BE0000959","# Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW: Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 2004 Mar 15;64(6):2070-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15026345# Knowles LM, Axelrod F, Browne CD, Sm"
7353,"DB01267","BE0000289","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243"
7354,"DB03978","BE0001962","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7355,"DB03850","BE0002101","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7356,"DB08689","BE0003849","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7357,"DB01403","BE0000533","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205"
7358,"DB04426","BE0004482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7359,"DB04272","BE0001966","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7360,"DB03543","BE0001558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7361,"DB07435","BE0003871","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7362,"DB01880","BE0001855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7363,"DB00371","BE0000381","# Rho JM, Donevan SD, Rogawski MA: Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther. 1997 Mar;280(3):1383-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9067327# Gonzalez LA, Gatch MB, Taylor CM, Be"
7364,"DB04604","BE0001062","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7365,"DB03176","BE0000687","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7366,"DB01373","BE0000218","# Shi X, Chen M, Huvos PE, Hardwicke PM: Amino acid sequence of a Ca(2+)-transporting ATPase from the sarcoplasmic reticulum of the cross-striated part of the adductor muscle of the deep sea scallop: comparison to serca enzymes of other animals. Comp Bioc"
7367,"DB00630","BE0003569","# David P, Nguyen H, Barbier A, Baron R: The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Miner Res. 1996 Oct;11(10):1498-507. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8889850"
7368,"DB08696","BE0004382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7369,"DB01942","BE0002643",""
7370,"DB04702","BE0004037","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7371,"DB01363","BE0000749","# Wee S, Ordway GA, Woolverton WL: Reinforcing effect of pseudoephedrine isomers and the mechanism of action. Eur J Pharmacol. 2004 Jun 16;493(1-3):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15189772# Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW,"
7372,"DB00139","BE0000447","# Takahashi R, Ishihara H, Tamura A, Yamaguchi S, Yamada T, Takei D, Katagiri H, Endou H, Oka Y: Cell type-specific activation of metabolism reveals that beta-cell secretion suppresses glucagon release from alpha-cells in rat pancreatic islets. Am J Physi"
7373,"DB01942","BE0001966","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7374,"DB00576","BE0000803","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7375,"DB04465","BE0004501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7376,"DB00774","BE0000267","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7377,"DB08761","BE0001873","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7378,"DB02596","BE0002806",""
7379,"DB01744","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7380,"DB04037","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7381,"DB03833","BE0001982","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7382,"DB03247","BE0002710",""
7383,"DB04116","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7384,"DB00363","BE0000572","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7385,"DB08617","BE0000230","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7386,"DB00160","BE0000316","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7387,"DB03613","BE0002575",""
7388,"DB01348","BE0000221","# Song JC, White CM: Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet. 2002;41(3):207-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11929321# Maul B, Krause W, Pankow"
7389,"DB00126","BE0002117","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7390,"DB04974","BE0002386",""
7391,"DB03709","BE0001578","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7392,"DB00700","BE0000668","# Moore TD, Nawarskas JJ, Anderson JR: Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Heart Dis. 2003 Sep-Oct;5(5):354-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14503934# Fraccarollo D, Galuppo P, Hildema"
7393,"DB00108","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7394,"DB07235","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7395,"DB04474","BE0001291","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7396,"DB00415","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
7397,"DB07206","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7398,"DB03461","BE0002717",""
7399,"DB00945","BE0004907","# Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, Alessi DR, Dunlop MG: Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012 Jun;142(7):1504-15.e"
7400,"DB04988","BE0000767","# Farhan H, Schuster C, Klinger M, Weisz E, Waxenecker G, Schuster M, Sexl V, Mudde GC, Freissmuth M, Kircheis R: Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen. J Pharmacol Exp T"
7401,"DB04422","BE0003310",""
7402,"DB07533","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7403,"DB07006","BE0003335","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7404,"DB08291","BE0002683","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7405,"DB05216","BE0002411",""
7406,"DB00799","BE0000663","# Baumann L, Vujevich J, Halem M, Martin LK, Kerdel F, Lazarus M, Pacheco H, Black L, Bryde J: Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging. Cutis. 2005 Jul;76(1):69-73. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1614429"
7407,"DB00667","BE0000968","# Petroianu G, Arafat K, Sasse BC, Stark H: Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents. Pharmazie. 2006 Mar;61(3):179-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16599255# Garduno-Torres B, Arias-"
7408,"DB01098","BE0000574","# Carbonell T, Freire E: Binding thermodynamics of statins to HMG-CoA reductase. Biochemistry. 2005 Sep 6;44(35):11741-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16128575# Chapman MJ, Caslake M, Packard C, McTaggart F: New dimension of statin action o"
7409,"DB05241","BE0002407",""
7410,"DB03413","BE0001318","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7411,"DB01069","BE0000451","# Bileviciute I, Stenfors C, Theodorsson E, Lundeberg T: Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw. Br J Pharmacol. 1998 Nov;125(6):1304-1"
7412,"DB01388","BE0002355","# Mocanu MM, Gadgil S, Yellon DM, Baxter GF: Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism. Cardiovasc Drugs Ther. 1999 Apr;13(2):115-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
7413,"DB08376","BE0004291","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7414,"DB04634","BE0003343","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7415,"DB00412","BE0000215","# Su JL, Winegar DA, Wisely GB, Sigel CS, Hull-Ryde EA: Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro. Hybridoma. 1999 Jun;18(3):273-80. \"Pubmed\":http://www.ncbi.nlm.nih.g"
7416,"DB02863","BE0001426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7417,"DB08271","BE0003689","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7418,"DB03461","BE0003126",""
7419,"DB07968","BE0000007","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7420,"DB04884","BE0000291",""
7421,"DB01624","BE0000020","# Lublin H, Gerlach J, Hagert U, Meidahl B, Molbjerg C, Pedersen V, Rendtorff C, Tolvanen E: Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. Eur Neuropsychopharmacol. 1991 Dec;1(4)"
7422,"DB00171","BE0000665","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7423,"DB07652","BE0004032","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7424,"DB01717","BE0004477","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7425,"DB00248","BE0000451","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
7426,"DB06884","BE0002088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7427,"DB04695","BE0003570","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7428,"DB04791","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7429,"DB02015","BE0002691",""
7430,"DB02004","BE0000854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7431,"DB01361","BE0003675","# Scharre KA, Eckels DD, Gershwin ME: Depression of colony formation by human thymus-derived lymphocytes with rifampin and other antimicrobial agents. J Infect Dis. 1981 Jun;143(6):832-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6972981"
7432,"DB05198","BE0000991",""
7433,"DB00656","BE0000289","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Overington JP, Al-Lazikani"
7434,"DB08134","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7435,"DB00986","BE0000045","# Haddad EB, Patel H, Keeling JE, Yacoub MH, Barnes PJ, Belvisi MG: Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways. Br J Pharmacol. 1999 May;127(2):413-20. \"Pubmed\":http://www.ncbi.n"
7436,"DB06589","BE0000369","# Sonpavde G, Hutson TE: Pazopanib: a novel multitargeted tyrosine kinase inhibitor. Curr Oncol Rep. 2007 Mar;9(2):115-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17288876"
7437,"DB00385","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Perabo FG, Muller SC: New agents in intravesical chemotherapy of superficial bladder cancer. Scand"
7438,"DB01161","BE0000311","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7439,"DB02538","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7440,"DB00909","BE0000141","# Kothare SV, Kaleyias J: Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety. Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):493-506. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18433351# Schulze-Bonhage A: Zonisamide in the tr"
7441,"DB07726","BE0004063","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7442,"DB01972","BE0001240","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7443,"DB02345","BE0003106","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7444,"DB04395","BE0001776","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7445,"DB02999","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7446,"DB04230","BE0004459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7447,"DB07855","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7448,"DB04555","BE0001600","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7449,"DB08634","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7450,"DB08437","BE0003826","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7451,"DB07547","BE0003752","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7452,"DB07475","BE0003915","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7453,"DB01830","BE0000842","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7454,"DB06881","BE0003741","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7455,"DB05309","BE0000326",""
7456,"DB06151","BE0000396","# Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, Bankston LA: Cysteine regulation of protein function--as exemplified by NMDA-receptor modulation. Trends Neurosci. 2002 Sep;25(9):474-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12183209"
7457,"DB01005","BE0000325","# Culligan K, Tissier A, Britt A: ATR regulates a G2-phase cell-cycle checkpoint in Arabidopsis thaliana. Plant Cell. 2004 May;16(5):1091-104. Epub 2004 Apr 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15075397# Zhou B, Liu X, Mo X, Xue L, Darwish D, Qi"
7458,"DB03255","BE0001346","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7459,"DB00078","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7460,"DB00677","BE0000426","# Malatova Z, Gottlieb M, Marsala J: Depression of acetylcholinesterase synthesis following transient cerebral ischemia in rat: pharmacohistochemical and biochemical investigation. Gen Physiol Biophys. 1999 Mar;18(1):57-71. \"Pubmed\":http://www.ncbi.nlm.ni"
7461,"DB06216","BE0000289","# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. Epub 2008 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18308814"
7462,"DB04087","BE0001797","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7463,"DB00135","BE0000230","# Bonnefond L, Frugier M, Touze E, Lorber B, Florentz C, Giege R, Rudinger-Thirion J, Sauter C: Tyrosyl-tRNA synthetase: the first crystallization of a human mitochondrial aminoacyl-tRNA synthetase. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 A"
7464,"DB00246","BE0000572","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7465,"DB03884","BE0004316","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7466,"DB00852","BE0000704","# Wu Z, Kong X, Zhang T, Ye J, Fang Z, Yang X: Pseudoephedrine/ephedrine shows potent anti-inflammatory activity against TNF-alpha-mediated acute liver failure induced by lipopolysaccharide/D-galactosamine. Eur J Pharmacol. 2014 Feb 5;724:112-21. doi: 10."
7467,"DB02557","BE0000266","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
7468,"DB01405","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7469,"DB00231","BE0000129","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
7470,"DB00073","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7471,"DB03088","BE0002939",""
7472,"DB04272","BE0002551",""
7473,"DB00936","BE0000262","# Graham GG, Scott KF: Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology. 2003;11(4):401-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15035793# Fiebich BL, Chrubasik S: Effects of an ethanolic salix extract on the release"
7474,"DB02622","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7475,"DB07879","BE0003523","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7476,"DB00909","BE0000535","# De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19703035# Supuran CT, Di Fiore A, De S"
7477,"DB03297","BE0001377","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7478,"DB01643","BE0001221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7479,"DB02766","BE0002024","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7480,"DB04319","BE0001762","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7481,"DB01942","BE0001525","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7482,"DB04147","BE0004163","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7483,"DB00330","BE0000034","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7484,"DB01558","BE0000381","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
7485,"DB00507","BE0002674","# Hoffman PS, Sisson G, Croxen MA, Welch K, Harman WD, Cremades N, Morash MG: Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Age"
7486,"DB01050","BE0000215","# Dill J, Patel AR, Yang XL, Bachoo R, Powell CM, Li S: A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons. J Neurosci. 2010 Jan 20;30(3):963-72. doi: 10.1523/JNEUROSCI.5045-09.2010. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2008990"
7487,"DB08791","BE0000915","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7488,"DB00835","BE0000560","# Yasuda SU, Yasuda RP: Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes. Pharmacotherapy. 1999 Apr;19(4):447-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10212017"
7489,"DB03439","BE0001671","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7490,"DB00521","BE0000172","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Bruck H, Poller U, Lussenhop H, Ponicke K, Temme T, Heusch G, Philipp T, Brodde OE: Beta 2-adrenoc"
7491,"DB01624","BE0000145","# Lublin H, Gerlach J, Hagert U, Meidahl B, Molbjerg C, Pedersen V, Rendtorff C, Tolvanen E: Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. Eur Neuropsychopharmacol. 1991 Dec;1(4)"
7492,"DB03982","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7493,"DB08427","BE0001491","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7494,"DB08437","BE0003835","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7495,"DB07953","BE0004066","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7496,"DB04310","BE0003873","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7497,"DB02323","BE0000194","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7498,"DB03247","BE0001616","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7499,"DB02820","BE0000317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7500,"DB07205","BE0000230","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7501,"DB00160","BE0000392","# Christensen M, Duno M, Lund AM, Skovby F, Christensen E: Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase. J Inherit Metab Dis. 2007 Apr;30(2):248-55. Epub 2007 Mar 1. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17334708# Lima S, Khr"
7502,"DB05125","BE0000382",""
7503,"DB03754","BE0001966","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7504,"DB04272","BE0003262",""
7505,"DB07271","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7506,"DB00145","BE0000292","# Gagnon D, Foucher A, Girard I, Ouellette M: Stage specific gene expression and cellular localization of two isoforms of the serine hydroxymethyltransferase in the protozoan parasite Leishmania. Mol Biochem Parasitol. 2006 Nov;150(1):63-71. Epub 2006 Jul"
7507,"DB03088","BE0002942",""
7508,"DB08310","BE0004268","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7509,"DB06042","BE0000026",""
7510,"DB00381","BE0003563","# Furukawa T, Nukada T, Suzuki K, Fujita Y, Mori Y, Nishimura M, Yamanaka M: Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine. Br J Pharmacol. 1997 Jul;121(6):1136-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9249249# Furukaw"
7511,"DB01124","BE0000644","# Proks P, Jones P, Ashcroft FM: Interaction of stilbene disulphonates with cloned K(ATP) channels. Br J Pharmacol. 2001 Mar;132(5):973-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11226127# Smith PA, Proks P: Inhibition of the ATP-sensitive potassium "
7512,"DB03161","BE0002627",""
7513,"DB00028","BE0000855","# Baerenwaldt A, Biburger M, Nimmerjahn F: Mechanisms of action of intravenous immunoglobulins. Expert Rev Clin Immunol. 2010 May;6(3):425-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20441428# Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, K"
7514,"DB01072","BE0004854","# Dierynck I, De Wit M, Gustin E, Keuleers I, Vandersmissen J, Hallenberger S, Hertogs K: Binding kinetics of darunavir to HIV-1 protease explain the potent antiviral activity and high genetic barrier. J Virol. 2007 Oct 10;. \"Pubmed\":http://www.ncbi.nlm.n"
7515,"DB04465","BE0001854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7516,"DB01619","BE0000442","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# ter Laak AM, Venhorst J, Donne-Op den Kelder GM, Timmerman H:"
7517,"DB00925","BE0000289","# Frang H, Cockcroft V, Karskela T, Scheinin M, Marjamaki A: Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors. J Biol Chem. 2001 Aug 17;276(33):31279-84. Epub 2001 Jun 6. \"Pubmed\":http://ww"
7518,"DB01213","BE0000400","# Yin SJ, Liao CS, Chen CM, Fan FT, Lee SC: Genetic polymorphism and activities of human lung alcohol and aldehyde dehydrogenases: implications for ethanol metabolism and cytotoxicity. Biochem Genet. 1992 Apr;30(3-4):203-15. \"Pubmed\":http://www.ncbi.nlm.n"
7519,"DB00929","BE0003522","# Nakae K, Hayashi F, Hayashi M, Yamamoto N, Iino T, Yoshikawa S, Gupta J: Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. Neurosci Lett. 2005 Nov 18;388(3):132-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16039053# Li J, L"
7520,"DB05271","BE0000389","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
7521,"DB01752","BE0002520",""
7522,"DB00163","BE0002326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7523,"DB06216","BE0004688","# Citrome L: Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatr Dis Treat. 2011;7:325-39. Epub 2011 May 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21655346# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharm"
7524,"DB05305","BE0002438",""
7525,"DB01070","BE0000779","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7526,"DB08537","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7527,"DB01727","BE0004504","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7528,"DB02119","BE0001289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7529,"DB00934","BE0000756","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881"
7530,"DB06148","BE0000581","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
7531,"DB08425","BE0003804","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7532,"DB01535","BE0000632","# Mayberg HS, Sadzot B, Meltzer CC, Fisher RS, Lesser RP, Dannals RF, Lever JR, Wilson AA, Ravert HT, Wagner HN Jr, et al.: Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol. 1991 Jul"
7533,"DB07710","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7534,"DB00706","BE0000715","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Noble AJ, Chess-Williams R, Couldwell C, Furukawa K, Uchyiuma T, Korstanje C, Chapple CR: The effe"
7535,"DB07767","BE0003784","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7536,"DB00457","BE0000715","# Nagaoka Y, Ahmed M, Hossain M, Bhuiyan MA, Ishiguro M, Nakamura T, Watanabe M, Nagatomo T: Amino acids of the human alpha1d-adrenergic receptor involved in antagonist binding. J Pharmacol Sci. 2008 Jan;106(1):114-20. Epub 2008 Jan 11. \"Pubmed\":http://ww"
7537,"DB00721","BE0000647","# Sato T, Kitayama S, Mitsuhata C, Ikeda T, Morita K, Dohi T: Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics. Naunyn Schmiedebergs Arch Pharmacol. 2000 Feb;361(2):214-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
7538,"DB00665","BE0000132","# Raynaud JP: Antiandrogens in combination with LH-RH agonists in prostate cancer. Am J Clin Oncol. 1988;11 Suppl 2:S132-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3071951# Moguilewsky M, Bertagna C, Hucher M: Pharmacological and clinical studies of "
7539,"DB07203","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7540,"DB03752","BE0000017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7541,"DB06151","BE0000030","# Dean O, Giorlando F, Berk M: N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21118657"
7542,"DB01144","BE0000267","# Winum JY, Casini A, Mincione F, Starnotti M, Montero JL, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits. Bioorg Med Chem Lett. 2"
7543,"DB03773","BE0002639",""
7544,"DB04163","BE0004001","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7545,"DB04464","BE0003922","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7546,"DB04491","BE0000854","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7547,"DB08453","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7548,"DB02102","BE0001594","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7549,"DB01331","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
7550,"DB01942","BE0000597","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7551,"DB01357","BE0000123","# Dulos J, Vijn P, van Doorn C, Hofstra CL, Veening-Griffioen D, de Graaf J, Dijcks FA, Boots AM: Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor alpha but not estrogen receptor beta. Arthritis Res Ther"
7552,"DB00817","BE0000798","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7553,"DB00969","BE0000311","# Clayton NM, Sargent R, Butler A, Gale J, Maxwell MP, Hunt AA, Barrett VJ, Cambridge D, Bountra C, Humphrey PP: The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small inte"
7554,"DB03147","BE0004566","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7555,"DB06090","BE0003438",""
7556,"DB02379","BE0001654","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7557,"DB08082","BE0002196","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7558,"DB01163","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
7559,"DB02551","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7560,"DB00911","BE0004796","# Fung HB, Doan TL: Tinidazole: a nitroimidazole antiprotozoal agent. Clin Ther. 2005 Dec;27(12):1859-84. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16507373# Lopez Nigro MM, Carballo MA: Genotoxicity and cell death induced by tinidazole (TNZ). Toxicol L"
7561,"DB00264","BE0000172","# Schafer M, Frischkopf K, Taimor G, Piper HM, Schluter KD: Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am J Physiol Cell Physiol. 2000 Aug;279(2):C495-503. \"Pubmed\":http://www.ncbi.nlm.n"
7562,"DB03042","BE0001469","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7563,"DB00114","BE0002167","# Heidenreich T, Wollers S, Mendel RR, Bittner F: Characterization of the NifS-like domain of ABA3 from Arabidopsis thaliana provides insight into the mechanism of molybdenum cofactor sulfuration. J Biol Chem. 2005 Feb 11;280(6):4213-8. Epub 2004 Nov 22. "
7564,"DB07475","BE0002347","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7565,"DB00623","BE0000020","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Van Kampen JM, Stoessl AJ: Dopamine D(1A) receptor function in a rodent model of tardive dyskinesi"
7566,"DB02028","BE0004544","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7567,"DB01186","BE0000797","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
7568,"DB03561","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7569,"DB02742","BE0001789","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7570,"DB03814","BE0001844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7571,"DB01273","BE0002341","# Mihalak KB, Carroll FI, Luetje CW: Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006 Sep;70(3):801-5. Epub 2006 Jun 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16766716"
7572,"DB08474","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7573,"DB00087","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7574,"DB07926","BE0000920","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7575,"DB03424","BE0001680","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7576,"DB02722","BE0002819",""
7577,"DB00172","BE0004615","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7578,"DB00200","BE0000734","# Kolhouse JF, Utley C, Stabler SP, Allen RH: Mechanism of conversion of human apo- to holomethionine synthase by various forms of cobalamin. J Biol Chem. 1991 Dec 5;266(34):23010-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1744096# Ogier de Baulny H, "
7579,"DB01253","BE0000501","# Gibson A, Carvajal A: Agonist profile of ergometrine (ergonovine) on a population of postsynaptic alpha-adrenoceptors. J Pharm Pharmacol. 1988 Feb;40(2):137-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2897449# Zhu F, Han B, Kumar P, Liu X, Ma X, Wei "
7580,"DB01399","BE0000017","# Stevenson DD: Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am. 2004 Aug;24(3):491-505, vii. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15242723# Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J: Temporal relation"
7581,"DB06892","BE0000870","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7582,"DB04083","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7583,"DB00025","BE0002120","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7584,"DB08883","BE0000640","# Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y: Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Ep"
7585,"DB03403","BE0000637","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7586,"DB00143","BE0000811","# Gallagher EP, Huisden CM, Gardner JL: Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. Toxicol In Vitro. 2007 Apr 27;. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17553661"
7587,"DB06963","BE0003745","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7588,"DB02119","BE0001450","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7589,"DB00006","BE0000048","# Scatena R: Bivalirudin: a new generation antithrombotic drug. Expert Opin Investig Drugs. 2000 May;9(5):1119-27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11060732# Bates ER: Bivalirudin for percutaneous coronary intervention and in acute coronary syn"
7590,"DB07854","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7591,"DB00201","BE0000924","# Riksen NP, Franke B, van den Broek P, Smits P, Rongen GA: The 1976C>T polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo. Pharmacogenet Genomics. 2007 Jul;17(7):551-4. \"Pubmed\":http://"
7592,"DB04548","BE0001736","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7593,"DB03800","BE0000324","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7594,"DB01439","BE0000632","# Pascoe JE, Williams KL, Mukhopadhyay P, Rice KC, Woods JH, Ko MC: Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys. Psychoneuroendocrinology. 2008 May;33(4):478-86. Epub 2008 Mar "
7595,"DB00148","BE0000082","# Tian XF, Zhang XS, Li YH, Wang ZZ, Zhang F, Wang LM, Yao JH: Proteasome inhibition attenuates lung injury induced by intestinal ischemia reperfusion in rats. Life Sci. 2006 Oct 26;79(22):2069-76. Epub 2006 Jun 23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
7596,"DB00151","BE0000963","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7597,"DB04530","BE0002654",""
7598,"DB00350","BE0000017","# Kurbel S, Kurbel B, Zanic-Matanic D: Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects? Med Hypotheses. 1999 Nov;53(5):402-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10616041"
7599,"DB02527","BE0003425","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7600,"DB02692","BE0000005","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7601,"DB03376","BE0000188","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7602,"DB02885","BE0001327","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7603,"DB08169","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7604,"DB02602","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7605,"DB08669","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7606,"DB03147","BE0000397","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7607,"DB00370","BE0004889","# Fernandez J, Alonso JM, Andres JI, Cid JM, Diaz A, Iturrino L, Gil P, Megens A, Sipido VK, Trabanco AA: Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents. J Med Chem. 2005 Mar 24;48(6):1709-12. \"Pub"
7608,"DB03340","BE0001606","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7609,"DB01576","BE0000486","# Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J, de Wit H: Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry. 2007 Jun 1;61(11):1296-305. Epub 2007 Jan 17. \"Pubmed\":http://www.ncbi.nlm.nih"
7610,"DB07324","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7611,"DB05335","BE0000017",""
7612,"DB00514","BE0000749","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7613,"DB01233","BE0000311","# Costall B, Gunning SJ, Naylor RJ, Tyers MB: The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig. Br J Pharmacol. 1987 Jun;91(2):263-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2955843"
7614,"DB08507","BE0001116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7615,"DB00909","BE0002437","# De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19703035# Supuran CT, Di Fiore A, De S"
7616,"DB01221","BE0004890","# Hustveit O, Maurset A, Oye I: Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol. 1995 Dec;77(6):355-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8835358"
7617,"DB06883","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7618,"DB05095","BE0000262","# Almansa C, Bartroli J, Belloc J, Cavalcanti FL, Ferrando R, Gomez LA, Ramis I, Carceller E, Merlos M, Garcia-Rafanell J: New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamid"
7619,"DB06857","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7620,"DB01651","BE0001213","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7621,"DB00274","BE0003685","# de la Rosa EJ, de Pedro MA, Vazquez D: Penicillin binding proteins: role in initiation of murein synthesis in Escherichia coli. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5632-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3898066"
7622,"DB01589","BE0003596","# Meldrum BS, Chapman AG: Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia. 1986;27 Suppl 1:S3-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3017690# Billard W, Crosby G, Iorio L, Chipkin R, Barnett A: Selective af"
7623,"DB03247","BE0002849",""
7624,"DB04078","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7625,"DB03775","BE0004052","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7626,"DB01381","BE0000795","# Hanrahan JR, Chebib M, Davucheron NL, Hall BJ, Johnston GA: Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2281-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12824018"
7627,"DB00334","BE0000393","# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. doi: 10.1177/0269881107082944. Epub 2008 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
7628,"DB00408","BE0000146","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
7629,"DB00275","BE0000062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Koike H, Sada T, Mizuno M: In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotens"
7630,"DB07637","BE0000654","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7631,"DB02994","BE0001210","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7632,"DB01915","BE0000814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7633,"DB01594","BE0003596","# Walash MI, Belal F, Metwally ME, Hefnawy MM: A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
7634,"DB07562","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7635,"DB00786","BE0003690","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
7636,"DB08128","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7637,"DB02213","BE0001477","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7638,"DB07880","BE0001668","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7639,"DB08067","BE0002408","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7640,"DB02659","BE0003999","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7641,"DB00711","BE0000248","# Bach MK, Brashler JR: Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor. Biochem Pharmacol. 1986 Feb 1;35(3):425-33. \"Pubmed\""
7642,"DB03906","BE0000735","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7643,"DB00054","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7644,"DB08185","BE0004200","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7645,"DB00458","BE0000533","# Palvimaki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J: Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berl). 1996 Aug;126(3):234-40. \"Pubmed\":http://www.ncbi.nlm"
7646,"DB02733","BE0001827","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7647,"DB00148","BE0000375","# Rosenberg EH, Munoz CM, Degrauw TJ, Jakobs C, Salomons GS: Overexpression of wild-type creatine transporter (SLC6A8) restores creatine uptake in primary SLC6A8-deficient fibroblasts. J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):345-6. \"Pubmed\":http://www.n"
7648,"DB05207","BE0000704",""
7649,"DB01023","BE0003565","# Lamers JM, Cysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. Biochem Pharmacol. 1985 Nov 1;34(21):3837-43. \"Pubmed\":http://www.n"
7650,"DB05399","BE0001114",""
7651,"DB00142","BE0002268","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7652,"DB08870","BE0003479","# Francisco JA, Cerveny CG, Meyer DL, Mixan BJ, Klussman K, Chace DF, Rejniak SX, Gordon KA, DeBlanc R, Toki BE, Law CL, Doronina SO, Siegall CB, Senter PD, Wahl AF: cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective an"
7653,"DB00768","BE0001206","# Kishimoto K, Kaneko S, Ohmori K, Tamura T, Hasegawa K: Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein. Mediators Inflamm. 2006;2006(1):42726. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16864903# Okada M, Tokumitsu H,"
7654,"DB03109","BE0001649","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7655,"DB00248","BE0000533","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
7656,"DB03499","BE0001914","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7657,"DB08174","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7658,"DB01624","BE0000501","# Khalifa AE: Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms. Pharmacol Biochem Behav. 2003 Jul;75(4):755-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12957216"
7659,"DB06840","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7660,"DB07939","BE0003355","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7661,"DB01272","BE0004831","# Hu D, Kamiya Y, Totani K, Kamiya D, Kawasaki N, Yamaguchi D, Matsuo I, Matsumoto N, Ito Y, Kato K, Yamamoto K: Sugar-binding activity of the MRH domain in the ER alpha-glucosidase II beta subunit is important for efficient glucose trimming. Glycobiology"
7662,"DB03384","BE0001826","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7663,"DB02798","BE0001675","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7664,"DB01363","BE0002198","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Ulus IH, Maher TJ, Wurtman RJ: Characterization of "
7665,"DB00431","BE0000055","# Vale C, Fonfria E, Bujons J, Messeguer A, Rodriguez-Farre E, Sunol C: The organochlorine pesticides gamma-hexachlorocyclohexane (lindane), alpha-endosulfan and dieldrin differentially interact with GABA(A) and glycine-gated chloride channels in primary "
7666,"DB00502","BE0000756","# Osinski MA, Uchic ME, Seifert T, Shaughnessy TK, Miller LN, Nakane M, Cox BF, Brioni JD, Moreland RB: Dopamine D2, but not D4, receptor agonists are emetogenic in ferrets. Pharmacol Biochem Behav. 2005 May;81(1):211-9. \"Pubmed\":http://www.ncbi.nlm.nih.g"
7667,"DB00497","BE0004879","# Leow KP, Wright AW, Cramond T, Smith MT: Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit. 1993 Oct;15(5):440-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8249052"
7668,"DB02418","BE0004530","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7669,"DB02379","BE0003242",""
7670,"DB04444","BE0000637","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7671,"DB06893","BE0003744","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7672,"DB07224","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7673,"DB08075","BE0004154","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7674,"DB04029","BE0003343","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7675,"DB03147","BE0004574","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7676,"DB01113","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7677,"DB01296","BE0000058","# Fenton JI, Chlebek-Brown KA, Caron JP, Orth MW: Effect of glucosamine on interleukin-1-conditioned articular cartilage. Equine Vet J Suppl. 2002 Sep;(34):219-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12405690# Mendis E, Kim MM, Rajapakse N, Kim SK"
7678,"DB02858","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7679,"DB04077","BE0001770","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7680,"DB01280","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7681,"DB06851","BE0003737","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7682,"DB04033","BE0003194","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7683,"DB07715","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7684,"DB04336","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7685,"DB07401","BE0003859","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7686,"DB03435","BE0001242","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7687,"DB08409","BE0003805","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7688,"DB08094","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7689,"DB02643","BE0003418","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7690,"DB00421","BE0000668","# Sitruk-Ware R: Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 2002 Jan-Feb;9(1):6-15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11791081# Rogerson FM, Yao YZ, Smith BJ, Dimopoulos N, Fuller PJ: Determinant"
7691,"DB00753","BE0000640","# Guo L, Wang Y: Glutamate stimulates glutamate receptor interacting protein 1 degradation by ubiquitin-proteasome system to regulate surface expression of GluR2. Neuroscience. 2007 Mar 2;145(1):100-9. Epub 2007 Jan 3. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
7692,"DB00157","BE0000522","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7693,"DB04272","BE0003259",""
7694,"DB03753","BE0000017","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7695,"DB01085","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7696,"DB05434","BE0000163",""
7697,"DB01904","BE0001214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7698,"DB03059","BE0002695",""
7699,"DB03685","BE0001788","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7700,"DB00726","BE0000311","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
7701,"DB00340","BE0000247","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7702,"DB00280","BE0000045","# Yamamoto N, Ozaki T, Keida Y, Ohtsuka M, Goto T: A comparison of the binding characteristics of class I antiarrhythmic agents for human muscarinic m1-m3 receptors. J Cardiovasc Pharmacol. 1999 Jul;34(1):53-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
7703,"DB00210","BE0000144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7704,"DB00009","BE0000538","# Longstaff C, Williams S, Thelwell C: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy. Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18673235# Melandri G, Vag"
7705,"DB07052","BE0003776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7706,"DB07416","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7707,"DB03591","BE0000838","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7708,"DB03147","BE0002988",""
7709,"DB02003","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7710,"DB04491","BE0001377","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7711,"DB03804","BE0001403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7712,"DB01032","BE0003645","# Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem. 1999 May 7;274(19):13675-80. \"Pubmed\":"
7713,"DB03837","BE0001646","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7714,"DB00333","BE0000311","# Deeb TZ, Sharp D, Hales TG: Direct subunit-dependent multimodal 5-hydroxytryptamine3 receptor antagonism by methadone. Mol Pharmacol. 2009 Apr;75(4):908-17. doi: 10.1124/mol.108.053322. Epub 2009 Jan 8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/191316"
7715,"DB00370","BE0000533","# Benelli A, Frigeri C, Bertolini A, Genedani S: Influence of mirtazapine on the sexual behavior of male rats. Psychopharmacology (Berl). 2004 Jan;171(3):250-8. Epub 2003 Nov 13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14615872# Millan MJ, Gobert A, R"
7716,"DB00417","BE0003618","# Lemaire S, Glupczynski Y, Duval V, Joris B, Tulkens PM, Van Bambeke F: Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-res"
7717,"DB04545","BE0001810","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7718,"DB00734","BE0000442","# Keks NA, Culhane C: Risperidone (Risperdal): clinical experience with a new antipsychosis drug. Expert Opin Investig Drugs. 1999 Apr;8(4):443-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15992090# Richelson E, Souder T: Binding of antipsychotic drugs"
7719,"DB07636","BE0003860","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7720,"DB00064","BE0000932","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7721,"DB01655","BE0001250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7722,"DB07893","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7723,"DB01914","BE0001330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7724,"DB01595","BE0002346","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
7725,"DB02867","BE0001369","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7726,"DB00157","BE0000550","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7727,"DB00536","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7728,"DB00694","BE0000742","# Aubel-Sadron G, Londos-Gagliardi D: Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 1984 May;66(5):333-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6380596# Zunino F, Capranico G: DNA topoi"
7729,"DB02263","BE0002057","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7730,"DB00157","BE0000541","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7731,"DB01373","BE0001177","# Lee TS, Mane S, Eid T, Zhao H, Lin A, Guan Z, Kim JH, Schweitzer J, King-Stevens D, Weber P, Spencer SS, Spencer DD, de Lanerolle NC: Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol Med. 200"
7732,"DB02506","BE0003811","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7733,"DB02824","BE0002839",""
7734,"DB00138","BE0000030","# Tomi M, Hosoya K, Takanaga H, Ohtsuki S, Terasaki T: Induction of xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci. 2002 Mar;43(3):774-9. \"Pubmed\":http://www.ncbi.nlm.n"
7735,"DB04922","BE0000691",""
7736,"DB06080","BE0000853",""
7737,"DB03247","BE0002577",""
7738,"DB08231","BE0004024","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7739,"DB03559","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7740,"DB01988","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7741,"DB08723","BE0004018","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7742,"DB04456","BE0001885","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7743,"DB08118","BE0001056","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7744,"DB04467","BE0001344",""
7745,"DB03389","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7746,"DB02772","BE0002831",""
7747,"DB03003","BE0002281","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7748,"DB01785","BE0004045","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7749,"DB01208","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7750,"DB07622","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7751,"DB03959","BE0000689","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7752,"DB03077","BE0001496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7753,"DB07820","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7754,"DB03153","BE0000077","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7755,"DB00471","BE0000705","# Nayak A: A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin Pharmacother. 2004 Mar;5(3):679-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15013935# Zhang YJ, Zhang L, Wang SB, Shen HH, Wei EQ: Montelukast modulates l"
7756,"DB01331","BE0000488","# Matsuhashi M, Tamaki S: Enzymatic studies on the mechanism of action of cefoxitin. Correlation between the affinities of cefoxitin to penicillin-binding proteins and its rates of inhibition of the respective penicillin-sensitive reactions in E. coli. J "
7757,"DB00909","BE0003635","# Janszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases] Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20025128# Kothare SV, Kaleyias J: Zonisamide: review of pharm"
7758,"DB03213","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7759,"DB00683","BE0000129","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
7760,"DB04624","BE0003340","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7761,"DB05014","BE0000147",""
7762,"DB00030","BE0000858","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7763,"DB01720","BE0001245","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7764,"DB08554","BE0001526","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7765,"DB02992","BE0001253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7766,"DB00661","BE0002357","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880"
7767,"DB06949","BE0003757","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7768,"DB05475","BE0000155",""
7769,"DB03258","BE0001782","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7770,"DB01587","BE0000795","# Blaschke G, Kley H, Muller WE: [Racemation of the benzodiazepines camazepam and ketazolam and receptor binding of enantiomers]. Arzneimittelforschung. 1986 Jun;36(6):893-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2874815# Mohler H, Fritschy JM, Rudo"
7771,"DB03716","BE0003167",""
7772,"DB03754","BE0001770","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7773,"DB03276","BE0000917","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7774,"DB04720","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7775,"DB00081","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7776,"DB00056","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7777,"DB07375","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7778,"DB04108","BE0001534","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7779,"DB04775","BE0002101","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7780,"DB01755","BE0001372","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7781,"DB06151","BE0000365","# Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, Bankston LA: Cysteine regulation of protein function--as exemplified by NMDA-receptor modulation. Trends Neurosci. 2002 Sep;25(9):474-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12183209"
7782,"DB01688","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7783,"DB00599","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
7784,"DB00244","BE0001154","# Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol. 2000 Dec;95(12):3452-7. \"Pubmed\":http://www.ncb"
7785,"DB00255","BE0000792","# Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products. Int J Toxicol. 2008;27 Suppl 4:1-82. \"Pubmed\":http://www.ncbi.n"
7786,"DB00801","BE0003595","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
7787,"DB08342","BE0004278","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7788,"DB01065","BE0002109","# Hardeland R: Melatonin: signaling mechanisms of a pleiotropic agent. Biofactors. 2009 Mar-Apr;35(2):183-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19449447# Macias M, Escames G, Leon J, Coto A, Sbihi Y, Osuna A, Acuna-Castroviejo D: Calreticulin-me"
7789,"DB08053","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7790,"DB06779","BE0000163","# Norrby K, Nordenhem A: Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo. APMIS. 2010 Dec;118(12):949-57. doi: 10.1111/j.1600-0463.2010.02635.x. Epub 2010 Oct 12. \"Pubmed\":http://www.ncbi.nlm.ni"
7791,"DB00438","BE0004648","# Hayes MV, Orr DC: Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983 Aug;12(2):119-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
7792,"DB00543","BE0000486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7793,"DB00934","BE0004863","# Buckley NA, McManus PR: Can the fatal toxicity of antidepressant drugs be predicted with pharmacological and toxicological data? Drug Saf. 1998 May;18(5):369-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9589848# Richelson E, Nelson A: Antagonism by a"
7794,"DB07548","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7795,"DB08753","BE0004391","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7796,"DB08037","BE0001852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7797,"DB03779","BE0001955","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7798,"DB07980","BE0003963","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7799,"DB01851","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7800,"DB08122","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7801,"DB00171","BE0000341","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7802,"DB00114","BE0004605","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7803,"DB04243","BE0002040","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7804,"DB02889","BE0002639",""
7805,"DB08282","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7806,"DB00651","BE0000924","# Schwabe U, Ukena D, Lohse MJ: Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):212-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2997628"
7807,"DB00114","BE0000164","# Sun L, Bartlam M, Liu Y, Pang H, Rao Z: Crystal structure of the pyridoxal-5'-phosphate-dependent serine dehydratase from human liver. Protein Sci. 2005 Mar;14(3):791-8. Epub 2005 Feb 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15689518# Yamada T, Ko"
7808,"DB07670","BE0003611","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7809,"DB04543","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7810,"DB07556","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7811,"DB04077","BE0004522","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7812,"DB08690","BE0003845","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7813,"DB04272","BE0001855","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7814,"DB07767","BE0004079","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7815,"DB02379","BE0003244",""
7816,"DB00145","BE0002303","# Styles NA, Falany JL, Barnes S, Falany CN: Quantification and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver. J Lipid Res. 2007 Jun;48(6):1305-15. Epub 2007 Mar 22. \"Pubmed\":http://w"
7817,"DB01131","BE0000330","# Kaneko A, Bergqvist Y, Takechi M, Kalkoa M, Kaneko O, Kobayakawa T, Ishizaki T, Bjorkman A: Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil. J Infect Dis. 1999 Apr;179(4):974-9. \"Pubmed\":htt"
7818,"DB07198","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7819,"DB03389","BE0002940",""
7820,"DB02613","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7821,"DB01215","BE0000471","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
7822,"DB02089","BE0000007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7823,"DB00562","BE0000419","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7824,"DB01023","BE0002355","# Peterson BZ, Catterall WA: Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore. Mol Pharmacol. 2006 Aug;70(2):667-75. Epub 2006 May 4. \"Pubmed\":http://www.nc"
7825,"DB05876","BE0001133",""
7826,"DB02053","BE0001253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7827,"DB01364","BE0000501","# Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Schaneberg BT, Khan IA, Feller DR: Pharmacological effects of ephedrine alkaloids on human alpha(1)- and alpha(2)-adrenergic receptor subtypes. J Pharmacol Exp Ther. 2007 Jul;322(1):214-21. Epub 2"
7828,"DB01303","BE0001133","# Wang K, Chen JQ, Chen Z, Chen JC: Inhibition of human phosphodiesterase 4A expressed in yeast cell GL62 by theophylline, rolipram, and acetamide-45. Acta Pharmacol Sin. 2002 Nov;23(11):1013-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12421478# Haider"
7829,"DB00978","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7830,"DB04967","BE0002414","# Luo M, Kelley MR: Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res. 2004 Jul-Aug;24(4):2127-34. \"Pubmed\":http://www.ncbi.n"
7831,"DB01743","BE0001305","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7832,"DB00697","BE0003580","# Rolon PA: Myxoglobulosis of the appendix. Int Surg. 1977 Jun-Jul;62(6-7):355-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/893017"
7833,"DB09018","BE0000756","# Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F: Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004 Feb 15;19(4):379-90. \"Pub"
7834,"DB02379","BE0000017","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7835,"DB06080","BE0000369",""
7836,"DB04932","BE0000241","# Bianchi G, Barone D, Lanzarotti E, Tettamanti R, Porta R, Moltrasio D, Cedro A, Salvetti L, Mantovani M, Prino G: Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. Eur J Pharmacol. 1993 Jul 20;238(2-3):327-3"
7837,"DB08932","BE0000043","# Bolli MH, Boss C, Binkert C, Buchmann S, Bur D, Hess P, Iglarz M, Meyer S, Rein J, Rey M, Treiber A, Clozel M, Fischli W, Weller T: The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-p ropylsulfamide (Macite"
7838,"DB05739","BE0000062",""
7839,"DB03862","BE0001219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7840,"DB00411","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7841,"DB08085","BE0000315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7842,"DB04272","BE0004551","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7843,"DB03788","BE0000315","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7844,"DB03814","BE0002025","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7845,"DB03509","BE0001717","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7846,"DB01325","BE0000322","# Temperini C, Cecchi A, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications? Org Biomol Chem. 2008 Jul 21;6(14):2499-506. Epub 2008 May 29. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1"
7847,"DB08378","BE0004294","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7848,"DB02494","BE0003830","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7849,"DB06939","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7850,"DB08402","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7851,"DB00619","BE0003600","# Nadal E, Olavarria E: Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies. Int J Clin Pract. 2004 May;58(5):511-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15206509# Waller CF: Imatinib"
7852,"DB00651","BE0000627","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7853,"DB03501","BE0000214","# Nguyen HP, Seto NO, Cai Y, Leinala EK, Borisova SN, Palcic MM, Evans SV: The influence of an intramolecular hydrogen bond in differential recognition of inhibitory acceptor analogs by human ABO(H) blood group A and B glycosyltransferases. J Biol Chem. 2"
7854,"DB00142","BE0000403","# Zhu A, Sun H, Raymond RM Jr, Furie BC, Furie B, Bronstein M, Kaufman RJ, Westrick R, Ginsburg D: Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase. Blood. 2007 Jun 15;109(12):5270-5. Epub 2007 Feb 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
7855,"DB07954","BE0000182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7856,"DB07860","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7857,"DB04566","BE0002080","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7858,"DB05153","BE0000369",""
7859,"DB03193","BE0004022","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7860,"DB08619","BE0004080","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7861,"DB04368","BE0001475","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7862,"DB04554","BE0001499","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7863,"DB00145","BE0000316","# Ricoult C, Echeverria LO, Cliquet JB, Limami AM: Characterization of alanine aminotransferase (AlaAT) multigene family and hypoxic response in young seedlings of the model legume Medicago truncatula. J Exp Bot. 2006;57(12):3079-89. Epub 2006 Aug 9. \"Pub"
7864,"DB01216","BE0000539","# Thigpen AE, Russell DW: Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor. J Biol Chem. 1992 Apr 25;267(12):8577-83. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1314830# Levy MA, Brandt M,"
7865,"DB03728","BE0003171",""
7866,"DB01151","BE0003930","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7867,"DB08775","BE0001504","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7868,"DB03247","BE0003024",""
7869,"DB08490","BE0000966","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7870,"DB01268","BE0000453","# Abrams TJ, Lee LB, Murray LJ, Pryer NK, Cherrington JM: SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer. Mol Cancer Ther. 2003 May;2(5):471-8. \"Pubmed\":http://www.ncbi.nlm.nih.g"
7871,"DB00916","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7872,"DB00118","BE0002089","# Lee BW, Sun HG, Zang T, Kim BJ, Alfaro JF, Zhou ZS: Enzyme-catalyzed transfer of a ketone group from an S-adenosylmethionine analogue: a tool for the functional analysis of methyltransferases. J Am Chem Soc. 2010 Mar 24;132(11):3642-3. \"Pubmed\":http://w"
7873,"DB04783","BE0002101","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7874,"DB06702","BE0000247","# Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E: Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. J Pharmacol Exp Ther. 2009 Mar;328(3)"
7875,"DB08828","BE0004659","Stated on FDA label.# Sandhiya S, Melvin G, Kumar SS, Dkhar SA: The dawn of hedgehog inhibitors: Vismodegib. J Pharmacol Pharmacother. 2013 Jan;4(1):4-7. doi: 10.4103/0976-500X.107628. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23662017"
7876,"DB04007","BE0001944","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7877,"DB00125","BE0000758","# Topal G, Brunet A, Walch L, Boucher JL, David-Dufilho M: Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther. 2006 Sep;318(3):1368-74. Epub 2006 Jun "
7878,"DB08159","BE0000971","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7879,"DB00222","BE0000207","# Muller G, Hartz D, Punter J, Okonomopulos R, Kramer W: Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics. Biochim Biophys Acta. 1994 May 11;1191(2):267-77. \"Pubmed\":http://www."
7880,"DB01267","BE0000389","# Leysen JE, Janssen PM, Megens AA, Schotte A: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry. 1994 May;55 Suppl:5-12. \"Pubmed\":http://www.ncbi.nlm."
7881,"DB07832","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7882,"DB07559","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7883,"DB00129","BE0002233","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7884,"DB02046","BE0003872","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7885,"DB02379","BE0001407","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7886,"DB01354","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
7887,"DB01577","BE0000118","# Horton DB, Siripurapu KB, Norrholm SD, Culver JP, Hojahmat M, Beckmann JS, Harrod SB, Deaciuc AG, Bardo MT, Crooks PA, Dwoskin LP: meso-Transdiene Analogs Inhibit Vesicular Monoamine Transporter-2 Function and Methamphetamine-evoked Dopamine Release. J "
7888,"DB03660","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7889,"DB04519","BE0002014",""
7890,"DB01159","BE0001028","# Weigl LG, Schreibmayer W: G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics. Mol Pharmacol. 2001 Aug;60(2):282-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11455015# Yamakura T, Lewohl JM, Harris RA: Different"
7891,"DB00157","BE0000329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7892,"DB05233","BE0000123",""
7893,"DB08252","BE0001668","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7894,"DB00228","BE0000415","# Namba T, Ishii TM, Ikeda M, Hisano T, Itoh T, Hirota K, Adelman JP, Fukuda K: Inhibition of the human intermediate conductance Ca(2+)-activated K(+) channel, hIK1, by volatile anesthetics. Eur J Pharmacol. 2000 Apr 28;395(2):95-101. \"Pubmed\":http://www."
7895,"DB03142","BE0001678","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7896,"DB03501","BE0000259","# Ramakrishnan B, Balaji PV, Qasba PK: Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site. J Mol Biol. 2002 Apr 26;318(2):491-502. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12051854# "
7897,"DB01645","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7898,"DB02817","BE0001246","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7899,"DB07961","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7900,"DB03267","BE0000906","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7901,"DB03439","BE0002639",""
7902,"DB01942","BE0002642",""
7903,"DB00292","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7904,"DB02255","BE0004104","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7905,"DB03757","BE0003758","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7906,"DB00583","BE0000373","# Cordente AG, Lopez-Vinas E, Vazquez MI, Swiegers JH, Pretorius IS, Gomez-Puertas P, Hegardt FG, Asins G, Serra D: Redesign of carnitine acetyltransferase specificity by protein engineering. J Biol Chem. 2004 Aug 6;279(32):33899-908. Epub 2004 May 21. \"P"
7907,"DB00005","BE0000949","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
7908,"DB03975","BE0001987","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7909,"DB01108","BE0000059","# Naville D, Keeney DS, Jenkin G, Murry BA, Head JR, Mason JI: Regulation of expression of male-specific rat liver microsomal 3 beta-hydroxysteroid dehydrogenase. Mol Endocrinol. 1991 Aug;5(8):1090-100. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1944305#"
7910,"DB03403","BE0002073",""
7911,"DB01151","BE0000092","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Overington JP, Al-Lazikani"
7912,"DB08624","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7913,"DB02281","BE0001128","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7914,"DB01267","BE0000442","# Cohen LJ: Risperidone. Pharmacotherapy. 1994 May-Jun;14(3):253-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7524043# Megens AA, Awouters FH, Schotte A, Meert TF, Dugovic C, Niemegeers CJ, Leysen JE: Survey on the pharmacodynamics of the new antipsych"
7915,"DB02469","BE0001243","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7916,"DB00174","BE0000236","# Dun Y, Mysona B, Itagaki S, Martin-Studdard A, Ganapathy V, Smith SB: Functional and molecular analysis of D-serine transport in retinal Muller cells. Exp Eye Res. 2007 Jan;84(1):191-9. Epub 2006 Nov 13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17094"
7917,"DB08084","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7918,"DB03727","BE0001629","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7919,"DB03642","BE0003417","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7920,"DB03316","BE0001842","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7921,"DB08140","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7922,"DB02379","BE0001386","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7923,"DB00363","BE0000575","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7924,"DB00402","BE0000381","# Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2009 Nov 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19942638# Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: S"
7925,"DB08055","BE0000842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7926,"DB00321","BE0001039","# Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K: Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol. 2009 Jun 26;16(6):644-56. \"Pubmed\":http://www.nc"
7927,"DB03041","BE0002000","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7928,"DB00286","BE0000123","# Ropero AB, Eghbali M, Minosyan TY, Tang G, Toro L, Stefani E: Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol. 2006 Sep;41(3):496-510. Epub 2006 Jul 28. \"Pubmed\":http://ww"
7929,"DB04355","BE0001910","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7930,"DB01265","BE0000555","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7931,"DB00756","BE0000114","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7932,"DB01346","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
7933,"DB00534","BE0000152","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7934,"DB07471","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7935,"DB04515","BE0001329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7936,"DB00141","BE0000259","# Ramakrishnan B, Boeggeman E, Qasba PK: Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. Biochemistry. 2005 Mar 8;44(9):3202-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15736931#"
7937,"DB00371","BE0000764","# Rho JM, Donevan SD, Rogawski MA: Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther. 1997 Mar;280(3):1383-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9067327# Gonzalez LA, Gatch MB, Taylor CM, Be"
7938,"DB08666","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7939,"DB08664","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7940,"DB04555","BE0001303","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7941,"DB00142","BE0000321","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7942,"DB02261","BE0001432","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7943,"DB00708","BE0000770","# Hurle MA: Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J Neurochem. 2001 Apr;77(2):486-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11299311# Levron JC:"
7944,"DB07646","BE0004030","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7945,"DB04286","BE0001940","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7946,"DB03401","BE0002654","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7947,"DB01388","BE0002354","# Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms. Pharmacology. 2006;78(1):11-20. Ep"
7948,"DB03171","BE0001719","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7949,"DB00714","BE0000533","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
7950,"DB00408","BE0000442","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
7951,"DB00308","BE0000708","# Doggrell SA, Hancox JC: Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opin Investig Drugs. 2005 May;14(5):655-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15926871# Foster RH, Wilde "
7952,"DB00794","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
7953,"DB00527","BE0000418","# Muto Y, Kudo S, Nozawa Y: Effects of local anesthetics on calmodulin-dependent guanylate cyclase in the plasma membrane of Tetrahymena pyriformis. Biochem Pharmacol. 1983 Dec 1;32(23):3559-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6140014# Volpi M"
7954,"DB03461","BE0003125",""
7955,"DB01136","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7956,"DB03997","BE0001481","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7957,"DB07490","BE0000548","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7958,"DB04156","BE0001662","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7959,"DB01021","BE0000732","# Takahashi N, Kondo Y, Fujiwara I, Ito O, Igarashi Y, Abe K: Characterization of Na+ transport across the cell membranes of the ascending thin limb of Henle's loop. Kidney Int. 1995 Mar;47(3):789-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7752578"
7960,"DB05122","BE0000590",""
7961,"DB04836","BE0000486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7962,"DB00334","BE0000659","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7963,"DB04141","BE0002254","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7964,"DB08240","BE0001683","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7965,"DB01910","BE0002516",""
7966,"DB01186","BE0000533","# Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I: Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO c"
7967,"DB02353","BE0000975","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7968,"DB08846","BE0000872","# Wang BH, Lu ZX, Polya GM: Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol. Planta Med. 1998 Apr;64(3):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9581512"
7969,"DB02841","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7970,"DB03227","BE0002622",""
7971,"DB05134","BE0001120",""
7972,"DB01068","BE0004797","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
7973,"DB05360","BE0000013",""
7974,"DB00381","BE0000267","# Puscas I, Gilau L, Coltau M, Pasca R, Domuta G, Baican M, Hecht A: Hypotensive effect of calcium channel blockers is parallel with carbonic anhydrase I inhibition. Clin Pharmacol Ther. 2000 Oct;68(4):443-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11"
7975,"DB02999","BE0000826","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7976,"DB00139","BE0000355","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7977,"DB00357","BE0003537","# Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, Tuckey RC: An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J. 2006 Jul;273(13):289"
7978,"DB03897","BE0004123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7979,"DB08012","BE0001612","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7980,"DB01142","BE0000486","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821# Stahl SM:"
7981,"DB04758","BE0000333",""
7982,"DB05658","BE0003344",""
7983,"DB00157","BE0000596","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7984,"DB05147","BE0001425",""
7985,"DB01224","BE0000581","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
7986,"DB01123","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7987,"DB00123","BE0000198","# Wu XR, Kenzior A, Willmot D, Scanlon S, Chen Z, Topin A, He SH, Acevedo A, Folk WR: Altered expression of plant lysyl tRNA synthetase promotes tRNA misacylation and translational recoding of lysine. Plant J. 2007 May;50(4):627-36. Epub 2007 Apr 8. \"Pubm"
7988,"DB03136","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7989,"DB04788","BE0003368","# Vassylyev DG, Svetlov V, Vassylyeva MN, Perederina A, Igarashi N, Matsugaki N, Wakatsuki S, Artsimovitch I: Structural basis for transcription inhibition by tagetitoxin. Nat Struct Mol Biol. 2005 Dec;12(12):1086-93. Epub 2005 Nov 6. \"Pubmed\":http://www."
7990,"DB00119","BE0000098","# Kumar V, Rangaraj N, Shivaji S: Activity of pyruvate dehydrogenase A (PDHA) in hamster spermatozoa correlates positively with hyperactivation and is associated with sperm capacitation. Biol Reprod. 2006 Nov;75(5):767-77. Epub 2006 Jul 19. \"Pubmed\":http:"
7991,"DB01038","BE0000020","# Vinar O, Formankova M, Taussigova D, Ruzicka S: Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial. Act Nerv Super (Praha). 1967 Nov;9(4):353-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/4889058# Bora G: Comparison of "
7992,"DB00308","BE0000154","# Doggrell SA, Hancox JC: Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opin Investig Drugs. 2005 May;14(5):655-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15926871# Foster RH, Wilde "
7993,"DB03760","BE0000065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7994,"DB04483","BE0001911","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7995,"DB03884","BE0004317","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
7996,"DB00640","BE0000241","# Trincavelli ML, Daniele S, Martini C: Adenosine receptors: what we know and what we are learning. Curr Top Med Chem. 2010;10(9):860-77. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20370662# Schenone S, Brullo C, Musumeci F, Bruno O, Botta M: A1 receptor"
7997,"DB02027","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7998,"DB03087","BE0004320","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
7999,"DB00739","BE0004290","# Neu HC: Aminopenicillins - clinical pharmacology and use in disease states. Int J Clin Pharmacol Biopharm. 1975 Mar;11(2):132-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1095502# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lacta"
8000,"DB04132","BE0000812","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8001,"DB07812","BE0001172","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8002,"DB04147","BE0001553","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8003,"DB01873","BE0001391","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8004,"DB00726","BE0004889","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
8005,"DB04661","BE0004495","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8006,"DB03352","BE0001321","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8007,"DB01992","BE0000574","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8008,"DB04396","BE0004512","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8009,"DB00087","BE0000901","# Nagler A, Condiotti R, Lubina A, Deutsch VR: Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells. Bone Marrow Transplant. 1997 Oct;20(7):525-31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9337053# Brett S, Baxter G, Cooper H,"
8010,"DB00071","BE0000941","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8011,"DB04499","BE0003318",""
8012,"DB00363","BE0000289","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
8013,"DB01678","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8014,"DB02058","BE0002131","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8015,"DB00157","BE0000224","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8016,"DB04563","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8017,"DB04522","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8018,"DB00413","BE0000756","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agon"
8019,"DB01429","BE0000197","# Sato R, Hisatome I, Tanaka Y, Sasaki N, Kotake H, Mashiba H, Katori R: Aprindine blocks the sodium current in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):331-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/166010"
8020,"DB08320","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8021,"DB04526","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8022,"DB05304","BE0002437",""
8023,"DB01303","BE0002366","# Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ: Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 2004 Sep 6;200(5):689-95. Epub 2004 Aug 30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
8024,"DB03462","BE0001995","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8025,"DB03592","BE0003133",""
8026,"DB00398","BE0000453","# Guida T, Anaganti S, Provitera L, Gedrich R, Sullivan E, Wilhelm SM, Santoro M, Carlomagno F: Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants. Clin Cancer Res. 2007 Jun 1;13(11):3363-9. \"Pubm"
8027,"DB01414","BE0000588","# Yotsuji A, Mitsuyama J, Hori R, Yasuda T, Saikawa I, Inoue M, Mitsuhashi S: Mechanism of action of cephalosporins and resistance caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis. Antimicrob Agents Chemother. 1988 Dec;"
8028,"DB08048","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8029,"DB02362","BE0001543","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8030,"DB00619","BE0001039","# Catani M, De Milito R, Simi M: [New orientations in the management of advanced, metastatic gastrointestinal stromal tumors (GIST): combination of surgery and systemic therapy with imatinib in a case of primary gastric location] Chir Ital. 2005 Jan-Feb;5"
8031,"DB08437","BE0003834","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8032,"DB04315","BE0004528","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8033,"DB04491","BE0001701","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8034,"DB03750","BE0001936","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8035,"DB08303","BE0000829","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8036,"DB01639","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8037,"DB04455","BE0001588","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8038,"DB07597","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8039,"DB09016","BE0000451","# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 1984 Jul;230(1):94-102. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6086881# Wander TJ, Nelson A, Okazaki H, Richels"
8040,"DB04457","BE0001970","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8041,"DB08203","BE0004001","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8042,"DB03088","BE0002941",""
8043,"DB08254","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8044,"DB00268","BE0000020","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
8045,"DB02007","BE0001309","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8046,"DB03147","BE0004141","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8047,"DB00616","BE0000221","# Dumoulin MJ, Adam A, Rouleau JL, Lamontagne D: Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed. J Cardiovasc Pharmacol. 2001 Apr;37(4):359-6"
8048,"DB02546","BE0002367","# Xu WS, Parmigiani RB, Marks PA: Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007 Aug 13;26(37):5541-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17694093"
8049,"DB01082","BE0000279","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8050,"DB00554","BE0000262","# Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F: Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol. 1999 Jun;26(6):1366-73. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10381057# Bugajski J, Glo"
8051,"DB08226","BE0003368","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8052,"DB03661","BE0003142",""
8053,"DB02379","BE0003250",""
8054,"DB08124","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8055,"DB03091","BE0002030","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8056,"DB00908","BE0000154","# Lesage F, Guillemare E, Fink M, Duprat F, Lazdunski M, Romey G, Barhanin J: TWIK-1, a ubiquitous human weakly inward rectifying K+ channel with a novel structure. EMBO J. 1996 Mar 1;15(5):1004-11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8605869# Fin"
8057,"DB01102","BE0000694","# Abou-Mohamed G, Nagarajan R, Ibrahim TM, Caldwell RW: Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing. Cardiovasc Drugs Ther. 1996 Mar;10(1):39-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8"
8058,"DB05069","BE0000411",""
8059,"DB07834","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8060,"DB07656","BE0002413","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8061,"DB00004","BE0000658","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8062,"DB08896","BE0000841","# FDA label"
8063,"DB00394","BE0000794","# Saklatvala J: Glucocorticoids: do we know how they work? Arthritis Res. 2002;4(3):146-50. Epub 2002 Jan 21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12010562# Issar M, Sahasranaman S, Buchwald P, Hochhaus G: Differences in the glucocorticoid to proge"
8064,"DB01411","BE0000705","# Yoo SH, Park SH, Song JS, Kang KH, Park CS, Yoo JH, Choi BW, Hahn MH: Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial. Respirology. 2001 Mar;6(1):15-21"
8065,"DB02126","BE0000629","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8066,"DB08135","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8067,"DB04052","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8068,"DB00797","BE0000442","# Roll C, Hanssler L: [Interaction of tolazoline and cimetidine in persistent fetal circulation of the newborn infant] Monatsschr Kinderheilkd. 1993 Apr;141(4):297-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8487790"
8069,"DB08690","BE0003859","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8070,"DB00438","BE0004649","# Hayes MV, Orr DC: Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983 Aug;12(2):119-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
8071,"DB01291","BE0000172","# van Zwieten PA: Receptor-mediated inotropic drugs. Eur Heart J. 1988 Jun;9 Suppl H:85-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2901958# Kenakin TP, Beek D: Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of a"
8072,"DB02210","BE0002711",""
8073,"DB00226","BE0000486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8074,"DB02137","BE0001458","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8075,"DB00194","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8076,"DB02500","BE0001403","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8077,"DB00789","BE0003559","# Akkemik E, Budak H, Ciftci M: Effects of some drugs on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro study. J Enzyme Inhib Med Chem. 2010 Mar 17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20235752# Berman HM, Westbrook J, Feng Z, Gil"
8078,"DB03195","BE0001221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8079,"DB03609","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8080,"DB01958","BE0001302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8081,"DB04280","BE0001709","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8082,"DB02594","BE0002804",""
8083,"DB04464","BE0003921","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8084,"DB03010","BE0001425","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8085,"DB00114","BE0000727","# Goh DL, Patel A, Thomas GH, Salomons GS, Schor DS, Jakobs C, Geraghty MT: Characterization of the human gene encoding alpha-aminoadipate aminotransferase (AADAT). Mol Genet Metab. 2002 Jul;76(3):172-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/121269"
8086,"DB01239","BE0000393","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8087,"DB00725","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8088,"DB00031","BE0002105","# Kralovich KR, Li L, Hembrough TA, Webb DJ, Karns LR, Gonias SL: Characterization of the binding sites for plasminogen and tissue-type plasminogen activator in cytokeratin 8 and cytokeratin 18. J Protein Chem. 1998 Nov;17(8):845-54. \"Pubmed\":http://www.n"
8089,"DB03900","BE0003844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8090,"DB01959","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8091,"DB04077","BE0003957","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8092,"DB07947","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8093,"DB06637","BE0004723","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
8094,"DB04514","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8095,"DB02758","BE0003768","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8096,"DB01666","BE0004526","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8097,"DB05304","BE0001029",""
8098,"DB02000","BE0001389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8099,"DB00233","BE0003768","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8100,"DB05475","BE0001164",""
8101,"DB02838","BE0004141","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8102,"DB01041","BE0004755","# Zhu YX, Kortuem KM, Stewart AK: Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma. Leuk Lymphoma. 2013 Apr;54(4):683-7. doi: 10.3109/10428194.2012.728597. Epub 2012 Sep 28. \"Pubmed\":h"
8103,"DB08544","BE0003930","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8104,"DB01329","BE0003687","# Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhashi S: Affinity of cefoperazone for penicillin-binding proteins. Antimicrob Agents Chemother. 1980 Jul;18(1):195-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6448021"
8105,"DB08526","BE0003970","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8106,"DB03570","BE0001562","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8107,"DB00087","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8108,"DB07497","BE0000698","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8109,"DB03069","BE0001707","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8110,"DB02379","BE0000926","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8111,"DB04511","BE0002494","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8112,"DB02134","BE0002009","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8113,"DB01972","BE0001634","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8114,"DB02452","BE0004639","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8115,"DB00197","BE0002088","# Wang Y, Fang F, Wong CW: Troglitazone is an estrogen-related receptor alpha and gamma inverse agonist. Biochem Pharmacol. 2010 Jul 1;80(1):80-5. Epub 2010 Mar 16. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20298676"
8116,"DB04957","BE0000090","# Schmitt H, Cabo C, Coromilas JC, Wit AL: Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction. J Cardiovasc Electrophysiol. 2001 Sep;"
8117,"DB01271","BE0004820","# Burrow TA, Leslie ND: Review of the use of idursulfase in the treatment of mucopolysaccharidosis II. Biologics. 2008 Jun;2(2):311-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19707363# Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N,"
8118,"DB01947","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8119,"DB00114","BE0002165","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8120,"DB02059","BE0004547","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8121,"DB04879","BE0000023","# Yamamoto A, Watanabe H, Sueki H, Nakanishi T, Yasuhara H, Iijima M: Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity. J Dermatol. 2007 J"
8122,"DB00166","BE0000094","# Prasad PD, Wang H, Huang W, Fei YJ, Leibach FH, Devoe LD, Ganapathy V: Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter. Arch Biochem Biophys. 1999 Jun 1;366(1):95-106. \"Pubmed\":http://www.ncbi.nlm.nih.g"
8123,"DB02540","BE0001476","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8124,"DB01558","BE0000764","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
8125,"DB06692","BE0003531","# Mahdy AM, Webster NR: Perioperative systemic haemostatic agents. Br J Anaesth. 2004 Dec;93(6):842-58. Epub 2004 Jul 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15277296"
8126,"DB00150","BE0000228","# Tsuchiya W, Umehara T, Kuno A, Hasegawa T: Determination of tryptophan tRNA recognition sites for tryptophanyl-tRNA synthetase from hyperthermophilic archaeon, Aeropyrum pernix K1. Nucleic Acids Symp Ser (Oxf). 2004;(48):185-6. \"Pubmed\":http://www.ncbi."
8127,"DB00139","BE0002221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8128,"DB00968","BE0002151","# SOURKES TL: Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine. Arch Biochem Biophys. 1954 Aug;51(2):444-56. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/13189588"
8129,"DB07847","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8130,"DB00210","BE0000663","# Shroot B, Michel S: Pharmacology and chemistry of adapalene. J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S96-103. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9204085# Griffiths CE, Ancian P, Humphries J, Poncet M, Rizova E, Michel S, Clucas A: Adapalene 0.1"
8131,"DB00382","BE0000426","# Davis KL: Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington. Geriatrics. 1999 Feb;54(2):42-7; quiz 48. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10024872# Wang H, Carlier PR, Ho WL, Wu DC, Lee NT, Li CP"
8132,"DB03145","BE0001327","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8133,"DB08818","BE0004952","# Wisniewski HG, Burgess WH, Oppenheim JD, Vilcek J: TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor. Biochemistry. 1994 Jun 14;33(23):7423-9. \"Pubmed\":http://www.ncbi.nlm.nih."
8134,"DB00696","BE0000291","# Bigal ME, Tepper SJ: Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep. 2003 Feb;7(1):55-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12525272"
8135,"DB01268","BE0000029","# O'Farrell AM, Foran JM, Fiedler W, Serve H, Paquette RL, Cooper MA, Yuen HA, Louie SG, Kim H, Nicholas S, Heinrich MC, Berdel WE, Bello C, Jacobs M, Scigalla P, Manning WC, Kelsey S, Cherrington JM: An innovative phase I clinical study demonstrates inhi"
8136,"DB05486","BE0003387",""
8137,"DB08579","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8138,"DB03227","BE0001809","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8139,"DB00133","BE0000323","# Sen S, Banerjee R: A pathogenic linked mutation in the catalytic core of human cystathionine beta-synthase disrupts allosteric regulation and allows kinetic characterization of a full-length dimer. Biochemistry. 2007 Apr 3;46(13):4110-6. Epub 2007 Mar 1"
8140,"DB02652","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8141,"DB00252","BE0000197","# Lenkowski PW, Ko SH, Anderson JD, Brown ML, Patel MK: Block of human NaV1.5 sodium channels by novel alpha-hydroxyphenylamide analogues of phenytoin. Eur J Pharm Sci. 2004 Apr;21(5):635-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/150666# Swadron SP,"
8142,"DB05297","BE0000246",""
8143,"DB04147","BE0003849","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8144,"DB03957","BE0001029","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8145,"DB04337","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8146,"DB00367","BE0000557","# Maruo T, Ohara N, Matsuo H, Xu Q, Chen W, Sitruk-Ware R, Johansson ED: Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas. Contraception. 2007 Jun;75(6 Suppl):S99-103. Epub 2007 Mar 21. \"Pubmed"
8147,"DB02924","BE0004320","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8148,"DB01328","BE0000744","# Rake JB, Newman DJ, Actor P: Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12. J Antibiot (Tokyo). 1984 May;37(5):572-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6376452"
8149,"DB02761","BE0001760","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8150,"DB02659","BE0003385","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8151,"DB00955","BE0000279","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8152,"DB02059","BE0002669",""
8153,"DB00720","BE0000624","# Lehenkari PP, Kellinsalmi M, Napankangas JP, Ylitalo KV, Monkkonen J, Rogers MJ, Azhayev A, Vaananen HK, Hassinen IE: Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-c"
8154,"DB00477","BE0000145","# Seeman P, Van Tol HH: Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg. 1993 Aug;6(4):602-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8104554"
8155,"DB03419","BE0003081",""
8156,"DB00905","BE0000592","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8157,"DB01221","BE0004957","# Martin LL, Bouchal RL, Smith DJ: Ketamine inhibits serotonin uptake in vivo. Neuropharmacology. 1982 Feb;21(2):113-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6460944"
8158,"DB00640","BE0000013","# Trincavelli ML, Daniele S, Martini C: Adenosine receptors: what we know and what we are learning. Curr Top Med Chem. 2010;10(9):860-77. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20370662# Schenone S, Brullo C, Musumeci F, Bruno O, Botta M: A1 receptor"
8159,"DB07163","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8160,"DB00913","BE0000770","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8161,"DB01354","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
8162,"DB00661","BE0000356","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880"
8163,"DB03434","BE0001920","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8164,"DB00143","BE0000962","# Barati MT, Merchant ML, Kain AB, Jevans AW, McLeish KR, Klein JB: Proteomic Analysis Defines Altered Cellular Redox Pathways and Advanced Glycation End Product (AGE) Metabolism in Glomeruli of db/db Diabetic Mice. Am J Physiol Renal Physiol. 2007 Jul 3;"
8165,"DB07030","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8166,"DB01340","BE0000221","# Yoshiyama M, Takeuchi K, Omura T, Kim S, Yamagishi H, Toda I, Teragaki M, Akioka K, Iwao H, Yoshikawa J: Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography. Hypertension. 1999 Apr;33(4):961-8. \"Pubmed\":"
8167,"DB04545","BE0002490",""
8168,"DB07780","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8169,"DB01594","BE0003595","# Walash MI, Belal F, Metwally ME, Hefnawy MM: A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
8170,"DB04683","BE0003359","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8171,"DB00786","BE0003691","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
8172,"DB00583","BE0000757","# Kristufek D, Rudorfer W, Pifl C, Huck S: Organic cation transporter mRNA and function in the rat superior cervical ganglion. J Physiol. 2002 Aug 15;543(Pt 1):117-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12181285# Amat di San Filippo C, Wang Y, Lo"
8173,"DB00157","BE0000027","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8174,"DB02664","BE0001395","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8175,"DB00078","BE0000066","# Wiseman GA, White CA, Witzig TE, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DH, Grillo-Lopez AJ: Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monocl"
8176,"DB00849","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Olsen RW, Li GD: GABA(A) receptors as molecular targets of general anesthetics: identification of "
8177,"DB00054","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8178,"DB08185","BE0004203","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8179,"DB04385","BE0002035","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8180,"DB00013","BE0002113","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8181,"DB00142","BE0002269","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8182,"DB03454","BE0001308","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8183,"DB06987","BE0003768","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8184,"DB03068","BE0002035","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8185,"DB03766","BE0001985","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8186,"DB00589","BE0000797","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
8187,"DB05087","BE0000381",""
8188,"DB04035","BE0003894","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8189,"DB07764","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8190,"DB07055","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8191,"DB08489","BE0003690","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8192,"DB08690","BE0003849","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8193,"DB03010","BE0001391","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8194,"DB01394","BE0000143","# Yee KW, Hagey A, Verstovsek S, Cortes J, Garcia-Manero G, O'Brien SM, Faderl S, Thomas D, Wierda W, Kornblau S, Ferrajoli A, Albitar M, McKeegan E, Grimm DR, Mueller T, Holley-Shanks RR, Sahelijo L, Gordon GB, Kantarjian HM, Giles FJ: Phase 1 study of A"
8195,"DB04207","BE0000073","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8196,"DB08149","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8197,"DB03579","BE0001512","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8198,"DB03577","BE0001102","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8199,"DB04147","BE0002795","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8200,"DB04657","BE0000176","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8201,"DB04841","BE0000418","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8202,"DB00630","BE0000776","# Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G: Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10620343# Chen X, "
8203,"DB03900","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8204,"DB01388","BE0000483","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mi"
8205,"DB00715","BE0000045","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
8206,"DB03417","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8207,"DB04522","BE0001975","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8208,"DB06889","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8209,"DB07058","BE0001065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8210,"DB03459","BE0002227","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8211,"DB00036","BE0000216","# Malinvaud G: [Reflections on the use of PPSB fraction (Prothrombin-proconvertin-Stuart factor-antihemophilic factor B)] Transfusion (Paris). 1966;9(3):245-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/5969560# BLATRIX C, SOULIER JP: [Preparation of a "
8212,"DB01239","BE0000451","# Antkiewicz-Michaluk L: The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system. Pol J Pharmacol Pharm. 1986 Jul-Aug;38(4):359-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3774629# Wander TJ, Nelson A, Okaza"
8213,"DB03374","BE0004372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8214,"DB02508","BE0002499","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8215,"DB01116","BE0000411","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8216,"DB01224","BE0000092","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Nasrallah HA: Atypical antipsychotic-induced met"
8217,"DB03225","BE0004141","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8218,"DB05223","BE0002368",""
8219,"DB05469","BE0000715",""
8220,"DB03382","BE0002148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8221,"DB04444","BE0003888","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8222,"DB08606","BE0002007","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8223,"DB01382","BE0000207","# Dabrowski M, Ashcroft FM, Ashfield R, Lebrun P, Pirotte B, Egebjerg J, Bondo Hansen J, Wahl P: The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. Diabetes. 2002 Jun;51(6"
8224,"DB00809","BE0000092","# Betz AJ, McLaughlin PJ, Burgos M, Weber SM, Salamone JD: The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors. Psychopharmacology (Berl). 2007 Oct;194(3"
8225,"DB00371","BE0000523","# Rho JM, Donevan SD, Rogawski MA: Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther. 1997 Mar;280(3):1383-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9067327# Gonzalez LA, Gatch MB, Taylor CM, Be"
8226,"DB07982","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8227,"DB00143","BE0001167","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8228,"DB07374","BE0003828","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8229,"DB00161","BE0000223","# Zhu B, Zhao MW, Eriani G, Wang ED: A present-day aminoacyl-tRNA synthetase with ancestral editing properties. RNA. 2007 Jan;13(1):15-21. Epub 2006 Nov 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17095543# Laforest MJ, Delage L, Marechal-Drouard L: Th"
8230,"DB01291","BE0000694","# Carie AE, Sebti SM: A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene. 2007 May 31;26(26):3777-88. Epub 2007 Jan 29. \"Pubmed\":http://www.nc"
8231,"DB08690","BE0003342","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8232,"DB02837","BE0004482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8233,"DB04938","BE0000123","# Komi J, Heikkinen J, Rutanen EM, Halonen K, Lammintausta R, Ylikorkala O: Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women. Gynecol Endocrinol. 2004 Mar;18(3):152-8. \"Pubmed\":http://www.ncbi.nl"
8234,"DB00157","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8235,"DB00605","BE0000747","# Sharma YR, Vajpayee RB, Bhatnagar R, Mohan M, Azad RV, Kumar M, Nath R: Topical sulindac therapy in diabetic senile cataracts: cataract-IV. Indian J Ophthalmol. 1989 Jul-Sep;37(3):127-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2632448# Crabbe MJ, F"
8236,"DB00842","BE0002344","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
8237,"DB01708","BE0000792","# Chen F, Knecht K, Birzin E, Fisher J, Wilkinson H, Mojena M, Moreno CT, Schmidt A, Harada S, Freedman LP, Reszka AA: Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology. 2005 Nov;146(11):4568-76. Epub 2005 Jun 30. \"Pubmed\":http:"
8238,"DB07802","BE0001209","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8239,"DB00452","BE0004799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8240,"DB04946","BE0000650","# Bobo WV: Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Expert Rev Clin Pharmacol. 2013 Jan;6(1):61-91. doi: 10.1586/ecp.12.70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
8241,"DB00470","BE0000061","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8242,"DB08045","BE0001898","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8243,"DB00643","BE0001367","# Lubega GW, Geary TG, Klein RD, Prichard RK: Expression of cloned beta-tubulin genes of Haemonchus contortus in Escherichia coli: interaction of recombinant beta-tubulin with native tubulin and mebendazole. Mol Biochem Parasitol. 1993 Dec;62(2):281-92. \""
8244,"DB00308","BE0000090","# Perry M, de Groot MJ, Helliwell R, Leishman D, Tristani-Firouzi M, Sanguinetti MC, Mitcheson J: Structural determinants of HERG channel block by clofilium and ibutilide. Mol Pharmacol. 2004 Aug;66(2):240-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15"
8245,"DB05883","BE0003309",""
8246,"DB00543","BE0000451","# Palvimaki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J: Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berl). 1996 Aug;126(3):234-40. \"Pubmed\":http://www.ncbi.nlm"
8247,"DB01063","BE0000756","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8248,"DB05824","BE0000365",""
8249,"DB01752","BE0001712","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8250,"DB07636","BE0003861","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8251,"DB05460","BE0000814","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8252,"DB00132","BE0000888","# Xiang M, Rahman MA, Ai H, Li X, Harbige LS: Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab. 2006;50(6):492-8. Epub 2006 Sep 19. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16988497# Des"
8253,"DB07835","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8254,"DB04763","BE0000322",""
8255,"DB08413","BE0003836","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8256,"DB00157","BE0000551","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8257,"DB00862","BE0000182","# Blount MA, Zoraghi R, Ke H, Bessay EP, Corbin JD, Francis SH: A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization. Mol Pharmac"
8258,"DB02154","BE0001559","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8259,"DB00279","BE0000687","# Jiang W, Miyamoto T, Kakizawa T, Sakuma T, Nishio S, Takeda T, Suzuki S, Hashizume K: Expression of thyroid hormone receptor alpha in 3T3-L1 adipocytes; triiodothyronine increases the expression of lipogenic enzyme and triglyceride accumulation. J Endoc"
8260,"DB00157","BE0000540","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8261,"DB03802","BE0000123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8262,"DB00563","BE0000330","# Al-Rashood ST, Aboldahab IA, Nagi MN, Abouzeid LA, Abdel-Aziz AA, Abdel-Hamide SG, Youssef KM, Al-Obaid AM, El-Subbagh HI: Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone ana"
8263,"DB00751","BE0000289","# Dupont LJ, Meade CJ, Demedts MG, Verleden GM: Epinastine (WAL 801CL) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptor. Eur Respir J. 1996 Jul;9(7):1433-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
8264,"DB00104","BE0002147","# Bronstein MD: Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome. Front Horm Res. 2006;35:129-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16809928# Xie Y, Tang CW, Wang CH: [Effect of HBV X gene transfection on "
8265,"DB01235","BE0000389","# Onofrj M, Bonanni L, Thomas A: An expert opinion on safinamide in Parkinson's disease. Expert Opin Investig Drugs. 2008 Jul;17(7):1115-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18549347# Deleu D, Northway MG, Hanssens Y: Clinical pharmacokinetic a"
8266,"DB08445","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8267,"DB00268","BE0000289","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
8268,"DB07349","BE0003815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8269,"DB03247","BE0002576",""
8270,"DB03615","BE0002467","# Horibe T, Nagai H, Sakakibara K, Hagiwara Y, Kikuchi M: Ribostamycin inhibits the chaperone activity of protein disulfide isomerase. Biochem Biophys Res Commun. 2001 Dec 21;289(5):967-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11741285"
8271,"DB07414","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8272,"DB03416","BE0001327","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8273,"DB02772","BE0002836",""
8274,"DB07490","BE0003961","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8275,"DB01285","BE0000848","# Johnston H, King PJ, O'Shaughnessy PJ: Effects of ACTH and expression of the melanocortin-2 receptor in the neonatal mouse testis. Reproduction. 2007 Jun;133(6):1181-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17636172# Carey LC, Su Y, Valego NK, Ros"
8276,"DB07752","BE0002372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8277,"DB01709","BE0001253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8278,"DB08690","BE0003886","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8279,"DB08309","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8280,"DB08813","BE0001126","# Nagy Z, Turcsik V, Blasko G: The effect of LMWH (Nadroparin) on tumor progression. Pathol Oncol Res. 2009 Dec;15(4):689-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19757196 # Sustar V, Jansa R, Frank M, Hagerstrand H, Krzan M, Iglic A, Kralj-Iglic V"
8281,"DB03154","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8282,"DB01023","BE0003323","# Lamers JM, Cysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. Biochem Pharmacol. 1985 Nov 1;34(21):3837-43. \"Pubmed\":http://www.n"
8283,"DB04152","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8284,"DB02840","BE0001120","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8285,"DB08293","BE0001898","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8286,"DB00909","BE0003634","# De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19703035# Supuran CT, Di Fiore A, De S"
8287,"DB07823","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8288,"DB08689","BE0002254","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8289,"DB03969","BE0001986","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8290,"DB03832","BE0000373","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8291,"DB00661","BE0002354","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880"
8292,"DB01588","BE0000381","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
8293,"DB04522","BE0001193","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8294,"DB01242","BE0003930","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8295,"DB02588","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8296,"DB03640","BE0001568","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8297,"DB00594","BE0000351","# Padiglia A, Medda R, Lorrai A, Murgia B, Pedersen JZ, Finazzi Agro A, Floris G: Interaction of Pig Kidney and Lentil Seedling Copper-Containing Amine Oxidases with Guanidinium Compounds. J Enzyme Inhib. 1999 Nov;15(1):91-100. \"Pubmed\":http://www.ncbi.nl"
8298,"DB04233","BE0003977","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8299,"DB03147","BE0004507","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8300,"DB01028","BE0000640","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8301,"DB06144","BE0000715","# Lindstrom E, Levander S: Sertindole: efficacy and safety in schizophrenia. Expert Opin Pharmacother. 2006 Sep;7(13):1825-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16925508"
8302,"DB07423","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8303,"DB06144","BE0000575","# Lindstrom E, Levander S: Sertindole: efficacy and safety in schizophrenia. Expert Opin Pharmacother. 2006 Sep;7(13):1825-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16925508"
8304,"DB02668","BE0000787","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8305,"DB00651","BE0001133","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8306,"DB07616","BE0001167","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8307,"DB00925","BE0000575","# Minneman KP, Theroux TL, Hollinger S, Han C, Esbenshade TA: Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol. 1994 Nov;46(5):929-36. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7969082"
8308,"DB00056","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8309,"DB00336","BE0000298","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8310,"DB03897","BE0004061","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8311,"DB04395","BE0003296",""
8312,"DB06950","BE0003757","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8313,"DB04978","BE0000742",""
8314,"DB01169","BE0001062","# Fauconneau B, Petegnief V, Sanfeliu C, Piriou A, Planas AM: Induction of heat shock proteins (HSPs) by sodium arsenite in cultured astrocytes and reduction of hydrogen peroxide-induced cell death. J Neurochem. 2002 Dec;83(6):1338-48. \"Pubmed\":http://www"
8315,"DB00074","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8316,"DB00801","BE0003594","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
8317,"DB00713","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
8318,"DB00667","BE0000112","# Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, Gaudio E, Alvaro D, Fava G, Marzioni M, Vaculin B, Alpini G: H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 path"
8319,"DB03699","BE0001297","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8320,"DB03655","BE0001667","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8321,"DB00905","BE0000610","# Sharif NA, Williams GW, Kelly CR: Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur J Pharmacol. 2001 Dec 7;432(2-3):211-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11740958# Sharif NA, Kelly CR, Crider JY: Agonist activity of"
8322,"DB01268","BE0000147","# O'Farrell AM, Abrams TJ, Yuen HA, Ngai TJ, Louie SG, Yee KW, Wong LM, Hong W, Lee LB, Town A, Smolich BD, Manning WC, Murray LJ, Heinrich MC, Cherrington JM: SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. Bl"
8323,"DB00502","BE0000581","# Leysen JE, Janssen PM, Megens AA, Schotte A: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry. 1994 May;55 Suppl:5-12. \"Pubmed\":http://www.ncbi.nlm."
8324,"DB03141","BE0003328","# Huang PP, Randolph JT, Klein LL, Vasavanonda S, Dekhtyar T, Stoll VS, Kempf DJ: Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors. Bioorg Med Chem Lett. 2004 Aug 2;14(15):4075-8. \"Pubmed\":http://www.ncbi.nlm."
8325,"DB04074","BE0001833","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8326,"DB02159","BE0001524","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8327,"DB01354","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
8328,"DB03374","BE0003762","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8329,"DB03200","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8330,"DB02152","BE0000915","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8331,"DB04233","BE0001553","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8332,"DB00114","BE0000323","# Taoka S, Banerjee R: Stopped-flow kinetic analysis of the reaction catalyzed by the full-length yeast cystathionine beta-synthase. J Biol Chem. 2002 Jun 21;277(25):22421-5. Epub 2002 Apr 10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11948191# Taoka S,"
8333,"DB01488","BE0000451","# Pierce PA, Peroutka SJ: Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology (Berl). 1989;97(1):118-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2540505# Su TP, Hayashi T, Vaupel DB: When t"
8334,"DB04315","BE0001796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8335,"DB04203","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8336,"DB00540","BE0000945","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Oct 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from: http://pdsp.med.unc.edu/pdsp.php# Brunton L, Chabner B, Knollman B. Goodman and Gilman?s The "
8337,"DB01565","BE0001063","# Liebmann C, Schnittler M, Hartrodt B, Born I, Neubert K: Structure-activity studies of novel casomorphin analogues: binding profiles towards mu 1-, mu 2- and delta -opioid receptors. Pharmazie. 1991 May;46(5):345-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
8338,"DB04779","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8339,"DB03147","BE0001230","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8340,"DB04089","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8341,"DB03760","BE0001692","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8342,"DB03034","BE0001790","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8343,"DB02129","BE0001452","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8344,"DB02692","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8345,"DB01582","BE0000803","# Hong YL, Hossler PA, Calhoun DH, Meshnick SR: Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob Agents Chemother. 1995 Aug;39(8):1756-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7486915# Friaza V, M"
8346,"DB08372","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8347,"DB07767","BE0004078","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8348,"DB07299","BE0001021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8349,"DB02138","BE0004036","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8350,"DB02379","BE0003243",""
8351,"DB05246","BE0000483","# Gomora JC, Daud AN, Weiergraber M, Perez-Reyes E: Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol. 2001 Nov;60(5):1121-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11641441# Coulter DA, Huguenard JR, Pr"
8352,"DB00122","BE0002181","# Lee JS, Kim JH, Jang IH, Kim HS, Han JM, Kazlauskas A, Yagisawa H, Suh PG, Ryu SH: Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity. J Cell Sci. 2005 Oct 1;11"
8353,"DB04901","BE0000847","# Gottlieb AB, Kang S, Linden KG, Lebwohl M, Menter A, Abdulghani AA, Goldfarb M, Chieffo N, Totoritis MC: Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe pl"
8354,"DB00241","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
8355,"DB08065","BE0000991","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8356,"DB00946","BE0000713","# Schalekamp T, Brasse BP, Roijers JF, van Meegen E, van der Meer FJ, van Wijk EM, Egberts AC, de Boer A: VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement. Clin Pharmacol The"
8357,"DB01023","BE0002354","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T: Selectivities of dihydropyridine der"
8358,"DB00560","BE0003710","# Olson MW, Ruzin A, Feyfant E, Rush TS 3rd, O'Connell J, Bradford PA: Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother. 2006 Jun;50(6):2156-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
8359,"DB07506","BE0003783","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8360,"DB02952","BE0003476","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8361,"DB04077","BE0004496","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8362,"DB00696","BE0000575","# Gornemann T, Jahnichen S, Schurad B, Latte KP, Horowski R, Tack J, Flieger M, Pertz HH: Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jan;376(5):321-30. Ep"
8363,"DB08436","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8364,"DB00852","BE0000647","# Wee S, Ordway GA, Woolverton WL: Reinforcing effect of pseudoephedrine isomers and the mechanism of action. Eur J Pharmacol. 2004 Jun 16;493(1-3):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15189772# Foley KF, Van Dort ME, Sievert MK, Ruoho AE, "
8365,"DB01238","BE0000797","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
8366,"DB00171","BE0000671","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8367,"DB04147","BE0003925","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8368,"DB07630","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8369,"DB03309","BE0001264","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8370,"DB03530","BE0001655","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8371,"DB07833","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8372,"DB04524","BE0000558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8373,"DB07942","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8374,"DB00188","BE0000470","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8375,"DB01135","BE0000738","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8376,"DB00568","BE0000864","# Singh BN: The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol. 1986;21 Suppl 2:109S-121S. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3530295# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca c"
8377,"DB04339","BE0000814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8378,"DB04315","BE0003279",""
8379,"DB01693","BE0000722","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8380,"DB08583","BE0000014","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8381,"DB06901","BE0003747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8382,"DB04762","BE0001217",""
8383,"DB03379","BE0003844","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8384,"DB00393","BE0000430","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Marchetti C, Usai C: High affinity block by nimodipine of the internal calcium elevation in chroni"
8385,"DB07498","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8386,"DB04764","BE0001474","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8387,"DB02659","BE0003989","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8388,"DB05428","BE0001979",""
8389,"DB03525","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8390,"DB04388","BE0001643","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8391,"DB02877","BE0000206","# Alvarez R, Vega MJ, Kammerer S, Rossin A, Germain P, Gronemeyer H, de Lera AR: 9-cis-retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6117-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
8392,"DB03020","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8393,"DB04153","BE0000009","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8394,"DB08813","BE0004689","# Nagy Z, Turcsik V, Blasko G: The effect of LMWH (Nadroparin) on tumor progression. Pathol Oncol Res. 2009 Dec;15(4):689-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19757196 # Sustar V, Jansa R, Frank M, Hagerstrand H, Krzan M, Iglic A, Kralj-Iglic V"
8395,"DB06751","BE0001133","# Muravyov AV, Yakusevich VV, Chuchkanov FA, Maimistova AA, Bulaeva SV, Zaitsev LG: Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study. Clin Hemorheol Microcirc. 2007;36(4):327-34. \"Pubmed\":http://ww"
8396,"DB00458","BE0003603","# Casis O, Sanchez-Chapula JA: Disopyramide, imipramine, and amitriptyline bind to a common site on the transient outward K+ channel. J Cardiovasc Pharmacol. 1998 Oct;32(4):521-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9781919"
8397,"DB03367","BE0001198","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8398,"DB00438","BE0003579","# Hayes MV, Orr DC: Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983 Aug;12(2):119-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
8399,"DB02379","BE0001485","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8400,"DB00154","BE0000262","# Das UN: Can COX-2 inhibitor-induced increase in cardiovascular disease risk be modified by essential fatty acids? J Assoc Physicians India. 2005 Jul;53:623-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16190133# Levin G, Duffin KL, Obukowicz MG, Hummer"
8401,"DB00262","BE0000648","# Akella SS, Harris C: Pyridine nucleotide flux and glutathione oxidation in the cultured rat conceptus. Reprod Toxicol. 1999 May-Jun;13(3):203-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10378469# Kirsch JD, Yi AK, Spitz DR, Krieg AM: Accumulation of"
8402,"DB01599","BE0000119","# Favari E, Zanotti I, Zimetti F, Ronda N, Bernini F, Rothblat GH: Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2345-50. Epub 2004 Oct 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15514211# Yama"
8403,"DB00074","BE0000901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8404,"DB00848","BE0000896","# Chang YL, Stanford CM, Keller JC: Calcium and phosphate supplementation promotes bone cell mineralization: implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res. 2000 Nov;52(2):270-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
8405,"DB08678","BE0003769","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8406,"DB03589","BE0000148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8407,"DB06637","BE0004718","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
8408,"DB03801","BE0001775","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8409,"DB03938","BE0001833","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8410,"DB07255","BE0002453","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8411,"DB04334","BE0001222","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8412,"DB01183","BE0000632","# Peng X, Neumeyer JL: Kappa receptor bivalent ligands. Curr Top Med Chem. 2007;7(4):363-73. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17305578# van Dorp EL, Yassen A, Dahan A: Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin "
8413,"DB01017","BE0000127","# Zhanel GG, Homenuik K, Nichol K, Noreddin A, Vercaigne L, Embil J, Gin A, Karlowsky JA, Hoban DJ: The glycylcyclines: a comparative review with the tetracyclines. Drugs. 2004;64(1):63-88. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14723559"
8414,"DB03284","BE0002584",""
8415,"DB03541","BE0000220","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8416,"DB03816","BE0001537","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8417,"DB00010","BE0000625","# Esposito P, Barbero L, Caccia P, Caliceti P, D'Antonio M, Piquet G, Veronese FM: PEGylation of growth hormone-releasing hormone (GRF) analogues. Adv Drug Deliv Rev. 2003 Sep 26;55(10):1279-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14499707# Chen X"
8418,"DB04566","BE0002231","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8419,"DB04257","BE0001563","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8420,"DB01097","BE0003721","# O'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK: The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS One. 2010 Oct 1;5(10). pii: e131"
8421,"DB06372","BE0004735","# Hawkins PN, Lachmann HJ, McDermott MF: Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med. 2003 Jun 19;348(25):2583-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12815153# Cronstein BN, Sunkureddi P: Mechanistic aspects of inf"
8422,"DB02343","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8423,"DB01351","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
8424,"DB03503","BE0001667","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8425,"DB07305","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8426,"DB02193","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8427,"DB08242","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8428,"DB01860","BE0004515","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8429,"DB05122","BE0003298",""
8430,"DB03380","BE0003476","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8431,"DB00713","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
8432,"DB01942","BE0002641",""
8433,"DB02693","BE0001270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8434,"DB00313","BE0000253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8435,"DB00974","BE0004812","# Broncel M, Wagner SC, Paul K, Hackenberger CP, Koksch B: Towards understanding secondary structure transitions: phosphorylation and metal coordination in model peptides. Org Biomol Chem. 2010 Jun 7;8(11):2575-9. Epub 2010 Mar 29. \"Pubmed\":http://www.ncb"
8436,"DB03229","BE0001833","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8437,"DB01041","BE0004796","# Stephens TD, Bunde CJ, Fillmore BJ: Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol. 2000 Jun 15;59(12):1489-99. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10799645# Shoji A, Kuwahara M, Ozaki H, Sawai H: Modified DNA aptamer that b"
8438,"DB04347","BE0001769","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8439,"DB04316","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8440,"DB01649","BE0001215","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8441,"DB00897","BE0000381","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
8442,"DB01347","BE0000062","# Timmermans PB: Pharmacological properties of angiotensin II receptor antagonists. Can J Cardiol. 1999 Nov;15 Suppl F:26F-8F. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10579749# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Re"
8443,"DB01159","BE0000484","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8444,"DB00900","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8445,"DB07404","BE0003350","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8446,"DB00897","BE0000129","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
8447,"DB08412","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8448,"DB01017","BE0000058","# Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW: Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain. 2002 Jun;125(Pt 6):1297-308. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12023318# Sut"
8449,"DB04080","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8450,"DB03999","BE0001636","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8451,"DB05010","BE0002340",""
8452,"DB05713","BE0000216",""
8453,"DB00202","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8454,"DB06899","BE0000270","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8455,"DB00241","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
8456,"DB08596","BE0003317","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8457,"DB06894","BE0003744","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8458,"DB03279","BE0000144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8459,"DB00559","BE0000043","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Gardiner SM, Kemp PA, March JE, Bennett T: Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor"
8460,"DB08896","BE0000014","# FDA label"
8461,"DB03062","BE0001502","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8462,"DB02379","BE0001107","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8463,"DB08589","BE0003007","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8464,"DB00282","BE0000776","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G: Alendronate is a specific, nanomolar"
8465,"DB04889","BE0000756","# Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E: Characterization of the antinociceptive actions of bicifadine in models of acute, persistent"
8466,"DB04265","BE0001411","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8467,"DB04466","BE0000956","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8468,"DB01942","BE0004569","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8469,"DB00141","BE0002263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8470,"DB03155","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8471,"DB04315","BE0003278","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8472,"DB00111","BE0000901","# Hoshino S, Oshimi K, Teramura M, Mizoguchi H: Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders. Blood. 1991 Dec 15;78(12"
8473,"DB00204","BE0001131","# Kiehn J, Wible B, Lacerda AE, Brown AM: Mapping the block of a cloned human inward rectifier potassium channel by dofetilide. Mol Pharmacol. 1996 Aug;50(2):380-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8700146"
8474,"DB00383","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8475,"DB02153","BE0000648","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8476,"DB00312","BE0004956","# Daniell LC: Effect of anesthetic and convulsant barbiturates on N-methyl-D-aspartate receptor-mediated calcium flux in brain membrane vesicles. Pharmacology. 1994 Nov;49(5):296-307. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7862741"
8477,"DB08234","BE0004248","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8478,"DB00142","BE0000166","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8479,"DB03593","BE0001215","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8480,"DB03501","BE0001521","# Thoden JB, Wohlers TM, Fridovich-Keil JL, Holden HM: Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase. J Biol Chem. 2001 Jun 8;276(23):20617-23. Epub 2001 Mar 7. \"Pubme"
8481,"DB02211","BE0002196","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8482,"DB00033","BE0000467","# Park-Min KH, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB: FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity. 2007 Jan;26(1):67-78. \"Pubmed\":h"
8483,"DB02255","BE0003872","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8484,"DB01120","BE0000207","# Gribble FM, Ashcroft FM: Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism. 2000 Oct;49(10 Suppl 2):3-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11078468# Harrower"
8485,"DB07908","BE0004118","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8486,"DB05184","BE0000435",""
8487,"DB08114","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8488,"DB00645","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8489,"DB02561","BE0002736",""
8490,"DB04575","BE0000123","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8491,"DB02505","BE0001694","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8492,"DB07739","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8493,"DB00485","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
8494,"DB04879","BE0000369","# Yamamoto A, Watanabe H, Sueki H, Nakanishi T, Yasuhara H, Iijima M: Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity. J Dermatol. 2007 J"
8495,"DB06843","BE0003733","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8496,"DB04315","BE0004627","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8497,"DB05407","BE0003384",""
8498,"DB00710","BE0004801","# Jahnke W, Henry C: An in vitro assay to measure targeted drug delivery to bone mineral. ChemMedChem. 2010 May 3;5(5):770-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20209564# Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russ"
8499,"DB01146","BE0000647","# Lapa GB, Mathews TA, Harp J, Budygin EA, Jones SR: Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties. Eur J Pharmacol. 2005 Jan 4;506(3):237-40. Epub 2004 Dec 8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15627433"
8500,"DB02740","BE0001389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8501,"DB04167","BE0003211",""
8502,"DB04063","BE0002016","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8503,"DB08153","BE0001898","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8504,"DB04502","BE0001292","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8505,"DB06216","BE0000501","# Shahid M, Walker GB, Zorn SH, Wong EH: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. Epub 2008 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18308814"
8506,"DB01588","BE0000523","# Schove LT, Perez JJ, Loew GH: Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. Bioorg Med Chem. 1994 Oct;2(10):1029-49. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7773620"
8507,"DB00848","BE0004927","# Culetto E, Baylis HA, Richmond JE, Jones AK, Fleming JT, Squire MD, Lewis JA, Sattelle DB: The Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive nicotinic acetylcholine receptor alpha subunit. J Biol Chem. 2004 Oct 8;279(41):42476-83. Ep"
8508,"DB00595","BE0000019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8509,"DB03635","BE0000946","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8510,"DB02463","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8511,"DB01595","BE0000471","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
8512,"DB01960","BE0001215","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8513,"DB00055","BE0000048","# Omar MN, Shouk TA, Khaleq MA: Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement. Clin Biochem. 1999 Jun;32(4):269-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10463819# Cvirn G, Gal"
8514,"DB00150","BE0001343","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8515,"DB02234","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8516,"DB00162","BE0000900","# Kaschula CH, Jin MH, Desmond-Smith NS, Travis GH: Acyl CoA:retinol acyltransferase (ARAT) activity is present in bovine retinal pigment epithelium. Exp Eye Res. 2006 Jan;82(1):111-21. Epub 2005 Jul 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1605413"
8517,"DB01136","BE0000572","# Koshimizu TA, Tsujimoto G, Hirasawa A, Kitagawa Y, Tanoue A: Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res. 2004 Sep 1;63(4):662-72. \"Pubmed\":http://ww"
8518,"DB00149","BE0000613","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8519,"DB00039","BE0002131","# Ostrovsky O, Berman B, Gallagher J, Mulloy B, Fernig DG, Delehedde M, Ron D: Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem. 2002 Jan 25;277(4):2444-53. Epu"
8520,"DB00128","BE0000725","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8521,"DB04310","BE0001645","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8522,"DB03147","BE0002917",""
8523,"DB00726","BE0000572","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
8524,"DB00734","BE0000291","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243"
8525,"DB03817","BE0002838",""
8526,"DB01576","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8527,"DB00125","BE0000136","# Rotmann A, Simon A, Martine U, Habermeier A, Closs EI: Activation of classical protein kinase C decreases transport via systems y+ and y+L. Am J Physiol Cell Physiol. 2007 Jun;292(6):C2259-68. Epub 2007 Feb 28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
8528,"DB03721","BE0001411","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8529,"DB01403","BE0000020","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205"
8530,"DB03515","BE0001236","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8531,"DB06918","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8532,"DB01196","BE0000792","# Ho SM: Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem. 2004 Feb 15;91(3):491-503. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14755680"
8533,"DB00518","BE0001367","# Solana HD, Sallovitz JM, Lanusse CE, Rodriguez JA: Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites. Methods Find Exp Clin Pharmacol. 2002 Jan-Feb;24(1):7-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11"
8534,"DB01239","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8535,"DB00907","BE0000486","# Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD: Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol. 1995 Oct;198(Pt 10):2197-212. \"Pubmed\":http"
8536,"DB03271","BE0000121","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8537,"DB00421","BE0000557","# Fagart J, Hillisch A, Huyet J, Barfacker L, Fay M, Pleiss U, Pook E, Schafer S, Rafestin-Oblin ME, Kolkhof P: A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule. J Biol Chem. 2010 Sep 24;285(39):29932-40."
8538,"DB00116","BE0000331","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8539,"DB05831","BE0002446",""
8540,"DB07140","BE0000330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8541,"DB03830","BE0000124","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8542,"DB01413","BE0004648","# Grassi GG, Grassi C: Cefepime: overview of activity in vitro and in vivo. J Antimicrob Chemother. 1993 Nov;32 Suppl B:87-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8150771"
8543,"DB01090","BE0003585","# Cachelin AB, Rust G: Beta-subunits co-determine the sensitivity of rat neuronal nicotinic receptors to antagonists. Pflugers Arch. 1995 Jan;429(3):449-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7761270"
8544,"DB00157","BE0000252","# Jadhav JP, Parshetti GK, Kalme SD, Govindwar SP: Decolourization of azo dye methyl red by Saccharomyces cerevisiae MTCC 463. Chemosphere. 2007 Jun;68(2):394-400. Epub 2007 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17292452# Zafar KS, Siegel D, "
8545,"DB00114","BE0002151","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8546,"DB03305","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8547,"DB02379","BE0002639",""
8548,"DB00849","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
8549,"DB02374","BE0001339","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8550,"DB00852","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8551,"DB00935","BE0000715","# Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bonisch H: Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010 Dec;24(6):729-39. doi: 10.1111/j.1472-8206.2009.00805.x. \"Pubmed\":ht"
8552,"DB04739","BE0000838",""
8553,"DB03499","BE0001588","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8554,"DB02734","BE0002671",""
8555,"DB02443","BE0001904","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8556,"DB01594","BE0000795","# Amin J, Brooks-Kayal A, Weiss DS: Two tyrosine residues on the alpha subunit are crucial for benzodiazepine binding and allosteric modulation of gamma-aminobutyric acidA receptors. Mol Pharmacol. 1997 May;51(5):833-41. \"Pubmed\":http://www.ncbi.nlm.nih.g"
8557,"DB00370","BE0000968","# Pytliak M, Vargova V, Mechirova V, Felsoci M: Serotonin receptors - from molecular biology to clinical applications. Physiol Res. 2011;60(1):15-25. Epub 2010 Oct 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20945968/# Fernandez J, Alonso JM, Andres J"
8558,"DB00157","BE0000570","# Dalfo D, Marques N, Albalat R: Analysis of the NADH-dependent retinaldehyde reductase activity of amphioxus retinol dehydrogenase enzymes enhances our understanding of the evolution of the retinol dehydrogenase family. FEBS J. 2007 Jul;274(14):3739-52. "
8559,"DB00672","BE0000207","# Mizuno CS, Chittiboyina AG, Kurtz TW, Pershadsingh HA, Avery MA: Type 2 diabetes and oral antihyperglycemic drugs. Curr Med Chem. 2008;15(1):61-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18220763"
8560,"DB01536","BE0000194","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8561,"DB00182","BE0000756","# Innis RB, Malison RT, al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP, Zoghbi SS, Baldwin RM, Laruelle M, Smith EO, et al.: Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates. Synapse."
8562,"DB02637","BE0001891","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8563,"DB00824","BE0000354","# Linden J, Thai T, Figler H, Jin X, Robeva AS: Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol. 1999 Oct;56(4):705-13"
8564,"DB00859","BE0004825","# Brewer GJ: Novel therapeutic approaches to the treatment of Wilson's disease. Expert Opin Pharmacother. 2006 Feb;7(3):317-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16448326"
8565,"DB04715","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8566,"DB04982","BE0000829","# Langan YM, Lucas R, Jewell H, Toublanc N, Schaefer H, Sander JW, Patsalos PN: Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia. 2003 J"
8567,"DB01442","BE0002196","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613"
8568,"DB01109","BE0000216","# Ignjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P: Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate? Thromb Res. 2007;120(3):347-51. Ep"
8569,"DB03065","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8570,"DB03751","BE0002590",""
8571,"DB03297","BE0001917","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8572,"DB01883","BE0001363","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8573,"DB00066","BE0000387","# Layman LC: Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. Semin Reprod Med. 2000;18(1):5-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11299519# Leng N, Dattatreyamurty B, Reichert LE Jr: Ident"
8574,"DB08389","BE0000631","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8575,"DB08649","BE0004362","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8576,"DB04233","BE0003971","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8577,"DB03088","BE0002940",""
8578,"DB02911","BE0000263","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8579,"DB00128","BE0000219","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8580,"DB01622","BE0000575","# Cahir M, King DJ: Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat. Eur Neuropsychopharmacol. 2005 Mar;15(2):231-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15695070"
8581,"DB02951","BE0001650","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8582,"DB02087","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8583,"DB00100","BE0002110","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8584,"DB01667","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8585,"DB00139","BE0002257","# Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE: Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paragangli"
8586,"DB00463","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
8587,"DB00495","BE0002449","# Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Velayudham P, Gouillou M, Spelman T, Hearps A, Fairley C, Smit de V, Pierce AB, Armishaw J, Crowe SM, Cooper DA, Koelsch KK, Liu JP, Chuah J, Lewin SR: Inhibition of telomerase activity by human immunodef"
8588,"DB01752","BE0002522",""
8589,"DB00966","BE0000062","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Karlberg BE, Lins LE, Hermansson K: Efficacy and safety of telmisartan, a selective AT1 receptor a"
8590,"DB08933","BE0000233","# Niwano Y, Koga H, Kodama H, Kanai K, Miyazaki T, Yamaguchi H: Inhibition of sterol 14 alpha-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent. Med Mycol. 1999 Oct;37(5):351-5. \"Pubmed\":http://www.ncbi.n"
8591,"DB05210","BE0002383",""
8592,"DB00110","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8593,"DB03814","BE0000259","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8594,"DB04464","BE0003996","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8595,"DB02547","BE0003278","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8596,"DB07522","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8597,"DB04953","BE0000897","# Wuttke TV, Seebohm G, Bail S, Maljevic S, Lerche H: The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol. 2005 Apr;67(4):1009-17. Epub 2005 Jan 20. \"Pubmed\":http"
8598,"DB03929","BE0000365","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8599,"DB01411","BE0000704","# Tomari S, Matsuse H, Machida I, Kondo Y, Kawano T, Obase Y, Fukushima C, Shimoda T, Kohno S: Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nucle"
8600,"DB04532","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8601,"DB00128","BE0003317","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8602,"DB00050","BE0000134","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8603,"DB00419","BE0000477","# Moyses C: Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease. Philos Trans R Soc Lond B Biol Sci. 2003 May 29;358(1433):955-60. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12803929# Weinreb NJ, Barranger JA, Charrow J, Grabowski "
8604,"DB03721","BE0002705",""
8605,"DB08693","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8606,"DB03907","BE0002089","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8607,"DB04047","BE0001450","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8608,"DB02580","BE0004310","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8609,"DB07175","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8610,"DB00408","BE0000020","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
8611,"DB02279","BE0003766","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8612,"DB02402","BE0004001","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8613,"DB02767","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8614,"DB03845","BE0001221","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8615,"DB00836","BE0000947","# Nomura A, Iwasaki Y, Aoki Y, Yamamori E, Mutsuga N, Yoshida M, Asai M, Oiso Y, Saito H: Effects of loperamide and other opioid-related substances on the transcriptional regulation of the rat pro-opiomelanocortin gene in AtT20 cells. Neuroendocrinology. "
8616,"DB00674","BE0002180","# Svoboda Z, Kvetina J, Kunesova G, Herink J, Bajgar J, Bartosova L, Zivny P, Palicka V: Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues. Neuro "
8617,"DB08185","BE0004197","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8618,"DB04899","BE0000556","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
8619,"DB00303","BE0000001","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8620,"DB07088","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8621,"DB02379","BE0001500","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8622,"DB00787","BE0001403","# Bennett MS, Wien F, Champness JN, Batuwangala T, Rutherford T, Summers WC, Sun H, Wright G, Sanderson MR: Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallogr"
8623,"DB04970","BE0000291","# Fisas MA, Farre A, Camarasa J, Escubedo E: Effects of lesopitron on the central nervous system arising from its interaction with 5-HT1A receptors. Pharmacology. 2004 Oct;72(2):57-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15331910# Micheli F: Lesop"
8624,"DB04126","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8625,"DB03220","BE0002214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8626,"DB08705","BE0001277","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8627,"DB00407","BE0000775","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8628,"DB04552","BE0000017","# Talbot S, Lin JC, Lahjouji K, Roy JP, Senecal J, Morin A, Couture R: Cigarette smoke-induced kinin B1 receptor promotes NADPH oxidase activity in cultured human alveolar epithelial cells. Peptides. 2011 Jul;32(7):1447-56. Epub 2011 May 11. \"Pubmed\":http"
8629,"DB08695","BE0001167","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8630,"DB00053","BE0004806","# Pastores GM, Hughes DA: Gaucher Disease  \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20301446"
8631,"DB02292","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8632,"DB04447","BE0003312",""
8633,"DB02943","BE0002281",""
8634,"DB02983","BE0000792","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8635,"DB08233","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8636,"DB00393","BE0002358","# Weant KA, Ramsey CN 3rd, Cook AM: Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage. Pharmacotherapy. 2010 Apr;30(4):405-17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20334460# Dong CJ, Guo Y, Agey P,"
8637,"DB01863","BE0004433","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8638,"DB00256","BE0000019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8639,"DB00087","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8640,"DB00799","BE0000144","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8641,"DB02651","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8642,"DB04619","BE0003337",""
8643,"DB08811","BE0002085","# Rundfeldt C, Socala K, Wlaz P: The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. J Neural Transm. 2010 Nov;117(11):1319-25. Epub 2010 Oct 22. \"Pub"
8644,"DB02868","BE0000418","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8645,"DB02347","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8646,"DB00111","BE0000651","# Light JA, Sasaki TM, Ghasemian R, Barhyte DY, Fowlkes DL: Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation. Clin Transplant. 2002;16 Suppl 7:30-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12372041# Agui"
8647,"DB01598","BE0003579","# Nicolau DP: Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother. 2008 Jan;9(1):23-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18076336# Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA: Compa"
8648,"DB01638","BE0001214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8649,"DB02931","BE0004584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8650,"DB00904","BE0000797","# van Wijngaarden I, Tulp MT, Soudijn W: The concept of selectivity in 5-HT receptor research. Eur J Pharmacol. 1990 Jun 12;188(6):301-12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2164935"
8651,"DB08248","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8652,"DB00280","BE0003603","# Casis O, Sanchez-Chapula JA: Disopyramide, imipramine, and amitriptyline bind to a common site on the transient outward K+ channel. J Cardiovasc Pharmacol. 1998 Oct;32(4):521-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9781919"
8653,"DB01839","BE0002565",""
8654,"DB02226","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8655,"DB01603","BE0003618","# Gardete S, de Lencastre H, Tomasz A: A link in transcription between the native pbpB and the acquired mecA gene in a strain of Staphylococcus aureus. Microbiology. 2006 Sep;152(Pt 9):2549-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16946250"
8656,"DB04077","BE0001835","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8657,"DB07028","BE0000747","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8658,"DB03929","BE0004463","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8659,"DB00514","BE0000641","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8660,"DB07200","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8661,"DB04675","BE0001447",""
8662,"DB04067","BE0002575",""
8663,"DB06989","BE0003769","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8664,"DB06616","BE0004745","# Ahmad S, Hughes MA, Johnson GL, Scott JE: Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors. J Biomol Screen. 2013 Apr;18(4):388-99. doi: 10.1177/1087057112466430. Epub 2012 Nov 7. \"Pub"
8665,"DB00070","BE0000984","# Chang NS: Hyaluronidase activation of c-Jun N-terminal kinase is necessary for protection of L929 fibrosarcoma cells from staurosporine-mediated cell death. Biochem Biophys Res Commun. 2001 May 4;283(2):278-86. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
8666,"DB06929","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8667,"DB00157","BE0000231","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8668,"DB02350","BE0001116","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8669,"DB02322","BE0000975","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8670,"DB01215","BE0000381","# Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol. 1978 Apr 1;48(3):263-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/639854# Miller LG, Greenblatt DJ, Barnhill JG, Deutsch SI, Shader R"
8671,"DB00420","BE0000045","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8672,"DB00964","BE0000289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8673,"DB00615","BE0003707","# Maddix DS, Tallian KB, Mead PS: Rifabutin: a review with emphasis on its role in the prevention of disseminated Mycobacterium avium complex infection. Ann Pharmacother. 1994 Nov;28(11):1250-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7849340"
8674,"DB03436","BE0001379","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8675,"DB01233","BE0000084","# Guillemot J, Compagnon P, Cartier D, Thouennon E, Bastard C, Lihrmann I, Pichon P, Thuillez C, Plouin PF, Bertherat J, Anouar Y, Kuhn JM, Yon L, Lefebvre H: Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocyt"
8676,"DB04345","BE0002551","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8677,"DB01078","BE0000732","# Zhao YN, Pan Y, Tao JL, Xing DM, Du LJ: Study on cardioactive effects of brazilein. Pharmacology. 2006;76(2):76-83. Epub 2005 Nov 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16319518# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic"
8678,"DB03461","BE0000008","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8679,"DB08671","BE0002012","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8680,"DB08030","BE0001116","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8681,"DB00945","BE0004876","# Stevenson MA, Zhao MJ, Asea A, Coleman CN, Calderwood SK: Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes. J Immunol."
8682,"DB01064","BE0002384","# Slomiany BL, Slomiany A: Salivary phospholipid secretion in response to beta-adrenergic stimulation is mediated by Src kinase-dependent epidermal growth factor receptor transactivation. Biochem Biophys Res Commun. 2004 May 21;318(1):247-52. \"Pubmed\":htt"
8683,"DB06859","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8684,"DB01073","BE0000546","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8685,"DB00344","BE0000486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8686,"DB03793","BE0003178",""
8687,"DB01353","BE0000764","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
8688,"DB00768","BE0001177","# Okada M, Tokumitsu H, Kubota Y, Kobayashi R: Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein. Biochem Biophys Res Commun. 2002 Apr 12;292(4):"
8689,"DB00994","BE0000279","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8690,"DB00398","BE0002411","# Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trai"
8691,"DB08399","BE0003840","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8692,"DB00119","BE0000102","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8693,"DB08715","BE0004017","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8694,"DB03310","BE0001189","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8695,"DB00734","BE0000581","# Leysen JE, Janssen PM, Megens AA, Schotte A: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry. 1994 May;55 Suppl:5-12. \"Pubmed\":http://www.ncbi.nlm."
8696,"DB04386","BE0003288",""
8697,"DB04530","BE0002002","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8698,"DB00477","BE0000146","# Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF: Discovery of a novel member of the histamine receptor family. Mol Pharmacol. 2001 Mar;59(3):427-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1"
8699,"DB03419","BE0003080",""
8700,"DB04196","BE0003133","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8701,"DB03685","BE0001963","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8702,"DB00726","BE0004872","# Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8863001"
8703,"DB01142","BE0000393","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Maj J, Gancarczyk L, Gorsz"
8704,"DB02586","BE0001337","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8705,"DB07477","BE0002135","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8706,"DB07196","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8707,"DB02836","BE0001441","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8708,"DB07951","BE0004065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8709,"DB02011","BE0000306","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8710,"DB01594","BE0003594","# Walash MI, Belal F, Metwally ME, Hefnawy MM: A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
8711,"DB07719","BE0000623","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8712,"DB00786","BE0003692","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
8713,"DB00827","BE0000366","# Jariyawat S, Sekine T, Takeda M, Apiwattanakul N, Kanai Y, Sophasan S, Endou H: The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther. 1999 Aug;290(2):672-7. \"Pubmed\":http://"
8714,"DB01788","BE0001327","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8715,"DB04971","BE0000215",""
8716,"DB07208","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8717,"DB02007","BE0000916","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8718,"DB04335","BE0003286",""
8719,"DB00139","BE0000152","# Yogeeswari P, Sriram D, Vaigundaragavendran J: The GABA shunt: an attractive and potential therapeutic target in the treatment of epileptic disorders. Curr Drug Metab. 2005 Apr;6(2):127-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15853764# Popov VN,"
8720,"DB04820","BE0002196","# Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS: Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma. Neuropharmacology. 1989 Aug;28(8):791-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2506486"
8721,"DB01240","BE0000117","# Nakayama T: Genetic polymorphisms of prostacyclin synthase gene and cardiovascular disease. Int Angiol. 2010 Apr;29(2 Suppl):33-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20357747# Ruan KH, Wu J, Cervantes V: Characterization of the substrate mimic"
8722,"DB02910","BE0001745","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8723,"DB03510","BE0002700",""
8724,"DB08665","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8725,"DB00013","BE0002112","# Uhrin P, Schofer C, Zaujec J, Ryban L, Hilpert M, Weipoltshammer K, Jerabek I, Pirtzkall I, Furtmuller M, Dewerchin M, Binder BR, Geiger M: Male fertility and protein C inhibitor/plasminogen activator inhibitor-3 (PCI): localization of PCI in mouse test"
8726,"DB00363","BE0000092","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
8727,"DB00726","BE0004890","# Eikmeier G, Muszynski K, Berger M, Gastpar M: High-dose trimipramine in acute schizophrenia. Preliminary results of an open trial. Pharmacopsychiatry. 1990 Sep;23(5):212-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1979173"
8728,"DB00880","BE0000535","# Puscas I, Coltau M, Baican M, Domuta G, Hecht A: Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action. Drugs Exp Clin Res. 1999;25(6):271-9. \"Pubmed\":http://www.ncbi.nlm"
8729,"DB08912","BE0004759","# FDA label"
8730,"DB03176","BE0000315","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8731,"DB04151","BE0002101","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8732,"DB01403","BE0000575","# Green B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15701205# Dahl SG, Hough E, Hals PA: Phenothiazine drugs and metabolites: molecular conformation and "
8733,"DB03761","BE0001501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8734,"DB00823","BE0000557","# Tamaya T, Nioka S, Furuta N, Shimura T, Takano N: Contribution of functional groups of 19-nor-progestogens to binding to progesterone and estradiol-17beta receptors in rabbit uterus. Endocrinology. 1977 Jun;100(6):1579-84. \"Pubmed\":http://www.ncbi.nlm.n"
8735,"DB07707","BE0003740","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8736,"DB01268","BE0000369","# Mendel DB, Laird AD, Xin X, Louie SG, Christensen JG, Li G, Schreck RE, Abrams TJ, Ngai TJ, Lee LB, Murray LJ, Carver J, Chan E, Moss KG, Haznedar JO, Sukbuntherng J, Blake RA, Sun L, Tang C, Miller T, Shirazian S, McMahon G, Cherrington JM: In vivo ant"
8737,"DB00151","BE0000151","# You D, Wang L, Yao F, Zhou X, Deng Z: A novel DNA modification by sulfur: DndA is a NifS-like cysteine desulfurase capable of assembling DndC as an iron-sulfur cluster protein in Streptomyces lividans. Biochemistry. 2007 May 22;46(20):6126-33. Epub 2007"
8738,"DB01016","BE0000708","# Hambrock A, Loffler-Walz C, Quast U: Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides. Br J Pharmacol. 2002 Aug;136(7):995-1004. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12145099# Nielsen FE, Bodvarsdottir T"
8739,"DB06983","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8740,"DB03165","BE0001417","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8741,"DB03461","BE0000589","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8742,"DB00794","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
8743,"DB04352","BE0001935","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8744,"DB02709","BE0001209","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
8745,"DB00757","BE0000311","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Conroy T, Cappelaere P, Fabbro M, Fauser AA, Splinter TA, Spielmann M, Schneider M, Chevallier B, "
8746,"DB03691","BE0001292","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8747,"DB02308","BE0001583","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8748,"DB01327","BE0003579","# Truesdell SE, Zurenko GE, Laborde AL: Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1989 Apr;23 Suppl D:13-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2722720# Y"
8749,"DB00674","BE0003588","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
8750,"DB00277","BE0000487","# Lipworth BJ: Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet. 2005 Jan 8-14;365(9454):167-75. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15639300"
8751,"DB03148","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8752,"DB05916","BE0003436",""
8753,"DB00116","BE0000268","# Salmassi TM, Leadbetter JR: Analysis of genes of tetrahydrofolate-dependent metabolism from cultivated spirochaetes and the gut community of the termite Zootermopsis angusticollis. Microbiology. 2003 Sep;149(Pt 9):2529-37. \"Pubmed\":http://www.ncbi.nlm.n"
8754,"DB02482","BE0002790",""
8755,"DB01226","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8756,"DB08041","BE0003804","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8757,"DB01644","BE0000648","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8758,"DB00171","BE0000599","# Walther T, Tschope C, Sterner-Kock A, Westermann D, Heringer-Walther S, Riad A, Nikolic A, Wang Y, Ebermann L, Siems WE, Bader M, Shakibaei M, Schultheiss HP, Dorner A: Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport imp"
8759,"DB01058","BE0004851","# Doenhoff MJ, Cioli D, Utzinger J: Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis. 2008 Dec;21(6):659-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18978535"
8760,"DB07965","BE0003417","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8761,"DB06867","BE0003739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8762,"DB00402","BE0000471","# Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2009 Nov 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19942638# Hanson SM, Morlock EV, Satyshur KA, Czajkowski C: S"
8763,"DB08320","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8764,"DB07026","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8765,"DB00142","BE0002162","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8766,"DB03247","BE0003036",""
8767,"DB00668","BE0000572","# Gobbi M, Frittoli E, Mennini T: The modulation of [3H]noradrenaline and [3H]serotonin release from rat brain synaptosomes is not mediated by the alpha 2B-adrenoceptor subtype. Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):382-6. \"Pubmed\":http://w"
8768,"DB08562","BE0004341","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8769,"DB01015","BE0000803","# Hong YL, Hossler PA, Calhoun DH, Meshnick SR: Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob Agents Chemother. 1995 Aug;39(8):1756-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7486915"
8770,"DB03813","BE0001829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8771,"DB07594","BE0001898","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8772,"DB00085","BE0004835","# Rawlings ND, Barrett AJ: Families of serine peptidases. Methods Enzymol. 1994;244:19-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7845208"
8773,"DB00508","BE0000393","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8774,"DB00851","BE0004796","# Lonn U, Lohn S: Prevention of dacarbazine damage of human neoplastic cell DNA by aphidicolin. Cancer Res. 1987 Jan 1;47(1):26-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/3098406"
8775,"DB00315","BE0000291","# Johnson DE, Rollema H, Schmidt AW, McHarg AD: Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. Eur J Pharmacol. 2001 Aug 17;425(3):203-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11513839"
8776,"DB01355","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
8777,"DB03654","BE0001977","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8778,"DB00421","BE0004886","# Spironolactone and endocrine dysfunction. Ann Intern Med. 1976 Nov;85(5):630-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/984618/# Desai; Meena P.; Vijayalakshmi Bhatia & P.S.N. Menon (1 January 2001).Pediatric Endocrine Disorders. Orient Blackswan. "
8779,"DB00434","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
8780,"DB04690","BE0000971","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Teicher BA: Next generation topoisomerase I inhibitors: Rationale and biomarker strategies. Bioche"
8781,"DB04400","BE0001289","# Deng H, Callender R, Dale GE: A vibrational structure of 7,8-dihydrobiopterin bound to dihydroneopterin aldolase. J Biol Chem. 2000 Sep 29;275(39):30139-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10896664"
8782,"DB07773","BE0004065","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8783,"DB02923","BE0001672","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8784,"DB08636","BE0003759","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8785,"DB00842","BE0002345","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
8786,"DB08724","BE0003372","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8787,"DB00363","BE0000045","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
8788,"DB02711","BE0001270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8789,"DB00684","BE0000279","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8790,"DB03015","BE0002214","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8791,"DB01613","BE0000556","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8792,"DB00536","BE0004524","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8793,"DB01326","BE0003688","# Yotsuji A, Mitsuyama J, Hori R, Yasuda T, Saikawa I, Inoue M, Mitsuhashi S: Mechanism of action of cephalosporins and resistance caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis. Antimicrob Agents Chemother. 1988 Dec;"
8794,"DB02396","BE0004467","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8795,"DB03413","BE0001205","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8796,"DB07445","BE0003880","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8797,"DB04395","BE0001097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8798,"DB04381","BE0000133","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8799,"DB01118","BE0000172","# Doggrell SA, Brown L: Present and future pharmacotherapy for heart failure. Expert Opin Pharmacother. 2002 Jul;3(7):915-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12083991"
8800,"DB07494","BE0003963","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8801,"DB04731","BE0003352",""
8802,"DB04272","BE0004625","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8803,"DB05366","BE0000557",""
8804,"DB00321","BE0000575","# Nojimoto FD, Mueller A, Hebeler-Barbosa F, Akinaga J, Lima V, Kiguti LR, Pupo AS: The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors. Neuropharmacology. 2010 Jul-Aug;59(1"
8805,"DB00996","BE0000691","# Maneuf YP, Luo ZD, Lee K: alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin Cell Dev Biol. 2006 Oct;17(5):565-70. Epub 2006 Sep 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17067834# Hota D, Bansal V, Pattanaik S: "
8806,"DB03489","BE0003107",""
8807,"DB02857","BE0001360","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8808,"DB00608","BE0000704","# Jang CH, Choi JH, Byun MS, Jue DM: Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Rheumatology (Oxford). 2006 Jun;45(6):703-10. Epub 2006 Jan 17. \"Pubmed"
8809,"DB00201","BE0002379","# Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR: Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem. 2002 Oct "
8810,"DB02379","BE0002735",""
8811,"DB02521","BE0004037","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8812,"DB00829","BE0003595","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
8813,"DB00463","BE0000471","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
8814,"DB08185","BE0004202","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8815,"DB08517","BE0003757","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8816,"DB05120","BE0000033",""
8817,"DB01244","BE0000356","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8818,"DB03401","BE0004516","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8819,"DB07281","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8820,"DB08663","BE0001732","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8821,"DB07349","BE0003816","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8822,"DB08073","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8823,"DB03685","BE0001973","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8824,"DB00604","BE0000090","# Walker BD, Singleton CB, Bursill JA, Wyse KR, Valenzuela SM, Qiu MR, Breit SN, Campbell TJ: Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states. Br J Pharmacol. 1999 Sep;128("
8825,"DB04745","BE0003357",""
8826,"DB05694","BE0000203",""
8827,"DB00388","BE0000501","# Hein, L. (2004). &alpha;-Adrenergic system. In S. Offermanns, & W. Rosenthal (Eds.). _Encyclopedic reference of molecular pharmacology_ (pp. 27-30). Berlin, Germany: Springer.# Martinez-Salas SG, Campos-Peralta JM, Pares-Hipolito J, Gallardo-Ortiz IA, I"
8828,"DB07178","BE0000332","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8829,"DB04154","BE0004000","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8830,"DB02731","BE0004060","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8831,"DB07490","BE0003960","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8832,"DB08818","BE0004512","# Prange CK, Pennacchio LA, Lieuallen K, Fan W, Lennon GG: Characterization of the human neurocan gene, CSPG3. Gene. 1998 Oct 23;221(2):199-205. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9795216"
8833,"DB04272","BE0002930",""
8834,"DB00242","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8835,"DB08816","BE0000110","# H. Spreitzer (February 4, 2008). \"Neue Wirkstoffe - AZD6140\" (in German). sterreichische Apothekerzeitung (3/2008): 135."
8836,"DB00157","BE0000780","# Baumchen C, Roth AH, Biedendieck R, Malten M, Follmann M, Sahm H, Bringer-Meyer S, Jahn D: D-Mannitol production by resting state whole cell biotransformation of D-fructose by heterologous mannitol and formate dehydrogenase gene expression in Bacillus m"
8837,"DB04227","BE0001667","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8838,"DB05206","BE0000521",""
8839,"DB01942","BE0002658",""
8840,"DB00909","BE0003637","# Janszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases] Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20025128# Kothare SV, Kaleyias J: Zonisamide: review of pharm"
8841,"DB04121","BE0003814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8842,"DB00740","BE0000030","# Wokke J: Riluzole. Lancet. 1996 Sep 21;348(9030):795-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8813989# Azbill RD, Mu X, Springer JE: Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res. 2000 Jul 21;871(2):1"
8843,"DB07218","BE0003790","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8844,"DB04771","BE0000048",""
8845,"DB00661","BE0002355","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880"
8846,"DB07752","BE0004068","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8847,"DB00540","BE0000405","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217"
8848,"DB01660","BE0001235","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8849,"DB00142","BE0000822","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8850,"DB04233","BE0003974","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8851,"DB00598","BE0000172","# Riva E, Mennini T, Latini R: The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers. Br J Pharmacol. 1991 Dec;104(4):823-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1687367# Monopoli A, Bamonte F, Forlan"
8852,"DB07822","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8853,"DB02294","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8854,"DB04735","BE0003354",""
8855,"DB01861","BE0001419","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8856,"DB07293","BE0003801","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8857,"DB03940","BE0001945","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8858,"DB03621","BE0000695","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8859,"DB08717","BE0004387","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8860,"DB00056","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8861,"DB08047","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8862,"DB00588","BE0000668","# Austin RJ, Maschera B, Walker A, Fairbairn L, Meldrum E, Farrow SN, Uings IJ: Mometasone furoate is a less specific glucocorticoid than fluticasone propionate. Eur Respir J. 2002 Dec;20(6):1386-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12503693# I"
8863,"DB00074","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8864,"DB05434","BE0000961",""
8865,"DB00801","BE0003593","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
8866,"DB00454","BE0004890","# Hustveit O: Binding of fentanyl and pethidine to muscarinic receptors in rat brain. Jpn J Pharmacol. 1994 Jan;64(1):57-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8164394"
8867,"DB00866","BE0000291","# Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, Verriele L, et al.: S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possess"
8868,"DB00960","BE0000797","# Dawson LA, Nguyen HQ: The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol. Neuropharmacology. 2000 Apr 3;39(6):1044-52. \"Pubmed\":http://www."
8869,"DB02613","BE0004027","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8870,"DB03856","BE0000404","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8871,"DB05767","BE0000704",""
8872,"DB00138","BE0002251","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8873,"DB01594","BE0000471","# Walash MI, Belal F, Metwally ME, Hefnawy MM: A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
8874,"DB01127","BE0000233","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Warrilow AG, Martel CM, Parker JE, Melo N, Lamb DC, Nes WD, K"
8875,"DB04714","BE0000776","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8876,"DB00273","BE0000322","# Maryanoff BE, McComsey DF, Costanzo MJ, Hochman C, Smith-Swintosky V, Shank RP: Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform. J Med Chem. 2005 Mar 24;48(6):1941-7. "
8877,"DB01218","BE0000090","# Tie H, Walker BD, Singleton CB, Valenzuela SM, Bursill JA, Wyse KR, Breit SN, Campbell TJ: Inhibition of HERG potassium channels by the antimalarial agent halofantrine. Br J Pharmacol. 2000 Aug;130(8):1967-75. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
8878,"DB00211","BE0000501","# Buckner SA, Milicic I, Daza AV, Meyer MD, Altenbach RJ, Williams M, Sullivan JP, Brioni JD: ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes. Eur J Pharmacol. 2002 Aug 2;449"
8879,"DB05767","BE0002387",""
8880,"DB04527","BE0004630","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8881,"DB02736","BE0001443","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8882,"DB00420","BE0000715","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8883,"DB01099","BE0000021","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8884,"DB01657","BE0001222","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8885,"DB07718","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8886,"DB00989","BE0000426","# Kennedy JS, Polinsky RJ, Johnson B, Loosen P, Enz A, Laplanche R, Schmidt D, Mancione LC, Parris WC, Ebert MH: Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans. J Clin Psychopharmacol. 1999 Dec;19(6):513-21. \"Pu"
8887,"DB07514","BE0000369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8888,"DB00415","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
8889,"DB00543","BE0000311","# Gozlan H, Saddiki-Traki F, Merahi N, Laguzzi R, Hamon M: [Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats]. Encephale. 1991 Dec;17 Spec No 3:415-22. \"Pubmed\":"
8890,"DB08088","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8891,"DB00114","BE0000603","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8892,"DB08699","BE0004384","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8893,"DB00246","BE0000442","# Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11132243# Arnt J: Differential effects of classical and ne"
8894,"DB00170","BE0000333","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8895,"DB08896","BE0000029","# FDA label"
8896,"DB08486","BE0000629","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8897,"DB00674","BE0000850","# Scott LJ, Goa KL: Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11129124# Lilienfeld S: Galantamine--a novel cholinergic drug with a unique dual mode of action for th"
8898,"DB00996","BE0004956","# Shimoyama M, Shimoyama N, Hori Y: Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain. 2000 Apr;85(3):405-14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10781913"
8899,"DB01238","BE0000289","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
8900,"DB08239","BE0001852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8901,"DB00464","BE0000380","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Jacobson BF, Franz RC, Hurly EM, Norman GL, Becker P, Myburgh"
8902,"DB07551","BE0003852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8903,"DB00122","BE0002180","# Hsieh BC, Matsumoto K, Cheng TJ, Yuu G, Chen RL: Choline biosensor constructed with chitinous membrane from soldier crab and its application in measuring cholinesterase inhibitory activities. J Pharm Biomed Anal. 2007 Jan 24;. \"Pubmed\":http://www.ncbi.n"
8904,"DB08745","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8905,"DB00695","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8906,"DB00685","BE0000366","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8907,"DB06828","BE0001680","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8908,"DB01030","BE0000091","# Kosovsky MJ, Soslau G: Immunological identification of human platelet mitochondrial DNA topoisomerase I. Biochim Biophys Acta. 1993 Jun 24;1164(1):101-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8390858"
8909,"DB06898","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8910,"DB01224","BE0000797","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
8911,"DB08673","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8912,"DB00376","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8913,"DB01392","BE0000342","# Lalchandani SG, Lei L, Zheng W, Suni MM, Moore BM, Liggett SB, Miller DD, Feller DR: Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype. J Pharmacol Exp Ther. 2002 Dec;303(3):979-84. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
8914,"DB00788","BE0000017","# James MJ, Cook-Johnson RJ, Cleland LG: Selective COX-2 Inhibitors, Eicosanoid Synthesis and Clinical Outcomes: A Case Study of System Failure. Lipids. 2007 Jun 2;. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17541796"
8915,"DB01734","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8916,"DB00777","BE0000575","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8917,"DB00284","BE0000876","# Salehi A, Fan BG, Ekelund M, Nordin G, Lundquist I: TPN-evoked dysfunction of islet lysosomal activity mediates impairment of glucose-stimulated insulin release. Am J Physiol Endocrinol Metab. 2001 Jul;281(1):E171-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
8918,"DB00142","BE0000030","# Natale NR, Magnusson KR, Nelson JK: Can selective ligands for glutamate binding proteins be rationally designed? Curr Top Med Chem. 2006;6(8):823-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16719820"
8919,"DB05308","BE0000324",""
8920,"DB07941","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8921,"DB00055","BE0000016","# Geng JP, Castellino FJ: Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII. Thromb Haemost. 1997 May;77(5)"
8922,"DB04353","BE0001342","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8923,"DB00852","BE0004924","# Fiebich BL, Collado JA, Stratz C, Valina C, Hochholzer W, Munoz E, Bellido LM: Pseudoephedrine inhibits T-cell activation by targeting NF-kappaB, NFAT and AP-1 signaling pathways. Immunopharmacol Immunotoxicol. 2012 Feb;34(1):98-106. doi: 10.3109/089239"
8924,"DB08381","BE0003822","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8925,"DB03403","BE0002020","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8926,"DB03737","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8927,"DB08523","BE0002536","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8928,"DB01623","BE0000451","# Kusumi I, Takahashi Y, Suzuki K, Kameda K, Koyama T: Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain. J Neural Transm. 2000;107(3):295-302. \"Pubmed\":http://ww"
8929,"DB00323","BE0002089","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Ries V, Selzer R, Eichhorn T, Oertel WH, Eggert K: Replacing a dopamine agonist by the COMT-inhibi"
8930,"DB07505","BE0003804","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8931,"DB00391","BE0000756","# Cavallotti C, Nuti F, Bruzzone P, Mancone M: Age-related changes in dopamine D2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):412-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12010185# Jaber M, Tison F, "
8932,"DB00451","BE0000687","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targe"
8933,"DB00413","BE0000289","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
8934,"DB01942","BE0001475","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8935,"DB08818","BE0004606","# Perides G, Lane WS, Andrews D, Dahl D, Bignami A: Isolation and partial characterization of a glial hyaluronate-binding protein. J Biol Chem. 1989 Apr 5;264(10):5981-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2466833# Bignami A, Lane WS, Andrews D, "
8936,"DB00241","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
8937,"DB01232","BE0004854","# Wittayanarakul K, Hannongbua S, Feig M: Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors. J Comput Chem. 2007 Sep 11;. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
8938,"DB00365","BE0000429","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8939,"DB04959","BE0002459","# Kanduc D: Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7. J Virol. 2002 Jul;76(14):7040-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12072504"
8940,"DB00075","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8941,"DB08808","BE0001012","# Lenard NR, Gettys TW, Dunn AJ: Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther. 2003 May;305(2):653-9. Epub 2003 Jan 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12606631# Matsushita M, Horinouchi "
8942,"DB06148","BE0000756","# Terai M, Hidaka K, Nakamura Y: Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum. Eur J Pharmacol. 1989 Dec 7;173(2-3):177-82. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2576228/# Roth,"
8943,"DB02659","BE0003988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8944,"DB02983","BE0001886","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8945,"DB03714","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8946,"DB05077","BE0000061",""
8947,"DB03790","BE0001988","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8948,"DB06674","BE0000704","# Mittal M, Raychaudhuri SP: Golimumab and certolizumab: the two new anti-tumor necrosis factor kids on the block. Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):602-8; quiz 609. doi: 10.4103/0378-6323.72445. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
8949,"DB01863","BE0001627","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8950,"DB04614","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8951,"DB08430","BE0004111","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8952,"DB02950","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8953,"DB03247","BE0002364","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8954,"DB02010","BE0001312","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8955,"DB04905","BE0000442","# Brandes LJ, Bogdanovic RP, Cawker MD, LaBella FS: Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels. Cancer Res. 1987 Aug 1;47(15):4025-31. \"Pubmed\":http://www"
8956,"DB01010","BE0000426","# Ravelli RB, Raves ML, Ren Z, Bourgeois D, Roth M, Kroon J, Silman I, Sussman JL: Static Laue diffraction studies on acetylcholinesterase. Acta Crystallogr D Biol Crystallogr. 1998 Nov 1;54(Pt 6 Pt 2):1359-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
8957,"DB06836","BE0001315","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8958,"DB03991","BE0001978","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8959,"DB00661","BE0000483","# Tfelt-Hansen P, Tfelt-Hansen J: Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009 Jan;49(1):117-25. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19125880# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Dat"
8960,"DB02855","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8961,"DB03499","BE0000148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8962,"DB04714","BE0004142","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8963,"DB00089","BE0000568","# Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, Bander NH: In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res. 2000 S"
8964,"DB01784","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8965,"DB07348","BE0002654","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8966,"DB07158","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8967,"DB00945","BE0001098","# Deng WG, Ruan KH, Du M, Saunders MA, Wu KK: Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts. FASEB J. 2001 Nov;15(13):2463-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
8968,"DB07431","BE0001373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8969,"DB00988","BE0000581","# Ostadali MR, Ahangari G, Eslami MB, Razavi A, Zarrindast MR, Ahmadkhaniha HR, Boulhari J: The Detection of Dopamine Gene Receptors (DRD1-DRD5) Expression on Human Peripheral Blood Lymphocytes by Real Time PCR. Iran J Allergy Asthma Immunol. 2004 Dec;3(4"
8970,"DB07959","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8971,"DB02251","BE0002715","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8972,"DB06372","BE0004734","# Tran TH, Pham JT, Shafeeq H, Manigault KR, Arya V: Role of Interleukin-1 Inhibitors in the Management of Gout. Pharmacotherapy. 2013 Apr 3. doi: 10.1002/phar.1265. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23553601# Cronstein BN, Sunkureddi P: Mechani"
8973,"DB01041","BE0001086","# Yasui K, Kobayashi N, Yamazaki T, Agematsu K: Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammation. Curr Pharm Des. 2005;11(3):395-401. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15723633# Chen X, Ji ZL, Chen YZ: T"
8974,"DB00056","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8975,"DB03365","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8976,"DB01401","BE0000017","# Nizankowska E, Dworski R, Soja J, Szczeklik A: Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients. Clin Exp Allergy. 1990 Nov;20(6):647-52. \"Pubmed\":http://www.ncbi.nlm.ni"
8977,"DB02514","BE0001349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8978,"DB02594","BE0002018","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8979,"DB00669","BE0000291","# Johnson DE, Rollema H, Schmidt AW, McHarg AD: Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. Eur J Pharmacol. 2001 Aug 17;425(3):203-10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11513839"
8980,"DB03049","BE0001511","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8981,"DB08330","BE0003860","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8982,"DB03843","BE0001349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8983,"DB03461","BE0000747","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8984,"DB01942","BE0002640",""
8985,"DB00122","BE0000494","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8986,"DB00887","BE0000047","# Reid KH, Guo SZ, Iyer VG: Agents which block potassium-chloride cotransport prevent sound-triggered seizures in post-ischemic audiogenic seizure-prone rats. Brain Res. 2000 May 2;864(1):134-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10793196"
8987,"DB01355","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
8988,"DB03904","BE0001991","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8989,"DB00829","BE0003594","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
8990,"DB02437","BE0001535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
8991,"DB05235","BE0000687",""
8992,"DB08646","BE0004354","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8993,"DB00574","BE0000393","# Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun JH, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW: Possible role of valvular serotonin 5-HT(2B) receptors in the car"
8994,"DB01238","BE0000756","# Hirose T, Kikuchi T: Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist. J Med Invest. 2005 Nov;52 Suppl:284-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16366516# Inoue A, Miki S, Seto M, Kikuchi T, Morita S, Ueda H, Mis"
8995,"DB04233","BE0003976","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8996,"DB08241","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8997,"DB08244","BE0001852","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
8998,"DB00155","BE0000263","# Hayakawa H, Raij L: Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. J Hypertens. 1999 May;17(5):611-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10403604# Trovati M, Massucco P, Mattiello L, Costamagna C, Aldieri "
8999,"DB00652","BE0000632","# Chien CC, Pasternak GW: (-)-Pentazocine analgesia in mice: interactions with a sigma receptor system. Eur J Pharmacol. 1995 Dec 27;294(1):303-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8788445"
9000,"DB03976","BE0004529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9001,"DB07582","BE0003427","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9002,"DB01969","BE0004459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9003,"DB07147","BE0003754","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9004,"DB01497","BE0000770","# Duttaroy A, Yoburn BC: In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice. Synapse. 2000 Aug;37(2):118-24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10881033# Melone M, Brecha NC, Sternini C, Ev"
9005,"DB05434","BE0001015",""
9006,"DB00842","BE0003599","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9007,"DB01337","BE0000045","# Milchert M, Spassov A, Meissner K, Nedeljkov V, Lehmann C, Wendt M, Loster BW, Mazurkiewicz-Janik M, Gedrange T, Pavlovic D: Skeletal muscle relaxants inhibit rat tracheal smooth muscle tone in vitro. J Physiol Pharmacol. 2009 Dec;60 Suppl 8:5-11. \"Pubm"
9008,"DB04083","BE0003207",""
9009,"DB04272","BE0002953",""
9010,"DB02059","BE0000542","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9011,"DB00108","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9012,"DB00355","BE0001444","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9013,"DB02503","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9014,"DB04517","BE0001758","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9015,"DB00031","BE0000211","# Longstaff C, Williams S, Thelwell C: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy. Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18673235# Melandri G, Vag"
9016,"DB02709","BE0000220","# Buryanovskyy L, Fu Y, Boyd M, Ma Y, Hsieh TC, Wu JM, Zhang Z: Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry. 2004 Sep 14;43(36):11417-26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15350128# Wang Z, Hsieh TC, Zhang "
9017,"DB06902","BE0002088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9018,"DB09029","BE0005863","# Ohtsuki M, Morita A, Abe M, Takahashi H, Seko N, Karpov A, Shima T, Papavassilis C, Nakagawa H: Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, ph"
9019,"DB01992","BE0001823","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9020,"DB05042","BE0000945",""
9021,"DB00707","BE0000499","# Korbelik M: Low density lipoprotein receptor pathway in the delivery of Photofrin: how much is it relevant for selective accumulation of the photosensitizer in tumors? J Photochem Photobiol B. 1992 Jan;12(1):107-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/p"
9022,"DB00141","BE0002262","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9023,"DB07105","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9024,"DB00607","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
9025,"DB00172","BE0002206","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9026,"DB00005","BE0001087","# Johnson CJ, Reilly KM, Murray KM: Etanercept in juvenile rheumatoid arthritis. Ann Pharmacother. 2001 Apr;35(4):464-71. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11302411# Pennica D, Lam VT, Mize NK, Weber RF, Lewis M, Fendly BM, Lipari MT, Goeddel DV"
9027,"DB07045","BE0003775","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9028,"DB00145","BE0000347","# Wang L, Zhang Y, Shao M, Zhang H: Spatiotemporal expression of the creatine metabolism related genes agat, gamt and ct1 during zebrafish embryogenesis. Int J Dev Biol. 2007;51(3):247-53. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17486546# Dutta U, Coh"
9029,"DB00800","BE0000342","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9030,"DB05744","BE0000918",""
9031,"DB01388","BE0002356","# Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms. Pharmacology. 2006;78(1):11-20. Ep"
9032,"DB00237","BE0004797","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models an"
9033,"DB00142","BE0000454","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9034,"DB02761","BE0001799","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9035,"DB06101","BE0000023",""
9036,"DB06274","BE0000420","# Neary P, Delaney CP: Alvimopan. Expert Opin Investig Drugs. 2005 Apr;14(4):479-88. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15882122# Beattie DT, Cheruvu M, Mai N, O'Keefe M, Johnson-Rabidoux S, Peterson C, Kaufman E, Vickery R: The in vitro pharmaco"
9037,"DB00408","BE0000112","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
9038,"DB06698","BE0000968","# Barak N: Betahistine: what's new on the agenda? Expert Opin Investig Drugs. 2008 May;17(5):795-804. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18447604# Lacour M, Sterkers O: Histamine and betahistine in the treatment of vertigo: elucidation of mechani"
9039,"DB00019","BE0000793","# Erkeland SJ, Aarts LH, Irandoust M, Roovers O, Klomp A, Valkhof M, Gits J, Eyckerman S, Tavernier J, Touw IP: Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled p"
9040,"DB06151","BE0004655","# Oka S, Kamata H, Kamata K, Yagisawa H, Hirata H: N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases. FEBS Lett. 2000 Apr 28;472(2-3):196-202. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10788610"
9041,"DB01632","BE0004582","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9042,"DB07041","BE0003773","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9043,"DB06702","BE0000405","# Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E: Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. J Pharmacol Exp Ther. 2009 Mar;328(3)"
9044,"DB01159","BE0000534","# Perouansky M, Kirson ED, Yaari Y: Halothane blocks synaptic excitation of inhibitory interneurons. Anesthesiology. 1996 Dec;85(6):1431-8; discussion 29A. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8968191"
9045,"DB01870","BE0004457","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9046,"DB00825","BE0000632","# Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A, Ghelardini C: Menthol: a natural analgesic compound. Neurosci Lett. 2002 Apr 12;322(3):145-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11897159# Taniguchi Y, Deguchi Y, Saita M, Noda K: [Anti"
9047,"DB02909","BE0004075","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9048,"DB00105","BE0000661","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9049,"DB00423","BE0000267","# Parr JS, Khalifah RG: Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. J Biol Chem. 1992 Dec 15;267(35):25044-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1460006"
9050,"DB03929","BE0000433","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9051,"DB00246","BE0000581","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9052,"DB03933","BE0001994","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9053,"DB01769","BE0001705","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9054,"DB02277","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9055,"DB06637","BE0003604","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
9056,"DB01021","BE0000267","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9057,"DB00172","BE0000188","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9058,"DB00025","BE0002117","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9059,"DB01831","BE0000228","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9060,"DB02758","BE0001217","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9061,"DB02264","BE0000689","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9062,"DB00786","BE0001116","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9063,"DB00393","BE0000303","# Weant KA, Ramsey CN 3rd, Cook AM: Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage. Pharmacotherapy. 2010 Apr;30(4):405-17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20334460# Dong CJ, Guo Y, Agey P,"
9064,"DB01163","BE0004290","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
9065,"DB06212","BE0000293","# Aperis G, Alivanis P: Tolvaptan: a new therapeutic agent. Rev Recent Clin Trials. 2011 May 1;6(2):177-88. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20868352# Dixon MB, Lien YH: Tolvaptan and its potential in the treatment of hyponatremia. Ther Clin Ri"
9066,"DB07786","BE0002214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9067,"DB02494","BE0003835","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9068,"DB04408","BE0001841","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9069,"DB01117","BE0000612","# Cushion MT, Collins M, Hazra B, Kaneshiro ES: Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii. Antimicrob Agents Chemother. 2000 Mar;44(3):713-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1068"
9070,"DB00122","BE0000615","# Enaw JO, Zhu H, Yang W, Lu W, Shaw GM, Lammer EJ, Finnell RH: CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population. BMC Med. 2006 Dec 21;4:36. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17184542# Li L, She"
9071,"DB00588","BE0000657","# Sano A, Munoz NM, Sano H, Choi J, Zhu X, Jacobs B, Leff AR: Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils. Am J Respir Crit Care Med. 1999 Jun;159(6):1903-9. \"Pubmed\":"
9072,"DB07247","BE0001178","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9073,"DB03111","BE0001326","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9074,"DB01352","BE0000826","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
9075,"DB02425","BE0002743",""
9076,"DB05046","BE0000632",""
9077,"DB00099","BE0000793","# Erkeland SJ, Aarts LH, Irandoust M, Roovers O, Klomp A, Valkhof M, Gits J, Eyckerman S, Tavernier J, Touw IP: Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled p"
9078,"DB00408","BE0000756","# Lee T, Tang SW: Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain. Psychiatry Res. 1984 Aug;12(4):277-85. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6239298# Hjerde E, Dahl SG, Sylte I: At"
9079,"DB04197","BE0000286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9080,"DB04464","BE0004084","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9081,"DB07320","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9082,"DB01105","BE0000486","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Heusser K, Engeli S, Tank J, Diedrich A, Wiesner S, Janke J, Luft FC, Jordan J: Sympathetic vasomo"
9083,"DB02307","BE0001528","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9084,"DB00651","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9085,"DB01810","BE0001504","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9086,"DB01708","BE0000886","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9087,"DB04327","BE0003285",""
9088,"DB04310","BE0002535","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9089,"DB08601","BE0000412","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9090,"DB04047","BE0003133",""
9091,"DB03661","BE0002135",""
9092,"DB01917","BE0000404","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9093,"DB00703","BE0000322","# Mincione F, Scozzafava A, Supuran CT: The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18336310"
9094,"DB01702","BE0004035","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9095,"DB08642","BE0000330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9096,"DB01472","BE0000289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9097,"DB01031","BE0000322","# Parr JS, Khalifah RG: Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. J Biol Chem. 1992 Dec 15;267(35):25044-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1460006# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Databas"
9098,"DB00909","BE0001143","# Janszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases] Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20025128# Kothare SV, Kaleyias J: Zonisamide: review of pharm"
9099,"DB04173","BE0003212",""
9100,"DB02048","BE0000263","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9101,"DB01090","BE0003584","# Cachelin AB, Rust G: Beta-subunits co-determine the sensitivity of rat neuronal nicotinic receptors to antagonists. Pflugers Arch. 1995 Jan;429(3):449-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7761270"
9102,"DB00114","BE0002150","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9103,"DB00574","BE0000533","# Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun JH, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW: Possible role of valvular serotonin 5-HT(2B) receptors in the car"
9104,"DB03381","BE0004476","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9105,"DB07143","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9106,"DB01466","BE0000770","# Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M: Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Brain Res. 2006 Apr 14;1083(1):61-9. Epub 2006 Mar 10. \"Pubmed\":http://www.nc"
9107,"DB00447","BE0004643","# Chambers HF, Miick C: Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptides. Antimicrob Agents Chemother. 1992 Mar;36(3):656-61. \"Pubmed\":http://www.ncbi.nlm"
9108,"DB03247","BE0003019",""
9109,"DB00615","BE0000461","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9110,"DB07135","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9111,"DB00157","BE0000571","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9112,"DB02427","BE0001555","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9113,"DB00795","BE0000069","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9114,"DB00628","BE0004797","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9115,"DB05183","BE0001154",""
9116,"DB00639","BE0004803","# Pfaller MA, Riley J, Koerner T: Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):31-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/218"
9117,"DB00385","BE0004796","# Brox L, Gowans B, Belch A: N-trifluoroacetyladriamycin-14-valerate and adriamycin induced DNA damage in the RPMI-6410 human lymphoblastoid cell line. Can J Biochem. 1980 Sep;58(9):720-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7006761# Perabo FG, Mu"
9118,"DB04120","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9119,"DB02721","BE0000227","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9120,"DB06692","BE0000211","# Mahdy AM, Webster NR: Perioperative systemic haemostatic agents. Br J Anaesth. 2004 Dec;93(6):842-58. Epub 2004 Jul 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15277296"
9121,"DB04147","BE0001470","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9122,"DB00920","BE0000442","# Mita H, Shida T: Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes. Arzneimittelforschung. 1995 Jan;45(1):36-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7893266# O"
9123,"DB00622","BE0000560","# Thayer SA, Welcome M, Chhabra A, Fairhurst AS: Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Biochem Pharmacol. 1985 Jan 15;34(2):175-80. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/298"
9124,"DB08590","BE0004344","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9125,"DB06903","BE0003748","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9126,"DB03754","BE0001790","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9127,"DB03152","BE0003883","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9128,"DB01229","BE0000246","# Gan Y, Wientjes MG, Au JL: Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors. Pharm Res. 2006 Jun;23(6):1324-31. Epub 2006 Jun 8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16741658# Thomadaki"
9129,"DB08732","BE0003801","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9130,"DB00290","BE0000167","# Rose JL, Reeves KC, Likhotvorik RI, Hoyt DG: Base excision repair proteins are required for integrin-mediated suppression of bleomycin-induced DNA breakage in murine lung endothelial cells. J Pharmacol Exp Ther. 2007 Apr;321(1):318-26. Epub 2007 Jan 3. "
9131,"DB00198","BE0002705","# Shi D, Yang J, Yang D, LeCluyse EL, Black C, You L, Akhlaghi F, Yan B: Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther."
9132,"DB02546","BE0002365","# Xu WS, Parmigiani RB, Marks PA: Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007 Aug 13;26(37):5541-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17694093# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic"
9133,"DB02659","BE0003987","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9134,"DB07841","BE0004073","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9135,"DB01992","BE0002679",""
9136,"DB07241","BE0003800","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9137,"DB00139","BE0002256","# Coros AM, Swenson L, Wolodko WT, Fraser ME: Structure of the CoA transferase from pig heart to 1.7 A resolution. Acta Crystallogr D Biol Crystallogr. 2004 Oct;60(Pt 10):1717-25. Epub 2004 Sep 23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15388917"
9138,"DB06848","BE0003736","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9139,"DB00624","BE0000132","# Small EJ, Ryan CJ: The case for secondary hormonal therapies in the chemotherapy age. J Urol. 2006 Dec;176(6 Pt 2):S66-71. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17084172# Omwancha J, Brown TR: Selective androgen receptor modulators: in pursuit of "
9140,"DB00157","BE0000098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9141,"DB00080","BE0004832","# Canepari P, Boaretti M: Lipoteichoic acid as a target for antimicrobial action. Microb Drug Resist. 1996 Spring;2(1):85-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9158727# Canepari P, Boaretti M, Lleo MM, Satta G: Lipoteichoic acid as a new target f"
9142,"DB05005","BE0002463",""
9143,"DB02933","BE0001128","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9144,"DB00110","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9145,"DB04187","BE0000807","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9146,"DB04377","BE0000574","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9147,"DB04120","BE0001459","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9148,"DB08234","BE0000330","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9149,"DB05105","BE0003373",""
9150,"DB03814","BE0001302","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9151,"DB00797","BE0000112","# Ward RM: Pharmacology of tolazoline. Clin Perinatol. 1984 Oct;11(3):703-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6386273# Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overing"
9152,"DB02767","BE0004021","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9153,"DB01162","BE0000575","# Boyle P, Robertson C, Manski R, Padley RJ, Roehrborn CG: Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia. Urology. 2001 Nov;58(5):717-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11711348# Chen X, Ji Z"
9154,"DB04447","BE0002830",""
9155,"DB00170","BE0000220","# Long DJ 2nd, Iskander K, Gaikwad A, Arin M, Roop DR, Knox R, Barrios R, Jaiswal AK: Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity. J"
9156,"DB05037","BE0001072",""
9157,"DB02580","BE0004311","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9158,"DB08231","BE0003181","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9159,"DB05419","BE0000666",""
9160,"DB00571","BE0001012","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Berg T, Piercey BW, Jensen J: Role of beta1-3-adrenoceptors in blood pressure control at rest and "
9161,"DB05773","BE0000511","# Barginear MF, John V, Budman DR: Trastuzumab-DM1: a clinical update of the novel antibody-drug conjugate for HER2-overexpressing breast cancer. Mol Med. 2013 Jan 22;18:1473-9. doi: 10.2119/molmed.2012.00302. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2"
9162,"DB05207","BE0000565",""
9163,"DB04441","BE0002011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9164,"DB03615","BE0002677",""
9165,"DB00569","BE0000280","# Paolucci F, Clavies MC, Donat F, Necciari J: Fondaparinux sodium mechanism of action: identification of specific binding to purified and human plasma-derived proteins. Clin Pharmacokinet. 2002;41 Suppl 2:11-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
9166,"DB03258","BE0001442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9167,"DB02670","BE0004581","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9168,"DB01331","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
9169,"DB03814","BE0003193",""
9170,"DB06616","BE0004315","# FDA label"
9171,"DB04855","BE0000141","# Lalevee N, Nargeot J, Barrere-Lemaire S, Gautier P, Richard S: Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol. 2003 Aug;14(8):885-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
9172,"DB03194","BE0004482","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9173,"DB02879","BE0001895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9174,"DB00157","BE0000162","# Mailloux RJ, Beriault R, Lemire J, Singh R, Chenier DR, Hamel RD, Appanna VD: The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS ONE. 2007 Aug 1;2(1):e690. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17668068"
9175,"DB00032","BE0000134","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9176,"DB00131","BE0000007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9177,"DB08461","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9178,"DB00170","BE0002329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9179,"DB00335","BE0000172","# Schafer M, Frischkopf K, Taimor G, Piper HM, Schluter KD: Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am J Physiol Cell Physiol. 2000 Aug;279(2):C495-503. \"Pubmed\":http://www.ncbi.nlm.n"
9180,"DB03884","BE0003766","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9181,"DB03147","BE0001354","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9182,"DB08515","BE0003912","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9183,"DB00393","BE0002359","# Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J: Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol. 2009 Feb;75(2):407-14. Epub 200"
9184,"DB01920","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9185,"DB03461","BE0000400","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9186,"DB02510","BE0000188","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9187,"DB00087","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9188,"DB00172","BE0001014","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9189,"DB01742","BE0001014","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9190,"DB02899","BE0003926","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9191,"DB03496","BE0000767","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9192,"DB06924","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9193,"DB00513","BE0000211","# Mochalkin I, Cheng B, Klezovitch O, Scanu AM, Tulinsky A: Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance. Biochemistry. 1999 Feb 16;38(7):1990-8. \"Pubmed\":http://www.ncbi.nlm.nih.g"
9194,"DB09028","BE0000849","# Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C: Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/25"
9195,"DB03147","BE0001184","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9196,"DB08550","BE0000865","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9197,"DB04147","BE0001610","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9198,"DB07316","BE0000329","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9199,"DB04006","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9200,"DB00067","BE0000165","# Hiroyama M, Wang S, Aoyagi T, Oikawa R, Sanbe A, Takeo S, Tanoue A: Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Eur J Pharmacol. 2007 Mar 22;559(2-3):89-97. Epub 2006 Dec 29. \"Pubmed\":http://www.ncbi"
9201,"DB01964","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9202,"DB02596","BE0001832","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9203,"DB04233","BE0003981","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9204,"DB08889","BE0002347","# Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ: Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models"
9205,"DB08185","BE0003279","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9206,"DB01565","BE0000947","# Somoza E: Influence of neuroleptics on the binding of met-enkephalin, morphine and dihydromorphine to synaptosome-enriched fractions of rat brain. Neuropharmacology. 1978 Aug;17(8):577-81. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/29252# Johnson N, Ho"
9207,"DB01403","BE0000045","# Dahl SG, Hough E, Hals PA: Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding. Biochem Pharmacol. 1986 Apr 15;35(8):1263-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
9208,"DB01136","BE0001074","# Chen JW, Lin FY, Chen YH, Wu TC, Chen YL, Lin SJ: Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc Bi"
9209,"DB06060","BE0001192",""
9210,"DB05168","BE0003405",""
9211,"DB03352","BE0002377",""
9212,"DB00540","BE0000501","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Nojimoto FD, Mueller A, He"
9213,"DB05488","BE0000799",""
9214,"DB01738","BE0000872","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9215,"DB07236","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9216,"DB07219","BE0000939","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9217,"DB01128","BE0000132","# Wang LG, Liu XM, Kreis W, Budman DR: Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor. Biochem Pharmacol. 1998 May 1;55(9):1427-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10076535# "
9218,"DB05785","BE0000144","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9219,"DB04359","BE0003136",""
9220,"DB00535","BE0001075","# Labro MT, el Benna J, Charlier N, Abdelghaffar H, Hakim J: Cefdinir (CI-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not the phagolysosome. J Immunol. 1994 Mar 1;152(5):2447-"
9221,"DB05744","BE0000704",""
9222,"DB00799","BE0000078","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9223,"DB07933","BE0000792","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9224,"DB01488","BE0000945","# Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK: 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. J Med Chem. 2000 Mar 9;43(5):1011-8. \"Pubmed\":http://www.ncbi.nlm"
9225,"DB04654","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9226,"DB04014","BE0000890","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9227,"DB01621","BE0000756","# Oades RD, Rao ML, Bender S, Sartory G, Muller BW: Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy. Behav Pharmaco"
9228,"DB01059","BE0000742","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9229,"DB02311","BE0000695","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9230,"DB04856","BE0000402","# Persiani S, D'Amato M, Jakate A, Roy P, Wangsa J, Kapil R, Rovati LC: Pharmacokinetic profile of dexloxiglumide. Clin Pharmacokinet. 2006;45(12):1177-88. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17112294"
9231,"DB02471","BE0004338","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9232,"DB00074","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9233,"DB00422","BE0000486","# Yang L, Wang YF, Li J, Faraone SV: Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1154-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15322419# Williard RL, Middaugh LD, Z"
9234,"DB02482","BE0001385","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9235,"DB01670","BE0001266","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9236,"DB00682","BE0000713","# Gebauer M: Synthesis and structure-activity relationships of novel warfarin derivatives. Bioorg Med Chem. 2007 Mar 15;15(6):2414-20. Epub 2007 Jan 17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17275317# Zhu Y, Shennan M, Reynolds KK, Johnson NA, Herrn"
9237,"DB03499","BE0002562",""
9238,"DB03317","BE0002904",""
9239,"DB04452","BE0001363","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9240,"DB01577","BE0000289","# Jeng CH, Wang Y: Methamphetamine modulates GABA-induced electrophysiological depression by alternating noradrenergic actions in cerebellar Purkinje neurons. Psychopharmacology (Berl). 1998 Mar;136(2):132-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/95"
9241,"DB04560","BE0001981","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9242,"DB08899","BE0000132","# FDA label"
9243,"DB03397","BE0002025","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9244,"DB05492","BE0000533",""
9245,"DB04315","BE0004638","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9246,"DB02433","BE0001253","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9247,"DB00408","BE0000145","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
9248,"DB03434","BE0001926","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9249,"DB00092","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9250,"DB07653","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9251,"DB00897","BE0003594","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9252,"DB00241","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
9253,"DB05218","BE0000704",""
9254,"DB00005","BE0000710","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9255,"DB00786","BE0003693","# Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10852638# Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and cli"
9256,"DB00371","BE0000795","# Rho JM, Donevan SD, Rogawski MA: Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther. 1997 Mar;280(3):1383-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9067327# Gonzalez LA, Gatch MB, Taylor CM, Be"
9257,"DB08009","BE0004147","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9258,"DB00040","BE0000527","# Katayama T, Shimamoto S, Oda H, Nakahara K, Kangawa K, Murakami N: Glucagon receptor expression and glucagon stimulation of ghrelin secretion in rat stomach. Biochem Biophys Res Commun. 2007 Jun 15;357(4):865-70. Epub 2007 Apr 9. \"Pubmed\":http://www.ncb"
9259,"DB00780","BE0002198","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Chiche F, Le Guillou M, Chetrite G, Lasnier F, Dugail I, Carpene C, Moldes M, Feve B: Antidepressa"
9260,"DB04522","BE0001200","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9261,"DB00290","BE0000199","# Rose JL, Reeves KC, Likhotvorik RI, Hoyt DG: Base excision repair proteins are required for integrin-mediated suppression of bleomycin-induced DNA breakage in murine lung endothelial cells. J Pharmacol Exp Ther. 2007 Apr;321(1):318-26. Epub 2007 Jan 3. "
9262,"DB03934","BE0001009","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9263,"DB08818","BE0004933","# Spicer AP, Joo A, Bowling RA Jr: A hyaluronan binding link protein gene family whose members are physically linked adjacent to chondroitin sulfate proteoglycan core protein genes: the missing links. J Biol Chem. 2003 Jun 6;278(23):21083-91. Epub 2003 Ma"
9264,"DB00051","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9265,"DB01001","BE0000694","# Brichetto L, Milanese M, Song P, Patrone M, Crimi E, Rehder K, Brusasco V: Beclomethasone rapidly ablates allergen-induced beta 2-adrenoceptor pathway dysfunction in human isolated bronchi. Am J Physiol Lung Cell Mol Physiol. 2003 Jan;284(1):L133-9. Epu"
9266,"DB02205","BE0001536","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9267,"DB01600","BE0000262","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9268,"DB02648","BE0000373","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9269,"DB00118","BE0000407","# Carretero MV, Latasa MU, Garcia-Trevijano ER, Corrales FJ, Wagner C, Mato JM, Avila MA: Inhibition of liver methionine adenosyltransferase gene expression by 3-methylcolanthrene: protective effect of S-adenosylmethionine. Biochem Pharmacol. 2001 May 1;6"
9270,"DB01375","BE0002470","# Zhang DW, Colombini M: Inhibition by aluminum hydroxide of the voltage-dependent closure of the mitochondrial channel, VDAC. Biochim Biophys Acta. 1989 Apr 25;991(1):68-78. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2469483# Zhang DW, Colombini M: Grou"
9271,"DB07373","BE0002499","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9272,"DB00334","BE0000342","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
9273,"DB01686","BE0000005","# van Guldener C, Nanayakkara PW, Stehouwer CD: Review: Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. Clin Chem Lab Med. 2007 Oct 15;. \"Pubmed\":http://www.n"
9274,"DB01728","BE0001200","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9275,"DB04473","BE0002815",""
9276,"DB04678","BE0000214",""
9277,"DB04832","BE0002196","# Egashira T, Takayama F, Yamanaka Y: The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species. Jpn J Pharmacol. 1999 Sep;81(1):115-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10580379"
9278,"DB03697","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9279,"DB08818","BE0004940","# Choi-Miura NH, Tobe T, Sumiya J, Nakano Y, Sano Y, Mazda T, Tomita M: Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growt"
9280,"DB00130","BE0002240","# Mong JA, Blutstein T: Estradiol modulation of astrocytic form and function: implications for hormonal control of synaptic communication. Neuroscience. 2006;138(3):967-75. Epub 2005 Dec 2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16326016# Rose C, Fel"
9281,"DB03306","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9282,"DB08264","BE0004259","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9283,"DB00777","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9284,"DB04147","BE0004173","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9285,"DB00950","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Amon U, Amon S, Gibbs BF: In vitro studies with fexofenadine, a new nonsedating histamine H1 recep"
9286,"DB03616","BE0002101","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9287,"DB05787","BE0001155",""
9288,"DB05227","BE0000451",""
9289,"DB01432","BE0004809","# Nichifor M, Cristea D, Mocanu G, Carpov A: Aminated polysaccharides as bile acid sorbents: in vitro study. J Biomater Sci Polym Ed. 1998;9(6):519-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9659597# Benson GM, Alston DR, Hickey DM, Jaxa-Chamiec AA, "
9290,"DB05254","BE0000895",""
9291,"DB03180","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9292,"DB00594","BE0000752","# Lee MG, Ahn W, Choi JY, Luo X, Seo JT, Schultheis PJ, Shull GE, Kim KH, Muallem S: Na(+)-dependent transporters mediate HCO(3)(-) salvage across the luminal membrane of the main pancreatic duct. J Clin Invest. 2000 Jun;105(11):1651-8. \"Pubmed\":http://ww"
9293,"DB03958","BE0004792","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9294,"DB08623","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9295,"DB00571","BE0000694","# Isaza C, Henao J, Ramirez E, Cuesta F, Cacabelos R: Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population. Methods Find Exp Clin Pharmacol. 2005 May;27(4):237-44."
9296,"DB00127","BE0000404","# Nilsson J, Grahn B, Heby O: Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Biochem J. 2000 Mar 15;346 Pt 3:699-704. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed"
9297,"DB03660","BE0001936","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9298,"DB07662","BE0000767","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9299,"DB01224","BE0000291","# Ichikawa J, Li Z, Dai J, Meltzer HY: Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism. Brain Res. 2002 Nov 2"
9300,"DB07008","BE0000005","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9301,"DB00808","BE0000672","# Ohya S, Asakura K, Muraki K, Watanabe M, Imaizumi Y: Molecular and functional characterization of ERG, KCNQ, and KCNE subtypes in rat stomach smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G277-87. \"Pubmed\":http://www.ncbi.nlm.n"
9302,"DB04803","BE0000735",""
9303,"DB00289","BE0000749","# Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9537821"
9304,"DB02172","BE0001220","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9305,"DB03635","BE0003136",""
9306,"DB04454","BE0000953","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9307,"DB01259","BE0000767","# Xia W, Mullin RJ, Keith BR, Liu LH, Ma H, Rusnak DW, Owens G, Alligood KJ, Spector NL: Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene. 2002 Sep 12;21"
9308,"DB00092","BE0000719","# Chamian F, Lin SL, Lee E, Kikuchi T, Gilleaudeau P, Sullivan-Whalen M, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG, Lowes MA: Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and rela"
9309,"DB00321","BE0000632","# Onali P, Dedoni S, Olianas MC: Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes. J Pharmacol Exp Ther. 2010 Jan;332(1):255-65. Epub 2009 Oct 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19828880"
9310,"DB01750","BE0003767","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9311,"DB00522","BE0002128","# Chowdhury RS, Forsmark CE: Review article: Pancreatic function testing. Aliment Pharmacol Ther. 2003 Mar 15;17(6):733-50. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12641496# Bujanover Y, Harel A, Geter R, Blau H, Yahav J, Spirer Z: The development of "
9312,"DB00819","BE0000267","# Puscas I, Coltau M, Pasca R: Nonsteroidal anti-inflammatory drugs activate carbonic anhydrase by a direct mechanism of action. J Pharmacol Exp Ther. 1996 Jun;277(3):1464-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8667211# Meierkord H, Grunig F, Guts"
9313,"DB08337","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9314,"DB08662","BE0003804","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9315,"DB04233","BE0001200","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9316,"DB07855","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9317,"DB00429","BE0000064","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Hay A, Wood S, Olson D, Slater D: Labour is associated with d"
9318,"DB02452","BE0001883","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9319,"DB00085","BE0004834","# Svendsen A: Lipase protein engineering. Biochim Biophys Acta. 2000 Dec 29;1543(2):223-238. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11150608"
9320,"DB02595","BE0001578","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9321,"DB07824","BE0002718","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9322,"DB07238","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9323,"DB03013","BE0001605","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9324,"DB00421","BE0004887","# Corvol P, Michaud A, Menard J, Freifeld M, Mahoudeau J: Antiandrogenic effect of spirolactones: mechanism of action. Endocrinology. 1975 Jul;97(1):52-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/166833"
9325,"DB04880","BE0000436","# Boldt J, Suttner S: Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone. Expert Opin Pharmacother. 2007 Sep;8(13):2135-47. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17714066# Sandroni C, Cava"
9326,"DB00184","BE0000849","# Espeseth T, Endestad T, Rootwelt H, Reinvang I: Nicotine receptor gene CHRNA4 modulates early event-related potentials in auditory and visual oddball target detection tasks. Neuroscience. 2007 Jul 29;147(4):974-85. Epub 2007 Jun 27. \"Pubmed\":http://www."
9327,"DB04824","BE0003538","# Uesawa Y, Staines AG, Lockley D, Mohri K, Burchell B: Identification of the human liver UDP-glucuronosyltransferase involved in the metabolism of p-ethoxyphenylurea (dulcin). Arch Toxicol. 2007 Mar;81(3):163-8. Epub 2006 Aug 5. \"Pubmed\":http://www.ncbi."
9328,"DB00072","BE0002093","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9329,"DB00842","BE0002346","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9330,"DB00656","BE0000533","# Fiorella D, Rabin RA, Winter JC: The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology (Berl). 1995 May;119(2):222-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7659770# Conn PJ, Sanders-Bu"
9331,"DB00811","BE0000681","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9332,"DB00114","BE0000791","# Yamagata S, Akamatsu T, Iwama T: Immobilization of Saccharomyces cerevisiae cystathionine gamma-lyase and application of the product to cystathionine synthesis. Appl Environ Microbiol. 2004 Jun;70(6):3766-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1"
9333,"DB04348","BE0001967","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9334,"DB06589","BE0002133","# Deeks ED: Pazopanib: in advanced soft tissue sarcoma. Drugs. 2012 Nov 12;72(16):2129-40. doi: 10.2165/11209950-000000000-00000. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23072642"
9335,"DB08064","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9336,"DB00366","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9337,"DB00514","BE0004904","# Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B: Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 2004 Mar;18(3):589-91. Epub 2004 Jan 20. \"Pubmed\":http://www.ncb"
9338,"DB03010","BE0001340","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9339,"DB05131","BE0000364",""
9340,"DB01583","BE0000315","# Bernal J: Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):249-59. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17315033# Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A: Thyroid hormone recepto"
9341,"DB00586","BE0000017","# Calkin AC, Sudhir K, Honisett S, Williams MR, Dawood T, Komesaroff PA: Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2. J Clin Endocrinol Metab. 2002 Nov;87(11):5072-5. \"Pubm"
9342,"DB03461","BE0000617","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9343,"DB03448","BE0001924","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9344,"DB00609","BE0000332","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC: eth"
9345,"DB01914","BE0001335","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9346,"DB00232","BE0000322","# Meyerson LR, Nesta D: [3H]acetazolamide binding to carbonic anhydrase in normal and transformed cells. Biochem Pharmacol. 1991 Mar 15-Apr 1;41(6-7):995-1000. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1901209# Schaeffer P, Vigne P, Frelin C, Lazdunski "
9347,"DB02811","BE0002180",""
9348,"DB00005","BE0002098","# Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr: The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid art"
9349,"DB00249","BE0000458","# Wild K, Bohner T, Folkers G, Schulz GE: The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci. 1997 Oct;6(10):2097-106. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9336833"
9350,"DB04199","BE0004113","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9351,"DB02234","BE0001483","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9352,"DB00437","BE0002204","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Suzuki I, Yamauchi T, Onuma M, Nozaki S: Allopurinol, an inhibitor of uric acid synthesis--can it "
9353,"DB02379","BE0002736",""
9354,"DB00157","BE0000542","# Markova EV, Zotova NV, Savchenko AA, Titova NM, Slepov EV, Cherdantsev DV, Konovalenko AN: [Lymphocyte metabolism in patients with acute pancreatitis with different genotypes of GSTM1 and GSTT1 genes] Biomed Khim. 2006 May-Jun;52(3):317-26. \"Pubmed\":htt"
9355,"DB01676","BE0002499","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9356,"DB00036","BE0000967","# Mine S, Yamazaki T, Miyata T, Hara S, Kato H: Structural mechanism for heparin-binding of the third Kunitz domain of human tissue factor pathway inhibitor. Biochemistry. 2002 Jan 8;41(1):78-85. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11772005# Narit"
9357,"DB05268","BE0000036",""
9358,"DB05342","BE0000574",""
9359,"DB00430","BE0000588","# Pfaller MA, Niles AC, Murray PR: In vitro antibacterial activity of cefpiramide. Antimicrob Agents Chemother. 1984 Mar;25(3):368-72. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6426381# Fass RJ, Helsel VL: In vitro activity of cefpiramide (SM-1652) agai"
9360,"DB03632","BE0001058","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9361,"DB00606","BE0000322","# Liljequist S, Cebers G, Kalda A: Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons. Biochem Pharmacol. 1"
9362,"DB03909","BE0000042","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9363,"DB00098","BE0003488","# Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003 Feb;3(2):189-96. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12586600"
9364,"DB04099","BE0001601","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9365,"DB04522","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9366,"DB07194","BE0001316","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9367,"DB02772","BE0002834",""
9368,"DB01752","BE0004586","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9369,"DB03003","BE0000814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9370,"DB04946","BE0000342","# FDA label"
9371,"DB08284","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9372,"DB00117","BE0000086","# Viergutz S, Retey J: Kinetic analysis of the reactions catalyzed by histidine and phenylalanine ammonia lyases. Chem Biodivers. 2004 Feb;1(2):296-302. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17191848# Lambrecht NW, Yakubov I, Sachs G: Fasting induce"
9373,"DB04580","BE0003329",""
9374,"DB01942","BE0002659",""
9375,"DB00909","BE0003636","# Janszky J: [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases] Ideggyogy Sz. 2009 Nov 30;62(11-12):383-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20025128# Kothare SV, Kaleyias J: Zonisamide: review of pharm"
9376,"DB08302","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9377,"DB00216","BE0000476","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9378,"DB03013","BE0003751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9379,"DB07778","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9380,"DB01354","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
9381,"DB07752","BE0004069","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9382,"DB08557","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9383,"DB08463","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9384,"DB01200","BE0000020","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
9385,"DB00142","BE0000823","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9386,"DB02236","BE0000882","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9387,"DB00408","BE0000575","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
9388,"DB04233","BE0003975","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9389,"DB00775","BE0001155","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Pro"
9390,"DB02905","BE0001229","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9391,"DB02759","BE0003751","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9392,"DB00171","BE0000269","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9393,"DB00424","BE0000405","# Lysikova M, Havlas Z, Tucek S: Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists. Neurochem Res."
9394,"DB00653","BE0000691","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9395,"DB00142","BE0000534","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9396,"DB07384","BE0003841","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9397,"DB00081","BE0002095","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9398,"DB00689","BE0004656","# Lepage S, Lakaye B, Galleni M, Thamm I, Crine M, Groslambert S, Frere JM: Saturation of penicillin-binding protein 1 by beta-lactam antibiotics in growing cells of Bacillus licheniformis. Mol Microbiol. 1995 Apr;16(2):365-72. \"Pubmed\":http://www.ncbi.nl"
9399,"DB00056","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9400,"DB07954","BE0001223","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9401,"DB06695","BE0000048","# Squizzato A, Dentali F, Steidl L, Ageno W: New direct thrombin inhibitors. Intern Emerg Med. 2009 Dec;4(6):479-84. Epub 2009 Sep 15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19756950# Liesenfeld KH, Schafer HG, Troconiz IF, Tillmann C, Eriksson BI, S"
9402,"DB04918","BE0002393","# Davies TA, Page MG, Shang W, Andrew T, Kania M, Bush K: Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrob Agents Chemot"
9403,"DB03389","BE0001329","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9404,"DB00074","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9405,"DB07564","BE0001405","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9406,"DB00801","BE0003592","# Iorio LC, Barnett A, Billard W: Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sci. 1984 Jul 2;35(1):105-13. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6738302# Wamsley JK, Golden JS, Yamamura HI, Ba"
9407,"DB00533","BE0000262","# Ehrich EW, Schnitzer TJ, McIlwain H, Levy R, Wolfe F, Weisman M, Zeng Q, Morrison B, Bolognese J, Seidenberg B, Gertz BJ: Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecox"
9408,"DB03747","BE0001153","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9409,"DB00851","BE0003559","# Akkemik E, Budak H, Ciftci M: Effects of some drugs on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro study. J Enzyme Inhib Med Chem. 2010 Mar 17. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20235752# Berman HM, Westbrook J, Feng Z, Gil"
9410,"DB01629","BE0001224","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9411,"DB03127","BE0001764","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9412,"DB00873","BE0000794","# Druzgala P, Hochhaus G, Bodor N: Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate. J Steroid Biochem Mol Biol. 1991 Feb;38(2):149-54. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2004"
9413,"DB07952","BE0004066","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9414,"DB04871","BE0000533","# Halford JC: Obesity drugs in clinical development. Curr Opin Investig Drugs. 2006 Apr;7(4):312-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16625817# Jandacek RJ: APD-356 (Arena). Curr Opin Investig Drugs. 2005 Oct;6(10):1051-6. \"Pubmed\":http://www.nc"
9415,"DB01142","BE0000560","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Ehlert FJ, Delen FM, Yun S"
9416,"DB01605","BE0000576","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9417,"DB03311","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9418,"DB02410","BE0002674",""
9419,"DB08336","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9420,"DB00287","BE0000610","# Ota T, Aihara M, Narumiya S, Araie M: The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4159-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16249494# Thieme H, Schimmat C,"
9421,"DB07954","BE0000706","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9422,"DB08734","BE0000324","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9423,"DB07065","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9424,"DB01397","BE0000017","# Moon C, Ahn M, Jee Y, Heo S, Kim S, Kim H, Sim KB, Koh CS, Shin YG, Shin T: Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclo"
9425,"DB01844","BE0000270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9426,"DB01567","BE0002346","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
9427,"DB07358","BE0001056","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9428,"DB01977","BE0000895","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9429,"DB02209","BE0001540","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9430,"DB00182","BE0000118","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S,"
9431,"DB03820","BE0001349","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9432,"DB04299","BE0001389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9433,"DB02754","BE0001898","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9434,"DB02452","BE0001811","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9435,"DB00107","BE0000751","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Land H, Grez M, Ruppert S, Schmale H, Rehbein M, Richter D, S"
9436,"DB01559","BE0000381","# Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 2008 Oct;9(8):827-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18855614"
9437,"DB05007","BE0002453",""
9438,"DB01051","BE0004950","# Tabary X, Moreau N, Dureuil C, Le Goffic F: Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I. Antimicrob Agents Chemother. 1987 Dec;31(12):1925-8. \"Pubmed\":http://www.ncbi"
9439,"DB01014","BE0000017","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9440,"DB03125","BE0001614","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9441,"DB08602","BE0000706","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9442,"DB08131","BE0001438","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9443,"DB02379","BE0003241",""
9444,"DB08638","BE0002884","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9445,"DB08442","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9446,"DB02351","BE0000048","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9447,"DB00145","BE0000331","# Vatsyayan R, Roy U: Molecular cloning and biochemical characterization of Leishmania donovani serine hydroxymethyltransferase. Protein Expr Purif. 2007 Apr;52(2):433-40. Epub 2006 Oct 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17142057# Rajinikanth"
9448,"DB05166","BE0003378",""
9449,"DB02669","BE0003783","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9450,"DB00293","BE0000324","# Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM: Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Exp Cell Res. 1999 Feb 25;247(1):"
9451,"DB00589","BE0000572","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
9452,"DB00167","BE0002328","# Wang P, Tang Y, Tirrell DA: Incorporation of trifluoroisoleucine into proteins in vivo. J Am Chem Soc. 2003 Jun 11;125(23):6900-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12783542# Fukunaga R, Fukai S, Ishitani R, Nureki O, Yokoyama S: Crystal struc"
9453,"DB00142","BE0000396","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9454,"DB03847","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9455,"DB03633","BE0001432","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9456,"DB03147","BE0002965",""
9457,"DB08846","BE0002437","# Innocenti A, Beyza Ozturk Sarikaya S, Gulcin I, Supuran CT: Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-64. doi: 10.1016/j"
9458,"DB00169","BE0000779","# Reinhart GA: Vitamin D analogs: novel therapeutic agents for cardiovascular disease? Curr Opin Investig Drugs. 2004 Sep;5(9):947-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15503649# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic "
9459,"DB08348","BE0004049","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9460,"DB01454","BE0000486","# Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15955613# Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanso"
9461,"DB08444","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9462,"DB00849","BE0000795","# Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14579514# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brai"
9463,"DB00114","BE0002174","# Nishijima S, Sugaya K, Morozumi M, Hatano T, Ogawa Y: Hepatic alanine-glyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats. J Urol. 2003 Feb;169(2):683-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12544342# Gable K,"
9464,"DB00424","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9465,"DB00517","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9466,"DB03226","BE0001853","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9467,"DB01561","BE0000194","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9468,"DB07199","BE0002403","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9469,"DB03136","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9470,"DB01186","BE0000659","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132# Lam YW: Clinical pharmacology of dopamine agonists. Phar"
9471,"DB02494","BE0003831","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9472,"DB06288","BE0000581","# Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G: A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol. 2002 Jan;17(1):1-13. \"Pubmed\":http://www.ncbi.nlm.nih"
9473,"DB04083","BE0002839",""
9474,"DB03247","BE0003025",""
9475,"DB01076","BE0000854","# Taldone T, Zito SW, Talele TT: Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. Bioorg Med Chem Lett. 2008 Jan 15;18(2):479-84. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18068977"
9476,"DB00157","BE0000328","# Luo C, Wang X, Long J, Liu J: An NADH-tetrazolium-coupled sensitive assay for malate dehydrogenase in mitochondria and crude tissue homogenates. J Biochem Biophys Methods. 2006 Aug 31;68(2):101-11. Epub 2006 Apr 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
9477,"DB04057","BE0001240","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9478,"DB01331","BE0002063","# Matsuhashi M, Tamaki S: Enzymatic studies on the mechanism of action of cefoxitin. Correlation between the affinities of cefoxitin to penicillin-binding proteins and its rates of inhibition of the respective penicillin-sensitive reactions in E. coli. J "
9479,"DB00075","BE0002097","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9480,"DB00406","BE0004796","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9481,"DB00590","BE0000575","# Lepor H: Alpha blockers for the treatment of benign prostatic hyperplasia. Rev Urol. 2007 Fall;9(4):181-90. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18231614# Greco KA, McVary KT: The role of combination medical therapy in benign prostatic hyperplasi"
9482,"DB05241","BE0002406",""
9483,"DB00528","BE0000679","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9484,"DB04303","BE0002828",""
9485,"DB01086","BE0000177","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9486,"DB04908","BE0000389","# Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S: Pharmacology of flibanserin. CNS Drug Rev. 2002 Summer;8(2):117-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12177684# Invernizzi RW, Sacchetti G, Parini S, Acconcia S, Samanin R: Fliba"
9487,"DB00436","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9488,"DB00115","BE0000734","# Stover PJ: Vitamin B12 and older adults. Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):24-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19904199# Allen LH: Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008 Jun;29(2 Suppl):S20-34; discu"
9489,"DB04147","BE0004182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9490,"DB00929","BE0000368","# Nakae K, Hayashi F, Hayashi M, Yamamoto N, Iino T, Yoshikawa S, Gupta J: Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. Neurosci Lett. 2005 Nov 18;388(3):132-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16039053# Li J, L"
9491,"DB04374","BE0003766","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9492,"DB07692","BE0000088","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9493,"DB07943","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9494,"DB03846","BE0001218","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9495,"DB05153","BE0000453",""
9496,"DB05295","BE0000779",""
9497,"DB07121","BE0003754","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9498,"DB04847","BE0002211",""
9499,"DB05276","BE0002427",""
9500,"DB02091","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9501,"DB01949","BE0000058","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9502,"DB02414","BE0001584","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9503,"DB08888","BE0000910","# FDA label"
9504,"DB01352","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
9505,"DB01178","BE0000736","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9506,"DB00842","BE0003592","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9507,"DB03865","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9508,"DB04074","BE0001822","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9509,"DB04005","BE0001480","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9510,"DB06149","BE0004826","# Lundstrom TS, Sobel JD: Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. Infect Dis Clin North Am. 2000 Jun;14(2):463-74. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10829266# Reynold"
9511,"DB03808","BE0003959","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9512,"DB00523","BE0000206","# Mizuiri H, Yoshida K, Toge T, Oue N, Aung PP, Noguchi T, Yasui W: DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci. 2005 Sep;9"
9513,"DB00797","BE0000572","# Trendelenburg AU, Sutej I, Starke K: Presynaptic alpha 2A/D-autoreceptors in the brain cortex of Cercopithecus aethiops. Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):341-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9089664"
9514,"DB03461","BE0000595","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9515,"DB02527","BE0004497","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9516,"DB03256","BE0001692","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9517,"DB01694","BE0001242","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9518,"DB04934","BE0000257","# Fujii K, Saito H, Tomioka H, Mae T, Hosoe K: Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648. Antimicrob Agents Chemother. 1995 Jul;39(7):1489-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7492091"
9519,"DB00044","BE0000134","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9520,"DB01778","BE0001289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9521,"DB03801","BE0001072","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9522,"DB08192","BE0000838","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9523,"DB00145","BE0000372","# Soriano A, Castillo R, Christov C, Andres J, Moliner V, Tunon I: Catalysis in glycine N-methyltransferase: testing the electrostatic stabilization and compression hypothesis. Biochemistry. 2006 Dec 19;45(50):14917-25. \"Pubmed\":http://www.ncbi.nlm.nih.go"
9524,"DB00485","BE0004643","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
9525,"DB00231","BE0000795","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
9526,"DB03661","BE0000558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9527,"DB01496","BE0000478","# Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10209232"
9528,"DB04574","BE0000123","# Brama M, Gnessi L, Basciani S, Cerulli N, Politi L, Spera G, Mariani S, Cherubini S, d'Abusco AS, Scandurra R, Migliaccio S: Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol Cell Endocrinol. 2007 Jan 29;26"
9529,"DB08677","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9530,"DB07735","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9531,"DB08157","BE0000267","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9532,"DB08231","BE0004238","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9533,"DB04132","BE0004541","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9534,"DB00906","BE0000249","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K: The selective"
9535,"DB02383","BE0004353","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9536,"DB08428","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9537,"DB00036","BE0001178","# HERMANSKY F, VITEK J: The role of proconvertin and Stuart factor in the inactivation of tissue thromboplastin by serum. Experientia. 1960 Oct 15;16:455-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/13713641# Rogers KS, Barton CL, Benson PA, Green RA: E"
9538,"DB02790","BE0001901","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9539,"DB00884","BE0000776","# Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G: Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10620343# Chen X, "
9540,"DB03654","BE0001233","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9541,"DB00991","BE0000017","# Kawai S: Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration. Inflamm Res. 1998 Oct;47 Suppl 2:S102-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9831331#"
9542,"DB07392","BE0003849","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9543,"DB01123","BE0004319","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9544,"DB00505","BE0000560","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9545,"DB00273","BE0000346","# Rogawski MA, Gryder D, Castaneda D, Yonekawa W, Banks MK, Lia H: GluR5 kainate receptors, seizures, and the amygdala. Ann N Y Acad Sci. 2003 Apr;985:150-62. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12724156# Gryder DS, Rogawski MA: Selective antagoni"
9546,"DB00112","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9547,"DB05345","BE0000442",""
9548,"DB07504","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9549,"DB03206","BE0001220","# Collyer CA, Blow DM: Observations of reaction intermediates and the mechanism of aldose-ketose interconversion by D-xylose isomerase. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1362-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2304904"
9550,"DB03419","BE0004582","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9551,"DB02415","BE0003941","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9552,"DB07398","BE0003853","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9553,"DB01618","BE0000756","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Seeman P, Tallerico T: Antipsychotic drugs which elicit littl"
9554,"DB02599","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9555,"DB00420","BE0000575","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9556,"DB02713","BE0001590","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9557,"DB06080","BE0000029",""
9558,"DB01677","BE0000148","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9559,"DB00248","BE0000172","# Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A: Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned "
9560,"DB07595","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9561,"DB02205","BE0000720","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9562,"DB04946","BE0000945","# Bobo WV: Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Expert Rev Clin Pharmacol. 2013 Jan;6(1):61-91. doi: 10.1586/ecp.12.70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/"
9563,"DB03468","BE0000865","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9564,"DB02764","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9565,"DB01159","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931 (Accessed December 2013)"
9566,"DB00696","BE0000289","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9567,"DB00201","BE0004922","# Ribeiro JA, Sebastiao AM: Caffeine and adenosine. J Alzheimers Dis. 2010;20 Suppl 1:S3-15. doi: 10.3233/JAD-2010-1379. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20164566# Essayan DM: Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol. 2001 N"
9568,"DB03264","BE0003045",""
9569,"DB01328","BE0003579","# Rake JB, Newman DJ, Actor P: Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12. J Antibiot (Tokyo). 1984 May;37(5):572-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6376452"
9570,"DB03739","BE0001857","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9571,"DB08491","BE0000920","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9572,"DB03909","BE0001580","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9573,"DB04722","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9574,"DB01638","BE0001220","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9575,"DB01717","BE0004536","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9576,"DB04652","BE0000668","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9577,"DB04141","BE0002257","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9578,"DB02316","BE0000558","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9579,"DB07738","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9580,"DB01567","BE0000381","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
9581,"DB04119","BE0004076","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9582,"DB03381","BE0001200","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9583,"DB00858","BE0000132","# Zakar T, Kaufmann G, Toth M: Assignment of anabolic-androgenic and antiandrogenic properties to some chlorine-substituted steroids on the basis of their binding characteristics to the androgen receptor of the rat seminal vesicle. Exp Clin Endocrinol. 19"
9584,"DB03780","BE0001405","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9585,"DB02386","BE0001395","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9586,"DB00721","BE0000738","# Wang H, Zhang Y, Li ST: The effect of local anesthetics on the inhibition of adult muscle-type nicotinic acetylcholine receptors by nondepolarizing muscle relaxants. Eur J Pharmacol. 2010 Mar 25;630(1-3):29-33. Epub 2010 Jan 4. \"Pubmed\":http://www.ncbi."
9587,"DB01207","BE0001893","# Park SJ, Lee JJ, Vanhoutte PM: Endothelin-1 releases endothelium-derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium. Zhongguo Yao Li Xue Bao. 1999 Oct;20(10):872-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pub"
9588,"DB01620","BE0000442","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Leurs R, Bast A, Timmerman H: High affinity, saturable [3H]me"
9589,"DB07625","BE0000895","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9590,"DB04355","BE0004501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9591,"DB08811","BE0000631","# Rundfeldt C, Socala K, Wlaz P: The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis. J Neural Transm. 2010 Nov;117(11):1319-25. Epub 2010 Oct 22. \"Pub"
9592,"DB00114","BE0000441","# Hanada K: Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta. 2003 Jun 10;1632(1-3):16-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12782147# Gable K, Han G, Monaghan E, Bacikova D, Natarajan M, Williams R, Dun"
9593,"DB07265","BE0003335","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9594,"DB01693","BE0001261","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9595,"DB07110","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9596,"DB04549","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9597,"DB00330","BE0000591","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9598,"DB00238","BE0004853","# Ambrose Z, Herman BD, Sheen CW, Zelina S, Moore KL, Tachedjian G, Nissley DV, Sluis-Cremer N: The human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogs."
9599,"DB00426","BE0000633","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9600,"DB00157","BE0000595","# Deng D, Li X, Fang X, Sun G: Characterization of two components of the 2-naphthoate monooxygenase system from Burkholderia sp. strain JT1500. FEMS Microbiol Lett. 2007 Aug;273(1):22-7. Epub 2007 Jun 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1755939"
9601,"DB00607","BE0004644","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
9602,"DB04596","BE0003288",""
9603,"DB00679","BE0000756","# Seeman P: Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage. Acta Psychiatr Scand Suppl. 1990;358:14-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1978482# Assie MB, Sleight AJ, Koek W: Biphasic displacement "
9604,"DB06096","BE0000797",""
9605,"DB04114","BE0000426","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9606,"DB00334","BE0000501","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919# Bymaster FP, Nelson DL, DeLapp NW"
9607,"DB00805","BE0000533","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9608,"DB00039","BE0002133","# Cancilla B, Davies A, Cauchi JA, Risbridger GP, Bertram JF: Fibroblast growth factor receptors and their ligands in the adult rat kidney. Kidney Int. 2001 Jul;60(1):147-55. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11422746# Yamanaka T, Sakamoto A, Ta"
9609,"DB02289","BE0001490","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9610,"DB03450","BE0001755","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9611,"DB07878","BE0001646","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9612,"DB00157","BE0000500","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9613,"DB03919","BE0001772","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9614,"DB00927","BE0000112","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Fukuda M, Tanaka S, Suzuki S, Kusama K, Kaneko T, Sakashita H: Cimetidine induces apoptosis of hum"
9615,"DB00688","BE0000761","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9616,"DB00131","BE0001287","# Terrin A, Di Benedetto G, Pertegato V, Cheung YF, Baillie G, Lynch MJ, Elvassore N, Prinz A, Herberg FW, Houslay MD, Zaccolo M: PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized pho"
9617,"DB03336","BE0002089","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9618,"DB04436","BE0004453","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9619,"DB01344","BE0004816","# Watson M, Abbott KC, Yuan CM: Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol. 2010 Oct;5(10):1723-6. Epub 2010 Aug 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20798253# Sterns RH, Rojas M, Bern"
9620,"DB03435","BE0000637","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9621,"DB05133","BE0001051",""
9622,"DB00131","BE0001277","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9623,"DB03351","BE0000330","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9624,"DB03256","BE0002961",""
9625,"DB07859","BE0001172","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9626,"DB02740","BE0003777","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9627,"DB02638","BE0000773","# Young WS, Li J, Wersinger SR, Palkovits M: The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience. 2006 Dec 28;143(4):1031-9. Epub 2006 Oct 4. \"Pubmed\":http://www.nc"
9628,"DB08425","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9629,"DB02888","BE0000695","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9630,"DB06589","BE0000689","# Deeks ED: Pazopanib: in advanced soft tissue sarcoma. Drugs. 2012 Nov 12;72(16):2129-40. doi: 10.2165/11209950-000000000-00000. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/23072642"
9631,"DB00656","BE0000451","# Pazzagli M, Giovannini MG, Pepeu G: Trazodone increases extracellular serotonin levels in the frontal cortex of rats. Eur J Pharmacol. 1999 Nov 3;383(3):249-57. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10594316# Marcoli M, Rosu C, Bonfanti A, Raiteri"
9632,"DB01151","BE0000560","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Overington JP, Al-Lazikani"
9633,"DB05736","BE0003417",""
9634,"DB00777","BE0000501","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9635,"DB01942","BE0001988","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9636,"DB07672","BE0002815","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9637,"DB02932","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9638,"DB00819","BE0003625","# Avvaru BS, Wagner JM, Maresca A, Scozzafava A, Robbins AH, Supuran CT, McKenna R: Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding poc"
9639,"DB04652","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9640,"DB03147","BE0001784","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9641,"DB00114","BE0002153","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9642,"DB00404","BE0004797","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. doi: 10.1111/j.1600-0404.2008.01004.x. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456#"
9643,"DB03731","BE0000286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9644,"DB00157","BE0000227","# Bieganowski P, Seidle HF, Wojcik M, Brenner C: Synthetic lethal and biochemical analyses of NAD and NADH kinases in Saccharomyces cerevisiae establish separation of cellular functions. J Biol Chem. 2006 Aug 11;281(32):22439-45. Epub 2006 Jun 7. \"Pubmed\""
9645,"DB08639","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9646,"DB07708","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9647,"DB00441","BE0004796","# Hastak K, Alli E, Ford JM: Synergistic chemosensitivity of triple-negative breast cancer cell lines to PARP inhibition, gemcitabine and cisplatin. Cancer Res. 2010 Aug 26. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20798217# Ledermann JA, Gabra H, Jays"
9648,"DB00749","BE0000262","# Chen WS, Liu JH, Wei SJ, Liu JM, Hong CY, Yang WK: Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor. Cancer Sci. 2003 Mar;94(3):253-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12"
9649,"DB06861","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9650,"DB00420","BE0000389","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9651,"DB00415","BE0003624","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
9652,"DB00463","BE0000829","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Krasowski MD, Harrison NL: General anae"
9653,"DB06871","BE0000123","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9654,"DB01727","BE0001239","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9655,"DB03576","BE0002839",""
9656,"DB01917","BE0000101","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9657,"DB00128","BE0001054","# Tao Z, Grewer C: Cooperation of the conserved aspartate 439 and bound amino acid substrate is important for high-affinity Na+ binding to the glutamate transporter EAAC1. J Gen Physiol. 2007 Apr;129(4):331-44. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/"
9658,"DB04233","BE0003936","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9659,"DB07807","BE0000916","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9660,"DB07574","BE0001388","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9661,"DB00120","BE0000692","# Luong TN, Kirsch JF: A continuous coupled spectrophotometric assay for tyrosine aminotransferase activity with aromatic and other nonpolar amino acids. Anal Biochem. 1997 Nov 1;253(1):46-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9356140# Rege AA: P"
9662,"DB04310","BE0003877","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9663,"DB05318","BE0002445",""
9664,"DB00143","BE0000648","# Messarah M, Boulakoud MS, Boumendjel A, Abdennour C, El Feki A: The impact of thyroid activity variations on some oxidizing-stress parameters in rats. C R Biol. 2007 Feb;330(2):107-12. Epub 2006 Dec 12. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/173035"
9665,"DB08535","BE0001072","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9666,"DB02735","BE0001197","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9667,"DB05764","BE0000246",""
9668,"DB07669","BE0004048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9669,"DB00156","BE0000234","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9670,"DB03759","BE0000829","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9671,"DB00270","BE0002396","# Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol. 1992 Oct;100(4):703-28. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1281221# Perez-Reyes E, Van "
9672,"DB00499","BE0000132","# Chang HC, Miyamoto H, Marwah P, Lardy H, Yeh S, Huang KE, Chang C: Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11173-"
9673,"DB01236","BE0000795","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9674,"DB00536","BE0001754","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9675,"DB04863","BE0001155","# Akkerhuis KM, van Den Brand MJ, van Der Zwaan C, Peels HO, Suryapranata H, van Der Wieken LR, Stibbe J, Hoffmann J, Baardman T, Deckers JW, Simoons ML: Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagoni"
9676,"DB00039","BE0001203","# Imagawa W, Cunha GR, Young P, Nandi S: Keratinocyte growth factor and acidic fibroblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem Biophys Res Commun. 1994 Nov 15;204(3):1165-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
9677,"DB01992","BE0002678",""
9678,"DB00139","BE0002255","# Ostergaard E, Christensen E, Kristensen E, Mogensen B, Duno M, Shoubridge EA, Wibrand F: Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet. 2007 Aug;81("
9679,"DB02264","BE0001121","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9680,"DB00051","BE0002098","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9681,"DB00080","BE0004833","# Jerala R: Synthetic lipopeptides: a novel class of anti-infectives. Expert Opin Investig Drugs. 2007 Aug;16(8):1159-69. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17685866# Lee SY, Fan HW, Kuti JL, Nicolau DP: Update on daptomycin: the first approved l"
9682,"DB08271","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9683,"DB08748","BE0004390","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9684,"DB08762","BE0003753","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9685,"DB07923","BE0003818","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9686,"DB07327","BE0002050","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9687,"DB00343","BE0000679","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9688,"DB04464","BE0003994","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9689,"DB00486","BE0000095","# Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G: Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol. 2002 Jan;135(1):181-7. \"Pubmed\":ht"
9690,"DB07530","BE0000779","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9691,"DB00788","BE0000262","# Albertini R, Aimbire F, Villaverde AB, Silva JA Jr, Costa MS: COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm Res. 2007 Jun;56(6):228-9. \"Pubmed\":ht"
9692,"DB00781","BE0004833","# Yuan Z, Tam VH: Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms. Expert Opin Investig Drugs. 2008 May;17(5):661-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18447592# Zavascki AP, Goldani LZ, Li J, Nation RL: Polymyxin B fo"
9693,"DB00865","BE0000118","# Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A: Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci. 1995 May;15(5 Pt 2):4102-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/775"
9694,"DB01142","BE0000451","# Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7855217# Maj J, Gancarczyk L, Gorsz"
9695,"DB00714","BE0000659","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
9696,"DB04128","BE0001449","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9697,"DB05037","BE0001082",""
9698,"DB02934","BE0002011","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9699,"DB07830","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9700,"DB05266","BE0001133","# Yagi K, Tada Y, Kitazato KT, Tamura T, Satomi J, Nagahiro S: Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats. Neurosurgery. 2010 Mar;66(3):551-9; discussion 559. \"Pubmed\":http://www.nc"
9701,"DB01407","BE0001012","# Baker JG: The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. Br J Pharmacol. 2010 Jul;160(5):1048-61. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20590599"
9702,"DB04165","BE0001865","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9703,"DB08626","BE0000266","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9704,"DB08646","BE0004356","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9705,"DB00114","BE0000331","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9706,"DB02990","BE0000332","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9707,"DB04464","BE0003926","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9708,"DB01154","BE0000708","# Kawano T, Oshita S, Takahashi A, Tsutsumi Y, Tomiyama Y, Kitahata H, Kuroda Y, Nakaya Y: Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology. 2004 Fe"
9709,"DB04841","BE0000012","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9710,"DB00107","BE0000844","# Spyranti Z, Fragiadaki M, Magafa V, Borovickova L, Spyroulias GA, Cordopatis P, Slaninova J: In position 7 L- and D-Tic-substituted oxytocin and deamino oxytocin: NMR study and conformational insights. Amino Acids. 2010 Jul;39(2):539-48. Epub 2010 Jan 2"
9711,"DB00047","BE0000033","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Le Roith D: Insulin glargine and receptor-mediated signalling: clinical implications in treating t"
9712,"DB02127","BE0004036","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9713,"DB07947","BE0003761","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9714,"DB05364","BE0002471",""
9715,"DB00157","BE0000161","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9716,"DB08679","BE0001594","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9717,"DB04396","BE0004493","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9718,"DB00540","BE0004872","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Oct 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from: http://pdsp.med.unc.edu/pdsp.php# Brunton L, Chabner B, Knollman B. Goodman and Gilman?s The "
9719,"DB00334","BE0000476","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
9720,"DB00102","BE0000205","# Papanas N, Maltezos E: Becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Clin Interv Aging. 2008;3(2):233-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18686746"
9721,"DB00043","BE0000015","# Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S: Omalizumab-induced reductions in mast cell Fce psilon RI expression and function. J Allergy Clin Immunol. 2004 Sep;114(3):527-30. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15356552# Mirkina I, Sch"
9722,"DB02492","BE0003505","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9723,"DB04940","BE0000026","# Dabydeen DA, Burnett JC, Bai R, Verdier-Pinard P, Hickford SJ, Pettit GR, Blunt JW, Munro MH, Gussio R, Hamel E: Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed bind"
9724,"DB04505","BE0001120","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9725,"DB02746","BE0001336","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9726,"DB04041","BE0001904","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9727,"DB00165","BE0000042","# Adams JB, George F, Audhya T: Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements. J Altern Complement Med. 2006 Jan-Feb;12(1):59-63. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
9728,"DB06637","BE0004502","# Judge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16472864"
9729,"DB00241","BE0002341","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
9730,"DB01942","BE0002652","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9731,"DB03499","BE0001750","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9732,"DB01892","BE0000956","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9733,"DB03881","BE0000250","# Shi W, Ting LM, Kicska GA, Lewandowicz A, Tyler PC, Evans GB, Furneaux RH, Kim K, Almo SC, Schramm VL: Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem. 2004 Apr 3"
9734,"DB00114","BE0002149","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9735,"DB00193","BE0000420","# Wentland MP, Lou R, Lu Q, Bu Y, VanAlstine MA, Cohen DJ, Bidlack JM: Syntheses and opioid receptor binding properties of carboxamido-substituted opioids. Bioorg Med Chem Lett. 2009 Jan 1;19(1):203-8. Epub 2008 Nov 7. \"Pubmed\":http://www.ncbi.nlm.nih.gov"
9736,"DB08488","BE0000216","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9737,"DB04746","BE0003358",""
9738,"DB01406","BE0000472","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9739,"DB08889","BE0004737","# FDA label# Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ: Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclin"
9740,"DB00262","BE0004796","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Johannessen TC, Bjerkvig R, Tysnes BB: DNA repair and cancer "
9741,"DB04874","BE0004796",""
9742,"DB08392","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9743,"DB07303","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9744,"DB04233","BE0003980","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9745,"DB02726","BE0000088","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9746,"DB03147","BE0001720","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9747,"DB00123","BE0000052","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9748,"DB04099","BE0001332","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9749,"DB00716","BE0000296","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9750,"DB01084","BE0000442","# Sharif NA, Su SX, Yanni JM: Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies. J Ocul Pharmacol. 1994 Winter;10(4):653-64. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pu"
9751,"DB01813","BE0002016","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9752,"DB05226","BE0000686",""
9753,"DB00157","BE0000100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9754,"DB01483","BE0000381","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Mehta AK, Ticku MK: An update on GABAA "
9755,"DB00334","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Poyurovsky M, Pashinian A, Levi A, Weizman R, Weizman A: The effect of betahistine, a histamine H1"
9756,"DB04277","BE0001752","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9757,"DB04141","BE0003855","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9758,"DB00714","BE0000572","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
9759,"DB06274","BE0000770","# Kraft MD: Emerging pharmacologic options for treating postoperative ileus. Am J Health Syst Pharm. 2007 Oct 15;64(20 Suppl 13):S13-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17909271# Buchler MW, Seiler CM, Monson JR, Flamant Y, Thompson-Fawcett MW"
9760,"DB04127","BE0001628","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9761,"DB08097","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9762,"DB00157","BE0000617","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9763,"DB04481","BE0001620","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9764,"DB02659","BE0001033","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9765,"DB02701","BE0001241","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9766,"DB01708","BE0003848","# Kohalmy K, Tamasi V, Kobori L, Sarvary E, Pascussi JM, Porrogi P, Rozman D, Prough RA, Meyer UA, Monostory K: Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos. 2007 Sep;35(9):1495-501. Epub 2007"
9767,"DB00185","BE0000092","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9768,"DB00999","BE0000322","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9769,"DB03496","BE0000890","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9770,"DB04396","BE0001939","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9771,"DB04272","BE0003272",""
9772,"DB03461","BE0000909","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9773,"DB05260","BE0000724","# Jenis LG, Waud CE, Stein GS, Lian JB, Baran DT: Effect of gallium nitrate in vitro and in normal rats. J Cell Biochem. 1993 Jul;52(3):330-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8366144# Guidon PT Jr, Salvatori R, Bockman RS: Gallium nitrate regu"
9774,"DB00157","BE0000376","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9775,"DB04799","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9776,"DB04343","BE0001689","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9777,"DB00836","BE0000770","# DeHaven-Hudkins DL, Burgos LC, Cassel JA, Daubert JD, DeHaven RN, Mansson E, Nagasaka H, Yu G, Yaksh T: Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J Pharmacol Exp Ther. 1999 Apr;289(1):494-502. \"Pubmed\":http:/"
9778,"DB00370","BE0000647","# Fernandez J, Alonso JM, Andres JI, Cid JM, Diaz A, Iturrino L, Gil P, Megens A, Sipido VK, Trabanco AA: Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents. J Med Chem. 2005 Mar 24;48(6):1709-12. \"Pub"
9779,"DB00753","BE0004797","# \"ChEMBL Compound Report Card\":https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256 (Accessed December 2013)"
9780,"DB01702","BE0003806","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9781,"DB04028","BE0001295","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9782,"DB00850","BE0000418","# Mongin AA, Cai Z, Kimelberg HK: Volume-dependent taurine release from cultured astrocytes requires permissive [Ca(2+)](i) and calmodulin. Am J Physiol. 1999 Oct;277(4 Pt 1):C823-32. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10516112# Kawai M, Nakashim"
9783,"DB00694","BE0004796","# Aubel-Sadron G, Londos-Gagliardi D: Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 1984 May;66(5):333-52. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6380596# Zunino F, Capranico G: DNA topoi"
9784,"DB04597","BE0003288",""
9785,"DB07916","BE0000444","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9786,"DB01848","BE0001249","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9787,"DB02923","BE0003955","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9788,"DB07778","BE0003861","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9789,"DB00398","BE0000023","# Lathia C, Lettieri J, Cihon F, Gallentine M, Radtke M, Sundaresan P: Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics. Cancer Chemother Pharmacol. 2006 May;57(5):685-92. Epub 2005 Aug 25. \"Pubmed\":http://ww"
9790,"DB00897","BE0003595","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9791,"DB08024","BE0000854","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9792,"DB07252","BE0002453","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9793,"DB04510","BE0004462","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9794,"DB04837","BE0000442","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9795,"DB04646","BE0003907","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9796,"DB04312","BE0000465","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9797,"DB07229","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9798,"DB08573","BE0001358","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9799,"DB04487","BE0000934","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9800,"DB00184","BE0000519","# FAHMY AR, RYMAN BE, WALSH EO: The inhibition of choline acetylase by nicotine. J Pharm Pharmacol. 1954 Sep;6(9):607-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/13192619"
9801,"DB04077","BE0000814","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9802,"DB01576","BE0000647","# Zhen J, Chen N, Reith ME: Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates. Neuropharmacology. 2005 Nov;49(6):769-79. Epub 2005 Aug 24. \"Pubm"
9803,"DB00162","BE0000255","# Qtaishat NM, Wiggert B, Pepperberg DR: Interphotoreceptor retinoid-binding protein (IRBP) promotes the release of all-trans retinol from the isolated retina following rhodopsin bleaching illumination. Exp Eye Res. 2005 Oct;81(4):455-63. Epub 2005 Jun 2."
9804,"DB01006","BE0002090","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Ebert AD, Bartley J, David M, Schweppe KW: [Aromatase inhibitors--theoretical concept and present "
9805,"DB03389","BE0002766",""
9806,"DB00593","BE0000483","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Gomora JC, Daud AN, Weiergraber M, Perez-Reyes E: Block of cloned human T-type calcium channels by"
9807,"DB00656","BE0000442","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Richelson E, Nelson A: Antagonism by antidepressants of neurotransmitter receptors of normal human"
9808,"DB01189","BE0000484","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9809,"DB00777","BE0000020","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9810,"DB06771","BE0000429","# Carter NJ, Scott LJ: Besifloxacin ophthalmic suspension 0.6%. Drugs. 2010;70(1):83-97. doi: 10.2165/11203820-000000000-00000. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20030427"
9811,"DB00391","BE0000581","# Lipina TV, Vishnivetskaia GB: [Effect of sulpiride on immobility reflex and pinch-induced catalepsy in CBA/Lac male mice with various social status] Zh Vyssh Nerv Deiat Im I P Pavlova. 2009 Jul-Aug;59(4):482-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubme"
9812,"DB04442","BE0001739","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9813,"DB02379","BE0001539","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9814,"DB07301","BE0003803","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9815,"DB01809","BE0002411","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9816,"DB00842","BE0000381","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9817,"DB00493","BE0004335","# Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7447421"
9818,"DB04473","BE0002816",""
9819,"DB00608","BE0002659","# Hiller N, Fritz-Wolf K, Deponte M, Wende W, Zimmermann H, Becker K: Plasmodium falciparum glutathione S-transferase--structural and mechanistic studies on ligand binding and enzyme inhibition. Protein Sci. 2006 Feb;15(2):281-9. Epub 2005 Dec 29. \"Pubmed"
9820,"DB00905","BE0000064","# Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX: Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther. "
9821,"DB01267","BE0002638","# Gunes A, Spina E, Dahl ML, Scordo MG: ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. Ther Drug Monit. 2008 Oct;30(5):628-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18708991"
9822,"DB08156","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9823,"DB01016","BE0000644","# Pondugula SR, Raveendran NN, Ergonul Z, Deng Y, Chen J, Sanneman JD, Palmer LG, Marcus DC: Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiol Genomics. 20"
9824,"DB07474","BE0000858","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9825,"DB00897","BE0000764","# Mohler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002 Jan;300(1):2-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752090# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and phar"
9826,"DB00151","BE0000153","# Jin HF, DU SX, Zhao X, Zhang SQ, Tian Y, Bu DF, Tang CS, DU JB: [Significance of endogenous sulfur dioxide in the regulation of cardiovascular system] Beijing Da Xue Xue Bao. 2007 Aug 18;39(4):423-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17657274#"
9827,"DB04640","BE0003892","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9828,"DB03769","BE0001684","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9829,"DB03708","BE0003094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9830,"DB04646","BE0003908","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9831,"DB05157","BE0001019",""
9832,"DB01766","BE0003739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9833,"DB00845","BE0000620","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9834,"DB04069","BE0001776","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9835,"DB00866","BE0000694","# Brodde OE, Wang XL, O'Hara N, Daul A, Schiess W: Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes. J Cardiovasc Pharmacol. 1986;8 Suppl 6:S70-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2"
9836,"DB04147","BE0003954","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9837,"DB07378","BE0000214","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9838,"DB00339","BE0004848","# Zimhony O, Cox JS, Welch JT, Vilcheze C, Jacobs WR Jr: Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis. Nat Med. 2000 Sep;6(9):1043-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10973326# Ngo SC, Z"
9839,"DB01875","BE0001313","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9840,"DB02128","BE0001292","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9841,"DB07915","BE0003969","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9842,"DB06876","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9843,"DB00142","BE0000721","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9844,"DB07796","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9845,"DB00655","BE0000123","# Margeat E, Bourdoncle A, Margueron R, Poujol N, Cavailles V, Royer C: Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta. J Mol Biol. 2003 Feb 7;326(1):77-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubm"
9846,"DB00363","BE0000342","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
9847,"DB06868","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9848,"DB04076","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9849,"DB01142","BE0000945","# Roth, BL; Driscol, J (12 January 2011). PDSP Ki Database. Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 20 October 2013."
9850,"DB07381","BE0001498","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9851,"DB08008","BE0000382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9852,"DB01050","BE0000017","# Chavez ML, DeKorte CJ: Valdecoxib: a review. Clin Ther. 2003 Mar;25(3):817-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12852704# Patrignani P: Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease. Thromb Res. 2003 Jun 15;110(5-6):28"
9853,"DB04382","BE0001421","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9854,"DB00666","BE0000203","# Barbieri RL: Comparison of the pharmacology of nafarelin and danazol. Am J Obstet Gynecol. 1990 Feb;162(2):581-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2137975# Suh J, Lee E, Hwang S, Yoon S, Yoon BK, Bae D, Choi D: Dose of GnRH agonist (nafarelin"
9855,"DB01925","BE0001308","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9856,"DB04447","BE0004076","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9857,"DB03758","BE0004331","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9858,"DB03389","BE0003073",""
9859,"DB03095","BE0001521","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9860,"DB08860","BE0000574","# Morgan RE, Campbell SE, Yu CY, Sponseller CA, Muster HA: Comparison of the safety, tolerability, and pharmacokinetic profile of a single oral dose of pitavastatin 4 mg in adult subjects with severe renal impairment not on hemodialysis versus healthy adu"
9861,"DB03057","BE0002015","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9862,"DB02138","BE0001535","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9863,"DB01645","BE0000871","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9864,"DB02280","BE0001286","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9865,"DB03147","BE0000298","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9866,"DB08776","BE0003382","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9867,"DB03288","BE0000007","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9868,"DB08648","BE0001491","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9869,"DB06838","BE0000048","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9870,"DB00215","BE0000501","# Bareggi SR, Mundo E, Dell'Osso B, Altamura AC: The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):741-53. \"Pubmed\":http://www.ncbi.nlm.n"
9871,"DB00473","BE0000197","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9872,"DB02379","BE0002078","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9873,"DB07089","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9874,"DB07333","BE0000369","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9875,"DB00451","BE0000315","# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17016423# Marazuela M, Nattero L, Moure D, Garcia-Polo I, Figueroa-Vega"
9876,"DB05240","BE0002379",""
9877,"DB05408","BE0001162",""
9878,"DB07763","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9879,"DB02873","BE0001019","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9880,"DB06711","BE0000289","# Piletz JE, Zhu H, Chikkala DN: Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther. 1996 Nov;279(2):694-702. \"Pubmed\":http://www.ncbi.nlm.nih.go"
9881,"DB04199","BE0004114","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9882,"DB02379","BE0002737",""
9883,"DB07383","BE0003531","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9884,"DB00306","BE0000849","# Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11264449# Arias HR, Bhumireddy P: Anesthetics as "
9885,"DB05147","BE0000143",""
9886,"DB07272","BE0003790","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9887,"DB00626","BE0000910","# Maxfield FR, Davies PJ, Klempner L, Willingham MC, Pastan I: Epidermal growth factor stimulation of DNA synthesis is potentiated by compounds that inhibit its clustering in coated pits. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5731-5. \"Pubmed\":http://w"
9888,"DB03983","BE0002927","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9889,"DB07921","BE0001198","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9890,"DB00073","BE0000066","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# van Meerten T, Hagenbeek A: CD20-targeted therapy: the next generation of antibodies. Semin Hemato"
9891,"DB04464","BE0000335","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9892,"DB00514","BE0000420","# Codd EE, Shank RP, Schupsky JJ, Raffa RB: Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995 Sep;274(3):1263-70. \"Pubmed\":http://www.ncb"
9893,"DB05014","BE0001104",""
9894,"DB02772","BE0002835",""
9895,"DB03390","BE0001102","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9896,"DB04077","BE0001737","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9897,"DB01558","BE0000471","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456"
9898,"DB06042","BE0002425",""
9899,"DB04395","BE0004549","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9900,"DB00714","BE0000291","# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18691132"
9901,"DB07209","BE0000215","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9902,"DB04411","BE0001493","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9903,"DB00909","BE0003631","# De Simone G, Scozzafava A, Supuran CT: Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des. 2009 Sep;74(3):317-21. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19703035# Supuran CT, Di Fiore A, De S"
9904,"DB08093","BE0001019","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9905,"DB01080","BE0000253","# Weber OM, Verhagen A, Duc CO, Meier D, Leenders KL, Boesiger P: Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. Magn Reson Imaging. 1999 Apr;17(3):41"
9906,"DB00268","BE0000389","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agon"
9907,"DB02515","BE0001540","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9908,"DB00714","BE0000145","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agon"
9909,"DB01026","BE0000132","# Eil C: Ketoconazole binds to the human androgen receptor. Horm Metab Res. 1992 Aug;24(8):367-70. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1526623"
9910,"DB08182","BE0003734","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9911,"DB04233","BE0003972","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9912,"DB00244","BE0004655","# Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol. 2000 Dec;95(12):3452-7. \"Pubmed\":http://www.ncb"
9913,"DB04260","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9914,"DB07401","BE0000938","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9915,"DB07765","BE0003983","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9916,"DB01692","BE0001270","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9917,"DB08650","BE0004365","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9918,"DB06204","BE0000486","# Tzschentke TM, Christoph T, Kogel B, Schiene K, Hennies HH, Englberger W, Haurand M, Jahnel U, Cremers TI, Friderichs E, De Vry J: (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor "
9919,"DB00052","BE0000345","# Keeler C, Jablonski EM, Albert YB, Taylor BD, Myszka DG, Clevenger CV, Hodsdon ME: The kinetics of binding human prolactin, but not growth hormone, to the prolactin receptor vary over a physiologic pH range. Biochemistry. 2007 Mar 6;46(9):2398-410. Epub"
9920,"DB04996","BE0004796",""
9921,"DB04817","BE0000017","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352"
9922,"DB00078","BE0002100","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9923,"DB07972","BE0004059","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9924,"DB00056","BE0001529","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9925,"DB03997","BE0001396","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9926,"DB00056","BE0002099","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9927,"DB08453","BE0003859","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9928,"DB00408","BE0000289","# National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Aug 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from:http://pdsp.med.unc.edu/pdsp.php"
9929,"DB07900","BE0001182","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9930,"DB04912","BE0000735","# Drummond GS, Kappas A: Chemoprevention of severe neonatal hyperbilirubinemia. Semin Perinatol. 2004 Oct;28(5):365-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15686268# Cannon JB, Martin C, Drummond GS, Kappas A: Targeted delivery of a heme oxygenase "
9931,"DB02810","BE0001486","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9932,"DB04395","BE0002079","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9933,"DB00074","BE0002096","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9934,"DB07574","BE0001275","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9935,"DB03670","BE0000623","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9936,"DB04216","BE0001424","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9937,"DB00835","BE0000442","# Bokesoy TA, Onaran HO: Atypical Schild plots with histamine H1 receptor agonists and antagonists in the rabbit aorta. Eur J Pharmacol. 1991 May 2;197(1):49-56. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1680053# Onaran HO, Bokesoy TA: Kinetics of antag"
9938,"DB00847","BE0002419","# Li W, Hexum TD: Cysteamine selectively enhances neuropeptide Y2 receptor binding activity. Biochem Biophys Res Commun. 1992 Apr 15;184(1):380-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1314592"
9939,"DB08180","BE0002373","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9940,"DB04016","BE0001038","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9941,"DB03159","BE0001739","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9942,"DB00456","BE0001358","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9943,"DB02714","BE0003317","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9944,"DB03928","BE0000791","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9945,"DB06148","BE0000393","# Roth, BL; Driscol, J (12 January 2011). \"PDSP Ki Database\". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 13 October 2013."
9946,"DB03029","BE0001248","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9947,"DB08700","BE0000915","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9948,"DB00831","BE0000666","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Seeman P, Lee T, Chau-Wong M, Wong K: Antipsychotic drug doses and neuroleptic/dopamine receptors."
9949,"DB01567","BE0002345","# Nakatsuka I, Shimizu H, Asami Y, Katoh T, Hirose A, Yoshitake A: Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. Life Sci. 1985 Jan 14;36(2):113-9. \"Pubmed\":http:/"
9950,"DB00332","BE0000560","# Wellington K: Ipratropium bromide HFA. Treat Respir Med. 2005;4(3):215-20; discussion 221-2. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15987237"
9951,"DB00033","BE0000711","# Matsuda A, Ebihara N, Kumagai N, Fukuda K, Ebe K, Hirano K, Sotozono C, Tei M, Hasegawa K, Shimizu M, Tamari M, Namba K, Ohno S, Mizuki N, Ikezawa Z, Shirakawa T, Hamuro J, Kinoshita S: Genetic polymorphisms in the promoter of the interferon gamma recep"
9952,"DB00217","BE0004872","# Hart GR, Anderson RJ: Withdrawal syndromes and the cessation of antihypertensive therapy. Arch Intern Med. 1981 Aug;141(9):1125-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/6114720# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Aci"
9953,"DB03147","BE0000067","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9954,"DB00768","BE0003602","# Okada M, Tokumitsu H, Kubota Y, Kobayashi R: Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein. Biochem Biophys Res Commun. 2002 Apr 12;292(4):"
9955,"DB03801","BE0002483",""
9956,"DB00534","BE0000502","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9957,"DB03297","BE0003048",""
9958,"DB00103","BE0004830","# Schaefer RM, Tylki-Szymanska A, Hilz MJ: Enzyme replacement therapy for Fabry disease: a systematic review of available evidence. Drugs. 2009 Nov 12;69(16):2179-205. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/19852524# El Dib RP, Pastores GM: Enzyme re"
9959,"DB07387","BE0003844","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9960,"DB07177","BE0003560","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9961,"DB03424","BE0001395","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9962,"DB03471","BE0001640","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9963,"DB00744","BE0000248","# Wenzel SE: Leukotriene receptor antagonists and related compounds. Can Respir J. 1999 Mar-Apr;6(2):189-93. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10322101# Hardy DB, Pereria LE, Yang K: Prostaglandins and leukotriene B4 are potent inhibitors of 11b"
9964,"DB00824","BE0000241","# Holgate ST: The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma. Br J Pharmacol. 2005 Aug;145(8):1009-15. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15980878# Chen X, Ji ZL, Chen YZ"
9965,"DB07551","BE0003850","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9966,"DB06262","BE0000289","# Davis MP: Recent advances in the treatment of pain. F1000 Med Rep. 2010 Aug 19;2:63. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21173850# Giovannoni MP, Ghelardini C, Vergelli C, Dal Piaz V: Alpha2-agonists as analgesic agents. Med Res Rev. 2009 Mar;29"
9967,"DB07596","BE0000322","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9968,"DB00803","BE0004833","# Vaara M: Polymyxins and their novel derivatives. Curr Opin Microbiol. 2010 Oct;13(5):574-81. Epub 2010 Sep 24. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20869908# Soon RL, Nation RL, Cockram S, Moffatt JH, Harper M, Adler B, Boyce JD, Larson I, Li J: "
9969,"DB02800","BE0001906","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9970,"DB00704","BE0000290","# Helm S, Trescot AM, Colson J, Sehgal N, Silverman S: Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification. Pain Physician. 2008 Mar-Apr;11(2):225-35. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18354714"
9971,"DB05205","BE0002198",""
9972,"DB01954","BE0000487","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9973,"DB05017","BE0000918",""
9974,"DB02379","BE0002490",""
9975,"DB07297","BE0000842","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9976,"DB02793","BE0002649",""
9977,"DB03147","BE0002616",""
9978,"DB03652","BE0002672",""
9979,"DB07364","BE0000890","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9980,"DB07737","BE0000988","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9981,"DB04786","BE0000387","# McGeary RP, Bennett AJ, Tran QB, Cosgrove KL, Ross BP: Suramin: clinical uses and structure-activity relationships. Mini Rev Med Chem. 2008 Nov;8(13):1384-94. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18991754# Bose CK: Follicle stimulating hormone re"
9982,"DB02494","BE0003832","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9983,"DB02266","BE0000132","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9984,"DB03247","BE0003026",""
9985,"DB04946","BE0000756","# Kongsamut S, Roehr JE, Cai J, Hartman HB, Weissensee P, Kerman LL, Tang L, Sandrasagra A: Iloperidone binding to human and rat dopamine and 5-HT receptors. Eur J Pharmacol. 1996 Dec 19;317(2-3):417-23. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8997630"
9986,"DB05351","BE0000349",""
9987,"DB08278","BE0001478","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9988,"DB00075","BE0002094","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9989,"DB00752","BE0002196","# Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11752352# Volz HP, Gleiter CH: Monoamine oxidase inhibitors. A perspective on their use in the elderly. Drug"
9990,"DB04335","BE0000250","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9991,"DB03359","BE0000426","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9992,"DB00231","BE0003597","# Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008 Aug;118(2):69-86. Epub 2008 Mar 31. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/18384456# Giersch A, Boucart M, Elliott M, Vidai"
9993,"DB02821","BE0000424","# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17139284# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of d"
9994,"DB00363","BE0000650","# Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17848919"
9995,"DB01373","BE0003566","# Martin SR, Avella G, Adrover M, de Nicola GF, Bullard B, Pastore A: Binding Properties of the Calcium-Activated F2 Isoform of Lethocerus Troponin C. Biochemistry. 2011 Feb 10. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/21250664# Kreutziger KL, Piroddi "
9996,"DB08915","BE0003728","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9997,"DB00970","BE0004951","# Felix CA, Hosler MR, Winick NJ, Masterson M, Wilson AE, Lange BJ: ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood. 1995 Jun 1;85(11):3250-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7756657"
9998,"DB08077","BE0000130","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
9999,"DB03461","BE0003124",""
10000,"DB07690","BE0004054","# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10592235"
